ID	Species	ncRNA	ncRNA type	Environmental factor (EF)	Phenotype	Sample	Condition of EF	Evidence	PubMed ID
1	Mouse	mmu-let-7	miRNA	high tidal volume ventilation (HVTV)	lung injury	lung tissues	high tidal volume ventilation (HVTV) treatment	upregulated	22659882
2	Mouse	mmu-let-7	miRNA	"hexahydro-1,3,5-trinitro-1,3,5-triazine (RDX)"	tumorigenesis	brain and liver tissue cells	"hexahydro-1,3,5-trinitro-1,3,5-triazine (RDX) treatment"	downregulated	19270793
3	Mouse	mmu-let-7	miRNA	morphine	contractility of  vascular smooth muscle cells	brain tissues	morphine treatment	morphine significantly upregulated let-7 expression in SH-SY5Y cells and in a mouse model of opioid tolerance.	20668208
4	Mouse	mmu-let-7	miRNA	antifibrotic peptide N-acetyl-seryl-aspartyl-lysyl-proline (AcSDKP)	diabetic nephropathy (DN)	diabetic CD-1 mice	antifibrotic peptide N-acetyl-seryl-aspartyl-lysyl-proline (AcSDKP) treatment	upregulated	24783220
5	Mouse	mmu-let-7	miRNA	synthetic preimplantation factor (sPIF)	duchenne muscular dystrophy (DMD)	myoblast	Synthetic preimplantation factor (sPIF) treatment	downregulated	30692507
6	Mouse	mmu-let-7	miRNA	concanamycin A (Con A)	hepatitis	mice liver tissues	con A infection	upregulated	23184091
7	Mouse	mmu-let-7	miRNA	Staphylococcus aureus	inflammation	mouse mammary tissue	intramammary infection of Globally Staphylococcus aureus treatment	differently regulated	25075227
8	Mouse	mmu-let-7	miRNA	maternal H. bakeri	maternal H. bakeri infection	brain tissues	maternal protein deficiency and/or nematode infection	upregulated in the developing fetal brain	28903026
9	Mouse	mmu-let-7	miRNA	lipopolysaccharide (LPS)	regeneration of the intestinal epithelia	intestinal tissues	lipopolysaccharide (LPS) treatment	downregulated	29621481
10	Mouse	mmu-let-7a	miRNA	high fat diet (HFD)	acute myocardial infarction (AMI)	liver tissue	high fat diet (HFD) feed	downregulated	19835573
11	Mouse	mmu-let-7a	miRNA	ethanol (EtOH)	alcoholic liver disease (ALD)	mouse mouse liver	ethanol treatment	downregulated in mouse liver	28536261
12	Mouse	mmu-let-7a	miRNA	alcohol	alcoholic liver disease (ALD)	liver tissues	alcohol exposure	downregulated	31734308
13	Mouse	mmu-let-7a	miRNA	ethanol (EtOH)	alcoholic liver disease (ALD)	mice hepatocytes	EtOH treatment	downregulated	31734308
14	Mouse	mmu-let-7a	miRNA	folate	apoptosis	mouse embryonic stem cells (mESCs)	folate deficiency induced	upregulated	22828209
15	Mouse	mmu-let-7a	miRNA	blast	blast traumatic brain injury (bTBI)	Balb/c mice	blast treatment	dysregulated	29020847
16	Mouse	mmu-let-7a	miRNA	diethylnitrosamine (DEN)	chronic cholestasis and cholangiocarcinoma	liver tissues	diethylnitrosamine (DEN) treatment	downregulated	21440549
17	Mouse	mmu-let-7a	miRNA	estradiol	embryo implantation	mouse dormant blastocysts	estradiol treatment	downregulated	24419497
18	Mouse	mmu-let-7a	miRNA	calcitonin (CT)	endometrial receptivity	uterine tissue	calcitonin (CT) treatment	upregulated	30536902
19	Mouse	mmu-let-7a	miRNA	calcitonin (CT)	endometrial receptivity	uterine tissue samples	calcitonin (CT) treatment	CT injection increased the expression of LIF and miRNA Let-7a in ovarian stimulation similar to that in normal ovarian cycles.	30536902
20	Mouse	mmu-let-7a	miRNA	dichloroacetate (DCA)	energy metabolism	MDA-MB-231 cells	dichloroacetate (DCA) treatment	upregulated	32248711
21	Mouse	mmu-let-7a	miRNA	gold nanoparticles (AuNPs)	epithelial-mesenchymal transition and peritoneal fibrosis	liver and lung of mouse fetuses	gold nanoparticles (AuNP) treatment	upregulated	24004569
22	Mouse	mmu-let-7a	miRNA	honeysuckle (HS)	enterovirus 71 (EV71) infection	brain tissues	Honeysuckle treatment	"Moreover, honeysuckle-induced?let-7a?suppression of EV71 RNA and protein expression as well as viral replication were investigated both in vitro and in vivo."	33669264
23	Mouse	mmu-let-7a	miRNA	lipopolysaccharide (LPS)	inflammation	"Kupffer cells, RAW264.7 cells"	lipopolysaccharide (LPS) treatment	let-7a regulates LPS-induced inflammatory responses by targeting TLR4.	31344555
24	Mouse	mmu-let-7a	miRNA	Japanese Encephalitis virus (JEV)	Japanese Encephalitis virus (JEV) infection	mouse neuronal (Neuro2a) cells or primary cortical neurons	Japanese Encephalitis virus (JEV) infection	upregulated	30556910
25	Mouse	mmu-let-7a	miRNA	hypoxia	melanoma	Mouse melanoma B16-F0 cells	hypoxia induce	downregulated	30872795
26	Mouse	mmu-let-7a	miRNA	hypoxia	melanoma	Mouse melanoma B16-F0 cell exosomes	hypoxia induce	upregulated	30872795
27	Mouse	mmu-let-7a	miRNA	ethanolic extract of an herbal formula comprising Sophorae Flos and Lonicerae Japonicae Flos (SLE)	metastasized melanoma	"B16F10 melanoma tissues, B16F10 melanoma lung metastasis in mice"	SLE treatment	upregulated	31514083
28	Mouse	mmu-let-7a	miRNA	coronary artery ligation	myocardial ischaemic injury	heart	subjected to coronary artery ligation	downregulated	26655604
29	Mouse	mmu-let-7a	miRNA	sevoflurane (SEV)	neurodegeneration (ND)	mouse embryonic stem cells (mESCs)	sevoflurane treatment	upregulated	27022747
30	Mouse	mmu-let-7a	miRNA	lipopolysaccharide (LPS)	osteoarthritis (OA)	ATDC5 cells	lipopolysaccharide (LPS) treatment	upregulated	31322277
31	Mouse	mmu-let-7a	miRNA	¦Á-Synuclein (¦Á-Syn)	parkinson's disease (PD)	PD mice substantia nigra pars compacta (SNpc) or BV-2 microglia cells in vitro	¦Á-Synuclein (¦Á-Syn) treatment	downregulated	31547989
32	Mouse	mmu-let-7a	miRNA	plasmodium chabaudi malaria	peak parasitemia	liver of mice	Plasmodium chabaudi malaria infection treatment	downregulated	21085987
33	Mouse	mmu-let-7a	miRNA	testosterone	prostate cancer	female mouse liver	Testosterone treatment	"upregulation of the 6 miRNAs miR-22, miR-690, miR-122, let-7A, miR-30D and let-7D"	20600201
34	Mouse	mmu-let-7a	miRNA	arsenite	lung fibrosis	murine bone marrow-derived macrophages (BMDMs)	arsenic (As) exposure	downregulated of H19 or upregulated of let-7a reversed the arsenite-induced M2 polarization of macrophages.	33162208
35	Mouse	mmu-let-7a	miRNA	arsenite	lung fibrosis	lung tissues; bone marrow-derived macrophages (BMDMs)	arsenite exposure	downregulated	33162208
36	Mouse	mmu-let-7a	miRNA	laparotomy and exposure of the junc_x0002_tion between the large and small intestines	sepsis	mouse large and small intestines	laparotomy and exposure of the junc_x0002_tion between the large and small intestines treatment	downregulated	25043848
37	Mouse	mmu-let-7a	miRNA	social defeat stress	sex differences of social defeat stress	female mice	social defeat stress treatment	upregulated	33358922
38	Mouse	mmu-let-7a	miRNA	fludrocortisone	uterine receptivity	epithelial endometrium	fludrocortisone treatment	upregulated	30968418
39	Mouse	mmu-let-7a	miRNA	bone morphogenetic protein 2 (BMP2)	chondrogenesis	Mouse embryonic fibroblasts (MEFs)	bone morphogenetic protein 2 (BMP2) treatment	upregulated	23519980
40	Mouse	mmu-let-7a-1-3p	miRNA	chronic unpredictable mild stress (CUMS)	major depressive disorder (MDD)	nucleus accumbens (NAc) tissues	chronic unpredictable mild stress (CUMS) induce	upregulated	30936699
41	Mouse	mmu-let-7a-1-3p	miRNA	dexmedetomidine (DEX)	spinal cord ischemia/reperfusion injury (SCII)	hypoxia-induced isolated activated microglia from SCIRI mice	dexamethasone (DEX) treatment	upregulated	31190218
42	Mouse	mmu-let-7a-1-3p	miRNA	oxygen-glucose deprivation and reoxygenation (OGD/R)	spinal cord ischemia/reperfusion injury (SCII)	isolated activated microglia from SCIRI mice	oxygen-glucose deprivation and reoxygenation (OGD/R) treatment	downregulated	31190218
43	Mouse	mmu-let-7a-2-3p	miRNA	dexmedetomidine (DEX)	spinal cord ischemia/reperfusion injury (SCII)	hypoxia-induced isolated activated microglia from SCIRI mice	dexamethasone (DEX) treatment	upregulated	31190218
44	Mouse	mmu-let-7a-2-3p	miRNA	oxygen-glucose deprivation and reoxygenation (OGD/R)	spinal cord ischemia/reperfusion injury (SCII)	isolated activated microglia from SCIRI mice	oxygen-glucose deprivation and reoxygenation (OGD/R) treatment	downregulated	31190218
45	Mouse	mmu-let-7a-5p	miRNA	¦¤9-tetrahydrocannabinol (THC)	acute respiratory distress syndrome (ARDS)	lung-infiltrated mononuclear cells (MNCs)	¦¤9Tetrahydrocannabinol (THC) treatment	downregulated	32612530
46	Mouse	mmu-let-7a-5p	miRNA	house dust mite (HDM)	asthma	C57BL/6J mice airway-secreted EVs (AEVs) were isolated from bronchoalveolar lavage fluid (BALF)	HDM treatment	dysregulated in airway-secreted EVs (AEVs) were isolated from bronchoalveolar lavage fluid (BALF)	28859242
47	Mouse	mmu-let-7a-5p	miRNA	anoxia/reoxygenation (A/R)	cardiovascular disease (CVD)	primary cardiomyocytes	anoxia/reoxygenation (A/R) treatment	downregulated	31894303
48	Mouse	mmu-let-7a-5p	miRNA	tumor necrosis factor alpha (TNF-¦Á) 	catecholamine resistance	Adipocytes differentiated from 3T3-L1 preadipocytes	tumor necrosis factor alpha (TNF-¦Á) treatment	downregulated	30933434
49	Mouse	mmu-let-7a-5p	miRNA	high glucose (HG)	diabetic nephropathy (DN)	renal mesangial cells	high glucose treatment	downregulated	30896854
50	Mouse	mmu-let-7a-5p	miRNA	fluke Fasciola gigantica (FgESPs)	F. gigantica infection	liver tissues	fluke Fasciola gigantica (FgESPs) infection	downregulated	33332355
51	Mouse	mmu-let-7a-5p	miRNA	schistosoma japonicum	liver fibrosis	serum exosomes	S. japonicum infection treatment	downregulated	32443549
52	Mouse	mmu-let-7a-5p	miRNA	lipopolysaccharide (LPS)	inflammation	RAW 264.7 cells	lipopolysaccharide (LPS) treatment	upregulated	32153563
53	Mouse	mmu-let-7a-5p	miRNA	anoxia/reoxygenation (A/R)	myocardial infarction (MI)	Primary cardiomyocyte	anoxia/reoxygenation (A/R) treatment	"Let-7a-5p inhibition enhanced A/R-induced apoptosis, Let-7a-5p inhibits cardiomyocytes death by targeting IGF2BP3."	31894303
54	Mouse	mmu-let-7a-5p	miRNA	Yiqi-Bushen-Tiaozhi (YBT)	nonalcoholic fatty liver disease/nonalcoholic steatohepatitis (NAFLD/NASH)	liver tissues	Yiqi-Bushen-Tiaozhi (YBT) treatment	upregulated	33281601
55	Mouse	mmu-let-7a-5p	miRNA	Vaccination during Crisis of Plasmodium chabaudi Blood-Stage Malaria	plasmodium chabaudi infection	Balb/c Mice liver	infect with Vaccination treatment	downregulated in the Liver	28123381
56	Mouse	mmu-let-7b	miRNA	high fat diet (HFD)	acute myocardial infarction (AMI)	liver tissue	high fat diet (HFD) feed	downregulated	19835573
57	Mouse	mmu-let-7b	miRNA	ethanol (EtOH)	alcoholic liver disease (ALD)	mouse mouse liver	ethanol treatment	downregulated in mouse liver	28536261
58	Mouse	mmu-let-7b	miRNA	blast	blast traumatic brain injury (bTBI)	Balb/c mice	blast treatment	dysregulated	29020847
59	Mouse	mmu-let-7b	miRNA	melatonin	cell proliferation	hippocampus dentate gyrus tissues	melatonin treatment	upregulated	31169197
60	Mouse	mmu-let-7b	miRNA	TGF-¦Â	diabetic nephropathy (DN)	mouse mesangial cells (MMCs)	TGF-¦Â treatment	downregulated	25354942
61	Mouse	mmu-let-7b	miRNA	trans-pellitorine	"fatty acid synthase, fatty acid uptake"	3T3-L1 cells	trans-pellitorine	upregulated	28620299
62	Mouse	mmu-let-7b	miRNA	di(2-ethylhexyl) phthalate (DEHP)	follicular development	ovarian	di(2-ethylhexyl) phthalate (DEHP) treatment	upregulated	29385306
63	Mouse	mmu-let-7b	miRNA	lipopolysaccharide (LPS)	inflammation	RAW 264.7 cells	lipopolysaccharide (LPS) treatment	dysregulated	24792623
64	Mouse	mmu-let-7b	miRNA	lithium (Li)	inflammation	primary cultures and in rat frontal cortex	Lithium?treatment	downregulated	21676127
65	Mouse	mmu-let-7b	miRNA	Japanese Encephalitis virus (JEV)	Japanese Encephalitis virus (JEV) infection	mouse neuronal (Neuro2a) cells or primary cortical neurons	Japanese Encephalitis virus (JEV) infection	upregulated	30556910
66	Mouse	mmu-let-7b	miRNA	epigallocatechin-3-gallate (EGCG)	melanoma	"Mouse melanoma B16, human melanoma Mewo and A375 cells"	Green tea polyphenol (-)-epigallocatechin-3-O-gallate (EGCG) treatment	upregulated	26754091
67	Mouse	mmu-let-7b	miRNA	prion	neurodegeneration (ND)	the brains tissues	prion infection treatment	upregulated	18987751
68	Mouse	mmu-let-7b	miRNA	arsenite	lung fibrosis	lung tissues	arsenite exposure	downregulated	33162208
69	Mouse	mmu-let-7b-5p	miRNA	acetaminophen (APAP)	drug-induced liver injury (DILI)	plasma	acetaminophen (APAP) treatment	upregulated	30125006
70	Mouse	mmu-let-7b-5p	miRNA	aerobic exercise	energy homeostasis	skeletal muscle	aerobic exercise training (AET) treatment	8 wk of aerobic training (Tr) markedly decreased let-7b-5p expression in murine skeletal muscle	32697599
71	Mouse	mmu-let-7b-5p	miRNA	Yiqi-Bushen-Tiaozhi (YBT)	nonalcoholic fatty liver disease/nonalcoholic steatohepatitis (NAFLD/NASH)	liver tissues	Yiqi-Bushen-Tiaozhi (YBT) treatment	upregulated	33281601
72	Mouse	mmu-let-7b-5p	miRNA	bis-enoxacin	osteoclastogenesis	4T1 murine breast cancer cells	bis-enoxacin treatment	downregulated	30385810
73	Mouse	mmu-let-7b-5p	miRNA	enoxacin	osteoclastogenesis	4T1 murine breast cancer cells	Enoxacin treatment	downregulated	30385810
74	Mouse	mmu-let-7b-5p	miRNA	Vaccination during Crisis of Plasmodium chabaudi Blood-Stage Malaria	plasmodium chabaudi infection	Balb/c Mice liver	infect with Vaccination treatment	downregulated in the Liver	28123381
75	Mouse	mmu-let-7c	miRNA	high fat diet (HFD)	acute myocardial infarction (AMI)	liver tissue	high fat diet (HFD) feed	downregulated	19835573
76	Mouse	mmu-let-7c	miRNA	angiotensin II (Ang II)	allergic airway inflammation	murine bone marrow-derived macrophages (BMDMs)	angiotensin II (Ang II) treatment	downregulated	32458348
77	Mouse	mmu-let-7c	miRNA	lipoxin A4 (LXA4)	bronchopulmonary dysplasia (BPD)	mouse lung epithelial cells (MLE-12) cells	"5S,6R-methyl-LXA4 treatment"	upregulated	28819748
78	Mouse	mmu-let-7c	miRNA	lipopolysaccharide (LPS)	chronic obstructive pulmonary disease (COPD)	alveolar macrophages	lipopolysaccharide (LPS) treatment	downregulated	26851791
79	Mouse	mmu-let-7c	miRNA	TGF-¦Â	diabetic nephropathy (DN)	mouse mesangial cells (MMCs)	TGF-¦Â treatment	downregulated	25354942
80	Mouse	mmu-let-7c	miRNA	lipopolysaccharide (LPS)	endometriosis	LPS-induced mouse endometritis tissues	lipopolysaccharide (LPS) treatment	downregulated	30406463
81	Mouse	mmu-let-7c	miRNA	IFN-¦Ã and lipopolysaccharide (LPS)	inflammation	RAW264.7 cells	"LPS , IFN-¦Ã treatment"	downregulated	25215948
82	Mouse	mmu-let-7c	miRNA	metformin (Met)	pancreatic cancer (PC)	human pancreatic cancer cells	metformin treatment	upregulated	22245693
83	Mouse	mmu-let-7c	miRNA	lithium (Li)	inflammation	primary cultures and in rat frontal cortex	Lithium?treatment	downregulated	21676127
84	Mouse	mmu-let-7c-1-3p	miRNA	echinococcus multilocularis metacestodes	echinococcus multilocularis infection	RAW 264.7 cells	E. multilocularis metacestodes treatment	downregulated	30322806
85	Mouse	mmu-let-7c-1-3p	miRNA	E. multilocularis metacestodes	infection and immunity of E. multilocularis	RAW264¡¤7 macrophage cells	E. multilocularis metacestodes for 6 and 12 h treatment	"upregulated (mmu-miR-378d,mmu-miR-155-5p, mmu-miR-146a-5p, mmu-miR-21a-5p , mmu-miR-125a-5p) and downregulated(mmu-miR-1981-5p , mmu-miR-let-7c-1-3p)"	28942753
86	Mouse	mmu-let-7c-1-3p	miRNA	lipopolysaccharide (LPS)	inflammation	RAW264.7 cells	lipopolysaccharide (LPS) treatment	downregulated	32955644
87	Mouse	mmu-let-7c-5p	miRNA	quercetin	chronic inflammatory diseases	LPS-treated murine bone marrow¨Cderived DCs (BMDCs)	quercetin treatment	upregulated	31338984
88	Mouse	mmu-let-7c-5p	miRNA	bilateral surgical destabilization of the medial meniscus (DMM)	osteoarthritis (OA)	male C57BL6 mice	bilateral surgical destabilization of the medial meniscus (DMM) treatment	dysregulated	29255152
89	Mouse	mmu-let-7c-5p	miRNA	Vaccination during Crisis of Plasmodium chabaudi Blood-Stage Malaria	plasmodium chabaudi infection	Balb/c Mice liver	infect with Vaccination treatment	downregulated in the Liver	28123381
90	Mouse	mmu-let-7c-5p	miRNA	oxygen glucose deprivation (OGD)	stroke	microglia	oxygen-glucose deprivation (OGD) treatment	downregulated	25934573
91	Mouse	mmu-let-7c-5p	miRNA	hypoxia	traumatic brain injury (TBI)	Primary mouse microglia	oxygen/glucose deprivation (OGD) treatment	downregulated	29408500
92	Mouse	mmu-let-7c-5p	miRNA	lipopolysaccharide (LPS)	traumatic brain injury (TBI)	Primary mouse microglia	lipopolysaccharides (LPS) treatment	downregulated	29408500
93	Mouse	mmu-let-7d	miRNA	arsenite	atherosclerosis (AS)	liver	arsenic (As) exposure	downregulated	22719926
94	Mouse	mmu-let-7d	miRNA	TGF-¦Â	diabetic nephropathy (DN)	mouse mesangial cells (MMCs)	TGF-¦Â treatment	downregulated	25354942
95	Mouse	mmu-let-7d	miRNA	cyclosporine A (CsA)	nephrotoxicity	mouse kidney	cyclosporine A treatment	upregulated	28414804
96	Mouse	mmu-let-7d	miRNA	berberine (BBR)	obesity	mouse primary preadipocytes isolated from epididymal white adipose tissue (eWAT)	berberine (BBR) treatment	upregulated	31527742
97	Mouse	mmu-let-7d	miRNA	6-hydroxydopamine (6-OHDA)	parkinson's disease (PD)	MN9D Cells	6-hydroxydopamine (6-OHDA) treatment	downregulated	29082467
98	Mouse	mmu-let-7d	miRNA	testosterone	prostate cancer	female mouse liver	Testosterone treatment	"upregulation of the 6 miRNAs miR-22, miR-690, miR-122, let-7A, miR-30D and let-7D"	20600201
99	Mouse	mmu-let-7d	miRNA	bleomycin (BLM)	lung fibrosis	exosomes of broncho-alveolar lavage fluids	bleomycin (BLM) treatment	downregulated	33179861
100	Mouse	mmu-let-7d	miRNA	diesel exhaust particle (DEP)	pulmonary inflammatory response	lung tissues	diesel exhaust particle (DEP) exposure	downregulated	30172002
101	Mouse	mmu-let-7d-3p	miRNA	licochalcone A (LA)	lung cancer	MLE-12 cells	Licochalcone A (lico A) treatment	upregulated	32505917
102	Mouse	mmu-let-7d-5p	miRNA	nonivamide	adipogenesis	3T3©\L1 pre©\adipocytes cells	nonivamide treatment	upregulated	25704235
103	Mouse	mmu-let-7d-5p	miRNA	tanshinone IIA (Tan IIA)	atherosclerosis (AS)	RAW 264.7 cells	Tanshinone IIA (Tan) treatment	upregulated	32337768
104	Mouse	mmu-let-7d-5p	miRNA	schistosoma japonicum	liver fibrosis	serum exosomes	S. japonicum infection treatment	downregulated	32443549
105	Mouse	mmu-let-7d-5p	miRNA	Vaccination during Crisis of Plasmodium chabaudi Blood-Stage Malaria	plasmodium chabaudi infection	Balb/c Mice liver	infect with Vaccination treatment	downregulated in the Liver	28123381
106	Mouse	mmu-let-7e	miRNA	staphylococcal enterotoxin B (SEB)	acute inflammatory lung injury	lung	staphylococcal enterotoxin B treatment	upregulated	25564423
107	Mouse	mmu-let-7e	miRNA	lipopolysaccharide (LPS)	acute lung injury (ALI)	bone marrow-derived macrophages (BMDMs)	lipopolysaccharide (LPS) treatment	LPS-induced microRNA lethal-7e ( let-7e) expression was significantly increased in MK2 -/- macrophages.	29770701
108	Mouse	mmu-let-7e	miRNA	lipopolysaccharide (LPS)	acute lung injury (ALI)	lung tissues and bronchoalveolar lavage fluid (BALF)	lipopolysaccharide (LPS) treatment	upregulated	33392621
109	Mouse	mmu-let-7e	miRNA	lipopolysaccharide (LPS)	cell proliferation	CD11b+ Gr1+ cells sorted from the bone marrow (BM)	lipopolysaccharide (LPS) treatment	upregulated	30221399
110	Mouse	mmu-let-7e	miRNA	lipopolysaccharide (LPS)	immune response	Myeloid-derived suppressor cells (MDSCs)	lipopolysaccharide (LPS) treatment	"let-7e was highly upregulated in the LPS-treated group,"	30221399
111	Mouse	mmu-let-7e	miRNA	smoking	smoking-related interstitial fibrosis (SRIF)	C57 mice circulating	6 months of chronic mainstream smoking exposure treatment	downregulated	22782705
112	Mouse	mmu-let-7e-5p	miRNA	dexamethasone (DEX)	asthma	lung tissues	dexamethasone (Dex) treatment	let-7e-5p was downregulated in the Dex group compared with that in the Model group.	32222886
113	Mouse	mmu-let-7e-5p	miRNA	¦Â-glycerophosphate (¦Â-GP) and pyruvic acid	coronary artery calcification (CAC)	mouse smooth muscle cell line (MOVAS-1)	¦Â-glycerophosphate (¦Â-GP) and pyruvic acid treatment	downregulated	31733402
114	Mouse	mmu-let-7e-5p	miRNA	¦Â-glycerophosphate (¦Â-GP) and pyruvic acid	coronary artery calcification (CAC)	exosomes from mouse vascular smooth muscle cells line MOVAS-1	"To induce calcification, the MOVAS-1 cells were maintained in normal cell culture medium supplied with 10 mM ¦Â-glycerophosphate (¦Â-GP) (Sigma, UK) and 10 nM pyruvic acid for 21 d successively, and the culture medium was renewed every 3 d."	downregulated	31733402
115	Mouse	mmu-let-7e-5p	miRNA	estradiol-17¦Â (E2)	systemic lupus erythematosus (SLE)	murine B cells	estradiol-17¦Â (E2) treatment	downegulated	25912736
116	Mouse	mmu-let-7f	miRNA	ethanol (EtOH)	alcoholic liver injury	mouse	mitochondrial and cellular damage induced by repeated ethanol withdrawal (EW) treatment	upregulated	25406171
117	Mouse	mmu-let-7f	miRNA	metformin (Met)	anti-cancer therapy	mice with 4-months-exposure of smoke	oral metformin was used at a dose of 800 mg/kg diet treatment	upregulated	24683044
118	Mouse	mmu-let-7f	miRNA	high glucose (HG)	diabetic nephropathy (DN)	MPC5 cells	high glucose (HG) treatment	LncRNA MALAT1/microRNA let-7f/KLF5 axis regulates podocyte injury in diabetic nephropathy	33232688
119	Mouse	mmu-let-7f	miRNA	ischemia	ischemia/reperfusion (I/R) injury	cerebral cortex and hippocampus	Ischemic preconditioning and ischemic postconditioning (IPostC) treatment	downregulated	27485299
120	Mouse	mmu-let-7f	miRNA	ethanolic extract of an herbal formula comprising Sophorae Flos and Lonicerae Japonicae Flos (SLE)	metastasized melanoma	"B16F10 melanoma tissues, B16F10 melanoma lung metastasis in mice"	SLE treatment	upregulated	31514083
121	Mouse	mmu-let-7f	miRNA	cigarette smoke (CS)	neovascularization	mouse ischemic muscles	cigarette smoke (CS)?exposure	downregulated	28345812
122	Mouse	mmu-let-7f	miRNA	social defeat stress	sex differences of social defeat stress	female mice	social defeat stress treatment	upregulated	33358922
123	Mouse	mmu-let-7f-2-3p	miRNA	high glucose (HG)	diabetic nephropathy (DN)	mouse podocytes	high glucose (HG) treatment	upregulated	33224036
124	Mouse	mmu-let-7f-5p	miRNA	azoxymethane (AOM) and dextran sulfate sodium (DSS)	colitis-associated colon cancer (CAC)	colon tissues	azoxymethane (AOM) and dextran sulfate sodium (DSS) treatment	downregulated	31275360
125	Mouse	mmu-let-7f-5p	miRNA	lipopolysaccharide (LPS)	inflammation	RAW 264.7 cells	lipopolysaccharide (LPS) treatment	upregulated	32153563
126	Mouse	mmu-let-7f-5p	miRNA	polymethylmethacrylate (PMMA)	osteolysis	RAW264.7 cells	polymethylmethacrylate treatment	The expression of let-7f-5p was increased in the process of M1 macrophage polarization that induced by PMMA	30176162
127	Mouse	mmu-let-7f-5p	miRNA	Vaccination during Crisis of Plasmodium chabaudi Blood-Stage Malaria	plasmodium chabaudi infection	Balb/c Mice liver	infect with Vaccination treatment	downregulated in the Liver	28123381
128	Mouse	mmu-let-7g	miRNA	blast	blast traumatic brain injury (bTBI)	Balb/c mice	blast treatment	dysregulated	29020847
129	Mouse	mmu-let-7g	miRNA	house dust mite (HDM)	chronic allergic asthma	C57BL/6 mice	HDM treatment	downregulated	24610935
130	Mouse	mmu-let-7g	miRNA	TGF-¦Â	diabetic nephropathy (DN)	mouse mesangial cells (MMCs)	TGF-¦Â treatment	downregulated	25354942
131	Mouse	mmu-let-7g	miRNA	binase	lymphosarcoma	RLS40 cells	binase treatment	downregulated	33147876
132	Mouse	mmu-let-7g	miRNA	doxorubicin (DOX)	myocardial injury	animal issues and cardiac cells	antibiotics treatment	The downregulated of let-7g in the myocardial-injury model suggests that let-7g may play an important role in the development of cardiac disease	22301161
133	Mouse	mmu-let-7g	miRNA	plasmodium chabaudi malaria	peak parasitemia	liver of mice	Plasmodium chabaudi malaria infection treatment	downregulated	21085987
134	Mouse	mmu-let-7g	miRNA	arsenite	lung fibrosis	lung tissues	arsenite exposure	downregulated	33162208
135	Mouse	mmu-let-7g	miRNA	diesel exhaust particle (DEP)	pulmonary inflammatory response	lung tissues	diesel exhaust particle (DEP) exposure	downregulated	30172002
136	Mouse	mmu-let-7g-3p	miRNA	Yiqi-Bushen-Tiaozhi (YBT)	nonalcoholic fatty liver disease/nonalcoholic steatohepatitis (NAFLD/NASH)	liver tissues	Yiqi-Bushen-Tiaozhi (YBT) treatment	upregulated	33281601
137	Mouse	mmu-let-7g-5p	miRNA	oxysterol 27-hydroxycholesterol (27-OHC)	Alzheimer's disease (AD)	brain tissues	oxysterol 27-hydroxycholesterol (27-OHC) treatment	downregulated	30582229
138	Mouse	mmu-let-7g-5p	miRNA	ursolic acid (UA)	osteogenesis	RANKL-treated RAW264.7 cells	ursolic acid treatment	downregulated	30827108
139	Mouse	mmu-let-7g-5p	miRNA	Vaccination during Crisis of Plasmodium chabaudi Blood-Stage Malaria	plasmodium chabaudi infection	Balb/c Mice liver	infect with Vaccination treatment	downregulated in the Liver	28123381
140	Mouse	mmu-let-7i	miRNA	TGF-¦Â	diabetic nephropathy (DN)	mouse mesangial cells (MMCs)	TGF-¦Â treatment	downregulated	25354942
141	Mouse	mmu-let-7i	miRNA	arsenite	lung fibrosis	lung tissues	arsenite exposure	downregulated	33162208
142	Mouse	mmu-let-7i	miRNA	cyclosporine A (CsA)	urinary tract infections (UTIs)	uropathogenic Escherichia coli (UPEC) infected kidneys	cyclosporine A treatment	upregulated	29069656
143	Mouse	mmu-let-7i-5p	miRNA	carbon tetrachloride (CCl4)	liver fibrosis	liver	CCl4 treatment	upregulated	27322257
144	Mouse	mmu-let-7i-5p	miRNA	carbon tetrachloride (CCl4)	liver fibrosis	liver tissues	carbon tetrachloride (CCl4) treatment	upregulated	29557526
145	Mouse	mmu-let-7i-5p	miRNA	Vaccination during Crisis of Plasmodium chabaudi Blood-Stage Malaria	plasmodium chabaudi infection	Balb/c Mice liver	infect with Vaccination treatment	downregulated in the Liver	28123381
146	Mouse	mmu-let-7k	miRNA	Psychosocial stress	mesenchymal stem cell transplantation (MSCT)	mouse bone marrow mesenchymal stem cells (MSCs)	Psychosocial stress treatment	Psychological stress attenuates therapeutic effects of MSCT in a DSS-induced colitis mouse model by elevating the levels of exosomal Mir7k/mmu-let-7 k (microRNA 7 k) in circulation	32910719
147	Mouse	mmu-let-7k	miRNA	oxygen	retinopathy of prematurity (ROP)	retinas tissue	"For OIR model construction, 7-day-old mice and their nursing mothers were maintained in 75% oxygen for 5 continuous days. On postnatal day (P) 12, the pups were returned to normoxic air and kept with their mothers for another 5 days. treatment"	downregulated in the OIR samples	31452702
148	Mouse	mmu-let-7k	miRNA	alpinia oxyphylla extract (AOE)	type 2 diabetes mellitus (T2DM)	db-/db- mouse kidney	A. oxyphylla extract (AOE) treatment	upregulated	28249617
149	Mouse	mmu-miR-1	miRNA	heat stress	ischemia/reperfusion (I/R) injury	the hearts and livers tissue cells	heat-shock (HS)	"Mice subjected to cytoprotective heat-shock (HS) showed a significant increase of miRNA-1, miRNA-21 and miRNA-24 in the heart."	19041309
150	Mouse	mmu-miR-1	miRNA	IFN-¦Â	autophagy	mouse cortical neurons	IFN-¦Â treatment	upregulated	31799933
151	Mouse	mmu-miR-1	miRNA	2-acetyl-5-tetrahydroxybutyl imidazole (THI)	breast cancer	C2C12 cells	2-acetyl-5-tetrahydroxybutyl imidazole (THI) treatment	upregulated	24077965
152	Mouse	mmu-miR-1	miRNA	sphingosine-1-phosphate (S1P)	breast cancer	C2C12 cells	sphingosine-1-phosphate (S1P) treatment	upregulated	24077965
153	Mouse	mmu-miR-1	miRNA	metformin (Met)	cardiac conduction delay	cardiomyocytes; heart tissues	metformin (Met) treatment	Met can noticeably inhibit miR-1 upregulation.	32450177
154	Mouse	mmu-miR-1	miRNA	doxorubicin (DOX)	cardiotoxicity	BALB/c mice injected C-26 tumor cells	doxorubicin treatment	upregulated	28560697
155	Mouse	mmu-miR-1	miRNA	oxygen-glucose deprivation and reoxygenation (OGD/R)	cerebral palsy	N2A neurons	oxygen-glucose deprivation and reoxygenation (OGD/R) treatment	upregulated	31500509
156	Mouse	mmu-miR-1	miRNA	tamoxifen (TAM)	chronic pain	dorsal root ganglion (DRG) neurons	completed tamoxifen treatment	downregulated	27346077
157	Mouse	mmu-miR-1	miRNA	bortezomib	congenital muscular dystrophy	dy(3K)/dy(3K) mice	bortezomib? treatment	downregulated	24631023
158	Mouse	mmu-miR-1	miRNA	streptozocin (STZ)	diabetes mellitus (DM)	hearts of diabetic mice	streptozotocin (STZ) treatment	downregulated	21584493
159	Mouse	mmu-miR-1	miRNA	streptozocin (STZ)	diabetes mellitus (DM)	CD1 mice of both genders	streptozocin (STZ) treatment	upregulated	24685144
160	Mouse	mmu-miR-1	miRNA	lycium barbarum polysaccharide (LBP)	heart failure (HF)	neonatal rat ventricular cardiomyocytes (NRVCs)	lycium barbarum polysaccharides (LBPs) treatment	LBPs significantly reduced the expression of myocardial miR-1.	30117672
161	Mouse	mmu-miR-1	miRNA	AICAR	hypertrophy	C2C12 cells	were incubat AMPK activator 5-aminoimidazole-4- carboxamide-1-_x0003-D-ribonucleoside treatment	upregulated	24347059
162	Mouse	mmu-miR-1	miRNA	hypoxia	hypoxic pulmonary hypertension (HPH)	mouse lung tissues	hypoxia treatment	downregulated in mouse lung tissues	29167124
163	Mouse	mmu-miR-1	miRNA	synthetic Sulfonyl-Hydrazone-1	iPSC-derived cardiac differentiation	Murine fibroblast-derived iPSCs	Synthetic Sulfonyl-Hydrazone-1 treatment	"small chemical compounds, such as SHZ, can constitute a novel and clinically feasible strategy to improve iPSC-derived cardiac differentiation"	21445862
164	Mouse	mmu-miR-1	miRNA	ischemia	ischemia/reperfusion (I/R) injury	cerebral cortex and hippocampus	Ischemic preconditioning and ischemic postconditioning (IPostC) treatment	downregulated	27485299
165	Mouse	mmu-miR-1	miRNA	botulinum toxin A (BTXA)	muscle atrophy	quadriceps muscle	botulinum toxin A (BTXA) treatment	downregulated	30427927
166	Mouse	mmu-miR-1	miRNA	dexamethasone (DEX)	muscle atrophy	Murine C2C12 myoblast cells	dexamethasone (DEX) treatment	upregulated	23716137
167	Mouse	mmu-miR-1	miRNA	prolonged aerobic exercise	muscle hypertrophy	plasma	"impact of extended-duration, submaximal aerobic exercise treatment"	upregulated	24436293
168	Mouse	mmu-miR-1	miRNA	heme oxygenase-1 (HMOX1)	myoblast differentiation	C2C12 cells	Heme oxygenase-1 (HMOX1) treatment	downregulated	21827279
169	Mouse	mmu-miR-1	miRNA	Soluble epoxide hydrolase inhibitors (sEHIs)	myocardial infarction (MI)	MI mouse ischemic myocaridum	"sEHI t-AUCB (0.2, 1, 5 mg/L in drinking-water) was administered daily seven days before MI treatment"	downregulated in ischemic myocaridum	29212255
170	Mouse	mmu-miR-1	miRNA	ischemia	myocardial ischaemic injury	mouse cardiomyocytes	ischemic pre-conditioning (IPC) treatment	"IPC-induced miRNAs trigger cardioprotection similar to the delayed phase of IPC, possibly through upregulating eNOS, HSP70, and the HSP70 transcription factor HSF-1."	19213952
171	Mouse	mmu-miR-1	miRNA	sciatic nerve partial ligation	pain	mouse dorsal root ganglion (DRG)	sciatic nerve partial ligation therapy treatment	downregulated	21385380
172	Mouse	mmu-miR-1	miRNA	hypoxia	pulmonary arterial hypertension (PAH)	mouse lung tissues	hypoxia induce	downregulated	29167124
173	Mouse	mmu-miR-1	miRNA	cyclopamine	regulating the activity of Shh signaling	embryonic lung cultures	cyclopamine treatment	dysregulated	24617895
174	Mouse	mmu-miR-1	miRNA	statins	skeletal muscle injury	skeletal muscle cells	statins? treatment	"In cultured skeletal muscle cells, statin increased the levels of miR-1a but decreased the levels of mitogen-activated protein kinase kinase kinase 1 (MAP3K1) in a time or dose dependent manner"	33864447
175	Mouse	mmu-miR-1	miRNA	astragalus Root dry extract (ARDE)	viral myocarditis (VM)	CVB3-infected mouse heart tissues and HL-1 cells	astragalus Root dry extract (ARDE) treatment	downregulated	30097120
176	Mouse	mmu-miR-1	miRNA	coxsackievirus B3 (CVB3)	viral myocarditis (VM)	mouse heart tissues and HL-1 cells	CVB3 infection	upregulated	30097120
177	Mouse	mmu-miR-100	miRNA	H2O2	apoptosis	cardiomyocytes	H2O2 treatment	upregulated	26191255
178	Mouse	mmu-miR-100	miRNA	1-methyl-4-phenylpyridinium (MPP+)	parkinson's disease (PD)	mouse midbrain tissues	1-methyl-4-phenylpyridinium (MPP+) treatment	downregulated	31298038
179	Mouse	mmu-miR-100	miRNA	retinoic acid (RA)	cell proliferation	mouse spermatogonial stem cells (SSCs)	retinoic acid treatment	downregulated	28569396
180	Mouse	mmu-miR-100-5p	miRNA	amyloid-¦Â (A¦Â)	Alzheimer's disease (AD)	Cortexes of the brains	amyloid-¦Â (A¦Â) treatment	downregulated	26635599
181	Mouse	mmu-miR-100-5p	miRNA	influenza virus	H5N2 influenza virus infection	lung tissues	H5N2 treatment	upregulated	25266911
182	Mouse	mmu-miR-100a	miRNA	rapamycin	HIV-associated nephropathy(HIVAN)	mice renal tissues	Rapamycin treatment	downregulated	23611955
183	Mouse	mmu-miR-101	miRNA	bleomycin (BLM)	acute lung injury (ALI)	lung	bleomycin (BLM) treatment	downregulated	26402323
184	Mouse	mmu-miR-101	miRNA	celecoxib	anti-inflammatory responses	male A/J mice	"celecoxib (30 mg/kg/d, administered by gavage) treatment"	upregulated	27562754
185	Mouse	mmu-miR-101	miRNA	geniposide (GEN)	atherosclerosis (AS)	LPS-treated RAW264.7 macrophage cell line	geniposide treatment	downregulated	30630636
186	Mouse	mmu-miR-101	miRNA	geniposide (GEN)	atherosclerosis (AS)	Atherosclerosis (AS) mouse aorta tissues	geniposide treatment	downregulated	30630636
187	Mouse	mmu-miR-101	miRNA	geniposide (GEN)	atherosclerosis (AS)	high fat diet fed ApoE-/- mice aorta tissues	geniposide (GEN) treatment	downregulated	30630636
188	Mouse	mmu-miR-101	miRNA	high fat diet (HFD)	atherosclerosis (AS)	ApoE-/- mice aorta tissues	high fat diet (HFD) feed	upregulated	30630636
189	Mouse	mmu-miR-101	miRNA	high fat diet (HFD)	atherosclerosis (AS)	aorta tissues	high fat diet (HFD) feed	upregulated	30630636
190	Mouse	mmu-miR-101	miRNA	lipopolysaccharide (LPS)	atherosclerosis (AS)	RAW264.7 macrophage cell line	lipopolysaccharide (LPS) treatment	upregulated	30630636
191	Mouse	mmu-miR-101	miRNA	IL-10	colonic inflammation	colonic intraepithelial lymphocytes	IL-10 treatment	downregulated	22043014
192	Mouse	mmu-miR-101	miRNA	IL-10	epithelial-mesenchymal transition (EMT)	colonic intraepithelial lymphocytes	IL-10 treatment	upregulated	22043014
193	Mouse	mmu-miR-101	miRNA	kaempferol	fracture healing	MC3T3-E1 cells	kaempferol treatment	upregulated	30942633
194	Mouse	mmu-miR-101	miRNA	tumor necrosis factor alpha (TNF-¦Á) 	osteoarthritis (OA)	?ATDC5 cells	tumor necrosis factor alpha (TNF-¦Á) treatment	?HULC protected ATDC5 cells against TNF-¦Á-induced inflammatory injury by repression of miR-101	30981080
195	Mouse	mmu-miR-101	miRNA	phyllanthus emblica L (PEL) extract	precancerous lung lesion	male A/J mice	phyllanthus emblica L (PEL) extract treatment	upregulation	27562754
196	Mouse	mmu-miR-101	miRNA	bleomycin (BLM)	lung fibrosis	mouse lung tissues	bleomycin (BLM) treatment	downregulated in lung tissues	28726637
197	Mouse	mmu-miR-101	miRNA	salvianolic acid A (Sal A)	spinal cord injury (SCI)	RBMECs cells	Sal A treatment	upregulated	28011395
198	Mouse	mmu-miR-101-3p	miRNA	Iodine-131 (131I)	papillary thyroid cancer (PTC)	PTC tissues	131I treatment	NEAT1 suppression could inhibit 131I resistance of PTC by upregulating miR-101-3p/FN1 expression and inactivated PI3K/AKT signaling pathway both in vitro and in vivo.	30596336
199	Mouse	mmu-miR-101-3p	miRNA	oxygen	bronchopulmonary dysplasia (BPD)	lung tissues	oxygen treatment	silencing of Xist suppressed BPD development by binding to miR-101-3p and downregulating HMGB3 and the TGF-b1/Smad3 axis.	33070148
200	Mouse	mmu-miR-101-5p	miRNA	schisandrin B (Sch B)	liver fibrosis	liver tissues	Schisandrin B (Sch B) treatment	Sch B can attenuate liver fibrosis by upregulating the expression of miR-101-5p	31975615
201	Mouse	mmu-miR-101a	miRNA	lipopolysaccharide (LPS)	acute aortic dissection (AAD)	aorta	lipopolysaccharide (LPS) treatment	downregulated	32634201
202	Mouse	mmu-miR-101a	miRNA	mangiferin	endoplasmic reticulum stress (ERS)	primary mouse hepatocytes	mangiferin treatment	downregulated	32413114
203	Mouse	mmu-miR-101a	miRNA	angiotensin II (Ang II)	hypertensive nephropathy (HN)	kidney tissues	angiotensin II (Ang II) treatment	downregulated	30304543
204	Mouse	mmu-miR-101a	miRNA	dietary methyl deficiency	hepatocellular carcinoma (HCC)	the liver tissues	Dietary methyl deficiency treatment	downregulated	20436259
205	Mouse	mmu-miR-101a	miRNA	"2, 3, 7, 8-tetrachlorodibenzo-p-dioxin (TCDD)"	liver damage	mouse liver cells	"2, 3, 7, 8-tetrachlorodi-benzo-p-dioxin (TCDD) treatment"	"TCDD dysregulates the expression of miR101a and miR122 and that COX-2, a target gene of miR101a, plays a significant role in liver damage in mice exposed to TCDD."	21602190
206	Mouse	mmu-miR-101a	miRNA	IL-1¦Â	¦Â-cell dysfunction	MIN6 cells	IL-1¦Â treatment	upregulated	26367486
207	Mouse	mmu-miR-101a-3p	miRNA	hypoxia	myocardial infarction (MI)	neonatal mice cardiomyocytes (NMCMs)	hypoxia treatment	downregulated	32315985
208	Mouse	mmu-miR-101b	miRNA	oral gavage	anti-inflammatory responses	dextran sodium sulfate (DSS)-induced colitis-associated tumorigenesis Apc(Min/+) mouse	via oral gavage for 5 weeks treatment	upregulated	24817032
209	Mouse	mmu-miR-101b	miRNA	high glucose (HG)	diabetic nephropathy (DN)	mouse mesangial cells (MES13 cells)	high glucose (HG) treatment	circ_0000491 aggravates the extracellular matrix of diabetic nephropathy glomerular mesangial cells through suppressing miR-101b by targeting TGF¦ÂRI.	32901868
210	Mouse	mmu-miR-101b	miRNA	dietary methyl deficiency	hepatocellular carcinoma (HCC)	the liver tissues	Dietary methyl deficiency treatment	downregulated	20436259
211	Mouse	mmu-miR-101b	miRNA	metformin (Met)	nonalcoholic steatohepatitis (NASH)	liver tissues	metformin treatment	downregulated	25672270
212	Mouse	mmu-miR-101b	miRNA	metformin (Met)	nonalcoholic steatohepatitis (NASH)	liver tissues	metformin treatment	downregulated	25672270
213	Mouse	mmu-miR-101b	miRNA	plasmodium chabaudi malaria	peak parasitemia	liver of mice	Plasmodium chabaudi malaria infection treatment	downregulated	21085987
214	Mouse	mmu-miR-103	miRNA	tetrabromobisphenol-A (TBBPA)	adipogenesis	3T3-L1 and C3H10T1/2 cells	TBBPA treatment	upregulated	28329833
215	Mouse	mmu-miR-103	miRNA	high fat diet (HFD)	adipose inflammation	mouse adipose tissues	high fat diet (HFD) feed	Overexpressing TRAF3 attenuated miR-103-induced inflammation by accelerating mitophagy.	30623853
216	Mouse	mmu-miR-103	miRNA	adjuvant	adjuvant-induced arthritis (AIA)	cartilage	adjuvant treatment	Long noncoding RNA-GAS5 siRNA prevented cartilage destruction by inhibiting miR-103 expression.	33343265
217	Mouse	mmu-miR-103	miRNA	baicalin (BAI)	asthma	ovalbumin (OVA)-induced asthma mouse lung tissues	baicalin (BAI) treatment	miR-103 was significantly upregulated after BA treatment.	33730981
218	Mouse	mmu-miR-103	miRNA	baicalin (BAI)	asthma	mouse bronchial smooth muscle cells (SMCs)	baicalin (BAI) treatment	upregulated	33730981
219	Mouse	mmu-miR-103	miRNA	platelet derived growth factor-BB (PDGF-BB)	asthma	mouse bronchial smooth muscle cells (SMCs)	platelet derived growth factor-BB (PDGF-BB)?treatment treatment	downregulated	33730981
220	Mouse	mmu-miR-103	miRNA	high fat diet (HFD)	atherosclerosis (AS)	thoracic aorta	high fat diet (HFD) feed	upregulated	31232476
221	Mouse	mmu-miR-103	miRNA	high fat diet (HFD)	atherosclerosis (AS)	Apolipoprotein E knockout (ApoE-/- ) mice thoracic aorta tissues	?high-fat-diet (HFD)?feed treatment	upregulated	31232476
222	Mouse	mmu-miR-103	miRNA	carboxymethyllysine (CML)	diabetes mellitus (DM)	fibroblast cell line 3T3©\L1	carboxymethyllysine (CML) treatment	upregulated	27137869
223	Mouse	mmu-miR-103	miRNA	trans-pellitorine	"fatty acid synthase, fatty acid uptake"	3T3-L1 cells	trans-pellitorine	upregulated	28620299
224	Mouse	mmu-miR-103	miRNA	high fat diet (HFD)	inflammatory response	skeletal muscle of mice	high fat diet (HFD) feed	"miR-375, miR-29, miR-320, miR-103/107 and miR-126, play a crucial role in the regulation of glucose and lipid metabolism through the control of pancreatic islet cell function"	22395471
225	Mouse	mmu-miR-103	miRNA	oxygen-glucose deprivation and reoxygenation (OGD/R)	ischemic neuronal injury	murine hippocampal neurons	oxygen-glucose deprivation and reoxygenation (OGD/R) treatment	OGDR downregulated miR-103 and miR-107 to induce NKILA upregulation in neuronal cells	30007440
226	Mouse	mmu-miR-103	miRNA	apigenin	hepatocellular carcinoma (HCC)	Huh7 cells; Hep3B cells	apigenin treatment	downregulated	23989853
227	Mouse	mmu-miR-103	miRNA	resveratrol	hepatic steatosis	Sprague-Dawley rats	resveratrol (RS) treatment	downregulated	28375178
228	Mouse	mmu-miR-103	miRNA	insulin-like growth factor 1 (IGF-1)	metastatic colorectal cancer (mCRC)	mouse intestinal crypt cells	insulin-like growth factors(IGF-1) treatment	downregulated	20886090
229	Mouse	mmu-miR-103	miRNA	morphine	morphine tolerance	mouse brain	chronic morphine men treatment	upregulated	24302561
230	Mouse	mmu-miR-103	miRNA	isoprenaline	myocardial infarction (MI)	hearts of the treated mice	isoprenaline treatment	Significant inhibition of miR-103 accompanied by increased FADD expression and markedly decreased expression of the other biomarkers were observed in the hearts of the treated mice.	33577038
231	Mouse	mmu-miR-103	miRNA	high fat diet (HFD)	prenatal inflammation	ovarian tissue	high fat diet (HFD) feed	"Obese mouse ovaries had decreased Irs1, Foxo3a, Cyp2e1, MiR-103, and MiR-21"	23954404
232	Mouse	mmu-miR-103-1-5p	miRNA	apigenin	acute myocardial infarction (AMI)	mouse myocardial cells	apigenin treatment	downregulated	32515357
233	Mouse	mmu-miR-103-3p	miRNA	fenofibrate	obesity	C57BL/6J male mice visceral adipose tissue	fenofibrate treatment	upregulated	28926107
234	Mouse	mmu-miR-103a	miRNA	cyclic mechanical stretch (CMS)	osteoblast differentiation and bone formation	bone	cyclic mechanical stretch (CMS) treatment	downregulated	25195535
235	Mouse	mmu-miR-103a-3p	miRNA	bilateral surgical destabilization of the medial meniscus (DMM)	osteoarthritis (OA)	male C57BL6 mice	bilateral surgical destabilization of the medial meniscus (DMM) treatment	dysregulated	29255152
236	Mouse	mmu-miR-103a-3p	miRNA	angiotensin II (Ang II)	renal inflammation and fibrosis	Urinary and serum	angiotensin II (Ang II) treatment	upregulated	31086184
237	Mouse	mmu-miR-103a-3p	miRNA	lipopolysaccharide (LPS)	sepsis	Bone marrow-derived macrophages	lipopolysaccharide (LPS) treatment	downregulated	33333289
238	Mouse	mmu-miR-103a-3p	miRNA	lipopolysaccharide (LPS)	sepsis	bone marrow-derived macrophages	lipopolysaccharide (LPS) treatment	miR-103a-3p was decreased while HMGB1 was increased in sepsis.	33333289
239	Mouse	mmu-miR-103a-3p	miRNA	lipopolysaccharide (LPS)	sepsis-induced liver injury	liver tissues	lipopolysaccharide (LPS) treatment	miR-103a-3p was elevated in the septic liver of LPS-induced mice.	32369227
240	Mouse	mmu-miR-105	miRNA	lipopolysaccharide (LPS)	inflammation	RAW264.7 cells	lipopolysaccharide (LPS) treatment	upregulated	26639663
241	Mouse	mmu-miR-105	miRNA	chlamydia muridarum variants (C. muridarum Var001 [CmVar001] and CmVar004)	plvic inflammatory disease	mouse	two Chlamydia muridarum variants (C. muridarum Var001 [CmVar001] and CmVar004) infection	were upregulated during CmVar004 infection compared to CmVar001 infection	24961692
242	Mouse	mmu-miR-106	miRNA	thyroid hormone	brain development	mouse fetal cortex	inject TH 12 h before sacrifice on GD 16 treatment	downregulated	24436321
243	Mouse	mmu-miR-106	miRNA	bone morphogenetic protein 9 (BMP9)	osteogenesis	The conditionally immortalized mouse multipotent adipose-derived cells iMADs	bone morphogenetic protein 9 (BMP9) treatment	downregulated	31825894
244	Mouse	mmu-miR-106a	miRNA	lipopolysaccharide (LPS)	acute lung injury (ALI)	mouse lung tissues and RAW264.7 cells	lipopolysaccharides (LPS) treatment	downregulated	31595149
245	Mouse	mmu-miR-106a	miRNA	ovalbumin (OVA)	asthma	lung tissues	ovalbumin (OVA) treatment	upregulated	27418244
246	Mouse	mmu-miR-106a	miRNA	"anti-benzo[a]pyrene-trans-7,8-diol-9,10-epoxide (anti-BPDE)"	bronchial epithelial cell cancer	16HBE-T cells	"anti-benzo[a]pyrene-trans-7,8-diol-9,10-epoxide (anti-BPDE) treatment"	upregulated	19462682
247	Mouse	mmu-miR-106a	miRNA	streptozocin (STZ)	diabetic peripheral neuropathy (DPN)	mouse dorsal root ganglion (DRG)	STZ treatment	downregulated in dorsal root ganglion (DRG)	28393703
248	Mouse	mmu-miR-106a	miRNA	tumor necrosis factor alpha (TNF-¦Á) 	inflammatory bowel disease (IBD)	colon tissues	tumor necrosis factor alpha (TNF-¦Á) treatment	upregulated	30327532
249	Mouse	mmu-miR-106a	miRNA	high glucose (HG)	podocyte injury	MPC5 cells	high glucose (HG) treatment	MiR-106a was downregulated in HG-induced MPC5 podocytes.	33116706
250	Mouse	mmu-miR-106a	miRNA	isoflurane	postoperative cognitive dysfunction (POCD)	hippocampus	isoflurane treatment	upregulated	31933141
251	Mouse	mmu-miR-106a	miRNA	cecal ligation and puncture (CLP)	sepsis	whole blood	cecal ligation and puncture (CLP) treatment	upregulated	24205035
252	Mouse	mmu-miR-106a	miRNA	lipopolysaccharide (LPS)	sepsis-induced acute kidney injury	TCMK-1 cells	lipopolysaccharides (LPS) treatment	upregulated	31432993
253	Mouse	mmu-miR-106a-5p	miRNA	folic acid	Alzheimer's disease (AD)	APP/PS1 mice brains and N2a cells	Folic acid deficiency treatment	downregulated	26345540
254	Mouse	mmu-miR-106a-5p	miRNA	streptozocin (STZ)	diabetic retinopathy (DR)	retina and serum of diabetic mice	streptozotocin treatment	downregulated	30883703
255	Mouse	mmu-miR-106b	miRNA	high fat diet (HFD)	brown adipocyte differentiation	brown adipose tissues	high fat diet (HFD) feed	upregulated	23954633
256	Mouse	mmu-miR-106b	miRNA	bovine type II collagen containing Freund's adjuvant	collagen-induced arthritis (CIA)	DAB/1 mice	bovine type II collagen containing Freund's adjuvant	upregulated	28957555
257	Mouse	mmu-miR-106b	miRNA	high glucose (HG)	diabetes mellitus (DM)	mouse pancreatic beta-cell line NIT-1 cells	30 mM high glucose	downregulated	28436095
258	Mouse	mmu-miR-106b	miRNA	isoflurane	drug-induced liver injury (DILI)	liver tissues	isoflurane treatment	downregulated	24598351
259	Mouse	mmu-miR-106b	miRNA	isoniazid (INH)	liver damage	liver tissues	isoniazid (INH) treatment	upregulated	29554950
260	Mouse	mmu-miR-106b	miRNA	glucocorticoid (GC)	osteoporosis	C57BL/6 mice	glucocorticoid	upregulated	28108317
261	Mouse	mmu-miR-106b	miRNA	puerarin	osteoporosis	MC3T3-E1 cells	puerarin treatment	upregulated	29375675
262	Mouse	mmu-miR-106b	miRNA	puerarin	osteoporosis	MC3T3-E1 cells	with 20 ?M puerarin treatment	upregulated	29375675
263	Mouse	mmu-miR-106b	miRNA	propofol (PPF)	propofol-induced developmental neurotoxicity	hippocampus	propofol treatment	downregulated	30242182
264	Mouse	mmu-miR-106b	miRNA	collagen	rheumatoid arthritis (RA)	synovial fibroblasts (SFs)	collagen treatment	upregulated	32152704
265	Mouse	mmu-miR-106b	miRNA	cecal ligation and puncture (CLP)	sepsis	whole blood	cecal ligation and puncture (CLP) treatment	upregulated	24205035
266	Mouse	mmu-miR-106b	miRNA	palmitic acid (PA)	skeletal muscle insulin resistance	C2C12 myocytes	palmitic acid (PA) treatment	upregulated	25529328
267	Mouse	mmu-miR-106b-3p	miRNA	Yiqi-Bushen-Tiaozhi (YBT)	nonalcoholic fatty liver disease/nonalcoholic steatohepatitis (NAFLD/NASH)	liver tissues	Yiqi-Bushen-Tiaozhi (YBT) treatment	downregulated	33281601
268	Mouse	mmu-miR-106b-3p	miRNA	paraquat (PQ)	paraquat (PQ)-induced acute lung injury and pulmonary fibrosis	MLE-12 cells	paraquat (PQ) treatment	downregulated	32741895
269	Mouse	mmu-miR-106b-5p	miRNA	ovalbumin (OVA)	asthma	lung tissues	ovalbumin (OVA) treatment	The present study revealed downregulated miR-106b-5p expression and upregulated SIX1 expression in asthmatic mice and TGF-¦Â1-induced BEAS-2B cells.	33495833
270	Mouse	mmu-miR-106b-5p	miRNA	bone marrow transplantation (BMT)	diabetes mellitus (DM)	mice with insulin-deficient diabetes	bone marrow transplantation (BMT) treatment	upregulated	27974246
271	Mouse	mmu-miR-106b-5p	miRNA	radiation	radiation-induced injury	blood	radiation treatment	downregulated	29799276
272	Mouse	mmu-miR-107	miRNA	tetrabromobisphenol-A (TBBPA)	adipogenesis	3T3-L1 and C3H10T1/2 cells	TBBPA treatment	upregulated	28329833
273	Mouse	mmu-miR-107	miRNA	amyloid-¦Â (A¦Â) 1-42	Alzheimer's disease (AD)	brain tissues	amyloid ¦Â1-42?(A¦Â) treatment	downregulated	29286086
274	Mouse	mmu-miR-107	miRNA	amyloid-¦Â (A¦Â) 1-42	Alzheimer's disease (AD)	mouse	amyloid ¦Â1-42?(A¦Â) treatment	downregulated	29286086
275	Mouse	mmu-miR-107	miRNA	high fat diet (HFD)	atherosclerosis (AS)	vascular endothelial cells (VECs) in coronary atherosclerosis mice	?high-fat-diet (HFD)?feed treatment	downregulated	30548623
276	Mouse	mmu-miR-107	miRNA	high fat diet (HFD)	coronary atherosclerosis (CAS)	Vascular endothelial cells (VECs)	high fat diet (HFD) feed	downregulated	30548623
277	Mouse	mmu-miR-107	miRNA	high fat diet (HFD)	inflammatory response	skeletal muscle of mice	high fat diet (HFD) feed	"miR-375, miR-29, miR-320, miR-103/107 and miR-126, play a crucial role in the regulation of glucose and lipid metabolism through the control of pancreatic islet cell function"	22395471
278	Mouse	mmu-miR-107	miRNA	oxygen-glucose deprivation and reoxygenation (OGD/R)	ischemic neuronal injury	murine hippocampal neurons	oxygen-glucose deprivation and reoxygenation (OGD/R) treatment	OGDR downregulated miR-103 and miR-107 to induce NKILA upregulation in neuronal cells	30007440
279	Mouse	mmu-miR-107	miRNA	resveratrol	hepatic steatosis	Sprague-Dawley rats	resveratrol (RS) treatment	downregulated	28375178
280	Mouse	mmu-miR-107	miRNA	morphine	morphine tolerance	mouse brain	chronic morphine men treatment	upregulated	24302561
281	Mouse	mmu-miR-107	miRNA	177lu-octreotate	neuroendocrine tumors	Female BALB/c nude mice	"inject 1.3, 3.6, 14, 45, or 140 MBq 177Lu-octreotate treatment"	"miR-194, miR-107, miR-3090, and miR-3077 were commonly regulated"	25386939
282	Mouse	mmu-miR-107	miRNA	oxygen glucose deprivation (OGD)	neuron apoptosis	HT-22 hippocampal neuron cell	oxygen-glucose deprivation (OGD) treatment	RMST/hnRNPK/p53/miR-107/Bcl2l2 axis plays an important role in regulating neuronal apoptosis	31852624
283	Mouse	mmu-miR-107	miRNA	diet	obesity	murine hepatic cells	diet treatment	downregulated	21120623
284	Mouse	mmu-miR-107	miRNA	agrimonia pilos polysaccharide (APP-AW) and its sulphated derivatives (S2)	steroid-induced osteonecrosis of femoral head (ONFH)	femoral head tissues	agrimonia pilos polysaccharide (APP-AW) and its sulphated derivatives (S2) treatment	APP-AW or S2 reversed the decreased miR- 107 level in rats suffering SANFH.	31786295
285	Mouse	mmu-miR-107	miRNA	agrimonia pilos polysaccharide (APP-AW) and its sulphated derivatives (S2)	steroid-induced osteonecrosis of femoral head (ONFH)	MC3T3-E1 cells	agrimonia pilos polysaccharide (APP-AW) and its sulphated derivatives (S3) treatment	upregulated	31786295
286	Mouse	mmu-miR-107	miRNA	agrimonia pilos polysaccharide (APP-AW) and its sulphated derivatives (S2)	steroid-induced osteonecrosis of femoral head (ONFH)	dexamethasone (DEX)-treated MC3T3-E1 cells	agrimonia pilos polysaccharide (APP-AW) and its sulphated derivatives (S4) treatment	upregulated	31786295
287	Mouse	mmu-miR-107	miRNA	agrimonia pilos polysaccharide (APP-AW) and its sulphated derivatives (S2)	steroid-induced osteonecrosis of femoral head (ONFH)	femoral head tissues	Agrimonia pilos polysaccharide (APP-AW)'s sulphated derivatives (S2) treatment	APP-AW or S2 reversed the decreased miR- 107 level in rats suffering SANFH.	31786295
288	Mouse	mmu-miR-107	miRNA	agrimonia pilos polysaccharide (APP-AW) and its sulphated derivatives (S2)	steroid-induced osteonecrosis of femoral head (ONFH)	MC3T3-E1 cells	Agrimonia pilos polysaccharide (APP-AW)'s sulphated derivatives (S2) treatment	upregulated	31786295
289	Mouse	mmu-miR-107	miRNA	dexamethasone (DEX)	steroid-induced osteonecrosis of femoral head (ONFH)	MC3T3-E1 cells	dexamethasone (DEX) treatment	downregulated	31786295
290	Mouse	mmu-miR-107	miRNA	cortical impact	traumatic brain injury (TBI)	cortex	cortical impact	downregulated	26426744
291	Mouse	mmu-miR-10a	miRNA	high fat diet (HFD)	atherosclerosis (AS)	blood plasma from apolipoprotein E-deficient (ApoE-/-) mice	high fat diet (HFD) feed	downregulated	29459264
292	Mouse	mmu-miR-10a	miRNA	"anti-benzo[a]pyrene-trans-7,8-diol-9,10-epoxide (anti-BPDE)"	bronchial epithelial cell cancer	16HBE-T cells	"anti-benzo[a]pyrene-trans-7,8-diol-9,10-epoxide (anti-BPDE) treatment"	downregulated	19462682
293	Mouse	mmu-miR-10a	miRNA	retinoic acid (RA)	cystic fibrosis (CF)	smooth muscle cell	retinoid acid treatment	downregulated	20118242
294	Mouse	mmu-miR-10a	miRNA	neurotoxicant sodium valproate (VPA)	developmental toxicity	murine embryonic stem cells (mESCs)	neurotoxicant sodium valproate (VPA) treatment	upregulated	24896083
295	Mouse	mmu-miR-10a	miRNA	concanamycin A (Con A)	fulminant hepatitis	Balb/c mice	conA injections of concanavalin A treatment	upregulation	25034766
296	Mouse	mmu-miR-10a	miRNA	retinoic acid (RA)	host defense and immunoregulation	na?ve CD4+ T cells	retinoic acid treatment	upregulated	22544395
297	Mouse	mmu-miR-10a	miRNA	angelica polysaccharide (AP)	inflammation	LPS-treated HT22 cells	angelica polysaccharide (AP) treatment	upregulated	31353963
298	Mouse	mmu-miR-10a	miRNA	lipopolysaccharide (LPS)	inflammation	HT22 cells	lipopolysaccharide (LPS) treatment	downregulated	31353963
299	Mouse	mmu-miR-10a	miRNA	olfactory discrimination training	olfactory discrimination	mouse hippocampal somatic cells	olfactory discrimination training treatment	dynamic and co-ordinated changes in miRNA expression accompany early stages of learning	20309390
300	Mouse	mmu-miR-10a	miRNA	bone morphogenetic proteins (BMPs)	osteogenesis	pluripotent stem (iPS) cells	bone morphogenetic proteins (BMPs) treatment	downregulated	22937097
301	Mouse	mmu-miR-10a	miRNA	ethanol (EtOH)	teratogenesis	fetal brains of mice	Ethanol?treatment	upregulated	19091803
302	Mouse	mmu-miR-10a	miRNA	high fat diet (HFD) and streptozotocin (STZ)	type 2 diabetes mellitus (T2DM)	ICR strain mice	high fat diet (HFD); streptozotocin (STZ)  treatment	downregulated	27292126
303	Mouse	mmu-miR-10a-5p	miRNA	lipopolysaccharide (LPS)	acute lung injury (ALI)	ALI lung tissues and mouse pulmonary microvascular endothelial cells (MPMVECs)	lipopolysaccharides (LPS) treatment	downregulated	31174540
304	Mouse	mmu-miR-10a-5p	miRNA	hypoxia	acute myocardial infarction (AMI)	The mouse cardiomyocyte cell line HL-1 cells	hypoxia induce	"MIAT and EGR2 were subsequently determined to be highly-expressed, whereas miR-10a-5p was found to be poorly-expressed in cardiomyocytes exposed to hypoxia as well as in MI mice using RT-qPCR and Western blot assay."	33819189
305	Mouse	mmu-miR-10a-5p	miRNA	high fat diet (HFD)	adipose tissue remodeling	adipose tissue macrophages (ATMs) in gonadal white adipose tissue (gWAT)	high fat diet (HFD) feed	downregulated	31668395
306	Mouse	mmu-miR-10a-5p	miRNA	"¦Â3-adrenergic receptor agonist CL316,243 (CL)"	adipose tissue remodeling	adipose tissue macrophages (ATMs) and PDGFR¦Á+ adipocyte stem cells (ASCs) in gonadal white adipose tissue (gWAT)	"¦Â3-adrenergic receptor agonist CL316,243 (CL) treatment"	upregulated	31668395
307	Mouse	mmu-miR-10a-5p	miRNA	fluke Fasciola gigantica (FgESPs)	F. gigantica infection	liver tissues	fluke Fasciola gigantica (FgESPs) infection	downregulated	33332355
308	Mouse	mmu-miR-10a-5p	miRNA	gut bacterial metabolite Urolithin A (UA)	immune response	murine CD4+ T cells	gut bacterial metabolite Urolithin A (UA) treatment	upregulated	31417547
309	Mouse	mmu-miR-10a-5p	miRNA	chronic unpredictable mild stress (CUMS)	major depressive disorder (MDD)	nucleus accumbens (NAc) tissues	chronic unpredictable mild stress (CUMS) induce	upregulated	30936699
310	Mouse	mmu-miR-10a-5p	miRNA	porcine hemagglutinating encephalomyelitis virus (PHEV)	porcine hemagglutinating encephalomyelitis virus (PHEV) infection	N2a cells; brain tissues	porcine hemagglutinating encephalomyelitis virus (PHEV) infection treatment	miR-10a-5p was constitutively upregulated by PHEV in both the N2a cells in vitro and mice brain in vivo	32153518
311	Mouse	mmu-miR-10b	miRNA	"hexahydro-1,3,5-trinitro-1,3,5-triazine (RDX)"	tumorigenesis	brain and liver tissue cells	"hexahydro-1,3,5-trinitro-1,3,5-triazine (RDX) treatment"	downregulated	19270793
312	Mouse	mmu-miR-10b	miRNA	binase	lymphosarcoma	RLS40 cells	binase treatment	downregulated	33147876
313	Mouse	mmu-miR-10b	miRNA	isoproterenol	cardiac fibrosis	heart tissues	isoproterenol (ISO) treatment	downregulated	27174579
314	Mouse	mmu-miR-10b	miRNA	streptozocin (STZ)	nonalcoholic steatohepatitis-hepatocellular carcinoma (NASH-HCC)	high fat dietmouse liver	STZ treatment	upregulated in liver	28345673
315	Mouse	mmu-miR-10b	miRNA	bone morphogenetic proteins (BMPs)	osteogenesis	pluripotent stem (iPS) cells	bone morphogenetic proteins (BMPs) treatment	downregulated	22937097
316	Mouse	mmu-miR-10b	miRNA	ethanol (EtOH)	teratogenesis	fetal brains of mice	Ethanol?treatment	upregulated	19091803
317	Mouse	mmu-miR-10b-5p	miRNA	lipopolysaccharide (LPS)	acute lung injury (ALI)	ALI lung tissues and mouse pulmonary microvascular endothelial cells (MPMVECs)	lipopolysaccharides (LPS) treatment	downregulated	31174540
318	Mouse	mmu-miR-10b-5p	miRNA	high fat diet (HFD)	hepatic insulin resistance	mouse liver tissues	high fat diet (HFD) feed	downregulated	30820263
319	Mouse	mmu-miR-10b-5p	miRNA	chronic unpredictable mild stress (CUMS)	major depressive disorder (MDD)	nucleus accumbens (NAc) tissues	chronic unpredictable mild stress (CUMS) induce	upregulated	30936699
320	Mouse	mmu-miR-10b-5p	miRNA	hypoxia	myocardial infarction (MI)	primary mouse cardiomyocyte	hypoxia induce	downregulated	31480879
321	Mouse	mmu-miR-10b-5p	miRNA	oxygen glucose deprivation (OGD)	neuronal cell injury	HT22 hippocampal neurons	oxygen-glucose deprivation (OGD) treatment	upregulated	32323054
322	Mouse	mmu-miR-10b-5p	miRNA	dexamethasone (DEX)	oxygen-glucose deprivation (OGD) induced neuron damage	HT22 hippocampal neurons	dexamethasone (Dex) treatment	downregulated	32323054
323	Mouse	mmu-miR-1188	miRNA	clamping the renal pedicle	bilateral renal ischemia	C57Bl/6 mice plasma and kidneys	clamping the renal pedicle treatment	upregulated	24695114
324	Mouse	mmu-miR-1192	miRNA	runt-related transcription factor-2 (Runx2)	tumorigenesis	C2C12 cells	Runt-related transcription factor-2 (Runx2) treatment	upregulated	24136232
325	Mouse	mmu-miR-1192	miRNA	dexamethasone (DEX)	muscle atrophy	Murine C2C12 myoblast cells	dexamethasone (DEX) treatment	downregulated	23716137
326	Mouse	mmu-miR-1192	miRNA	swimming	myocardial infarction (MI)	hypoxia-induced neonatal cardiomyocytes	4-wk swim training treatment	upregulated	31733833
327	Mouse	mmu-miR-1192	miRNA	swimming	myocardial infarction (MI)	plasma	swim training treatment	miR-1192 was increased after exercise	31733833
328	Mouse	mmu-miR-1192	miRNA	estradiol	vulvovaginal candidiasis (VVC)	female mouse vaginal tissues	estradiol treatment	downregulated	30355939
329	Mouse	mmu-miR-1192	miRNA	oil	vulvovaginal candidiasis (VVC)	female mouse vaginal tissues	oil treatment	downregulated	30355939
330	Mouse	mmu-miR-1198	miRNA	clozapine (CLZ)	psychotic disorders	mouse brain	clozapine treatment	upregulated	23318695
331	Mouse	mmu-miR-1199-5p	miRNA	lipopolysaccharide (LPS)	neuroinflammation	BV2 cells	lipopolysaccharide (LPS) treatment	upregulated	33301806
332	Mouse	mmu-miR-122	miRNA	"4-phenylbutyric acid (PBA, endoplasmic reticulum stress inhibitor)"	acute alcoholic liver injury	ethanol-treated mice serum exosomes	4-phenylbutyric acid (PBA) treatment	downregulated	31361816
333	Mouse	mmu-miR-122	miRNA	ethanol (EtOH)	acute alcoholic liver injury	serum exosomes	ethanol treatment	upregulated	31361816
334	Mouse	mmu-miR-122	miRNA	concanamycin A (Con A)	acute hepatitis	liver injury mice plasma	Con A (ConA) treatment	upregulated	30867286
335	Mouse	mmu-miR-122	miRNA	cisplatin (DDP)	acute kidney injury (AKI)	kidney	cisplatin treatment	downregulated	24759152
336	Mouse	mmu-miR-122	miRNA	acetaminophen (APAP)	acute liver failure (ALF)	mouse liver tissues	acetaminophen (APAP) treatment	upregulated	28616908
337	Mouse	mmu-miR-122	miRNA	acetaminophen (APAP)	acute liver failure (ALF)	mouse liver tissues	acetaminophen (APAP) treatment	upregulated in liver	28963035
338	Mouse	mmu-miR-122	miRNA	alcohol	alcoholic hepatitis (AH)	sera	alcohol exposure	upregulated	26264599
339	Mouse	mmu-miR-122	miRNA	alcohol	alcoholic liver disease (ALD)	mouse liver	Lieber-DeCarli alcohol treatment	downregulated in liver	28987423
340	Mouse	mmu-miR-122	miRNA	ethanol (EtOH)	alcoholic liver disease (ALD)	liver tissues	ethanol treatment	downregulated	28987423
341	Mouse	mmu-miR-122	miRNA	ethanol (EtOH)	alcoholic liver disease (ALD)	Kupffer cells from the livers and RAW 264.7 cells	ethanol treatment	downregulated	31325635
342	Mouse	mmu-miR-122	miRNA	rhinoviruses (RVs)	asthma	infant mice lung tissues	rhinoviruses (RVs) infection treatment	"Here, we found that RV infection induced the expression of miRNA 122 (miR-122) in mouse lungs and in human airway epithelial cells"	33830082
343	Mouse	mmu-miR-122	miRNA	high fat diet (HFD)	atherosclerosis (AS)	mouse aortic Endothelial cells	high fat diet (HFD) feed	upregulated	31228514
344	Mouse	mmu-miR-122	miRNA	diethylnitrosamine (DEN)	chronic hepatitis	liver injury mice plasma	diethylnitrosamine (DEN) treatment	upregulated	30867286
345	Mouse	mmu-miR-122	miRNA	"2,4,6-trinitrobenzene sulfonic acid (TNBS)"	crohn disease (CD)	mice colitis tissues	"2,4,6-trinitro-benzene-sulfonic acid (TNBS) treatment"	downregulated	31019652
346	Mouse	mmu-miR-122	miRNA	high glucose (HG)	diabetic nephropathy (DN)	Mouse podocytes (MPC5)	high glucose treatment	upregulated	30095204
347	Mouse	mmu-miR-122	miRNA	high doses of acetaminophen (APAP)	drug-induced liver injury (DILI)	mouse liver tissues	high doses of acetaminophen (APAP) treatment	upregulated	30381674
348	Mouse	mmu-miR-122	miRNA	high fat diet (HFD)	epithelial-mesenchymal transition (EMT)	aortic tissues; serum	high fat diet (HFD) feed	MiR-122 is upregulated in aortic tissues of ApoE-/- mice fed with HFD.	33278397
349	Mouse	mmu-miR-122	miRNA	short form augmenter of liver regeneration (sfALR)	fatty liver disease	The BALB/c mouse liver parenchymal cells	short form augmenter of liver regeneration (sfALR) treatment	upregulated	26476698
350	Mouse	mmu-miR-122	miRNA	carbon tetrachloride (CCl4)	fibrosis	liver tissue of mice	CCl4 treatment	downregulated	23178710
351	Mouse	mmu-miR-122	miRNA	ischemia	liver damage	liver tissues	serum levels hepatic ischaemia and reperfusion (I/R) injury treatment	upregulated	25039534
352	Mouse	mmu-miR-122	miRNA	TGF-¦Â	hepatic fibrogenesis	"hepatic stellate cells (HSCs) and fibroblasts, the major sources of fibrogenic cells in liver tissues"	TNF-¦Átreatment treatment	downregulated	25909171
353	Mouse	mmu-miR-122	miRNA	methionine choline-deficient diet (MCD)	liver damage	liver tissues	MCD treatment	upregulated	24217942
354	Mouse	mmu-miR-122	miRNA	leptin	hepatic stellate cell (HSC) activation	hepatic stellate cell (HSC)	leptin treatment	leptin reduced miR-122 level.	29248466
355	Mouse	mmu-miR-122	miRNA	ethanol (EtOH)	liver damage	liver mononuclear cells and Kupffer cells	ethanol treatment	upregulated	25973575
356	Mouse	mmu-miR-122	miRNA	acetaminophen (APAP)	hepatotoxicity	C57BL/6J mice serum	acetaminophen (APAP) treatment	upregulated in early and progressively up to 6 h in the serum	28755860
357	Mouse	mmu-miR-122	miRNA	paracetamol	hepatotoxicity	Pentoject-culled C57BL/6J mice serum	paracetamol treatment	upregulated in serum	30090508
358	Mouse	mmu-miR-122	miRNA	high fat diet (HFD)	high fat diet?influence	liver tissue	high fat diet (HFD) feed	upregulated	19835573
359	Mouse	mmu-miR-122	miRNA	angiotensin II (Ang II)	hypertension	kidney tissues	angiotensin II (Ang II) treatment	upregulated	30256768
360	Mouse	mmu-miR-122	miRNA	lychee pulp phenolics (LPPs)	hypolipidemic mechanism	high-fat diet (HFD) mouse hepatocytes	lychee pulp phenolics (LPPs) treatment	downregulated in mouse hepatocytes	28121324
361	Mouse	mmu-miR-122	miRNA	penetrating keratoplasty (PKP)	corneal transplantation rejection	BALB/c mice	"the recipients were BALB/s mice, and the donors were C57BL/6 mice. The diameter of the corneal graft was 2?mm treatment"	downregulated	28540063
362	Mouse	mmu-miR-122	miRNA	lipopolysaccharide (LPS)	inflammation	blood	lipopolysaccharide (LPS) treatment	upregulated	27477940
363	Mouse	mmu-miR-122	miRNA	dextran-iron	iron overload (IO)	C57BL/6 mice	feeding mice a 3% dextran-iron diet	downregulated	29176318
364	Mouse	mmu-miR-122	miRNA	oxygen glucose deprivation (OGD)	ischemic brain injury	mouse N2A neuroblastoma (N2A) cells	oxygen-glucose deprivation (OGD) treatment	miR-122 expression was significantly decreased in both N2A cells after OGD	29715465
365	Mouse	mmu-miR-122	miRNA	oxygen glucose deprivation (OGD)	ischemic stroke (IS)	N2a cells	oxygen and glucose deprivation (OGD) treatment	downregulated	33177827
366	Mouse	mmu-miR-122	miRNA	leishmania	leishmaniasis	"the liver and J774 macrophages, and in spleens from infected mice"	Leishmania infection	upregulated	29943317
367	Mouse	mmu-miR-122	miRNA	dietary methyl deficiency	hepatocellular carcinoma (HCC)	the liver tissues	Dietary methyl deficiency treatment	downregulated	20436259
368	Mouse	mmu-miR-122	miRNA	silymarin (Sm)	liver damage	blood and liver tissues	silymarin (Sm) treatment	upregulated	31811641
369	Mouse	mmu-miR-122	miRNA	"2, 3, 7, 8-tetrachlorodibenzo-p-dioxin (TCDD)"	liver damage	mouse liver cells	"2, 3, 7, 8-tetrachlorodi-benzo-p-dioxin (TCDD) treatment"	"TCDD dysregulates the expression of miR101a and miR122 and that COX-2, a target gene of miR101a, plays a significant role in liver damage in mice exposed to TCDD."	21602190
370	Mouse	mmu-miR-122	miRNA	leptin	liver fibrosis	HCS were isolated from adult Kunming mice	leptin treatment	downregulated	29054053
371	Mouse	mmu-miR-122	miRNA	"1,4-bis[2-(3,5-dichloropyridyloxy)]benzene (TCPOBOP)"	liver growth	C57BL/6J male mice liver	"1,4-bis[2-(3,5-dichloropyridyloxy)]benzene (TCPOBOP) treatment"	upregulated in liver	28095325
372	Mouse	mmu-miR-122	miRNA	acetaminophen (APAP)	liver damage	liver tissues	acetaminophen (APAP) treatment	upregulated	19246379
373	Mouse	mmu-miR-122	miRNA	bile duct ligation (BDL)	liver damage	Serum	bile-duct ligation (BDL) treatment	Serum miR-122 increased significantly after BDL-induced cholestatic injury	24086271
374	Mouse	mmu-miR-122	miRNA	isoniazid (INH)	liver damage	liver tissues	isoniazid treatment	downregulated	26535639
375	Mouse	mmu-miR-122	miRNA	isoniazid (INH)	liver damage	liver tissues	isoniazid (INH) treatment	downregulated	27446292
376	Mouse	mmu-miR-122	miRNA	isoniazid (INH)	liver damage	liver tissues	isoniazid (INH) treatment	upregulated	29554950
377	Mouse	mmu-miR-122	miRNA	resveratrol	hepatic steatosis	Sprague-Dawley rats	resveratrol (RS) treatment	downregulated	28375178
378	Mouse	mmu-miR-122	miRNA	free fatty acids (FFAs) inducer CL316243	metabolic syndrome	C57BL/6 mice livers	CL316243 treatment	upregulated	28802563
379	Mouse	mmu-miR-122	miRNA	ischemia/reperfusion (I/R) 	myocardial ischaemic injury	mouse plasma;Bone marrow-derived macrophage (BMDM);Rat neonatal CMs	ischemia/reperfusion (I/R) treatment	differently regulated	28768728
380	Mouse	mmu-miR-122	miRNA	"berberis aristata, elaeis guineensis?and?coffea canephora"	nonalcoholic fatty liver disease (NAFLD)	mouse liver tissues	"Berberis Aristata, Elaeis Guineensis?and?Coffea Canephora treatment"	both these miRNAs had similar levels to SD-mice in HFD+E-mice	33924725
381	Mouse	mmu-miR-122	miRNA	high fat diet (HFD)	nonalcoholic fatty liver disease (NAFLD)	liver tissues	high fat diet (HFD) feed	upregulated	31126802
382	Mouse	mmu-miR-122	miRNA	high fat diet (HFD)	nonalcoholic fatty liver disease (NAFLD)	mouse liver tissues	high fat diet (HFD) feed	both these miRNAs had similar levels to SD-mice in HFD+E-mice	33924725
383	Mouse	mmu-miR-122	miRNA	methionine choline-deficient diet (MCD)	nonalcoholic fatty liver disease (NAFLD)	liver tissue	methionine and choline-deficient treatment	MiR-122 levels increased	24217942
384	Mouse	mmu-miR-122	miRNA	silybin	nonalcoholic fatty liver disease (NAFLD)	FaO cells	silybin treatment	upregulated	31816412
385	Mouse	mmu-miR-122	miRNA	isochlorogenic acid B (ICAB)	nonalcoholic steatohepatitis (NASH)	NASH mouse liver tissues	Isochlorogenic acid B (ICAB) treatment	upregulated	30180301
386	Mouse	mmu-miR-122	miRNA	methionine choline-deficient diet (MCD)	nonalcoholic steatohepatitis (NASH)	liver tissues	methionine- and choline-deficient (MCD) diet feed	downregulated	30180301
387	Mouse	mmu-miR-122	miRNA	high concentration of free fatty acids	nonalcoholic steatohepatitis (NASH)	NCTC-1469 cells	high concentration of free fatty acids treatment	miR-122 levels was downregulated in HFFA-induced NASH cell-like model.	32054840
388	Mouse	mmu-miR-122	miRNA	isochlorogenic acid B (ICAB)	nonalcoholic steatohepatitis (NASH)	non-alcoholic steatohepatitis (NASH) rats liver tissues	Isochlorogenic acid B (ICAB) treatment	upregulated	30180301
389	Mouse	mmu-miR-122	miRNA	metformin (Met)	nonalcoholic steatohepatitis (NASH)	liver tissues	metformin treatment	downregulated	25672270
390	Mouse	mmu-miR-122	miRNA	methionine choline-deficient diet (MCD)	nonalcoholic steatohepatitis (NASH)	liver tissues	methionine- and choline-deficient (MCD) diet feed	downregulated	30180301
391	Mouse	mmu-miR-122	miRNA	methionine choline-deficient diet (MCD)	nonalcoholic steatohepatitis (NASH)	liver tissues	were fed a methionine-choline-deficient (MCD) diet for eight weeks treatment	upregulated	25269746
392	Mouse	mmu-miR-122	miRNA	streptozocin (STZ)	nonalcoholic steatohepatitis (NASH)	high-fat diet mouse	STZ treatment	downregulated	29216638
393	Mouse	mmu-miR-122	miRNA	streptozocin (STZ)	nonalcoholic steatohepatitis-hepatocellular carcinoma (NASH-HCC)	high fat dietmouse liver	STZ treatment	upregulated in liver	28345673
394	Mouse	mmu-miR-122	miRNA	aerobic training	obesity	exosomes of serum	aerobic training	downregulated	32744099
395	Mouse	mmu-miR-122	miRNA	monosodium glutamate (MSG)	obesity	liver tissues	monosodium glutamate (MSG)-injected mice with developed central obesity treatment	dysregulated	24465854
396	Mouse	mmu-miR-122	miRNA	hepatocarcinogen diethylnitrosamine (DEN)	pathological changes in the brain	liver tissue of mice	hepatocarcinogen diethylnitrosamine (DEN) treatment	upregulated	24113455
397	Mouse	mmu-miR-122	miRNA	testosterone	prostate cancer	female mouse liver	Testosterone treatment	"upregulation of the 6 miRNAs miR-22, miR-690, miR-122, let-7A, miR-30D and let-7D"	20600201
398	Mouse	mmu-miR-122	miRNA	soluble egg antigen (SEA)of Schistosoma japonicum	schistosomiasis	mouse hepatocytes (AML12)	SEA treatment	upregulated	29469324
399	Mouse	mmu-miR-122	miRNA	streptozocin (STZ)	smooth muscle cell differentiation	mouse liver	streptozotocin (STZ) treatment	Upregulation of miR-34a and downregulated of miR-122 was found in livers of STZ-induced diabetic mice	19372595
400	Mouse	mmu-miR-122	miRNA	"TCDD (2,3,7,8-tetrachlorodibenzo-p-dioxin)"	thymic atrophy and alterations in T cell differentiation	fetal thymocytes of mice	"TCDD (2,3,7,8-tetrachlorodibenzo-p-dioxin) treatment"	upregulated	23024791
401	Mouse	mmu-miR-122	miRNA	atorvastatin	type 2 diabetes mellitus (T2DM)	C57Bl/6 mice	injected once a day with 20 mg/kg atorvastatin intraperitoneally for 5 days	downregulated	27899485
402	Mouse	mmu-miR-122-3p	miRNA	acetaminophen (APAP)	liver damage	mouse serum	acetaminophen (APAP) treatment	upregulated	30844585
403	Mouse	mmu-miR-122-3p	miRNA	diosbuibin B (DB)	liver damage	mouse serum	diosbuibin B (DB) treatment	upregulated	30844585
404	Mouse	mmu-miR-122-3p	miRNA	ethyl acetate fraction of airpotato yam	liver damage	ICR and C57BL/6 mice	treat with ethyl acetate fraction of airpotato yam	significantly upregulated with no significant elevation of serum ALT/AST activity	28844483
405	Mouse	mmu-miR-122-3p	miRNA	monocrotaline (MCT)	liver damage	mouse serum	monocrotaline (MCT) treatment	upregulated	30844585
406	Mouse	mmu-miR-122-3p	miRNA	toosendanin (TSN)	liver damage	mouse serum	toosendanin (TSN) treatment	upregulated	30844585
407	Mouse	mmu-miR-1224	miRNA	alcohol	alcoholic liver disease (ALD)	mouse liver cells	Lieber-DeCarli alcohol treatment	upragulated	19572984
408	Mouse	mmu-miR-1224	miRNA	methionine choline-deficient diet (MCD)	alcoholic liver disease (ALD)	liver tissues	methionine-choline-deficient (MCD) diets treatment	upragulated	19572984
409	Mouse	mmu-miR-1224	miRNA	clamping the renal pedicle	bilateral renal ischemia	C57Bl/6 mice plasma and kidneys	clamping the renal pedicle treatment	upregulated	24695114
410	Mouse	mmu-miR-1224	miRNA	lipopolysaccharide (LPS)	glioblastoma multiforme (GBM)	spleens of mice	lipopolysaccharide (LPS)? treatment	upregulated	21320120
411	Mouse	mmu-miR-1224	miRNA	dopamine	neurodegeneration (ND)	N2a cells	dopamine treatment	downregulated	30738894
412	Mouse	mmu-miR-1224	miRNA	total-body irradiation (TBI)	radiation nephropathy	mouse urinary	a single LD50 of total-body irradiation (TBI) or clinically relevant fractionated doses (2 Gy twice daily for 3 days) treatment	upregulated in mouse urinary	28977780
413	Mouse	mmu-miR-1224-5p	miRNA	"2, 3, 7, 8-tetrachlorodibenzo-p-dioxin (TCDD)"	bordetella pertussis infection	Pertussis Toxin (PTX) treated mice CD4+ T cells	"2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) treatment"	downregulated	31681214
414	Mouse	mmu-miR-1225-5p	miRNA	nuclear factor kappa-¦¢ ligand (RANKL)	osteoclastogenesis	bone marrow-derived macrophages (BMMs)	nuclear factor kappa-¦¢ ligand (RANKL) treatment	downregulated	31017694
415	Mouse	mmu-miR-1225-5p	miRNA	streptozocin (STZ)	type 1 diabetes mellitus (T1DM)	serum	streptozocin (STZ) treatment	Secretions of miR-1225-5p was significantly increased in streptozotocin-treated mice	29370422
416	Mouse	mmu-miR-122-5p	miRNA	acetaminophen (APAP)	acetaminophen (APAP)-induced liver injury (AILI)	serums	acetaminophen (APAP) treatment	upregulated	32779042
417	Mouse	mmu-miR-122-5p	miRNA	lipopolysaccharide (LPS)	acute kidney injury (AKI)	renal cortex	lipopolysaccharide (LPS) treatment	upregulated	33782973
418	Mouse	mmu-miR-122-5p	miRNA	concanamycin A (Con A)	acute liver failure (ALF)	RAW264.7 cells	concanavalin A (Con A) treatment	upregulated	32739513
419	Mouse	mmu-miR-122-5p	miRNA	lipopolysaccharide (LPS)	acute lung injury (ALI)	Murine lung vascular endothelial cells (MLECs); lung tissues	lipopolysaccharide (LPS) treatment	upregulated	32470454
420	Mouse	mmu-miR-122-5p	miRNA	apigenin	cardiac fibrosis	TGF-¦Â1-treated mouse cardiac fibroblasts	apigenin treatment	upregulated	33607460
421	Mouse	mmu-miR-122-5p	miRNA	TGF-¦Â1	cardiac fibrosis	Mouse cardiac fibroblasts	TGF-¦Â1 treatment	downregulated	33607460
422	Mouse	mmu-miR-122-5p	miRNA	doxorubicin (DOX)	doxorubicin (DOX)-induced cardiotoxicity	Plasma	doxorubicin (DOX) treatment	downregulated	30627229
423	Mouse	mmu-miR-122-5p	miRNA	acetaminophen (APAP)	drug-induced liver injury (DILI)	plasma	acetaminophen (APAP) treatment	miR-122-5p and miR-192-5p were consistently upregulated in early to late stages of all the liver injury models.	30125006
424	Mouse	mmu-miR-122-5p	miRNA	¦¤9-tetrahydrocannabinol (THC) and Cannabidiol (CBD)	experimental autoimmune encephalomyelitis (EAE)	murine brain-derived CD4+ T cells	¦¤9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) combination treatment	downregulated	31497013
425	Mouse	mmu-miR-122-5p	miRNA	fluke Fasciola gigantica (FgESPs)	F. gigantica infection	liver tissues	fluke Fasciola gigantica (FgESPs) infection	downregulated	33332355
426	Mouse	mmu-miR-122-5p	miRNA	perfluorooctanoic acid	hepatotoxicity	liver tissues	Perfluorooctanoic acid (PFOA) exposure treatment	upregulated	24459700
427	Mouse	mmu-miR-122-5p	miRNA	Vaccination during Crisis of Plasmodium chabaudi Blood-Stage Malaria	plasmodium chabaudi infection	Balb/c Mice liver	infect with Vaccination treatment	downregulated in the Liver	28123381
428	Mouse	mmu-miR-122-5p	miRNA	cadmium (Cd)	toxic effects of cadmium	rat kidneys; NRK-52E	cadmium (Cd) treatment	upregulated	31626960
429	Mouse	mmu-miR-122-5p	miRNA	5-chloro-N-[4-chloro-3-(trifluoromethyl)phenyl]thiophene-2-sulfonamide (FX5)	type 2 diabetes mellitus (T2DM)	mouse primary hepatocytes	5-chloro-N-[4-chloro-3-(trifluoromethyl)phenyl]thiophene-2-sulfonamide (FX5)  treatment	FX5 antagonized Dex or glucagon- induced enhancement on miR122-5p expression.	33316780
430	Mouse	mmu-miR-122-5p	miRNA	dexamethasone (DEX)	type 2 diabetes mellitus (T2DM)	mouse primary hepatocytes	dexamethasone (DEX) treatment	upregulated	33316780
431	Mouse	mmu-miR-122-5p	miRNA	glucagon	type 2 diabetes mellitus (T2DM)	mouse primary hepatocytes	glucagon treatment	upregulated	33316780
432	Mouse	mmu-miR-122?5p	miRNA	carbon tetrachloride (CCl4)	hepatotoxicity	blood	carbon tetrachloride (CCl4) treatment	upregulated	32528856
433	Mouse	mmu-miR-122a	miRNA	tumor necrosis factor alpha (TNF-¦Á) 	intestinal inflammation	mice enterocytes	tumor necrosis factor alpha (TNF-¦Á) treatment	upregulated	21763238
434	Mouse	mmu-miR-122a	miRNA	tert-butyl hydroperoxide (TBHP)	oxidative stress	adult male mice strain Balb/c	TBHP treatment	differently regulated	25141839
435	Mouse	mmu-miR-124	miRNA	candida albicans (C. albicans)	acute kidney injury (AKI)	kidney tissues	candida albicans infection	downregulated	29568906
436	Mouse	mmu-miR-124	miRNA	itraconazole (ITR)	acute kidney injury (AKI)	candidiasis-induced acute kidney injury (AKI) mouse kidney tissues	itraconazole (ITR) treatment	upregulated	29568906
437	Mouse	mmu-miR-124	miRNA	d-galactosamine and lipopolysaccharide (LPS)	acute liver injury (ALI)	liver tissues and cells	d-galactosamine and lipopolysaccharide treatment	upregulated	31628693
438	Mouse	mmu-miR-124	miRNA	sedum sarmentosum extract	acute liver injury (ALI)	liver tissues	S. sarmentosum extract treatment	miR-124 was increased in liver tissues after S sarmentosum extract was administered	32178661
439	Mouse	mmu-miR-124	miRNA	forsythoside A (FA)	acute lung injury (ALI)	MLE-12 cells	forsythoside A (FA) treatment	miR-124 expression was upregulated after FA treatment.	32987027
440	Mouse	mmu-miR-124	miRNA	H2O2	acute lung injury (ALI)	primary mouse lung epithelial cells (LECs)	H2O2 treatment	downregulated	31938089
441	Mouse	mmu-miR-124	miRNA	hyperoxia	acute lung injury (ALI)	primary mouse lung epithelial cells (LECs)	hyperoxia treatment	downregulated	31938089
442	Mouse	mmu-miR-124	miRNA	lipopolysaccharide (LPS)	acute lung injury (ALI)	lung tissues	lipopolysaccharides (LPS) treatment	downregulated	31476692
443	Mouse	mmu-miR-124	miRNA	Mito-TEMPO	acute lung injury (ALI)	hyperoxia-/H2O2-treated primary mouse lung epithelial cells (LECs)	Mito-TEMPO treatment	upregulated	31938089
444	Mouse	mmu-miR-124	miRNA	N-acetyl-L-cysteine (NAC)	acute lung injury (ALI)	hyperoxia-/H2O2-treated primary mouse lung epithelial cells (LECs)	N-acetyl-L-cysteine (NAC) treatment	upregulated	31938089
445	Mouse	mmu-miR-124	miRNA	lithium (Li)	acute poststroke	brain tissues	lithium (1 mg/kg bolus followed by 2 mg/kg/day over up to 7 days) was intraperitoneally administered starting 0-9 h after reperfusion onset	upregulated in brain	27126323
446	Mouse	mmu-miR-124	miRNA	insulin	adipogenesis	3T3-L1 cells	Insulin treatment	"insulin-induced miR-124 plays a pivotal role in post-transcriptional regulation of Dlx5 during adipogenic differentiation and that miR-124 exerts pro-adipogenic effects by targeting Dlx5, at least in part"	23648570
447	Mouse	mmu-miR-124	miRNA	"3,4-dihydroxyphenylethanol (DOPET)"	Alzheimer's disease (AD)	oA42i (oligomeric amyloid ¦Â1-42 plus ibotenic acid) induced AD mouse hippocampi	"3,4-dihydroxyphenylethanol (DOPET) treatment"	upregulated	29901389
448	Mouse	mmu-miR-124	miRNA	bilateral common carotid artery occlusion (2-VO)	Alzheimer's disease (AD)	hippocampus tissues of AD mouse	bilateral common carotid artery?occlusion (2VO) induce	The expression of miR-124 was significantly downregulated in 2VO-induced AD mice models	31743528
449	Mouse	mmu-miR-124	miRNA	H2O2	Alzheimer's disease (AD)	N2a mouse neuroblastoma cells	Hydrogen peroxide (H2O2)?treatment	The expression of miR-124 was significantly downregulated in H2O2-treated N2a cells	31743528
450	Mouse	mmu-miR-124	miRNA	oA42i (oligomeric amyloid ¦Â1-42 plus ibotenic acid)	Alzheimer's disease (AD)	hippocampi	oA42i (oligomeric amyloid ¦Â1-42 plus ibotenic acid) treatment	downregulated	29901389
451	Mouse	mmu-miR-124	miRNA	streptozocin (STZ)	Alzheimer's disease (AD)	mouse brain tissues	streptozocin treatment	downregulated	31014193
452	Mouse	mmu-miR-124	miRNA	H2O2	Alzheimer's disease (AD)	N2a cells	Hydrogen peroxide (H2O2 ) treatment	miR-124 expression level was upregulated in H2O2-treated N2a cells.	31743528
453	Mouse	mmu-miR-124	miRNA	ischemia	apoptosis	brain tissues	ischemia?treatment	upregulated	23826665
454	Mouse	mmu-miR-124	miRNA	folate	apoptosis	mouse embryonic stem cells (mESCs)	folate deficiency induced	upregulated	22828209
455	Mouse	mmu-miR-124	miRNA	arsenite	arsenic induted deficits in differentiation	prenatal C57BL/6 mouse brain	arsenic (As) exposure	downregulated	27751817
456	Mouse	mmu-miR-124	miRNA	metformin (Met)	atherosclerosis (AS)	carotid	Metformin treatment	Administration of metformin reduced miR-124 expression.	29502204
457	Mouse	mmu-miR-124	miRNA	IL-4 and IL-13	breast cancer	macrophages	IL-4 and IL-13 treatment	upregulated	24358127
458	Mouse	mmu-miR-124	miRNA	doxorubicin (DOX)	cardiac injury	heart sissues; primary cardiomyocytes	doxorubicin treatment	MiR-124 was downregulated in Dox-induced cardiac injury.	31672275
459	Mouse	mmu-miR-124	miRNA	doxorubicin (DOX)	cardiotoxicity	heart tissues and primary cardiomyocytes	doxorubicin treatment	downregulated	31672275
460	Mouse	mmu-miR-124	miRNA	melatonin	cell proliferation	hippocampus dentate gyrus tissues	melatonin treatment	upregulated	31169197
461	Mouse	mmu-miR-124	miRNA	paclitaxel (PTX)	chemotherapy-induced peripheral neuropathy (CiPN)	mouse dorsal root ganglion (DRG) and sciatic nerve tissues	Paclitaxel treatment	upregulated	30677061
462	Mouse	mmu-miR-124	miRNA	lipopolysaccharide (LPS)	cholinergic anti-inflammatory action	Mouse macrophage cell line RAW264.7 ;human HEK293 cell line	lipopolysaccharide (LPS) treatment	miR-124 is upregulated by cholinergic agonists in LPS-exposed cells and mice	23979021
463	Mouse	mmu-miR-124	miRNA	"5-Aza-2'-deoxycytidine (5-Aza-dC, decitabine)"	chondrogenesis	C3H10T1/2 cells	"5-Aza-2'-deoxycytidine (5-Aza-dC, decitabine) treatment"	upregulated	28979686
464	Mouse	mmu-miR-124	miRNA	hypoxia	chondrogenesis	C3H10T1/2 cells	under hypoxic conditions (2% O2)	downregulated	28979686
465	Mouse	mmu-miR-124	miRNA	collagen	collagen-induced arthritis (CIA)	synovial tissues	collagen treatment	downregulated	33337986
466	Mouse	mmu-miR-124	miRNA	vitamin D	collagen-induced arthritis (CIA)	Th17 cells	vitamin D (VD) treatment	upregulated	30792721
467	Mouse	mmu-miR-124	miRNA	kainic acid (KA)	convulsive seizures	hippocampal neural stem/progenitor cells (NSPCs)	kainic acid (KA) treatment	upregulated	30837840
468	Mouse	mmu-miR-124	miRNA	oxidized low density lipoprotein (ox-LDL)	coronary artery disease (CAD)	RAW264.7 cells	oxidized low-density lipoprotein (ox-LDL) treatment	downregulated	32611832
469	Mouse	mmu-miR-124	miRNA	resveratrol	experimental autoimmune encephalomyelitis (EAE)	encephalitogenic CD4+ T cells from EAE mice	"Resveratrol (3,5,4'-trihydroxy-trans-stilbene) (RES) treatment"	upregulated	30941623
470	Mouse	mmu-miR-124	miRNA	TGF-¦Â1	fibrogenesis	Lung resident mesenchymal stem cells (LR-MSCs)	transforming growth factor (TGF)-¦Â1 treatment	upregulated	30802451
471	Mouse	mmu-miR-124	miRNA	angiotensin II (Ang II)	heart failure (HF)	heart tissues	angiotensin II (Ang II) treatment	upregulated	29581851
472	Mouse	mmu-miR-124	miRNA	shikonin	heart failure (HF)	heart tissues	Shikonin treatment	downregulated	31604527
473	Mouse	mmu-miR-124	miRNA	morphine	immune response	microglia	morphine treatment	upregulated	25539811
474	Mouse	mmu-miR-124	miRNA	IL-1¦Â	inflammation	ATDC5 cells	interleukin-1¦Â treatment	downregulated	31608709
475	Mouse	mmu-miR-124	miRNA	lipopolysaccharide (LPS)	inflammation	Mouse macrophage cell line RAW264.7	lipopolysaccharide (LPS) treatment	upregulated	27063215
476	Mouse	mmu-miR-124	miRNA	lipopolysaccharide (LPS)	inflammation	ATDC5 cells	lipopolysaccharide (LPS) treatment	downregulated	31190561
477	Mouse	mmu-miR-124	miRNA	lycium barbarum polysaccharide (LBP)	inflammation	interleukin-1¦Â-treated ATDC5 cells	Lycium barbarum polysaccharide (LBP) treatment	upregulated	31608709
478	Mouse	mmu-miR-124	miRNA	bacillus calmette-guerin (BCG)	inflammatory response	RAW264.7 AM cells	bacillus calmette-guerin (BCG) treatment	upregulated	24995397
479	Mouse	mmu-miR-124	miRNA	ischemia	ischemia/reperfusion (I/R) injury	cerebral cortex and hippocampus	Ischemic preconditioning and ischemic postconditioning (IPostC) treatment	downregulated	27485299
480	Mouse	mmu-miR-124	miRNA	chronic unpredictable mild stress (CUMS)	major depressive disorder (MDD)	hippocampus tissues	chronic unpredictable mild stress (CUMS) treatment	downregulated	31626919
481	Mouse	mmu-miR-124	miRNA	lipopolysaccharide (LPS)	major depressive disorder (MDD)	BV2 cells	lipopolysaccharide (LPS) treatment	downregulated	31626919
482	Mouse	mmu-miR-124	miRNA	methamphetamine (METH)	methamphetamine (METH) addiction	precursors	methamphetamine (METH) treatment	downregulated	29516602
483	Mouse	mmu-miR-124	miRNA	mycobacterium bovis bacille Calmette-Gu¨¦rin (BCG)	mycobacterium tuberculosis (Mtb) infection	female C57/BL6 mice	infect with Mycobacterium bovis BCG treatment	upregulated in lungs	24705038
484	Mouse	mmu-miR-124	miRNA	H2O2	myocardial infarction (MI)	neonatal rat ventricular myocytes (NRVMs)	H2O2 treatment	miR-124 was significantly upregulated in a mice model of MI and in neonatal rat ventricular myocytes (NRVMs) with H2O2 treatment.	30439699
485	Mouse	mmu-miR-124	miRNA	H2O2	myocardial infarction (MI)	primary cardiomyocyte	H2O2 treatment	upregulated	31100313
486	Mouse	mmu-miR-124	miRNA	hypoxia	myocardial infarction (MI)	primary cardiomyocyte	hypoxia induce	upregulated	31100313
487	Mouse	mmu-miR-124	miRNA	hypoglossal nerve injury	nerve injury	injured hypoglossal motor neurons	injury mouse nerve treatment	downregulated	24184980
488	Mouse	mmu-miR-124	miRNA	retinoic acid (RA)	cell differentiation	L929 cells	retinoic acid? treatment	upregulated	31823894
489	Mouse	mmu-miR-124	miRNA	ketamine	neurodegeneration (ND)	murine hippocampus	high-dosage ketamine treatment	upregulated	24825585
490	Mouse	mmu-miR-124	miRNA	lipopolysaccharide (LPS)	neuroinflammation	N9 microglia	lipopolysaccharide (LPS) treatment	downregulated	28096568
491	Mouse	mmu-miR-124	miRNA	cocaine	neuronal adaptations	NG-108-15 cells£» HEK293T cells	cocaine treatment	"LV-miR-124 and let-7d expression in the NAc attenuates cocaine CPP, whereas LV-miR-181a enhances it"	21307844
492	Mouse	mmu-miR-124	miRNA	cocaine	neuronal function	mouse nucleus accumbens (NAc)	cocaine treatment	cocaine treatment persistently downregulated miR-124 in NAc.	32641757
493	Mouse	mmu-miR-124	miRNA	extra-virgin olive oil rich in phenols (H-EVOO)	neuronal function	cortex	H-EVOO treatment	upregulated	26695409
494	Mouse	mmu-miR-124	miRNA	ketamine	neurotoxicity	Hippocampal	ketamine treatment	upregulated	24825585
495	Mouse	mmu-miR-124	miRNA	morphine	opioid-induced damage to microglia	mouse BV2 cells	morphin treatment	upregulated	25539811
496	Mouse	mmu-miR-124	miRNA	IL-6	osteoclastogenesis	M-CSF stimulated mouse bone marrow-derived macrophages	IL-6 treatment	downregulated	30547186
497	Mouse	mmu-miR-124	miRNA	tumor necrosis factor alpha (TNF-¦Á) 	osteoclastogenesis	M-CSF stimulated mouse bone marrow-derived macrophages	tumor necrosis factor alpha (TNF-¦Á) treatment	downregulated	30547186
498	Mouse	mmu-miR-124	miRNA	macrophage colony stimulating factor (M-CSF)	osteoporosis	bone marrow monocytes (BMMs) from OVX mice	co-cultured with RANKL (50 ng/ml) containing M-CSF (20ng/ml)	downregulated	29045940
499	Mouse	mmu-miR-124	miRNA	"1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)"	parkinson's disease (PD)	mouse brain tissues	"1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) treatment"	downregulated	30995872
500	Mouse	mmu-miR-124	miRNA	lipopolysaccharide (LPS)	parkinson's disease (PD)	immortalized murine microglial cell line BV2 cells	lipopolysaccharide (LPS) treatment	downregulated	30995872
501	Mouse	mmu-miR-124	miRNA	"1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)"	parkinson's disease (PD)	brian tissues	"1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) treatment"	downregulated in the expression of brain-enriched miR-124	24792712
502	Mouse	mmu-miR-124	miRNA	lipopolysaccharide (LPS)	parkinson's disease (PD)	BV2 cells	lipopolysaccharide (LPS) treatment	Brain-specific miR-124 was downregulated in the LPS- stimulated BV2 cells.	29329581
503	Mouse	mmu-miR-124	miRNA	docosahexaenoic acid (DHA)	spinal cord injury (SCI)	BV-2 mouse microglial cells	Docosahexaenoic acid (DHA) treatment	upregulated	30972415
504	Mouse	mmu-miR-124	miRNA	H2O2	spinal cord injury (SCI)	BV-2 cells	H2O2 treatment	downregulated	30720072
505	Mouse	mmu-miR-124	miRNA	nicotine	ulcerative colitis (UC)	ulcerative colon	Nicotine treatment	upregulated	27709266
506	Mouse	mmu-miR-124-3p	miRNA	lipopolysaccharide (LPS)	acute respiratory distress syndrome (ARDS)	lung tissues	lipopolysaccharide (LPS) treatment	downregulated	32391561
507	Mouse	mmu-miR-124-3p	miRNA	lipopolysaccharide (LPS)	acute respiratory distress syndrome (ARDS)	serum	lipopolysaccharide (LPS) treatment	downregulated	32934950
508	Mouse	mmu-miR-124-3p	miRNA	myostatin	adipogenesis	3T3-L1 cells	myostatin treatment	upregulated	30576242
509	Mouse	mmu-miR-124-3p	miRNA	myostatin	adipogenesis	3T3-L1 cells	myostatin treatment	upregulated	30576242
510	Mouse	mmu-miR-124-3p	miRNA	carbon tetrachloride (CCl4)	liver fibrosis	liver tissues	carbon tetrachloride (CCl4) treatment	downregulated	30673982
511	Mouse	mmu-miR-124-3p	miRNA	rosiglitazone	liver fibrosis	TGF-¦Â1 treated primary mouse hepatic stellate cells (HSCs)	Rosiglitazone (RGZ) treatment	upregulated	30673982
512	Mouse	mmu-miR-124-3p	miRNA	rosiglitazone	liver fibrosis	carbon tetrachloride (CCl4) treated mouse liver tissues	Rosiglitazone (RGZ) treatment	upregulated	30673982
513	Mouse	mmu-miR-124-3p	miRNA	TGF-¦Â1	liver fibrosis	Primary mouse hepatic stellate cells (HSCs)	TGF-¦Â1 treatment	downregulated	30673982
514	Mouse	mmu-miR-124-3p	miRNA	repetitive traumatic brain injury (rTBI) mouse model brain extracts	nerve injury	BV2 microglia	repetitive traumatic brain injury (rTBI) mouse model brain extracts treatment	upregulated	31190315
515	Mouse	mmu-miR-124-3p	miRNA	high fat diet (HFD)	nonalcoholic fatty liver disease (NAFLD)	liver tissues	high fat diet (HFD) feed	"In response to high-fat diet (HFD), expression of miR-124-3p was increased in the liver."	33324345
516	Mouse	mmu-miR-124-3p	miRNA	"1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)"	parkinson's disease (PD)	substantia nigra (SN) area	"1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) treatment"	"?HOXA11-AS promoted MPTP-mediated SH-SY5Y neuronal injury and LPS-induced microglia activation, while miR-124-3p had the opposite effects."	33839699
517	Mouse	mmu-miR-124-3p	miRNA	lipopolysaccharide (LPS)	parkinson's disease (PD)	BV2 cells	lipopolysaccharide (LPS) treatment	downregulated	33839699
518	Mouse	mmu-miR-124-3p	miRNA	hypoxia	pulmonary hypertension (PH)	pulmonary arterial smooth muscle cells (PASMCs)	hypoxia treatment	downregulated	33657879
519	Mouse	mmu-miR-124-3p	miRNA	lipopolysaccharide (LPS)	severe community-acquired pneumonia (SCAP)	Ana-1 macrophages	lipopolysaccharide (LPS) treatment	downregulated	30535475
520	Mouse	mmu-miR-124-3p	miRNA	lipopolysaccharide (LPS)	severe community-acquired pneumonia (SCAP)	Ana-1 macrophages	lipopolysaccharide (LPS) treatment	downregulated	30535475
521	Mouse	mmu-miR-1244	miRNA	curcumin (Cur)	nasopharyngeal carcinoma (NPC)	mice	injected into the tumour centre at a concentration of 150 mg/kg treatment	dysregulated	24896104
522	Mouse	mmu-miR-124-5p	miRNA	lipopolysaccharide (LPS)	acute lung injury (ALI)	mouse Alveolar Type 2 Epithelial Cells.	lipopolysaccharide (LPS) treatment	MiR-124-5p is increased in the LPS-induced ALI cell model.	32190682
523	Mouse	mmu-miR-124-5p	miRNA	tanshinone IIA (Tan IIA)	acute myocardial infarction (AMI)	H9c2 cells	Tanshinone IIA (TSA) treatment	"TSA exerts the protective role against H/R induced apoptosis, oxidative and MMP loss of cardiomyocytes via regulating AK003290 and miR-124-5p signaling"	32220226
524	Mouse	mmu-miR-124-5p	miRNA	chronic unpredictable mild stress (CUMS)	major depressive disorder (MDD)	nucleus accumbens (NAc) tissues	chronic unpredictable mild stress (CUMS) induce	downregulated	30936699
525	Mouse	mmu-miR-1246	miRNA	lipopolysaccharide (LPS)	acute lung injury (ALI)	lung tissues	lipopolysaccharide (LPS) treatment	"In ALI mice, miRNA-1246 expression is effectively upregulated."	30253370
526	Mouse	mmu-miR-1246	miRNA	alcohol	alcoholic hepatitis (AH)	sera	alcohol exposure	upregulated	26264599
527	Mouse	mmu-miR-1247	miRNA	carbon tetrachloride (CCl4)	acute kidney injury (AKI)	mouse liver	carbon tetrachloride (CCl4) treatment	upregulated	28285099
528	Mouse	mmu-miR-1247-3p	miRNA	oxygen-glucose deprivation and reoxygenation (OGD/R)	stroke	neuro2a (N2a) cells	oxygen-glucose deprivation and reoxygenation (OGD/R) treatment	downregulated	30779911
529	Mouse	mmu-miR-1249	miRNA	chronic intermittent hypoxia (CIH)	obstructive sleep apnoea-hypopnoea syndrome (OSAHS)	mouse aortic endothelial cells (MAECs)	chronic intermittent hypoxia (CIH) treatment	upregulated	29108914
530	Mouse	mmu-miR-1249-5p	miRNA	Sphingosine-1-phosphate (S1P)	liver disease	liver tissues; liver macrophages	sphingosine 1-phosphate (S1P) treatment	downregulated	32672363
531	Mouse	mmu-miR-1249-5p	miRNA	X-rays	radiation-induced injury	bone marrow stem cells	X-ray treatment	"mmu-circRNA_016901 affects the expression of TGF-¦Â3 through miRNA1249-5p, and thus participates in the regulation of the radiation damage mechanism of bone marrow mesenchymal stem cells"	32552977
532	Mouse	mmu-miR-124a	miRNA	duloxetine	depression	frontal lobe and hippocampus	duloxetine treatment	downregulated	26823914
533	Mouse	mmu-miR-124a	miRNA	neurotoxicant sodium valproate (VPA)	developmental toxicity	murine embryonic stem cells (mESCs)	neurotoxicant sodium valproate (VPA) treatment	downregulated	24896083
534	Mouse	mmu-miR-124a	miRNA	exenatide (EXA)	insulin sensitivity	pancreas	exenatide treatment	"The levels of miRNA-15a, 29c, 124a, and 375 in the pancreas were significantly increased in HFD control mice.These effects were reversed by treatment with exenatide."	26314504
535	Mouse	mmu-miR-124a	miRNA	exenatide (EXA)	insulin sensitivity	liver	exenatide treatment	"the levels of miRNA-29c, 124a, and 146a in the liver were significantly increased. These effects were reversed by treatment with exenatide."	26314504
536	Mouse	mmu-miR-124a	miRNA	exenatide (EXA)	insulin sensitivity	muscle	exenatide treatment	"The levels of miRNA-15a, 29c, 124a, and 146a in the muscle were significantly increased. These effects were reversed by treatment with exenatide."	26314504
537	Mouse	mmu-miR-124a	miRNA	exenatide (EXA)	insulin sensitivity	serum	exenatide treatment	"the levels of miRNA-15a, 29c, 124a, and 375 in the serum were significantly decreased. These effects were reversed by treatment with exenatide."	26314504
538	Mouse	mmu-miR-124a	miRNA	high fat diet (HFD)	insulin sensitivity	pancreas	high fat diet (HFD) feed	upregulated	26314504
539	Mouse	mmu-miR-124a	miRNA	high fat diet (HFD)	insulin sensitivity	liver	high fat diet (HFD) feed	upregulated	26314504
540	Mouse	mmu-miR-124a	miRNA	high fat diet (HFD)	insulin sensitivity	muscle	high fat diet (HFD) feed	upregulated	26314504
541	Mouse	mmu-miR-124a	miRNA	high fat diet (HFD)	insulin sensitivity	serum	high fat diet (HFD) feed	downregulated	26314504
542	Mouse	mmu-miR-124a	miRNA	high fat diet (HFD)	nonalcoholic fatty liver disease (NAFLD)	liver tissues	high fat diet (HFD) feed	upregulated	30861258
543	Mouse	mmu-miR-124a	miRNA	liraglutide	nonalcoholic fatty liver disease (NAFLD)	high fat diet-fed mice liver tissues	liraglutide treatment	downregulated	30861258
544	Mouse	mmu-miR-124a	miRNA	bone morphogenetic proteins (BMPs)	osteogenesis	pluripotent stem (iPS) cells	bone morphogenetic proteins (BMPs) treatment	downregulated	22937097
545	Mouse	mmu-miR-125	miRNA	xanthomicrol	breast cancer	4T1 cells	xanthomicrol treatment	downregulated	33217075
546	Mouse	mmu-miR-125	miRNA	carbon tetrachloride (CCl4)	liver fibrosis	hepatic tissue	carbon tetrachloride (CCl4) treatment	Exos delivery of mmu_circ_0000623 inhibited liver fibrosis protein expression by promoting miR- 125/ATG4D-mediated autophagy.	32633558
547	Mouse	mmu-miR-125a	miRNA	pristane (PS)	"acute ""SLE-like"" lung inflammation"	lung tissues	pristane treatment	downregulated	30089723
548	Mouse	mmu-miR-125a	miRNA	candida albicans (C. albicans)	Alzheimer's disease (AD)	mouse macrophages	candida albicans infection	upregulated	21060679
549	Mouse	mmu-miR-125a	miRNA	histone deacetylase inhibitors (HDIs) short-chain fatty acid (SCFA) butyrate	antibody-mediated systemic autoimmunity	B cells	SCFA HDI butyrate treatment	upregulated	32265934
550	Mouse	mmu-miR-125a	miRNA	mycobacterium tuberculosis (Mtb)	autophagy	lungs tissues;spleens tissues;liver tissues	M. tuberculosis treatment	upregulated	25917095
551	Mouse	mmu-miR-125a	miRNA	bilobalide (BB)	inflammation	IL-17-treated ATDC5 cells	bilobalide (BIL) treatment	downregulated	31593333
552	Mouse	mmu-miR-125a	miRNA	IL-17	inflammation	ATDC5 cells	?interleukin (IL)-17 treatment	upregulated	31593333
553	Mouse	mmu-miR-125a	miRNA	high fat diet (HFD)	obesity	liver tissues	high fat diet (HFD) feed	miR-125a levels was downregulated in livers of mice fed chow or HF diet.	31988048
554	Mouse	mmu-miR-125a	miRNA	high fat diet (HFD)	obesity	BALB/c and C57BL/6J mice adipose tissue	high fat diet (HFD) feed	upregulated	24675842
555	Mouse	mmu-miR-125a	miRNA	bone morphogenetic protein 9 (BMP9)	osteogenesis	The conditionally immortalized mouse multipotent adipose-derived cells iMADs	bone morphogenetic protein 9 (BMP9) treatment	downregulated	31825894
556	Mouse	mmu-miR-125a-3p	miRNA	MOG 35-55 peptide	experimental autoimmune encephalomyelitis (EAE)	oligodendrocyte precursor cells (OPCs)	MOG35-55 treatment	miR-125a-3p is upregulated in OPCs isolated from the spinal cord of chronic experimental autoimmune encephalomyelitis (EAE) mice.	32163190
557	Mouse	mmu-miR-125a-3p	miRNA	Legionella pneumophila (L. pneumophila)	Legionella pneumophila (L. pneumophila) infection	WT and MyD88-/- murine bone marrow-derived macrophages (BMM)	infected with L. pneumophila	downregulated	28445535
558	Mouse	mmu-miR-125a-3p	miRNA	urocortin 1 (Ucn-1)	myocardial ischemia/reperfusion (I/R) injury (MIRI)	I/R mosue	administration of Ucn-1 at the beginning of reperfusion treatment	upregulated	28827743
559	Mouse	mmu-miR-125a-3p	miRNA	silica	lung fibrosis	lung tissues	silica treatment	downregulated	30658076
560	Mouse	mmu-miR-125a-3p	miRNA	TGF-¦Â1	lung fibrosis	NIH/3T3 cells	TGF-¦Â1 treatment	downregulated	30658076
561	Mouse	mmu-miR-125a-5p	miRNA	lipopolysaccharide (LPS)	acute kidney injury (AKI)	RAW264.7 macrophages	lipopolysaccharide (LPS) treatment	downregulated	32388658
562	Mouse	mmu-miR-125a-5p	miRNA	inorganic nitrite	acute myocardial infarction (AMI)	heart tissues	single-dose of nitrite	downregulated	28090786
563	Mouse	mmu-miR-125a-5p	miRNA	ischemia/reperfusion (I/R) 	acute myocardial infarction (AMI)	heart tissues	ischemia/reperfusion (I/R) treatment	upregulated	28090786
564	Mouse	mmu-miR-125a-5p	miRNA	folate	apoptosis	mouse embryonic stem cells (mESCs)	folate deficiency induced	upregulated	22828209
565	Mouse	mmu-miR-125a-5p	miRNA	histone deacetylase inhibitor (HDACi)	B cell differentiation	B cells of C57BL/6J	"stimulated with LPS and IL-4 and treated with HDI (VPA, 500 ?M) or nil for 60 h"	upregulated	28994753
566	Mouse	mmu-miR-125a-5p	miRNA	high glucose (HG)	diabetic nephropathy (DN)	Mouse podocytes (MPC5)	high glucose treatment	downregulated	30095204
567	Mouse	mmu-miR-125a-5p	miRNA	echinococcus multilocularis metacestodes	echinococcus multilocularis infection	RAW 264.7 cells	E. multilocularis metacestodes treatment	upregulated	30322806
568	Mouse	mmu-miR-125a-5p	miRNA	myelin oligodendrocyte glycoprotein	experimental autoimmune encephalomyelitis (EAE)	spinal ventral horn of EAE mice	myelin oligodendrocyte glycoprotein 35-55 peptides treatment	upregulated	31428926
569	Mouse	mmu-miR-125a-5p	miRNA	myelin oligodendrocyte glycoprotein	experimental autoimmune encephalomyelitis (EAE)	lumbosacral spinal cord	myelin oligodendrocyte glycoprotein 35-55 peptides treatment	upregulated	31428926
570	Mouse	mmu-miR-125a-5p	miRNA	high fat diet (HFD)	hepatocellular carcinoma (HCC)	plasma and hepatic tissues	high fat diet (HFD) feed	upregulated	26728044
571	Mouse	mmu-miR-125a-5p	miRNA	E. multilocularis metacestodes	infection and immunity of E. multilocularis	RAW264¡¤7 macrophage cells	E. multilocularis metacestodes for 6 and 12 h treatment	"upregulated (mmu-miR-378d,mmu-miR-155-5p, mmu-miR-146a-5p, mmu-miR-21a-5p , mmu-miR-125a-5p) and downregulated(mmu-miR-1981-5p , mmu-miR-let-7c-1-3p)"	28942753
572	Mouse	mmu-miR-125a-5p	miRNA	curcumin (Cur)	nasopharyngeal carcinoma (NPC)	mice	injected into the tumour centre at a concentration of 150 mg/kg treatment	dysregulated	24896104
573	Mouse	mmu-miR-125a-5p	miRNA	gefitinib	nasopharyngeal carcinoma (NPC)	NPC tumor bearing-mice serum	geftinib treatment	upregulated	24602316
574	Mouse	mmu-miR-125a-5p	miRNA	high fat diet (HFD)	obesity	obesity	high fat diet (HFD) feed	downregulated	29393878
575	Mouse	mmu-miR-125a-5p	miRNA	macrophage colony-stimulating factor (M-CSF) and receptor activator of NF-¦ÊB ligand (RANKL)	osteoclastogenesis	RAW 264.7 osteoclast precursor cell	RANKL plus M-CSF treatment	upregulated	30976285
576	Mouse	mmu-miR-125a-5p	miRNA	paraquat (PQ)	paraquat (PQ)-induced acute lung injury and pulmonary fibrosis	MLE-12 cells	paraquat (PQ) treatment	downregulated	32741895
577	Mouse	mmu-miR-125a-5p	miRNA	anandamide (AEA)	pro-inflammatory activity	mouse	anandamide treatment	AEA differentil regulate the expression of miRNA	24699635
578	Mouse	mmu-miR-125a-5p	miRNA	triptolide (TPL)	systemic lupus erythematosus (SLE)	MRL/lpr mice serum	triptolide (TPL) treatment	upregulated	30861393
579	Mouse	mmu-miR-125a-5p	miRNA	dioscin	type 2 diabetes mellitus (T2DM)	high-fat diet-induced T2DM KK-Ay mice tissues	dioscin treatment	upregulated	31881477
580	Mouse	mmu-miR-125a-5p	miRNA	high fat diet (HFD)	type 2 diabetes mellitus (T2DM)	liver tissues	streptozotocin treatment	downregulated	31881477
581	Mouse	mmu-miR-125a-5p	miRNA	palmitic acid (PA)	type 2 diabetes mellitus (T2DM)	AML12 cells	palmitic acid treatment	downregulated	30555566
582	Mouse	mmu-miR-125a-5p	miRNA	dioscin	type 2 diabetes mellitus (T2DM)	AML12 cells	dioscin treatment	Dioscin was found to markedly elevate miR-125a-5p level and decrease STAT3 expression.	31881477
583	Mouse	mmu-miR-125b	miRNA	amyloid-¦Â (A¦Â)	Alzheimer's disease (AD)	Mouse primary hippocampal neurons	amyloid-¦Â (A¦Â) treatment	upregulated	30706990
584	Mouse	mmu-miR-125b	miRNA	melatonin	Alzheimer's disease (AD)	A¦Â-treated mouse primary hippocampal neurons	melatonin treatment	downregulated	30706990
585	Mouse	mmu-miR-125b	miRNA	epigallocatechin-3-gallate (EGCG)	Alzheimer's disease (AD)	AD mouse serum	EGCG treatment groups (2 mg/kg/day)	upregulated	28731435
586	Mouse	mmu-miR-125b	miRNA	estradiol-17¦Â (E2)	Alzheimer's disease (AD)	Primary cortical neurons	estradiol-17¦Â (E2) treatment	upregulated	27235580
587	Mouse	mmu-miR-125b	miRNA	ethanol (EtOH)	apoptosis	neural crest cells (NCCs)	ethanol treatment	downregulated	26024858
588	Mouse	mmu-miR-125b	miRNA	alcohol	brain injury and neurodegeneration	cerebral cortex	chronic alcohol administration	upregulated	30374194
589	Mouse	mmu-miR-125b	miRNA	androgen receptor (ASC-J9 ?)	cardiac fibrosis	cardiac fibroblasts (CFs)	androgen receptor (ASC-J9 ?) treatment	ASC-J9 ? attenuates the expression of miR-125b.	30340830
590	Mouse	mmu-miR-125b	miRNA	interleukin-1 receptor antagonist protein (IRAP)	cartilage impact injury	porcine knee joint	Interleukin-1 Receptor Antagonist Protein (IRAP) treatment	upregulated	26521750
591	Mouse	mmu-miR-125b	miRNA	oxyELITE pro-new formula (OEP-NF)	drug-induced liver injury (DILI)	female B6C3F1 mice liver	administering 10X and 3X mouse-equivalent doses (MED) of OEP-NF treatment	upregulated in the liver	28843594
592	Mouse	mmu-miR-125b	miRNA	cocaine	effects of cocaine action	dopaminergic neuronal cells and nucleus accumbens (NAc) of mice	acute and chronic cocaine exposure	downregulated	28828398
593	Mouse	mmu-miR-125b	miRNA	cyclophosphamide	embryonic maldevelopment	the fore- and hindlimbs of mice	cyclophosphamide treatment	downregulated	20170545
594	Mouse	mmu-miR-125b	miRNA	estrogen (ES)	hepatic steatosis	liver	estrogen treatment	upregulated	26272872
595	Mouse	mmu-miR-125b	miRNA	ganoderma lucidum polysaccharides (GLPs)	hepatocellular carcinoma (HCC)	mouse hepatoma H22 cell line	Ganoderma lucidum polysaccharides (GLPS) treatment	upregulated	25889022
596	Mouse	mmu-miR-125b	miRNA	aluminum-sulfate	inflammatory neurodegeneration	C57BL/6J mice blood	serum exposure to a standard mouse diet that included aluminum-sulfate	upregulated	29354323
597	Mouse	mmu-miR-125b	miRNA	¦Ã-rays	irradiation-induced tumors	bone marrow (BM)	low-power long-term ¦Ã-irradiation	downregulated	32483710
598	Mouse	mmu-miR-125b	miRNA	hypoxia	ischemic injury	bone marrow mesenchymal stem cells (BM-MSCs)	hypoxia treatment	upregulated	30613290
599	Mouse	mmu-miR-125b	miRNA	ultraviolet (UV) irradiation	ischemic tolerance	mouse embryonic fibroblast cells	ultraviolet radiation (UV) treatment	UV radiation induces upregulated of miR-125b	22854965
600	Mouse	mmu-miR-125b	miRNA	isoniazid (INH)	liver damage	liver tissues	isoniazid (INH) treatment	upregulated	29554950
601	Mouse	mmu-miR-125b	miRNA	ischemia/reperfusion (I/R) 	myocardial ischemia/reperfusion (I/R) injury (MIRI)	heart tissues	ischemia/reperfusion (I/R) treatment	upregulated	24576954
602	Mouse	mmu-miR-125b	miRNA	retinoic acid (RA)	cell differentiation	Neuro-2A cells	retinoic acid? treatment	downregulated	31823894
603	Mouse	mmu-miR-125b	miRNA	streptozocin (STZ)	nonalcoholic steatohepatitis-hepatocellular carcinoma (NASH-HCC)	high fat dietmouse liver	STZ treatment	upregulated in liver	28345673
604	Mouse	mmu-miR-125b	miRNA	lipopolysaccharide (LPS)	osteoarthritis (OA)	ATDC5 cells	lipopolysaccharides (LPS) treatment	downregulated	29550827
605	Mouse	mmu-miR-125b	miRNA	lipopolysaccharide (LPS)	osteoarthritis (OA)	ATDC5 cells	lipopolysaccharide (LPS) treatment	Overexpression of THRIL promoted LPS-induced ATDC5 cell inflammatory injury by down-regulating miR-125b and then activating JAK1/STAT3 and NF-¦ÊB pathways.	30521964
606	Mouse	mmu-miR-125b	miRNA	H2O2	oxidative stress	mouse hippocampal HT22 cells	?H2O2 treatment	"Following stimulation with H2O2, we observed downregulated of miR-125b expression, upregulation of p53 expression, mitochondria were damaged and increased cell death"	33475982
607	Mouse	mmu-miR-125b	miRNA	SDF-1¦Á analog CTCE-0214 (CTCE)	sepsis	mouse with polymicrobial sepsis	EPC therapy treatment	upregulated in endothelial progenitor cells (EPCs)	24707934
608	Mouse	mmu-miR-125b	miRNA	high fat diet (HFD)	type 2 diabetes mellitus (T2DM)	liver tissues	high fat diet (HFD) feed	upregulated	29319168
609	Mouse	mmu-miR-125b-1-3p	miRNA	rutin (RUT)	pirarubicin (THP) cardiotoxicity	HL-1 cells	rutin (RUT) treatment	Rutin protects against pirarubicin-induced cardiotoxicity by adjusting microRNA-125b-1-3p-mediated JunD signaling pathway	32016695
610	Mouse	mmu-miR-125b-5p	miRNA	hypoxia/reoxygenation (H/R)	acute myocardial infarction (AMI)	The mouse cardiomyocyte cell line HL-1	hypoxia/reperfusion induce	downregulated	32010261
611	Mouse	mmu-miR-125b-5p	miRNA	amyloid-¦Â (A¦Â)	Alzheimer's disease (AD)	primary mouse cortical neurons (MCN) and Neuro2a (N2a) cells	amyloid-¦Â (A¦Â) treatment	downregulated	32251872
612	Mouse	mmu-miR-125b-5p	miRNA	melatonin	anti-inflammatory responses	RAW264.7 cells (a murine macrophage cell line) and mouse bone marrow-derived macrophages (BMDMs)	metformin treatment	Metformin might show anti-inflammatory effects in macrophages through the induction of Dicer and the subsequent upregulation of miR-34a-5p and miR-125b-5p.	31102492
613	Mouse	mmu-miR-125b-5p	miRNA	brucella.suis	brucellosis	The RAW264.7 macrophage	Brucella infection treatment	downregulated	27473222
614	Mouse	mmu-miR-125b-5p	miRNA	high glucose (HG)	diabetic nephropathy (DN)	Mouse podocytes (MPC5)	high glucose treatment	downregulated	30095204
615	Mouse	mmu-miR-125b-5p	miRNA	high fat diet (HFD)	insulin resistance (IR)	heart tissue	high fat diet (HFD) feed	downregulated	30632304
616	Mouse	mmu-miR-125b-5p	miRNA	oxygen glucose deprivation (OGD)	ischemic stroke (IS)	HT-22 cells	oxygen-glucose deprivation treatment	Overexpression of circRNA circUCK2 Attenuates Cell Apoptosis in Cerebral Ischemia-Reperfusion Injury via miR-125b-5p/GDF11 Signaling	33230465
617	Mouse	mmu-miR-125b-5p	miRNA	hypoxia/reoxygenation (H/R)	myocardial infarction (MI)	HL-1 cells	hypoxia/reoxygenation (H/R) treatment	LncRNA MALAT1 prevents the protective effects of miR-125b-5p against acute myocardial infarction through positive regulation of NLRC5.	32010261
618	Mouse	mmu-miR-125b-5p	miRNA	manganese (Mn)	parkinson's disease (PD)	MN9D dopaminergic cell exosomes	Mn exposure (300¦ÌM MnCl2) for 24h	upregulated in exosomes	28450057
619	Mouse	mmu-miR-125b-5p	miRNA	learning	persistent memory	C57BL/6J mouse hippocampal	Object-location memory task	upregulated	28927503
620	Mouse	mmu-miR-125b-5p	miRNA	high fat diet (HFD) and streptozotocin (STZ)	type 2 diabetes mellitus (T2DM)	pancreatic ¦Â-cells	high-fat diet plus low dosage of streptozotocin treatment	downregulated	30684546
621	Mouse	mmu-miR-125b-5p	miRNA	metformin (Met)	type 2 diabetes mellitus (T2DM)	RAW264.7 cells	metformin (Met) treatment	Metformin might show anti-inflammatory effects in macrophages through the induction of Dicer and the subsequent upregulation of miR-34a-5p and miR-125b-5p.	31102492
622	Mouse	mmu-miR-126	miRNA	CTCE-0214 (CTCE)	acute respiratory distress syndrome (ARDS)	lung	CTCE-0214 (CTCE) treatment	upregulated	27031787
623	Mouse	mmu-miR-126	miRNA	atorvastatin	atherosclerosis (AS)	ApoE-/- mice carotid arterial wall	atorvastatin treatment	upregulated in carotid arterial wall	26886754
624	Mouse	mmu-miR-126	miRNA	cigarette smoke (CS)	atherosclerosis (AS)	aortic tissues of ApoE KO mice	cigarette smoke (CS) exposure	downregulated	29642385
625	Mouse	mmu-miR-126	miRNA	high fat diet (HFD)	atherosclerosis (AS)	apolipoprotein E-knockout mice	high fat diet (HFD) feed	downregulated	28713948
626	Mouse	mmu-miR-126	miRNA	notoginsenoside R1 (NGR1)	atherosclerosis (AS)	serum;aorta	notoginsenoside R1 (NGR3) treatment	downregulated	24933211
627	Mouse	mmu-miR-126	miRNA	E26 transformation-specific variant 2 (ETV2; also known as ER71)	cardiovascular lineage development	mouse embryonic stem cells (mESCs)	E26 transformation-specific variant 2 (ETV2; also known as ER71) treatment	upregulated	31744543
628	Mouse	mmu-miR-126	miRNA	training	dexamethasone (DEX)-induced microvascular rarefaction	muscle	training	upregulated	31991160
629	Mouse	mmu-miR-126	miRNA	high glucose (HG)	diabetic atherosclerosis	aorta	high glucose treatment	downregulated	27993686
630	Mouse	mmu-miR-126	miRNA	ischemia	diabetic retinopathy (DR)	retina tissues	ischemia induced	miR-126 was significantly decreased in retina from OIR mice	21586283
631	Mouse	mmu-miR-126	miRNA	high glucose (HG)	inflammation	macrophage	high glucose treatment	downregulated	27827458
632	Mouse	mmu-miR-126	miRNA	high glucose (HG)	inflammation	human gingival fibroblasts	high (25 mmol/L) glucose	downregulated	28598282
633	Mouse	mmu-miR-126	miRNA	high fat diet (HFD)	inflammatory response	skeletal muscle of mice	high fat diet (HFD) feed	"miR-375, miR-29, miR-320, miR-103/107 and miR-126, play a crucial role in the regulation of glucose and lipid metabolism through the control of pancreatic islet cell function"	22395471
634	Mouse	mmu-miR-126	miRNA	danhong injection (DHI)	myocardial infarction (MI)	myocardial infarction (MI) mouse heart tissues	danhong injection (DHI) treatment	upregulated	31629250
635	Mouse	mmu-miR-126	miRNA	exercise training (ET)	myocardial infarction (MI)	Bone marrow-derived endothelial progenitor cells (EPCs) were isolated from the MI mice after 4 weeks of exercise	Exercise training (ET) induce	upregulated	29265525
636	Mouse	mmu-miR-126	miRNA	exercise training (ET)	myocardial infarction (MI)	MI. C57BL/6 mice bone marrow-derived endothelial progenitor cells (EPCs)	r 4 weeks of exercise	upregulated	29265525
637	Mouse	mmu-miR-126	miRNA	ischemia	myocardial ischemia/reperfusion (I/R) injury (MIRI)	Plasma	left anterior descending artery (LAD) ligation	HOTAIR aggravates myocardial IR by competitively binding SRSF1 with microRNA-126.	32964995
638	Mouse	mmu-miR-126	miRNA	maternal diet	obesity and obesity-associated insulin resistance	adipose tissues	maternal diet-induced obesity on offspring adipose tissue insulin signalling treatment	expression in the aetiology of insulin resistance in later life is upregulated	24749062
639	Mouse	mmu-miR-126	miRNA	exogenous ghrelin	peripheral arterial disease (PAD)	ischemic gastrocnemius tissues	exogenous ghrelin treatment	upregulated	32788622
640	Mouse	mmu-miR-126	miRNA	mycobacterium tuberculosis (Mtb)	pulmonary tuberculosis (PTB)	lung tissues	mycobacterium tuberculosis (Mtb) treatment	downregulated	33089914
641	Mouse	mmu-miR-126	miRNA	pSTAT3-specific inhibitor AG-490	pulmonary tuberculosis (PTB)	lung tissues	pSTAT3-specific inhibitor AG-490 treatment	upregulated	33089914
642	Mouse	mmu-miR-126	miRNA	SDF-1¦Á analog CTCE-0214 (CTCE)	sepsis	mouse with polymicrobial sepsis	EPC therapy treatment	upregulated in endothelial progenitor cells (EPCs)	24707934
643	Mouse	mmu-miR-126	miRNA	resveratrol	type 2 diabetes mellitus (T2DM)	mouse insulinoma cell line Min6	resveratrol (RSV) treatment	The expression level of miR-126 was upregulated by RSV	29710530
644	Mouse	mmu-miR-1264	miRNA	ischemia/reperfusion (I/R) 	acute ischemic and hemorrhagic stroke	mouse circulation	ischemia/reperfusion (I/R) treatment	upregulated	28193834
645	Mouse	mmu-miR-126-5p	miRNA	lipopolysaccharide (LPS)	acute lung injury (ALI)	alveolar type II (ATII) cells	lipopolysaccharide (LPS) treatment	upregulated	27146208
646	Mouse	mmu-miR-126-5p	miRNA	lipopolysaccharide (LPS)	inflammation	RAW 264.7 cells	lipopolysaccharide (LPS) treatment	dysregulated	24792623
647	Mouse	mmu-miR-126a	miRNA	Shexiang Tongxin dropping pill (STDP)	atherosclerosis (AS)	serial transverse aortic sections	Shexiang Tongxin dropping pill (STDP) treatment	downregulated	25449459
648	Mouse	mmu-miR-126a	miRNA	Shexiang Tongxin dropping pill (STDP)	atherosclerosis (AS)	(ApoE(-/-)) mice aortic	STDP (30 mg/kg/day) on atherosclerotic lesions treatment	downregulated	25449459
649	Mouse	mmu-miR-126a	miRNA	doxorubicin (DOX)	breast cancer	breast tumor-bearing mice	doxorubicin treatment	upregulated	27345402
650	Mouse	mmu-miR-126a	miRNA	whole grain highland barley (WGH)	type 2 diabetes mellitus (T2DM)	liver tissues	whole grain highland barley (WGH) treatment	downregulated	33104141
651	Mouse	mmu-miR-126a-3p	miRNA	lipopolysaccharide (LPS)	endotoxemia-induced vascular injury	aortas tissues	lipopolysaccharide (LPS) treatment	downregulated	26968021
652	Mouse	mmu-miR-126a-5p	miRNA	angiotensin II (Ang II)	abdominal aortic aneurysm (AAA)	aortas	angiotensin II (Ang II) treatment	miR-126a-5p expression was significantly lower in AAA tissues than in control aortas.	32291538
653	Mouse	mmu-miR-126a-5p	miRNA	ischemia/reperfusion (I/R) 	ischemia/reperfusion (I/R) injury	mouse serum	ischemia/reperfusion (I/R) treatment	upregulated in the serum	29212219
654	Mouse	mmu-miR-127	miRNA	blast	blast traumatic brain injury (bTBI)	Balb/c mice	blast treatment	dysregulated	29020847
655	Mouse	mmu-miR-127	miRNA	doxorubicin (DOX)	heart failure (HF)	myocardial tissues	doxorubicin (DOX) treatment	upregulated	30272299
656	Mouse	mmu-miR-127	miRNA	ginkgo biloba extract (GBE)	hepatocellular carcinoma (HCC)	non-tumor (ENT) liver	ginkgo biloba extract (GBE) treatment	upregulated	32306082
657	Mouse	mmu-miR-127	miRNA	tumor necrosis factor alpha (TNF-¦Á) 	irritable bowel syndrome (IBS)	mouse interstitial cells of Cajal (ICC)	tumor necrosis factor alpha (TNF-¦Á) treatment	MiR-127 upregulated largely reversed the effects of TUG1 on TNF-¦Á-treated ICC.	30657572
658	Mouse	mmu-miR-127	miRNA	lipopolysaccharide (LPS)	lung injury	"mouse bronchoalveolar lavage fluid, serum and lung tissue"	lipopolysaccharide (LPS) treatment	"upregulated in bronchoalveolar lavage fluid, serum and lung tissue"	28765901
659	Mouse	mmu-miR-127	miRNA	metformin (Met)	nonalcoholic steatohepatitis (NASH)	liver tissues	metformin treatment	upregulated	25672270
660	Mouse	mmu-miR-127	miRNA	piperine	osteoarthritis (OA)	ATDC5 cells	piperine treatment	Piperine reduced the expression of miR-127 in ATDC5 cells	29710511
661	Mouse	mmu-miR-127	miRNA	lipopolysaccharide (LPS)	spinal cord injury (SCI)	?PC-12 cell	lipopolysaccharide (LPS) treatment	"miR-127 was negatively regulated by TUG1. Effects of TUG1 on LPS-treated PC-12 cells were reversed by miR-127 overexpression. Besides, TUG1 inactivated NF-¦ÊB and p38MAPK pathways in LPS-treated PC-12 cells via down-regulating miR-127. Dynactin 4 and protein tyrosine phosphatase (PTP) were the target genes of miR-127. miR-127 regulated the NF-¦ÊB and p38MAPK pathways in PC-12 cells at least by targeting dynactin 4 and PTP."	31326411
662	Mouse	mmu-miR-1271	miRNA	huaier extract	acute kidney injury (AKI)	kidney tissues	Huaier extract (HE) treatment	HE appreciably reduced the degree of kidney injury and fibrosis and restored the expression of the microRNA miR-1271 after IRI.	33457422
663	Mouse	mmu-mir-127-3p	miRNA	recombinant-specific gram-negative pathogen Escherichia coli (Xen14) and gram-positive pathogen Staphylococcus aureus (Xen29)	bacterial infection	blood	recombinant-specific gram-negative pathogen Escherichia coli (Xen14) and gram-positive pathogen Staphylococcus aureus (Xen29) treatment	upregulated	25563241
664	Mouse	mmu-miR-127-3p	miRNA	doxorubicin (DOX)	doxorubicin (DOX)-induced cardiotoxicity	Plasma	doxorubicin (DOX) treatment	downregulated	30627229
665	Mouse	mmu-miR-127-5p	miRNA	arctigenin	endotoxic shock	Splenic myeloid-derived suppressor cells (MDSCs) were isolated from spleen of mice challenged by LPS (10 ¦Ìg/g)	arctigenin treatment	upregulated	30143931
666	Mouse	mmu-miR-127-5p	miRNA	chronic unpredictable mild stress (CUMS)	major depressive disorder (MDD)	nucleus accumbens (NAc) tissues	chronic unpredictable mild stress (CUMS) induce	downregulated	30936699
667	Mouse	mmu-miR-1278	miRNA	H2O2	myocardial infarction (MI)	newborn murine ventricular cardiomyocytes (NMVCs)	H2O2 treatment	"miR-1278 is low in H2O2-treated NMVCs and post-MI cardiac tissues, and the overexpression of miR-1278 in these protects against cell death by modulating IL-22 and CXCL14 expression."	33275986
668	Mouse	mmu-miR-1278	miRNA	H2O2	myocardial infarction (MI)	newborn murine ventricular cardiomyocytes (NMVCs)	H2O2 treatment	The levels of miR-1278 were reduced in the infarct regions of heart tissues of the MI mouse model and in H2O2-treated newborn murine ventricular cardiomyocytes (NMVCs) compared to those in the heart tissues of healthy mice and non-treated NMVCs.	33275986
669	Mouse	mmu-miR-128	miRNA	ischemia	acute kidney injury (AKI)	renal tubules	ischemia treatment	upregulated	27959449
670	Mouse	mmu-miR-128	miRNA	Staphylococcus aureus	acute lung injury (ALI)	mouse lung tissues and RAW264.7 cells	Staphylococcus aureus (S. aureus) infection treatment	downregulated	30802676
671	Mouse	mmu-miR-128	miRNA	amyloid-¦Â (A¦Â)	Alzheimer's disease (AD)	primary mouse cortical neurons (MCN) and Neuro2a (N2a) cells	amyloid-¦Â (A¦Â) treatment	upregulated	30328325
672	Mouse	mmu-miR-128	miRNA	oxidized low density lipoprotein (ox-LDL)	atherosclerosis (AS)	mouse macrophages atherogenic Evs	oxidized low-density lipoprotein (ox-LDL) treatment	enrichment in atherogenic EVs	28882869
673	Mouse	mmu-miR-128	miRNA	oxidized low density lipoprotein (ox-LDL)	atherosclerosis (AS)	peritoneal macrophages; Bone-marrow derived macrophages (BMDMs)	oxidized low-density lipoprotein (ox-LDL) treatment	upregulated	28882869
674	Mouse	mmu-miR-128	miRNA	oxidized low density lipoprotein (ox-LDL)	atherosclerosis (AS)	RAW264.7 cells	oxidized low-density lipoprotein (ox-LDL) treatment	miR-128 expression was remarkably decreased in ox-LDL-incubated RAW264.7 cells.	30203508
675	Mouse	mmu-miR-128	miRNA	neurotoxicant sodium valproate (VPA)	developmental toxicity	murine embryonic stem cells (mESCs)	neurotoxicant sodium valproate (VPA) treatment	downregulated	24896083
676	Mouse	mmu-miR-128	miRNA	high glucose (HG)	diabetic nephropathy (DN)	Mouse podocytes (MPC5)	high glucose treatment	downregulated	30095204
677	Mouse	mmu-miR-128	miRNA	dexmedetomidine (DEX)	hypoxic/ischemic brain damage (HIBD)	hypoxia induced neonatal mice brain tissues	dexamethasone (DEX) treatment	upregulated	30875657
678	Mouse	mmu-miR-128	miRNA	hypoxia	hypoxic/ischemic brain damage (HIBD)	neonatal mice brain tissues	hypoxia induce	downregulated	30875657
679	Mouse	mmu-miR-128	miRNA	methamphetamine (METH)	methamphetamine (METH)-induced locomotor sensitization	nucleus accumbens (NAc)	repeated-intermittent METH exposure	A significant increase of miR-128 in the NAc of mice upon repeated-intermittent METH exposure but not acute METH administration.	32058631
680	Mouse	mmu-miR-128	miRNA	prion	neurodegeneration (ND)	the brains tissues	prion infection treatment	upregulated	18987751
681	Mouse	mmu-miR-128	miRNA	spinal cord segment-derived conditioned medium (CM) of SCI (CM-SCI)	neuropathic pain (NP)	mouse microglial cell line BV2	CM-SCI treatment	downregulated	28114268
682	Mouse	mmu-miR-128	miRNA	methamphetamine (METH)	neuroplasticity	mouse nucleus accumbens (NAc)	Methamphetamine (METH) treatment	We identified a significant increase of miR-128 in the NAc of mice upon repeated-intermittent METH exposure but not acute METH administration.	32058631
683	Mouse	mmu-miR-128	miRNA	high fat diet (HFD)	nonalcoholic fatty liver disease (NAFLD)	liver tissues	high fat diet (HFD) feed	downregulated	31889412
684	Mouse	mmu-miR-128	miRNA	hypoxia	stress response	mouse myogenic C2C12 cells	hypoxia (2% O2) for 4?h	downregulated	29138682
685	Mouse	mmu-miR-1281	miRNA	mycobacterium tuberculosis (Mtb)	pulmonary tuberculosis (PTB)	lung tissues	mycobacterium tuberculosis (Mtb) treatment	downregulated	33089914
686	Mouse	mmu-miR-1281	miRNA	pSTAT3-specific inhibitor AG-490	pulmonary tuberculosis (PTB)	lung tissues	pSTAT3-specific inhibitor AG-490 treatment	upregulated	33089914
687	Mouse	mmu-miR-128-1-5p	miRNA	anandamide and norgestimate	depression	chronic mild stress (CMS) model of depression mouse	anandamide and norgestimate treatment	upregulated	28716528
688	Mouse	mmu-miR-128-1-5p	miRNA	manganese (Mn)	parkinson's disease (PD)	MN9D dopaminergic cell exosomes	Mn exposure (300¦ÌM MnCl2) for 24h	upregulated in exosomes	28450057
689	Mouse	mmu-miR-128-3p	miRNA	lipopolysaccharide (LPS)	acute kidney injury (AKI)	TCMK-1 cells	lipopolysaccharide (LPS) treatment	upregulated	32500307
690	Mouse	mmu-miR-128-3p	miRNA	angiotensin II (Ang II)	atrial fibrosis	mouse atrial tissues	angiotensin II (Ang II) treatment	LncRNA PVT1 promotes atrial fibrosis via miR-128-3p-SP1-TGF-¦Â1-Smad axis in atrial fibrillation.	30894138
691	Mouse	mmu-miR-128-3p	miRNA	doxorubicin (DOX)	liver damage	Alpha mouse liver 12 (AML-12) cells	doxorubicin (Dox)?treatment	upregulated	31112750
692	Mouse	mmu-miR-128-3p	miRNA	FTY720-C2	parkinson's disease (PD)	dopaminergic MN12D cells	FTY720-C2 treatment	upregulated	30359694
693	Mouse	mmu-miR-128-3p	miRNA	"1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)"	parkinson's disease (PD)	hippocampus	"1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) treatment"	"We found that Axin1 was upregulated in hippocampal tissues and cells of the MPTP-lesioned mouse model of PD, while Hif1a and miR-128-3p were downregulated."	32167488
694	Mouse	mmu-miR-128-3p	miRNA	FTY720-C2	parkinson's disease (PD)	MN9D cells	FTY720-C2 treatment	upregulated	30359694
695	Mouse	mmu-miR-128-3p	miRNA	learning	persistent memory	C57BL/6J mouse hippocampal	Object-location memory task	upregulated	28927503
696	Mouse	mmu-miR-1286	miRNA	GANT61	osteosarcoma (OS)	"OS cells (SaOS-2 , U2OS)"	GANT61 treatment	"In vivo experiments further confirmed that GANT61 inhibited tumor growth and RAB13 expression, but enhanced miRNA-1286. The study demonstrated that GANT61 inhibited cell aggressive phenotype and tumor growth by inducing oxidative stress through the miRNA-1286/RAB31 axis."	32936498
697	Mouse	mmu-miR-129	miRNA	amyloid-¦Â (A¦Â) 25-35	Alzheimer's disease (AD)	brain tissues	amyloid-¦Â (A¦Â) 25-35 treatment	"Elevated H19, HMGB1 and decreased miR-129 were found in A¦Â25-35-treated PC12 cells as well as in brain tissues of AD mice."	33410377
698	Mouse	mmu-miR-129	miRNA	dexamethasone (DEX)	Alzheimer's disease (AD)	hippocampal tissues	dexamethasone (DEX) treatment	Dex administration resulted in the enhancement of miR-129 expression with declined hippocampal neuron apoptosis and attenuated cognitive impairment in A¦Â1-42-injected mice.	32839917
699	Mouse	mmu-miR-129	miRNA	"anti-benzo[a]pyrene-trans-7,8-diol-9,10-epoxide (anti-BPDE)"	bronchial epithelial cell cancer	16HBE-T cells	"anti-benzo[a]pyrene-trans-7,8-diol-9,10-epoxide (anti-BPDE) treatment"	upregulated	19462682
700	Mouse	mmu-miR-129	miRNA	angiotensin II (Ang II)	hypertensive nephropathy (HN)	Wild-type (C57BL/6J) mice	angiotensin II (Ang II) treatment	downregulated	28213404
701	Mouse	mmu-miR-129	miRNA	GYY4137	hypertensive nephropathy (HN)	Wild-type (C57BL/6J) mice	were treated with GYY4137 for 4 wk	upregulated	28213404
702	Mouse	mmu-miR-129	miRNA	trinitrobenzene sulfonic acid (TNBS)	inflammatory bowel disease (IBD)	colon tissues	trinitrobenzene sulphonic acid (TNBS) treatment	downregulated	31945730
703	Mouse	mmu-miR-129	miRNA	"1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)"	parkinson's disease (PD)	midbrain samples	"1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) treatment"	downregulated	30260025
704	Mouse	mmu-miR-129	miRNA	resveratrol	parkinson's disease (PD)	Parkinson's disease (PD) mice midbrain samples	resveratrol (RS) treatment	upregulated	30260025
705	Mouse	mmu-miR-129	miRNA	particulate matter (PM2.5)	PM2.5 exposure	mosue bronchoalveolar lavage fluid (BALF)	"were subjected to intratracheal instillation of 2.5, 10, or 20mg/kg PM2.5 treatment"	upregulated in bronchoalveolar lavage fluid (BALF)	29107863
706	Mouse	mmu-miR-129	miRNA	particulate matter (PM2.5)	pulmonary toxicological	lung tissues	particulate matter (PM2.5) exposure treatment	upregulated	29107863
707	Mouse	mmu-miR-1291	miRNA	manganese (Mn)	parkinson's disease (PD)	MN9D dopaminergic cell exosomes	Mn exposure (300¦ÌM MnCl2) for 24h	upregulated in exosomes	28450057
708	Mouse	mmu-miR-129-1-3p	miRNA	doxycycline	c-Src-mediated tumor progression	HCT116 cells; HT29 cells	doxycycline treatment	c-Src promotes tumor progression through downregulated of microRNA-129-1-3p	31799727
709	Mouse	mmu-miR-129-1-3p	miRNA	pirarubicin (THP)	pirarubicin (THP) cardiotoxicity	HL-1 cells	Pirarubicin (THP) treatment	downregulated	31957170
710	Mouse	mmu-miR-129-1-3p	miRNA	alpinia oxyphylla extract (AOE)	type 2 diabetes mellitus (T2DM)	db-/db- mouse kidney	A. oxyphylla extract (AOE) treatment	downregulated	28249617
711	Mouse	mmu-miR-129-3p	miRNA	osteopontin (OPN)	rheumatoid arthritis (RA)	Osteoblasts	Osteopontin (OPN)treatment	downregulated	27851983
712	Mouse	mmu-miR-129-5p	miRNA	lipopolysaccharide (LPS)	acute lung injury (ALI)	murine alveolar epithelial cell line (MLE)-12 cells	lipopolysaccharide (LPS) treatment	downregulated	32682121
713	Mouse	mmu-miR-129-5p	miRNA	physical exercise	Alzheimer's disease (AD)	hippocampus	physical exercise treatment	miR-129-5p is significantly upregulated by physical exercise	32434194
714	Mouse	mmu-miR-129-5p	miRNA	trichostatin A (TSA)	cell division	hearts	trichostatin A (TSA) treatment	upregulated	26946427
715	Mouse	mmu-miR-129-5p	miRNA	ultraviolet (UV) irradiation	corneal epithelium impairment	corneal epithelial cells (CECs)	ultraviolet ray treatment	upregulated	30515795
716	Mouse	mmu-miR-129-5p	miRNA	ultraviolet (UV) irradiation	corneal epithelium impairment	corneal epithelial cells (CECs)	ultraviolet ray treatment	upregulated	30515795
717	Mouse	mmu-miR-129-5p	miRNA	anandamide and norgestimate	depression	chronic mild stress (CMS) model of depression mouse	anandamide and norgestimate treatment	downregulated	28716528
718	Mouse	mmu-miR-129-5p	miRNA	lipopolysaccharide (LPS)	LPS-induced podocyte apoptosis	MPC5 cells	lipopolysaccharide (LPS) treatment	Podocytes with LPS significantly inhibits the expression of miR-129-5p.	33039954
719	Mouse	mmu-miR-129-5p	miRNA	low choline (LC)	neural progenitor cell (NPC) self-renewal	Neural progenitor cells were isolated from embryonic ED 14 brains	low choline (LC) treatment	upregulated	30521373
720	Mouse	mmu-miR-129-5p	miRNA	low choline (LC)	neurogenesis	cortical neural progenitor cell (NPC)	low choline (LC) treatment	upregulated	30521373
721	Mouse	mmu-miR-129-5p	miRNA	alcohol	nonalcoholic fatty liver disease (NAFLD)	AML-12 cells	Lieber-DeCarli alcohol treatment	NEAT1/microRNA-129-5p/SOCS2 axis regulates liver fibrosis in alcoholic steatohepatitis	33228663
722	Mouse	mmu-miR-129-5p	miRNA	methionine choline-deficient diet (MCD)	nonalcoholic steatohepatitis (NASH)	mouse liver tissues	methionine-choline-deficient (MCD) treatment	Liver tissues from mice fed a methionine-choline-deficient (MCD) diet exhibited increased expression of NEAT1 and PEG3 along with lower miR-129-5p expression.	33574830
723	Mouse	mmu-miR-129-5p	miRNA	lipopolysaccharide (LPS)	secondary injury after spinal cord injury (SCI)	BV-2 cells	lipopolysaccharide (LPS) treatment	miR-129-5p alleviated SCI in mice via suppressing the apoptosis and inflammatory response through HMGB1//TLR4/NF-¦ÊB pathway.	32096822
724	Mouse	mmu-miR-129-5p	miRNA	laparotomy and exposure of the junc_x0002_tion between the large and small intestines	sepsis	mouse large and small intestines	laparotomy and exposure of the junc_x0002_tion between the large and small intestines treatment	downregulated	25043848
725	Mouse	mmu-miR-1297	miRNA	sevoflurane (SEV)	neurotoxicity	mouse neurons	sevoflurane treatment	"In sevoflurane-exposed mice, miR-1297 expression was upregulated compared with the control group"	33843359
726	Mouse	mmu-miR-1298	miRNA	ischemia/reperfusion (I/R) 	acute ischemic and hemorrhagic stroke	mouse circulation	ischemia/reperfusion (I/R) treatment	upregulated	28193834
727	Mouse	mmu-miR-130	miRNA	cyclosporine A (CsA)	nephrotoxicity	mouse kidney	cyclosporine A treatment	upregulated	28414804
728	Mouse	mmu-miR-130	miRNA	tumor necrosis factor alpha (TNF-¦Á) 	hepatocellular carcinoma (HCC)	white adipose tissues	TNF¦Á treatment	"Primary transcripts of miR-130 were increased after TNF¦Á stimulation,p65 binding to the promoter regions of miR-130 was enhanced after TNF¦Á treatment"	24396868
729	Mouse	mmu-miR-1306-5p	miRNA	manganese (Mn)	parkinson's disease (PD)	MN9D dopaminergic cell exosomes	Mn exposure (300¦ÌM MnCl2) for 24h	upregulated in exosomes	28450057
730	Mouse	mmu-miR-130a	miRNA	alcohol	alcoholic hepatitis (AH)	sera	alcohol exposure	upregulated	26264599
731	Mouse	mmu-miR-130a	miRNA	antibiotics	allergic airway diseases (AAD)	bronchoalveolar lavage fluid (BALF)	antibiotics treatment	downregulated	29702281
732	Mouse	mmu-miR-130a	miRNA	angiotensin II (Ang II)	cardiac fibrosis	mice	angiotensin II (Ang II) treatment	upregulated	29114000
733	Mouse	mmu-miR-130a	miRNA	adherent-invasive escherichia coli (AIEC)	crohn disease (CD)	mouse enterocytes	adherent invasive escherichia coli (AIEC) treatment	upregulated	24148619
734	Mouse	mmu-miR-130a	miRNA	doxorubicin (DOX)	doxorubicin (DOX)-induced cardiotoxicity	heart tissues	doxorubicin (Dox) treatment	The expression of miR-130a increases sharply upon Dox treatment.	29988029
735	Mouse	mmu-miR-130a	miRNA	iron	iron deficiency	liver tissues	iron-deficient diet? treatment	liver expression of the microRNA is upregulated	25002578
736	Mouse	mmu-miR-130a	miRNA	free fatty acids (FFA)	nonalcoholic fatty liver disease (NAFLD)	cultured mouse primary hepatocytes	free fatty acid (FFA) treatment	downregulated	31064820
737	Mouse	mmu-miR-130a	miRNA	high fat diet (HFD)	nonalcoholic fatty liver disease (NAFLD)	liver tissues	high fat diet (HFD) feed	downregulated	31064820
738	Mouse	mmu-miR-130a	miRNA	monocrotaline (MCT)	pulmonary arterial hypertension (PAH)	pulmonary arterial endothelial cells (PAEC)	MCT treated 3M	upregulated	28755990
739	Mouse	mmu-miR-130a-3p	miRNA	ovalbumin (OVA)	asthma	pulmonary macrophages	ovalbumin (OVA) treatment	downregulated	32524675
740	Mouse	mmu-miR-130a-3p	miRNA	high glucose (HG)	glomerulonephritis	Mice MPC5 podocytes	high glucose (HG) treatment	downregulated	29434693
741	Mouse	mmu-miR-130a-3p	miRNA	paraquat (PQ)	paraquat (PQ)-induced acute lung injury and pulmonary fibrosis	MLE-12 cells	paraquat (PQ) treatment	downregulated	32741895
742	Mouse	mmu-miR-130a-3p	miRNA	high glucose (HG)	podocyte injury	mouse podocytes	high glucose (HG) treatment	Ablation of lncRNA MIAT mitigates high glucose-stimulated inflammation and apoptosis of podocyte via miR-130a-3p/TLR4 signaling axis.	32972755
743	Mouse	mmu-miR-130a-3p	miRNA	hypoxia	postmyocardial infarction	AC16 cells	hypoxia treatment	miR-130a-3p was underexpressed in post-MI myocardial cells.	29226319
744	Mouse	mmu-miR-130a-3p	miRNA	oxygen	retinopathy of prematurity (ROP)	C57BL/6 neonatal mice retinal tissue	7-day-old mice were maintained in 75% oxygen conditions for 5 days treatment	dysregulatedin retinal tissue	27922698
745	Mouse	mmu-miR-130a-5p	miRNA	influenza virus	H5N2 influenza virus infection	lung tissues	H5N2 treatment	upregulated	25266911
746	Mouse	mmu-miR-130a-5p	miRNA	oxygen glucose deprivation (OGD)	ischemic stroke (IS)	Mouse brain microvascular endothelial cells (BMECs)	oxygen glucose deprivation (OGD) treatment	downregulated	32627090
747	Mouse	mmu-miR-130b	miRNA	H2O2	Alzheimer's disease (AD)	Primary hippocampal neuron cells	H2O2 treatment	upregulated	24423585
748	Mouse	mmu-miR-130b	miRNA	H2O2	Alzheimer's disease (AD)	senescence accelerated mouse prone 8 (SAMP8) and prone 10 (SAMP10)	"different concentrations (0, 100, 200, 400 and 800 ¦ÌM) of H2O2 treatment"	upregulated	24423585
749	Mouse	mmu-miR-130b	miRNA	folate	apoptosis	mouse embryonic stem cells (mESCs)	folate deficiency induced	upregulated	22828209
750	Mouse	mmu-miR-130b	miRNA	oxidized low density lipoprotein (ox-LDL)	atherosclerosis (AS)	RAW264.7 cells	oxidized low-density lipoprotein (ox-LDL) treatment	downregulated	29172088
751	Mouse	mmu-miR-130b	miRNA	hypoxia	cerebral ischemia/reperfusion (I/R) injury	brain tissues	middle cerebral artery occlusion (MCAO) treatment	downregulated	28804561
752	Mouse	mmu-miR-130b	miRNA	TGF-¦Â1	diabetic nephropathy (DN)	glomerular mesangial cells (MC)	TGF-¦Â1 treatment	downregulated	25204661
753	Mouse	mmu-miR-130b	miRNA	particle	osteolysis	MC3T3-E1 cells	particle treatment	upregulated	28382864
754	Mouse	mmu-miR-130b	miRNA	ortho-silicic acid	osteoporosis	MC3T3-E1 cell; C2C12 cells	ortho-silicic acid treatment	MiR-130b is upregulated during the osteogenesis by the applicationof ortho-silicic acid.	33130075
755	Mouse	mmu-miR-130b	miRNA	Co-Cr-Mo alloy particles	periprosthetic osteolysis	Raw264.7 cells and bone marrowderived macrophages (BMM)	Co-Cr-Mo alloy particles treatment	upregulated	30488739
756	Mouse	mmu-miR-130b-3p	miRNA	extracellular cold-inducible RNA-binding protein (eCIRP)	inflammation	serum	extracellular cold-inducible RNA-binding protein (eCIRP) treatment	upregulated	31724825
757	Mouse	mmu-miR-130b-3p	miRNA	IFN-¦Ã and lipopolysaccharide (LPS)	macrophage polarization	RAW 264.7 cells	interferon-¦Ã (IFN-¦Ã) and lipopolysaccharide (LPS) treatment	downregulated	32853398
758	Mouse	mmu-miR-130b-3p	miRNA	aldosterone	renal fibrosis	mouse cortical collecting duct cells	aldosterone treatment (10-6 M; 3 days)	upregulated	29070573
759	Mouse	mmu-miR-130b-3p	miRNA	aldosterone	renal fibrosis	mouse cortical collecting duct cells	aldosterone treatment (10-6 M; 3 days)	dysregulated	29070573
760	Mouse	mmu-miR-132	miRNA	staphylococcal enterotoxin B (SEB)	acute inflammatory lung injury	lung	staphylococcal enterotoxin B treatment	upregulated	25564423
761	Mouse	mmu-miR-132	miRNA	soluble A¦Â oligomers	Alzheimer's disease (AD)	cultured primary neurons	soluble A¦Â oligomers treatment	downregulated	31669733
762	Mouse	mmu-miR-132	miRNA	amyloid-¦Â (A¦Â)	Alzheimer's disease (AD)	primary neurons	amyloid-¦Â (A¦Â) treatment	Soluble A¦Â oligomers decreased miR-132 expression and increased HDAC3 levels in cultured primary neurons.	31669733
763	Mouse	mmu-miR-132	miRNA	melatonin	Alzheimer's disease (AD)	primary cortical neurons	melatonin treatment	A¦Â25-35 exposure significantly decreased the expression of miR-132.	29322615
764	Mouse	mmu-miR-132	miRNA	oleanolic acid (OLA)	anhedonic and anxiogenic behaviours	hippocampal neuronal	3-week oleanolic acid treatment	upregulated	25079084
765	Mouse	mmu-miR-132	miRNA	Shexiang Tongxin dropping pill (STDP)	atherosclerosis (AS)	serial transverse aortic sections	Shexiang Tongxin dropping pill (STDP) treatment	downregulated	25449459
766	Mouse	mmu-miR-132	miRNA	Shexiang Tongxin dropping pill (STDP)	atherosclerosis (AS)	(ApoE(-/-)) mice aortic	STDP (30 mg/kg/day) on atherosclerotic lesions treatment	downregulated	25449459
767	Mouse	mmu-miR-132	miRNA	hypoxia	blood-brain barrier (BBB) dysfunction	mouse brain microvascular endothelial cells (BMEC)	hypoxia induce	upregulated	30617994
768	Mouse	mmu-miR-132	miRNA	angiotensin II (Ang II)	cardiac remodeling	mice heart tissues	angiotensin II (Ang II) treatment	upregulated	31325434
769	Mouse	mmu-miR-132	miRNA	klotho	cardiac remodeling	Ang II-treated mice heart tissues	klotho treatment	downregulated	31325434
770	Mouse	mmu-miR-132	miRNA	TGF-¦Â1 inhibitor LY364947	cardiac remodeling	Ang II-treated mice heart tissues	TGF-¦Â1 inhibitor LY364947 treatment	downregulated	31325434
771	Mouse	mmu-miR-132	miRNA	melatonin	cell proliferation	hippocampus dentate gyrus tissues	melatonin treatment	upregulated	31169197
772	Mouse	mmu-miR-132	miRNA	"2, 3, 7, 8-tetrachlorodibenzo-p-dioxin (TCDD)"	colitis-associated colon cancer (CAC)	"colon, spleen and lymph nodes"	"2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) treatment"	upregulated	29017096
773	Mouse	mmu-miR-132	miRNA	"3,3'-diindolylmethane (DIM)"	colitis-associated colon cancer (CAC)	"mouse colon, spleen and lymph nodes"	"3,3'-diindolylmethane (DIM) treatment"	upregulated	29017096
774	Mouse	mmu-miR-132	miRNA	duloxetine	depression	frontal lobe and hippocampus	duloxetine treatment	upregulated	26823914
775	Mouse	mmu-miR-132	miRNA	lipopolysaccharide (LPS)	depression	lateral ventricle	lipopolysaccharide (LPS) treatment	downregulated	27378528
776	Mouse	mmu-miR-132	miRNA	gallic acid (GA)	experimental autoimmune encephalomyelitis (EAE)	"The CD4+CD62L+ T cells were isolated from the spleen and cultured under Th17-polarizing conditions, and peritoneal macrophages were stimulated with LPS"	?gallic acid (GA)?treatment treatment	upregulated	31026283
777	Mouse	mmu-miR-132	miRNA	lipopolysaccharide (LPS)	inflammation	RAW264.7 cells	lipopolysaccharide (LPS) treatment	upregulated	26639663
778	Mouse	mmu-miR-132	miRNA	lipopolysaccharide (LPS)	inflammatory injury	HT-22 cells	lipopolysaccharide (LPS) treatment	miR-132 was downregulated by LPS in HT-22 cells	29377244
779	Mouse	mmu-miR-132	miRNA	¦Ã-rays	ionizing radiation (IR) injury	mouse hippocampal neuronal HT22 cells	¦Ã-rays treatment	downregulated	25329592
780	Mouse	mmu-miR-132	miRNA	ischemia	ischemic injury	mouse cortex	ischaemic preconditioning (IP) treatment	downregulated	20010955
781	Mouse	mmu-miR-132	miRNA	deoxycorticosterone acetate (DOCA)	kidney damage	hypertensive mice kidneys and urine	injection of Deoxycorticosterone acetate (Doca)	upregulated in the kidneys and urine	29255279
782	Mouse	mmu-miR-132	miRNA	carbon tetrachloride (CCl4)	liver fibrosis	liver tissues	carbon tetrachloride (CCl4) treatment	downregulated	29100790
783	Mouse	mmu-miR-132	miRNA	TGF-¦Â	liver fibrosis	Isolated primary cultured mouse hepatocytes	TGF-¦Â treatment	downregulated	29100790
784	Mouse	mmu-miR-132	miRNA	cAMP-response element binding protein (CREB)	neuronal morphogenesis	PC12 cells and neonatal rat cortical neurons	cAMP-response element binding protein (CREB) treatment	CREB-regulated miRNA regulates neuronal morphogenesis by responding to extrinsic trophic cues	16260724
785	Mouse	mmu-miR-132	miRNA	high fat diet (HFD)	nonalcoholic fatty liver disease (NAFLD)	C57bl/6J mice liver	high fat diet (HFD) feed	upregulated	28381526
786	Mouse	mmu-miR-132	miRNA	H2O2	oxidative stress	mouse oocytes	were exposed to 25 ?M H2O2 treatment	downregulated	24963165
787	Mouse	mmu-miR-132	miRNA	glutamate	pain	primary neurons in the spinal cord of mouse embryos	100 ¦Ìmol/L glutamate	upregulated	28244951
788	Mouse	mmu-miR-132	miRNA	exogenous ghrelin	peripheral arterial disease (PAD)	ischemic gastrocnemius tissues	exogenous ghrelin treatment	upregulated	32788622
789	Mouse	mmu-miR-132	miRNA	anandamide (AEA)	pro-inflammatory activity	mouse	anandamide treatment	AEA differentil regulate the expression of miRNA	24699635
790	Mouse	mmu-miR-132	miRNA	CREB activator forskolin	renin-angiotensin-aldosterone system regulation	MMDD-1 cells	CREB activator Forskolin treatment	CREB activator Forskolin induces miR-132 expression after 24 h.	32409785
791	Mouse	mmu-miR-132	miRNA	CREB-inhibitor 666-15	renin-angiotensin-aldosterone system regulation	MMDD-1 cells	CREB-inhibitor 666-15 treatment	CREB-inhibitor 666-15 reduces low salt induced miR-132 expression.	32409785
792	Mouse	mmu-miR-132	miRNA	Salt inducible kinase inhibitor MRT67307	renin-angiotensin-aldosterone system regulation	MMDD-1 cells	Salt inducible kinase inhibitor MRT67307 treatment	Salt inducible kinase inhibitor MRT67307 increases high-salt-reduced miR-132 expression	32409785
793	Mouse	mmu-miR-132	miRNA	brain-derived neurotrophic factor (BDNF)	retinocollicular/tectal map formation	retinal ganglion cell (RGC)	brain-derived neurotrophic factor (BDNF) treatment	upregulated	24431455
794	Mouse	mmu-miR-132	miRNA	cigarette smoke (CS)	rheumatoid arthritis (RA)	Th17 cells	cigarette smoke (CS) exposure	CS markedly increased the expression of miR-132 in the Th17 cells from the lymph nodes of AIA mice.	33443169
795	Mouse	mmu-miR-132	miRNA	cigarette smoke extract (CSE)	rheumatoid arthritis (RA)	Th17 cells	cigarette smoke extract (CSE) treatment	we show that?microRNA-132?is specifically induced in Th17 cells in the presence of either AhR agonist or CS-enriched medium.	33443169
796	Mouse	mmu-miR-132-3p	miRNA	H2O2	acute myocardial infarction (AMI)	primary cardiomyocytes	H2O2 treatment	LncRNA TUG1 mediates ischemic myocardial injury by targeting miR-132-3p/HDAC3 axis.	31858814
797	Mouse	mmu-miR-132-3p	miRNA	H2O2	acute myocardial infarction (AMI)	mouse primary cardiomyocytes	hydrogen peroxide (H2O2) treatment	"miR-132-3p was downregulated, whereas TUG1 upregulated in H2O2-challenged cardiomyocytes."	31858814
798	Mouse	mmu-miR-132-3p	miRNA	gravitational mechanical unloading	disuse osteopenia	bone marrow-derived mesenchymal stem cells (BMSCs)	gravitational mechanical unloading	upregulated	32054528
799	Mouse	mmu-miR-132-3p	miRNA	lipopolysaccharide (LPS)	inflammation	RAW264.7 cells	lipopolysaccharide (LPS) treatment	upregulated	32955644
800	Mouse	mmu-miR-132-3p	miRNA	angiostrongylus cantonensis (A. cantonensis)	inflammation	male Balb/c mice	angiostrongylus cantonensis (A. cantonensis) infection	upregulated	24142285
801	Mouse	mmu-miR-132-3p	miRNA	folic acid	kidney injury and fibrosis	kidney cortex	folic acid treatment	upregulated	26707937
802	Mouse	mmu-miR-132-3p	miRNA	chlamydia muridarum variants (C. muridarum Var001 [CmVar001] and CmVar004)	plvic inflammatory disease	mouse	two Chlamydia muridarum variants (C. muridarum Var001 [CmVar001] and CmVar004) infection	were upregulated during CmVar004 infection compared to CmVar001 infection	24961692
803	Mouse	mmu-miR-133	miRNA	hydrocinnamoyl-L-valyl pyrrolidine (AS-1)	cardiac hypertrophy	hypertrophic cardiomyocytes	hydrocinnamoyl-L-valyl pyrrolidine (AS-1) treatment	downregulated	31015570
804	Mouse	mmu-miR-133	miRNA	streptozocin (STZ)	congenital heart disease (CHD)	C57BL/6 mice blood	injection of streptozotocin before mating treatment	dysregulated	27998767
805	Mouse	mmu-miR-133	miRNA	sEHI t-AUCB (trans-4-[4-(3-adamantan-1-yl-ureido)-cyclohexyloxy]-benzoic acid)	myocardial infarction (MI)	muscle	sEHI t-AUCB (trans-4-[4-(3-adamantan-1-yl-ureido)-cyclohexyloxy]-benzoic acid) treatment	downregulated	29843720
806	Mouse	mmu-miR-133-3p	miRNA	doxorubicin (DOX)	doxorubicin (DOX)-induced cardiotoxicity	plasma	doxorubicin (DOX) treatment	upregulated	30453253
807	Mouse	mmu-miR-133a	miRNA	lipopolysaccharide (LPS)	acute aortic dissection (AAD)	aorta	lipopolysaccharide (LPS) treatment	downregulated	32634201
808	Mouse	mmu-miR-133a	miRNA	lipopolysaccharide (LPS)	acute kidney injury (AKI)	TCMK-1 cells	lipopolysaccharide (LPS) treatment	The miR-133a expression was decreased in TCMK-1 cells treated with LPS.	32196613
809	Mouse	mmu-miR-133a	miRNA	fluticasone	asthma	chronic asthma mouse	fluticasone treatment	downregulated	29191361
810	Mouse	mmu-miR-133a	miRNA	ovalbumin (OVA)	asthma	lung tissues	Ovalbumin treatment	downregulated	30146725
811	Mouse	mmu-miR-133a	miRNA	ovalbumin (OVA)	asthma	lung tissues	ovalbumin (OVA) treatment	miR-133a was downregulated in asthma.	30146725
812	Mouse	mmu-miR-133a	miRNA	high fat diet (HFD)	atherosclerosis (AS)	aortas	high fat diet (HFD) feed	downregulated	29268138
813	Mouse	mmu-miR-133a	miRNA	oxidized low density lipoprotein (ox-LDL)	atherosclerosis (AS)	RAW264.7 and MOVAS cells	ox-LDL treatment	downregulated	29268138
814	Mouse	mmu-miR-133a	miRNA	oxidized low density lipoprotein (ox-LDL)	atherosclerosis (AS)	RAW264.7 cells; MOVAS cells	oxidized low-density lipoprotein (ox-LDL) treatment	downregulated	29268138
815	Mouse	mmu-miR-133a	miRNA	reversine	browning of white adipocytes	differentiated adipocytes from 3T3©\L1 cells	reversine treatment	downregulated	30132867
816	Mouse	mmu-miR-133a	miRNA	reversine	browning of white adipocytes	3T3©\L1 cells	reversine treatment	downregulated	30132867
817	Mouse	mmu-miR-133a	miRNA	hydrogen sulfide (H2S)	cardiac hypertrophy	HL1 cardiomyocytes cell line	Na2S treatment	upregulated	28623294
818	Mouse	mmu-miR-133a	miRNA	fibroblast growth factor 18 (FGF18)	cell differentiation	mouse preosteoblasts	collagen membranes (CMs) containing FGF-18 treatment	downregulated	29544382
819	Mouse	mmu-miR-133a	miRNA	cigarette smoke (CS)	chronic obstructive pulmonary disease (COPD)	airway epithelial cells	cigarette smoke (CS) exposure	upregulated	30341388
820	Mouse	mmu-miR-133a	miRNA	high carbon dioxide (CO2)	chronic obstructive pulmonary disease (COPD)	mouse airway smooth muscle cells	High carbon dioxide (CO2) treatment	downregulated	30185650
821	Mouse	mmu-miR-133a	miRNA	sevoflurane (SEV)	cognitive impairment	primary hippocampal neuron cells	sevoflurane exposure treatment	The expression of miR-133a was increased with increasing concentrations of sevoflurane exposure	31264218
822	Mouse	mmu-miR-133a	miRNA	sevoflurane (SEV)	cognitive impairment	Primary hippocampal neuron cells	"To establish an in vitro sevoflurane©\ induced neurotoxicity model, the primary hippocampal neuron cells were treated with different concentrations of sevoflurane for 6 hr treatment"	"miR-133a was the direct target of lncRNA Gm15621 In addition, we also found that Sox4 was a downstream target of miR-133a and lncRNA Gm15621 exerted its biological functions by regulating the expression of Sox4 In summary, our findings revealed that lncRNA Gm15621 ameliorated the sevoflurane-induced neurotoxicity and the important role of Gm15621/miR-133a/Sox4 axis in cognitive disorder"	31264218
823	Mouse	mmu-miR-133a	miRNA	azoxymethane (AOM) and dextran sulfate sodium (DSS)	colorectal cancer (CRC)	mouse colon tissues	azoxymethane (AOM) and dextran sulfate sodium (DSS) treatment	downregulated	24464560
824	Mouse	mmu-miR-133a	miRNA	azoxymethane (AOM) and dextran sulfate sodium (DSS)	colorectal cancer (CRC)	mouse colon tissues	azoxymethane (AOM) and dextran sulfate sodium (DSS) treatment	downregulated	24464560
825	Mouse	mmu-miR-133a	miRNA	bortezomib	congenital muscular dystrophy	dy(3K)/dy(3K) mice	bortezomib? treatment	downregulated	24631023
826	Mouse	mmu-miR-133a	miRNA	TGF-¦Â	coronary heart disease (CHD)	primary murine HSC	TGF-¦Â treatment	Treatment of primary murine and human HSC with transforming growth factor (TGF)-¦Â resulted in a significant downregulated of miR-133a in these cells	23183523
827	Mouse	mmu-miR-133a	miRNA	neurotoxicant sodium valproate (VPA)	developmental toxicity	murine embryonic stem cells (mESCs)	neurotoxicant sodium valproate (VPA) treatment	upregulated	24896083
828	Mouse	mmu-miR-133a	miRNA	high glucose (HG)	diabetes mellitus (DM)	wild type (WT) mice smooth muscle	treated with 30 mM glucose (HG)	downregulated	28678840
829	Mouse	mmu-miR-133a	miRNA	streptozocin (STZ)	diabetes mellitus (DM)	heart	expression in the hearts of streptozotocin-induced diabetic animals treatment	downregulated in the hearts	24428157
830	Mouse	mmu-miR-133a	miRNA	concanamycin A (Con A)	fulminant hepatitis	Balb/c mice	conA injections of concanavalin A treatment	dysregulated	25034766
831	Mouse	mmu-miR-133a	miRNA	regular physical activity	healthy metabolic profile	circulating exosomes	regular physical activity treatment	upregulated	33199621
832	Mouse	mmu-miR-133a	miRNA	castrated	impaired metabolic flexibility in elderly individuals	male C57BL/6J mice	castrated treatment	upregulated	24478708
833	Mouse	mmu-miR-133a	miRNA	dextran sodium sulfate (DSS)	inflammatory bowel disease (IBD)	C57BL/6 mice colonic tissue	dextran-sulfate-sodium (DSS) treatment	downregulated	28104982
834	Mouse	mmu-miR-133a	miRNA	synthetic Sulfonyl-Hydrazone-1	iPSC-derived cardiac differentiation	Murine fibroblast-derived iPSCs	Synthetic Sulfonyl-Hydrazone-1 treatment	"small chemical compounds, such as SHZ, can constitute a novel and clinically feasible strategy to improve iPSC-derived cardiac differentiation"	21445862
835	Mouse	mmu-miR-133a	miRNA	granulocyte-macrophage colony stimulating factor (GM-CSF)	lung injury	normal alveolar epithelial cells	alveolar epithelial cells GM-CSF during hyperoxia treatment	downregulated	24371146
836	Mouse	mmu-miR-133a	miRNA	botulinum toxin A (BTXA)	muscle atrophy	quadriceps muscle	botulinum toxin A (BTXA) treatment	downregulated	30427927
837	Mouse	mmu-miR-133a	miRNA	prolonged aerobic exercise	muscle hypertrophy	plasma	"impact of extended-duration, submaximal aerobic exercise treatment"	upregulated	24436293
838	Mouse	mmu-miR-133a	miRNA	heme oxygenase-1 (HMOX1)	myoblast differentiation	C2C12 cells	Heme oxygenase-1 (HMOX1) treatment	downregulated	21827279
839	Mouse	mmu-miR-133a	miRNA	hypoxia	myocardial ischemia/reperfusion (I/R) injury (MIRI)	I/R mice myocardial tissues	The myocardial I/R injury was induced by temporary ligation of the left anterior descending coronary artery.	downregulated	31734557
840	Mouse	mmu-miR-133a	miRNA	ischemia/reperfusion (I/R) 	myocardial ischaemic injury	mouse plasma;Bone marrow-derived macrophage (BMDM);Rat neonatal CMs	ischemia/reperfusion (I/R) treatment	differently regulated	28768728
841	Mouse	mmu-miR-133a	miRNA	erythropoietin (EPO)	obesity and glucose homeostasis	high-fat diet (HFD) C57BL/6J mice	intraperitoneal injection of recombinant human EPO (200 IU/kg)thrice a week for four weeks	downregulated	28288167
842	Mouse	mmu-miR-133a	miRNA	dietary methionine restriction (MR)	osteoblast differentiation and function	"male C57BL/6J mice bone marrow,plasma and liver"	fed diets containing 0.86% or 0.12% methionine for 5 weeks	"upregulated (miR-31 in plasma and liver, and miR-133a, miR-335-5p, and miR-204 in the bone marrow"	27191548
843	Mouse	mmu-miR-133a	miRNA	Sodium Tanshinone IIA Sulfonate (STS)	peripheral arterial disease (PAD)	ischemic hindlimb in diabetic mice	Sodium Tanshinone IIA Sulfonate (STS) treatment	downregulated	31623833
844	Mouse	mmu-miR-133a	miRNA	cecal ligation and puncture (CLP)	polymicrobial sepsis	C57Bl/6 mice	cecal ligation and puncture (CLP) treatment	different regulation	24413579
845	Mouse	mmu-miR-133a	miRNA	progesterone (P4)	cell proliferation	mouse endometrial epithelial cells	progesterone treatment	upregulated	27458709
846	Mouse	mmu-miR-133a	miRNA	progesterone (P4)	cell proliferation	endometrial epithelial cells	progesterone treatment	upregulated	27458709
847	Mouse	mmu-miR-133a	miRNA	low salt (LS)	expression regulation	kidney tissues	low salt (LS) treatment	Expression of miR-133a was decreased in mice given LS.	33131307
848	Mouse	mmu-miR-133a	miRNA	lipopolysaccharide (LPS)	sepsis	RAW264.7 macrophages	lipopolysaccharide (LPS) treatment	MiRNA-133a aggravates inflammatory responses in sepsis by targeting SIRT1.	32771944
849	Mouse	mmu-miR-133a	miRNA	reversine	reversine-induced dedifferentiation	C2C12 murine myoblasts	reversine treatment	downregulated	24513286
850	Mouse	mmu-miR-133a	miRNA	growth factor-1 receptor	vascular smooth muscle cell migration and proliferation	vascular smooth muscle cell	growth factor-1 receptor? treatment	"In atherosclerosis induced by ApoE deficiency, reduced miR-133a expression is associated with lower IGF-1R levels and suppressive VSMC growth"	24401233
851	Mouse	mmu-miR-133a*	miRNA	granulocyte-macrophage colony stimulating factor (GM-CSF)	lung injury	normal alveolar epithelial cells	alveolar epithelial cells GM-CSF during hyperoxia treatment	downregulated	24371146
852	Mouse	mmu-miR-133a*	miRNA	dexamethasone (DEX)	muscle atrophy	Murine C2C12 myoblast cells	dexamethasone (DEX) treatment	upregulated	23716137
853	Mouse	mmu-mir-133a-1-3p	miRNA	recombinant-specific gram-negative pathogen Escherichia coli (Xen14) and gram-positive pathogen Staphylococcus aureus (Xen29)	bacterial infection	blood	recombinant-specific gram-negative pathogen Escherichia coli (Xen14) and gram-positive pathogen Staphylococcus aureus (Xen29) treatment	upregulated	25563241
854	Mouse	mmu-mir-133a-1-5p	miRNA	recombinant-specific gram-negative pathogen Escherichia coli (Xen14) and gram-positive pathogen Staphylococcus aureus (Xen29)	bacterial infection	blood	recombinant-specific gram-negative pathogen Escherichia coli (Xen14) and gram-positive pathogen Staphylococcus aureus (Xen29) treatment	upregulated	25563241
855	Mouse	mmu-mir-133a-2-3p	miRNA	recombinant-specific gram-negative pathogen Escherichia coli (Xen14) and gram-positive pathogen Staphylococcus aureus (Xen29)	bacterial infection	blood	recombinant-specific gram-negative pathogen Escherichia coli (Xen14) and gram-positive pathogen Staphylococcus aureus (Xen29) treatment	upregulated	25563241
856	Mouse	mmu-miR-133a-3p	miRNA	intranasal instillation	asthma	lung and bronchial tissues	intranasal instillation treatment	downregulated	28267638
857	Mouse	mmu-miR-133a-3p	miRNA	guanidinoacetic acid (GAA)	cell differentiation	C2C12 cells	Guanidinoacetic acid (GAA) treatment	downregulated	30235878
858	Mouse	mmu-miR-133a-3p	miRNA	doxorubicin (DOX)	doxorubicin (DOX)-induced cardiotoxicity	Plasma	doxorubicin (DOX) treatment	downregulated	30627229
859	Mouse	mmu-miR-133a-3p	miRNA	pilocarpine	epilepsy	blood and brain	pilocarpine treatment	upregulated	32590288
860	Mouse	mmu-miR-133a-3p	miRNA	cold	obesity	brown adipose tissue (BAT)	cold treatment	downregulated	33015181
861	Mouse	mmu-miR-133b	miRNA	ovalbumin (OVA)	allergic rhinitis (AR)	Nasal mucosa tissues;serum	intraperitoneal sensitization and intranasal challenge with ovalbumin (OVA)	downregulated	28662502
862	Mouse	mmu-miR-133b	miRNA	oxygen glucose deprivation (OGD)	cerebral ischemia/reperfusion (I/R) injury	HT22 cells	oxygen-glucose deprivation (OGD) treatment	"Circ_HECTD1 knockdown inhibited the expression of TRAF3 by targeting miR-133b, thereby attenuating neuronal injury caused by cerebral ischemia"	33148417
863	Mouse	mmu-miR-133b	miRNA	oxygen-glucose deprivation and reoxygenation (OGD/R)	cerebral ischemia/reperfusion (I/R) injury	HT22 cells	oxygen-glucose deprivation and reoxygenation (OGD/R) treatment	"The results showed that the expression of circ-HECTD1 and tumor necrosis factor receptor-associated factor 3 (TRAF3) was remarkably upregulated, while miR-133b was downregulated in oxygen-glucose deprivation (OGD)-induced HT22 cells and mouse middle cerebral artery occlusion (MCAO) model circ-HECTD1 knockdown relieved OGD-caused neuronal cell death in vitro Simultaneously, circ-HECTD1 knockdown improved cerebral infarction volume and neuronal apoptosis in MCAO mice"	33148417
864	Mouse	mmu-miR-133b	miRNA	regular physical activity	healthy metabolic profile	circulating exosomes	regular physical activity treatment	upregulated	33199621
865	Mouse	mmu-miR-133b	miRNA	low pH	hypoxia-induced extracellular acidosis	RAW 264.7 cells	low pH treatment	Only the upregulated of the miR-133b by low pH was seen in all normal cells.	30178347
866	Mouse	mmu-miR-133b	miRNA	castrated	impaired metabolic flexibility in elderly individuals	male C57BL/6J mice	castrated treatment	upregulated	24478708
867	Mouse	mmu-miR-133b	miRNA	4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)	lung cancer	lung cancer cells	drug treatment	lung carcinogen NNK exposure changes the expression of serum miRNAs. Serum miR-206 and miR-133b could be associated with lung carcinogenesis induced by NNK	23337359
868	Mouse	mmu-miR-133b	miRNA	granulocyte-macrophage colony stimulating factor (GM-CSF)	lung injury	normal alveolar epithelial cells	alveolar epithelial cells GM-CSF during hyperoxia treatment	downregulated	24371146
869	Mouse	mmu-miR-133b	miRNA	botulinum toxin A (BTXA)	muscle atrophy	quadriceps muscle	botulinum toxin A (BTXA) treatment	downregulated	30427927
870	Mouse	mmu-miR-133b	miRNA	heme oxygenase-1 (HMOX1)	myoblast differentiation	C2C12 cells	Heme oxygenase-1 (HMOX1) treatment	downregulated	21827279
871	Mouse	mmu-miR-133b	miRNA	rotenone (ROT)	parkinson's disease (PD)	mouse MN9D cells	rotenone treatment	"Interference of SNHG14 reduced rotenone-induced DA neuron damage through miR-133b in MN9D cells and ¦Á-syn was responsible for the protective effect of miR-133b Similarly, interference of SNHG14 mitigated neuron injury in PD mouse model"	31683259
872	Mouse	mmu-miR-133b	miRNA	coxsackievirus B3 (CVB3)	viral myocarditis (VM)	neonatal mouse cardiomyocytes	infect with CVB virus	downregulated	29096746
873	Mouse	mmu-mir-133b-3p	miRNA	recombinant-specific gram-negative pathogen Escherichia coli (Xen14) and gram-positive pathogen Staphylococcus aureus (Xen29)	bacterial infection	blood	recombinant-specific gram-negative pathogen Escherichia coli (Xen14) and gram-positive pathogen Staphylococcus aureus (Xen29) treatment	upregulated	25563241
874	Mouse	mmu-miR-133b-3p	miRNA	murine cytomegalovirus (MCMV)	murine cytomegalovirus (MCMV) infection	peripheral blood monocytes	murine cytomegalovirus (MCMV) infection	downregulated	33245094
875	Mouse	mmu-miR-133b-3p	miRNA	perfluorooctanoic acid	testicular toxicity	BALB/c mice testes tissue	Perfluorooctanoic acid (PFOA) exposure treatment	upregulated	28126411
876	Mouse	mmu-miR-134	miRNA	bisphenol A (BPA)	aging	mouse embryoid bodies (mEB)	bisphenol A (BPA) treatment	downregulated	24090592
877	Mouse	mmu-miR-134	miRNA	hypoxia	cerebral ischemia injury (CII)	brain tissues	middle cerebral artery occlusion (MCAO) treatment	dysregulated	25003713
878	Mouse	mmu-miR-134	miRNA	duloxetine	depression	frontal lobe and hippocampus	duloxetine treatment	downregulated	26823914
879	Mouse	mmu-miR-134	miRNA	pilocarpine	epilepsy	hippocampus	pilocarpine treatment	upregulated	24874920
880	Mouse	mmu-miR-134	miRNA	pilocarpine	epilepsy	intracerebroventricular	pilocarpine treatment	status epilepticus induced by pilocarpine was associated with upregulation of miR-134 within the hippocampus of mice	24874920
881	Mouse	mmu-miR-134	miRNA	triclosan (TCS)	general cytotoxicity	mouse embryonic stem cells (mESC)	were acutely exposed to TCS for 24 h treatment	upregulated	24879426
882	Mouse	mmu-miR-134	miRNA	oxygen glucose deprivation (OGD)	ischemic stroke (IS)	mouse brain tissues	oxygen-glucose deprivation (OGD) treatment	upregulated	25304362
883	Mouse	mmu-miR-134	miRNA	choline- and folate-deficient (CFD) diet	liver damage	plasma	choline- and folate-deficient (CFD) diet treatment	upregulated	26878785
884	Mouse	mmu-miR-134	miRNA	prolonged aerobic exercise	muscle hypertrophy	plasma	"impact of extended-duration, submaximal aerobic exercise treatment"	upregulated	24436293
885	Mouse	mmu-miR-134	miRNA	choline- and folate-deficient (CFD) diet	nonalcoholic fatty liver disease (NAFLD)	plasma	choline- and folate-deficient (CFD) treatment	upregulated	26878785
886	Mouse	mmu-miR-134	miRNA	retinoic acid (RA)	susceptibility of tumour cells to natural killer cell-mediated cytotoxicity	mouse embryonic stem cells (mESCs)	?retinoic acid treatment	upregulated	17916804
887	Mouse	mmu-miR-134-5p	miRNA	hypoxia/reoxygenation (H/R)	myocardial infarction (MI)	cardiomyocytes	hypoxia/reoxygenation (H/R) treatment	upregulated	32684588
888	Mouse	mmu-miR-134-5p	miRNA	"1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)"	parkinson's disease (PD)	"ventral midbrains, mouse dopaminergic neuronal cell line MN9D"	"1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) treatment"	"circDLGAP4 exerted its functions via regulating miR-134-5p, circDLGAP4 exerts neuroprotective effects via modulating miR-134-5p/CREB pathway both in human and mouse."	31761328
889	Mouse	mmu-miR-134-5p	miRNA	"1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)"	parkinson's disease (PD)	midbrain tissues	"1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) treatment"	miR-134-5p was verified to be increased in PD animal.	31761328
890	Mouse	mmu-miR-134-5p	miRNA	angiotensin II (Ang II)	thoracic aortic dissection (TAD)	aorta specimens	angiotensin II (Ang II) treatment	downregulated	30951965
891	Mouse	mmu-miR-135-5p	miRNA	cold	obesity	brown adipose tissue (BAT)	cold treatment	downregulated	33015181
892	Mouse	mmu-miR-135a	miRNA	chronic intermittent hypoxia (CIH)	aortic endothelial function	aortic endothelial cells	chronic intermittent hypoxia (CIH) treatment	MEG3 suppresses the apoptosis of aortic endothelial cells in mice with chronic intermittent hypoxia via downregulated of HIF-1¦Á by competitively binding to microRNA-135a.	32642094
893	Mouse	mmu-miR-135a	miRNA	oxidized low density lipoprotein (ox-LDL)	atherosclerosis (AS)	RAW264.7 cells	oxidized low-density lipoprotein (ox-LDL) treatment	downregulated	29663503
894	Mouse	mmu-miR-135a	miRNA	fibroblast growth factor 18 (FGF18)	cell differentiation	mouse preosteoblasts	collagen membranes (CMs) containing FGF-18 treatment	downregulated	29544382
895	Mouse	mmu-miR-135a	miRNA	antidepressant	depression and anxiety disorders	adult mouse	antidepressant treatment	upregulated	24952960
896	Mouse	mmu-miR-135a	miRNA	high glucose (HG)	diabetic nephropathy (DN)	mouse mesangial cells; mouse tubular epithelial cells	high glucose (HG) treatment	miR-135a expression was markedly upregulated in tubular epithelial cells cultured in high-glucose conditions.	33203695
897	Mouse	mmu-miR-135a	miRNA	adriamycin (ADR)	focal segmental glomerulosclerosis (FSGS)	mouse	adriamycin (ADR) treatment	upregulated	28949388
898	Mouse	mmu-miR-135a	miRNA	dextran sodium sulfate (DSS)	inflammatory bowel disease (IBD)	colon tissues	dextran sodium sulfate (DSS) treatment	downregulated	29636643
899	Mouse	mmu-miR-135a	miRNA	H2O2	oxidative stress	hippocampal HT-22 cells	H2O2 treatment	upregulated	31728857
900	Mouse	mmu-miR-135a	miRNA	paeoniflorin	oxidative stress	H2O2-treated hippocampal HT-22 cells	Paeoniflorin (PF) treatment	downregulated	31728857
901	Mouse	mmu-miR-135a	miRNA	ovalbumin (OVA) and urban particulate matter (PM)	pulmonary arterial hypertension (PAH)	mouse lung	"exposure to combined Th2 antigen (Ovalbumin, OVA) and urban particulate matter (PM) treatment"	upregulated	28415675
902	Mouse	mmu-miR-135a*	miRNA	nonylphenol (NP)	tumorigenesis	Sertoli TM5 cells	nonylphenol (NP) treatment	upregulated	21914226
903	Mouse	mmu-miR-135a-1*	miRNA	H1N1 influenza virus	endometriosis and endometrial carcinoma	mouse lung?tissues	H1N1 influenza virus infection	upregulated	24066118
904	Mouse	mmu-miR-135a-5p	miRNA	Physical exercise	age-related cognitive decline	neural precursor cells (NPCs) of the mouse dentate gyrus (DG)	Physical exercise treatment	downregulated	31130358
905	Mouse	mmu-miR-135a-5p	miRNA	doxorubicin (DOX)	cardiotoxicity	heart tissues	doxorubicin (DOX) treatment	CircRNA-Arhgap12 could sponge miR-135a-5p in mouse cardiomyocytes during DOX-induced cardiotoxicity.	33245966
906	Mouse	mmu-miR-135a-5p	miRNA	hydrogen sulfide (H2S)	MPTP-induced mouse subacute	astrocytic	H2S treatment	downregulated	27842305
907	Mouse	mmu-miR-135a-5p	miRNA	chlamydia muridarum variants (C. muridarum Var001 [CmVar001] and CmVar004)	plvic inflammatory disease	mouse	two Chlamydia muridarum variants (C. muridarum Var001 [CmVar001] and CmVar004) infection	were upregulated during CmVar004 infection compared to CmVar001 infection	24961692
908	Mouse	mmu-miR-135b	miRNA	angiotensin II (Ang II)	cardiac hypertrophy	Neonatal mice cardiomyocytes	angiotensin II (Ang II) treatment	downregulated	30037628
909	Mouse	mmu-miR-135b	miRNA	azoxymethane (AOM)	colorectal cancer (CRC)	plasma and colon tissues	azoxymethane (AOM) treatment	upregulated	30311185
910	Mouse	mmu-miR-135b	miRNA	lactobacillus acidophilus and bifidobacterium bifidum probiotics	colorectal cancer (CRC)	plasma and colon tissues from azoxymethane (AOM)-treated mice	Lactobacillus acidophilus and Bifidobacterium bifidum probiotics treatment	downregulated	30311185
911	Mouse	mmu-miR-135b	miRNA	helicobacter pylori (H. pylori)	gastric MALT lymphoma (GML)	GML-developing d3Tx mice stomachs	infect with H. pylori	upregulated	28560185
912	Mouse	mmu-miR-135b	miRNA	N-ethyl-N-nitrosourea (ENU)	hepatocellular carcinoma (HCC)	liver tissues	N-ethyl-N-nitrosourea (ENU) treatment	downregulated	21029445
913	Mouse	mmu-miR-135b	miRNA	cigarette smoke or nontypeable Haemophilus influenzae (NTHi)	cell proliferation	lung tissue	cigarette smoke or nontypeable Haemophilus influenzae (NTHi) treatment	upregulated	23440414
914	Mouse	mmu-miR-135b	miRNA	H2O2	myocardial infarction (MI)	Primary cultured neonatal mice ventricular cardiomyocytes (NMVCs)	hydrogen peroxide (H2O2) treatment	downregulated	31870781
915	Mouse	mmu-miR-135b-5p	miRNA	dexamethasone (DEX)	asthma	lung tissues	dexamethasone (Dex) treatment	miR-135b-5p was upregulated in the Dex group compared with that in the Model group.	32222886
916	Mouse	mmu-miR-135b-5p	miRNA	oxygen-glucose deprivation and reoxygenation (OGD/R)	cerebral ischemia/reperfusion (I/R) injury	HT22 cells	oxygen-glucose deprivation and reoxygenation (OGD/R) treatment	miR-135b-5p expression was significantly decreased in hippocampal neurons receiving OGD/R treatment	30002689
917	Mouse	mmu-miR-135b-5p	miRNA	helicobacter pylori (H. pylori)	gastric cancer (GC)	mouse gastric tissue	Helicobacter pylori infection	upregulated	29985646
918	Mouse	mmu-miR-135b-5p	miRNA	osteogenic differentiation medium	osteoporosis	MC3T3-E1 cells	osteogenic differentiation medium induction	downregulated	32010267
919	Mouse	mmu-miR-135b-5p	miRNA	dextran sodium sulfate (DSS)	ulcerative colitis (UC)	colonic tissues	dextran sulfate sodium (DSS) treatment	upregulated	32779953
920	Mouse	mmu-miR-136	miRNA	high-content hydrogen water (HHW)	nonalcoholic fatty liver disease (NAFLD)	liver tissues	high-content hydrogen water (HHW) treatment	MiR-136 was downregulated in NAFLD mice model after HHW treatment.	29261513
921	Mouse	mmu-miR-136	miRNA	polyinosinic-polycytidilic acid (Poly(I:C))	orchitis	testicular cells	poly I:C treatment	downregulated	31195953
922	Mouse	mmu-miR-136	miRNA	lipopolysaccharide (LPS)	osteoarthritis (OA)	?murine chondrogenic ATDC5 cell	lipopolysaccharide (LPS) treatment	upregulated	30074264
923	Mouse	mmu-miR-136-5p	miRNA	IL-17	inflammation	C57BL/6 mouse astrocytes	IL-17 (100ng/ml) for various periods of time (0-48 hours) and at various doses (0-200 ng)	upregulated	28355611
924	Mouse	mmu-miR-136-5p	miRNA	barium chloride	muscle injury	C2C12 cells	barium chloride treatment	upregulated	32954829
925	Mouse	mmu-miR-137	miRNA	oxygen-glucose deprivation and reoxygenation (OGD/R)	ischemic stroke (IS)	Mouse hippocampal neuron HT22 cells	oxygen-glucose deprivation and reoxygenation (OGD/R) treatment	downregulated	33746585
926	Mouse	mmu-miR-137	miRNA	qingda granule (QDG)	ischemic stroke (IS)	oxygen-glucose deprivation/reoxygenation (OGD/R) treated HT22 cells	Qingda granule (QDG) treatment	upregulated	33746585
927	Mouse	mmu-miR-137	miRNA	amyloid-¦Â (A¦Â)	Alzheimer's disease (AD)	Neuro2a (N2a) cells	amyloid-¦Â (A¦Â) treatment	downregulated	28655611
928	Mouse	mmu-miR-137	miRNA	isorhapontigenin (ISO)	bladder cancer	Human bladder cancer cell line UMUC3	isorhapontigenin (ISO)treatment	upregulated	26832795
929	Mouse	mmu-miR-137	miRNA	H2O2	cardiomyocyte apoptosis	cardiomyocyte	H2O2 treatment	upregulated	26566162
930	Mouse	mmu-miR-137	miRNA	propofol (PPF)	cell apoptosis and autophagy	HT-22 cells	Propofol treatment	upregulated	31678238
931	Mouse	mmu-miR-137	miRNA	kainic acid (KA)	convulsive seizures	hippocampal neural stem/progenitor cells (NSPCs)	kainic acid (KA) treatment	upregulated	30837840
932	Mouse	mmu-miR-137	miRNA	neurotoxicant sodium valproate (VPA)	developmental toxicity	murine embryonic stem cells (mESCs)	neurotoxicant sodium valproate (VPA) treatment	downregulated	24896083
933	Mouse	mmu-miR-137	miRNA	pentylenetetrazol (PTZ)	epilepsy	temporal neocortex; hippocampus	pentylenetetrazol (PTZ) treatment	downregulated	29894770
934	Mouse	mmu-miR-137	miRNA	pilocarpine	epilepsy	temporal neocortex; hippocampus	pilocarpine treatment	downregulated	29894770
935	Mouse	mmu-miR-137	miRNA	vaccinium bracteatum Thunb.(VBT)	gluconeogenesis	mouse liver	VBT treatment	downregulated in liver	28946187
936	Mouse	mmu-miR-137	miRNA	olive leaf extract (OLE)	hypertension and inappropriate antidiuretic hormone secretion (SIADH)	kidneys tissues	Olive Leaf Extract (OLE) treatment	?In vivo experiments revealed that treatment with OLE increases the expression of the CaSR mRNA and decreases AQP2 mRNA paralleled by an increase of the AQP2-targeting miRNA-137.	33633156
937	Mouse	mmu-miR-137	miRNA	oxygen glucose deprivation (OGD)	ischemic stroke (IS)	mouse primary brain neurons	oxygen-glucose deprivation (OGD) treatment	miR-137 expression was significantly decreased in neurons exposed to OGD compared with their control groups	29307821
938	Mouse	mmu-miR-137	miRNA	resveratrol	neuroblastoma (NB)	neuroblastoma cell line Neuro-2a (N-2a) cells	RSV treatment	upregulated	25505154
939	Mouse	mmu-miR-137	miRNA	extra-virgin olive oil rich in phenols (H-EVOO)	neuronal function	cortex	H-EVOO treatment	upregulated	26695409
940	Mouse	mmu-miR-137	miRNA	"1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)"	parkinson's disease (PD)	mouse serum exosomes	"1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) treatment"	upregulated	31301273
941	Mouse	mmu-miR-137	miRNA	H2O2	spinal cord injury (SCI)	C8-D1A and C8-B4 cells	hydrogen peroxide	downregulated	29125882
942	Mouse	mmu-miR-137	miRNA	H2O2	spinal cord injury (SCI)	C8-D1A and C8-B4 cells	H2O2 treatment	downregulated	29125882
943	Mouse	mmu-miR-137	miRNA	cortical impact	traumatic brain injury (TBI)	cortex	cortical impact	downregulated	26426744
944	Mouse	mmu-miR-137-3p	miRNA	oxygen glucose deprivation (OGD)	myocardial infarction (MI)	primary cardiomyocytes	oxygen glucose deprivation (OGD) treatment	downregulated	32371945
945	Mouse	mmu-miR-137-3p	miRNA	bupivacaine	neurotoxicity	C57BL/6 mice dorsal root ganglion neurons (DRGNs)	bupivacaine treatment	downregulated	28899795
946	Mouse	mmu-miR-138	miRNA	concanamycin A (Con A)	acute liver injury (ALI)	liver macrophage	Concanamycin A (Con A)?treatment	upregulated	31152110
947	Mouse	mmu-miR-138	miRNA	H2O2	acute spinal cord injury (ASCI)	BV-2 cells	H2O2 treatment	"After treatment of various concentrations of H2O2, the cell viabilities were reduced, and miR-138 expression was downregulated."	29749242
948	Mouse	mmu-miR-138	miRNA	coxsackievirus B3 (CVB3)	acute viral myocarditis (VM)	mouse myocardium; primary cardiomyocytes	Coxsackievirus B3 (CVB3) infection	lncRNA HIF1A-AS1 promotes NF-¦ÊB signaling and subsequently aggravates cardiomyocyte apoptosis and inflammation via targeting miR-138.	33224748
949	Mouse	mmu-miR-138	miRNA	P. aeruginosa strain PAO1	bacterial infection	lung tissues	P. aeruginosa strain PAO1 treatment	upregulated	29945883
950	Mouse	mmu-miR-138	miRNA	hypoxia/reoxygenation (H/R)	hypoxia/reoxygenation (H/R) injury	H9C2 cells	hypoxia/reoxygenation (H/R) treatment	lncRNA ROR sponges miR-138 to aggravate H/R-induced myocardial cell injury by upregulating the expression of Mst1.	32240614
951	Mouse	mmu-miR-138	miRNA	hyperoside	hypoxia-induced cardiac dysfunctions	H9C2 cells	Hyperoside (Hyp) treatment	The expression levels of miR-138 were increased in the hypoxic myocardium in the presence of Hyp	33649812
952	Mouse	mmu-miR-138	miRNA	lipopolysaccharide (LPS)	inflammation	RAW264.7 macrophages	lipopolysaccharide (LPS) treatment	upregulated	30157481
953	Mouse	mmu-miR-138	miRNA	morphine	morphine induced neuroinflammation	mouse primary astrocytes	morphine treatment	upregulated	33304479
954	Mouse	mmu-miR-138	miRNA	hypoxia	myocardial ischemia/reperfusion (I/R) injury (MIRI)	heart tissues	The left anterior descending branch of LCA was ligated.	downregulated	31602205
955	Mouse	mmu-miR-138	miRNA	H2O2	osteoporotic injury of osteoblasts	MC3T3-E1 cells	H2O2 treatment	upregulated	29291636
956	Mouse	mmu-miR-138-5p	miRNA	gentamicin	acute kidney injury (AKI)	urine	gentamicin treatment	upregulated	27074385
957	Mouse	mmu-miR-138-5p	miRNA	lipopolysaccharide (LPS)	acute respiratory distress syndrome (ARDS)	serum	lipopolysaccharide (LPS) treatment	upregulated	32934950
958	Mouse	mmu-miR-138-5p	miRNA	propofol (PPF)	cognitive function	Primary neonatal mouse oligodendrocyte (OLGs)	propofol treatment	upregulated	33411226
959	Mouse	mmu-miR-138-5p	miRNA	oxygen glucose deprivation (OGD)	ischemic stroke (IS)	Primary astrocyte	oxygen-glucose deprivation (OGD)-induce treatment	downregulated	31485266
960	Mouse	mmu-miR-138-5p	miRNA	cigarette smoke extract (CSE)	male infertility	Leydig and Sertoli cells	cigarette smoke?extract?(CSE) treatment	Quantitative polymerase chain reaction and Western blot assays showed a negative correlation between miR-138-5p and Caspase-3 expression.	33856081
961	Mouse	mmu-miR-138-5p	miRNA	dexmedetomidine (DEX)	myocardial ischemia/reperfusion (I/R) injury (MIRI)	mouse myocardial tissues	?dexmedetomidine (Dex)? treatment	"Dex improved cardiac function, alleviated myocardial damage, reduced inflammatory factor contents, collagen fibers, and Ltb4r1 expression while increased miR-138-5p expression in myocardial tissues of mice with MI/RI"	33509010
962	Mouse	mmu-miR-138-5p	miRNA	high fat diet (HFD)	obesity	preadipocyte	high fat diet (HFD) feed	"CircSAMD4A regulated preadipocyte differentiation by acting as a miR-138-5p sponge, and thus increasing EZH2 expression."	32292524
963	Mouse	mmu-miR-138-5p	miRNA	IL-1¦Â	osteoarthritis (OA)	mouse chondrocytes	IL-1¦Â treatment	downregulated	29305974
964	Mouse	mmu-miR-138-5p	miRNA	IL-1¦Â	osteoarthritis (OA)	ATDC5 cells	IL-1¦Â treatment	MiR-138-5p was downregulated in ATDC5 cells.	31486753
965	Mouse	mmu-miR-139	miRNA	oxygen-glucose deprivation and reoxygenation (OGD/R)	cerebral ischemia/reperfusion (I/R) injury	BV-2 cells	oxygen-glucose deprivation and reoxygenation (OGD/R) treatment	MiR-139 was significantly downregulated whereas c-Jun was obviously upregulated after OGD/R treatment.	32807449
966	Mouse	mmu-miR-139	miRNA	particulate matter (PM2.5)	PM2.5 exposure	mosue bronchoalveolar lavage fluid (BALF)	"were subjected to intratracheal instillation of 2.5, 10, or 20mg/kg PM2.5 treatment"	upregulated in bronchoalveolar lavage fluid (BALF)	29107863
967	Mouse	mmu-miR-139	miRNA	particulate matter (PM2.5)	pulmonary toxicological	lung tissues	particulate matter (PM2.5) exposure treatment	upregulated	29107863
968	Mouse	mmu-miR-139-3p	miRNA	mechanical unloading	bone loss	MC3T3-E1 cells	Mechanical unloading treatment	LncRNA ODSM-mediated regulation of osteoblast apoptosis and differentiation partially depends on miR-139-3p under MG unloading conditions.	32071307
969	Mouse	mmu-miR-139-3p	miRNA	urocortin 1 (Ucn-1)	myocardial ischemia/reperfusion (I/R) injury (MIRI)	I/R mosue	administration of Ucn-1 at the beginning of reperfusion treatment	downregulated	28827743
970	Mouse	mmu-miR-139-5p	miRNA	high fat diet (HFD)	atherosclerosis (AS)	arterial tissues of mice	high fat diet (HFD) feed	downregulated	33331071
971	Mouse	mmu-miR-139-5p	miRNA	Jiang Tang Xiao Ke Granule	diabetes mellitus (DM)	KKAy diabetic mice	Jiang Tang Xiao Ke Granule treatment	dysregulated	29163176
972	Mouse	mmu-miR-139-5p	miRNA	high glucose (HG)	diabetes mellitus (DM)	Min6 cells	high glucose (HG) treatment	upregulated	31735337
973	Mouse	mmu-miR-139-5p	miRNA	H1N1 influenza virus	endometriosis and endometrial carcinoma	mouse lung?tissues	H1N1 influenza virus infection	upregulated	24066118
974	Mouse	mmu-miR-139-5p	miRNA	fructus meliae toosendan (FMT)	liver damage	eft lateral liver lobe	Fructus Meliae Toosendan (FMT) treatment	downregulated	26539117
975	Mouse	mmu-miR-139-5p	miRNA	prion	neurodegeneration (ND)	the brains tissues	prion infection treatment	upregulated	18987751
976	Mouse	mmu-miR-139-5p	miRNA	25-hydroxycholesterol (25-HC)	osteoclastogenesis	mouse bone marrow macrophages (BMMs) cultured in receptor activator of NF-¦ÊB ligand (RANKL) and monocyte macrophage colony-stimulating factor (M-CSF)	25-hydroxycholesterol (25-HC) treatment	downregulated	28257846
977	Mouse	mmu-miR-13a	miRNA	azoxymethane (AOM)	colorectal cancer (CRC)	plasma and colon tissues	azoxymethane (AOM) treatment	downregulated	30311185
978	Mouse	mmu-miR-13a	miRNA	lactobacillus acidophilus and bifidobacterium bifidum probiotics	colorectal cancer (CRC)	plasma and colon tissues from azoxymethane (AOM)-treated mice	Lactobacillus acidophilus and Bifidobacterium bifidum probiotics treatment	upregulated	30311185
979	Mouse	mmu-miR-1-3p	miRNA	doxorubicin (DOX)	doxorubicin (DOX)-induced cardiotoxicity	Plasma	doxorubicin (DOX) treatment	downregulated	30627229
980	Mouse	mmu-miR-1-3p	miRNA	acetaminophen (APAP)	drug-induced liver injury (DILI)	plasma	acetaminophen (APAP) treatment	upregulated	30125006
981	Mouse	mmu-miR-140	miRNA	ethanol (EtOH)	brain growth deficits associated with prenatal alcohol exposure	extracellular vesicles from neural stem cells (NSCs)	ethanol (EtOH) exposure	upregulated	31009095
982	Mouse	mmu-miR-140	miRNA	TGF-¦Â3	cartilage defection	C3H10T1/2 mesenchymal stem cells (MSCs)	TGF-¦Â3 treatment	upregulated	29067438
983	Mouse	mmu-miR-140	miRNA	interleukin-1 receptor antagonist protein (IRAP)	cartilage impact injury	porcine knee joint	Interleukin-1 Receptor Antagonist Protein (IRAP) treatment	upregulated	26521750
984	Mouse	mmu-miR-140	miRNA	lipopolysaccharide (LPS)	hepatitis	liver tissues	lipopolysaccharide (LPS) treatment	?Microarray showed that lncRNA TUG1 was upregulated in LPS-induced hepatocyte inflammation.	33644034
985	Mouse	mmu-miR-140	miRNA	high fat diet (HFD)	myofibroblast differentiation	mosue mammary adipose tissue	high fat diet (HFD) feed	downregulated in mammary adipose tissue	27895151
986	Mouse	mmu-miR-140	miRNA	fluid shear stress (FSS)	osteoblastic differentiation	MC3T3-E1 cells	fluid shear stress (FSS)treatment	downregulated	23595392
987	Mouse	mmu-miR-140	miRNA	endotoxin	sepsis	skeletal muscle tissue	endotoxin treatment	downregulated	31042421
988	Mouse	mmu-miR-140-3p	miRNA	ovalbumin (OVA)	allergic bronchial asthma	bronchial smooth muscles (BSMs)	ovalbumin antigen treatment	downregulated	33121100
989	Mouse	mmu-miR-140-3p	miRNA	X-rays	bystander effect	C57BL/6 mice extracellular vesicles (EVs)	otal-body irradiated with X-rays	downregulated	28396668
990	Mouse	mmu-miR-140-3p	miRNA	angiotensin II (Ang II)	cardiac hypertrophy	neonatal mouse ventricular cardiomyocytes (NMVCs)	angiotensin II (Ang II) treatment	miR-140-3p was markedly decreased in NMVCs with overexpression of circRNA_000203.	31397837
991	Mouse	mmu-miR-140-3p	miRNA	ethanol (EtOH) and nicotine	chronic hepatitis C virus (HCV) infection	mouse fetal murine cerebral cortical	ethanol and nicotine treatment	downregulated	22458409
992	Mouse	mmu-miR-140-3p	miRNA	lentivirus	collagen-induced arthritis (CIA)	synovial	lentivirus (LV) treatment	downregulated	26473405
993	Mouse	mmu-miR-140-3p	miRNA	doxorubicin (DOX)	doxorubicin (DOX)-induced cardiotoxicity	plasma	doxorubicin (DOX) treatment	downregulated	30453253
994	Mouse	mmu-miR-140-3p	miRNA	bilateral surgical destabilization of the medial meniscus (DMM)	osteoarthritis (OA)	male C57BL6 mice	bilateral surgical destabilization of the medial meniscus (DMM) treatment	dysregulated	29255152
995	Mouse	mmu-miR-140-5p	miRNA	apigenin	acute kidney injury (AKI)	hypoxia/reoxygenation (H/R)-treated mouse renal tubular epithelial cells (mRTECs)	apigenin treatment	upregulated	33653497
996	Mouse	mmu-miR-140-5p	miRNA	cisplatin (DDP)	acute kidney injury (AKI)	mouse kidney	cisplatin treatment	upregulated	28928081
997	Mouse	mmu-miR-140-5p	miRNA	hypoxia/reoxygenation (H/R)	acute kidney injury (AKI)	mouse renal tubular epithelial cells (mRTECs)	hypoxia/reoxygenation (H/R) treatment	downregulated	33653497
998	Mouse	mmu-miR-140-5p	miRNA	lipopolysaccharide (LPS)	acute lung injury (ALI)	lung tissues	lipopolysaccharide (LPS) treatment	downregulated	30344669
999	Mouse	mmu-miR-140-5p	miRNA	lipopolysaccharide (LPS)	acute lung injury (ALI)	MLE-12 cells	lipopolysaccharide (LPS) treatment	downregulated	31769066
1000	Mouse	mmu-miR-140-5p	miRNA	shikonin	acute lung injury (ALI)	mouse MLE©\12 cell	Shikonin treatment	"Shikonin could improve acute lung injury induced by sepsis The mechanism might be correlation miRNA-140-5p expression increasing, and regulated targeted gene TLR4, with TLR4 expression depressing, the downstream myeloid differentiation protein 88 and nuclear factor ¦ÊB proteins expression were suppressed"	31769066
1001	Mouse	mmu-miR-140-5p	miRNA	shikonin	acute lung injury (ALI)	MLE-12 cells	Shikonin treatment	upregulated	31769066
1002	Mouse	mmu-miR-140-5p	miRNA	"1,25-dihydroxyvitamin D 3 (calcitriol)"	bone development	murine primary osteoblasts and MC3T3 cells	"1,25-dihydroxyvitamin D 3 (calcitriol) treatment"	upregulated	29604361
1003	Mouse	mmu-miR-140-5p	miRNA	lentivirus	collagen-induced arthritis (CIA)	synovial	lentivirus (LV) treatment	downregulated	26473405
1004	Mouse	mmu-miR-140-5p	miRNA	catalpol	diabetic cardiomyopathy (DCM)	high glucose (HG) treated mouse cardiomyocytes	catalpol treatment	"upregulated, overexpression of miR-140-5p or silencing of HDAC4 rescued Neat1-induced cardiomyocyte apoptosis"	31078585
1005	Mouse	mmu-miR-140-5p	miRNA	xuebijing (XBJ)	lung fibrosis	lung tissues	xuebijing (XBJ) treatment	XBJ administration upregulated miR-140-5p expression in mice with PQ-induced pulmonary fibrosis.	32462952
1006	Mouse	mmu-miR-140-5p	miRNA	IL-1¦Â	osteoarthritis (OA)	primary mandibular condylar chondrocytes (MCCs)	IL-1¦Â treatment	upregulated	30728776
1007	Mouse	mmu-miR-140-5p	miRNA	fluid shear stress (FSS)	osteogenesis	MC3T3-E1 cells	Fluid shear stress (FSS)? treatment	miR-140-5p was significantly downregulated when MC3T3-E1 cells were exposed to FSS.	33588662
1008	Mouse	mmu-miR-140-5p	miRNA	Xuebijing (XBJ)	paraquat (PQ)-induced pulmonary fibrosis	lung tissues	Xuebijing (XBJ) treatment	XBJ administration upregulated miR-140-5p expression in mice with PQ-induced pulmonary fibrosis	32462952
1009	Mouse	mmu-miR-141	miRNA	melatonin	cardiac fibrosis	high glucose (HG)-treated cardiac fibroblasts (CFs)	Melatonin treatment	melatonin produces an antifibrotic effect via inhibiting lncR-MALAT1/miR-141-mediated NLRP3 inflammasome activation and TGF-¦Â1/Smads signaling	32067273
1010	Mouse	mmu-miR-141	miRNA	kainic acid (KA)	epilepsy	brain tissues	kainic acid treatment	miRNA-141 expression levels were increased in epilepsy mice.	30548678
1011	Mouse	mmu-miR-141	miRNA	shikonin	epithelial-mesenchymal transition (EMT)	mouse skin tissues	Shikonin treatment	downregulated	23861701
1012	Mouse	mmu-miR-141	miRNA	alcohol	intestinal injury and intestinal endotoxemia of alcoholic hepatitis	intestinal tissues	Lieber-Decarli alcohol feed	downregulated	31173169
1013	Mouse	mmu-miR-141	miRNA	methionine choline-deficient diet (MCD)	nonalcoholic steatohepatitis (NASH)	liver tissues	fed a methionine and choline deficient (MCD) diet for 2 week	upregulated in liver	29093267
1014	Mouse	mmu-miR-141	miRNA	bone morphogenetic protein 2 (BMP2)	preosteoblast differentiation	pre-osteoblast	bone morphogenetic protein 2 (BMP2) treatment	downregulated	19454767
1015	Mouse	mmu-miR-141	miRNA	X-rays	radiation-induced oral mucositis (RIOM)	tongue tissues	25 Gy X-ray irradiation treatment	upregulated	31346357
1016	Mouse	mmu-miR-141	miRNA	streptozocin (STZ)	type 1 diabetes mellitus (T1DM)	diabetic heart tissues	?streptozotocin treatment	upregulated	23034391
1017	Mouse	mmu-miR-141	miRNA	"2,4,6-trinitrobenzene sulfonic acid (TNBS)"	crohn disease (CD)	colon tissues	"2,4,6-trinitrobenzene sulfonic acid (TNBS)/ethanol treatment"	downregulated	24000293
1018	Mouse	mmu-miR-141-3p	miRNA	fatty acid amide hydrolase inhibitor (FAAH-II)	colitis	colitis mouse colon tissues	FAAH-II treatment	dysregulated	27327245
1019	Mouse	mmu-miR-141-3p	miRNA	aldose reductase	diabetic nephropathy (DN)	renal mesangial cells	aldose reductase treatment	upregulated	24161443
1020	Mouse	mmu-miR-141-3p	miRNA	high glucose (HG)	diabetic nephropathy (DN)	mesangial cells	high glucose (HG) treatment	LncRNA SNHG16 induces proliferation and fibrogenesis via modulating miR-141-3p and CCND1 in diabetic nephropathy.	32504027
1021	Mouse	mmu-miR-141-3p	miRNA	porcine cardiac myosin (PCM)	experimental autoimmune myocarditis (EAM)	heart tissues	porcine cardiac myosin (PCM) induce	downregulated	31225989
1022	Mouse	mmu-miR-141-3p	miRNA	D-glucose	osteoarthritis (OA)	ATDC5 cells	D-glucose treatment	downregulated	29319178
1023	Mouse	mmu-miR-141-3p	miRNA	coix seed Oil (CSO)	triple negative breast cancer (TNBC)	mouse triple-negative breast cancer (TNBC) tissues	coix Seed Oil (CSO) treatment	upregulated	33101013
1024	Mouse	mmu-miR-142	miRNA	Klebsiella pneumoniae	acute lung injury (ALI)	Bronchoalveolar lavage fluid (BALF) microvesicles (MVs)	Klebsiella pneumoniae infection	upregulated	31331947
1025	Mouse	mmu-miR-142	miRNA	lipopolysaccharide (LPS)	acute lung injury (ALI)	Bronchoalveolar lavage fluid (BALF) microvesicles (MVs)	lipopolysaccharide (LPS) treatment	upregulated	31331947
1026	Mouse	mmu-miR-142	miRNA	amyloid-¦Â (A¦Â) 1-40	age-related macular degeneration (AMD)	C57BL/6 mice eye tissues	amyloid-¦Â (A¦Â) 1-40 treatment	upregulated	28324113
1027	Mouse	mmu-miR-142	miRNA	Glabridin (GLA)	breast cancer	MDA-MB-231 and BT-551 breast cancer cells	Glabridin (GLA) treatment	upregulation	24754877
1028	Mouse	mmu-miR-142	miRNA	doxycycline	colitis	colon tissues	doxycycline (DXC) treatment	upregulated	30076847
1029	Mouse	mmu-miR-142	miRNA	minocycline (MNC)	colitis	colon tissues	minocycline (MNC) treatment	upregulated	30076847
1030	Mouse	mmu-miR-142	miRNA	tigecycline (TGC)	colitis	colon tissues	tigecycline (TGC) treatment	upregulated	30076847
1031	Mouse	mmu-miR-142	miRNA	IL-15	innate immune response	type 1 innate lymphoid cells (ILCs) isolated from spleen tissues	Interleukin-15 (IL-15) treatment	upregulated	31402259
1032	Mouse	mmu-miR-142	miRNA	artesunate (ART)	ovarian cancer (OC)	peripheral CD4+ T cells and Th1 differentiation from CD4+ T cells	Artesunate treatment	upregulated	31038546
1033	Mouse	mmu-miR-142	miRNA	cecal ligation and puncture (CLP)	sepsis	mouse	cecal ligation and puncture (CLP) treatment	downregulated	29793310
1034	Mouse	mmu-miR-142	miRNA	catalpol	spinal cord injury (SCI)	BV2 cells	catalpol treatment	CTP was found to be upregulated miR-142 and the protective effects of CTP on apoptosis	33628189
1035	Mouse	mmu-miR-142-3p	miRNA	H2O2	acute myocardial infarction (AMI)	primary cultured cardiomyocytes	H2O2 treatment	downregulated	31145943
1036	Mouse	mmu-miR-142-3p	miRNA	borneol	asthma	CD4 + T cells	borneol treatment	Borneol inhibited CD4 + T cells infiltration in vivo and proliferation in vitro by downregulating miR-26a and miR-142-3p.	33272847
1037	Mouse	mmu-miR-142-3p	miRNA	borneol	asthma	CD4+ T cells isolated from the spleen of OVA-induced asthma mice	borneol treatment	Borneol inhibited CD4 + T cells infiltration in vivo and proliferation in vitro by downregulating miR-26a and miR-142-3p.	33272847
1038	Mouse	mmu-miR-142-3p	miRNA	ovalbumin (OVA)	asthma	lung tissues	ovalbumin treatment	upregulated	29722559
1039	Mouse	mmu-miR-142-3p	miRNA	lipopolysaccharide (LPS)	cell death	BM cells	lipopolysaccharide (LPS) treatment	Targeting of microRNA-142-3p in dendritic cells regulates endotoxin-induced mortality	21474672
1040	Mouse	mmu-miR-142-3p	miRNA	cholic acid (CA)	cholestasis	mouse liver	CA treatment	upregulated	28153841
1041	Mouse	mmu-miR-142-3p	miRNA	streptozocin (STZ)	diabetes mellitus (DM)	hearts of diabetic mice	streptozotocin (STZ) treatment	upregulated	21584493
1042	Mouse	mmu-miR-142-3p	miRNA	prednisolone	duchenne muscular dystrophy (DMD)	diaphragm muscle	prednisolone treatment	downregulated	29883261
1043	Mouse	mmu-miR-142-3p	miRNA	vamorolone	duchenne muscular dystrophy (DMD)	diaphragm muscle	vamorolone treatment	downregulated	29883261
1044	Mouse	mmu-miR-142-3p	miRNA	IL-10	epithelial-mesenchymal transition (EMT)	colonic intraepithelial lymphocytes	IL-10 treatment	upregulated	22043014
1045	Mouse	mmu-miR-142-3p	miRNA	lipopolysaccharide (LPS)	hirschsprung's disease (HSCR)	neural precursor cells (NPCs)	lipopolysaccharides (LPS) treatment	downregulated	29956457
1046	Mouse	mmu-miR-142-3p	miRNA	flaxseed (FS)	inflammation	mouse exposed to X-ray	fed 10% FS or a 0% FS isocaloric control diet treatment	dysregulated	24755684
1047	Mouse	mmu-miR-142-3p	miRNA	histone deacetylase inhibitor trichostatin A (TSA)	inflammatory diseases	LPS-treated macrophages	histone deacetylase inhibitor trichostatin A treatment	upregulated	27788393
1048	Mouse	mmu-miR-142-3p	miRNA	licochalcone A (LA)	melanoma	B16 cells	licochalcone A (LCA) treatment	MiR- 142-3p level was significantly upregulated in LCA-treated B16 cells in a time- and dose-dependent manner	31793097
1049	Mouse	mmu-miR-142-3p	miRNA	ischemia/reperfusion (I/R) 	myocardial injury	cardiomyocyte M6200 cells	ischemia/reperfusion (I/R) treatment	downregulated	28025989
1050	Mouse	mmu-miR-142-3p	miRNA	lipopolysaccharide (LPS)	osteoarthritis (OA)	chondrocytes	lipopolysaccharide (LPS) treatment	downregulated	27447821
1051	Mouse	mmu-miR-142-3p	miRNA	Vaccination during Crisis of Plasmodium chabaudi Blood-Stage Malaria	plasmodium chabaudi infection	Balb/c Mice liver	infect with Vaccination treatment	downregulated in the Liver	28123381
1052	Mouse	mmu-miR-142-3p	miRNA	chlamydia muridarum variants (C. muridarum Var001 [CmVar001] and CmVar004)	plvic inflammatory disease	mouse	two Chlamydia muridarum variants (C. muridarum Var001 [CmVar001] and CmVar004) infection	were upregulated during CmVar004 infection compared to CmVar001 infection	24961692
1053	Mouse	mmu-miR-142-3p	miRNA	"5-Aza-2'-deoxycytidine (5-Aza-dC, decitabine)"	cell proliferation	mouse 3T3 cells	"5-Aza-2'-deoxycytidine (5-Aza-dC, decitabine) treatment"	downregulated	25544846
1054	Mouse	mmu-miR-142-3p	miRNA	high inorganic phosphate (Pi)	uremia	blood of DBA/2 mice	high phosphate diet (HPD) feed	downregulated	30453118
1055	Mouse	mmu-miR-142-3p	miRNA	high inorganic phosphate (Pi)	vascular relaxation	blood of DBA/2 mice	high phosphate diet (HPD) feed	downregulated	30453118
1056	Mouse	mmu-miR-142-5p	miRNA	ovalbumin (OVA)	asthma	pulmonary macrophages	ovalbumin (OVA) treatment	upregulated	32524675
1057	Mouse	mmu-miR-142-5p	miRNA	oleanolic acid (OLA)	diabetic nephropathy (DN)	streptozotocin induced diabetic nephropathy (DN) mouse kidney tissues	oleanolic acid (OLA) treatment	downregulated	31410746
1058	Mouse	mmu-miR-142-5p	miRNA	prednisolone	duchenne muscular dystrophy (DMD)	diaphragm muscle	prednisolone treatment	downregulated	29883261
1059	Mouse	mmu-miR-142-5p	miRNA	vamorolone	duchenne muscular dystrophy (DMD)	diaphragm muscle	vamorolone treatment	downregulated	29883261
1060	Mouse	mmu-miR-142-5p	miRNA	pilocarpine	epilepsy	male NMRI mice	inject intraperitoneally with pilocarpine treatment	downregulated	25078263
1061	Mouse	mmu-miR-142-5p	miRNA	IL-10	epithelial-mesenchymal transition (EMT)	colonic intraepithelial lymphocytes	IL-10 treatment	upregulated	22043014
1062	Mouse	mmu-miR-142-5p	miRNA	retinoid binding protein peptide 161-180	experimental autoimmune uveoretinitis (EAU)	ocular tissues	retinoid binding protein peptide 161-180 treatment	upregulated	20881307
1063	Mouse	mmu-miR-142-5p	miRNA	high fat diet (HFD)	nonalcoholic fatty liver disease (NAFLD)	liver tissues	high fat diet (HFD) feed	upregulated	31889412
1064	Mouse	mmu-miR-142-5p	miRNA	high fat diet (HFD)	nonalcoholic fatty liver disease (NAFLD)	liver tissues	high fat diet (HFD) feed	upregulated	31889412
1065	Mouse	mmu-miR-142-5p	miRNA	plasmodium chabaudi malaria	peak parasitemia	liver of mice	Plasmodium chabaudi malaria infection treatment	downregulated	21085987
1066	Mouse	mmu-miR-142-5p	miRNA	angiotensin II (Ang II)	cell proliferation	cardiac fibroblasts (CFs)	angiotensin II (Ang II) treatment	downregulated	32268073
1067	Mouse	mmu-miR-142-5p	miRNA	TGF-¦Â1	cell proliferation	cardiac fibroblasts (CFs)	TGF-¦Â1 ttreatment treatment	downregulated	32268073
1068	Mouse	mmu-miR-142-5p	miRNA	smoking	smoking-related interstitial fibrosis (SRIF)	C57 mice circulating	6 months of chronic mainstream smoking exposure treatment	downregulated	22782705
1069	Mouse	mmu-miR-142-5p	miRNA	pilocarpine	temporal lobe epilepsy (TLE)	hippocampus	pilocarpine treatment	upregulated	32439493
1070	Mouse	mmu-miR-142a	miRNA	helicobacter pylori (H. pylori)	gastric MALT lymphoma (GML)	GML-developing d3Tx mice stomachs	infect with H. pylori	upregulated	28560185
1071	Mouse	mmu-miR-142a	miRNA	ischemia/reperfusion (I/R) 	myocardial ischaemic injury	mouse plasma;Bone marrow-derived macrophage (BMDM);Rat neonatal CMs	ischemia/reperfusion (I/R) treatment	differently regulated	28768728
1072	Mouse	mmu-miR-142a-3p	miRNA	lipopolysaccharide (LPS)	acute lung injury (ALI)	ALI mice lung tissues and RAW264.7 cells	lipopolysaccharide (LPS) treatment	upregulated	31494298
1073	Mouse	mmu-miR-142a-3p	miRNA	methamphetamine (METH)	methamphetamine (METH)-mediated neurotoxicity	BV2 cells and mouse brain	Methamphetamine (METH) treatment	downregulated	30914375
1074	Mouse	mmu-miR-142a-5p	miRNA	genipin (GNP)	hyperlipidemia	obese mouse	GNP liver	upregulated	29197188
1075	Mouse	mmu-miR-142a-5p	miRNA	genipin (GNP)	hyperlipidemia	high fat diet-induced obese mice	genipin (GNP) treatment	upregulated	29197188
1076	Mouse	mmu-miR-143	miRNA	"3-Isobutyl_x0002_l-methylxanthine (MIX), dexamethasone (DEX)"	adipogenesis	3T3-L1cells	"adding 10 lg/ml insulin, 1 lM DEX, and 0.5 mM MIX treatment"	upregulated	25366176
1077	Mouse	mmu-miR-143	miRNA	angiotensin II (Ang II)	aortic dissection (AD)	mouse vascular smooth muscle cells (VSMCs)	angiotensin II (Ang II) treatment	downregulated	28167124
1078	Mouse	mmu-miR-143	miRNA	hepatic antigen S100	autoimmune hepatitis (AIH)	mouse liver tissues	hepatic antigen S100 treatment	Infection or transfection of mir-143 in mice or hepatocytes significantly attenuated the development of alleviation of hepatocyte injury.	31808606
1079	Mouse	mmu-miR-143	miRNA	estradiol-17¦Â (E2)	cervical cancer (CC)	Osteosarcoma Saos2 cell line	estradiol-17¦Â (E2) treatment	downregulated	27278606
1080	Mouse	mmu-miR-143	miRNA	dextran sodium sulfate (DSS)	colitis	colon tissues	dextran sodium sulfate (DSS) treatment	downregulated	29867475
1081	Mouse	mmu-miR-143	miRNA	probiotic Escherichia coli Nissle 1917 (EcN)	colitis	dextran sodium sulfate (DSS)-induced colitis mouse colon tissues	probiotic Escherichia coli Nissle 1917 (EcN) treatment	upregulated	29867475
1082	Mouse	mmu-miR-143	miRNA	azoxymethane (AOM) and dextran sulfate sodium (DSS)	colorectal cancer (CRC)	mouse colon tissues	azoxymethane (AOM) and dextran sulfate sodium (DSS) treatment	downregulated	24464560
1083	Mouse	mmu-miR-143	miRNA	azoxymethane (AOM) and dextran sulfate sodium (DSS)	colorectal cancer (CRC)	mouse colon tissues	azoxymethane (AOM) and dextran sulfate sodium (DSS) treatment	downregulated	24464560
1084	Mouse	mmu-miR-143	miRNA	high fat diet (HFD)	diabetes mellitus (DM)	mouse liver cells	high fat diet (HFD) treatment	downregulated	21441927
1085	Mouse	mmu-miR-143	miRNA	streptozocin (STZ)	diabetes mellitus (DM)	hearts of diabetic mice	streptozotocin (STZ) treatment	downregulated	21584493
1086	Mouse	mmu-miR-143	miRNA	angelica polysaccharide (AP)	diabetes mellitus (DM)	TNF-¦Á-treated MIN6 cell line	angelica polysaccharide (AP) treatment	upregulated	31746030
1087	Mouse	mmu-miR-143	miRNA	carboxymethyllysine (CML)	diabetes mellitus (DM)	fibroblast cell line 3T3©\L1	carboxymethyllysine (CML) treatment	upregulated	27137869
1088	Mouse	mmu-miR-143	miRNA	tumor necrosis factor alpha (TNF-¦Á) 	diabetes mellitus (DM)	MIN6 cell line	tumor necrosis factor alpha (TNF-¦Á) treatment	downregulated	31746030
1089	Mouse	mmu-miR-143	miRNA	doxorubicin (DOX)	doxorubicin (DOX)-induced cardiotoxicity	heart tissues	doxorubicin (Dox) treatment	Doxorubicin treatment increased the expression of miR-143.	32170053
1090	Mouse	mmu-miR-143	miRNA	lipopolysaccharide (LPS)	hepatocyte injury	AML12 cells	lipopolysaccharide (LPS) treatment	Infection or transfection of mir-143 in mice or hepatocytes significantly attenuated the development of alleviation of hepatocyte injury.	31808606
1091	Mouse	mmu-miR-143	miRNA	dextran sodium sulfate (DSS)	inflammatory bowel disease (IBD)	colon tissues	dextran sulfate sodium (DSS) treatment	downregulated	30236870
1092	Mouse	mmu-miR-143	miRNA	oxygen glucose deprivation (OGD)	ischemic stroke (IS)	primary cortical neurons	oxygen-glucose deprivation (OGD) treatment	upregulated	30129112
1093	Mouse	mmu-miR-143	miRNA	listeria	Listeria infection	murine ileum tissues	Listeria infection	downregulated	24327339
1094	Mouse	mmu-miR-143	miRNA	high fat diet (HFD)	metastatic colorectal cancer (mCRC)	adipose tissue of mice	?high-fat diet treatment	the expression of miR-143 in the mesenteric fat was upregulated in mice fed a high-fat diet	18809385
1095	Mouse	mmu-miR-143	miRNA	6-Gingerol (6-G)	myocardial ischemia/reperfusion (I/R) injury (MIRI)	HL-1 cells	6-Gingerol (6-G) treatment	we found that 6-G elevated cellular H19 expression in hypoxia/reoxygenation (H/R)-treated HL-1 cells.	33758383
1096	Mouse	mmu-miR-143	miRNA	methamphetamine (METH)	neuroinflammation	BV2 cells	Methamphetamine treatment	downregulated	30394308
1097	Mouse	mmu-miR-143	miRNA	methamphetamine (METH)	neuroinflammation	BV2 cells	methamphetamine (METH) treatment	downregulated	30394308
1098	Mouse	mmu-miR-143	miRNA	clozapine (CLZ)	phencyclidine-induced schizophrenia-related locomotor hyperactivity	"phencyclidine (PCP)-induced mice plasma, prefrontal cortex (PFC) and hippocampus"	clozapine treatment	upregulated	31233824
1099	Mouse	mmu-miR-143	miRNA	eticlopride	phencyclidine-induced schizophrenia-related locomotor hyperactivity	HT-22 neuronal cell line and primary cortical cultured neuronswere	eticlopride treatment	upregulated	31233824
1100	Mouse	mmu-miR-143	miRNA	phencyclidine (PCP)	phencyclidine-induced schizophrenia-related locomotor hyperactivity	"plasma, prefrontal cortex (PFC) and hippocampus"	phencyclidine (PCP) treatment	downregulated	31233824
1101	Mouse	mmu-miR-143	miRNA	quinpirole	phencyclidine-induced schizophrenia-related locomotor hyperactivity	HT-22 neuronal cell line and primary cortical cultured neuronswere	quinpirole treatment	downregulated	31233824
1102	Mouse	mmu-miR-143	miRNA	progesterone (P4)	cell proliferation	mouse endometrial epithelial cells	progesterone (P4) treatment	upregulated	29661100
1103	Mouse	mmu-miR-143	miRNA	cyclopamine	regulating the activity of Shh signaling	embryonic lung cultures	cyclopamine treatment	dysregulated	24617895
1104	Mouse	mmu-miR-143	miRNA	haloperidol	schizophrenia (SZ)	"phencyclidine (PCP)-induced mice plasma, prefrontal cortex (PFC) and hippocampus"	haloperidol treatment	upregulated	31233824
1105	Mouse	mmu-miR-143	miRNA	laparotomy and exposure of the junc_x0002_tion between the large and small intestines	sepsis	mouse large and small intestines	laparotomy and exposure of the junc_x0002_tion between the large and small intestines treatment	upregulated	25043848
1106	Mouse	mmu-miR-143	miRNA	radiation	thymic lymphoma (RITL)	BALB/c mice	radiation treatment	downregulated	28736328
1107	Mouse	mmu-miR-143	miRNA	mycobacterium tuberculosis (Mtb)	tuberculosis (TB)	M(IL-4/IL-13) macrophages	Mycobacterium tuberculosis (Mtb) HN878 infection	upregulated	30941122
1108	Mouse	mmu-miR-143-3p	miRNA	oxygen-glucose deprivation and reoxygenation (OGD/R)	cerebral ischemia/reperfusion (I/R) injury	SH-SY5Y cells	oxygen-glucose deprivation and reoxygenation (OGD/R) treatment	MiR-143-3p was significantly upregulated during cerebral I/R injury both in vivo and in vitro	33709299
1109	Mouse	mmu-miR-143-3p	miRNA	"4,4'-methylenedianiline (MDA)"	cholestasis	plasma	"4,4'-Methylenedianiline (MDA) treatment"	upregulated	30125006
1110	Mouse	mmu-miR-143-3p	miRNA	thioacetamide (TAA)	cholestasis	plasma	thiacetamide (TAA) treatment	upregulated	30125006
1111	Mouse	mmu-miR-143-3p	miRNA	¦Á-naphthylisothiocyanate (ANIT)	cholestasis	plasma	¦Á-naphthylisothiocyanate (ANIT) treatment	upregulated	30125006
1112	Mouse	mmu-miR-143-3p	miRNA	collagen	collagen-induced arthritis (CIA)	RA rats blood and the dorsal root ganglion (DRG)	collagen treatment	downregulated	30066874
1113	Mouse	mmu-miR-143-3p	miRNA	metformin (Met)	diabetic nephropathy (DN)	SV40-MES-13 cells	Metformin (MET) treatment	"Metformin inhibits extracellular matrix accumulation, inflammation and proliferation of mesangial cells in diabetic nephropathy by regulating H19/miR-143-3p/TGF-¦Â1 axis."	32391614
1114	Mouse	mmu-miR-143-3p	miRNA	fluke Fasciola gigantica (FgESPs)	F. gigantica infection	liver tissues	fluke Fasciola gigantica (FgESPs) infection	downregulated	33332355
1115	Mouse	mmu-miR-143-3p	miRNA	mycoplasma pneumoniae (M. pneumoniae)	fibromyalgia	lung tissues	Mycoplasma pneumoniae (MP) infection	"Compared with model group, model mice had upregulated miR-143-3p expression."	32597476
1116	Mouse	mmu-miR-143-3p	miRNA	hypoxanthine (HX)	hyperuricemia	renal tissues	The hyperuricemic mice mode were induced by combination of peritoneal injection of potassium oxonate (PO) at dose of 250 mg/kg and intragastric administration of hypoxanthine (HX) at dose of 300 mg/kg daily for 8 weeks.	downregulated	31378369
1117	Mouse	mmu-miR-143-3p	miRNA	potassium oxonate (PO)	hyperuricemia	renal tissues	The hyperuricemic mice mode were induced by combination of peritoneal injection of potassium oxonate (PO) at dose of 250 mg/kg and intragastric administration of hypoxanthine (HX) at dose of 300 mg/kg daily for 8 weeks.	downregulated	31378369
1118	Mouse	mmu-miR-143-3p	miRNA	bilateral surgical destabilization of the medial meniscus (DMM)	osteoarthritis (OA)	male C57BL6 mice	bilateral surgical destabilization of the medial meniscus (DMM) treatment	dysregulated	29255152
1119	Mouse	mmu-miR-143-5p	miRNA	carbon tetrachloride (CCl4)	liver fibrosis	liver tissues	carbon tetrachloride (CCl4) treatment	upregulated	29557526
1120	Mouse	mmu-miR-144	miRNA	angiotensin II (Ang II)	cardiac fibrosis	heart sissues	angiotensin II (Ang II) treatment	downregulated	32765685
1121	Mouse	mmu-miR-144	miRNA	erythropoietin (EPO)	chronic kidney disease (CKD)	renal fibroblasts	Erythropoietin (EPO) treatment	upregulated	26469975
1122	Mouse	mmu-miR-144	miRNA	cisplatin (DDP)	cisplatin (DDP)-induced nephrotoxicity	renal tissues	cisplatin treatment	downregulated	31781349
1123	Mouse	mmu-miR-144	miRNA	streptozocin (STZ)	diabetic cardiomyopathy (DCM)	heart sissues	streptozocin (STZ) treatment	MiR-144 was identified to be decreased in HG-induced cardiomyocytes and in streptozotocin (STZ)-challenged heart samples.	31907983
1124	Mouse	mmu-miR-144	miRNA	metformin (Met)	endometrial hyperplasia (EH)	endometrial tissues	metformin (Met) treatment	Met upregulateb the expression of miR-144 in a dose-dependent manner.	31894313
1125	Mouse	mmu-miR-144	miRNA	metformin (Met)	endometrial hyperplasia (EH)	endometrial hyperplasia (EH) mice uterus	metformin (Met) treatment	upregulated	31894313
1126	Mouse	mmu-miR-144	miRNA	tamoxifen (TAM)	endometrial hyperplasia (EH)	uterus	tamoxifen treatment	downregulated	31894313
1127	Mouse	mmu-miR-144	miRNA	streptozocin (STZ)	hyperglycemia	heart	STZ-induced diabetic mice treatment	downregulated	26164195
1128	Mouse	mmu-miR-144	miRNA	streptozocin (STZ)	hyperglycemia-induced cardiac dysfunction	heart tissues	streptozotocin (STZ) treatment	downregulated	31907983
1129	Mouse	mmu-miR-144	miRNA	chronic constriction injury (CCI)	neuropathic pain (NP)	dorsal root ganglions (DRGs)	chronic constriction injury (CCI) treatment	downregulated	31737949
1130	Mouse	mmu-miR-144	miRNA	cortical impact	traumatic brain injury (TBI)	cortex	cortical impact	upregulated	26426744
1131	Mouse	mmu-miR-144-3p	miRNA	lipopolysaccharide (LPS)	acute kidney injury (AKI)	kidney tissues	lipopolysaccharide (LPS) treatment	miR-144-3p was upregulated at 24h.	32727087
1132	Mouse	mmu-miR-144-3p	miRNA	lipopolysaccharide (LPS)	acute lung injury (ALI)	lung tissues	lipopolysaccharide (LPS) treatment	upregulated	29492259
1133	Mouse	mmu-miR-144-3p	miRNA	lipopolysaccharide (LPS)	acute lung injury (ALI)	lung tissues	lipopolysaccharide (LPS) treatment	miR-144-3p was upregulated while Caveolin-2 was downregulated in response to LPS treatment.	33418009
1134	Mouse	mmu-miR-144-3p	miRNA	7-chlorokynurenic acid (7-CTKA)	antidepressant	mouse	7-CTKA intraperitoneal injection	downregulated	25034119
1135	Mouse	mmu-miR-144-3p	miRNA	dietary zinc restriction	anxiety- and trauma-related disorders	C57BL/6 (BL6) mice	dietary zinc restriction	upregulated	28104225
1136	Mouse	mmu-miR-144-3p	miRNA	collagen	arthritis	mouse hind paws tissues	collagen treatment	downregulated	31396316
1137	Mouse	mmu-miR-144-3p	miRNA	moxibustion	collagen-induced arthritis (CIA)	CIA mouse hind paws tissues	Moxibustion treatment	upregulated	31396316
1138	Mouse	mmu-miR-144-3p	miRNA	chronic unpredictable mild stress (CUMS)	depression	prefrontal cortex	chronic unpredictable mild stress (CUMS) treatment	downregulated	27701406
1139	Mouse	mmu-miR-144-3p	miRNA	chronic unpredictable mild stress (CUMS)	depression	NAc tissue	chronic unpredictable mild stress (CUMS) treatment	upregulated	31430030
1140	Mouse	mmu-miR-144-3p	miRNA	electroacupuncture (EA)	electroacupuncture (EA)	CD4 T cells	electroacupuncture (EA) treatment	upregulated	32026263
1141	Mouse	mmu-miR-144-3p	miRNA	dietary zinc restriction	impaired fear extinction	basolateral amygdala	dietary zinc restriction	upregulated	28104225
1142	Mouse	mmu-miR-144-3p	miRNA	oxygen glucose deprivation (OGD)	ischemia/reperfusion (I/R) injury	N2a cells	oxygen-glucose deprivation treatment	Overexpression of long non-coding RNA Rian attenuates cell apoptosis from cerebral ischemia-reperfusion injury via Rian/miR-144-3p/GATA3 signaling	33294587
1143	Mouse	mmu-miR-144-3p	miRNA	licochalcone A (LA)	lung cancer	MLE-12 cells	Licochalcone A (lico A) treatment	downregulated	32505917
1144	Mouse	mmu-miR-144-3p	miRNA	chronic unpredictable mild stress (CUMS)	major depressive disorder (MDD)	nucleus accumbens (NAc) tissues	chronic unpredictable mild stress (CUMS) induce	upregulated	30936699
1145	Mouse	mmu-miR-144-3p	miRNA	hypoxia/reoxygenation (H/R)	myocardial infarction (MI)	HL-1 cardiomyocytes	hypoxia/reoxygenation (H/R) induce	downregulated	31227612
1146	Mouse	mmu-miR-144-3p	miRNA	oxygen glucose deprivation (OGD)	myocardial infarction (MI)	primary cardiomyocytes	oxygen glucose deprivation (OGD) treatment	downregulated	32371945
1147	Mouse	mmu-miR-144-3p	miRNA	oxygen-glucose deprivation and reoxygenation (OGD/R)	neuronal cell injury	HT22 cells	oxygen-glucose deprivation and reoxygenation (OGD/R) treatment	downregulated	29457851
1148	Mouse	mmu-miR-144-3p	miRNA	lipopolysaccharide (LPS)	sepsis-induced myocardial injury	HL-1 cells	lipopolysaccharide (LPS) treatment	MiR-144-3p was downregulated in LPS-treated myocardial cells.	32016991
1149	Mouse	mmu-miR-144-3p	miRNA	mycobacterium tuberculosis (Mtb)	tuberculosis (TB)	macrophage RAW264.7 cells	Mycobacterium bovis Bacillus Calmette-Gu¨¦rin (BCG)	upregulated	28636635
1150	Mouse	mmu-miR-144-5p	miRNA	angiotensin II (Ang II)	abdominal aortic aneurysm (AAA)	aorta tissues	angiotensin II (Ang II) treatment	downregulated	32278833
1151	Mouse	mmu-miR-144-5p	miRNA	oxidized low density lipoprotein (ox-LDL)	abdominal aortic aneurysm (AAA)	RAW 264.7 cells	oxidized low-density lipoprotein (ox-LDL) treatment	downregulated	32278833
1152	Mouse	mmu-miR-145	miRNA	JWH-133	acute liver failure (ALF)	GalN/LPS-induced ALF	JWH-133 treatment	downregulated	25749929
1153	Mouse	mmu-miR-145	miRNA	oxygen-glucose deprivation and reoxygenation (OGD/R)	angiogenesis	mouse brain microvascular endothelial cells (BMECs)	oxygen-glucose deprivation and reoxygenation (OGD/R) treatment	the levels of lncRNA-MALAT1 and miR-145 were upregulated in OGD-induced BMECs miR-145 functioned as an anti-angiogenic and pro-apoptotic factor in OGD treated BMECs via down-regulating VEGF-A and ANGPT2 directly	30038058
1154	Mouse	mmu-miR-145	miRNA	angiotensin II (Ang II)	aortic dissection (AD)	mouse vascular smooth muscle cells (VSMCs)	angiotensin II (Ang II) treatment	downregulated	28167124
1155	Mouse	mmu-miR-145	miRNA	sevoflurane (SEV)	apoptosis	hippocampal neural cell line HT22	treat with 4.1% sevoflurane treatment	downregulated	31966430
1156	Mouse	mmu-miR-145	miRNA	angiotensin II (Ang II)	cardiac fibrosis	cardiac fibroblasts	angiotensin II (Ang II) treatment	downregulated	30146700
1157	Mouse	mmu-miR-145	miRNA	coronary artery ligation	cardiac fibrosis	heart	subjected to coronary artery ligation	miR-145 expression was downregulated at 3 days but was restored at 7 days	24001939
1158	Mouse	mmu-miR-145	miRNA	IL-10	cardiac fibrosis	mouse bone marrow fibroblast progenitor cells (BM-FPCs)	IL10 treatment	downregulated	28667100
1159	Mouse	mmu-miR-145	miRNA	doxorubicin (DOX)	cardiotoxicity	BALB/c mice injected C-26 tumor cells	doxorubicin treatment	upregulated	28560697
1160	Mouse	mmu-miR-145	miRNA	oxygen-glucose deprivation and reoxygenation (OGD/R)	cerebral ischemia/reperfusion (I/R) injury	MA-C cells	oxygen-glucose deprivation and reoxygenation (OGD/R) treatment	"TUG1 could interact directly with miR-145, and downregulated of miR-145 could efficiently reverse the function of TUG1 siRNA on AQP4 expression"	31709761
1161	Mouse	mmu-miR-145	miRNA	azoxymethane (AOM) and dextran sulfate sodium (DSS)	colorectal cancer (CRC)	mouse colon tissues	azoxymethane (AOM) and dextran sulfate sodium (DSS) treatment	downregulated	24464560
1162	Mouse	mmu-miR-145	miRNA	azoxymethane (AOM) and dextran sulfate sodium (DSS)	colorectal cancer (CRC)	mouse colon tissues	azoxymethane (AOM) and dextran sulfate sodium (DSS) treatment	downregulated	24464560
1163	Mouse	mmu-miR-145	miRNA	myostatin	cell differentiation	C2C12 cells	1 ¦Ìg of recombinant myostatin	dysregulated	28691106
1164	Mouse	mmu-miR-145	miRNA	isoproterenol	extracellular matrices (ECMs) homeostasis	the hearts of TAC mice	isoproterenol treatment	downegulated	23624080
1165	Mouse	mmu-miR-145	miRNA	H2O2	granulosa cell (GC) apoptosis	mouse granulosa cells (mGCs)	H2O2 treatment	downregulated	28564582
1166	Mouse	mmu-miR-145	miRNA	oxygen-glucose deprivation and reoxygenation (OGD/R)	ischemia/reperfusion (I/R) injury	MA-C cells	oxygen-glucose deprivation and reoxygenation (OGD/R) treatment	downregulated	31709761
1167	Mouse	mmu-miR-145	miRNA	fentanyl	ischemia/reperfusion (I/R) injury	"HL-1, a cardiac muscle cell line from the AT-1 mouse atrial cardiomyocyte"	fentanyl treatment	upregulated	27862640
1168	Mouse	mmu-miR-145	miRNA	carbon tetrachloride (CCl4)	liver fibrosis	liver	CCl4 treatment	downregulated	27289031
1169	Mouse	mmu-miR-145	miRNA	solar-simulated UV (ssUV)	melanogenesis	Murine melan-a melanocytes(from black mice)	solar-simulated UV (ssUV) treatment	downregulated	22895360
1170	Mouse	mmu-miR-145	miRNA	hypoxia	myocardial infarction (MI)	H9c2 cells;HL-1 cells	hypoxia treatment	upregulated	28980287
1171	Mouse	mmu-miR-145	miRNA	hypoxia	myocardial infarction (MI)	HL-1 cells	hypoxia induce	upregulated	28980287
1172	Mouse	mmu-miR-145	miRNA	hypoxia	myocardial infarction (MI)	cardiac fibroblasts	hypoxia treatment	downregulated	24001939
1173	Mouse	mmu-miR-145	miRNA	sevoflurane (SEV)	myocardial ischemia/reperfusion (I/R) injury (MIRI)	myocardial tissues of ischemia/reperfusion (I/R) mice	sevoflurane treatment	upregulated	30873621
1174	Mouse	mmu-miR-145	miRNA	hypoxia/reoxygenation (H/R)	myocardial ischemia/reperfusion (I/R) injury (MIRI)	HL-1 cells	hypoxia-reoxygenation (H/R)treatment	upregulated	27862640
1175	Mouse	mmu-miR-145	miRNA	salidroside (SAL)	osteoarthritis (OA)	LPS-induce inflammatory injury of ATDC5 cells	salidroside (SAL) treatment	"SAL significantly alleviated LPS-induced inflammatory injury Meanwhile, the expression of miR-145 was upregulated by SAL"	30586667
1176	Mouse	mmu-miR-145	miRNA	salidroside (SAL)	osteoarthritis (OA)	ATDC5 cells	salidroside (SAL) treatment	the expression of miR-145 was upregulated by SAL	30586667
1177	Mouse	mmu-miR-145	miRNA	receptor activator of nuclear factor-¦ÊB ligand (RANKL)	osteoclastogenesis	bone marrow-derived macrophages (BMDMs)	receptor activator of nuclear factor-kB ligand (RANKL) treatment	downregulated	29577879
1178	Mouse	mmu-miR-145	miRNA	oxygen	oxygen-induced retinopathy (OIR)	retinas tissues	neonatal mice with their nursing mother were exposed to 75% oxygen at P7 for 5 days and then returned to room air at P12. treatment	upregulated	30981984
1179	Mouse	mmu-miR-145	miRNA	progesterone (P4)	cell proliferation	mouse endometrial epithelial cells	progesterone (P4) treatment	upregulated	29661100
1180	Mouse	mmu-miR-145	miRNA	hypoxia	pulmonary arterial hypertension (PAH)	pulmonary artery smooth muscle cells (PASMCs)	?hypoxia treatment	upregulated	22715469
1181	Mouse	mmu-miR-145	miRNA	monocrotaline (MCT)	pulmonary hypertension (PH)	lung tissues	monocrotaline (MCT) treatment	upregulated	26980205
1182	Mouse	mmu-miR-145	miRNA	lipopolysaccharide (LPS)	sepsis-induced acute lung injury	lung tissues	lipopolysaccharide (LPS) treatment	downregulated	30841464
1183	Mouse	mmu-miR-145	miRNA	hypoxia	stroke	mouse brain microvascular endothelial cells (BMECs)	oxygen-glucose deprivation (OGD) induce	the levels of lncRNA-MALAT1 and miR-145 were upregulated in OGD-induced BMECs. miR-145 functioned as an anti-angiogenic and pro-apoptotic factor in OGD treated BMECs via down-regulating VEGF-A and ANGPT2 directly.	30038058
1184	Mouse	mmu-miR-145	miRNA	ethanol (EtOH)	teratogenesis	fetal brains of mice	Ethanol?treatment	upregulated	19091803
1185	Mouse	mmu-miR-145-5p	miRNA	H2O2	abdominal aortic aneurysm (AAA)	vascular smooth muscle cell (VSMC)	oxidative stress	Silencing of long non-coding RNA Sox2ot inhibits oxidative stress and inflammation of vascular smooth muscle cells in abdominal aortic aneurysm via microRNA-145-mediated Egr1 inhibition.	32629426
1186	Mouse	mmu-miR-145-5p	miRNA	lipopolysaccharide (LPS)	acute lung injury (ALI)	mouse lung tissues and mouse type II alveolar epithelial cells (AT II)	?lipopolysaccharide (LPS) treatment	downregulated	31353880
1187	Mouse	mmu-miR-145-5p	miRNA	house dust mite (HDM) extract	asthma	airway epithelial cells	house dust mite (HDM) extract exposure	upregulated	31264490
1188	Mouse	mmu-miR-145-5p	miRNA	oxygen glucose deprivation (OGD)	cerebral infarction (CI)	BV-2 cells	oxygen/glucose deprivation (OGD) treatment	downregulated	28215748
1189	Mouse	mmu-miR-145-5p	miRNA	cigarette smoke (CS)	chronic obstructive pulmonary disease (COPD)	lung tissues	cigarette smoke (CS) exposure	upregulated	30595527
1190	Mouse	mmu-miR-145-5p	miRNA	fatty acid amide hydrolase inhibitor (FAAH-II)	colitis	colitis mouse colon tissues	FAAH-II treatment	dysregulated	27327245
1191	Mouse	mmu-miR-145-5p	miRNA	high glucose (HG)	diabetic nephropathy (DN)	podocytes	high glucose (HG) treatment	MicroRNA-145-5p attenuates high glucose-induced apoptosis by targeting the Notch signaling pathway in podocytes.	32104249
1192	Mouse	mmu-miR-145-5p	miRNA	high glucose (HG)	diabetic retinopathy (DR)	?RGC-5 cells	high glucose treatment	upregulated	31272285
1193	Mouse	mmu-miR-145-5p	miRNA	fatty acid amide hydrolase (FAAH) blockade	experimental colitis	colon	Fatty acid amide hydrolase (FAAH) blockade treatment	upregulated	27327245
1194	Mouse	mmu-miR-145-5p	miRNA	mycobacterium tuberculosis (Mtb)	pulmonary tuberculosis (PTB)	RAW264.7 cells	mycobacterium tuberculosis (MTB) infection	miR-145-5p was lowly expressed in PTB.	33035634
1195	Mouse	mmu-miR-145a	miRNA	progesterone (P4)	anti-proliferative action	In endometrial epithelial cells from endometrial epithelium of ovariectomized mice	progesterone treatment	upregulation	24925854
1196	Mouse	mmu-miR-145a	miRNA	lipopolysaccharide (LPS)	inflammation	RAW264.7 cells	lipopolysaccharide (LPS) treatment	upregulated	26639663
1197	Mouse	mmu-miR-145a	miRNA	oxygen-glucose deprivation and reoxygenation (OGD/R)	ischemia/reperfusion (I/R) injury	astrocyte cells	oxygen-glucose deprivation and reoxygenation (OGD/R) treatment	MALAT1 promotes cerebral ischemia-reperfusion injury by affecting AQP4 expression through competitively binding miR-145	32138732
1198	Mouse	mmu-miR-145a	miRNA	lipopolysaccharide (LPS)	sepsis	Lung pericytes	lipopolysaccharide (LPS) treatment	miR-145a levels were decreased in lung pericytes in sepsis.	32285112
1199	Mouse	mmu-miR-145a-5p	miRNA	fractionated radiation	ionizing radiation (IR) injury	LLC1 cells	fractionated dose (FD) irradiation	upregulated	28599420
1200	Mouse	mmu-miR-145a-5p	miRNA	oxygen glucose deprivation (OGD)	neuroinflammation	BV-2 microglial cells	oxygen-glucose deprivation (OGD) induce treatment	downregulated	31551710
1201	Mouse	mmu-miR-145a-5p	miRNA	estradiol-17¦Â (E2)	systemic lupus erythematosus (SLE)	murine B cells	estradiol-17¦Â (E2) treatment	downegulated	25912736
1202	Mouse	mmu-miR-145b	miRNA	lipopolysaccharide (LPS)	acute aortic dissection (AAD)	aorta	lipopolysaccharide (LPS) treatment	downregulated	32634201
1203	Mouse	mmu-miR-146	miRNA	high tidal volume ventilation (HVTV)	lung injury	lung tissues	high tidal volume ventilation (HVTV) treatment	upregulated	22659882
1204	Mouse	mmu-miR-146	miRNA	TGF-¦Â	acute contusion	mouse C2C12 myoblasts	TGF-¦Â treatment	downregulated	28510617
1205	Mouse	mmu-miR-146	miRNA	candida albicans (C. albicans)	Alzheimer's disease (AD)	mouse macrophages	candida albicans infection	upregulated	21060679
1206	Mouse	mmu-miR-146	miRNA	"retinoic acid (RA), leukemia inhibitory factor (LIF) and basic fibroblast growth factor (bFGF)"	cell differentiation	mouse bone marrow mesenchymal stem cells (BMSCs)	"retinoic acid (RA), leukemia inhibitory factor (LIF) and basic fibroblast growth factor (bFGF) treatment"	downregulated	32195202
1207	Mouse	mmu-miR-146	miRNA	retinoic acid (RA)	elevated level of homocysteine (Hcy)	spermatogonial	retinoic acid treatment	downregulated	20177001
1208	Mouse	mmu-miR-146	miRNA	lipopolysaccharide (LPS)	inner ear inflammatory	scala tympani	LPS was injected directly into treatment	upregulated	24470395
1209	Mouse	mmu-miR-146	miRNA	schistosoma japonicum	schistosomiasis	liver macrophage	exposed percutaneously to 16 S. japonicum cercaria treatment	downregulated	27780686
1210	Mouse	mmu-miR-146	miRNA	clostridium difficile	colitis	colonic lamina propria of mice	Clostridium difficile infection	upregulated	23071818
1211	Mouse	mmu-miR-146a	miRNA	lipopolysaccharide (LPS)	acute lung injury (ALI)	bronchoalveolar lavage fluid (BALF)	lipopolysaccharide (LPS) treatment	upregulated	29863671
1212	Mouse	mmu-miR-146a	miRNA	¦Â-Patchoulene (¦Â-PAE)	acute lung injury (ALI)	lipopolysaccharide (LPS) treated mouse lung	¦Â-PAE pretreatment treatment	upregulated in lung	28711783
1213	Mouse	mmu-miR-146a	miRNA	acetaminophen (APAP)	alcoholic liver disease (ALD)	mouse liver tissues	acetaminophen(APAP) treatment	upregulated	22684891
1214	Mouse	mmu-miR-146a	miRNA	ovalbumin (OVA)	allergic asthma (AA)	Type II innate lymphoid cells (ILC2)?from asthma mice lung tissues	ovalbumin (OVA) treatment	upregulated	31435003
1215	Mouse	mmu-miR-146a	miRNA	ragweed (SRW)	allergic conjunctivitis (AC)	corneal epithelium and conjunctiva	ragweed (SRW) treatment	downregulated	26166175
1216	Mouse	mmu-miR-146a	miRNA	ovalbumin (OVA)	allergic rhinitis (AR)	AR mouse	ovalbumin (OVA) treatment	downregulated in nasal mucosa	26700406
1217	Mouse	mmu-miR-146a	miRNA	lipopolysaccharide (LPS)	Alzheimer's disease (AD)	RAW264.7 cells	lipopolysaccharide (LPS) treatment	The isolated EVs derived from LPS-treated RAW cells contained significantly higher levels of miR-146a than those derived from PBS-treated RAW cells.	33185814
1218	Mouse	mmu-miR-146a	miRNA	sulforaphane (SFN)	Alzheimer's disease (AD)	temporal cortex and hippocampus	Sulforaphane treatment	downregulated	26827637
1219	Mouse	mmu-miR-146a	miRNA	"dimethyl fumarate (DMF) ,metabolite monomethyl fumarate (MMF)"	anti-inflammatory responses	primary astrocyte cultures derived from C57BL/6 mouse stimulated with IL-1¦Â	"pretreat with DMF, MMF"	downregulated	28589165
1220	Mouse	mmu-miR-146a	miRNA	dexamethasone (DEX)	asthma	splenic CD4+ T lymphocytes	dexamethasone (DEX) treatment	downregulated	22580216
1221	Mouse	mmu-miR-146a	miRNA	"IL-33, TSLP, and IL-7"	asthma	ILC2s	"IL-33, TSLP, and IL-7 treatment"	"During stimulation of ILC2s, miR-146a expression gradually increased with a decrease of cell proliferation."	31435003
1222	Mouse	mmu-miR-146a	miRNA	ovalbumin (OVA)	asthma	lung tissues	OVA (ovalbumin) treatment	upregulated	31298396
1223	Mouse	mmu-miR-146a	miRNA	oxidized low density lipoprotein (ox-LDL)	atherosclerosis (AS)	mouse macrophages atherogenic Evs	oxidized low-density lipoprotein (ox-LDL) treatment	enrichment in atherogenic EVs	28882869
1224	Mouse	mmu-miR-146a	miRNA	oxidized low density lipoprotein (ox-LDL)	atherosclerosis (AS)	peritoneal macrophages; Bone-marrow derived macrophages (BMDMs)	oxidized low-density lipoprotein (ox-LDL) treatment	upregulated	28882869
1225	Mouse	mmu-miR-146a	miRNA	"2,4,6-trinitrobenzene sulfonic acid (TNBS)"	atopic dermatitis (AD)	mouse skin	"2,4,6-trinitrobenzene sulfonic acid (TNBS)/ethanol treatment"	upregulated	31545496
1226	Mouse	mmu-miR-146a	miRNA	lipopolysaccharide (LPS)	autoimmune lymphoproliferative syndrome	heart tissues;liver tissues;lung tissues;kidney tissues; spleen tissues;lymph nodes	lipopolysaccharide (LPS) treatment	upregulated	23645835
1227	Mouse	mmu-miR-146a	miRNA	hypoxia	autophagy	chondrocytes of C57BL/6J mouse	hypoxia treatment	upregulated	27845876
1228	Mouse	mmu-miR-146a	miRNA	hypoxia	autophagy	Chondrocytes	Hypoxia treatment	upregulated	26492575
1229	Mouse	mmu-miR-146a	miRNA	lipopolysaccharide (LPS)	bone loss	RAW 264.7 cells	lipopolysaccharide (LPS) treatment	upregulated	30387844
1230	Mouse	mmu-miR-146a	miRNA	lipopolysaccharide (LPS)	bone marrow transplantation	mouse hematopoietic stem/progenitor cells	lipopolysaccharide (LPS) treatment	upregulated	20933052
1231	Mouse	mmu-miR-146a	miRNA	hemoglobin (Hb)	brain inflammation	Primary microglial cells	hemoglobin (Hb) treatment	downregulated	32317924
1232	Mouse	mmu-miR-146a	miRNA	epstein-barr virus (EBV)	tumorigenesis	"Lymphocyte cell lines (IB4, X50-7, Rael, Akata, JY, JC5, P3HR1, Mutu, and BL30)"	Epstein-Barr virus (EBV) infection	upregulated	18057241
1233	Mouse	mmu-miR-146a	miRNA	celecoxib	tumorigenesis	wild-type (HPV16) mice	celecoxib treatment	upregulated	28551628
1234	Mouse	mmu-miR-146a	miRNA	angiotensin II (Ang II)	cell proliferation	Mouse aortic vascular smooth muscle cell (VSMC)	angiotensin II (Ang II) treatment	upregulated	31009837
1235	Mouse	mmu-miR-146a	miRNA	salvianolic acid B (Sal B)	cell proliferation	Ang II-treated mouse aortic vascular smooth muscle cell (VSMC)	salvianolic acid B (Sal B) treatment	downregulated	31009837
1236	Mouse	mmu-miR-146a	miRNA	porphyromonas endodontalis lipopolysaccharide ( P. endodontalis LPS)	chronic apical periodontitis (CAP)	MC3T3-E1 cells	Porphyromonas endodontalis lipopolysaccharide ( P. endodontalis LPS) treatment	upregulated	30125982
1237	Mouse	mmu-miR-146a	miRNA	porphyromonas endodontalis lipopolysaccharide ( P. endodontalis LPS)	chronic apical periodontitis (CAP)	MC3T3-E1 cells	Porphyromonas endodontalis lipopolysaccharide ( P. endodontalis LPS) treatment	upregulated	30125982
1238	Mouse	mmu-miR-146a	miRNA	borrelia burgdorferi	chronic infection	mouse joint tissue	infect Borrelia burgdorferi treatment	upregulated	24967703
1239	Mouse	mmu-miR-146a	miRNA	IL-1¦Â and TNF-¦Á	diabetes mellitus (DM)	MIN6 cells	IL-1¦Â and TNF-¦Á treatment	upregulated	20086228
1240	Mouse	mmu-miR-146a	miRNA	streptozocin (STZ)	diabetic osteoarthritis (OA)	cartilage tissues	streptozotocin (STZ) treatment	"PVT1 expression was significantly increased, whereas miR-146a was markedly decreased in diabetic OA mice than in non-diabetic OA and control"	33569722
1241	Mouse	mmu-miR-146a	miRNA	glucose	diabetic peripheral neuropathy (DPN)	DRG neurons	incubat high glucose (45 mM) for 24h treatment	downregulated	24316060
1242	Mouse	mmu-miR-146a	miRNA	high glucose (HG)	diabetic peripheral neuropathy (DPN)	macrophage	high glucose (HG) treatment	LncRNA HCG18 was highly expressed in DPN model and HG-induced macrophages.	32996080
1243	Mouse	mmu-miR-146a	miRNA	"(2E,6E)-2,6-bis(2-(trifluoromethyl)benzylidene)cyclohexanone (C66)"	diabetic wound healing	wounds	"(2 E,6 E)-2,6-bis(2-(trifluoromethyl)benzylidene)cyclohexanone (C66) treatment"	"miR-146a was significantly decreased in diabetic wounds, while C66 increased miR-146a in diabetic wounds."	32092902
1244	Mouse	mmu-miR-146a	miRNA	[6]-gingerol-fractions (GF)	diabetic wound healing	diabetic skin wounds	[6]-gingerol-fractions (GF) treatment	upregulated	31428171
1245	Mouse	mmu-miR-146a	miRNA	vitamin D	diabetic wound healing	diabetic skin wounds	vitamin D treatment	upregulated	31428171
1246	Mouse	mmu-miR-146a	miRNA	prednisolone	duchenne muscular dystrophy (DMD)	diaphragm muscle	prednisolone treatment	downregulated	29883261
1247	Mouse	mmu-miR-146a	miRNA	vamorolone	duchenne muscular dystrophy (DMD)	diaphragm muscle	vamorolone treatment	downregulated	29883261
1248	Mouse	mmu-miR-146a	miRNA	ischemia/reperfusion (I/R) 	intestinal ischemia/reperfusion (I/R) injury	m-ICcl2?cells	ischemia/reperfusion (I/R) treatment	downregulated	23143987
1249	Mouse	mmu-miR-146a	miRNA	IL-10	epithelial-mesenchymal transition (EMT)	colonic intraepithelial lymphocytes	IL-10 treatment	upregulated	22043014
1250	Mouse	mmu-miR-146a	miRNA	high glucose (HG)	experimental diabetic peripheral neuropathy	dorsal root ganglion (DRG) neurons	high glucose treatment	downregulated	22499183
1251	Mouse	mmu-miR-146a	miRNA	azilsartan medoxomil (AZL-M)	heart failure (HF)	plasma	azilsartan medoxomil (AZL-M) treatment	"MiR-146a, miR-149, miR-150, and miR-342-3p were reproducibly reduced in the plasma of CSQ-tg mice."	27321284
1252	Mouse	mmu-miR-146a	miRNA	azilsartan medoxomil (AZL-M)	heart failure (HF)	calsequestrin (CSQ)-tg mouse	azilsartan medoxomil (AZL-M) treatment	upregulated	27321284
1253	Mouse	mmu-miR-146a	miRNA	lactoferrin (LF)	inflammation	lipopolysaccharide (LPS)-treated RAW264.7 cells	Lactoferrin treatment	"?LF could induce a decrease in inflammatory selected miRNAs,?mmu-mir-155, and?mmu-mir-146a expression."	33435756
1254	Mouse	mmu-miR-146a	miRNA	"limonin, (12S,12aS,Z)-8-((2-(diethylamino)ethoxy)imino)-12-(furan-3-yl)-6,6,8a,12a-tetramethyldodecahydro-1H,3H-oxireno[2,3-d]pyrano[4',3':3,3a]isobenzofuro[5,4-f]isochromene-3,10(9aH)-dione (V-A-4)"	inflammation	lipopolysaccharide (LPS)-stimulated RAW264.7 cells	"limonin, (12S,12aS,Z)-8-((2-(diethylamino)ethoxy)imino)-12-(furan-3-yl)-6,6,8a,12a-tetramethyldodecahydro-1H,3H-oxireno[2,3-d]pyrano[4',3':3,3a]isobenzofuro[5,4-f]isochromene-3,10(9aH)-dione (V-A-4) treatment"	upregulated	29477914
1255	Mouse	mmu-miR-146a	miRNA	lipopolysaccharide (LPS)	inflammation	RAW264.7 macrophage cells	lipopolysaccharide (LPS) treatment	upregulated	23974950
1256	Mouse	mmu-miR-146a	miRNA	lipopolysaccharide (LPS)	inflammation	RAW 264.7 cells	lipopolysaccharide (LPS) treatment	dysregulated	24792623
1257	Mouse	mmu-miR-146a	miRNA	rare ginsenoside from ginseng(Rg6)	inflammation	LPS treated bone marrow-derived macrophages (BMDMs)	Rg6 treatment	upregulated	30867482
1258	Mouse	mmu-miR-146a	miRNA	resveratrol and hydroxytyrosol	inflammation	LPS treated RAW 264.7	resveratrol and hydroxytyrosol 10¦ÌM treatment	downregulated	27998828
1259	Mouse	mmu-miR-146a	miRNA	resveratrol and hydroxytyrosol	inflammation	LPS treated RAW 264.7	resveratrol and hydroxytyrosol 10¦ÌM treatment	downregulated	27998828
1260	Mouse	mmu-miR-146a	miRNA	selenium (Se)	inflammation	mouse mammary epithelial cellsmouse mammary epithelial cells	Se treatment	upregulated	29340029
1261	Mouse	mmu-miR-146a	miRNA	¦¤9-tetrahydrocannabinol (THC)	inflammation	total lymph node cells and CD4(+) T cells	¦¤9-Tetrahydrocannabinol (THC) treatment	upregulated	27268054
1262	Mouse	mmu-miR-146a	miRNA	herpes simplex virus 1 (HSV-1)	inflammation and innate immunity	mouse brain tissue	infect with HSV-1	upregulated	28045967
1263	Mouse	mmu-miR-146a	miRNA	"1,25-dihydroxyvitamin D (1,25(OH)2D)"	inflammation	3T3-L1 adipocytes;epididymal adipose tissue	"1,25-dihydroxyvitamin D (1,25(OH)2D) treatment"	downregulated	28055298
1264	Mouse	mmu-miR-146a	miRNA	high fat diet (HFD)	obesity	C57BL/6J mice	high fat diet (HFD) feed	downregulated	28652200
1265	Mouse	mmu-miR-146a	miRNA	aluminum-sulfate	inflammatory neurodegeneration	C57BL/6J mice blood	serum exposure to a standard mouse diet that included aluminum-sulfate	upregulated	29354323
1266	Mouse	mmu-miR-146a	miRNA	influenza A virus (IAV)	influenza A virus (IAV) infection	mouse lung tissues	Influenza A virus (IAV) infection	upregulated	30611999
1267	Mouse	mmu-miR-146a	miRNA	brucella.suis	innate immune response	RAW264.7 cells	brucella.suis infection	upregulated	29387067
1268	Mouse	mmu-miR-146a	miRNA	cannabinoids	innate immune response	LPS-treated BV-2 microglial cells	cannabinoids treatment	downregulated	30742662
1269	Mouse	mmu-miR-146a	miRNA	exenatide (EXA)	insulin sensitivity	liver	exenatide treatment	"the levels of miRNA-29c, 124a, and 146a in the liver were significantly increased. These effects were reversed by treatment with exenatide."	26314504
1270	Mouse	mmu-miR-146a	miRNA	exenatide (EXA)	insulin sensitivity	muscle	exenatide treatment	"The levels of miRNA-15a, 29c, 124a, and 146a in the muscle were significantly increased. These effects were reversed by treatment with exenatide."	26314504
1271	Mouse	mmu-miR-146a	miRNA	high fat diet (HFD)	insulin sensitivity	liver	high fat diet (HFD) feed	upregulated	26314504
1272	Mouse	mmu-miR-146a	miRNA	high fat diet (HFD)	insulin sensitivity	muscle	high fat diet (HFD) feed	upregulated	26314504
1273	Mouse	mmu-miR-146a	miRNA	listeria monocytogenes (L. monocytogenes)	leishmaniasis	"macrophage-like cell line RAW264.7 and murine primary bone marrow-derive macrophages (BMDMs), mouse spleen and liver"	Listeria monocytogenes (L. monocytogenes) infection	upregulated	29587465
1274	Mouse	mmu-miR-146a	miRNA	integrin CD11b	liver fibrosis	"Dendritic cells (DCs),Bone marrow-derived DCs (BMDCs)"	Integrin CD11b?treatment	Integrin CD11b negatively regulates TLR9-triggered dendritic cell cross-priming by upregulating microRNA-146a	22551553
1275	Mouse	mmu-miR-146a	miRNA	ischemia/reperfusion (I/R) 	hepatic ischemia/reperfusion injury (HIRI)	mice Kupffer cells	ischemia/reperfusion (I/R) treatment	downregulated	24987958
1276	Mouse	mmu-miR-146a	miRNA	lipopolysaccharide (LPS)	macrophage inflammatory response	RAW264.7 macrophage cells	lipopolysaccharide (LPS) treatment	upregulated	22415194
1277	Mouse	mmu-miR-146a	miRNA	mycobacteria	inflammatory response	Mouse primary peritoneal macrophages and bone marrow-derived macrophages (BMDMs)	mycobacteria infection	mycobacteria-induced miR-146a could modulate inflammatoryresponse by targeting IRAK1 and TRAF6 and facilitate mycobacteria replication in macrophage	24358114
1278	Mouse	mmu-miR-146a	miRNA	calophyllum inophyllum Linn. (Guttiferae)	multiple myeloma (MM)	RAW264.7 cells	Calophyllum inophyllum L. treatment	downregulated	22735972
1279	Mouse	mmu-miR-146a	miRNA	"3,3'-diindolylmethane (DIM)"	multiple sclerosis (MS)	activated T cells during the development of experimental autoimmune encephalomyelitis (EAE)	"3,3'-Diindolylmethane (DIM) treatment"	upregulated	24898268
1280	Mouse	mmu-miR-146a	miRNA	cuprizone (CPZ)	multiple sclerosis (MS)	corpus callosum	cuprizone (CPZ) treatment	miR-146a was increasingly upregulated during CPZ-induced de- and remyelination.	29593734
1281	Mouse	mmu-miR-146a	miRNA	freeze-dried mouse spinal cord homogenate	multiple sclerosis (MS)	Biozzi ABH mice	experimental autoimmune encephalomyelitis treatment	upregulated	25515214
1282	Mouse	mmu-miR-146a	miRNA	amyloid-¦Â (A¦Â) 42	murine scrapie	murine brain	amyloid-¦Â (A¦Â) 43 peptide metal treatment	upregulated	22043907
1283	Mouse	mmu-miR-146a	miRNA	neurotoxic metal	murine scrapie	murine brain	neurotoxic metal treatment	upregulated	22043907
1284	Mouse	mmu-miR-146a	miRNA	proinflammatory cytokines	murine scrapie	murine brain	pro-inflammatory cytokine treatment	upregulated	22043907
1285	Mouse	mmu-miR-146a	miRNA	ischemia/reperfusion (I/R) 	myocardial ischaemic injury	mouse plasma;Bone marrow-derived macrophage (BMDM);Rat neonatal CMs	ischemia/reperfusion (I/R) treatment	differently regulated	28768728
1286	Mouse	mmu-miR-146a	miRNA	prion	neurodegeneration (ND)	the brains tissues	prion infection treatment	upregulated	18987751
1287	Mouse	mmu-miR-146a	miRNA	lipopolysaccharide (LPS)	neuroinflammation	N9 microglia	lipopolysaccharide (LPS) treatment	upregulated	28096568
1288	Mouse	mmu-miR-146a	miRNA	lipopolysaccharide (LPS)	neuroinflammation	microvesicles (MVs) of BV2 cells treated with CHPG	lipopolysaccharide (LPS) treatment	downregulated in microvesicles (MVs) released	29170640
1289	Mouse	mmu-miR-146a	miRNA	mGlu5 receptor agonist CHPG	neuroinflammation	microvesicles (MVs) released from microglia BV2 cells	treat 24 h with the mGlu5 receptor agonist CHPG (200 ¦ÌM)	upregulated in microvesicles (MVs) released from microglia BV2 cells	29170640
1290	Mouse	mmu-miR-146a	miRNA	spirulina diet	neuroinflammation	cerebral cortex	spirulina diet treatment	Spirulina diet to lactating mothers preserved the LPS-induced increase in anti-inflammatory miR-146a	29845202
1291	Mouse	mmu-miR-146a	miRNA	Japanese encephalitis virus (JEV)	neuroinflammation	mouse microglial C8-B4 cells	infect with JEV	upregulated	28190197
1292	Mouse	mmu-miR-146a	miRNA	high fat diet (HFD)	obesity	nucleus accumbens	high fat diet (HFD) feed	Significant reductions in the levels of miR-155 (82%) and miR-146a (41%) levels were observed within the nucleus accumbens of HFD mice compared to CTL.	28652200
1293	Mouse	mmu-miR-146a	miRNA	hypoxia	osteoarthritis (OA)	Chondrocytes	hypoxia treatment	upregulated	26492575
1294	Mouse	mmu-miR-146a	miRNA	kaempferol	osteoarthritis (OA)	LPS-treated cultured chondrocyte-like ATDC5 cells	kaempferol treatment	downregulated	30776646
1295	Mouse	mmu-miR-146a	miRNA	lipopolysaccharide (LPS)	osteoarthritis (OA)	ATDC5 cells	lipopolysaccharide (LPS) treatment	upregulated	29183039
1296	Mouse	mmu-miR-146a	miRNA	lipopolysaccharide (LPS)	osteoarthritis (OA)	cultured chondrocyte-like ATDC5 cells	lipopolysaccharide (LPS) treatment	upregulated	30776646
1297	Mouse	mmu-miR-146a	miRNA	tumor necrosis factor alpha (TNF-¦Á) 	osteoclast differentiation	RAW264.7 cells	tumor necrosis factor alpha (TNF-¦Á) treatment	upregulated	23078176
1298	Mouse	mmu-miR-146a	miRNA	tumor necrosis factor alpha (TNF-¦Á) 	osteoporosis	MC3T3-E1 cells	tumor necrosis factor alpha (TNF-¦Á) treatment	Rtn4-Exos attenuated TNF-¦Á-induced cytotoxicity and apoptosis in murine MC3T3-E1 cells by sponging miR-146a	32400849
1299	Mouse	mmu-miR-146a	miRNA	ovalbumin (OVA)	allergic inflammation of dendritic cells (DCs)	Bone marrow-derived DCs (BMDCs)	OVA treatment	OVA treatment significantly upregulated miR-146a in BMDCs in a dose- and time-dependent manner.	31957545
1300	Mouse	mmu-miR-146a	miRNA	CpG	autoimmune and inflammatory diseases	murine bone marrow-derived dendritic cells	?CpG treatment	upregulated	23244216
1301	Mouse	mmu-miR-146a	miRNA	particulate matter (PM2.5)	PM2.5 exposure	mosue bronchoalveolar lavage fluid (BALF)	"were subjected to intratracheal instillation of 2.5, 10, or 20mg/kg PM2.5 treatment"	upregulated in bronchoalveolar lavage fluid (BALF)	29107863
1302	Mouse	mmu-miR-146a	miRNA	lipopolysaccharide (LPS)	postoperative cognitive dysfunction (POCD)	BV-2 microglial cells	lipopolysaccharide (LPS) treatment	upregulated	30685530
1303	Mouse	mmu-miR-146a	miRNA	probiotics (VSL#3)	postoperative cognitive dysfunction (POCD)	hippocampal tissues	probiotics (VSL#3)?treatment treatment	"Finally, VSL#3 treatment upregulated the expression of miR-146a to block BTG2/Bax axis and consequently inhibited neuronal apoptosis and reduced oxidative stress in POCD mice"	33725320
1304	Mouse	mmu-miR-146a	miRNA	particulate matter (PM2.5)	pulmonary toxicological	lung tissues	particulate matter (PM2.5) exposure treatment	upregulated	29107863
1305	Mouse	mmu-miR-146a	miRNA	prion	retinoblastoma (RB)	mouse brain tissues	prion treatment	over-expression	22363497
1306	Mouse	mmu-miR-146a	miRNA	collagen	rheumatoid arthritis (RA)	splenocytes	collagen treatment	downregulated	32938348
1307	Mouse	mmu-miR-146a	miRNA	Salmonella Typhimurium	salmonella typhimurium infection	Murine macrophages(murine RAW 264.7 cells)	Salmonella Typhimurium infection treatment	upregulated	21468030
1308	Mouse	mmu-miR-146a	miRNA	schistosomiasis	schistosomiasis liver inflammation	mouse liver tissues	schistosomiasis treatment	6W infected mice were significantly higher than those of the normal mice and of the 12W infected mice	25051829
1309	Mouse	mmu-miR-146a	miRNA	lipopolysaccharide (LPS)	sepsis	peritoneal macrophages	lipopolysaccharide (LPS) treatment	microRNA-146a was upregulated in macrophage stimulated by lipopolysaccharide.	30103197
1310	Mouse	mmu-miR-146a	miRNA	SiO2	silicosis	NR8383 cells	SiO2 treatment	upregulated	26239160
1311	Mouse	mmu-miR-146a	miRNA	aldara	skin inflammation	skin	aldara treatment	upregulated	25662483
1312	Mouse	mmu-miR-146a	miRNA	IL-17	skin inflammation	mouse keratinocytes	IL-17 treatment	upregulated	27568078
1313	Mouse	mmu-miR-146a	miRNA	sunitinib (SU)	sunitinib-induced cardiac dysfunction	the myocardium of sunitinib-treated mice	sunitinib treatment	downregulated	31507414
1314	Mouse	mmu-miR-146a	miRNA	mycobacteria	tuberculosis (TB)	RAW264.7 cells	mycobacterial treatment	upregulation	27025258
1315	Mouse	mmu-miR-146a	miRNA	antioxidant of bamboo leaves (AOB)	vascular development	embryoid bodies (EBs)	antioxidant of bamboo leaves (AOB) treatment	miR-146a was markedly downregulated following AOB treatment compared with the control.	29207159
1316	Mouse	mmu-miR-146a	miRNA	aerobic exercise	vascular injury	HUVECs	aerobic exercise training (AET) treatment	"aerobic exercise and statins may induce miR-146a expression, thereby reducing vascular TRAF and TLR4 signaling and vascular      inflammatory injury in AS."	24022569
1317	Mouse	mmu-miR-146a	miRNA	aerobic exercise	vascular injury	high-fat diet-E-null mice	aerobic exercise training (AET) treatment	aerobic exercise and statins may induce miR-146a expression	24022569
1318	Mouse	mmu-miR-146a	miRNA	live L. acidophilus	¦Â-lactoglobulin (¦Â-Lg) allergy	murine splenocytes	live L. acidophilus treatment	downregulated	30156972
1319	Mouse	mmu-miR-146a	miRNA	IL-6	osteoarthritis (OA)	ATDC5 cells	IL-6 treatment	miR©\146a level was negatively modulated by IL©\6 and lncRNA CHRF in ATDC5 cell	31026064
1320	Mouse	mmu-miR-146a	miRNA	dexamethasone (DEX)	osteonecrosis of femoral head (ONFH)	MC3T3-E1 cells from murine osteoblastic	dexamethasone (DEX) treatment	upregulated	28975995
1321	Mouse	mmu-miR-146a	miRNA	heme oxygenase-1 (HMOX1)	myoblast differentiation	C2C12 cells	Heme oxygenase-1 (HMOX1) treatment	upregulated	21827279
1322	Mouse	mmu-miR-146a-3p	miRNA	particulate matter (PM2.5)	macrophage polarization	RAW264.7 cells	Fine particulate matter (PM2.5) exposure treatment	upregulated	30911272
1323	Mouse	mmu-miR-146a-5p	miRNA	lipopolysaccharide (LPS)	acute kidney injury (AKI)	kidney tissues	lipopolysaccharide (LPS) treatment	miR-146a-5p was upregulated at 6h and 48h.	32727087
1324	Mouse	mmu-miR-146a-5p	miRNA	house dust mite (HDM)	asthma	lung tissue	house dust mite allergen treatment	upregulated	31698144
1325	Mouse	mmu-miR-146a-5p	miRNA	long-chain polyunsaturated fatty acids (LCPUFAs)	asthma	HDM mice lung tissue	long-chain polyunsaturated fatty acids (LCPUFAs) treatment	downregulated	31698144
1326	Mouse	mmu-miR-146a-5p	miRNA	echinococcus multilocularis metacestodes	echinococcus multilocularis infection	RAW 264.7 cells	E. multilocularis metacestodes treatment	upregulated	30322806
1327	Mouse	mmu-miR-146a-5p	miRNA	ethanol (EtOH)	ethanol-induced neuroinflammation and brain damage	brain cortices	ethanol treatment	upregulated	32937997
1328	Mouse	mmu-miR-146a-5p	miRNA	ethanol (EtOH)	ethanol-induced neuroinflammation and brain damage	plasma exosomes	ethanol treatment	downregulated	32937997
1329	Mouse	mmu-miR-146a-5p	miRNA	¦¤9-tetrahydrocannabinol (THC) and Cannabidiol (CBD)	experimental autoimmune encephalomyelitis (EAE)	murine brain-derived CD4+ T cells	¦¤9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) combination treatment	downregulated	31497013
1330	Mouse	mmu-miR-146a-5p	miRNA	schistosoma japonicum	liver fibrosis	serum exosomes	S. japonicum infection treatment	downregulated	32443549
1331	Mouse	mmu-miR-146a-5p	miRNA	E. multilocularis metacestodes	infection and immunity of E. multilocularis	RAW264¡¤7 macrophage cells	E. multilocularis metacestodes for 6 and 12 h treatment	"upregulated (mmu-miR-378d,mmu-miR-155-5p, mmu-miR-146a-5p, mmu-miR-21a-5p , mmu-miR-125a-5p) and downregulated(mmu-miR-1981-5p , mmu-miR-let-7c-1-3p)"	28942753
1332	Mouse	mmu-miR-146a-5p	miRNA	lipopolysaccharide (LPS)	inflammation	BV2 mouse microglial cells	lipopolysaccharide (LPS) treatment	upregulated	31530042
1333	Mouse	mmu-miR-146a-5p	miRNA	resveratrol	inflammation	LPS-treated BV2 mouse microglial cells	resveratrol (RSV) treatment	upregulated	31530042
1334	Mouse	mmu-miR-146a-5p	miRNA	angiostrongylus cantonensis (A. cantonensis)	inflammation	male Balb/c mice	angiostrongylus cantonensis (A. cantonensis) infection	upregulated	24142285
1335	Mouse	mmu-miR-146a-5p	miRNA	isosteviol Sodium (STV-Na)	ischemic stroke (IS)	microglia/macrophage polarization in ischemic stroke	Isosteviol Sodium (STV-Na) treatment	upregulated	31434993
1336	Mouse	mmu-miR-146a-5p	miRNA	Legionella pneumophila (L. pneumophila)	Legionella pneumophila (L. pneumophila) infection	WT and MyD88-/- murine bone marrow-derived macrophages (BMM)	infected with L. pneumophila	downregulated	28445535
1337	Mouse	mmu-miR-146a-5p	miRNA	high fat diet (HFD)	nonalcoholic fatty liver disease (NAFLD)	mouse liver tissues	high fat diet (HFD) feed	downregulated	31484042
1338	Mouse	mmu-miR-146a-5p	miRNA	methionine choline-deficient diet (MCD)	nonalcoholic fatty liver disease (NAFLD)	liver tissues	methionine-choline deficient (MCD) treatment	downregulated	26537990
1339	Mouse	mmu-miR-146a-5p	miRNA	bis-enoxacin	osteoclastogenesis	4T1 murine breast cancer cells	bis-enoxacin treatment	downregulated	30385810
1340	Mouse	mmu-miR-146a-5p	miRNA	enoxacin	osteoclastogenesis	4T1 murine breast cancer cells	Enoxacin treatment	downregulated	30385810
1341	Mouse	mmu-miR-146a-5p	miRNA	aldosterone	renal fibrosis	mouse cortical collecting duct cells	aldosterone treatment (10-6 M; 3 days)	downregulated	29070573
1342	Mouse	mmu-miR-146a-5p	miRNA	aldosterone	renal fibrosis	mouse cortical collecting duct cells	aldosterone treatment (10-6 M; 3 days)	dysregulated	29070573
1343	Mouse	mmu-miR-146a-5p	miRNA	cisplatin (DDP)	renal fibrosis	kidney tissues	cisplatin treatment	upregulated	33664736
1344	Mouse	mmu-miR-146a-5p	miRNA	TGF-¦Â1	renal fibrosis	mouse renal tubular epithelial cells (mRTECs)	TGF-¦Â1 treatment	upregulated	33664736
1345	Mouse	mmu-miR-146a-5p	miRNA	environmental toxin bisphenol A (BPA)	testicular steroidogenesis dysfuction	interstitial Leydig cells (LCs)	environmental toxin bisphenol A (BPA) treatment	upregulated	29746863
1346	Mouse	mmu-miR-146a-5p	miRNA	H2O2	thymic stromal cells senescence	thymic stromal cells	oxidative stress	downregulated	33002743
1347	Mouse	mmu-miR-146a-5p	miRNA	trinitrobenzene sulfonic acid (TNBS)	visceral pain in colitis	lumbosacral spinal cord	trinitrobenzene sulfonic acid (TNBS) treatment	upregulated	29550454
1348	Mouse	mmu-miR-146b	miRNA	lipopolysaccharide (LPS)	acute lung injury (ALI)	"Bronchial alveolar lavage (BAL), peripheral blood isolated serum, splenocytes and lung tissues"	lipopolysaccharide (LPS) treatment	upregulated	30500983
1349	Mouse	mmu-miR-146b	miRNA	inorganic nitrite	acute myocardial infarction (AMI)	heart tissues	single-dose of nitrite	downregulated	28090786
1350	Mouse	mmu-miR-146b	miRNA	ischemia/reperfusion (I/R) 	acute myocardial infarction (AMI)	heart tissues	ischemia/reperfusion (I/R) treatment	upregulated	28090786
1351	Mouse	mmu-miR-146b	miRNA	lipopolysaccharide (LPS)	acute respiratory distress syndrome (ARDS)	"bronchial alveolar lavage (BAL) fluid, peripheral blood, splenocytes and lung tissues"	lipopolysaccharide (LPS) treatment	upregulated	30500983
1352	Mouse	mmu-miR-146b	miRNA	actinomycetemcomitans (Aa)	atherosclerosis (AS)	blood	actinomycetemcomitans (Aa) treatment	upregulated	25743474
1353	Mouse	mmu-miR-146b	miRNA	IL-1¦Â	atherosclerosis (AS)	mouse aortic smooth muscle cell lines	IL-1¦Â treatment	upregulated	33084403
1354	Mouse	mmu-miR-146b	miRNA	IL-6	atherosclerosis (AS)	mouse aortic smooth muscle cell lines	IL-6 treatment	upregulated	33084403
1355	Mouse	mmu-miR-146b	miRNA	tumor necrosis factor alpha (TNF-¦Á) 	atherosclerosis (AS)	mouse aortic smooth muscle cell lines	tumor necrosis factor alpha (TNF-¦Á) treatment	upregulated	33084403
1356	Mouse	mmu-miR-146b	miRNA	calorie restriction (CR)	hepatic steatosis	high-fat (HF) diet-induced obesity prone (OP) mice thyroid and liver tissues	calorie restriction (CR) treatment	upregulated	31863770
1357	Mouse	mmu-miR-146b	miRNA	exercise (Ex)	hepatic steatosis	high-fat (HF) diet-induced obesity prone (OP) mice thyroid and liver tissues	exercise (Ex) treatment	upregulated	31863770
1358	Mouse	mmu-miR-146b	miRNA	high fat diet (HFD)	hepatic steatosis	liver tissues	high fat diet (HFD) feed	upregulated	30776032
1359	Mouse	mmu-miR-146b	miRNA	high fat diet (HFD)	hepatic steatosis	mice thyroid and liver tissues	high fat diet (HFD) feed	downregulated	31863770
1360	Mouse	mmu-miR-146b	miRNA	low fat diet (LFD)	hepatic steatosis	high-fat (HF) diet-induced obesity prone (OP) mice thyroid and liver tissues	low-fat diet (LF) treatment	upregulated	31863770
1361	Mouse	mmu-miR-146b	miRNA	myricetin	hepatic steatosis	liver tissues	myricetin treatment	myricetin inhibited miR-146b upregulated induced by HFD.	30776032
1362	Mouse	mmu-miR-146b	miRNA	quercetin	hepatic steatosis	high-fat (HF) diet-induced obesity prone (OP) mice thyroid and liver tissues	quercetin (Que) treatment	upregulated	31863770
1363	Mouse	mmu-miR-146b	miRNA	ginkgo biloba extract (GBE)	hepatocellular carcinoma (HCC)	non-tumor (ENT) liver	ginkgo biloba extract (GBE) treatment	upregulated	32306082
1364	Mouse	mmu-miR-146b	miRNA	influenza A virus (IAV)	immune response	lung tissues	influenza A virus infection	downregulated	30513647
1365	Mouse	mmu-miR-146b	miRNA	lipopolysaccharide (LPS)	inflammation	RAW 264.7 cells	lipopolysaccharide (LPS) treatment	dysregulated	24792623
1366	Mouse	mmu-miR-146b	miRNA	deoxycorticosterone acetate (DOCA)	kidney damage	hypertensive mice kidneys and urine	injection of Deoxycorticosterone acetate (Doca)	upregulated in the kidneys and urine	29255279
1367	Mouse	mmu-miR-146b	miRNA	dextran sodium sulfate (DSS)	mucosal repair	"mucosa, lamina propria cells or epithelial cells"	dextran sulfate sodium (DSS) treatment	upregulated	30445446
1368	Mouse	mmu-miR-146b	miRNA	low fat diet (LFD)	obesity	thyroid	low fat diet (LFD) treatment	downregulated	31863770
1369	Mouse	mmu-miR-146b	miRNA	low fat diet (LFD)	obesity	thyroid	low fat diet (LFD) treatment	upregulated	31863770
1370	Mouse	mmu-miR-146b	miRNA	quercetin	obesity	thyroid	quercetin (QUE) treatment	upregulated	31863770
1371	Mouse	mmu-miR-146b	miRNA	zerumbone	obesity	3T3-L1 cells	zerumbone treatment	downregulated	28445161
1372	Mouse	mmu-miR-146b	miRNA	resveratrol	osteoarthritis (OA)	ATDC5 cells	resveratrol (Res) treatment	miR-146b was upregulated by RSV	29843156
1373	Mouse	mmu-miR-146b	miRNA	P. gingivalis	P. gingivalis infection	ApoE mice heart and aorta tissues	infect with P. gingivalis treatment	upregulated	28646427
1374	Mouse	mmu-miR-146b	miRNA	tanshinone IIA (Tan IIA)	P. gingivalis infection	ApoE mice serum and in heart	TSA (60 mg kg-/--/--1 day-1) treatment	downregulated	28646427
1375	Mouse	mmu-miR-146b	miRNA	particulate matter (PM2.5)	PM2.5 exposure	mosue bronchoalveolar lavage fluid (BALF)	"were subjected to intratracheal instillation of 2.5, 10, or 20mg/kg PM2.5 treatment"	upregulated in bronchoalveolar lavage fluid (BALF)	29107863
1376	Mouse	mmu-miR-146b	miRNA	particulate matter (PM2.5)	pulmonary toxicological	lung tissues	particulate matter (PM2.5) exposure treatment	upregulated	29107863
1377	Mouse	mmu-miR-146b	miRNA	schistosoma japonicum	schistosomiasis	murine liver	Schistosoma japonicum infection treatment	upregulated	23825609
1378	Mouse	mmu-miR-146b	miRNA	high fat diet (HFD)	visceral obesity and metabolic dysfunction	C57BL/6N mice	high fat diet (HFD) feed	upregulated	24931160
1379	Mouse	mmu-miR-146b	miRNA	dexamethasone (DEX)	asthma	splenic CD4+ T lymphocytes	dexamethasone (DEX) treatment	downregulated	22580216
1380	Mouse	mmu-miR-146b-3p	miRNA	influenza virus	H5N2 influenza virus infection	lung tissues	H5N2 treatment	upregulated	25266911
1381	Mouse	mmu-miR-146b-3p	miRNA	lipopolysaccharide (LPS)	inflammation	RAW264.7 cells	lipopolysaccharide (LPS) treatment	upregulated	32955644
1382	Mouse	mmu-miR-146b-5p	miRNA	3¦Â-hydroxycholest-5-en-7-one	anti-inflammatory responses	RAW 264.7 cells	3¦Â-hydroxycholest-5-en-7-one treatment	upregulated	32771556
1383	Mouse	mmu-miR-146b-5p	miRNA	tanshinone IIA (Tan IIA)	atherosclerosis (AS)	RAW 264.7 cells	Tanshinone IIA (Tan) treatment	downregulated	32337768
1384	Mouse	mmu-miR-146b-5p	miRNA	tensile	cementoblastogenesis	cementoblast cell line OCCM-30 cells	tensile treatment	upregulated	27941605
1385	Mouse	mmu-miR-146b-5p	miRNA	folic acid	kidney injury and fibrosis	kidney cortex	folic acid treatment	upregulated	26707937
1386	Mouse	mmu-miR-146b-5p	miRNA	carbon tetrachloride (CCl4)	liver fibrosis	liver tissues	carbon tetrachloride (CCl4) treatment	upregulated	29557526
1387	Mouse	mmu-miR-146b-5p	miRNA	hypoxia	myocardial infarction (MI)	mouse infarcted myocardium	hypoxia treatment	"Herein, miR-146b-5p was found to be upregulated in the infarcted myocardium of mice and the serum of myocardial ischemia patients."	32845445
1388	Mouse	mmu-miR-146b-5p	miRNA	FTY720-C2	parkinson's disease (PD)	dopaminergic MN13D cells	FTY720-C2 treatment	upregulated	30359694
1389	Mouse	mmu-miR-146b-5p	miRNA	FTY720-C2	parkinson's disease (PD)	MN9D cells	FTY720-C2 treatment	upregulated	30359694
1390	Mouse	mmu-miR-146b-5p	miRNA	platelet-derived growth factor (PDGF)	vascular disease	Vascular smooth muscle cells (VSMCs)	PDGF treatment	upregulated	26722482
1391	Mouse	mmu-miR-147	miRNA	elastase	abdominal aortic aneurysm (AAA)	murine aortic tissues	elastase treatment	"A 10-fold upregulated of microRNA (miR)-147, a key mediator of macrophage inflammatory responses, was observed in murine aortic tissue in elastase-treated mice compared with controls on d 14."	29812968
1392	Mouse	mmu-miR-147	miRNA	norcantharidin (NCTD)	hepatocellular carcinoma (HCC)	liver tissues	intraperitoneal injection of different concentration of NCTD treatment	upregulated	24719559
1393	Mouse	mmu-miR-147	miRNA	dexamethasone (DEX)	muscle atrophy	Murine C2C12 myoblast cells	dexamethasone (DEX) treatment	downregulated	23716137
1394	Mouse	mmu-miR-147-3p	miRNA	chlamydia muridarum variants (C. muridarum Var001 [CmVar001] and CmVar004)	plvic inflammatory disease	mouse	two Chlamydia muridarum variants (C. muridarum Var001 [CmVar001] and CmVar004) infection	were upregulated during CmVar004 infection compared to CmVar001 infection	24961692
1395	Mouse	mmu-miR-147a	miRNA	sildenafil	diabetic peripheral neuropathy (DPN)	mouse	sildenafil at a dose of 10 mg/kg for 4 weeks treatment	upregulated	24316060
1396	Mouse	mmu-miR-147a	miRNA	praziquantel (PZQ)	inflammation	mouse liver	schistosomiasis treatment	increase in the PZQ-ed mice compared to the 12W infected mice	25051829
1397	Mouse	mmu-miR-147a	miRNA	thymosin ¦Â4 (T¦Â4)	neurological injury	mouse N20.1 OPC cell line	"T¦Â4, ranging from 25 to 100 ng/ml for 5 days treatment"	upregulation	24828500
1398	Mouse	mmu-miR-147a	miRNA	lipopolysaccharide (LPS)	pneumonia	TC-1 cells	lipopolysaccharide (LPS) treatment	downregulated	33318298
1399	Mouse	mmu-miR-148a	miRNA	cerulein	acute pancreatitis (AP)	pancreatic tissues of mice	cerulein treatment	downregulated	31122822
1400	Mouse	mmu-miR-148a	miRNA	ethanol (EtOH)	alcoholic hepatitis (AH)	"mouse liver tissues, AML cells, Mouse primary hepatocytes"	Lieber-DeCarli alcohol diet or binge alcohol exposure	downregulated	29475852
1401	Mouse	mmu-miR-148a	miRNA	alcohol	alcoholic liver disease (ALD)	cultured hepatocytes and mouse livers	alcohol exposure	downregulated	29475852
1402	Mouse	mmu-miR-148a	miRNA	arsenite	atherosclerosis (AS)	liver	arsenic (As) exposure	upregulated	22719926
1403	Mouse	mmu-miR-148a	miRNA	high methionine diet	atherosclerosis (AS)	ApoE mice	high methionine diet	upregulated	28472596
1404	Mouse	mmu-miR-148a	miRNA	hypoxia/reoxygenation (H/R)	hepatic ischemia/reperfusion injury (HIRI)	primary Kupffer cells (KCs)	hypoxia/reoxygenation (H/R) treatment	downregulated	30244246
1405	Mouse	mmu-miR-148a	miRNA	listeria	Listeria infection	murine ileum tissues	Listeria infection	downregulated	24327339
1406	Mouse	mmu-miR-148a	miRNA	carbon tetrachloride (CCl4)	liver fibrosis	liver tissues	carbon tetrachloride (CCl4) treatment	downregulated	30362572
1407	Mouse	mmu-miR-148a	miRNA	carbon tetrachloride (CCl4)	liver fibrosis	mouse liver tissue	carbon tetrachloride (CCl4) treatment	downregulated	30362572
1408	Mouse	mmu-miR-148a	miRNA	TGF-¦Â	liver fibrosis	"mouse Primary hepatic stellate cells (PHSCs), The human immortalized HSC line LX©\2,Human L©\02 hepatocytes"	TGF-¦Â treatment	downregulated	30362572
1409	Mouse	mmu-miR-148a	miRNA	"1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)"	parkinson's disease (PD)	substantia nigra tissue	"1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) treatment"	upregulated	31059019
1410	Mouse	mmu-miR-148a	miRNA	lithium (Li)	parkinson's disease (PD)	substantia nigra tissues	Lithium treatment	downregulated	31059019
1411	Mouse	mmu-miR-148a-3p	miRNA	concanamycin A (Con A)	acute liver failure (ALF)	RAW264.7 cells	concanavalin A (Con A) treatment	upregulated	32739513
1412	Mouse	mmu-miR-148a-3p	miRNA	adipogenesis medium	adipocyte and osteoblast differentiation	ST2 or C3H10T1/2 cells	"adipogenic medium ((¦Á-MEM containing 10% FBS, 0.5 ¦ÌM dexamethasone, 0.25 mM methylisobutylxanthine, 5 ¦Ìg/ml insulin, and 50 ¦ÌM indomethacin) treatment"	upregulated	30728459
1413	Mouse	mmu-miR-148a-3p	miRNA	osteogenic differentiation medium	adipogenesis	ST2 or MC3T3-E1 cells	"osteogenic medium (¦Á-MEM containing 10% FBS, 50 ¦Ìg/ml ascorbic acid, and 5 mM ¦Â-glycerophosphate) treatment"	downregulated	30728459
1414	Mouse	mmu-miR-148a-3p	miRNA	lipopolysaccharide (LPS)	LPS-induced inflammation and sepsis	RAW264.7 cells	lipopolysaccharide (LPS) treatment	"In the LPS induced macrophages, the increasing of miR-148a-3p was milder in the RBP-J-/- macrophages than in the wild type macrophages."	32719678
1415	Mouse	mmu-miR-148a-3p	miRNA	metformin (Met)	oxidative stress	N2a cells	metformin treatment	metformin upregulated the expression of miR-148a-3p?in both MCAO/R-treated mice and OGD/R-treated N2a cells.	31934270
1416	Mouse	mmu-miR-148b	miRNA	isoproterenol	cardiac fibrosis	heart tissues	isoproterenol (ISO) treatment	downregulated	27174579
1417	Mouse	mmu-miR-148b-3p	miRNA	oxygen-glucose deprivation and reoxygenation (OGD/R)	cerebral ischemia/reperfusion (I/R) injury	HT22 cells	oxygen-glucose deprivation and reoxygenation (OGD/R) treatment	miR-148b-3p expression was significantly decreased in neurons in response to OGD/R exposure.	31868937
1418	Mouse	mmu-miR-148b-3p	miRNA	hypoxia/reoxygenation (H/R)	myocardial ischemia/reperfusion (I/R) injury (MIRI)	primary mouse cardiomyocytes	hypoxia/reoxygenation (H/R) treatment	miR-148b-3p expression was significantly upregulated in response to H/R treatment in cardiomyocytes.	30308185
1419	Mouse	mmu-miR-149	miRNA	arsenite	diabetes mellitus (DM)	Min6 cells	arsenite exposure	upregulated	29905828
1420	Mouse	mmu-miR-149	miRNA	azilsartan medoxomil (AZL-M)	heart failure (HF)	plasma	azilsartan medoxomil (AZL-M) treatment	"MiR-146a, miR-149, miR-150, and miR-342-3p were reproducibly reduced in the plasma of CSQ-tg mice."	27321284
1421	Mouse	mmu-miR-149	miRNA	melatonin	ischemic injury	Primary myoblast	Melatonin treatment	Melatonin increases mitochondrial function under oxidative stress conditions by upregulating miR-149.	32089265
1422	Mouse	mmu-miR-149	miRNA	silica dust	lung fibrosis	mouse lung tissues	silica dust treatment	downregulated	24641842
1423	Mouse	mmu-miR-149-3p	miRNA	oxygen-glucose deprivation and reoxygenation (OGD/R)	ischemia/reperfusion (I/R) injury	N2a cells	oxygen-glucose deprivation and reoxygenation (OGD/R) treatment	downregulated	33216728
1424	Mouse	mmu-miR-149-3p	miRNA	bilateral surgical destabilization of the medial meniscus (DMM)	osteoarthritis (OA)	male C57BL6 mice	bilateral surgical destabilization of the medial meniscus (DMM) treatment	dysregulated	29255152
1425	Mouse	mmu-miR-149-5p	miRNA	3¦Â-hydroxycholest-5-en-7-one	anti-inflammatory responses	RAW 264.7 cells	3¦Â-hydroxycholest-5-en-7-one treatment	downregulated	32771556
1426	Mouse	mmu-miR-149-5p	miRNA	high glucose (HG)	diabetes mellitus (DM)	pancreatic beta cell line (MIN6 cells)	high-glucose (HG) treatment	downregulated	31260649
1427	Mouse	mmu-miR-149-5p	miRNA	high fat diet (HFD)	hepatic insulin resistance	mouse liver tissues	high fat diet (HFD) feed	upregulated	30820263
1428	Mouse	mmu-miR-149-5p	miRNA	allopurinol	hyperuricemia	liver tissues	allopurinol treatment	"miR-149-5p was significantly upregulated in the livers of HFD-fed mice, while the expression was downregulated by allopurinol therapy."	32070295
1429	Mouse	mmu-miR-149-5p	miRNA	ursolic acid (UA)	hyperuricemia	AML-12 cells	uric acid treatment	MiR-149-5p expression was also significantly upregulated in uric acid-stimulated hepatocytes	32070295
1430	Mouse	mmu-miR-15	miRNA	"hexahydro-1,3,5-trinitro-1,3,5-triazine (RDX)"	tumorigenesis	brain and liver tissue cells	"hexahydro-1,3,5-trinitro-1,3,5-triazine (RDX) treatment"	downregulated	19270793
1431	Mouse	mmu-miR-15	miRNA	monosodium luminol	neurodegeneration (ND)	central nervous system (CNS) tissues of?mice	Monosodium luminol treatment	downregulated	20201611
1432	Mouse	mmu-miR-150	miRNA	lipopolysaccharide (LPS)	acute lung injury (ALI)	lung tissues	lipopolysaccharide (LPS) treatment	downregulated	31398659
1433	Mouse	mmu-miR-150	miRNA	celecoxib	tumorigenesis	wild-type (HPV16) mice	celecoxib treatment	upregulated	28551628
1434	Mouse	mmu-miR-150	miRNA	dextran sodium sulfate (DSS)	chronic inflammatory bowel diseases (IBDs)	colon tissue of DSS-treated mice	dextran sulphate sodium (DSS)? treatment	upregulated	21590770
1435	Mouse	mmu-miR-150	miRNA	cigarette smoke (CS)	chronic obstructive pulmonary disease (COPD)	the lungs of CS-exposed mice	cigarette smoke (CS) exposure	downregulated	29205062
1436	Mouse	mmu-miR-150	miRNA	cigarette smoke (CS)	chronic obstructive pulmonary disease (COPD)	mouse lungs	Cigarette smoke (CS) exposure	downregulated	29205062
1437	Mouse	mmu-miR-150	miRNA	dextran sodium sulfate (DSS)	colitis	colon tissues	dextran sodium sulfate (DSS) treatment	upregulated	29867475
1438	Mouse	mmu-miR-150	miRNA	probiotic Escherichia coli Nissle 1917 (EcN)	colitis	dextran sodium sulfate (DSS)-induced colitis mouse colon tissues	probiotic Escherichia coli Nissle 1917 (EcN) treatment	downregulated	29867475
1439	Mouse	mmu-miR-150	miRNA	doxorubicin (DOX)	doxorubicin (DOX)-induced cardiotoxicity	male B6C3F1 mice	were injected intravenously with 3mg/kg doxorubicin treatment	downregulated	25448438
1440	Mouse	mmu-miR-150	miRNA	adriamycin (ADR)	focal segmental glomerulosclerosis (FSGS)	renal tissues	adriamycin (ADR) treatment	upregulated	31787235
1441	Mouse	mmu-miR-150	miRNA	adriamycin (ADR)	focal segmental glomerulosclerosis (FSGS)	kidney tissues	adriamycin (ADR) treatment	Renal miR-150 increased in adriamycin-induced FSGS mice.	31787235
1442	Mouse	mmu-miR-150	miRNA	helicobacter pylori (H. pylori)	gastric MALT lymphoma (GML)	GML-developing d3Tx mice stomachs	infect with H. pylori	upregulated	28560185
1443	Mouse	mmu-miR-150	miRNA	azilsartan medoxomil (AZL-M)	heart failure (HF)	plasma	azilsartan medoxomil (AZL-M) treatment	"MiR-146a, miR-149, miR-150, and miR-342-3p were reproducibly reduced in the plasma of CSQ-tg mice."	27321284
1444	Mouse	mmu-miR-150	miRNA	hypoxia	hepatocyte proliferation	mice Primary hepatocytes	hypoxia treatment	miR-150 expression is subject to negative regulation by HIF-1¦Á	23715613
1445	Mouse	mmu-miR-150	miRNA	oxygen glucose deprivation (OGD)	hypoxic/ischemic brain damage (HIBD)	brain microvascular endothelial cells (BMECs)	oxygen-glucose deprivation (OGD) treatment	OGD exposure augmented the level of Rmst while reduced the expression of miR-150 in bEnd3 cells	32728986
1446	Mouse	mmu-miR-150	miRNA	flaxseed (FS)	inflammation	mouse exposed to X-ray	fed 10% FS or a 0% FS isocaloric control diet treatment	dysregulated	24755684
1447	Mouse	mmu-miR-150	miRNA	"1,25-dihydroxyvitamin D (1,25(OH)2D)"	inflammation	epididymal adipose tissue	"1,25-dihydroxyvitamin D (1,25(OH)2D) treatment"	downregulated	28055298
1448	Mouse	mmu-miR-150	miRNA	oxygen glucose deprivation (OGD)	ischemic stroke (IS)	mouse brain microvascular endothelial (bEnd.3) cells	oxygen-glucose deprivation (OGD) treatment	"SNHG12 expression was elevated, whereas miR-150 reduced in OGD-exposed bEnd.3 cells."	30193860
1449	Mouse	mmu-miR-150	miRNA	hypoxia	kidney damage	tubular epithelial cells (TECs)	hypoxia treatment	Injured tubular epithelial cells activate fibroblasts to promote kidney fibrosis through miR-150-containing exosomes.	32315664
1450	Mouse	mmu-miR-150	miRNA	¦Ã-rays	leukemia	the whole blood cells of mice	Gy ¦Ã-rays treatment	miRNA signatures induced by ionising radiation in mouse blood are radiation type- and radiation dose-specific	21271940
1451	Mouse	mmu-miR-150	miRNA	carbon tetrachloride (CCl4)	liver fibrosis	hepatic stellate cells (HSCs)	CCl4 treatment	downregulated	30548190
1452	Mouse	mmu-miR-150	miRNA	IL-4	macrophage polarization	mouse peritoneal macrophages (MPMs) and MSF-differentiated mouse bone marrow-derived macrophages (BMDMs)	IL-4 treatment	upregulated	31647949
1453	Mouse	mmu-miR-150	miRNA	lipopolysaccharide (LPS)	macrophage polarization	mouse peritoneal macrophages (MPMs) and MSF-differentiated mouse bone marrow-derived macrophages (BMDMs)	lipopolysaccharide (LPS) treatment	downregulated	31647949
1454	Mouse	mmu-miR-150	miRNA	high fat diet (HFD)	nonalcoholic fatty liver disease (NAFLD)	mouse	high fat diet (HFD) feed	upregulated	31966555
1455	Mouse	mmu-miR-150	miRNA	high fat diet (HFD)	nonalcoholic fatty liver disease (NAFLD)	mouse liver	high fat diet (HFD) feed	"HFD-fed mice had downregulated expression of miR-150, whereas the expression level was upregulated after MIM or NaB treatment."	33721354
1456	Mouse	mmu-miR-150	miRNA	metabolites of intestinal microflora (MIM)	nonalcoholic fatty liver disease (NAFLD)	mouse liver	metabolites of intestinal microflora (MIM) treatment	"HFD-fed mice had downregulated expression of miR-150, whereas the expression level was upregulated after MIM or NaB treatment."	33721354
1457	Mouse	mmu-miR-150	miRNA	Sodium butyrate (NaB)	nonalcoholic fatty liver disease (NAFLD)	mouse liver	Sodium butyrate (NaB) treatment	"HFD-fed mice had downregulated expression of miR-150, whereas the expression level was upregulated after MIM or NaB treatment"	33721354
1458	Mouse	mmu-miR-150	miRNA	IL-1	osteoarthritis (OA)	ATDC5 cells	Interleukin-1 (IL-1) treatment	upregulated	29996115
1459	Mouse	mmu-miR-150	miRNA	cecal ligation and puncture (CLP)	polymicrobial sepsis	C57Bl/6 mice	cecal ligation and puncture (CLP) treatment	different regulation	24413579
1460	Mouse	mmu-miR-150	miRNA	streptozocin (STZ)	type 1 diabetes mellitus (T1DM)	splenocytes; islet ¦Â cells	streptozocin (STZ) treatment	downregulated	32360624
1461	Mouse	mmu-miR-150	miRNA	high fat diet (HFD)	type 2 diabetes mellitus (T2DM)	blood; retina	high fat diet (HFD) feed	WT mice fed with an HFD for only 1?month had a significant decrease of miR-150 in the blood and retina.	32973073
1462	Mouse	mmu-miR-150-3p	miRNA	cold	obesity	brown adipose tissue (BAT)	cold treatment	downregulated	33015181
1463	Mouse	mmu-miR-150-5p	miRNA	high fat diet (HFD)	atherosclerosis (AS)	ApoE-/- mice heart tissues	high fat diet (HFD) feed	We found that ZFAS1 and Notch3 were upregulated while miR-150-5p was downregulated in atherosclerosis mice and ox-LDL-treated HUVECs.	33278458
1464	Mouse	mmu-miR-150-5p	miRNA	angiotensin II (Ang II)	cardiac fibrosis	heart tissues	angiotensin II (Ang II) treatment	downregulated	31122130
1465	Mouse	mmu-miR-150-5p	miRNA	enterovirus 71 (EV71)	enterovirus 71 (EV71) infection	mouse	infect with EV71	downregulated	28469998
1466	Mouse	mmu-miR-150-5p	miRNA	¦¤9-tetrahydrocannabinol (THC) and Cannabidiol (CBD)	experimental autoimmune encephalomyelitis (EAE)	murine brain-derived CD4+ T cells	¦¤9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) combination treatment	downregulated	31497013
1467	Mouse	mmu-miR-150-5p	miRNA	fluke Fasciola gigantica (FgESPs)	F. gigantica infection	liver tissues	fluke Fasciola gigantica (FgESPs) infection	upregulated	33332355
1468	Mouse	mmu-miR-150-5p	miRNA	carbon tetrachloride (CCl4)	liver fibrosis	liver tissues	carbon tetrachloride (CCl4) treatment	downregulated	33342075
1469	Mouse	mmu-miR-150-5p	miRNA	schistosoma japonicum	liver fibrosis	serum exosomes	S. japonicum infection treatment	downregulated	32443549
1470	Mouse	mmu-miR-150-5p	miRNA	schistosomiasis japonica	hepatic fibrogenesis	serum	S. japonicum infection treatment	downregulated	30482723
1471	Mouse	mmu-miR-150-5p	miRNA	"2, 3, 7, 8-tetrachlorodibenzo-p-dioxin (TCDD)"	inflammation	myeloid-derived suppressor cells (MDSCs)	"2, 3, 7, 8-tetrachlorodibenzo-p-dioxin (TCDD) treatment"	downregulated	31492743
1472	Mouse	mmu-miR-150-5p	miRNA	carbon tetrachloride (CCl4)	liver fibrosis	Liver tissue	carbon tetrachloride (CCl4) treatment	upregulated	31833387
1473	Mouse	mmu-miR-150-5p	miRNA	carbon tetrachloride (CCl4)	liver fibrosis	hepatic stellate cells (HSCs)	carbon tetrachloride (CCl4) treatment	downregulated	31833387
1474	Mouse	mmu-miR-150-5p	miRNA	carbon tetrachloride (CCl4)	liver fibrosis	hepatocytes	carbon tetrachloride (CCl4) treatment	upregulated	31833387
1475	Mouse	mmu-miR-150-5p	miRNA	Rhein	uric acid nephropathy (UAN)	Mouse kidney epithelial cell line (TCMK-1)	Rhein treatment	rhein has a protective effect against UAN by inhibiting renal inflammatory injury via lincRNA-Cox2/miR-150-5p/STAT1 axis	32504995
1476	Mouse	mmu-miR-151	miRNA	di(2-ethylhexyl) phthalate (DEHP)	follicular development	ovarian	di(2-ethylhexyl) phthalate (DEHP) treatment	upregulated	29385306
1477	Mouse	mmu-miR-151	miRNA	high-dose ascorbate bears cytotoxic	melanoma	human melanoma cells	with physiological (200 ¦ÌM) or pharmacological (8 mM) ascorbate for 1 h treatment	the expression of miRNAs was altered 12 h after ascorbate ment of BLM cells in physiological or pharmacological doses. Pharmacological doses upregulated 32 miRNAs	25202679
1478	Mouse	mmu-miR-151	miRNA	anandamide (AEA)	pro-inflammatory activity	mouse	anandamide treatment	AEA differentil regulate the expression of miRNA	24699635
1479	Mouse	mmu-miR-151-3p	miRNA	schistosoma japonicum	liver fibrosis	serum exosomes	S. japonicum infection treatment	miR-151-3p was decresed on 6 weeks after S japonicum infection	32443549
1480	Mouse	mmu-miR-151-5p	miRNA	high fat diet (HFD)	erectile dysfunction (ED)	mouse	high fat diet (HFD) feed	dysregulated	25533598
1481	Mouse	mmu-miR-151a-3p	miRNA	deflazacort	inflammation	RAW 264.7 cells	deflazacort treatment	downregulated	32153563
1482	Mouse	mmu-miR-151a-3p	miRNA	lipopolysaccharide (LPS)	inflammation	RAW 264.7 cells	lipopolysaccharide (LPS) treatment	upregulated	32153563
1483	Mouse	mmu-miR-151a-3p	miRNA	prednisolone	inflammation	RAW 264.7 cells	lipopolysaccharide (LPS) treatment	downregulated	32153563
1484	Mouse	mmu-miR-152	miRNA	hypoxia	activation of hepatic stellate cells (HSCs)	hepatic stellate cells (HSCs)	hypoxia treatment	Hypoxia induces the activation of hepatic stellate cells through the PVT1-miR-152-ATG14 signaling pathway.	31893334
1485	Mouse	mmu-miR-152	miRNA	salvia-Nelumbinis naturalis (SNN)	anti-inflammatory responses	Kupffer cells were isolated from C57BL/6 mice and treated with LPS	SNN treatment	upregulated	28167852
1486	Mouse	mmu-miR-152	miRNA	high fat diet (HFD)	atherosclerosis (AS)	aortic tissues	high fat diet (HFD) feed	downregulated	30551500
1487	Mouse	mmu-miR-152	miRNA	high methionine diet	atherosclerosis (AS)	ApoE mice	high methionine diet	upregulated	28472596
1488	Mouse	mmu-miR-152	miRNA	oxidized low density lipoprotein (ox-LDL)	atherosclerosis (AS)	RAW264.7 cell	oxidized low-density lipoprotein (ox-LDL) treatment	downregulated	30551500
1489	Mouse	mmu-miR-152	miRNA	high glucose (HG)	diabetes mellitus (DM)	Freshly isolated mouse pancreatic islets	high glucose treatment	upregulated	30106118
1490	Mouse	mmu-miR-152	miRNA	progesterone (P4)	early embryonic development and implantation	mouse endometrial epithelium	progesterone treatment	upregulated	30668148
1491	Mouse	mmu-miR-152	miRNA	progesterone (P4)	endometrial cancer (EC)	endometrial epithelial cells (EECs)	P4 treatment	upregulated	28122483
1492	Mouse	mmu-miR-152	miRNA	high fat diet (HFD)	hepatic insulin resistance	liver	high fat diet (HFD) feed	downregulated	26996529
1493	Mouse	mmu-miR-152	miRNA	hypoxia	hepatic stellate cell (HSC) activation	primary mouse HSCs	hypoxia induce	downregulated	31893334
1494	Mouse	mmu-miR-152	miRNA	glucose	high glucose impairment	mouse NCTC 1469 hepatocytes and mouse primary hepatocytes	following exposure to 25 mM glucose for 48 h treatment	downregulated	25070263
1495	Mouse	mmu-miR-152	miRNA	DNA methyltransferase 1	liver fibrosis	liver	DNA methyltransferase 1 treatment	"miR-152 induced by Sal B, contributed to DNMT1 downregulated and epigenetically regulated PTCH1, resulting in the inhibition of EMT in liver fibrosis."	26257392
1496	Mouse	mmu-miR-152	miRNA	polyinosinic-polycytidilic acid (Poly(I:C))	myocardial infarction (MI)	neonatal cardiomyocytes	poly (I:C) treatment	upregulated	29358670
1497	Mouse	mmu-miR-152	miRNA	gemcitabine (GEM)	osteosarcoma (OS)	MG63 cells	gemcitabine treatment	miR-152 level was significantly reduced in MG63/DOX cells.	30661902
1498	Mouse	mmu-miR-152	miRNA	"dietary 3,3'-diindolylmethane (DIM)"	pancreatic cancer (PC)	athymic BALB/c nude mice injected with PANC-1 and PANC-28 tumor cells	diet containing 2000 ppm of Bio-DIM for 6w	upregulated	28659310
1499	Mouse	mmu-miR-152	miRNA	ischemia	renal fibrosis	Renal tissues	the left ureter was ligated at the lower pole level of kidney for 7 days	downregulated	28285987
1500	Mouse	mmu-miR-152	miRNA	ethanol (EtOH)	teratogenesis	fetal brains of mice	Ethanol?treatment	upregulated	19091803
1501	Mouse	mmu-miR-152-3p	miRNA	X-rays	bystander effect	C57BL/6 mice extracellular vesicles (EVs)	otal-body irradiated with X-rays	upregulated	28396668
1502	Mouse	mmu-miR-152-3p	miRNA	oxygen-glucose deprivation and reoxygenation (OGD/R)	ischemic stroke (IS)	Murine hippocampal HT22 neurons	oxygen-glucose deprivation and reoxygenation (OGD/R) treatment	downregulated	31326116
1503	Mouse	mmu-miR-153	miRNA	isoflurane	neurotoxicity	mouse neurocyte	isoflurane induce	"In isoflurane-induced mice, miRNA-153 expression was downregulated compared with in the control group. downregulated of miRNA-153 induced neurocyte apoptosis, reduced cell growth and promoted oxidative stress in an in vitro model."	30896808
1504	Mouse	mmu-miR-153	miRNA	high fat diet (HFD)	nonalcoholic fatty liver disease (NAFLD)	liver tissues	high fat diet (HFD) feed	upregulated	31889412
1505	Mouse	mmu-miR-153	miRNA	icariin (ICA)	osteoporosis	MC3T3-E1 cells	icariin treatment	upregulated	29904399
1506	Mouse	mmu-miR-153	miRNA	oxygen-glucose deprivation and reoxygenation (OGD/R)	oxygen-glucose deprivation/reoxygenation (OGD/R) injury	primary hippocampal neurons	oxygen-glucose deprivation and reoxygenation (OGD/R) treatment	upregulated	28245071
1507	Mouse	mmu-miR-153	miRNA	laparotomy and exposure of the junc_x0002_tion between the large and small intestines	sepsis	mouse large and small intestines	laparotomy and exposure of the junc_x0002_tion between the large and small intestines treatment	upregulated	25043848
1508	Mouse	mmu-miR-153	miRNA	mifepristone (MIF)	triple negative breast cancer (TNBC)	patient-derived xenografts in NOD-SCID mice	mifepristone (MIF) treatment	upregulation in tumors	26941846
1509	Mouse	mmu-miR-153	miRNA	bilobalide (BB)	type 1 diabetes mellitus (T1DM)	TNF-¦Á-treated MIN6 cells	Bilobalide (BB) treatment	upregulated	31667906
1510	Mouse	mmu-miR-153	miRNA	bilobalide (BB)	type 1 diabetes mellitus (T1DM)	MIN6 cells	Bilobalide (BB) treatment	MiR-153 expression was elevated by BB when induced by TNF-¦Á.	31667906
1511	Mouse	mmu-miR-153	miRNA	tumor necrosis factor alpha (TNF-¦Á) 	type 1 diabetes mellitus (T1DM)	MIN6 cells	tumor necrosis factor alpha (TNF-¦Á) treatment	downregulated	31667906
1512	Mouse	mmu-miR-153-3p	miRNA	isoprenaline	cardiac hypertrophy	primary cardiac myocytes	Isoprenaline (ISO) treatment	ISO promoted mitochondrial fission and enhanced the expression of miR-153-3p in cardiomyocytes.	31903137
1513	Mouse	mmu-miR-153-3p	miRNA	oxygen-glucose deprivation and reoxygenation (OGD/R)	cerebral ischemia/reperfusion (I/R) injury	primary mouse cerebral cortical neurons	oxygen-glucose deprivation and reoxygenation (OGD/R) treatment	downregulated	32912499
1514	Mouse	mmu-miR-154	miRNA	hyperoxia	bronchopulmonary dysplasia (BPD)	alveolar type 2 cells (AT2)	hyperoxia treatment	Hyperoxia treatment maintains high levels of miR-154 in alveolar type 2 cells (AT2).	32252341
1515	Mouse	mmu-miR-154	miRNA	ethanol (EtOH)	teratogenesis	fetal brains of mice	Ethanol?treatment	downregulated	19091803
1516	Mouse	mmu-miR-154-5p	miRNA	angiotensin II (Ang II)	cardiac remodeling	heart tissues	angiotensin II (Ang II) treatment	upregulated	31612078
1517	Mouse	mmu-miR-154-5p	miRNA	telmisartan	cardiac remodeling	Angiotensin II (AngII)-induced cardiomyocytes	telmisartan treatment	downregulated	31612078
1518	Mouse	mmu-miR-155	miRNA	trinitrobenzene sulfonic acid (TNBS)	colitis	colons and in cells of LNs	trinitrobenzene sulphonic acid (TNBS) treatment	upregulated	20143464
1519	Mouse	mmu-miR-155	miRNA	high tidal volume ventilation (HVTV)	lung injury	lung tissues	high tidal volume ventilation (HVTV) treatment	upregulated	22659882
1520	Mouse	mmu-miR-155	miRNA	IL-10	acquired Immune Deficiency Syndrome (AIDS)	TLR4-induced mouse B cells	IL-10 treatment	downregulated	25381386
1521	Mouse	mmu-miR-155	miRNA	monosodium urate (MSU)	acute gout	bone marrow-derived macrophages (BMDMs)	monosodium urate (MSU) treatment	MiR-155 expression was quickly upregulated in BMDMs from WT mice following MSU treatment in vitro.	29996893
1522	Mouse	mmu-miR-155	miRNA	chikusetsusaponin IVa (CsIVa)	acute inflammatory response	mouse liver; RAW264.7 cells	chikusetsusaponin IVa (CsIVa) treatment	"LPS induced high expression of miR-155, which was reversed by Chikusetsusaponin IVa (CsIVa)."	33110183
1523	Mouse	mmu-miR-155	miRNA	lipopolysaccharide (LPS)	acute inflammatory response	murine macrophages	lipopolysaccharide (LPS) treatment	upregulated	19596814
1524	Mouse	mmu-miR-155	miRNA	staphylococcal enterotoxin B (SEB)	acute inflammatory lung injury	lung	staphylococcal enterotoxin B treatment	upregulated	25564423
1525	Mouse	mmu-miR-155	miRNA	concanamycin A (Con A)	acute liver injury (ALI)	liver tissues	concanavalin A (ConA) treatment	upregulated	29420849
1526	Mouse	mmu-miR-155	miRNA	D-galactosamine/lipopolysaccharide (D-GalN/LPS)	acute liver injury (ALI)	liver tissues	D-GalN/LPS treatment	upregulated	31061003
1527	Mouse	mmu-miR-155	miRNA	lipopolysaccharide (LPS)	acute liver injury (ALI)	Raw264.7 cells	LPS treatment	upregulated	31061003
1528	Mouse	mmu-miR-155	miRNA	lipopolysaccharide (LPS)	acute lung injury (ALI)	murine alveolar macrophage cell line MH-S	Isoflurane treatment	downregulated	25553444
1529	Mouse	mmu-miR-155	miRNA	lipopolysaccharide (LPS)	acute lung injury (ALI)	bronchoalveolar lavage fluid (BALF)	lipopolysaccharide (LPS) treatment	upregulated	29863671
1530	Mouse	mmu-miR-155	miRNA	lipopolysaccharide (LPS)	acute lung injury (ALI)	bone marrow-derived lymphocytes	lipopolysaccharide (LPS) treatment	miR-155 expressed in bone marrow-derived lymphocytes promoted LPS-induced ALI through the modulation of the Ang-2-Tie-2 pathway.	30717971
1531	Mouse	mmu-miR-155	miRNA	lipopolysaccharide (LPS)	acute lung injury (ALI)	macrophages	lipopolysaccharide (LPS) treatment	upregulated	27371731
1532	Mouse	mmu-miR-155	miRNA	caerulein (Cae)	acute pancreatitis (AP)	pancreatic tissue	caerulein (Cae) treatment	upregulated	29937734
1533	Mouse	mmu-miR-155	miRNA	citrus aurantium L. dry extracts (CAde)	adipogenesis	3T3-L1 pre-adipocytes	Citrus aurantium L. dry extracts (CAde) treatment	downregulated	31654716
1534	Mouse	mmu-miR-155	miRNA	tumor necrosis factor alpha (TNF-¦Á) 	adipogenesis	3T3-L1 preadipocytes	tumor necrosis factor alpha (TNF-¦Á) treatment	upregulated	21986534
1535	Mouse	mmu-miR-155	miRNA	amyloid-¦Â (A¦Â) 1-40	age-related macular degeneration (AMD)	C57BL/6 mice eye tissues	amyloid-¦Â (A¦Â) 1-40 treatment	upregulated	28324113
1536	Mouse	mmu-miR-155	miRNA	acetaminophen (APAP)	alcoholic liver disease (ALD)	mouse liver tissues	acetaminophen(APAP) treatment	upregulated	22684891
1537	Mouse	mmu-miR-155	miRNA	alcohol	alcoholic liver disease (ALD)	liver tissue of mice	alcohol exposure	upregulated	21062749
1538	Mouse	mmu-miR-155	miRNA	alcohol	alcoholic liver disease (ALD)	liver tissues	alcohol exposure	upregulated	31090940
1539	Mouse	mmu-miR-155	miRNA	IL-33	allergic rhinitis (AR)	nasal mucosal	recombinant murine IL-33 treatment	upregulated	32946865
1540	Mouse	mmu-miR-155	miRNA	alogliptin	Alzheimer's disease (AD)	LPS-treated rats brain tissues	alogliptin treatment	downregulated	33125461
1541	Mouse	mmu-miR-155	miRNA	candida albicans (C. albicans)	Alzheimer's disease (AD)	mouse macrophages	candida albicans infection	upregulated	21060679
1542	Mouse	mmu-miR-155	miRNA	lipopolysaccharide (LPS)	Alzheimer's disease (AD)	brain tissues	lpopolysaccharide (LPS) treatment	upregulated	33125461
1543	Mouse	mmu-miR-155	miRNA	resveratrol	anti-adipogenic	3T3-L1 maturing pre-adipocytes	treat with 25 ¦ÌM of trans-resveratrol (RSV) treatment	upregulated	28953910
1544	Mouse	mmu-miR-155	miRNA	histone deacetylase inhibitors (HDIs) short-chain fatty acid (SCFA) butyrate	antibody-mediated systemic autoimmunity	B cells	SCFA HDI butyrate treatment	upregulated	32265934
1545	Mouse	mmu-miR-155	miRNA	"dimethyl fumarate (DMF) ,metabolite monomethyl fumarate (MMF)"	anti-inflammatory responses	primary astrocyte cultures derived from C57BL/6 mouse stimulated with IL-1¦Â	"pretreat with DMF, MMF"	downregulated	28589165
1546	Mouse	mmu-miR-155	miRNA	ginsenoside Rb1	anti-inflammatory responses	lipopolysaccharides (LPS) treated RAW264.7 cells	Ginsenoside Rb1 treatemnt	upregulated	28729651
1547	Mouse	mmu-miR-155	miRNA	lipopolysaccharide (LPS)	anti-inflammatory responses	mouse macrophage RAW 264.7 cells	lipopolysaccharide (LPS) treatment	upregulated	24689881
1548	Mouse	mmu-miR-155	miRNA	mycobacterium bovis bacille Calmette-Gu¨¦rin (BCG)	anti-mycobacterial response	RAW264.7 cells	BCG infection treatment	upregulated	24937178
1549	Mouse	mmu-miR-155	miRNA	mycobacterium tuberculosis (Mtb)	apoptosis	RAW264.7 cells	secreted antigenic target 6-kDa protein (ESAT-6) of Mycobacterium tuberculosis (Mtb)?treatment	upregulated	25721573
1550	Mouse	mmu-miR-155	miRNA	IL-33	asthma	type 2 innate lymphoid cells (ILC2s of wild-type (WT) mice	IL-33 treatment	upregulated	27492144
1551	Mouse	mmu-miR-155	miRNA	actinomycetemcomitans (Aa)	atherosclerosis (AS)	blood	actinomycetemcomitans (Aa) treatment	upregulated	25743474
1552	Mouse	mmu-miR-155	miRNA	cigarette smoke (CS)	atherosclerosis (AS)	aortic tissues of ApoE KO mice	cigarette smoke (CS) exposure	upregulated	29642385
1553	Mouse	mmu-miR-155	miRNA	conjugated linoleic acid (CLA)	atherosclerosis (AS)	aorta tissues	conjugated linoleic acid (CLA) treatment	1% cholesterol diet increased miR-155 expression while CLA blend supplementation decreased miR-155 expression in the aorta during atherosclerosis regression in vivo.	33391256
1554	Mouse	mmu-miR-155	miRNA	high fat diet (HFD)	atherosclerosis (AS)	apolipoprotein E knock-out (apoE) mice aortas	high fat diet (HFD) feed	upregulated	27856635
1555	Mouse	mmu-miR-155	miRNA	lipopolysaccharide (LPS)	atherosclerosis (AS)	RAW264.7 cells	lipopolysaccharide (LPS) treatment	upregulated	26823719
1556	Mouse	mmu-miR-155	miRNA	oxidized low density lipoprotein (ox-LDL)	atherosclerosis (AS)	RAW264.7 cells	oxidized low-density lipoprotein (ox-LDL) treatment	upregulated	26823719
1557	Mouse	mmu-miR-155	miRNA	oxidized low density lipoprotein (ox-LDL)	atherosclerosis (AS)	RAW264.7 cells	oxidized low-density lipoprotein (ox-LDL) treatment	upregulation	27843203
1558	Mouse	mmu-miR-155	miRNA	paeonol (PAE)	atherosclerosis (AS)	M1 macrophage	Paeonol treatment	"Paeonol significantly reduced the LPS and IFN-¦Ã-induced high expression of F4/80 and CD86, the secretion of inflammatory factors IL-6 and TNF-¦Á(P<005 or P<001), decreased the expression level of miR-155"	32495566
1559	Mouse	mmu-miR-155	miRNA	Shexiang Tongxin dropping pill (STDP)	atherosclerosis (AS)	serial transverse aortic sections	Shexiang Tongxin dropping pill (STDP) treatment	downregulated	25449459
1560	Mouse	mmu-miR-155	miRNA	Shexiang Tongxin dropping pill (STDP)	atherosclerosis (AS)	(ApoE(-/-)) mice aortic	STDP (30 mg/kg/day) on atherosclerotic lesions treatment	downregulated	25449459
1561	Mouse	mmu-miR-155	miRNA	high fat diet (HFD)	atherosclerosis (AS)	aortas	high fat diet (HFD) feed	upregulated	27856635
1562	Mouse	mmu-miR-155	miRNA	oxidized low density lipoprotein (ox-LDL)	atherosclerosis (AS)	vascular endothelial cells (VECs); vascular smooth muscle cells (VSMCs); RAW 264.7 cells	oxidized low-density lipoprotein (ox-LDL) treatment	miR-155 inhibits oxidized low-density lipoprotein-induced apoptosis in different cell models by targeting the p85¦Á/AKT pathway	32081664
1563	Mouse	mmu-miR-155	miRNA	lipopolysaccharide (LPS)	Dendritic cell (DC) maturation	?Mouse Monocyte	lipopolysaccharide (LPS) treatment	upregulated	24198819
1564	Mouse	mmu-miR-155	miRNA	concanamycin A (Con A)	autoimmune hepatitis (AIH)	liver tissues	concanavalin A (ConA) treatment	miR-155 was raised in liver tissues after 48 h exposure to ConA.	30290123
1565	Mouse	mmu-miR-155	miRNA	lipopolysaccharide (LPS)	autophagy	tibiae from LPS-injected mice and in osteoclasts (OC) stimulated by lipopolysaccharide (LPS)	lipopolysaccharides (LPS) treatment	upregulated	30144578
1566	Mouse	mmu-miR-155	miRNA	listeria monocytogenes (L. monocytogenes)	bacterial infection	brain tissues and microglia	Listeria monocytogenes infection	upregulated	30538705
1567	Mouse	mmu-miR-155	miRNA	bile acids	bile-containing gastroesophageal reflux	murine hypopharyngeal mucosa (HM)	bile acids treatment	upregulated	29529473
1568	Mouse	mmu-miR-155	miRNA	IFN-¦Á	biliary atresia (BA)	bile duct cells	IFN-¦Á treatment	upregulated	27817193
1569	Mouse	mmu-miR-155	miRNA	ischemia	blindness	retinal vascular networks	ischemia treatment	"Under ischemic conditions, dysregulated miR-155 and CCN1 expression increases the inflammatory load and microglial activation, prompting aberrant angiogenic responses"	26242736
1570	Mouse	mmu-miR-155	miRNA	selenium (Se)	bone infection or osteomyelitis	MC3T3-E1 cells	selenium treatment	downregulated	32511663
1571	Mouse	mmu-miR-155	miRNA	mycobacterium bovis bacille Calmette-Gu¨¦rin (BCG)	breast cancer	Murine macrophages	Mycobacterium bovis BCG infection	M. bovis BCG-driven miR-155 dictates cell fate decisions of infected macrophages	22473996
1572	Mouse	mmu-miR-155	miRNA	TGF-¦Â	breast cancer	normal murine mammary gland (NMuMG) epithelial cells	TGF-¦Â treatment	upregulated	18794355
1573	Mouse	mmu-miR-155	miRNA	lipopolysaccharide (LPS)	inflammation	Raw264.7£» HEK293T cell lines	lipopolysaccharide (LPS) treatment	upregulated	24362029
1574	Mouse	mmu-miR-155	miRNA	angiotensin II (Ang II)	cardiac hypertrophy	primary cardiomyocyte	angiotensin II (Ang II) treatment	"CYTOR knockdown reduced IKKi protein levels while activated NF-kB signaling pathway, whereas miR-155 inhibition exerted an opposing effect; the effect of CYTOR could be partially attenuated by miR-155 inhibition."	30794866
1575	Mouse	mmu-miR-155	miRNA	polysaccharide from the roots of Actinidia eriantha (AEPS)	cell activation	RAW264.7 macrophages	AEPS treatment	"miR-155 inhibitor significantly downregulated the mRNA expression of proinflammatory factors (IL-1¦Â, IL-6, COX-2 and NOS2), and blocked the production of NO in RAW2647 cell induced by AEPS"	30914371
1576	Mouse	mmu-miR-155	miRNA	hypoxia	cerebral ischemia injury (CII)	N2a cells	oxygen-glucose deprivation/reoxygenation (OGD/R) induce	upregulated	29951932
1577	Mouse	mmu-miR-155	miRNA	minocycline (MNC)	cerebral ischemia injury (CII)	oxygen-glucose deprivation/reoxygenation (OGD/R) induced N2a cells	Minocycline treatment	downregulated	29951932
1578	Mouse	mmu-miR-155	miRNA	helicobacter pylori (H. pylori)	chronic gastritis and colitis	gastric mucosa of?mice	Helicobacter pylori infection	upregulated	21880981
1579	Mouse	mmu-miR-155	miRNA	hypoxia	chronic kidney disease (CKD)	renal tissues	chronic intermittent hypoxia (CIH) treatment	upregulated	29953588
1580	Mouse	mmu-miR-155	miRNA	cigarette smoke extract (CSE)	chronic obstructive pulmonary disease (COPD)	lung tissues; alveolar macrophages	cigarette smoke extract (CSE) exposure	upregulated	31819170
1581	Mouse	mmu-miR-155	miRNA	IL-10	clinical inflammatory lung disease	BAL cells and splenocytes	IL-10¨Csecreting M2-like macrophages	"we report that C/EBPb, a target molecule of miR-155, was upregulated and associated with IL-10 secretion and M2-like phenotype of macrophages"	23514739
1582	Mouse	mmu-miR-155	miRNA	dextran sodium sulfate (DSS)	colitis	colon tissues	dextran sodium sulfate (DSS) treatment	upregulated	29867475
1583	Mouse	mmu-miR-155	miRNA	dextran sodium sulfate (DSS)	colitis	colon tissues	dextran sulfate sodium (DSS) treatment	upregulated	33770552
1584	Mouse	mmu-miR-155	miRNA	dextran sodium sulfate (DSS)	colitis	C57BL/6J mice colonic tissue	dextran-sulfate-sodium (DSS) treatment	upregulated	28752563
1585	Mouse	mmu-miR-155	miRNA	Lactobacillus fermentum (L. fermentum)	colitis	C57BL/7J mice colonic tissues	infect with L. fermentum	downregulated	28752563
1586	Mouse	mmu-miR-155	miRNA	pristimerin	colitis	DSS-induced colitis mice colon tissues	pristimerin (Pris) treatment	downregulated	33770552
1587	Mouse	mmu-miR-155	miRNA	probiotic Escherichia coli Nissle 1917 (EcN)	colitis	dextran sodium sulfate (DSS)-induced colitis mouse colon tissues	probiotic Escherichia coli Nissle 1917 (EcN) treatment	downregulated	29867475
1588	Mouse	mmu-miR-155	miRNA	ionizing radiation (IR)	colorectal cancer (CRC)	murine lymphocytes	ionizing radiation?treatment	upregulated	23496831
1589	Mouse	mmu-miR-155	miRNA	IL-10	colonic inflammation	colonic intraepithelial lymphocytes	IL-10 treatment	downregulated	22043014
1590	Mouse	mmu-miR-155	miRNA	azoxymethane (AOM)	colorectal cancer (CRC)	plasma and colon tissues	azoxymethane (AOM) treatment	upregulated	30311185
1591	Mouse	mmu-miR-155	miRNA	lactobacillus acidophilus and bifidobacterium bifidum probiotics	colorectal cancer (CRC)	plasma and colon tissues from azoxymethane (AOM)-treated mice	Lactobacillus acidophilus and Bifidobacterium bifidum probiotics treatment	downregulated	30311185
1592	Mouse	mmu-miR-155	miRNA	"1,25-dihydroxyvitamin D 3 (calcitriol)"	coronary heart disease (CHD)	"HEK293T, L929 and RAW264.7 cells"	"1,25-dihydroxyvitamin D 3 (calcitriol) treatment"	downregulated	23436936
1593	Mouse	mmu-miR-155	miRNA	dengue virus (DENV)	dengue virus (DENV) infection	brain tissues	dengue virus (DENV) infection	miR-155 was time-dependently downregulated upon dengue virus (DENV) infection.	32277848
1594	Mouse	mmu-miR-155	miRNA	streptozocin (STZ)	diabetes mellitus (DM)	"kidney, heart, PBMCs"	streptozotocin (STZ) treatment	downregulated	25929727
1595	Mouse	mmu-miR-155	miRNA	high glucose (HG)	diabetic nephropathy (DN)	podocytes	high glucose (HG) treatment	"miRNA-155 was found to be highly expressed in serum and kidney tissue of mice with diabetic nephropathy and in cultured podocytes,"	33748285
1596	Mouse	mmu-miR-155	miRNA	[6]-gingerol-fractions (GF)	diabetic wound healing	diabetic skin wounds	[6]-gingerol-fractions (GF) treatment	downregulated	31428171
1597	Mouse	mmu-miR-155	miRNA	vitamin D	diabetic wound healing	diabetic skin wounds	vitamin D treatment	downregulated	31428171
1598	Mouse	mmu-miR-155	miRNA	adiponectin	metabolic processes	RAW 264.7 cells	adiponectin (ApN) treatment	upregulated	24084329
1599	Mouse	mmu-miR-155	miRNA	pristane (PS)	diffuse alveolar hemorrhage (DAH)	lung	pristane treatment	upregulated	26556607
1600	Mouse	mmu-miR-155	miRNA	IFN-¦Ã	inflammation	DJ-1-KO cells	IFN-¦Ã treatment	upregulated	24963279
1601	Mouse	mmu-miR-155	miRNA	cyclophosphamide	embryonic maldevelopment	the fore- and hindlimbs of mice	cyclophosphamide treatment	downregulated	20170545
1602	Mouse	mmu-miR-155	miRNA	kainic acid (KA)	epilepsy	brain tissues	kainic acid (KA) treatment	upregulated	30928987
1603	Mouse	mmu-miR-155	miRNA	progesterone (P4)	epithelial-mesenchymal transition (EMT)	The murine macrophage cell line RAW264.7	progesterone treatment	"progesterone suppresses TLRs-triggered immune response by regulating miR-155, and the decreased miR-155 contributes to inhibit TLR-induced IL-6 and IFN-¦Â via increased SOCS1 expression"	22546503
1604	Mouse	mmu-miR-155	miRNA	IL-10	epithelial-mesenchymal transition (EMT)	colonic intraepithelial lymphocytes	IL-10 treatment	upregulated	22043014
1605	Mouse	mmu-miR-155	miRNA	ethanol (EtOH) and burn injury	ethanol and burn injury	mouse T cells	ethanol and burn injury treatment	downregulated	25126745
1606	Mouse	mmu-miR-155	miRNA	lipopolysaccharide (LPS)	experimental autoimmune prostatitis (EAP)	prostatic tissues	lipopolysaccharide (LPS) treatment	LPS enhanced the upregulation of miR-155.	32436368
1607	Mouse	mmu-miR-155	miRNA	staphylococcal enterotoxin B (SEB)	food poisoning	lung	exposure to SEB treatment	upregulated	24778118
1608	Mouse	mmu-miR-155	miRNA	helicobacter pylori (H. pylori)	gastric MALT lymphoma (GML)	GML-developing d3Tx mice stomachs	infect with H. pylori	upregulated	28560185
1609	Mouse	mmu-miR-155	miRNA	influenza virus	H9N2 influenza virus infection	Dendritic cells (DCs)	H9N2 avian influenza virus (H9N2 AIV) treatment	upregulated	27285980
1610	Mouse	mmu-miR-155	miRNA	vitamin C loaded human serum albumin (HSA) nanoparticles	healing of wounds	3T3 fibroblast cells	vitamin C loaded human serum albumin (HSA) nanoparticles treatment	downregulated	31035807
1611	Mouse	mmu-miR-155	miRNA	CoCl2	heart failure (HF)	cardiac stem cells (CSCs)	CoCl2 treatment	downregulated	30362213
1612	Mouse	mmu-miR-155	miRNA	hepatitis B virus (HBV)	hepatitis B virus (HBV) infection	RAW264.7 cells	HBsAg treatment	upregulated	29349567
1613	Mouse	mmu-miR-155	miRNA	high fat diet (HFD)	hepatocellular carcinoma (HCC)	plasma and hepatic tissues	high fat diet (HFD) feed	upregulated	26728044
1614	Mouse	mmu-miR-155	miRNA	norcantharidin (NCTD)	hepatocellular carcinoma (HCC)	liver tissues	intraperitoneal injection of different concentration of NCTD treatment	upregulated	24719559
1615	Mouse	mmu-miR-155	miRNA	dextran sodium sulfate (DSS)	humoral autoimmune intestinal injury	Foxp3+ Treg cells	dextran sulfate sodium (DSS) treatment	upregulated	30927737
1616	Mouse	mmu-miR-155	miRNA	IL-10	immune response	mouse bone marrow-derived mast cells (BMMC)	IL-10 treatment	upregulated	27183599
1617	Mouse	mmu-miR-155	miRNA	streptococcus pneumoniae Endopeptidase O (PepO)	pneumococcal diseases	peritoneal exudate macrophages (PEMs)	PepO treatment	upregulated	28193634
1618	Mouse	mmu-miR-155	miRNA	corticosterone	immune response	100 ng/ml BAFF and 100 ng/ml IL4 in-vitro-induced germinal center B cells	corticosterone (CORT) treatment	downregulated	30414952
1619	Mouse	mmu-miR-155	miRNA	either yeasts or hyphal forms of Candida albicans	immune response	murine bone marrow-derived macrophages (BMDMs)	either yeasts or hyphal forms of Candida albicans	upregulated	27294852
1620	Mouse	mmu-miR-155	miRNA	granulocyte-macrophage colony stimulating factor (GM-CSF) and IL-6	immune response	bone marrow cells	GM-CSF£¬ IL-6 treatment	upregulated	24391219
1621	Mouse	mmu-miR-155	miRNA	TGF-¦Â	immune response	bone marrow cells and spleen MDSC	TGF-¦Â treatment	upregulated	24391219
1622	Mouse	mmu-miR-155	miRNA	aflatoxin M1?(AFM1)	immunotoxicity	isolated T cells from spleens of mice	aflatoxin M1?(AFM1)?exposure	downregulated	30739504
1623	Mouse	mmu-miR-155	miRNA	"(R)-2-isobutyl 3-methyl 3,4-dihydro-1H-pyrido[3,4-b]indole-2,3(9H)-dicarboxylate"	inflammation	lipopolysaccharide (LPS)-stimulated RAW 264.7 cells	"(R)-2-isobutyl 3-methyl 3,4-dihydro-1H-pyrido[3,4-b]indole-2,3(9H)-dicarboxylate treatment"	downregulated	24299616
1624	Mouse	mmu-miR-155	miRNA	alcohol	inflammation	mouse	chronic alcohol administration	upregulated	28584078
1625	Mouse	mmu-miR-155	miRNA	CTB-UE	inflammation	H. pylori-induced gastric mouse	CTB-UE treatment	upregulated	25483699
1626	Mouse	mmu-miR-155	miRNA	curcumin (Cur)	inflammation	LPS-induced Raw264.7	curcumin treatment	downregulated	28264607
1627	Mouse	mmu-miR-155	miRNA	heat stress	inflammation	BV-2 microglial cells (BV-2 cells)	heat stress treatment	upregulated	30778287
1628	Mouse	mmu-miR-155	miRNA	high fat diet (HFD)	inflammation	ApoE-/- mice vessel segments	high fat diet (HFD) feed	upregulated	30765689
1629	Mouse	mmu-miR-155	miRNA	lactoferrin (LF)	inflammation	lipopolysaccharide (LPS)-treated RAW264.7 cells	Lactoferrin treatment	"?LF could induce a decrease in inflammatory selected miRNAs,?mmu-mir-155, and?mmu-mir-146a expression."	33435756
1630	Mouse	mmu-miR-155	miRNA	"limonin, (12S,12aS,Z)-8-((2-(diethylamino)ethoxy)imino)-12-(furan-3-yl)-6,6,8a,12a-tetramethyldodecahydro-1H,3H-oxireno[2,3-d]pyrano[4',3':3,3a]isobenzofuro[5,4-f]isochromene-3,10(9aH)-dione (V-A-4)"	inflammation	lipopolysaccharide (LPS)-stimulated RAW264.7 cells	"limonin, (12S,12aS,Z)-8-((2-(diethylamino)ethoxy)imino)-12-(furan-3-yl)-6,6,8a,12a-tetramethyldodecahydro-1H,3H-oxireno[2,3-d]pyrano[4',3':3,3a]isobenzofuro[5,4-f]isochromene-3,10(9aH)-dione (V-A-4) treatment"	upregulated	29477914
1631	Mouse	mmu-miR-155	miRNA	lipopolysaccharide (LPS)	inflammation	mice Bone marrow macrophage cells	LPS treatment	LPS induces KH-type splicing regulatory protein-dependent processing of microRNA-155 pre-cursors in macrophages	19423639
1632	Mouse	mmu-miR-155	miRNA	lipopolysaccharide (LPS)	inflammation	mouse macrophages	lipopolysaccharide (LPS) treatment	upregulated	29133016
1633	Mouse	mmu-miR-155	miRNA	lipopolysaccharide (LPS)	inflammation	"the BV2 cells, primary microglia and the mouse cortex"	lipopolysaccharide (LPS) treatment	upregulated	29805490
1634	Mouse	mmu-miR-155	miRNA	lipopolysaccharide (LPS)	inflammation	Raw264.7 cells	lipopolysaccharide (LPS) treatment	upregulated	29854576
1635	Mouse	mmu-miR-155	miRNA	lipopolysaccharide (LPS)	inflammation	bone marrow-derived macrophages (BMDMs)	lipopolysaccharide (LPS) treatment	upregulated	30721702
1636	Mouse	mmu-miR-155	miRNA	lipopolysaccharide (LPS)	inflammation	BV-2 microglial cells	lipopolysaccharide (LPS) treatment	upregulated	30720115
1637	Mouse	mmu-miR-155	miRNA	oxidized low density lipoprotein (ox-LDL)	inflammation	RAW264.7 cells	oxidized low-density lipoprotein (ox-LDL) treatment	upregulated	28871950
1638	Mouse	mmu-miR-155	miRNA	oxidized low density lipoprotein (ox-LDL)	inflammation	RAW264.7 macrophages	oxidized low-density lipoprotein (ox-LDL) treatment	upregulated	29977930
1639	Mouse	mmu-miR-155	miRNA	tremella fuciformis polysaccharides (TFPS)	inflammation	LPS-treated Raw264.7 cells	Tremella fuciformis polysaccharides (TFPS)treatment treatment	downregulated	29854576
1640	Mouse	mmu-miR-155	miRNA	tumor necrosis factor alpha (TNF-¦Á) 	inflammation	Vascular smooth muscle cells (VSMCs)	tumor necrosis factor alpha (TNF-¦Á) treatment	upregulated	30765689
1641	Mouse	mmu-miR-155	miRNA	¦Á-mangostin	inflammation	macrophages	¦Á-mangostin treatment	downregulated	31806859
1642	Mouse	mmu-miR-155	miRNA	herpes simplex virus 1 (HSV-1)	inflammation and innate immunity	mouse brain tissue	infect with HSV-1	upregulated	28045967
1643	Mouse	mmu-miR-155	miRNA	"1,25-dihydroxyvitamin D (1,25(OH)2D)"	inflammation	3T3-L1 adipocytes; epididymal adipose tissue	"1,25-dihydroxyvitamin D (1,25(OH)2D) treatment"	downregulated	28055298
1644	Mouse	mmu-miR-155	miRNA	praziquantel (PZQ)	inflammation	mouse liver	schistosomiasis treatment	increase in the PZQ-ed mice compared to the 12W infected mice	25051829
1645	Mouse	mmu-miR-155	miRNA	influenza A virus (IAV)	inflammation	C57BL/6 mice lung	infect with influenza A/PR/8/34	upregulated	28193481
1646	Mouse	mmu-miR-155	miRNA	high fat diet (HFD)	obesity	C57BL/6J mice	high fat diet (HFD) feed	downregulated	28652200
1647	Mouse	mmu-miR-155	miRNA	dextran sodium sulfate (DSS)	inflammatory bowel disease (IBD)	colon tissues	dextran sodium sulfate (DSS) treatment	miR-155 expression was increased 4.74-fold in DSS-induced colon tissues compared with that in normal controls.	32713852
1648	Mouse	mmu-miR-155	miRNA	dextran sodium sulfate (DSS)	inflammatory bowel disease (IBD)	colon tissues	dextran sulfate sodium (DSS) treatment	upregulated	30236870
1649	Mouse	mmu-miR-155	miRNA	apigenin	inflammatory diseases	lungs from LPS-treated mice	dietary apigenin treatment	downregulated	25641956
1650	Mouse	mmu-miR-155	miRNA	resveratrol	inflammatory diseases	LPS-stimulated RAW264.7 murine macrophages	resveratrol (RS) treatment	downregulated	28004106
1651	Mouse	mmu-miR-155	miRNA	Sinomenine (SIN)	inflammatory diseases	RAW264.7 cells	Sinomenine (SIN) treatment	"SIN treatment significantly reduced LPS-induced inflammatory cytokine release, suppressed the expression of miR-155"	32116077
1652	Mouse	mmu-miR-155	miRNA	resveratrol	inflammatory response	lipopolysaccharide (LPS)-stimulated RAW264.7 murine macrophages	resveratrol (RS) treatment	downregulated	28004106
1653	Mouse	mmu-mir-155	miRNA	IL-10	inflammatory response	RAW264.7 cells	IL-10 treatment	upregulated	32324763
1654	Mouse	mmu-miR-155	miRNA	dexamethasone (DEX)	inflammatory therapeutics	Raw264.7 cells	dexamethasone (Dex) treatment	Dexamethasone decreased expression of pro-inflammatory microRNA-155 in exosomes from LPS-induced RAW264.7 macrophages.	31949716
1655	Mouse	mmu-miR-155	miRNA	cannabinoids	innate immune response	LPS-treated BV-2 microglial cells	cannabinoids treatment	downregulated	30742662
1656	Mouse	mmu-miR-155	miRNA	lipopolysaccharide (LPS)	inner ear inflammatory	scala tympani	LPS was injected directly into treatment	upregulated	24470395
1657	Mouse	mmu-miR-155	miRNA	alcohol	intestinal inflammation and barrier dysfunction	mouse	acute binge and chronic alcohol feeding in the small bowel (SB) in mice treatment	upregulated	25156614
1658	Mouse	mmu-miR-155	miRNA	dexamethasone (DEX)	intracerebral haemorrhage (ICH)	astrocytes	dexamethasone (DEX) treatment	downregulated	27601160
1659	Mouse	mmu-miR-155	miRNA	hypoxia	ischemic stroke (IS)	mouse brain tissues	middle cerebral artery occlusion (MCAO)	miR-155 is a direct target of lncRNA Oprm1. lncRNA Oprm1/miR-155/GATA3 axis plays an important role in cerebral I/R injury.	31187646
1660	Mouse	mmu-miR-155	miRNA	oxygen-glucose deprivation and reoxygenation (OGD/R)	ischemic stroke (IS)	N2a cells	oxygen-glucose deprivation and reoxygenation (OGD/R) treatment	miR-155 is a direct target of lncRNA Oprm1 lncRNA Oprm1/miR-155/GATA3 axis plays an important role in cerebral I/R injury	31187646
1661	Mouse	mmu-miR-155	miRNA	gualou guizhi decoction (GLGZD)	ischemic brain injury	BV2 cells	GuaLou GuiZhi Decoction (GLGZD) treatment	GuaLou GuiZhi Decoction (GLGZD) might exert its anti-inflammatory action by inhibiting the expression of miR-155.	32173634
1662	Mouse	mmu-miR-155	miRNA	CoCl2	ischemic heart disease (IHD)	cardiac stem cells (CSCs)	CoCl 2 treatment	A dose-dependent decrease of miR-155 expression in CSCs treated with CoCl2.	30362213
1663	Mouse	mmu-miR-155	miRNA	Japanese encephalitis virus (JEV)	Japanese encephalitis virus (JEV) infection	brain tissues	infect with JEV treatment	upregulated	24522920
1664	Mouse	mmu-miR-155	miRNA	deoxycorticosterone acetate (DOCA)	kidney damage	hypertensive mice kidneys and urine	injection of Deoxycorticosterone acetate (Doca)	upregulated in the kidneys and urine	29255279
1665	Mouse	mmu-miR-155	miRNA	lipopolysaccharide (LPS)	kidney damage	mouse renal tissues	intraperitoneally injected with LPS	upregulated in renal tissues	31966808
1666	Mouse	mmu-miR-155	miRNA	leishmania	leishmaniasis	"the liver and J774 macrophages, and in spleens from infected mice"	Leishmania infection	upregulated	29943317
1667	Mouse	mmu-miR-155	miRNA	quercetin-3-glucuronide (Q3G)	leukemia	RAW264.7 macrophages	quercetin-3-glucuronide (Q3G) treatment	downregulated	20579867
1668	Mouse	mmu-miR-155	miRNA	dietary methyl deficiency	hepatocellular carcinoma (HCC)	the liver tissues	Dietary methyl deficiency treatment	upregulated	20436259
1669	Mouse	mmu-miR-155	miRNA	acetaminophen (APAP)	liver damage	liver£¬blood	acetaminophen (APAP) treatment	upregulated	27673475
1670	Mouse	mmu-miR-155	miRNA	Triggering receptors expressed on myeloid cell-1 (TREM-1)	liver fibrosis	macrophages and lungs	Triggering receptors expressed on myeloid cell-1 (TREM-1) knockout treatment	downregulated	26684249
1671	Mouse	mmu-miR-155	miRNA	"(R)-2-isobutyl 3-methyl 3,4-dihydro-1H-pyrido[3,4-b]indole-2,3(9H)-dicarboxylate"	liver fibrosis	RAW 264.7 cells	"(R)-2-isobutyl 3-methyl 3,4-dihydro-1H-pyrido[3,4-b]indole-2,3(9H)-dicarboxylate (1) treatment"	downregulated	24299616
1672	Mouse	mmu-miR-155	miRNA	leishmania RNA virus 1 (LRV1)	leishmania RNA virus 1 (LRV1) infection	macrophage of naive mice	leishmania RNA virus 1 (LRV1) treatment	upregulated	27593513
1673	Mouse	mmu-miR-155	miRNA	binase	lymphosarcoma	RLS40 cells	binase treatment	downregulated	33147876
1674	Mouse	mmu-miR-155	miRNA	lipopolysaccharide (LPS)	macrophage inflammatory response	RAW264.7 macrophage cells	lipopolysaccharide (LPS) treatment	upregulated	22415194
1675	Mouse	mmu-miR-155	miRNA	cypermethrin (CYM)	macrophage polarization	LPS-treated RAW264.7 cells	Cypermethrin (CYM) treatment	downregulated	29471534
1676	Mouse	mmu-miR-155	miRNA	IFN-¦Ã and lipopolysaccharide (LPS)	macrophage polarization	RAW264.7 cells	LPS/IFN-¦Ã treatment	upregulated	30384539
1677	Mouse	mmu-miR-155	miRNA	IL-4 and IL-13	macrophage polarization	RAW264.7 cells	IL-4 and IL-13 treatment	downregulated	30384539
1678	Mouse	mmu-miR-155	miRNA	lipopolysaccharide (LPS)	macrophage polarization	RAW264.7 cells	lipopolysaccharide (LPS) treatment	upregulated	29471534
1679	Mouse	mmu-miR-155	miRNA	the fraction of Hedyotis diffusa and Scutellaria barbata herb couple(YDW11)	macrophage polarization	LPS/IFN-¦Ã-induced M1 macrophage (RAW264.7 cells)	the fraction of Hedyotis diffusa and Scutellaria barbata herb couple(YDW11) treatment	downregulated	30384539
1680	Mouse	mmu-miR-155	miRNA	the fraction of Hedyotis diffusa and Scutellaria barbata herb couple(YDW11)	macrophage polarization	IL-4/IL-13-induced M2 macrophage (RAW264.7 cells)	the fraction of Hedyotis diffusa and Scutellaria barbata herb couple(YDW11) treatment	upregulated	30384539
1681	Mouse	mmu-miR-155	miRNA	genetically attenuated parasites (GAP) that arrest in the liver	malaria	mouse liver	GAP-injected mice treatment	upregulated	25189739
1682	Mouse	mmu-miR-155	miRNA	selenium (Se)	mastitis	Staphylococcus aureus (S. aureus)-infected mouse mammary tissues and primary mouse mammary epithelial cells (MMECs)	Selenium (Se) supplementation treatment	downregulated	31545328
1683	Mouse	mmu-miR-155	miRNA	Staphylococcus aureus	mastitis	mouse mammary tissues and primary mouse mammary epithelial cells (MMECs)	Staphylococcus aureus (S. aureus) infection treatment	upregulated	31545328
1684	Mouse	mmu-miR-155	miRNA	lipopolysaccharide (LPS)	microglial activation	N9 microglial cells	lipopolysaccharide (LPS) treatment	upregulated	29410668
1685	Mouse	mmu-miR-155	miRNA	sulforaphane (SFN)	microglial activation	LPS-treated N9 microglial cells	Sulforaphane (SFN) treatment	downregulated	29410668
1686	Mouse	mmu-miR-155	miRNA	murine norovirus (MNV)	murine norovirus (MNV) infection	bone marrow derived macrophage (BMDM); RAW264.7 cells; BV-2 cells; caecum; colon tissues	murine norovirus (MNV) infection	downregulated	29900416
1687	Mouse	mmu-miR-155	miRNA	dexamethasone (DEX)	muscle atrophy	Murine C2C12 myoblast cells	dexamethasone (DEX) treatment	upregulated	23716137
1688	Mouse	mmu-miR-155	miRNA	sevoflurane (SEV)	myocardial ischemia/reperfusion (I/R) injury (MIRI)	myocardial tissues	sevoflurane treatment	"The treatment of sevoflurane could reduce miR-155 expression and increased SIRT1 expression in the myocardial tissues, under which conditions, cardiac functions were promoted, accompanied by reduced infarct size and inhibited cardiomyocyte apoptosis"	31099069
1689	Mouse	mmu-miR-155	miRNA	3-acetyl-11-keto-¦Â-boswellic acid (AKBA) and dexamethasone (DEX)	neuroinflammation	brain tissues	3-acetyl-11-keto-¦Â-boswellic acid (AKBA) and dexamethasone (DEX) treatment	"The treatment of LPS-injected mice with either AKBA or DEX led to a signif- icant decrease in the relative miR-155 expression by 2.52 ¡À 0.33 and 3.78 ¡À 0.44, respectively, compared to LPS group."	29079998
1690	Mouse	mmu-miR-155	miRNA	lipopolysaccharide (LPS)	neuroinflammation	N9 microglia	lipopolysaccharide (LPS) treatment	upregulated	28096568
1691	Mouse	mmu-miR-155	miRNA	lipopolysaccharide (LPS)	neuroinflammation	BV2 microglia	lipopolysaccharides (LPS) treatment	upregulated	28875362
1692	Mouse	mmu-miR-155	miRNA	propofol (PPF)	neuroinflammation	LPS-treated BV2 microglia	Propofol treatment	downregulated	28875362
1693	Mouse	mmu-miR-155	miRNA	lipopolysaccharide (LPS)	neuroinflammation	mouse brain tissues	lipopolysaccharide (LPS) treatment	upregulated in the brain	29079998
1694	Mouse	mmu-miR-155	miRNA	alcohol	neuronal survival and neurite growth	primary or immortalized mouse microglia	alcohol exposure	upregulated	23951048
1695	Mouse	mmu-miR-155	miRNA	lipopolysaccharide (LPS)	neuropathic pain (NP)	BV-2 cells	lipopolysaccharide (LPS) treatment	"LPS induced M1 polarization in BV-2 cells with increasing of CD86, iNOS and miR-155."	32337959
1696	Mouse	mmu-miR-155	miRNA	phorbol-12-myristate-13-acetate(PMA)	neutrophil extracellular traps (NETs) generation	Neutrophils were separated from bone marrow cells	PMA treatment	upregulated	31736940
1697	Mouse	mmu-miR-155	miRNA	lipopolysaccharide (LPS)	acute respiratory distress syndrome (ARDS)	lung tissues	lipopolysaccharide (LPS) treatment	upregulated	26684249
1698	Mouse	mmu-miR-155	miRNA	green tea (GT)	obesity	adipose tissues	green tea (GT) treatment	GT reverses HFD-induced upregulated of miR-155 and -335 in epididymal adipose tissues.	29734116
1699	Mouse	mmu-miR-155	miRNA	high fat diet (HFD)	obesity	macrophage	high fat diet (HFD) feed	upregulated	27671445
1700	Mouse	mmu-miR-155	miRNA	high fat diet (HFD)	obesity	nucleus accumbens	high fat diet (HFD) feed	Significant reductions in the levels of miR-155 (82%) and miR-146a (41%) levels were observed within the nucleus accumbens of HFD mice compared to CTL.	28652200
1701	Mouse	mmu-miR-155	miRNA	high fat diet (HFD)	obesity	renal tissues	high fat diet (HFD) feed	upregulated	30715692
1702	Mouse	mmu-miR-155	miRNA	palmitic acid (PA)	obesity	The mouse renal microvascular endothelial cells (MECs)	palmitic acid (PA) treatment	upregulated	30715692
1703	Mouse	mmu-miR-155	miRNA	P. aeruginosa	ocular infection	Eight-week-old female C3H/HeJ mice corneas tissues	infect with ?P. aeruginosa treatment	?miR-155 expression was upregulated	24403554
1704	Mouse	mmu-miR-155	miRNA	tumor necrosis factor alpha (TNF-¦Á) 	osteoclast differentiation	RAW264.7 cells	tumor necrosis factor alpha (TNF-¦Á) treatment	upregulated	23078176
1705	Mouse	mmu-miR-155	miRNA	IFN-¦Â	osteoclast-mediated diseases	Murine macrophage cell line RAW26	Interferon-¦Â treatment	upregulated	22771905
1706	Mouse	mmu-miR-155	miRNA	alendronate	osteoporosis	Osteoporosis mice osteoclasts	alendronate treatment	downregulated	31317664
1707	Mouse	mmu-miR-155	miRNA	manganese (Mn)	oxidative stress	neuronal CATH.a cell line	Mn treatment	downregulated	30090472
1708	Mouse	mmu-miR-155	miRNA	P. gingivalis	P. gingivalis infection	ApoE mice heart and aorta tissues	infect with P. gingivalis treatment	upregulated	28646427
1709	Mouse	mmu-miR-155	miRNA	tanshinone IIA (Tan IIA)	P. gingivalis infection	ApoE mice serum and in heart	TSA (60 mg kg-/--/--1 day-1) treatment	downregulated	28646427
1710	Mouse	mmu-miR-155	miRNA	F. novicida	pancreatic cancer (PC)	L929 cells	F. novicida?infection	downregulated	20041145
1711	Mouse	mmu-miR-155	miRNA	tumor necrosis factor alpha (TNF-¦Á) 	periodontitis	OCCM-30 cells	tumor necrosis factor alpha (TNF-¦Á) treatment	upregulated	28692806
1712	Mouse	mmu-miR-155	miRNA	lipopolysaccharide (LPS)	peripheral and CNS inflammation	primary murine microglia	lipopolysaccharide (LPS) treatment	upregulated	26134658
1713	Mouse	mmu-miR-155	miRNA	particulate matter (PM2.5)	PM2.5 exposure	mosue bronchoalveolar lavage fluid (BALF)	"were subjected to intratracheal instillation of 2.5, 10, or 20mg/kg PM2.5 treatment"	upregulated in bronchoalveolar lavage fluid (BALF)	29107863
1714	Mouse	mmu-miR-155	miRNA	cecal ligation and puncture (CLP)	polymicrobial sepsis	C57Bl/6 mice	cecal ligation and puncture (CLP) treatment	different regulation	24413579
1715	Mouse	mmu-miR-155	miRNA	dexamethasone (DEX)	preadipocyte differentiation	3T3-L1 preadipocytes	dexamethasone (Dex) treatment	miR-155 levels were upregulated (2.4-fold) by glucocorticoids in differentiating 3T3-L1 preadipocytes.	29352275
1716	Mouse	mmu-miR-155	miRNA	salmonella	programmed cell death	RAW 264.7 cells	salmonella treatment	upregulated	29608690
1717	Mouse	mmu-miR-155	miRNA	pseudomonas aeruginosa (PA)	pseudomonas aeruginosa lung infection	sorted lung macrophages	RP73 clinical strain of P. aeruginosa infection treatment	downregulated	28422188
1718	Mouse	mmu-miR-155	miRNA	resolvin D1 (RvD1)	pseudomonas aeruginosa lung infection	sorted lung macrophages from RP73 clinical strain of P. aeruginosa infected mouse	resolvin (Rv) D1 treatment	upregulated	28422188
1719	Mouse	mmu-miR-155	miRNA	particulate matter (PM2.5)	pulmonary toxicological	lung tissues	particulate matter (PM2.5) exposure treatment	upregulated	29107863
1720	Mouse	mmu-miR-155	miRNA	photo-oxidative damage (PD)	retinal degenerative diseases	retinal tissues; serum	photo-oxidative damage (PD) treatment	"Upregulation of miR-155 was detected in retinal tissue, serum and s-mEVs in response to photo-oxidative damage, localising to the nucleus of a subset of retinal ganglion cells and glial cells and in the cytoplasm of photoreceptors"	33037565
1721	Mouse	mmu-miR-155	miRNA	schistosoma japonicum	schistosomiasis	murine liver	Schistosoma japonicum infection treatment	upregulated	23825609
1722	Mouse	mmu-miR-155	miRNA	schistosomiasis	schistosomiasis liver inflammation	mouse liver tissues	schistosomiasis treatment	6W infected mice were significantly higher than those of the normal mice and of the 12W infected mice	25051829
1723	Mouse	mmu-miR-155	miRNA	lipopolysaccharide (LPS)	scleroderma fibrosis	RAW 264.7 and 293T cells	lipopolysaccharide (LPS) treatment	upregulated	18299402
1724	Mouse	mmu-miR-155	miRNA	dexamethasone (DEX)	sepsis	liver tissues	dexamethasone (DEX) treatment	downregulated	24244697
1725	Mouse	mmu-miR-155	miRNA	lipopolysaccharide (LPS)	sepsis	liver tissues	lipopolysaccharide (LPS) treatment	upregulated	24244697
1726	Mouse	mmu-miR-155	miRNA	SDF-1¦Á analog CTCE-0214 (CTCE)	sepsis	mouse with polymicrobial sepsis	EPC therapy treatment	upregulated in endothelial progenitor cells (EPCs)	24707934
1727	Mouse	mmu-miR-155	miRNA	lipopolysaccharide (LPS)	septic shock	Mouse Aorta and Left ventricular (LV)	lipopolysaccharide (LPS) treatment	upregulated	29979224
1728	Mouse	mmu-miR-155	miRNA	nuclear factor kappa-B (NF-¦ÊB) inhibitor Bay11-708211	supraesophageal bile reflux	hypopharyngeal mucosa	NF-¦ÊB inhibitor (BAY 11-7082) treatment	"Pre- but not post-application of NF-¦ÊB inhibitor, significantly blocks overexpression of Il6 and prostaglandin H synthases 2 (Ptgs2), and reverses miR-21, miR-155, miR-99a phenotypes."	32934775
1729	Mouse	mmu-miR-155	miRNA	T. gondii	T. gondii induced hepatic damage	liver tissues	T. gondii treatment	revealed a significant elevation in miRNA-155 expression and a significant reduction of BChE activity in all the infected untreated groups compared to the uninfected mice	33840057
1730	Mouse	mmu-miR-155	miRNA	lithium chloride and pilocarpine	temporal lobe epilepsy (TLE)	brain tissues	lithium-pilocarpine treatment	upregulated	27303295
1731	Mouse	mmu-miR-155	miRNA	controlled cortical impact (CCI)	traumatic brain injury (TBI)	mouse hippocampus	controlled cortical impact (CCI)	upregulated	28804446
1732	Mouse	mmu-miR-155	miRNA	mycobacterium tuberculosis (Mtb)	tuberculosis (TB)	murine RAW264.7 cells and bone marrow-derived macrophages (BMDMs)	Mycobacterium tuberculosis (M.tb.)? infection	upregulated	22712528
1733	Mouse	mmu-miR-155	miRNA	triptolide (TPL)	ileocolonic anastomosis inflammation	lleum tissues; colon tissues	triptolide (TPL) treatment	downregulated	23911388
1734	Mouse	mmu-miR-155	miRNA	insulin	type 2 diabetes mellitus (T2DM)	liver tissues;adipose tissues;skeletal muscle tissues	?insulin? treatment	upregulated	27711113
1735	Mouse	mmu-miR-155	miRNA	artesunate (ART)	ulcerative colitis (UC)	RAW264.7 cells	artesunate (ART) treatment	ART treatment also reduced the expressions of pro-inflammatory factors and miR-155.	33524272
1736	Mouse	mmu-miR-155	miRNA	cinnamaldehyde (CA)	ulcerative colitis (UC)	RAW264.7 cells	Cinnamaldehyde (CA) treatment	downregulated	30530166
1737	Mouse	mmu-miR-155	miRNA	cinnamaldehyde (CA)	ulcerative colitis (UC)	colon tissues	Cinnamaldehyde (CA) treatment	downregulated	30530166
1738	Mouse	mmu-miR-155	miRNA	dextran sodium sulfate (DSS)	ulcerative colitis (UC)	DSS-induced mice colon tissues	Dextran sodium sulfate (DSS) treatment	upregulated	30530166
1739	Mouse	mmu-miR-155	miRNA	dextran sodium sulfate (DSS)	ulcerative colitis (UC)	mouse colon tissues	dextran-sulfate-sodium (DSS) treatment	upregulated	28888763
1740	Mouse	mmu-miR-155	miRNA	propofol (PPF)	unilateral ureteral obstruction (UUO)	UUO mouse	UUO mouse treatment	downregulated in kidney	27158339
1741	Mouse	mmu-miR-155	miRNA	live L. acidophilus	¦Â-lactoglobulin (¦Â-Lg) allergy	murine splenocytes	live L. acidophilus treatment	downregulated	30156972
1742	Mouse	mmu-miR-155	miRNA	oxidized low density lipoprotein (ox-LDL)	atherosclerosis (AS)	RAW264.7 cells	oxidized low-density lipoprotein (ox-LDL) treatment	upregulated	23797321
1743	Mouse	mmu-miR-155	miRNA	mycobacteria	depression	RAW264.7 cells	mycobacteria?infection	upregulated	24130493
1744	Mouse	mmu-miR-155	miRNA	IL-10	inflammation	BMDM	IL-10? treatment	downregulated	20435894
1745	Mouse	mmu-miR-155-3p	miRNA	lipopolysaccharide (LPS)	inflammation	RAW264.7 cells	lipopolysaccharide (LPS) treatment	upregulated	32955644
1746	Mouse	mmu-miR-155-5p	miRNA	angiostrongylus cantonensis (A. cantonensis)	angiostrongylus cantonensis (A. cantonensis) infection	mouse	angiostrongylus cantonensis (A. cantonensis) infection	upregulated	24682888
1747	Mouse	mmu-miR-155-5p	miRNA	"IL-4, IL-13 and IL-33"	allergic asthma (AA)	RAW264.7 cells	"IL-4,IL-13 and IL-33 treatment"	upregulated	29621782
1748	Mouse	mmu-mir-155-5p	miRNA	second-hand smoke (SHS)	asthma	lung	second-hand smoke (SHS) treatment	upregulated	26859758
1749	Mouse	mmu-miR-155-5p	miRNA	histone deacetylase inhibitor (HDACi)	B cell differentiation	B cells of C57BL/6J	"stimulated with LPS and IL-4 and treated with HDI (VPA, 500 ?M) or nil for 60 h"	upregulated	28994753
1750	Mouse	mmu-miR-155-5p	miRNA	apigenin	cardiac fibrosis	TGF-¦Â1-treated mouse cardiac fibroblasts (M6300)	apigenin treatment	downregulated	32800930
1751	Mouse	mmu-miR-155-5p	miRNA	apigenin	cardiac fibrosis	M6300 cells	apigenin treatment	downregulated	32800930
1752	Mouse	mmu-miR-155-5p	miRNA	TGF-¦Â1	cardiac fibrosis	Mouse cardiac fibroblasts (M6300)	TGF-¦Â1 treatment	upregulated	32800930
1753	Mouse	mmu-miR-155-5p	miRNA	geniposide and ginsenoside Rg1	cerebral ischemia injury (CII)	oxygen-glucose deprivation (OGD) treated BV2 mouse microglial cells	Geniposide+Ginsenoside Rg1 dual treatment	downregulated	29257264
1754	Mouse	mmu-miR-155-5p	miRNA	oxygen-glucose deprivation and reoxygenation (OGD/R)	cerebral ischemia injury (CII)	BV2 mouse microglial cells	oxygen-glucose deprivation and reoxygenation (OGD/R) treatment	upregulated	29257264
1755	Mouse	mmu-miR-155-5p	miRNA	echinococcus multilocularis metacestodes	echinococcus multilocularis infection	RAW 264.7 cells	E. multilocularis metacestodes treatment	upregulated	30322806
1756	Mouse	mmu-miR-155-5p	miRNA	angiostrongylus cantonensis (A. cantonensis)	eosinophilic meningitis (EM)	murine microglial cell line N9	angiostrongylus cantonensis (A. cantonensis) infection	The current study confirmed that miR-155-5p peaked at 21 days after A. cantonensis infection.	32966836
1757	Mouse	mmu-miR-155-5p	miRNA	¦¤9-tetrahydrocannabinol (THC) and Cannabidiol (CBD)	experimental autoimmune encephalomyelitis (EAE)	murine brain-derived CD4+ T cells	¦¤9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) combination treatment	downregulated	31497013
1758	Mouse	mmu-miR-155-5p	miRNA	fluke Fasciola gigantica (FgESPs)	F. gigantica infection	liver tissues	fluke Fasciola gigantica (FgESPs) infection	upregulated	33332355
1759	Mouse	mmu-miR-155-5p	miRNA	deoxycorticosterone acetate-salt hypertension	hypertensive nephropathy (HN)	kidney tissues	deoxycorticosterone acetate-salt hypertension treatment	upregulated	31782248
1760	Mouse	mmu-miR-155-5p	miRNA	E. multilocularis metacestodes	infection and immunity of E. multilocularis	RAW264¡¤7 macrophage cells	E. multilocularis metacestodes for 6 and 12 h treatment	"upregulated (mmu-miR-378d,mmu-miR-155-5p, mmu-miR-146a-5p, mmu-miR-21a-5p , mmu-miR-125a-5p) and downregulated(mmu-miR-1981-5p , mmu-miR-let-7c-1-3p)"	28942753
1761	Mouse	mmu-miR-155-5p	miRNA	lactic acid (LA)	inflammation	bone marrow-derived mast cells (BMMC) of C57BL/6 mouse	lactic acid (LA) treatment	downregulated	27559047
1762	Mouse	mmu-miR-155-5p	miRNA	lipopolysaccharide (LPS)	inflammation	RAW264.7 cells	lipopolysaccharide (LPS) treatment	upregulated	32955644
1763	Mouse	mmu-miR-155-5p	miRNA	dexamethasone (DEX)	innate immune response	immature DCs (iDCs)	dexamethasone (DEX) treatment	downregulated	30174602
1764	Mouse	mmu-miR-155-5p	miRNA	IL-10	innate immune response	immature DCs (iDCs)	IL-10 treatment	downregulated	30174602
1765	Mouse	mmu-miR-155-5p	miRNA	methamphetamine (METH)	methamphetamine (METH)-mediated neurotoxicity	BV2 cells and mouse brain	Methamphetamine (METH) treatment	MiR-155-5p was significantly reduced by METH in vitro but increased in vivo.	30914375
1766	Mouse	mmu-miR-155-5p	miRNA	preformed fibrils (PFFs) of human wild-type ¦ÁSyn	microglial activation	Mouse primary microglia	preformed fibrils (PFFs) of human wild-type ¦ÁSyn treatment	upregulated	31182996
1767	Mouse	mmu-miR-155-5p	miRNA	triptolide (TPL)	microglial activation	preformed fibrils (PFFs) of human wild-type ¦ÁSyn-treated mouse primary microglia	triptolide (T10) treatment	downregulated	31182996
1768	Mouse	mmu-miR-155-5p	miRNA	neurotoxicant cuprizone (CPZ)	myelin abnormalities	myelin	Neurotoxicant cuprizone (CPZ) treatment	miR-155-5p and miR-20a-5p upregulations enhanced NgR induction through Smad 2 and Smad 4 suppression in demyelination.	31963761
1769	Mouse	mmu-miR-155-5p	miRNA	rosmarinic acid (RA)	parkinson's disease (PD)	ventral midbrain	rosmarinic acid (RA) treatment	MPTP injection increased the relative expression of miR-155-5p and RA treatment decreased its expression.	32946211
1770	Mouse	mmu-miR-155-5p	miRNA	geniposide and ginsenoside Rg3	stroke	BV2 mouse microglial cells	exposed to geniposide (40 ?g/ml) + ginsenoside Rg1 (8 ?g/ml)	upregulated	29257264
1771	Mouse	mmu-miR-155-5p	miRNA	"chlorpromazine, procainamide, manganese"	systemic lupus erythematosus (SLE)	mouse	"chlorpromazine, procainamide, manganese"	dysregulated	29349090
1772	Mouse	mmu-miR-155-5p	miRNA	T-2 toxin	T-2 toxin-induced inflammatory response	RAW264.7 cells	T-2 toxin treatment	upregulated	32240701
1773	Mouse	mmu-miR-15a	miRNA	amyloid-¦Â (A¦Â) 25-35	Alzheimer's disease (AD)	hippocampal neurons	amyloid-¦Â (A¦Â) 25-35 treatment	TUG1 knockdown restricts apoptosis of hippocampal neurons in AD by elevating miR-15a and suppressing ROCK1 expression.	32577774
1774	Mouse	mmu-miR-15a	miRNA	folate	apoptosis	mouse embryonic stem cells (mESCs)	folate deficiency induced	upregulated	22828209
1775	Mouse	mmu-miR-15a	miRNA	IL-22	colitis	CT-26 cells	Interleukin-22 (IL-22) treatment	downregulated	29023933
1776	Mouse	mmu-miR-15A	miRNA	IL-17A	colorectal cancer (CRC)	intestinal epithelial cells (IECs) of C57BL/B6 mice	IL17A treatment	downregulated	29031499
1777	Mouse	mmu-miR-15a	miRNA	[6]-gingerol-fractions (GF)	diabetic wound healing	diabetic skin wounds	[6]-gingerol-fractions (GF) treatment	upregulated	31428171
1778	Mouse	mmu-miR-15a	miRNA	vitamin D	diabetic wound healing	diabetic skin wounds	vitamin D treatment	upregulated	31428171
1779	Mouse	mmu-miR-15a	miRNA	bleomycin (BLM)	idiopathic pulmonary fibrosis (IPF)	mouse lung tissues	bleomycin (BLM) treatment	downregulated	30644438
1780	Mouse	mmu-miR-15a	miRNA	TGF-¦Â1	idiopathic pulmonary fibrosis (IPF)	neonatal primary lung fibroblasts	transforming growth factor (TGF)-¦Â1 treatment	downregulated	30644438
1781	Mouse	mmu-miR-15a	miRNA	TGF-¦Â1	idiopathic pulmonary fibrosis (IPF)	mouse primary lung fibroblasts	TGF-¦Â1 treatment	"miR-15a antagonized the function of PFAR and inhibited PFAR induced extracellular collagen deposition, fibroblasts proliferation, migration and differentiation"	31273058
1782	Mouse	mmu-miR-15a	miRNA	exenatide (EXA)	insulin sensitivity	pancreas	exenatide treatment	"The levels of miRNA-15a, 29c, 124a, and 375 in the pancreas were significantly increased in HFD control mice.These effects were reversed by treatment with exenatide."	26314504
1783	Mouse	mmu-miR-15a	miRNA	exenatide (EXA)	insulin sensitivity	muscle	exenatide treatment	"The levels of miRNA-15a, 29c, 124a, and 146a in the muscle were significantly increased. These effects were reversed by treatment with exenatide."	26314504
1784	Mouse	mmu-miR-15a	miRNA	exenatide (EXA)	insulin sensitivity	serum	exenatide treatment	"the levels of miRNA-15a, 29c, 124a, and 375 in the serum were significantly decreased. These effects were reversed by treatment with exenatide."	26314504
1785	Mouse	mmu-miR-15a	miRNA	high fat diet (HFD)	insulin sensitivity	pancreas	high fat diet (HFD) feed	upregulated	26314504
1786	Mouse	mmu-miR-15a	miRNA	high fat diet (HFD)	insulin sensitivity	muscle	high fat diet (HFD) feed	upregulated	26314504
1787	Mouse	mmu-miR-15a	miRNA	high fat diet (HFD)	insulin sensitivity	serum	high fat diet (HFD) feed	downregulated	26314504
1788	Mouse	mmu-miR-15a	miRNA	ischemia/reperfusion (I/R) 	keratinocyte migration and boosts re-epithelialization during skin wound healing	heart tissues	ischemia/reperfusion (I/R) treatment	upregulated	22783320
1789	Mouse	mmu-miR-15a	miRNA	dietary methyl deficiency	hepatocellular carcinoma (HCC)	the liver tissues	Dietary methyl deficiency treatment	downregulated	20436259
1790	Mouse	mmu-miR-15a	miRNA	concanamycin A (Con A)	liver damage	liver tissues	concanavalin A (ConA) treatment	downregulated	29023933
1791	Mouse	mmu-miR-15a	miRNA	high fat diet (HFD)	obesity	C57Bl/6 mice	high fat diet (HFD) feed	upregulated	28944834
1792	Mouse	mmu-miR-15a	miRNA	peroxisome proliferator-activated receptor delta (PPARdelta)	obstructive cholestasis	mouse Cerebral vascular endothelial cell (CEC)	peroxisome proliferator-activated receptor delta (PPARdelta)?treatment treatment	upregulation of PPARdelta can alleviate ODG-activated microRNA-15a (miR-15a) expression in CECs	20445066
1793	Mouse	mmu-miR-15a	miRNA	Tripterygium glycosides (TGs)	premature ovarian failure (POF)	ovarian granulosa cells (OGCs)	Tripterygium glycosides (TGs) treatment	upregulated	30092342
1794	Mouse	mmu-miR-15a	miRNA	radiation	radiation-induced fibrosis (RIF)	"CH3 mice muscle, skin, and subcutaneous tissue"	the right hind legs of 9-week old CH3 mice by a single-fraction dose of irradiation to 35 Gy treatment	dysregulated	24986745
1795	Mouse	mmu-miR-15a	miRNA	H2O2	spinal cord injury (SCI)	C8-D1A and C8B4 cells	H2O2 treatment	downregulated	31773669
1796	Mouse	mmu-miR-15a	miRNA	IFN	systemic lupus erythematosus (SLE)	splenic cellular and plasma	interferon treatment	upregulated	22578383
1797	Mouse	mmu-miR-15a*	miRNA	recombinant Adeno-Cre viruses (AdV-Cre)	lung adenocarcinoma (LUAD)	lung	recombinant Adeno-Cre viruses (AdV-Cre) treatment	upregulated	25359683
1798	Mouse	mmu-miR-15a-3p	miRNA	delvestidine (DLTD)	bone marrow-derived dendritic cells (BMDCs) maturity	bone marrow-derived dendritic cells (BMDCs)	Delvestidine (DLTD) treatment	upregulated	32871480
1799	Mouse	mmu-miR-15a-5p	miRNA	lipopolysaccharide (LPS)	acute kidney injury (AKI)	Mouse podocytes (MPC5)	MPC5 were treated with 100 ng/mL LPS (Sigma-Aldrich) for 48 h	miR-15a-5p was significantly downregulated in LPS-treated MPCs.	31658856
1800	Mouse	mmu-miR-15a-5p	miRNA	ozone (O3)	asthma	CD4+ T cells and ASMCs	ozone treatment	lncRNA PVT1-miR-15a-5p/miR-29c-3p-PI3K-Akt-mTOR axis was implicated in ozone-induced asthma development by promoting ASMC proliferation and Th1/Th2 imbalance	33223504
1801	Mouse	mmu-miR-15a-5p	miRNA	phenylephrine (PE)	cardiac hypertrophy	cardiomyocytes	phenylephrine [PE] treatment	upregulated	31889385
1802	Mouse	mmu-miR-15a-5p	miRNA	ischemia	cerebral ischemia injury (CII)	region of the gerbil hippocampus	transient common carotid artery occlusion (tCCAO) treatment	upregulated	25646661
1803	Mouse	mmu-miR-15b	miRNA	Bortezomib	acute allograft rejection (AR) after renal transplant	AR renal tissues	bortezomib? treatment	upregulated	31377589
1804	Mouse	mmu-miR-15b	miRNA	TNF	acute liver failure (ALF)	liver tissue	TNF treatment	upregulated	22374434
1805	Mouse	mmu-miR-15b	miRNA	folate	apoptosis	mouse embryonic stem cells (mESCs)	folate deficiency induced	upregulated	22828209
1806	Mouse	mmu-miR-15b	miRNA	puerarin	cardiac hypertrophy	Ang II-induced cardiac hypertrophy	Puerarin treatment	upregulated	27145790
1807	Mouse	mmu-miR-15b	miRNA	rosemary	colorectal cancer (CRC)	nude mice CRC tissues	rosemary treatment	downregulated	24892299
1808	Mouse	mmu-miR-15b	miRNA	herpes simplex virus 1 (HSV-1)	inflammation and innate immunity	mouse brain tissue	infect with HSV-1	upregulated	28045967
1809	Mouse	mmu-miR-15b	miRNA	epigallocatechin-3-gallate (EGCG)	inflammation	CD4 naive T cells isolated from C57BL/6 mice	10 ¦ÌM EGCG	upregulated	27851983
1810	Mouse	mmu-miR-15b	miRNA	ischemia/reperfusion (I/R) 	keratinocyte migration and boosts re-epithelialization during skin wound healing	heart tissues	ischemia/reperfusion (I/R) treatment	upregulated	22783320
1811	Mouse	mmu-miR-15b	miRNA	nicotine	neurobehavioral effects of nicotine	the spermatozoa of F0 mice;the brains of F1 mice	nicotine both the spermatozoa of F0 mice and the brains of F1 mice	downregulated in both the spermatozoa of F0 mice and the brains of F1 mice	28779169
1812	Mouse	mmu-miR-15b	miRNA	Japanese encephalitis virus (JEV)	neuroinflammation	glial cells and mouse brains	Japanese encephalitis virus (JEV) treatment	upregulated	26202983
1813	Mouse	mmu-miR-15b	miRNA	cigarette smoke (CS)	ovarian toxicity	ovarian tissues	cigarette smoke (CS) treatment	upregulated	29377183
1814	Mouse	mmu-miR-15b	miRNA	lipopolysaccharide (LPS)	sepsis and septic shock	blood cells	LPS treatment	upregulated	23395002
1815	Mouse	mmu-miR-15b	miRNA	cyclophosphamide (CP)	premature ovarian failure (POF)	mouse ovarian granulosa cells (mOGCs)	cyclophosphamide treatment	upregulated	31310795
1816	Mouse	mmu-miR-15b-5p	miRNA	chronic unpredictable mild stress (CUMS)	depression	prefrontal cortex	chronic unpredictable mild stress (CUMS) treatment	downregulated	27701406
1817	Mouse	mmu-miR-15b-5p	miRNA	chronic unpredictable mild stress (CUMS)	depression	NAc tissue	chronic unpredictable mild stress (CUMS) treatment	upregulated	31430030
1818	Mouse	mmu-miR-15b-5p	miRNA	high glucose (HG)	diabetic nephropathy (DN)	The mouse podocytes	high glucose (HG) treatment	downregulated	31025335
1819	Mouse	mmu-miR-15b-5p	miRNA	high glucose (HG)	diabetic nephropathy (DN)	mesangial cells (MCs)	high glucose (HG) treatment	HG elevated miR-15b-5p expression.	31991106
1820	Mouse	mmu-miR-15b-5p	miRNA	sevoflurane (SEV)	endoplasmic reticulum stress (ERS)	HT22 cells	Sev treatment	upregulated	31966678
1821	Mouse	mmu-miR-15b-5p	miRNA	chronic unpredictable mild stress (CUMS)	major depressive disorder (MDD)	brain	chronic unpredictable mild stress (CUMS) treatment	"microRNA-15b-5p play a critical role in chronic stress-induced depression by decreasing synaptic proteins, innervations, and activities in the nucleus accumbens."	32209659
1822	Mouse	mmu-miR-15b-5p	miRNA	"1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)"	parkinson's disease (PD)	midbrain tissues	"1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) treatment"	downregulated	29217406
1823	Mouse	mmu-miR-15b-5p	miRNA	"1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)"	parkinson's disease (PD)	midbrain tissues	"1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) treatment"	downregulated	29217406
1824	Mouse	mmu-miR-1-5p	miRNA	lipopolysaccharide (LPS)	myocardial dysfunction	cardiomyocytes	lipopolysaccharide (LPS) treatment	The lncRNA RMRP axis acts as a sponge for miR-1-5p. RMRP inhibits LPS-induced apoptosis of cardiomyocytes and mitochondrial damage by suppressing the post-transcriptional regulatory function of miR-1-5p on HSPA4.	31900829
1825	Mouse	mmu-miR-16	miRNA	ischemia/reperfusion (I/R) 	acute kidney injury (AKI)	C57BL/6 male mice	ischemia/reperfusion (I/R) treatment	upregulated	27297958
1826	Mouse	mmu-miR-16	miRNA	TNF	acute liver failure (ALF)	liver tissue	TNF treatment	upregulated	22374434
1827	Mouse	mmu-miR-16	miRNA	lipopolysaccharide (LPS)	acute lung injury (ALI)	lung tissues	lipopolysaccharide (LPS) treatment	downregulated	30784935
1828	Mouse	mmu-miR-16	miRNA	folate	apoptosis	mouse embryonic stem cells (mESCs)	folate deficiency induced	upregulated	22828209
1829	Mouse	mmu-miR-16	miRNA	thyroid hormone	brain development	mouse fetal cortex	inject TH 12 h before sacrifice on GD 16 treatment	downregulated	24436321
1830	Mouse	mmu-miR-16	miRNA	"hexahydro-1,3,5-trinitro-1,3,5-triazine (RDX)"	tumorigenesis	brain and liver tissue cells	"hexahydro-1,3,5-trinitro-1,3,5-triazine (RDX) treatment"	downregulated	19270793
1831	Mouse	mmu-miR-16	miRNA	angiotensin II (Ang II)	cardiovascular disease (CVD)	mouse VSMC line	angiotensin II (Ang II) treatment	downregulated	29104843
1832	Mouse	mmu-miR-16	miRNA	fluoxetine (Prozac)	colorectal cancer (CRC)	serotonergic raphe nuclei of mice	fluoxetine (Prozac) treatment	upregulated	20847275
1833	Mouse	mmu-miR-16	miRNA	fluoxetine (Prozac)	Dendritic cell cross-priming	serotonergic raphe neurons	fluoxetine (Prozac) treatment	"Fluoxetine, acting on serotonergic raphe neurons, decreases the amount of miR-16 in the hippocampus"	22833211
1834	Mouse	mmu-miR-16	miRNA	Deoxycorticosterone acetate (Doca)	hypertensive heart disease (HHD)	mouse HHD cells	injection of Deoxycorticosterone acetate (Doca)	upregulated in HHD cells	28531963
1835	Mouse	mmu-miR-16	miRNA	bleomycin (BLM)	idiopathic pulmonary fibrosis (IPF)	sera	bleomycin (BLM) treatment	Rictor-targeting exosomal microRNA-16 ameliorates lung fibrosis by inhibiting the mTORC2-SPARC axis.	33307020
1836	Mouse	mmu-miR-16	miRNA	dextran sodium sulfate (DSS)	inflammatory bowel disease (IBD)	rectal mucosa	dextran sulfate sodium treatment	upregulated	32361613
1837	Mouse	mmu-miR-16	miRNA	carbon tetrachloride (CCl4)	liver fibrosis	Liver tissues	carbon tetrachloride (CCl4) treatment	downregulated	29080810
1838	Mouse	mmu-miR-16	miRNA	lipopolysaccharide (LPS)	lung injury	lung tissues	lipopolysaccharide (LPS) treatment	downregulated	22185353
1839	Mouse	mmu-miR-16	miRNA	"3,3'-diindolylmethane (DIM)"	multiple sclerosis (MS)	activated T cells during the development of experimental autoimmune encephalomyelitis (EAE)	"3,3'-Diindolylmethane (DIM) treatment"	upregulated	24898268
1840	Mouse	mmu-miR-16	miRNA	monosodium glutamate (MSG)	obesity	liver tissues	monosodium glutamate (MSG)-injected mice with developed central obesity treatment	dysregulated	24465854
1841	Mouse	mmu-miR-16	miRNA	chronic intermittent hypoxia (CIH)	obstructive sleep apnoea-hypopnoea syndrome (OSAHS)	mouse aortic endothelial cells (MAECs)	chronic intermittent hypoxia (CIH) treatment	downregulated	29108914
1842	Mouse	mmu-miR-16	miRNA	lipopolysaccharide (LPS)	sepsis and septic shock	blood cells	LPS treatment	upregulated	23395002
1843	Mouse	mmu-miR-16	miRNA	plasmodium	plasmodium infection	exosomes derived from the plasma	infect with Plasmodium treatment	upregulated	28650446
1844	Mouse	mmu-miR-16	miRNA	cecal ligation and puncture (CLP)	sepsis	whole blood	cecal ligation and puncture (CLP) treatment	upregulated	24205035
1845	Mouse	mmu-miR-16	miRNA	epigallocatechin-3-gallate (EGCG)	breast cancer	"Murine breast cancer cell lines, 4T1"	Epigallocatechin gallate (EGCG)	EGCG upregulated miR-16 in 4T1 cells and in the exosomes	24044575
1846	Mouse	mmu-miR-16-1	miRNA	IL-22	colitis	CT-26 cells	Interleukin-22 (IL-22) treatment	downregulated	29023933
1847	Mouse	mmu-miR-16-1	miRNA	IL-17A	colorectal cancer (CRC)	intestinal epithelial cells (IECs) of C57BL/B6 mice	IL17A treatment	downregulated	29031499
1848	Mouse	mmu-miR-16-1	miRNA	triptolide (TPL)	crohn disease (CD)	IL-10-/- mice undergoing ileocecal resection (ICR)	triptolide (TPL) treatment	downregulated	28627592
1849	Mouse	mmu-miR-16-1	miRNA	concanamycin A (Con A)	liver damage	liver tissues	concanavalin A (ConA) treatment	downregulated	29023933
1850	Mouse	mmu-miR-16-2-3p	miRNA	delvestidine (DLTD)	bone marrow-derived dendritic cells (BMDCs) maturity	bone marrow-derived dendritic cells (BMDCs)	Delvestidine (DLTD) treatment	upregulated	32871480
1851	Mouse	mmu-miR-16-5p	miRNA	anandamide and norgestimate	depression	chronic mild stress (CMS) model of depression mouse	anandamide and norgestimate treatment	downregulated	28716528
1852	Mouse	mmu-miR-16-5p	miRNA	enterovirus 71 (EV71)	hand-foot-mouth disease (HFMD)	two-week old Kunming (KM) mice muscle	intraperitoneally injected with high-virulence EV71 (GZ-CII strain)	upregulated	29180670
1853	Mouse	mmu-miR-16-5p	miRNA	manganese (Mn)	parkinson's disease (PD)	MN9D dopaminergic cell exosomes	Mn exposure (300¦ÌM MnCl2) for 24h	upregulated in exosomes	28450057
1854	Mouse	mmu-miR-17	miRNA	hydrochloric acid	acute lung injury (ALI)	C57BL/6 mice microvesicle (MV)release from lung epithelium	"hydrochloric acid (0.1 N, pH 1.5) was intratracheally instilled into the mouse lung"	upregulated in microvesicle (MV)release from lung epithelium	28674181
1855	Mouse	mmu-miR-17	miRNA	lipopolysaccharide (LPS)	acute lung injury (ALI)	lung tissues	lipopolysaccharide (LPS) treatment	"Using a lipopolysaccharide (LPS)-induced ALI mouse model, it was observed that miR-17 was significantly downregulated in lung tissues"	32626914
1856	Mouse	mmu-miR-17	miRNA	lipopolysaccharide (LPS)	acute lung injury (ALI)	type II epithelial cells from 6-week-old mice	lipopolysaccharide (LPS) treatment	downregulated	24486549
1857	Mouse	mmu-miR-17	miRNA	hyperoxia	bronchopulmonary dysplasia (BPD)	lung tissues	hyperoxia treatment	downregulated	33143661
1858	Mouse	mmu-miR-17	miRNA	hyperoxia	bronchopulmonary dysplasia (BPD)	lung tissues	hyperoxia (Hyp) treatment	Downregulated lncRNA H19 relieved pulmonary injury via targeting miR-17 to downregulate STAT3 and reduced inflammatory response caused by p-STAT3 in BPD newborn mice.	33285606
1859	Mouse	mmu-miR-17	miRNA	"retinoic acid (RA), leukemia inhibitory factor (LIF) and basic fibroblast growth factor (bFGF)"	cell differentiation	mouse bone marrow mesenchymal stem cells (BMSCs)	"retinoic acid (RA), leukemia inhibitory factor (LIF) and basic fibroblast growth factor (bFGF) treatment"	downregulated	32195202
1860	Mouse	mmu-miR-17	miRNA	high glucose (HG)	apoptosis	uteri	High glucose treatment	downregulated	26660634
1861	Mouse	mmu-miR-17	miRNA	ischemia/reperfusion (I/R) 	head and neck squamous cell carcinoma (HNSCC)	heart tissues	ischemia/reperfusion (I/R) treatment	the miR-17-92 cluster may protect the heart by diminishing the apoptosis and alleviating ischemia/reperfusion injury	23639284
1862	Mouse	mmu-miR-17	miRNA	high glucose (HG)	inflammation	RAW264.7 macrophages or mouse peritoneal macrophages	high glucose treatment	downregulated	29477089
1863	Mouse	mmu-miR-17	miRNA	lipopolysaccharide (LPS)	inflammation	RAW264.7 macrophages or mouse peritoneal macrophages	lipopolysaccharide (LPS) treatment	downregulated	29477089
1864	Mouse	mmu-miR-17	miRNA	¦¤9-tetrahydrocannabinol (THC)	inflammation	total lymph node cells and CD4(+) T cells	¦¤9-Tetrahydrocannabinol (THC) treatment	downregulated	27268054
1865	Mouse	mmu-miR-17	miRNA	retinoic acid (RA)	neuroblastoma (NB)	The SH-SY5Y cells	retinoic acid treatment	downregulated of miR-17 family	19666108
1866	Mouse	mmu-miR-17	miRNA	plasmodium	plasmodium infection	exosomes derived from the plasma	infect with Plasmodium treatment	upregulated	28650446
1867	Mouse	mmu-miR-17	miRNA	imiquimod (IMQ)	psoriasis-like dermatitis	the mouse skin tissues	IMQ treatment	dysregulated	27579777
1868	Mouse	mmu-miR-17	miRNA	cecal ligation and puncture (CLP)	sepsis	whole blood	cecal ligation and puncture (CLP) treatment	upregulated	24205035
1869	Mouse	mmu-miR-17	miRNA	di(2-ethylhexyl) phthalate (DEHP)	skeletal muscle insulin resistance	skeletal muscle cells	di(2-ethylhexyl) phthalate (DEHP) treatment	The miR-17/Keap1-Nrf2/miR-200a axis contributed to DEHP-induced insulin resistance.	32802189
1870	Mouse	mmu-miR-17	miRNA	genistein	spermatogenesis	ICR mice testis	"different doses of GEN (0, 0.5, 5, 50 and 250 mg/kg/day) for 35 days"	upregulated	28938591
1871	Mouse	mmu-miR-17	miRNA	IFN-¦Ã	type 1 diabetes mellitus (T1DM)	¦Â-cells	IFN¦Ãtreatment	downregulated	26858253
1872	Mouse	mmu-miR-17	miRNA	cigarette smoke extract (CSE)	¦Â-cell dysfunction	MIN6 cells	cigarette smoke extract (CSE) treatment	"cigarette smoke extract (CSE) downregulated the levels of the transcription factor, mafA, and microRNA (miR)-17."	29856480
1873	Mouse	mmu-miR-17	miRNA	high glucose (HG)	neural tube defects (NTDs)	"C17.2 mouse neural stem cells, newborn mouse cerebellar progenitor cells"	High Glucose treatment	downregulated	26660634
1874	Mouse	mmu-miR-17-3p	miRNA	swimming	cardiac hypertrophy	C57BL/6 mice ventricle samples	starting swimming from 10 minutes twice daily with 10 minutes increase each day until 90 minutes reached 14 for 21 days treatment	upregulated in ventricle samples	28255358
1875	Mouse	mmu-miR-17-3p	miRNA	high glucose (HG)	diabetic nephropathy (DN)	mesangial cells (MCs)	high glucose (HG) treatment	It was found that expression of circ_0037128 was significantly increased in mouse DN model and high glucose treated mesangial cells (MCs)	32860899
1876	Mouse	mmu-miR-17-3p	miRNA	adrenaline	heart failure (HF)	Primary NMCMs (neonatal mouse cardiomyocytes)	adrenaline treatment	downregulated	31595165
1877	Mouse	mmu-miR-175p	miRNA	"1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)"	neurodegenerative diseases	N2a cells	"1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) treatment"	upregulated	29250806
1878	Mouse	mmu-miR-17-5p	miRNA	ovalbumin (OVA)	allergic rhinitis (AR)	spleen cells	ovalbumin (OVA) treatment	miR-17-5p expression was higher in the OVA group.	31999672
1879	Mouse	mmu-miR-17-5p	miRNA	high fat diet (HFD)	atherosclerosis (AS)	vascular smooth muscle cell (VSMC)	high fat diet (HFD) feed	"p53-dependent lincRNA-p21 expression downregulated miR-17-5p, whichconsequently protecting against AS progression via SIRT7 elevation."	33169349
1880	Mouse	mmu-miR-17-5p	miRNA	high-cholesterol diet	atherosclerosis (AS)	macrophages of ApoE-/- mice	high-cholesterol diet feed	upregulated	30850242
1881	Mouse	mmu-miR-17-5p	miRNA	high-cholesterol diet	atherosclerosis (AS)	macrophages of ApoE-/- mice fed with a high-cholesterol diet	high-cholesterol diet feed	upregulated	30850242
1882	Mouse	mmu-miR-17-5p	miRNA	"paraquat (PQ) and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)"	dopaminergic (DA) neuron differentiation	neuro-2a cells	"paraquat (PQ) and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) treatment"	dysregulated	29250806
1883	Mouse	mmu-miR-17-5p	miRNA	dexmedetomidine (DEX)	doxorubicin (DOX)-induced cardiotoxicity	cardiomyocytes	dexmedetomidine (Dex) treatment	upregulated	32190669
1884	Mouse	mmu-miR-17-5p	miRNA	electroacupuncture (EA)	electroacupuncture (EA)	CD4 T cells	electroacupuncture (EA) treatment	upregulated	32026263
1885	Mouse	mmu-miR-17-5p	miRNA	di(2-ethylhexyl) phthalate (DEHP)	follicular development	ovarian	di(2-ethylhexyl) phthalate (DEHP) treatment	upregulated	29385306
1886	Mouse	mmu-miR-17-5p	miRNA	WY14643	hepatocellular carcinoma (HCC)	Mycfl/fl mice	"two days of Wy-14,643 treatment"	upregulated	24096051
1887	Mouse	mmu-miR-17-5p	miRNA	pinostilbene hydrate (PSH)	liver fibrosis	hepatic stellate cells (HSCs)	Pinostilbene hydrate (PSH) treatment	upregulated	32919323
1888	Mouse	mmu-miR-17-5p	miRNA	"1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)"	neurodegenerative diseases	N2a cells	"1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) treatment"	upregulated	29250806
1889	Mouse	mmu-miR-17-5p	miRNA	paraquat (PQ)	neurodegenerative diseases	N2a cells	paraquat (PQ) treatment	downregulated	29250806
1890	Mouse	mmu-miR-17-5p	miRNA	high fat diet (HFD)	obesity and obesity-associated insulin resistance	C57Bl/J mice	high fat diet (HFD) feed	downregulated	28265343
1891	Mouse	mmu-miR-17-5p	miRNA	IL-1¦Â	osteoarthritis (OA)	murine induced pluripotent stem cell (miPSC)	IL-1¦Â treatment	"RNA-seq results show that miR-17-5p increase from 4 to 24 hours, but slightly decrease from 24 to 72 hours in IL-1¦Â stimulated pellets."	32767602
1892	Mouse	mmu-miR-17-5p	miRNA	tumor necrosis factor alpha (TNF-¦Á) 	osteoarthritis (OA)	murine induced pluripotent stem cell (miPSC)	tumor necrosis factor alpha (TNF-¦Á) treatment	"RNA-seq results show that miR-17-5p increase from 4 to 24 hours, but slightly decrease from 24 to 72 hours in TNF-¦Á stimulated pellets"	32767602
1893	Mouse	mmu-miR-17-5p	miRNA	radiation	radiation-induced injury	blood	radiation treatment	downregulated	29799276
1894	Mouse	mmu-miR-17-5p	miRNA	lipopolysaccharide (LPS)	sepsis	Peripheral Blood Mononuclear Cells from mouse peripheral blood and Raw264.7 macrophages	lipopolysaccharide (LPS) treatment	downregulated	30506107
1895	Mouse	mmu-miR-17-5p	miRNA	schisandrin B (Sch B)	sepsis	LPS-treated mouse peripheral Blood Mononuclear Cells or Raw264.7 macrophages	Schisandrin B (Sch B) treatment	upregulated	30506107
1896	Mouse	mmu-miR-17-92	miRNA	ischemia/reperfusion (I/R) 	acute kidney injury (AKI)	mouse renal tubular	ischemia/reperfusion (I/R) treatment	upregulated in renal tubular	29699633
1897	Mouse	mmu-miR-17-92	miRNA	mouse mammary tumor virus (MMTV)	breast cancer	mouse mammary HC11 cells	infect with MMTV	upregulated	29096160
1898	Mouse	mmu-miR-17-92	miRNA	"hexahydro-1,3,5-trinitro-1,3,5-triazine (RDX)"	tumorigenesis	brain and liver tissue cells	"hexahydro-1,3,5-trinitro-1,3,5-triazine (RDX) treatment"	downregulated	19270793
1899	Mouse	mmu-miR-17-92	miRNA	streptozocin (STZ)	islet beta-cell repair	Islets	streptozotocin treatment	MiR-17-92¦ÂKO mice showed dramatically elevated fasting blood glucose and impaired glucose tolerance after streptozotocin treatment	32038500
1900	Mouse	mmu-miR-17-92	miRNA	grape seed procyanidin extract (GSPE)	lung cancer	A549 cells	grape seed procyanidin extract (GSE) treatment	downregulated	27289489
1901	Mouse	mmu-miR-17-92	miRNA	rapamycin	myocardial infarction (MI)	cardiomyocytes	rapamycin (RAPA) treatment	STAT3-miR-17/20 signalling axis plays a critical role in attenuating myocardial infarction following rapamycin treatment in diabetic mice	31738412
1902	Mouse	mmu-miR-18	miRNA	IL-1¦Â	diabetes mellitus (DM)	MIN6 cells	IL-1¦Â treatment	upregulated	31258677
1903	Mouse	mmu-miR-18	miRNA	gold nanoparticles (AuNPs)	epithelial-mesenchymal transition and peritoneal fibrosis	liver and lung of mouse fetuses	gold nanoparticles (AuNP) treatment	upregulated	24004569
1904	Mouse	mmu-miR-181	miRNA	"hexahydro-1,3,5-trinitro-1,3,5-triazine (RDX)"	tumorigenesis	brain and liver tissue cells	"hexahydro-1,3,5-trinitro-1,3,5-triazine (RDX) treatment"	downregulated	19270793
1905	Mouse	mmu-miR-181a	miRNA	curcumin (Cur)	acute kidney injury (AKI)	kidney tissues	curcumin treatment	Curcumin treatment decreased miR-181a expression level.	32338107
1906	Mouse	mmu-miR-181a	miRNA	transglutaminase 2 (TG2)	allergic inflammation	B16F1 mouse melanoma cells	TGaseII treatment	downregulated	25202021
1907	Mouse	mmu-miR-181a	miRNA	amyloid-¦Â (A¦Â)	Alzheimer's disease (AD)	primary hippocampal cells	amyloid-¦Â (A¦Â) treatment	A¦Â treatment inhibited cLTP-dependent induction of translin and subsequent reduction of miR-181a.	32087004
1908	Mouse	mmu-miR-181a	miRNA	IL-1¦Â	Alzheimer's disease (AD)	primary murine astrocyte and neuron co-culture	IL-1¦Â treatment	microRNA-181a was significantly decreased following the IL-1¦Â treatment.	29710703
1909	Mouse	mmu-miR-181a	miRNA	histone deacetylase inhibitors (HDIs) short-chain fatty acid (SCFA) butyrate	antibody-mediated systemic autoimmunity	B cells	SCFA HDI butyrate treatment	upregulated	32265934
1910	Mouse	mmu-miR-181a	miRNA	dexamethasone (DEX)	asthma	splenic CD4+ T lymphocytes	dexamethasone (DEX) treatment	downregulated	22580216
1911	Mouse	mmu-miR-181a	miRNA	TGF-¦Â	cirrhosis and hepatocellular cancer	liver	TGF-¦Â treatment	upregulated	24576072
1912	Mouse	mmu-miR-181a	miRNA	streptozocin (STZ)	diabetic corneal nerve	trigeminal ganglion tissue (TG)	streptozotocin (STZ) treatment		31926967
1913	Mouse	mmu-miR-181a	miRNA	cocaine and amphetamines	drug-induced synaptic plasticity	Primary neuronal cells; synaptoneurosomes tissues	cocaine and amphetamines treatment	dysregulated	22144581
1914	Mouse	mmu-miR-181a	miRNA	MOG 35-55 peptide emulsified and pertussis toxin	"experimental autoimmune encephalomyelitis (EAE),multiple sclerosis (MS)"	brain tissues	wereinjected subcutaneously with MOG 35-55 peptide emulsified and pertussis toxin	downregulated in brain	28769921
1915	Mouse	mmu-miR-181a	miRNA	di(2-ethylhexyl) phthalate (DEHP)	follicular development	ovarian	di(2-ethylhexyl) phthalate (DEHP) treatment	upregulated	29385306
1916	Mouse	mmu-miR-181a	miRNA	oxidized low density lipoprotein (ox-LDL)	hyperlipidemia	dendritic cells (DCs)	oxidized low-density lipoprotein (ox-LDL) treatment	upregulated	22956783
1917	Mouse	mmu-miR-181a	miRNA	lipopolysaccharide (LPS)	inflammation	blood	lipopolysaccharides (LPS) or streptozotocin treatment	upregulated	23220232
1918	Mouse	mmu-miR-181a	miRNA	streptozocin (STZ)	inflammation	blood	lipopolysaccharides (LPS) or streptozotocin treatment	upregulated	23220232
1919	Mouse	mmu-miR-181a	miRNA	brucella.suis	innate immune response	RAW264.7 cells	brucella.suis infection	upregulated	29387067
1920	Mouse	mmu-miR-181a	miRNA	morphine	neurogenesis	mouse	morphine treatment	upregulated	24964978
1921	Mouse	mmu-miR-181a	miRNA	palmitic acid (PA)	nonalcoholic fatty liver disease (NAFLD)	primary mouse hepatocytes (PMH)	palmitic acid (PA) treatment	upregulated	30558790
1922	Mouse	mmu-miR-181a	miRNA	bone morphogenetic proteins (BMPs)	osteogenesis	pluripotent stem (iPS) cells	bone morphogenetic proteins (BMPs) treatment	downregulated	22937097
1923	Mouse	mmu-miR-181a	miRNA	3-nitropropionic acid	oxidative stress	ovary tissues	3-nitropropionic acid treatment	upregulated	31359035
1924	Mouse	mmu-miR-181a	miRNA	H2O2	oxidative stress	primary mouse mGC	H2O2	upregulated	28981116
1925	Mouse	mmu-miR-181a	miRNA	oxygen-glucose deprivation and reoxygenation (OGD/R)	oxidative stress	N2a cells	oxygen-glucose deprivation and reoxygenation (OGD/R) treatment	downregulated	30949956
1926	Mouse	mmu-miR-181a	miRNA	sphingosine-1-phosphate (S1P)	oxidative stress	H2O2 treated primary mouse GCs (mGCs)	sphingosine-1-phosphate (S1P) treatment	downregulated	31359035
1927	Mouse	mmu-miR-181a	miRNA	particulate matter (PM2.5)	PM2.5 exposure	mosue bronchoalveolar lavage fluid (BALF)	"were subjected to intratracheal instillation of 2.5, 10, or 20mg/kg PM2.5 treatment"	upregulated in bronchoalveolar lavage fluid (BALF)	29107863
1928	Mouse	mmu-miR-181a	miRNA	particulate matter (PM2.5)	pulmonary toxicological	lung tissues	particulate matter (PM2.5) exposure treatment	upregulated	29107863
1929	Mouse	mmu-miR-181a	miRNA	"TCDD (2,3,7,8-tetrachlorodibenzo-p-dioxin)"	thymic atrophy and alterations in T cell differentiation	fetal thymocytes of mice	"TCDD (2,3,7,8-tetrachlorodibenzo-p-dioxin) treatment"	upregulated	23024791
1930	Mouse	mmu-miR-181a	miRNA	high glucose (HG)	wound healing	granulation tissues	streptozocin (STZ) treatment	miR-181a was upregulated in the diabetic wound healing mouse model.	30565672
1931	Mouse	mmu-miR-181a-1	miRNA	¦Â-elemene	oxygen-induced retinopathy (OIR)	Retinas tissues	¦Â-elemene treatment	upregulated	30664207
1932	Mouse	mmu-miR-181a-1-3p	miRNA	"15-deoxy-¦¤12, 14-prostaglandin J2 (15d-PGJ2)"	liver damage	bone marrow (BM)-derived macrophage (BMM) of liver injury mouse	"15-deoxy-¦¤12, 14-prostaglandin J2 (15d-PGJ2) treatment"	upregulated	28748390
1933	Mouse	mmu-miR-181a-5p	miRNA	brucella abortus	brucellosis	"bone marrow-derived macrophages, spleens"	brucella abortus infection	upregulated	29942317
1934	Mouse	mmu-miR-181a-5p	miRNA	oxygen-glucose deprivation and reoxygenation (OGD/R)	cerebral ischemia injury (CII)	Mouse N2a cells	oxygen-glucose deprivation and reoxygenation (OGD/R) treatment	"?miR-181a-5p was highly expressed in serum of ACI patients, MCAO mice, and OGD/R-induced N2a cells"	33360253
1935	Mouse	mmu-miR-181a-5p	miRNA	oxygen-glucose deprivation and reoxygenation (OGD/R)	cerebral ischemia injury (CII)	N2a cells	oxygen-glucose deprivation and reoxygenation (OGD/R) treatment	miR-181a-5p was highly expressed in OGD/R-induced N2a cells	33360253
1936	Mouse	mmu-miR-181a-5p	miRNA	high glucose (HG)	diabetic cardiomyopathy (DCM)	cardiomyocytes	high glucose (HG) treatment	downregulated	31353329
1937	Mouse	mmu-miR-181a-5p	miRNA	high glucose (HG)	diabetic cardiomyopathy (DCM)	primary cultured cardiomyocyte	high glucose treatment	downregulated	31353329
1938	Mouse	mmu-miR-181a-5p	miRNA	streptozocin (STZ)	diabetic cardiomyopathy (DCM)	myocardium	streptozocin treatment	downregulated	31353329
1939	Mouse	mmu-miR-181a-5p	miRNA	streptozocin (STZ)	diabetic cardiomyopathy (DCM)	myocardial tissues	streptozotocin (STZ) treatment	downregulated	31353329
1940	Mouse	mmu-miR-181a-5p	miRNA	lipopolysaccharide (LPS)	sepsis	RAW 264.7 cells	lipopolysaccharide (LPS) treatment	upregulated	31844680
1941	Mouse	mmu-miR-181a-5p	miRNA	social defeat stress	sex differences of social defeat stress	female mice	social defeat stress treatment	upregulated	33358922
1942	Mouse	mmu-miR-181b	miRNA	high fat diet (HFD)	nervous and immune system diseases	the aortic intima and plasma in mice	high fat diet (HFD) feed	MiR-181b expression was reduced in the aortic intima and plasma in apolipoprotein E-deficient mice fed a high-fat diet	24084690
1943	Mouse	mmu-miR-181b	miRNA	angiotensin II (Ang II)	abdominal aortic aneurysm (AAA)	vascular smooth muscle cell and mouse-aorta-origin vascular smooth muscle (MOVAS) cells	angiotensin II (Ang II) treatment	upregulated	30417353
1944	Mouse	mmu-miR-181b	miRNA	angiotensin II (Ang II)	abdominal aortic aneurysm (AAA)	angiotensin II (AngII) treated mouse-aorta-origin vascular smooth muscle (MOVAS) cells	angiotensin II (Ang II) treatment	upregulated	30417353
1945	Mouse	mmu-miR-181b	miRNA	licochalcone A (LA)	abdominal aortic aneurysm (AAA)	angiotensin II (AngII)-treated mouse vascular smooth muscle cell and mouse-aorta-origin vascular smooth muscle (MOVAS) cells	Licochalcone A (LA) treatment	downregulated	30417353
1946	Mouse	mmu-miR-181b	miRNA	licochalcone A (LA)	abdominal aortic aneurysm (AAA)	Mouse-aorta-origin vascular smooth muscle (MOVAS) cells	Licochalcone A (LA) treatment	downregulated	30417353
1947	Mouse	mmu-miR-181b	miRNA	ovalbumin (OVA)	asthma	lung tissues	ovalbumin (OVA) treatment	miR-181b was found to be downregulated in lung tissues in the OVA-challenged mice.	33640857
1948	Mouse	mmu-miR-181b	miRNA	high fat diet (HFD)	atherosclerosis (AS)	mouse	high fat diet (HFD) feed	downregulated	24084690
1949	Mouse	mmu-miR-181b	miRNA	oxygen glucose deprivation (OGD)	cerebral artery occlusion	HT22 cell	oxygen-glucose deprivation (OGD) treatment	downregulated	27642276
1950	Mouse	mmu-miR-181b	miRNA	CoCl2	cerebral ischemic stroke (CIS)	N2A neuroblastoma cells	CoCl2 treatment	miR-181b expression was significantly decreased in N2A neuroblastoma cells after CoCl 2-induced hypoxic injury in vitro.	29807144
1951	Mouse	mmu-miR-181b	miRNA	estrogen (ES)	renal fibrosis	mouse uterus tissues	Estrogen treatment	mirn451 was significantly increased by estrogen administration whereas mirn181b and mirn204 expression was significantly reduced	20720260
1952	Mouse	mmu-miR-181b	miRNA	high-fat/high-cholesterol diet or a high-protein diet	dyslipidemia	DO mice	a high-fat/high-cholesterol diet or a high-protein diet for 18 wk	dysregulated	28916633
1953	Mouse	mmu-miR-181b	miRNA	brucella.suis	innate immune response	RAW264.7 cells	brucella.suis infection	upregulated	29387067
1954	Mouse	mmu-miR-181b	miRNA	erythrocyte lysates	intracerebral haemorrhage (ICH)	Primary cortical neurons from C57BL/6 mice	erythrocyte lysates treatment	downregulated	30503822
1955	Mouse	mmu-miR-181b	miRNA	erythrocyte lysates	intracerebral haemorrhage (ICH)	Primary cortical neurons from C57BL/6 mice	erythrocyte lysates treatment	downregulated	30503822
1956	Mouse	mmu-miR-181b	miRNA	carbon tetrachloride (CCl4)	liver fibrosis	liver tissues	carbon tetrachloride (CCl4) treatment	upregulated	31790896
1957	Mouse	mmu-miR-181b	miRNA	liquiritigenin (LQ)	liver fibrosis	carbon tetrachloride (CCl4)-treated mice liver tissues	Liquiritigenin (LQ) treatment	downregulated	31790896
1958	Mouse	mmu-miR-181b	miRNA	liquiritigenin (LQ)	liver fibrosis	hepatic stellate cells (HSC)	Liquiritigenin (LQ) treatment	LQ led to a significant reduction in miR-181b expression.	31790896
1959	Mouse	mmu-miR-181b	miRNA	hypoxia	apoptosis	brain tissues	MCAO surgical procedure	downregulated	27642276
1960	Mouse	mmu-miR-181b	miRNA	sevoflurane (SEV)	neurotoxicity	HT22 cells	Sevoflurane treatment	downregulated	32150149
1961	Mouse	mmu-miR-181b	miRNA	high fat diet (HFD)	nonalcoholic fatty liver disease (NAFLD)	mouse	high fat diet (HFD) feed	upregulated	28899784
1962	Mouse	mmu-miR-181b	miRNA	tert-butyl hydroperoxide (TBHP)	oxidative stress	adult male mice strain Balb/c	TBHP treatment	differently regulated	25141839
1963	Mouse	mmu-miR-181b	miRNA	cecal ligation and puncture (CLP)	sepsis	late sepsis	cecal ligation and puncture (CLP) treatment	upregulated	24980967
1964	Mouse	mmu-miR-181b	miRNA	SiO2	silicosis	NR8383 cells	SiO2 treatment	downregulated	26239160
1965	Mouse	mmu-miR-181-b	miRNA	MOG 35-55 peptide emulsified and pertussis toxin	"experimental autoimmune encephalomyelitis (EAE),multiple sclerosis (MS)"	brain tissues	wereinjected subcutaneously with MOG 35-55 peptide emulsified and pertussis toxin	downregulated in brain	28769921
1966	Mouse	mmu-miR-181b	miRNA	lipopolysaccharide (LPS)	neuropathic pain (NP)	BV2 cells	?lipopolysaccharide (LPS) treatment	"In this study, we found that lncRNA p21 and tumor necrosis factor alpha-induced protein 1 (Tnfaip1) expression were upregulated and miR-181b expression was downregulated in lipopolysaccharide (LPS)-induced and activated BV-2 microglia"	33774143
1967	Mouse	mmu-miR-181b1	miRNA	neuraminidase (NA)	H9N2 influenza virus infection	Dendritic cells (DCs)	Neuraminidase (NA) treatment	downregulated	27285980
1968	Mouse	mmu-miR-181b-5p	miRNA	histone deacetylase inhibitor (HDACi)	B cell differentiation	B cells of C57BL/6J	"stimulated with LPS and IL-4 and treated with HDI (VPA, 500 ?M) or nil for 60 h"	upregulated	28994753
1969	Mouse	mmu-miR-181b-5p	miRNA	high fat diet (HFD)	hepatic insulin resistance	serum and livers of diabetic mice	high fat diet (HFD) feed	downregulated	30627917
1970	Mouse	mmu-miR-181b-5p	miRNA	deoxycorticosterone acetate-salt hypertension	hypertensive nephropathy (HN)	kidney tissues	deoxycorticosterone acetate-salt hypertension treatment	downregulated	31782248
1971	Mouse	mmu-miR-181b-5p	miRNA	tumor necrosis factor alpha (TNF-¦Á) 	inflammation	mouse cementoblast cell line OCCM©\30	tumor necrosis factor alpha (TNF-¦Á) treatment	downregulated	31131439
1972	Mouse	mmu-miR-181b-5p	miRNA	lipopolysaccharide (LPS)	postoperative cognitive dysfunction (POCD)	BV-2 cell lines	lipopolysaccharide (LPS) treatment	downregulated	31003188
1973	Mouse	mmu-miR-181c	miRNA	H2O2	acute ischemic stroke (AIS)	BV2 microglia	H2O2 treatment	miR-181c reduced proliferation but increased the apoptosis of these cells with or without LPS/H2O2 treatment.	28053821
1974	Mouse	mmu-miR-181c	miRNA	lipopolysaccharide (LPS)	acute ischemic stroke (AIS)	BV2 microglia	lipopolysaccharide (LPS) treatment	miR-181c reduced proliferation but increased the apoptosis of these cells with or without LPS/H2O2 treatment.	28053821
1975	Mouse	mmu-miR-181c	miRNA	ischemia	acute kidney injury (AKI)	renal tubules	ischemia treatment	upregulated	27959449
1976	Mouse	mmu-miR-181c	miRNA	hypoxia	cerebral hypoxic diseases	primary microglia	hypoxia treatment	downregulated	25545945
1977	Mouse	mmu-miR-181c	miRNA	cigarette smoke (CS)	chronic obstructive pulmonary disease (COPD)	mouse	cigarette smoke (CS) exposure	downregulated	28806967
1978	Mouse	mmu-miR-181c	miRNA	high glucose (HG)	diabetes mellitus (DM)	endothelial cells (MAECs and END-D)	high glucose	downregulated	28223216
1979	Mouse	mmu-miR-181c	miRNA	myelin oligodendrocyte glycoprotein	experimental autoimmune encephalomyelitis (EAE)	CD4+ T cells	(MOG residues 35-55 treatment	miR-181c expression was significantly increased in EAE mice.	29545117
1980	Mouse	mmu-miR-181c	miRNA	high fat diet (HFD)	obesity-induced cardiac dysfunction	heart sissues	high fat diet (HFD) feed	HFD significantly upregulated heart levels of miR-181c and led to cardiac hypertrophy in wild-type mice.	32442661
1981	Mouse	mmu-miR-181c-5p	miRNA	reconstituted high-density lipoproteins (rHDL)	diabetes-impaired angiogenesis	diabetic mice ischaemic hindlimb	reconstituted high-density lipoproteins (rHDL) treatment	downregulated	30206364
1982	Mouse	mmu-miR-181c-5p	miRNA	oxygen glucose deprivation (OGD)	ischemic stroke (IS)	primary neuronal cells	oxygen glucose deprivation (OGD)-induce treatment	downregulated	31334597
1983	Mouse	mmu-miR-181c-5p	miRNA	berberine (BBR)	post-stroke inflammation	ipsilateral cortex tissues	berberine (BBR) treatment	Malat1 functions as a ceRNA to contribute to berberine-mediated inhibition of HMGB1 by sponging miR-181c-5p in poststroke inflammation.	31431734
1984	Mouse	mmu-miR-181c-5p	miRNA	berberine (BBR)	post-stroke inflammation	MCAO treated ipsilateral cortex tissues	?berberine (BBR)?treatment treatment	upregulated	31431734
1985	Mouse	mmu-miR-181d	miRNA	coxsackievirus B3 (CVB3)	acute viral myocarditis (VM)	mouse heart tissues	Coxsackievirus B3 (CVB3) infection	upregulated	30915768
1986	Mouse	mmu-miR-181d	miRNA	losartan	diabetic nephropathy (DN)	kidney tissues	losartan treatment	downregulated	27770539
1987	Mouse	mmu-miR-181d	miRNA	lipopolysaccharide (LPS)	inflammation	C57BL/6 mouse	lipopolysaccharide (LPS) treatment	downregulated	24416377
1988	Mouse	mmu-miR-181d	miRNA	isoproterenol	cardiac fibrosis	heart tissues	isoproterenol (ISO) treatment	downregulated	27174579
1989	Mouse	mmu-miR-181d-5p	miRNA	acupuncture with low-frequency electrical stimulation (Acu/LFES)	muscle atrophy	serum exosome	acupuncture with low-frequency electrical stimulation (Acu/LFES) treatment	miR-181d-5p is increased in the serum exosome of Acu/LFES-treated mice.	30132347
1990	Mouse	mmu-miR-182	miRNA	lipopolysaccharide (LPS)	acute lung injury (ALI)	RAW264.7 cells	lipopolysaccharide (LPS) treatment	miR-182 is inhibited in RAW264.7 cells stimulated with LPS.	32003008
1991	Mouse	mmu-miR-182	miRNA	alcohol	alcoholic liver disease (ALD)	mouse liver cells	Lieber-DeCarli alcohol treatment	downregulated	19572984
1992	Mouse	mmu-miR-182	miRNA	methionine choline-deficient diet (MCD)	alcoholic liver disease (ALD)	liver tissues	methionine-choline-deficient (MCD) diets treatment	downregulated	19572984
1993	Mouse	mmu-miR-182	miRNA	CTLA4-Ig	alloimmune	CD4CD44 T cells	CTLA4-Ig	downregulated	27893611
1994	Mouse	mmu-miR-182	miRNA	oxygen glucose deprivation (OGD)	blood-brain barrier (BBB) dysfunction	N2a cells	oxygen glucose deprivation (OGD) treatment	MiR-182 expression was markedly upregulated and arrived at a peak 2 hours after OGD in N2a cells and was later downregulated.	32808351
1995	Mouse	mmu-miR-182	miRNA	oxygen glucose deprivation (OGD)	blood-brain barrier (BBB) dysfunction	bEnd.3 cells	oxygen glucose deprivation (OGD) treatment	"miR-182 in bEnd.3 cells began to increase at 4 hours after OGD, remained el- evated until 8 hours with a peak at 6 hours."	32808351
1996	Mouse	mmu-miR-182	miRNA	oxygen glucose deprivation (OGD)	blood-brain barrier (BBB) dysfunction	microglia; brain vascular pericytes	oxygen glucose deprivation (OGD) treatment	The level of miR-182 in microglia and brain vascular pericytes gradually decreased with the OGD time extension when compared with the respective control groups.	32808351
1997	Mouse	mmu-miR-182	miRNA	alcohol	brain injury and neurodegeneration	cerebral cortex	chronic alcohol administration	downregulated	30374194
1998	Mouse	mmu-miR-182	miRNA	dexamethasone (DEX)	catabolic diseases	mouse C2C12 myoblasts	dexamethasone (Dex) treatment	downregulated	24871856
1999	Mouse	mmu-miR-182	miRNA	tetramethylpyrazine (TMP)	glaucoma	mouse primary retinal ganglion cells (RGCs)	Tetramethylpyrazine (TMP) treatment	upregulated	31173163
2000	Mouse	mmu-miR-182	miRNA	cisplatin (DDP)	hearing loss	cochlea	cisplatin treatment	upregulated	27607577
2001	Mouse	mmu-miR-182	miRNA	high fat diet (HFD)	hepatocellular carcinoma (HCC)	plasma and hepatic tissues	high fat diet (HFD) feed	upregulated	26728044
2002	Mouse	mmu-miR-182	miRNA	lipopolysaccharide (LPS)	innate immune response	RAW264.7 cells	lipopolysaccharide (LPS) treatment	upregulated	30625496
2003	Mouse	mmu-miR-182	miRNA	pseudomonas aeruginosa (PA)	innate immune response	RAW264.7 cells	Pseudomonas aeruginosa (PA) infection treatment	upregulated	30625496
2004	Mouse	mmu-miR-182	miRNA	oxygen-glucose deprivation and reoxygenation (OGD/R)	intestinal ischemia/reperfusion (I/R) injury	mice intestinal mucosa epithelial (MIME) cells	oxygen-glucose deprivation and reoxygenation (OGD/R) treatment	downregulated	31593847
2005	Mouse	mmu-miR-182	miRNA	"TCDD (2,3,7,8-tetrachlorodibenzo-p-dioxin)"	kaposi's sarcoma (KS)	fetal thymocytes of mice	"TCDD (2,3,7,8-tetrachlorodibenzo-p-dioxin) treatment"	downregulated	23024791
2006	Mouse	mmu-miR-182	miRNA	narrow band noise	noise-induced deafness	outer hair cells	2-4 kHz narrow band noise at 100 dB SPL 6h per day for 3 consecutive days treatment	downregulated	25026825
2007	Mouse	mmu-miR-182	miRNA	perfluorooctanoic acid	perfluorooctanoic acid toxicity	mouse liver tissues	Perfluorooctanoic acid (PFOA) exposure treatment	upregulated	25092180
2008	Mouse	mmu-miR-182	miRNA	peritoneal dialysis fluid (PDF)	peritoneal fibrosis	peritoneal tissues	peritoneal dialysis fluid (PDF) treatment	upregulated	25827714
2009	Mouse	mmu-miR-182	miRNA	soluble egg antigen (SEA)of Schistosoma japonicum	schistosomiasis	mouse hepatocytes (AML12)	SEA treatment	downregulated	29469324
2010	Mouse	mmu-miR-182-5p	miRNA	cisplatin (DDP)	acute kidney injury (AKI)	kidney tissues	cisplatin treatment	upregulated	33647908
2011	Mouse	mmu-miR-182-5p	miRNA	lipopolysaccharide (LPS)	acute lung injury (ALI)	lung tissues; bronchoalveolar lavage fluid (BALF); RAW264.7 cells	lipopolysaccharide (LPS) treatment	"miR-182-5p was significantly downregulated in lung tissue and bronchoalveolar lavage fluid (BALF), as well as decreased in LPS-treated RAW264.7 cells."	31949658
2012	Mouse	mmu-miR-182-5p	miRNA	tumor necrosis factor alpha (TNF-¦Á) 	asthma	airway smooth muscle (ASM) cells	tumor necrosis factor alpha (TNF-¦Á) treatment	TNF-¦Á stimulation markedly reduced miR-182-5p expression in ASM cells	32283508
2013	Mouse	mmu-miR-182-5p	miRNA	oxygen glucose deprivation (OGD)	cerebral ischemia/reperfusion (I/R) injury	BV2 cells	oxygen-glucose deprivation (OGD) treatment	downregulated	30292407
2014	Mouse	mmu-miR-182-5p	miRNA	oxygen-glucose deprivation and reoxygenation (OGD/R)	cerebral ischemia/reperfusion (I/R) injury	HT22 (mouse hippocampal neuronal cells)	oxygen-glucose deprivation and reoxygenation (OGD/R) treatment	lncRNA SNHG14 promotes OGD/R-induced neuron injury by inducing excessive mitophagy via miR-182-5p/BINP3 axis in HT22 mouse hippocampal neuronal cells	32912324
2015	Mouse	mmu-miR-182-5p	miRNA	ethanol (EtOH)	ethanol-induced neuroinflammation and brain damage	plasma exosomes	ethanol treatment	downregulated	32937997
2016	Mouse	mmu-miR-182-5p	miRNA	fatty acid amide hydrolase (FAAH) blockade	experimental colitis	colon	Fatty acid amide hydrolase (FAAH) blockade treatment	upregulated	27327245
2017	Mouse	mmu-miR-182-5p	miRNA	microcystin (MC)	female mammals' reproductive toxicity	mouse granulosa cells (mGCs)	microcystin-LR (MC-LR) for 48 h	dysregulated	28161121
2018	Mouse	mmu-miR-182-5p	miRNA	trichloroethylene (TCE)	hepatocarcinogenesis	mouse liver tissues	Trichloroethylene (TCE) treatment	upregulated	31524101
2019	Mouse	mmu-miR-182-5p	miRNA	trichloroethylene (TCE)	hepatocellular carcinoma (HCC)	mouse liver cell lines (BNL CL.2 and Hepa1-6)	TCE at non-toxic doses (0.1 and/or 0.3 mM) treatment	upregulated	28013219
2020	Mouse	mmu-miR-182-5p	miRNA	bleomycin (BLM)	idiopathic pulmonary fibrosis (IPF)	pulmonary tissues	bleomycin (BLM) treatment	upregulated	31884830
2021	Mouse	mmu-miR-182-5p	miRNA	lipopolysaccharide (LPS)	inflammation	RAW264.7 cells	lipopolysaccharide (LPS) treatment	downregulated	32955644
2022	Mouse	mmu-miR-182-5p	miRNA	cyclosporine A (CsA)	liver toxicity	mouse hepatocytes	cyclosporine A treatment	upregulated	25047351
2023	Mouse	mmu-miR-182-5p	miRNA	bleomycin (BLM)	lung fibrosis	lung tissues	bleomycin (BLM) treatment	miR-182-5p was upregulated in pulmonary fibrosis.	31884830
2024	Mouse	mmu-miR-182-5p	miRNA	murine cytomegalovirus (MCMV)	murine cytomegalovirus (MCMV) infection	cardiac tissue	murine cytomegalovirus (MCMV) infection	downregulated	33245094
2025	Mouse	mmu-miR-182-5p	miRNA	glial cell-derived neurotrophic factor (GDNF)	parkinson's disease (PD)	primary midbrain neurons (PMNs)	glial cell line-derived neurotrophic factor (GDNF) treatment	upregulated	29858093
2026	Mouse	mmu-miR-182-5p	miRNA	staphylococcus aureus pneumonia	sepsis	?intestinal tissues	Staphylococcus aureus pneumonia infection treatment	upregulated	31318050
2027	Mouse	mmu-miR-182-5p	miRNA	H2O2	spinal cord injury (SCI)	C8-D1A cells	H2O2 treatment	miR-182-5p was significantly reduced in a dose dependent manner under dif- ferent concentrations of H2O2 stimulation.	31938420
2028	Mouse	mmu-miR-182-5p	miRNA	cyclophosphamide (CP)	systemic lupus erythematosus (SLE)	C3.MRL-Faslpr/J mice	C3.MRL-Faslpr/J mice treatment	downregulated	27924862
2029	Mouse	mmu-miR-182-5p	miRNA	trichloroethylene (TCE)	trichloroethylene (TCE) hepatocarcinogenesis	liver tissues	Trichloroethylene (TCE) treatment	downregulated of lncRNA BACE1-AS inhibits iNOS activation in the substantial nigra and improve oxidative stress injury in PD rats by upregulating miR-34b-5p and downregulating BACE1	31942800
2030	Mouse	mmu-miR-1827	miRNA	house dust mite (HDM)	asthma	C57BL/6J mice airway-secreted EVs (AEVs) were isolated from bronchoalveolar lavage fluid (BALF)	HDM treatment	dysregulated in airway-secreted EVs (AEVs) were isolated from bronchoalveolar lavage fluid (BALF)	28859242
2031	Mouse	mmu-miR-183	miRNA	alcohol	alcoholic liver disease (ALD)	mouse liver cells	Lieber-DeCarli alcohol treatment	downregulated	19572984
2032	Mouse	mmu-miR-183	miRNA	methionine choline-deficient diet (MCD)	alcoholic liver disease (ALD)	liver tissues	methionine-choline-deficient (MCD) diets treatment	downregulated	19572984
2033	Mouse	mmu-miR-183	miRNA	HO-1 inducers	bone resorption	Raw264.7 cells	HO-1 inducers treatment	downregulated	26163109
2034	Mouse	mmu-miR-183	miRNA	alcohol	brain injury and neurodegeneration	cerebral cortex	chronic alcohol administration	downregulated	30374194
2035	Mouse	mmu-miR-183	miRNA	gentamicin	hearing restoration	hair cells from mouse cochlea.	Gentamicin treatment	downregulated	29901127
2036	Mouse	mmu-miR-183	miRNA	lipopolysaccharide (LPS)	innate immune response	RAW264.7 cells	lipopolysaccharide (LPS) treatment	upregulated	30625496
2037	Mouse	mmu-miR-183	miRNA	pseudomonas aeruginosa (PA)	innate immune response	RAW264.7 cells	Pseudomonas aeruginosa (PA) infection treatment	upregulated	30625496
2038	Mouse	mmu-miR-183	miRNA	narrow band noise	noise-induced deafness	outer hair cells	2-4 kHz narrow band noise at 100 dB SPL 6h per day for 3 consecutive days treatment	downregulated	25026825
2039	Mouse	mmu-miR-183	miRNA	perfluorooctanoic acid	perfluorooctanoic acid toxicity	mouse liver tissues	Perfluorooctanoic acid (PFOA) exposure treatment	upregulated	25092180
2040	Mouse	mmu-miR-183-5p	miRNA	brucella.suis	brucellosis	CD14 knock-down RAW264.7 (224.3) macrophages	brucella infection	upregulated	28443393
2041	Mouse	mmu-miR-183-5p	miRNA	oxygen glucose deprivation (OGD)	cerebral ischemia injury (CII)	N2a cells	oxygen glucose deprivation (OGD) treatment	downregulated	32901892
2042	Mouse	mmu-miR-183-5p	miRNA	Sinomenine (SIN)	cerebral ischemia/reperfusion (I/R) injury	BV-2 cells	sinomenine treatment	Sinomenine pre- treatment increased miRNA-183-5p	30084807
2043	Mouse	mmu-miR-183-5p	miRNA	adenine	chronic kidney disease (CKD)	kidney tissues	adenine treatment	upregulated	32526762
2044	Mouse	mmu-miR-183-5p	miRNA	lipopolysaccharide (LPS)	inflammation	RAW264.7 cells	lipopolysaccharide (LPS) treatment	downregulated	32955644
2045	Mouse	mmu-miR-183-5p	miRNA	collagenase VII-S	intracerebral haemorrhage (ICH)	brain tissues	collagenase VII-Streatment	downregulated	32602850
2046	Mouse	mmu-miR-183-5p	miRNA	X rays	ionizing radiation (IR) injury	male Kunming mice blood	0.5-2 Gy total-body carbon-ion irradiation treatment	dysregulatedin blood	28632432
2047	Mouse	mmu-miR-183-5p	miRNA	palmitic acid (PA)	myogenic differentiation	C2C12 cells	Long-chain SFA palmitic acid (PA) treatment	miR-183-5p expression was found to be increased significantly in PA-treated C2C12 myo- blasts	33148375
2048	Mouse	mmu-miR-183-5p	miRNA	palmitic acid (PA)	nonalcoholic fatty liver disease (NAFLD)	AML12 cell	palmitic acid (PA) treatment	Expression of miR-183-5p was increased in the livers of three murine models and also in the AML12 cell model	33421522
2049	Mouse	mmu-miR-183-5p	miRNA	"4,4'-methylene diphenyl diisocyanate (MDI)"	occupational asthma (OA)	Female BALB/c mice blood	"4,4'-methylene diphenyl diisocyanate (MDI) exposure"	upregulated	30074411
2050	Mouse	mmu-miR-183-5p	miRNA	"diisocyanate, 4,4'-methylene diphenyl diisocyanate (MDI)"	occupational asthma (OA)	Female BALB/c mice blood	Female BALB/c mice were exposed to one of three exposure regimens: dermal exposure to 1% MDI in acetone; nose-only exposure to 4580?¡À?1497?¦Ìg/m3 MDI-aerosol for 60?minutes; or MDI dermal exposure/sensitization followed by MDI-aerosol inhalation challenge.	upregulated	30074411
2051	Mouse	mmu-miR-183-5p	miRNA	glial cell-derived neurotrophic factor (GDNF)	parkinson's disease (PD)	primary midbrain neurons (PMNs)	glial cell line-derived neurotrophic factor (GDNF) treatment	upregulated	29858093
2052	Mouse	mmu-miR-183c	miRNA	dihydroartemisinin (DHA)	asthma	asthma mice lung tissues	dihydroartemisinin (DHA) treatment	downregulated	31115390
2053	Mouse	mmu-miR-183c	miRNA	ovalbumin (OVA)	asthma	lung tissues	ovalbumin (OVA) treatment	upregulated	31115390
2054	Mouse	mmu-miR-184	miRNA	BAM8-22	bone cancer pain (BCP)	LPS-treated BV-2 mouse microglial cells	BAM8-22 treatment	upregulated	31833017
2055	Mouse	mmu-miR-184	miRNA	lipopolysaccharide (LPS)	bone cancer pain (BCP)	BV-2 mouse microglial cells	lipopolysaccharide (LPS) treatment	downregulated	31833017
2056	Mouse	mmu-miR-184	miRNA	lipopolysaccharide (LPS)	bone cancer pain (BCP)	BV-2 cells	lipopolysaccharide (LPS) treatment	"After BAM8-22 treatment, increased miR-184 level was observed in both BCP mice and LPS-treated BV-2 cells."	31833017
2057	Mouse	mmu-miR-184	miRNA	phenylephrine (PE)	cardiac hypertrophy	cardiomyocytes	phenylephrine (PE) treatment	miR-184 was downregulated in the cardiomyocytes treated with phenylephrine (PE)	29616999
2058	Mouse	mmu-miR-184	miRNA	high fat diet (HFD)	diabetic cardiomyopathy (DCM)	heart sissues	high fat diet (HFD) feed	miR-184 decreased significantly during the 24 weeks of high fat diet exposure.	32229289
2059	Mouse	mmu-miR-184	miRNA	ketogenic	insulin resistance (IR)	pancreatic ¦Â cell	ketogenic diet treatment	upregulated	24361012
2060	Mouse	mmu-miR-184	miRNA	huagan tongluo Fang (HGTLF)	liver fibrosis	CD4+ T cells	Huagan tongluo Fang (HGTLF) treatment	miR-184 was most significantly expressed after HGTLF drug stimulation.	32380055
2061	Mouse	mmu-miR-184	miRNA	ischemia	oxygen-induced retinopathy (OIR)	retinas tissues	ischemia treatment	downregulated	25796186
2062	Mouse	mmu-miR-184	miRNA	ischemia	renal fibrosis	mouse renal tissues	left anterior descending artery (LAD) ligation	upregulated	30536131
2063	Mouse	mmu-miR-184	miRNA	cortical impact	traumatic brain injury (TBI)	cortex	cortical impact	upregulated	26426744
2064	Mouse	mmu-miR-1843-3p	miRNA	propofol (PPF)	propofol-induced developmental neurotoxicity	hippocampus	propofol treatment	upregulated	30242182
2065	Mouse	mmu-miR-184-3p	miRNA	3¦Â-hydroxycholest-5-en-7-one	anti-inflammatory responses	RAW 264.7 cells	3¦Â-hydroxycholest-5-en-7-one treatment	downregulated	32771556
2066	Mouse	mmu-miR-184-3p	miRNA	microcystin-leucine arginine (MC-LR)	male infertility	Primary sertoli cells (SC) were isolated from 14-day-old ICR mouse testes	Microcystin-leucine-arginine (MC-LR) treatment	downregulated	29071384
2067	Mouse	mmu-miR-184-3p	miRNA	microcystin-leucine arginine (MC-LR)	male reproductive disorders	primary SC were isolated from 14-day-old ICR mouse	MC-LR at 500 nM on day 4	downregulated	29071384
2068	Mouse	mmu-miR-184-5p	miRNA	streptozocin (STZ)	diabetic neuropathic pain (DNP)	mouse lumbar spinal dorsal horn	STZ treatment	differently regulated	25498543
2069	Mouse	mmu-miR-184-5p	miRNA	oxygen glucose deprivation (OGD)	ischemic stroke (IS)	primary brain microvascular endothelial cells (bEnd.3)	oxygen-glucose deprivation (OGD) treatment	LncOGD-1006 might act as a ceRNA to inhibit apoptosis in bEnd3 cells by targeting miR-184-5p/CAAP1 pathway	33336752
2070	Mouse	mmu-miR-185	miRNA	resveratrol	acute liver injury (ALI)	liver mononuclear cells (MNCs)	resveratrol (Res) treatment	downregulated	30619104
2071	Mouse	mmu-miR-185	miRNA	hyperoxia	acute lung injury (ALI)	mouse primary lung epithelial cells	mouse primary lung epithelial cells treatment	upregulated	26747785
2072	Mouse	mmu-miR-185	miRNA	oxidized low density lipoprotein (ox-LDL)	atherosclerosis (AS)	mouse macrophages atherogenic Evs	oxidized low-density lipoprotein (ox-LDL) treatment	enrichment in atherogenic EVs	28882869
2073	Mouse	mmu-miR-185	miRNA	oxidized low density lipoprotein (ox-LDL)	atherosclerosis (AS)	peritoneal macrophages; Bone-marrow derived macrophages (BMDMs)	oxidized low-density lipoprotein (ox-LDL) treatment	upregulated	28882869
2074	Mouse	mmu-miR-185	miRNA	carbon tetrachloride (CCl4)	liver fibrosis	liver tissues	CCl4 treatment	downregulated	29499960
2075	Mouse	mmu-miR-185	miRNA	carbon tetrachloride (CCl4)	liver fibrosis	liver tissues	intraperitoneally injected with CCl4 (0.5 mL/kg body weight) three times a week for 4 weeks	downregulated	29499960
2076	Mouse	mmu-miR-185-5p	miRNA	Jiang Tang Xiao Ke Granule	diabetes mellitus (DM)	liver tissues	Jiang Tang Xiao Ke treatment	downregulated	32210802
2077	Mouse	mmu-miR-185-5p	miRNA	high glucose (HG)	diabetic nephropathy (DN)	mesangial cell	?high glucose (HG)?treatment treatment	The expression of Gm26917 was induced by HG but weakened by RSG	33790061
2078	Mouse	mmu-miR-185-5p	miRNA	rosiglitazone	diabetic nephropathy (DN)	mesangial cell	Rosiglitazone (RSG) treatment	The expression of Gm26917 was induced by HG but weakened by RSG	33790061
2079	Mouse	mmu-miR-185-5p	miRNA	acetaminophen (APAP)	liver damage	AML12 cells	acetaminophen (APAP) treatment	circ-CBFB acts as a miRNA sponge of miR-185-5p to mediate p66Shc in APAP-induced liver injury.	33159035
2080	Mouse	mmu-miR-186	miRNA	dexamethasone (DEX)	glucocorticoid-induced osteoporosis (GIOP)	tibia of GIOP mice	dexamethasone (DEX) treatment	downregulated in the tibia of GIOP mice	29257214
2081	Mouse	mmu-miR-186	miRNA	icariin (ICA)	glucocorticoid-induced osteoporosis (GIOP)	tibia	icariin treatment	upregulated	29257214
2082	Mouse	mmu-miR-186	miRNA	monosodium glutamate (MSG)	obesity	liver tissues	monosodium glutamate (MSG)-injected mice with developed central obesity treatment	dysregulated	24465854
2083	Mouse	mmu-miR-186	miRNA	papain	osteoarthritis (OA)	OA cartilages	papain treatment	downregulated	30500068
2084	Mouse	mmu-miR-186	miRNA	papain	osteoarthritis (OA)	OA cartilages	intra-articular injection of papain into mice	downregulated	30500068
2085	Mouse	mmu-miR-186	miRNA	complete freund's adjuvant (CFA)	trigeminal neuropathic pain	trigeminal ganglions (TGs)	complete Freund's adjuvant (CFA) treatment	downregulated	30020320
2086	Mouse	mmu-miR-186	miRNA	aerobic exercise	vascular cognitive impairment (VCI)	HT22 cells	aerobic exercise training (AET) treatment	"Aerobic exercise could shorten the average time that mice reached the platform in the Morris water maze, increase the expression level of circRIMS2 and BDNF, reduce miR-186 expression, and inhibit neuronal apoptosis."	33413076
2087	Mouse	mmu-miR-186-5p	miRNA	oxygen-glucose deprivation and reoxygenation (OGD/R)	ischemic stroke (IS)	BV2 cells	oxygen-glucose deprivation and reoxygenation (OGD/R) treatment	upregulated	33516048
2088	Mouse	mmu-miR-186-5p	miRNA	fractionated radiation	ionizing radiation (IR) injury	LLC1 cells	fractionated dose (FD) irradiation	upregulated	28599420
2089	Mouse	mmu-miR-187	miRNA	glutamate	oxidative stress	RGC-5 cells	glutamate treatment	downregulated	30170060
2090	Mouse	mmu-miR-187	miRNA	H2O2	oxidative stress	RGC-5 cells	H2O2 treatment	downregulated	30170060
2091	Mouse	mmu-miR-188	miRNA	amyloid-¦Â (A¦Â)	Alzheimer's disease (AD)	BV2;N2a cells	amyloid-¦Â (A¦Â) treatment	downregulated	32779043
2092	Mouse	mmu-miR-188	miRNA	arsenite	atherosclerosis (AS)	liver	arsenic (As) exposure	downregulated	22719926
2093	Mouse	mmu-miR-188	miRNA	homocysteine (Hcy)	cardiac hypertrophy	HL-1 cell line	homocysteine treatment	downregulated	19669742
2094	Mouse	mmu-miR-188	miRNA	high fat diet (HFD)	nonalcoholic fatty liver disease (NAFLD)	liver tissues	high fat diet (HFD) feed	miR-188 was upregulated in the liver of obese mice.	32252024
2095	Mouse	mmu-miR-188-5p	miRNA	angiotensin II (Ang II)	cardiac hypertrophy	cardiomyocytes	angiotensin II (Ang II) treatment	DSCAM-AS1 mediates pro-hypertrophy role of GRK2 in cardiac hypertrophy aggravation via absorbing miR-188-5p.	32377998
2096	Mouse	mmu-miR-188-5p	miRNA	hypoxia	choroidal neovascularization (CNV)-related diseases	"bone marrow-derived cells (BMCs), including mesenchymal stem cells (MSCs)"	hypoxia induce	downregulated	29908885
2097	Mouse	mmu-miR-188-5p	miRNA	carbon tetrachloride (CCl4)	liver fibrosis	liver	CCl4 treatment	upregulated	27322257
2098	Mouse	mmu-miR-1894-5p	miRNA	delvestidine (DLTD)	bone marrow-derived dendritic cells (BMDCs) maturity	bone marrow-derived dendritic cells (BMDCs)	Delvestidine (DLTD) treatment	downregulated	32871480
2099	Mouse	mmu-miR-1896	miRNA	IL-17	experimental autoimmune encephalomyelitis (EAE)	astrocytes from EAE mice	interleukin-17 (IL-17) treatment	upregulated	30294880
2100	Mouse	mmu-miR-1896	miRNA	IL-17	multiple sclerosis (MS)	Primary mouse astrocytes	interleukin-17 (IL-17) treatment	upregulated	30294880
2101	Mouse	mmu-miR-1897-3p	miRNA	clamping the renal pedicle	bilateral renal ischemia	C57Bl/6 mice plasma and kidneys	clamping the renal pedicle treatment	upregulated	24695114
2102	Mouse	mmu-miR-1897-5p	miRNA	cigarette smoke (CS)	ovarian toxicity	ovarian tissues	cigarette smoke (CS) treatment	upregulated	29377183
2103	Mouse	mmu-miR-18a	miRNA	polyphyllin VI (PP-VI)	breast cancer	mouse mammary carcinoma 4T1	Polyphyllin VI (PP-VI) treatment	downregulated	30817902
2104	Mouse	mmu-miR-18a	miRNA	hyperoxia	bronchopulmonary dysplasia (BPD)	lung tissues	hyperoxia treatment	downregulated	33143661
2105	Mouse	mmu-miR-18a	miRNA	panax notoginseng saponins (PNS)	comanifestation of cancer	heart tissues	PNS treatment	reduced expression of miR-18a in tumor and upregulated expression of miR-18a in heart	24903055
2106	Mouse	mmu-miR-18a	miRNA	duloxetine	depression	frontal lobe and hippocampus	duloxetine treatment	upregulated	26823914
2107	Mouse	mmu-miR-18a	miRNA	hyperoxia	hyperoxia-induced acute lung injury (HALI)	MLE-12 cells	hyperoxia treatment	downregulated	32084370
2108	Mouse	mmu-miR-18a	miRNA	¦¤9-tetrahydrocannabinol (THC)	inflammatory lung injury	splenocytes	¦¤(9) tetrahydrocannabinol (THC) treatment	upregulated	25425209
2109	Mouse	mmu-miR-18a	miRNA	panax notoginseng saponins (PNS)	breast cancer	mammary carcinoma 4T1 cells	Panax Notoginseng Saponins (PNS) treatment	downregulated	27641158
2110	Mouse	mmu-miR-18a	miRNA	TGF-¦Â	myofibroblast formation	cortical bone derived stem cells (CBSCs)	TGF-¦Â treatment	The upregulation of miR-18a was validated in adult fibroblasts treated with CBSCs compared to control cells	32656212
2111	Mouse	mmu-miR-18a	miRNA	oxygen glucose deprivation (OGD)	neuronal cell injury	Neuro-2a (N2a)	oxygen-glucose deprivation (OGD) treatment	"Silencing of SNHG15 led to CXCL13 upregulation through sequestering miR-18a and the following ERK/MEK activation, thus enhancing viability while reducing apoptosis of N2a cells."	32862188
2112	Mouse	mmu-miR-18a	miRNA	acetylcholine (ACh)	peripheral nerve injury (PNI)	hematopoietic stem cells (HSCs)	acetylcholine (ACh) treatment	"The therapeutic agents can thus be targeted to the enzyme protein, its encoding mRNA transcripts, or the regulator microRNA-132, opening new venues for therapeutic interference with multiple nervous and immune system diseases"	22448158
2113	Mouse	mmu-miR-18a	miRNA	mycobacterium tuberculosis (Mtb)	tuberculosis (TB)	RAW264.7 cells and secreted exosomes	Mycobacterium tuberculosis (Mtb) infection	upregulated	31845528
2114	Mouse	mmu-miR-18a	miRNA	mycobacterium tuberculosis (Mtb)	tuberculosis (TB)	RAW264.7 cells	mycobacterium tuberculosis (Mtb) treatment	miR-18a was induced both in Mtb-infected RAW264.7 cells and its derived exosomes compared with the controls.	31845528
2115	Mouse	mmu-mir-18a-5p	miRNA	second-hand smoke (SHS)	asthma	lung	second-hand smoke (SHS) treatment	upregulated	26859758
2116	Mouse	mmu-miR-18a-5p	miRNA	resveratrol	chronically diabetic nephropathy	db/db mice renal tissues	resveratrol (Res) treatment	upregulated	29164562
2117	Mouse	mmu-miR-18a-5p	miRNA	folic acid	kidney injury and fibrosis	kidney cortex	folic acid treatment	upregulated	26707937
2118	Mouse	mmu-miR-18a-5p	miRNA	oxygen	proliferative retinopathy (OIR)	retinal tissues	oxygen treatment	upregulated	32210827
2119	Mouse	mmu-miR-18b	miRNA	"TCDD (2,3,7,8-tetrachlorodibenzo-p-dioxin)"	kaposi's sarcoma (KS)	fetal thymocytes of mice	"TCDD (2,3,7,8-tetrachlorodibenzo-p-dioxin) treatment"	downregulated	23024791
2120	Mouse	mmu-miR-19	miRNA	imiquimod (IMQ)	psoriasis-like dermatitis	the mouse skin tissues	IMQ treatment	dysregulated	27579777
2121	Mouse	mmu-miR-190	miRNA	"1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)"	parkinson's disease (PD)	substantia nigra pars compacta (SNpc)	"1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) treatment"	downregulated	31232472
2122	Mouse	mmu-miR-190	miRNA	lipopolysaccharide (LPS)	parkinson's disease (PD)	BV2 cells	lipopolysaccharide (LPS) treatment	downregulated	31232472
2123	Mouse	mmu-miR-190	miRNA	cortical impact	traumatic brain injury (TBI)	cortex	cortical impact	downregulated	26426744
2124	Mouse	mmu-miR-1902	miRNA	lipopolysaccharide (LPS)	bacterial infection	"the whole blood, serum and white blood cells (WBCs) of C57BL/6 and Tlr2-/- mice"	lipopolysaccharide (LPS) treatment	upregulated	23286671
2125	Mouse	mmu-miR-1903	miRNA	walnut	colorectal cancer (CRC)	colorectal tumor tissue	walnut-containing diet treatment	downregulated	25882694
2126	Mouse	mmu-miR-1904	miRNA	lipopolysaccharide (LPS)	bacterial infection	"the whole blood, serum and white blood cells (WBCs) of C57BL/6 and Tlr2-/- mice"	lipopolysaccharide (LPS) treatment	upregulated	23286671
2127	Mouse	mmu-miR-1906	miRNA	microcystin (MC)	female mammals' reproductive toxicity	mouse granulosa cells (mGCs)	microcystin-LR (MC-LR) for 48 h	dysregulated	28161121
2128	Mouse	mmu-miR-1907	miRNA	high fat diet (HFD)	atherosclerosis (AS)	ApoE (-/-) mice endothelial cell	high fat diet (HFD) feed	upregulated	28804559
2129	Mouse	mmu-miR-190a-5p	miRNA	streptozocin (STZ)	diabetic neuropathic pain (DNP)	mouse lumbar spinal dorsal horn	STZ treatment	differently regulated	25498543
2130	Mouse	mmu-miR-190b	miRNA	high fat diet (HFD)	nonalcoholic fatty liver disease (NAFLD)	liver tissues	high fat diet (HFD) feed	upregulated	29575055
2131	Mouse	mmu-miR-190b	miRNA	¦Â-elemene	oxygen-induced retinopathy (OIR)	Retinas tissues	¦Â-elemene treatment	upregulated	30664207
2132	Mouse	mmu-miR-191	miRNA	ischemia/reperfusion (I/R) 	acute myocardial infarction (AMI)	heart tissues	ischemia/reperfusion (I/R) treatment	upregulated	28090786
2133	Mouse	mmu-miR-191	miRNA	arsenite	arsenicism	liver tissues	arsenite exposure	upregulated	33743404
2134	Mouse	mmu-miR-191*	miRNA	smoking	smoking-related interstitial fibrosis (SRIF)	C57 mice circulating	6 months of chronic mainstream smoking exposure treatment	downregulated	22782705
2135	Mouse	mmu-miR-1912-5p	miRNA	dioscorea bulbifera (DB)	liver damage	livers	dioscoreae bulbifera (EF) treatment	upregulated	27609015
2136	Mouse	mmu-miR-191-5p	miRNA	amyloid-¦Â (A¦Â) 1-40	age-related macular degeneration (AMD)	retinal pigment epithelium (RPE) cell	amyloid-¦Â (A¦Â) 1-40 treatment	A¦Â1-40?-mediated RPE damage by inducing a decrease in endogenous miR-191-5p expression.	33715208
2137	Mouse	mmu-miR-191-5p	miRNA	epigallocatechin-3-gallate (EGCG)	Alzheimer's disease (AD)	AD mouse serum	EGCG treatment groups (2 mg/kg/day)	upregulated	28731435
2138	Mouse	mmu-miR-191-5p	miRNA	house dust mite (HDM)	asthma	C57BL/6J mice airway-secreted EVs (AEVs) were isolated from bronchoalveolar lavage fluid (BALF)	HDM treatment	dysregulated in airway-secreted EVs (AEVs) were isolated from bronchoalveolar lavage fluid (BALF)	28859242
2139	Mouse	mmu-miR-192	miRNA	staphylococcal enterotoxin B (SEB)	acute inflammatory lung injury	lung	staphylococcal enterotoxin B treatment	upregulated	25564423
2140	Mouse	mmu-miR-192	miRNA	acetaminophen (APAP)	acute liver failure (ALF)	mouse liver tissues	acetaminophen (APAP) treatment	upregulated	28616908
2141	Mouse	mmu-miR-192	miRNA	alcohol	alcoholic hepatitis (AH)	sera	alcohol exposure	upregulated	26264599
2142	Mouse	mmu-miR-192	miRNA	TGF-¦Â	chronic hepatitis C virus (HCV) infection	Primary mouse MCs (MMCs) were cultured from renal glomeruli	Transforming growth factor-¦Â treatment	upregulated	23649518
2143	Mouse	mmu-miR-192	miRNA	alcohol extract of coreopsis tinctoria Nutt (AC)	diabetic nephropathy (DN)	db/db (DN) mice	alcohol extract of Coreopsis tinctoria Nutt (AC) treatment	downregulated	31032350
2144	Mouse	mmu-miR-192	miRNA	TGF-¦Â	diabetic nephropathy (DN)	diabetic glomeruli	TGF-¦Â treatment	upregulated	17360662
2145	Mouse	mmu-miR-192	miRNA	TGF-¦Â	DNA damage	tubular epithelial cells	TGF-¦Â treatment	downregulated	23207693
2146	Mouse	mmu-miR-192	miRNA	oxyELITE pro-new formula (OEP-NF)	drug-induced liver injury (DILI)	female B6C3F1 mice liver	administering 10X and 3X mouse-equivalent doses (MED) of OEP-NF treatment	upregulated in the liver	28843594
2147	Mouse	mmu-miR-192	miRNA	bisphenol A (BPA)	hepatic steatosis and lipid accumulation	male post-weaning C57BL/6 mice liver	bisphenol A (BPA) treatment	downregulated mouse liver	28483554
2148	Mouse	mmu-miR-192	miRNA	high fat diet (HFD)	high fat diet?influence	liver tissue	high fat diet (HFD) feed	upregulated	19835573
2149	Mouse	mmu-miR-192	miRNA	Sinomenine (SIN)	inflammation	ATDC5 cells injured by lipopolysaccharides (LPS)	Sinomenine (SIN) treatment	miR-192 was downregulated by SIN treatment	31094031
2150	Mouse	mmu-miR-192	miRNA	silymarin (Sm)	liver damage	blood and liver tissues	silymarin (Sm) treatment	upregulated	31811641
2151	Mouse	mmu-miR-192	miRNA	acetaminophen (APAP)	liver damage	liver tissues	acetaminophen (APAP) treatment	upregulated	19246379
2152	Mouse	mmu-miR-192	miRNA	dexamethasone (DEX)	muscle atrophy	Murine C2C12 myoblast cells	dexamethasone (DEX) treatment	upregulated	23716137
2153	Mouse	mmu-miR-192	miRNA	cyclosporine A (CsA)	nephrotoxicity	mouse kidney	cyclosporine A treatment	upregulated	28414804
2154	Mouse	mmu-miR-192	miRNA	pioglitazone	nonalcoholic fatty liver disease (NAFLD)	liver tissues of adiponectin knockout (adipoKO) mouse	pioglitazone treatment	resistance to pioglitazone treatment in adipoKO mice was associated with increased expression of miR-192	31176759
2155	Mouse	mmu-miR-192	miRNA	streptozocin (STZ)	nonalcoholic steatohepatitis-hepatocellular carcinoma (NASH-HCC)	high fat dietmouse liver	STZ treatment	upregulated in liver	28345673
2156	Mouse	mmu-miR-192	miRNA	aerobic training	obesity	exosomes of serum	aerobic training	downregulated	32744099
2157	Mouse	mmu-miR-192	miRNA	metformin (Met)	pancreatic cancer (PC)	human pancreatic cancer cells	metformin treatment	upregulated	22245693
2158	Mouse	mmu-miR-192	miRNA	plasmodium chabaudi malaria	peak parasitemia	liver of mice	Plasmodium chabaudi malaria infection treatment	downregulated	21085987
2159	Mouse	mmu-miR-192	miRNA	TGF-¦Â1	renal fibrosis	kidneys of diabetic mice	TGF-¦Â1 treatment	TGF-¦Â1 upregulates microRNA-192 (miR-192) in cultured glomerular mesangial cells	22223877
2160	Mouse	mmu-miR-192-5p	miRNA	ovalbumin (OVA)	asthma	lung tissues	ovalbumin (OVA) treatment	downregulated	31918268
2161	Mouse	mmu-miR-192-5p	miRNA	lipopolysaccharide (LPS)	autophagy	RAW 264.7 cells	lipopolysaccharide (LPS) treatment	downregulated	29845275
2162	Mouse	mmu-miR-192-5p	miRNA	chronic unpredictable mild stress (CUMS)	depression	Hippocampus	chronic unpredictable mild stress (CUMS) treatment	downregulated	30118321
2163	Mouse	mmu-miR-192-5p	miRNA	Jiang Tang Xiao Ke Granule	diabetes mellitus (DM)	KKAy diabetic mice	Jiang Tang Xiao Ke Granule treatment	dysregulated	29163176
2164	Mouse	mmu-miR-192-5p	miRNA	acetaminophen (APAP)	drug-induced liver injury (DILI)	plasma	acetaminophen (APAP) treatment	miR-122-5p and miR-192-5p were consistently upregulated in early to late stages of all the liver injury models.	30125006
2165	Mouse	mmu-miR-192-5p	miRNA	perfluorooctanoic acid	hepatotoxicity	liver tissues	Perfluorooctanoic acid (PFOA) exposure treatment	upregulated	24459700
2166	Mouse	mmu-miR-192-5p	miRNA	hypoxia	immunological tumor escape	B16F10	hypoxia treatment	upregulated	33066331
2167	Mouse	mmu-miR-192-5p	miRNA	carbon tetrachloride (CCl4)	liver damage	liver	CCl4 treatment	upregulated	27129188
2168	Mouse	mmu-miR-192?5p	miRNA	carbon tetrachloride (CCl4)	hepatotoxicity	blood	carbon tetrachloride (CCl4) treatment	upregulated	32528856
2169	Mouse	mmu-miR-1929-3p	miRNA	murine cytomegalovirus (MCMV)	essential hypertension (EH)	blood vessel	murine cytomegalovirus (MCMV) infection	"MCMV infection increased the blood pressure, promoted vascular remodeling, caused endothelial cell injury, and downregulated miR-1929-3p."	33416142
2170	Mouse	mmu-miR-1929-3p	miRNA	murine cytomegalovirus (MCMV)	murine cytomegalovirus (MCMV) infection	thoracic aorta	murine cytomegalovirus (MCMV) infection	downregulated	33245094
2171	Mouse	mmu-miR-1929-3p	miRNA	murine cytomegalovirus (MCMV)	murine cytomegalovirus (MCMV) infection	cardiac tissue	murine cytomegalovirus (MCMV) infection	downregulated	33245094
2172	Mouse	mmu-miR-1929-3p	miRNA	murine cytomegalovirus (MCMV)	vascular remodeling	blood vessels	murine cytomegalovirus (MCMV) infection	"MCMV infection increased the blood pressure, promoted vascular remodeling, caused endothelial cell injury, and downregulated miR-1929-3p."	33416142
2173	Mouse	mmu-miR-193	miRNA	high fat diet (HFD)	chondrogenesis	white adipose tissues	high fat diet (HFD) feed	downregulated	22496873
2174	Mouse	mmu-miR-193	miRNA	TGF-¦Â	liver fibrosis	liver	TGF-¦Â treatment	downregulated	26120970
2175	Mouse	mmu-miR-193	miRNA	chronic intermittent hypoxia (CIH)	obstructive sleep apnoea-hypopnoea syndrome (OSAHS)	mouse aortic endothelial cells (MAECs)	chronic intermittent hypoxia (CIH) treatment	upregulated	29108914
2176	Mouse	mmu-miR-193	miRNA	clozapine (CLZ)	psychotic disorders	mouse brain	clozapine treatment	upregulated	23318695
2177	Mouse	mmu-miR-193*	miRNA	staphylococcal enterotoxin B (SEB)	acute inflammatory lung injury	lung	staphylococcal enterotoxin B treatment	upregulated	25564423
2178	Mouse	mmu-miR-1930-5p	miRNA	oxygen glucose deprivation (OGD)	intracerebral haemorrhage (ICH)	Primary brain microvascular endothelial cells (BMECs)	oxygen-and-glucose-deprivation (OGD) treatment	downregulated	33836898
2179	Mouse	mmu-miR-193-3p	miRNA	apolipoprotein A-I mimetic peptide 4F	pulmonary arterial hypertension (PAH)	hypoxia mouse model lung tissue and serum	apolipoprotein A-I mimetic peptide 4F treatment	downregulated	24963038
2180	Mouse	mmu-miR-1934	miRNA	stretch	myoblast proliferation	C2C12 myoblasts	stretch treatment	downregulated	27840929
2181	Mouse	mmu-miR-193-5p	miRNA	adenine	chronic kidney disease (CKD)	kidney tissues	adenine treatment	upregulated	32526762
2182	Mouse	mmu-miR-1937a	miRNA	high fat diet (HFD)	erectile dysfunction (ED)	mouse	high fat diet (HFD) feed	dysregulated	25533598
2183	Mouse	mmu-miR-1937c	miRNA	high fat diet (HFD)	erectile dysfunction (ED)	mouse	high fat diet (HFD) feed	dysregulated	25533598
2184	Mouse	mmu-miR-193a	miRNA	insulin-like growth factor 2 (IGF-2)	cell proliferation	C-kit-positive cardiac stem cells (CSCs)	Insulin-like growth factor (IGF)-1 treatment	downregulated	29467020
2185	Mouse	mmu-miR-193a	miRNA	streptozocin (STZ)	diabetic nephropathy (DN)	lumbar spinal dorsal horn	streptozocin (STZ) treatment	downregulated	31665716
2186	Mouse	mmu-miR-193a	miRNA	oxyELITE pro-new formula (OEP-NF)	drug-induced liver injury (DILI)	female B6C3F1 mice liver	administering 10X and 3X mouse-equivalent doses (MED) of OEP-NF treatment	upregulated in the liver	28843594
2187	Mouse	mmu-miR-193a	miRNA	melatonin	leukemia	U937T cells	melatonin (MLT) treatment	upregulated	31119862
2188	Mouse	mmu-miR-193a	miRNA	ligustrazine (Lig)	lung fibrosis	paraquat (PQ)-exposed mice lung tissues	Ligustrazine (Lig) treatment	upregulated	30744607
2189	Mouse	mmu-miR-193a	miRNA	paraquat (PQ)	lung fibrosis	lung tissues	paraquat (PQ) exposure	downregulated	30744607
2190	Mouse	mmu-miR-193a-3p	miRNA	concanamycin A (Con A)	liver fibrosis	liver tissues	concanavalin A (ConA) treatment	downregulated	30945448
2191	Mouse	mmu-miR-193a-3p	miRNA	plasmodium chabaudi malaria	peak parasitemia	liver of mice	Plasmodium chabaudi malaria infection treatment	downregulated	21085987
2192	Mouse	mmu-miR-193a-5p	miRNA	resveratrol	acute lung injury (ALI)	lung tissues	resveratrol (Res) treatment	miR-193a was strongly induced by SEB and was downregulated by RES treatment	29512867
2193	Mouse	mmu-miR-193a-5p	miRNA	diethylnitrosamine (DEN)	hepatocellular carcinoma (HCC)	liver tissues	diethylnitrosamine (DEN) treatment	downregulated	30165047
2194	Mouse	mmu-miR-193a-5p	miRNA	diethylnitrosamine (DEN)	hepatocellular carcinoma (HCC)	liver tissues	diethylnitrosamine (DEN) treatment	downregulated	30165047
2195	Mouse	mmu-miR-193b	miRNA	H2O2	Alzheimer's disease (AD)	Primary hippocampal neuron cells	H2O2 treatment	upregulated	24423585
2196	Mouse	mmu-miR-193b	miRNA	H2O2	Alzheimer's disease (AD)	senescence accelerated mouse prone 8 (SAMP8) and prone 10 (SAMP10)	"different concentrations (0, 100, 200, 400 and 800 ¦ÌM) of H2O2 treatment"	upregulated	24423585
2197	Mouse	mmu-miR-193b	miRNA	luteinising hormone (LH)	functions of Leydig cells	mouse TM3 Leydig cells	luteinising hormone (LH) treatment	upregulated	28762514
2198	Mouse	mmu-miR-193b	miRNA	high fat diet (HFD)	hepatocellular carcinoma (HCC)	plasma and hepatic tissues	high fat diet (HFD) feed	upregulated	26728044
2199	Mouse	mmu-miR-193b	miRNA	luteinising hormone (LH)	steroidogenesis	mouse TM3 Leydig cells	luteinising hormone(LH) treatment	dysregulated	28762514
2200	Mouse	mmu-miR-193b*	miRNA	cecal ligation and puncture (CLP)	polymicrobial sepsis	C57Bl/6 mice	cecal ligation and puncture (CLP) treatment	different regulation	24413579
2201	Mouse	mmu-miR-193b-3p	miRNA	concanamycin A (Con A)	autoimmune hepatitis (AIH)	liver tissues	concanavalin A (Con A) treatment	downregulated	32965791
2202	Mouse	mmu-mir-193b-3p	miRNA	recombinant-specific gram-negative pathogen Escherichia coli (Xen14) and gram-positive pathogen Staphylococcus aureus (Xen29)	bacterial infection	blood	recombinant-specific gram-negative pathogen Escherichia coli (Xen14) and gram-positive pathogen Staphylococcus aureus (Xen29) treatment	upregulated	25563241
2203	Mouse	mmu-miR-193b-3p	miRNA	concanamycin A (Con A)	liver fibrosis	liver tissues	concanavalin A (ConA) treatment	downregulated	30945448
2204	Mouse	mmu-miR-194	miRNA	carbon tetrachloride (CCl4)	liver fibrosis	liver tissues	carbon tetrachloride (CCl4) treatment	downregulated	31496625
2205	Mouse	mmu-miR-194	miRNA	lipopolysaccharide (LPS)	acute lung injury (ALI)	lung tissues	lipopolysaccharide (LPS) treatment	downregulated	32522221
2206	Mouse	mmu-miR-194	miRNA	high fat diet (HFD)	acute myocardial infarction (AMI)	liver tissue	high fat diet (HFD) feed	downregulated	19835573
2207	Mouse	mmu-miR-194	miRNA	ethanol (EtOH)	alcoholic liver disease (ALD)	liver tissues	ethanol treatment	"MiR-194 was upregulated in the alcoholic liver disease, which was significantly suppressed by Yangonin (Yan)."	33068587
2208	Mouse	mmu-miR-194	miRNA	yangonin (Yan)	alcoholic liver disease (ALD)	ethanol-induced liver injury rats liver tissues	Yangonin (Yan) treatment	"MiR-194 was upregulated in the alcoholic liver disease, which was significantly suppressed by Yangonin (Yan)"	33068587
2209	Mouse	mmu-miR-194	miRNA	bupivacaine	bupivacaine-induced neurotoxicity	mouse DRG neurons	bupivacaine treatment	lincRNA PADNA/miR-194/FBXW7 axis plays an important role in the neurotoxicity process.	32791990
2210	Mouse	mmu-miR-194	miRNA	replicative senescence and stress	cell senescence	NIH/3T3 cells	replicative senescence and stress treatment	upregulated	27981676
2211	Mouse	mmu-miR-194	miRNA	lipopolysaccharide (LPS)	inflammation	RAW264.7 cells	lipopolysaccharide (LPS) treatment	upregulated	26639663
2212	Mouse	mmu-miR-194	miRNA	silymarin (Sm)	liver damage	blood and liver tissues	silymarin (Sm) treatment	upregulated	31811641
2213	Mouse	mmu-miR-194	miRNA	177lu-octreotate	neuroendocrine tumors	Female BALB/c nude mice	"inject 1.3, 3.6, 14, 45, or 140 MBq 177Lu-octreotate treatment"	"miR-194, miR-107, miR-3090, and miR-3077 were commonly regulated"	25386939
2214	Mouse	mmu-miR-194	miRNA	green tea (GT)	nonalcoholic fatty liver disease (NAFLD)	liver tissues from Male C57Bl/6 mice were fed with a high-fat diet for 4 weeks	green tea (GT) treatment	upregulated	31885789
2215	Mouse	mmu-miR-194	miRNA	high fat diet (HFD)	nonalcoholic fatty liver disease (NAFLD)	male C57BL/6J mice liver	high fat diet (HFD) feed	upregulated	28951211
2216	Mouse	mmu-miR-194	miRNA	high fat diet (HFD)	nonalcoholic fatty liver disease (NAFLD)	liver tissues	high fat diet (HFD) feed	downregulated	31885789
2217	Mouse	mmu-miR-194	miRNA	metformin (Met)	nonalcoholic steatohepatitis (NASH)	liver tissues	metformin treatment	downregulated	25672270
2218	Mouse	mmu-miR-1941	miRNA	stretch	myoblast proliferation	C2C12 myoblasts	stretch treatment	upregulated	27840929
2219	Mouse	mmu-miR-194-5p	miRNA	ethyl acetate fraction of airpotato yam	liver damage	ICR and C57BL/6 mice	treat with ethyl acetate fraction of airpotato yam	significantly upregulated with no significant elevation of serum ALT/AST activity	28844483
2220	Mouse	mmu-miR-194-5p	miRNA	chronic unpredictable mild stress (CUMS)	major depressive disorder (MDD)	nucleus accumbens (NAc) tissues	chronic unpredictable mild stress (CUMS) induce	upregulated	30936699
2221	Mouse	mmu-miR-194-5p	miRNA	liraglutide	type 2 diabetes mellitus (T2DM)	whole bone marrow exosomes	liraglutide 0.2 mg/kg for 2 months	dysregulated	29133778
2222	Mouse	mmu-miR-1946a	miRNA	alcohol	lung injury	lung tissues; murine primary lung fibroblasts	chronic alcohol administration	Chronic alcohol ingestion attenuates miR-1946a in the murine lung.	33154445
2223	Mouse	mmu-miR-195	miRNA	lipopolysaccharide (LPS)	acute aortic dissection (AAD)	aorta	lipopolysaccharide (LPS) treatment	downregulated	32634201
2224	Mouse	mmu-miR-195	miRNA	carbon tetrachloride (CCl4)	acute liver injury (ALI)	liver tissues	carbon tetrachloride (CCl4) treatment	miR-195 was markedly increased in CCl4-induced ALI.	32277959
2225	Mouse	mmu-miR-195	miRNA	angiotensin II (Ang II)	aortic aneurysmal disease	C57BL6 mice	angiotensin II (Ang II) treatment	downregulated	25201911
2226	Mouse	mmu-miR-195	miRNA	palmitate	apoptosis	neonatal mouse cardiomyocytes	palmitate drug treatment	upregulated	21622680
2227	Mouse	mmu-miR-195	miRNA	streptozocin (STZ)	apoptosis	mouse podocytes?(diabetic nephropathy)	streptozocin (STZ) treatment	upregulated	22123611
2228	Mouse	mmu-miR-195	miRNA	oxytocin (OT)	breast cancer	Mouse mammary adenocarcinoma tumors	Oxytocin (OT) treatment	upregulated	30076862
2229	Mouse	mmu-miR-195	miRNA	puerarin	cardiac hypertrophy	Ang II-induced cardiac hypertrophy	Puerarin treatment	upregulated	27145790
2230	Mouse	mmu-miR-195	miRNA	thyroid stimulating hormone	cell proliferation	Rat FRTL-5 thyroid cells	thyroid stimulating hormone treatment	downregulated	22301781
2231	Mouse	mmu-miR-195	miRNA	cigarette smoke (CS)	chronic obstructive pulmonary disease (COPD)	lung tissues	cigarette smoke (CS) exposure	upregulated	29223853
2232	Mouse	mmu-miR-195	miRNA	cigarette smoke (CS)	chronic obstructive pulmonary disease (COPD)	mouse lung	cigarette smoke (CS) exposure	upregulated in the lung	29223853
2233	Mouse	mmu-miR-195	miRNA	streptozocin (STZ)	diabetes mellitus (DM)	hearts of diabetic mice	streptozotocin (STZ) treatment	upregulated	21584493
2234	Mouse	mmu-miR-195	miRNA	IFN-¦Â	liver fibrosis	hepatic stellate cells (HSCs)	interferon-¦Â treatment	upregulated	21792910
2235	Mouse	mmu-miR-195	miRNA	saturated fatty acid (SFA) and high fat diet (HFD)	hepatic insulin sensitivity	hepatocytes	saturated fatty acid (SFA) and high fat diet (HFD) treatment	significantly induce miR-195 expression in hepatocytes	25240198
2236	Mouse	mmu-miR-195	miRNA	diethylnitrosamine (DEN)	hepatocellular carcinoma (HCC)	liver tissues	diethylnitrosamine (DEN) treatment	upregulated	32216509
2237	Mouse	mmu-miR-195	miRNA	"5-Aza-2'-deoxycytidine (5-Aza-dC, decitabine)"	muscle cell proliferation and differentiation	mouse skeletal myoblast C2C12 cells	"5-Aza-2'-deoxycytidine (5-Aza-dC, decitabine) treatment"	upregulated	28255268
2238	Mouse	mmu-miR-195	miRNA	lipopolysaccharide (LPS)	parkinson's disease (PD)	BV2 cells	lipopolysaccharide (LPS) treatment	downregulated	31059087
2239	Mouse	mmu-miR-195	miRNA	cecal ligation and puncture (CLP)	sepsis	whole blood	cecal ligation and puncture (CLP) treatment	upregulated	24205035
2240	Mouse	mmu-miR-1953	miRNA	lipopolysaccharide (LPS)	spinal cord injury (SCI)	BV2 cells	lipopolysaccharide (LPS) treatment	downregulated	33524472
2241	Mouse	mmu-miR-1954	miRNA	angiotensin II (Ang II)	cardiac fibrosis	heart tissues	angiotensin II (Ang II) treatment	downregulated	31640463
2242	Mouse	mmu-miR-195-5p	miRNA	lipopolysaccharide (LPS)	osteoarthritis (OA)	ATDC5 cells	lipopolysaccharide (LPS) treatment	upregulated	30942447
2243	Mouse	mmu-miR-195-5p	miRNA	orthodontic mechanical loading	osteogenic differentiation and bone formation	periodontal tissues of mice	orthodontic mechanical loading	downregulated	28181691
2244	Mouse	mmu-miR-1959	miRNA	eimeria papillata	eimeria papillata infection	mouse jejunum	Eimeria papillata infection	upregulated	21093440
2245	Mouse	mmu-miR-195a-3p	miRNA	hypoxia	angiogenesis	mesenchymal stem cells (MSCs)	hypoxia treatment	downregulated	26989874
2246	Mouse	mmu-miR-195a-3p	miRNA	heat shock factor 1 (HSF1)	cardiac remodeling	heart tissues and endothelial cells (ECs)	Heat shock transcription factor 1 (HSF1) deficiency	upregulated	29626503
2247	Mouse	mmu-miR-196	miRNA	hypoxic/ischemic	hypoxic/ischemic brain damage (HIBD)	primary hippocampal cells	hypoxic/ischemic stress	"Snhg3 acted as the sponge of miR-196 in the hippocampal cells by regulating the expression of miR-196 target genes, XIAP and CAAP1."	31751562
2248	Mouse	mmu-miR-1960	miRNA	propofol (PPF)	propofol-induced developmental neurotoxicity	hippocampus	propofol treatment	downregulated	30242182
2249	Mouse	mmu-miR-196a	miRNA	"AhR agonists benzo[a]pyrene (B[a]P) and FICZ, AhR antagonist CH-223191"	aryl hydrocarbon receptor (AhR)	AhR(+/+) mouse lung fibroblasts	"B[a]P and FICZ ,CH-223191 treatment"	downregulated	25178717
2250	Mouse	mmu-miR-196a	miRNA	¦Â-adrenergic	brown adipogenesis	WAT-progenitor cells	¦Â-adrenergic treatment	upregulated	22545021
2251	Mouse	mmu-miR-196a	miRNA	losartan	diabetic nephropathy (DN)	kidney tissues	losartan treatment	downregulated	27770539
2252	Mouse	mmu-miR-196a	miRNA	progesterone (P4)	infertility	uterine horn of 6-week-old female mice (C57BL/6)	progesterone treatment	dysregulated	30603515
2253	Mouse	mmu-miR-197	miRNA	lipopolysaccharide (LPS)	inflammation	The mouse immortalized podocyte cell line MPC5	lipopolysaccharide (LPS) treatment	upregulated	31115515
2254	Mouse	mmu-miR-1971	miRNA	gentamicin	acute kidney injury (AKI)	urine	gentamicin treatment	upregulated	27074385
2255	Mouse	mmu-miR-1971	miRNA	fluoxetine (Prozac)	post-traumatic stress disorder (PTSD)	mouse prefrontal cortices (PFCs)	Fluoxetine treatment	downregulated	23847554
2256	Mouse	mmu-miR-1981	miRNA	brucella.suis	chronic infection	RAW264.7 cells	brucella infection	upregulated	22904669
2257	Mouse	mmu-miR-1981-3p	miRNA	high glucose (HG)	diabetic nephropathy (DN)	mouse podocytes	high glucose (HG) treatment	downregulated	33224036
2258	Mouse	mmu-miR-1981-5p	miRNA	echinococcus multilocularis metacestodes	echinococcus multilocularis infection	RAW 264.7 cells	E. multilocularis metacestodes treatment	downregulated	30322806
2259	Mouse	mmu-miR-1981-5p	miRNA	E. multilocularis metacestodes	infection and immunity of E. multilocularis	RAW264¡¤7 macrophage cells	E. multilocularis metacestodes for 6 and 12 h treatment	"upregulated (mmu-miR-378d,mmu-miR-155-5p, mmu-miR-146a-5p, mmu-miR-21a-5p , mmu-miR-125a-5p) and downregulated(mmu-miR-1981-5p , mmu-miR-let-7c-1-3p)"	28942753
2260	Mouse	mmu-miR-1983	miRNA	adiponectin	frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS)	?adipose tissue (AT)	adiponectin (ApN) treatment	downregulated	23015294
2261	Mouse	mmu-miR-199	miRNA	sodium arsenite (NaAsO2)	arsenic inhibited cellular differentiation	pluripotent P19 mouse embryonal carcinoma cells	sodium arsenite treatment	downregulated	29121352
2262	Mouse	mmu-miR-199	miRNA	glucose	diabetes mellitus (DM)	mouse insulinoma cells (MIN6) and mouse pancreatic beta-cells	glucose treatment	upregulated	31882540
2263	Mouse	mmu-miR-199	miRNA	hypoxia	hepatic ischemia/reperfusion injury (HIRI)	BNL-CL2	hypoxia induce	downregulated	31827704
2264	Mouse	mmu-miR-199-3p	miRNA	ovalbumin (OVA)	allergic rhinitis (AR)	nasal tissues	ovalbumin (OVA) treatment	upregulated	31124216
2265	Mouse	mmu-miR-199-3p	miRNA	high glucose (HG)	pancreatic ¦Â-cell dysfunction	mouse islets; mouse insulinoma cells (MIN6)	high glucose (HG) treatment	upregulated	31882540
2266	Mouse	mmu-miR-199-5p	miRNA	high-fat high-fructose diet (HFHFD)	nonalcoholic fatty liver disease (NAFLD)	liver tissues	High-fatty and high-frutose-diet feed	upregulated	30347922
2267	Mouse	mmu-miR-199-5p	miRNA	total saponins of Panax japonicas(TPSJ)	nonalcoholic fatty liver disease (NAFLD)	NAFLD mouse liver tissues	total saponins of Panax japonicas(TPSJ) treatment	downregulated	30347922
2268	Mouse	mmu-miR-199-5p	miRNA	high glucose (HG)	pancreatic ¦Â-cell dysfunction	mouse islets; mouse insulinoma cells (MIN6)	high glucose (HG) treatment	upregulated	31882540
2269	Mouse	mmu-miR-199a	miRNA	lipopolysaccharide (LPS)	acute kidney injury (AKI)	kidney tissues	lipopolysaccharide (LPS) treatment	The upregulation of ANRIL can reduce the expression of microRNA-199a and increases the number of apoptotic cells	32069473
2270	Mouse	mmu-miR-199a	miRNA	oxygen-glucose deprivation and reoxygenation (OGD/R)	brain microvascular endothelial cell injury	brain microvascular endothelial cells	oxygen-glucose deprivation and reoxygenation (OGD/R) treatment	downregulated	30233065
2271	Mouse	mmu-miR-199a	miRNA	tough decoys (TuDs)	cardiac hypertrophy	cardiac samples	tough decoys (TuDs) treatment	upregulated	33473326
2272	Mouse	mmu-miR-199a	miRNA	high-fat/high-cholesterol diet or a high-protein diet	dyslipidemia	DO mice	a high-fat/high-cholesterol diet or a high-protein diet for 18 wk	dysregulated	28916633
2273	Mouse	mmu-miR-199a	miRNA	rapamycin	HIV-associated nephropathy(HIVAN)	mice renal tissues	Rapamycin treatment	downregulated	23611955
2274	Mouse	mmu-miR-199a	miRNA	progesterone (P4)	infertility	uterine horn of 6-week-old female mice (C57BL/6)	progesterone treatment	dysregulated	30603515
2275	Mouse	mmu-miR-199a	miRNA	hypoxia	ischemic stroke (IS)	primary neuronal cells and N2a cells	oxygen-glucose deprivation (OGD) treatment	downregulated	30144542
2276	Mouse	mmu-miR-199a	miRNA	oxygen-glucose deprivation and reoxygenation (OGD/R)	ischemic stroke (IS)	brain microvascular endothelial cells (BMECs)	oxygen-glucose deprivation and reoxygenation (OGD/R) treatment	downregulated	29883549
2277	Mouse	mmu-miR-199a	miRNA	lipopolysaccharide (LPS)	lung injury	lung tissues	lipopolysaccharide (LPS) treatment	downregulated	22185353
2278	Mouse	mmu-miR-199a	miRNA	pristane (PS)	lupus nephritis (LN)	kidney tissues	pristane treatment	upregulated	30316188
2279	Mouse	mmu-miR-199a	miRNA	carbon tetrachloride (CCl4)	multiple myeloma (MM)	liver tissue of mouse	CCl4 treatment	upregulated	21283674
2280	Mouse	mmu-miR-199a	miRNA	lipopolysaccharide (LPS)	sepsis-induced acute respiratory distress syndrome	mouse alveolar macrophages	?LPS?treatment treatment	upregulated	29351405
2281	Mouse	mmu-miR-199a*	miRNA	carbon tetrachloride (CCl4)	multiple myeloma (MM)	liver tissue of mouse	CCl4 treatment	upregulated	21283674
2282	Mouse	mmu-miR-199a-3p	miRNA	high fat diet (HFD)	adipogenesis	mouse adipose tissue	high fat diet (HFD) feed	downregulated in adipose tissue	28803985
2283	Mouse	mmu-miR-199a-3p	miRNA	alcohol	alcoholic liver disease (ALD)	mouse liver cells	Lieber-DeCarli alcohol treatment	downregulated	19572984
2284	Mouse	mmu-miR-199a-3p	miRNA	methionine choline-deficient diet (MCD)	alcoholic liver disease (ALD)	liver tissues	methionine-choline-deficient (MCD) diets treatment	downregulated	19572984
2285	Mouse	mmu-miR-199a-3p	miRNA	estradiol-17¦Â (E2)	autophagy	mouse osteocyte-like MLO-Y4 cells	estradiol-17¦Â (E2) treatment	downregulated	28708244
2286	Mouse	mmu-miR-199a-3p	miRNA	CL 316243 disodium salt	brown adipocyte differentiation	mouse interscapular brown brown adipose tissues (iBAT)	CL 316243 disodium salt treatment	downregulated	29753771
2287	Mouse	mmu-miR-199a-3p	miRNA	cold	brown adipocyte differentiation	mouse interscapular brown brown adipose tissues (iBAT)	cold induce	downregulated	29753771
2288	Mouse	mmu-miR-199a-3p	miRNA	brucella.suis	brucellosis	CD14 knock-down RAW264.7 (224.3) macrophages	brucella infection	upregulated	28443393
2289	Mouse	mmu-miR-199a-3p	miRNA	lipopolysaccharide (LPS)	cervical remodeling	cervical samples	lipopolysaccharide (LPS) treatment	downregulated	32468045
2290	Mouse	mmu-miR-199a-3p	miRNA	sarpogrelate and telmisartan	chronic kidney disease (CKD)	urinary	sarpogrelate and telmisartan treatment	miR-199a-3p was commonly reduced by sarpogrelate and telmisartan treatment	33359069
2291	Mouse	mmu-miR-199a-3p	miRNA	streptozocin (STZ)	diabetes mellitus (DM)	hearts of diabetic mice	streptozotocin (STZ) treatment	upregulated	21584493
2292	Mouse	mmu-miR-199a-3p	miRNA	¦Â-hydroxy-¦Â-methylbutyrate (HMB)	cell differentiation	muscle	¦Â-hydroxy-¦Â-methylbutyrate (HMB) treatment	upregulated	31891490
2293	Mouse	mmu-miR-199a-3p	miRNA	low-protein diet (LP0.5)	glucose homeostasis	¦Â cells	low-protein diet (LP0.5)	downregulated	25180600
2294	Mouse	mmu-miR-199a-3p	miRNA	carbon tetrachloride (CCl4)	liver fibrosis	liver tissues	carbon tetrachloride (CCl4) treatment	upregulated	29557526
2295	Mouse	mmu-miR-199a-3p	miRNA	¦Â-hydroxy-¦Â-methylbutyrate (HMB)	myofiber specification	"gastrocnemius, soleus muscle and C2C12 myotubes"	¦Â-hydroxy-¦Â-methylbutyrate (HMB) treatment	upregulated	31891490
2296	Mouse	mmu-miR-199a-3p	miRNA	high fat diet (HFD)	nonalcoholic fatty liver disease (NAFLD)	C57BL/6J mice liver	high fat diet (HFD) feed	downregulated in the livers	28469795
2297	Mouse	mmu-miR-199a-5p	miRNA	qiliqiangxin (QL)	acute myocardial infarction (AMI)	PE induced cardiomyocytes	Qiliqiangxin (QL) treatment	the increase of miR-199a-5p in PE-treated cardiomyocytes was reversed by the treatment with QL	27161004
2298	Mouse	mmu-miR-199a-5p	miRNA	X-rays	bystander effect	C57BL/6 mice extracellular vesicles (EVs)	otal-body irradiated with X-rays	upregulated	28396668
2299	Mouse	mmu-miR-199a-5p	miRNA	receptor activator of nuclear factor-¦ÊB ligand (RANKL)	cell differentiation	bone marrow macrophages (BMMs) and RAW 264.7 cells	receptor activator of nuclear factor kappa-B ligand (RANKL) treatment	upregulated	30387167
2300	Mouse	mmu-miR-199a-5p	miRNA	oxygen-glucose deprivation and reoxygenation (OGD/R)	cerebral ischemia/reperfusion (I/R) injury	HT22 cells	oxygen-glucose deprivation and reoxygenation (OGD/R) treatment	upregulated	31990992
2301	Mouse	mmu-miR-199a-5p	miRNA	resolvin D1 (RvD1)	extracellular matrix synthesis	macrophages	resolvin D1 (RvD1) treatment	upregulated	24249635
2302	Mouse	mmu-miR-199a-5p	miRNA	hyperoxia	hyperoxia-induced acute lung injury (HALI)	mice lungs and lung epithelial cells (MLE12)	hyperoxia induce	upregulated	31390652
2303	Mouse	mmu-miR-199a-5p	miRNA	resolvin D1 (RvD1)	insulin resistance and nonalcoholic steatohepatitis (NASH)	obese mice with NASH	resolvin D1 (RvD1) treatment	upregulated	24249635
2304	Mouse	mmu-miR-199a-5p	miRNA	oxygen glucose deprivation (OGD)	ischemic stroke (IS)	N-2a cells	oxygen and glucose deprivation treatment	ANRIL protects N-2a cells against ischemia induced injury by elevated CAV-1 by competitively interacting with miR-199a-5p	31907708
2305	Mouse	mmu-miR-199a-5p	miRNA	¦Á-Tocotrienol (TCT)	ischemic stroke (IS)	primary cortical neuronal cells	¦Á-Tocotrienol (TCT)?treatment treatment	downregulated	21719775
2306	Mouse	mmu-miR-199a-5p	miRNA	Japanese encephalitis virus (JEV)	Japanese encephalitis virus (JEV) infection	BV-2 cells; mouse neuroblastoma cell line NA; mouse brain endothelial cell line bEnd.3 	Japanese encephalitis virus (JEV) infection	downregulated	32461319
2307	Mouse	mmu-miR-199a-5p	miRNA	fructus meliae toosendan (FMT)	liver damage	eft lateral liver lobe	Fructus Meliae Toosendan (FMT) treatment	downregulated	26539117
2308	Mouse	mmu-miR-199a-5p	miRNA	high fat diet (HFD)	nonalcoholic fatty liver disease (NAFLD)	adipose tissues	high fat diet (HFD) feed	microRNA 199a-5p (miR-199a-5p) was significantly upregulated in high fat diet-induced steatosis mouse model.	33037981
2309	Mouse	mmu-miR-199a-5p	miRNA	methionine choline-deficient diet (MCD)	nonalcoholic steatohepatitis (NASH)	liver tissues	were fed a methionine-choline-deficient (MCD) diet for eight weeks treatment	upregulated	25269746
2310	Mouse	mmu-miR-199a-5p	miRNA	dexamethasone (DEX)	osteoporosis	osteoblasts	dexamethasone (Dex) treatment	upregulated	25878056
2311	Mouse	mmu-miR-199a-5p	miRNA	bile acids	sustained endoplasmic reticulum stress	mouse liver tissue	bile acids treatment	upregulated	23598416
2312	Mouse	mmu-miR-199b-3p	miRNA	hypoxia	ischemic stroke (IS)	?brain tissues	middle cerebral artery occlusion-reperfusion (MCAO-R)?induce	downregulated	31204565
2313	Mouse	mmu-miR-199b-5p	miRNA	atrasentan	diabetic nephropathy (DN)	mice renal proximal tubular epithelial cells	atractylon (Atr)?treatment	downregulated	29623952
2314	Mouse	mmu-miR-199b-5p	miRNA	hypoxia	myocardial infarction (MI)	heart tiisues	permanent ligation of the left coronary artery	upregulated in heart	30159417
2315	Mouse	mmu-miR-199b-5p	miRNA	curcumin (Cur)	neuroinflammation	LPS-treated BV2 microglial cells	curcumin treatment	upregulated	31862869
2316	Mouse	mmu-miR-199b-5p	miRNA	lipopolysaccharide (LPS)	neuroinflammation	BV2 microglial cells	lipopolysaccharide (LPS) treatment	downregulated	31862869
2317	Mouse	mmu-miR-199b-5p	miRNA	partial pancreatectomy (PPx)	cell proliferation	pancreas	partial pancreatectomy (PPx) treatment	upregulated	27280801
2318	Mouse	mmu-miR-19a	miRNA	hyperoxia	bronchopulmonary dysplasia (BPD)	lung tissues	hyperoxia treatment	downregulated	33143661
2319	Mouse	mmu-miR-19a	miRNA	high glucose (HG)	cardiomyocyte senescence	Neonatal mouse ventricular cells (NMVCs)	high glucose (HG) treatment	downregulated	33664669
2320	Mouse	mmu-miR-19a	miRNA	IL-10	colonic inflammation	colonic intraepithelial lymphocytes	IL-10 treatment	downregulated	22043014
2321	Mouse	mmu-miR-19a	miRNA	lipopolysaccharide (LPS)	endometriosis	uterine tissues	lipopolysaccharide (LPS) treatment	downregulated	30673803
2322	Mouse	mmu-miR-19a	miRNA	IL-10	epithelial-mesenchymal transition (EMT)	colonic intraepithelial lymphocytes	IL-10 treatment	upregulated	22043014
2323	Mouse	mmu-miR-19a	miRNA	ischemia	ischemia/reperfusion (I/R) injury	cerebral cortex and hippocampus	Ischemic preconditioning and ischemic postconditioning (IPostC) treatment	upregulated	27485299
2324	Mouse	mmu-miR-19a	miRNA	grape seed procyanidin extract (GSPE)	lung cancer	A549 cells	grape seed procyanidin extract (GSE) treatment	downregulated	27289489
2325	Mouse	mmu-miR-19a	miRNA	microwave	microwave-induced adverse health outcomes 	mouse hippocampus	7 days after 30 mW/cm microwave exposure treatment	downregulated	24748327
2326	Mouse	mmu-miR-19a	miRNA	bleomycin and silica	lung fibrosis	fibroblasts	bleomycin and silica treatment	"qPCR revealed a significant increase of miR-19a, 19b, and 20a-expression in activated fibroblasts in the early phase of bleomycin and silica models."	29923329
2327	Mouse	mmu-miR-19a	miRNA	smoking	smoking-related interstitial fibrosis (SRIF)	C57 mice circulating	6 months of chronic mainstream smoking exposure treatment	downregulated	22782705
2328	Mouse	mmu-miR-19a-3p	miRNA	angiotensin II (Ang II)	cardiac hypertrophy	neonatal mouse cardiomyocytes (NMCMs)	angiotensin II (Ang II) treatment	downregulated	29664809
2329	Mouse	mmu-miR-19a-3p	miRNA	H2O2	myocardial infarction (MI)	Primary neonatal mice cardiomyocytes (NMCMs)	H2O2 treatment	miR-19a-3p level was upregulated in response to H2O2 treatment.	33352533
2330	Mouse	mmu-miR-19b	miRNA	short ragweed pollen	allergic conjunctivitis (AC)	conjunctiva; cornea; cervical lymph nodes (CLN)	short ragweed pollen treatment	"In the murine AC model, miR-19b was aberrantly downregulated"	32150250
2331	Mouse	mmu-miR-19b	miRNA	hyperoxia	bronchopulmonary dysplasia (BPD)	lung tissues	hyperoxia treatment	downregulated	33143661
2332	Mouse	mmu-miR-19b	miRNA	diosgenin (DIO)	cholesterol metabolism and atherogenesis	THP-1 macrophages	diosgenin (DIO) treatment	downregulated	25765596
2333	Mouse	mmu-miR-19b	miRNA	pectin (fermented to butyrate in the colon) (FPA)	colon tumorigenesis	colonic stem cells	(fermented to butyrate in the colon) (FPA) treatment	upregulated	26493444
2334	Mouse	mmu-miR-19b	miRNA	acetaminophen (APAP)	drug-induced liver injury (DILI)	mouse liver	?acetaminophen (APAP) treatment	downregulated	31077331
2335	Mouse	mmu-miR-19b	miRNA	myelin oligodendrocyte glycoprotein	experimental autoimmune encephalomyelitis (EAE)	EAE mouse brain tissues	myelin oligodendrocyte glycoprotein (MOG35- 55) treatment	downregulated	30289071
2336	Mouse	mmu-miR-19b	miRNA	"5-Aza-2'-deoxycytidine (5-Aza-dC, decitabine)"	gastric cancer (GC)	balb/c nu-nu mice injected with 107 GC cells	"5-Aza-2'-deoxycytidine (5-Aza-dC, decitabine) treatment"	upregulated	25270964
2337	Mouse	mmu-miR-19b	miRNA	fibrinogen	haemorrhagic shock	lung tissue	fibrinogen treatment	"Pulmonary microRNA-19b was increased after haemorrhagic shock and lactated Ringers, but reduced to sham levels by plasma and fibrinogen."	33539284
2338	Mouse	mmu-miR-19b	miRNA	Deoxycorticosterone acetate (Doca)	hypertensive heart disease (HHD)	mouse HHD cells	injection of Deoxycorticosterone acetate (Doca)	upregulated in HHD cells	28531963
2339	Mouse	mmu-miR-19b	miRNA	hypoxia	hypoxia-induced injury	BV2 cells	hypoxia induce	downregulated	30767206
2340	Mouse	mmu-miR-19b	miRNA	recombinant Adeno-Cre viruses (AdV-Cre)	lung adenocarcinoma (LUAD)	lung	recombinant Adeno-Cre viruses (AdV-Cre) treatment	downregulated	25359683
2341	Mouse	mmu-miR-19b	miRNA	grape seed procyanidin extract (GSPE)	lung cancer	A549 cells	grape seed procyanidin extract (GSE) treatment	downregulated	27289489
2342	Mouse	mmu-miR-19b	miRNA	dexamethasone (DEX)	metabolic disease	murine adipocytes	dexamethasone (Dex) treatment	"DEX treatment elevated miR-19b expression in SAT-and VAT-derived differentiated cells in a dose-dependent manner, and peak levels were observed at 1 ¦ÌM."	29077919
2343	Mouse	mmu-miR-19b	miRNA	fluid shear stress (FSS)	osteoblastic differentiation	MC3T3-E1 cells	fluid shear stress (FSS)treatment	downregulated	23595392
2344	Mouse	mmu-miR-19b	miRNA	bone morphogenetic proteins (BMPs)	osteogenesis	pluripotent stem (iPS) cells	bone morphogenetic proteins (BMPs) treatment	downregulated	22937097
2345	Mouse	mmu-miR-19b	miRNA	bleomycin and silica	lung fibrosis	fibroblasts	bleomycin and silica treatment	"qPCR revealed a significant increase of miR-19a, 19b, and 20a-expression in activated fibroblasts in the early phase of bleomycin and silica models."	29923329
2346	Mouse	mmu-miR-19b	miRNA	monocrotaline (MCT)	pulmonary hypertension (PH)	lung tissues	monocrotaline (MCT) treatment	upregulated	26980205
2347	Mouse	mmu-miR-19b	miRNA	mycobacterium tuberculosis (Mtb)	pulmonary tuberculosis (PTB)	lung tissues	mycobacterium tuberculosis (Mtb) treatment	downregulated	33089914
2348	Mouse	mmu-miR-19b	miRNA	pSTAT3-specific inhibitor AG-490	pulmonary tuberculosis (PTB)	lung tissues	pSTAT3-specific inhibitor AG-490 treatment	upregulated	33089914
2349	Mouse	mmu-miR-19b-1	miRNA	hypoxia	ischemia/reperfusion (I/R) injury	mice heart tissues in vivo and primary murine cardiomyocytes in vitro	hypoxia induce	downregulated	30607541
2350	Mouse	mmu-miR-19b-3p	miRNA	lipopolysaccharide (LPS)	acute kidney injury (AKI)	tubular epithelial cells (TECs)-derived exosomes	lipopolysaccharide (LPS) treatment	upregulated	31097789
2351	Mouse	mmu-miR-19b-3p	miRNA	angiotensin II (Ang II)	cardiac hypertrophy	neonatal mouse cardiomyocytes (NMCMs)	angiotensin II (Ang II) treatment	downregulated	29664809
2352	Mouse	mmu-miR-19b-3p	miRNA	adriamycin (ADR)	chronic proteinuric kidney	tubular epithelial cells (TECs)-derived exosomes	adriamycin (ADR) treatment	upregulated	31097789
2353	Mouse	mmu-miR-19b-3p	miRNA	carbon tetrachloride (CCl4)	liver fibrosis	liver tissues	carbon tetrachloride (CCl4) treatment	downregulated	29572892
2354	Mouse	mmu-miR-19b-3p	miRNA	glyphosate	neurodevelopmental disorder	prefrontal cortex of mouse offspring	glyphosate	dysregulated	29467848
2355	Mouse	mmu-miR-19b-3p	miRNA	IL-1¦Â	osteoarthritis (OA)	Murine ATDC5 cells	IL-1¦Â treatment	downregulated	31227976
2356	Mouse	mmu-miR-19b-3p	miRNA	paraquat (PQ)	paraquat (PQ)-induced acute lung injury and pulmonary fibrosis	MLE-12 cells	paraquat (PQ) treatment	downregulated	32741895
2357	Mouse	mmu-miR-19b-3p	miRNA	lipopolysaccharide (LPS)	sepsis-induced acute kidney injury	mouse pulmonary microvascular endothelial cells (PMVECs)	lipopolysaccharide (LPS) treatment	The level of miR-19b-3p was determined to be downregulated in vitro and in vivo	33760339
2358	Mouse	mmu-miR-19b-3p	miRNA	lipopolysaccharide (LPS)	tubulointerstitial inflammation	renal exosomes; tubule-derived exosomes	lipopolysaccharide (LPS) treatment	upregulated	31097789
2359	Mouse	mmu-miR-1a	miRNA	urethane	lung cancer	mouse lung tissue cells	urethane via ip injection treatment	downregulated	23761296
2360	Mouse	mmu-miR-1a	miRNA	high fat diet (HFD)	obesity	C57BL/6J male mice skeletal muscle	high fat diet (HFD) feed	upregulated	28926107
2361	Mouse	mmu-miR-1a-1-5p	miRNA	streptozocin (STZ)	diabetic pregnancy	female mice hyperglycemic ED9.5 embryos	streptozotocin treatment	dysregulatedin hyperglycemic ED95 embryos	27908722
2362	Mouse	mmu-miR-1a-3p	miRNA	guanidinoacetic acid (GAA)	cell differentiation	C2C12 cells	Guanidinoacetic acid (GAA) treatment	downregulated	30235878
2363	Mouse	mmu-miR-1a-3p	miRNA	high fat diet (HFD)	hepatic insulin resistance	mouse liver tissues	high fat diet (HFD) feed	downregulated	30820263
2364	Mouse	mmu-miR-2	miRNA	torasemide	cardiac fibrosis	cardiac fibroblasts	Torasemide treatment	upregulated	26047574
2365	Mouse	mmu-miR-20	miRNA	western diet	coronary artery disease (CAD)	mouse	fed with western diet treatment	downregulated	28888922
2366	Mouse	mmu-miR-20	miRNA	Staphylococcus aureus	inflammation	mouse mammary tissue	intramammary infection of Globally Staphylococcus aureus treatment	differently regulated	25075227
2367	Mouse	mmu-miR-200	miRNA	TGF-¦Â1	epithelial-mesenchymal transition (EMT)	Kidneys tissue	TGF-¦Â1 treatment	downregulated	22012804
2368	Mouse	mmu-miR-200	miRNA	rapamycin	HIV-associated nephropathy(HIVAN)	mice renal tissues	Rapamycin treatment	downregulated	23611955
2369	Mouse	mmu-miR-200	miRNA	cyclosporine A (CsA)	nephrotoxicity	mouse kidney	cyclosporine A treatment	upregulated	28414804
2370	Mouse	mmu-miR-200	miRNA	high fat diet (HFD)	nonalcoholic fatty liver disease (NAFLD)	serum	high fat diet (HFD) feed	upregulated	32324317
2371	Mouse	mmu-miR-200a	miRNA	H2O2	acute myocardial infarction (AMI)	mouse cardiomyocytes	H2O2 treatment	The expression of miR-200a was upregulated in H 2O 2-treated cardiomyocytes.	31896068
2372	Mouse	mmu-miR-200a	miRNA	H2O2	acute myocardial infarction (AMI)	primary cultured mouse?cardiomyocytes	H2O2 treatment	upregulated	31896068
2373	Mouse	mmu-miR-200a	miRNA	isorhynchophylline (IRN)	asthma	ovalbumin (OVA)-induced asthma mice lung tissues	Isorhynchophylline (IRN) treatment	upregulated	31733831
2374	Mouse	mmu-miR-200a	miRNA	isorhynchophylline (IRN)	asthma	TGF-¦Â1-treated airway smooth muscle cells (ASMCs)	Isorhynchophylline (IRN) treatment	upregulated	31733831
2375	Mouse	mmu-miR-200a	miRNA	isorhynchophylline (IRN)	asthma	airway smooth muscle cells (ASMCs)	Isorhynchophylline (IRN) treatment	IRN administration inhibited miR-200a expression level.	31733831
2376	Mouse	mmu-miR-200a	miRNA	ovalbumin (OVA)	asthma	airway smooth muscle cells (ASMCs)	ovalbumin (OVA) treatment	upregulated	30423573
2377	Mouse	mmu-miR-200a	miRNA	ovalbumin (OVA)	asthma	lung tissues	ovalbumin (OVA) treatment	downregulated	31733831
2378	Mouse	mmu-miR-200a	miRNA	TGF-¦Â1	asthma	airway smooth muscle cells (ASMCs)	TGF-¦Â1 treatment	downregulated	31733831
2379	Mouse	mmu-miR-200a	miRNA	piceatannol (PIC)	atherosclerosis (AS)	RAW 264.7 cells	piceatannol (PIC) treatment	PIC increased miR-200a level in RAW2647 cells	32886103
2380	Mouse	mmu-miR-200a	miRNA	alcohol	brain injury and neurodegeneration	cerebral cortex	chronic alcohol administration	downregulated	30374194
2381	Mouse	mmu-miR-200a	miRNA	Glabridin (GLA)	breast cancer	MDA-MB-231 and BT-549 breast cancer cells	Glabridin (GLA) treatment	upregulation	24754877
2382	Mouse	mmu-miR-200a	miRNA	rosiglitazone	cardiac hypertrophy	adipocytes	rosiglitazone (RSG) treatment	upregulated	27734035
2383	Mouse	mmu-miR-200a	miRNA	doxorubicin (DOX)	cardiotoxicity	primary cultured cardiomyocyte	Doxorubicin (DOX) treatment	downregulated	31781322
2384	Mouse	mmu-miR-200a	miRNA	all-trans retinoic acid (ATRA)	cell differentiation	mouse hepatic progenitor cells (HPCs)	all-trans retinoic acid (ATRA) treatment	upregulated	31515718
2385	Mouse	mmu-miR-200a	miRNA	astaxanthin	colorectal cancer (CRC)	Mouse colon cancer cell CT26	astaxanthin (ATX) treatment	upregulated	31263239
2386	Mouse	mmu-miR-200a	miRNA	dexamethasone (DEX)	endometrial receptivity	endometrium tissues	dexamethasone (DEX) treatment	upregulated	30993706
2387	Mouse	mmu-miR-200a	miRNA	high glucose (HG)	endothelial dysfunction	aortic endothelial cells (ECs)	high glucose (HG) treatment	High glucose (HG) reduced miR-200a levels.	32031966
2388	Mouse	mmu-miR-200a	miRNA	shikonin	epithelial-mesenchymal transition (EMT)	mouse skin tissues	Shikonin treatment	downregulated	23861701
2389	Mouse	mmu-miR-200a	miRNA	calorie restriction (CR)	hepatic steatosis	high-fat (HF) diet-induced obesity prone (OP) mice thyroid and liver tissues	calorie restriction (CR) treatment	upregulated	31863770
2390	Mouse	mmu-miR-200a	miRNA	exercise (Ex)	hepatic steatosis	high-fat (HF) diet-induced obesity prone (OP) mice thyroid and liver tissues	exercise (Ex) treatment	upregulated	31863770
2391	Mouse	mmu-miR-200a	miRNA	high fat diet (HFD)	hepatic steatosis	mice thyroid and liver tissues	high fat diet (HFD) feed	downregulated	31863770
2392	Mouse	mmu-miR-200a	miRNA	low fat diet (LFD)	hepatic steatosis	high-fat (HF) diet-induced obesity prone (OP) mice thyroid and liver tissues	low-fat diet (LF) treatment	upregulated	31863770
2393	Mouse	mmu-miR-200a	miRNA	quercetin	hepatic steatosis	high-fat (HF) diet-induced obesity prone (OP) mice thyroid and liver tissues	quercetin (Que) treatment	upregulated	31863770
2394	Mouse	mmu-miR-200a	miRNA	progesterone (P4)	infertility	uterine horn of 6-week-old female mice (C57BL/6)	progesterone treatment	dysregulated	30603515
2395	Mouse	mmu-miR-200a	miRNA	carbon tetrachloride (CCl4)	liver fibrosis	liver tissues	carbon tetrachloride (CCl4) treatment	miR-200a was significantly reduced in liver tissues of a carbon tetrachloride (CCl4)-induced rat model.	32319630
2396	Mouse	mmu-miR-200a	miRNA	triptolide (TPL)	male hypogonadism	MLTC-1 cells	triptolide (TPL) treatment	downregulated of miR-200a could protect MLTC-1 cells against TP by inducing autophagy	33204070
2397	Mouse	mmu-miR-200a	miRNA	high glucose (HG)	cell differentiation	neural stem cells (NSCs)	high glucose treatment	downregulated	23776576
2398	Mouse	mmu-miR-200a	miRNA	fructose	metabolic disorders	C57BL/6JNju mice	fructose treatment	upregulated	28732575
2399	Mouse	mmu-miR-200a	miRNA	fructose	metabolic disorders	human-derived HepG2 cells	fructose treatment	upregulated	28732575
2400	Mouse	mmu-miR-200a	miRNA	carbon tetrachloride (CCl4)	multiple myeloma (MM)	liver tissue of mouse	CCl4 treatment	upregulated	21283674
2401	Mouse	mmu-miR-200a	miRNA	leptin	obesity	hypothalamus?tissues	leptin treatment	downregulated	24394757
2402	Mouse	mmu-miR-200a	miRNA	low fat diet (LFD)	obesity	thyroid	low fat diet (LFD) treatment	downregulated	31863770
2403	Mouse	mmu-miR-200a	miRNA	low fat diet (LFD)	obesity	thyroid	low fat diet (LFD) treatment	upregulated	31863770
2404	Mouse	mmu-miR-200a	miRNA	monosodium glutamate (MSG)	obesity	liver tissues	monosodium glutamate (MSG)-injected mice with developed central obesity treatment	dysregulated	24465854
2405	Mouse	mmu-miR-200a	miRNA	quercetin	obesity	thyroid	quercetin (QUE) treatment	upregulated	31863770
2406	Mouse	mmu-miR-200a	miRNA	growth hormone (GH)	osteosarcoma (OS)	LM8 cells	growth hormone (GH) treatment	downregulated	26289744
2407	Mouse	mmu-miR-200a	miRNA	bone morphogenetic protein 2 (BMP2)	preosteoblast differentiation	pre-osteoblast	bone morphogenetic protein-2 treatment	downregulated	19454767
2408	Mouse	mmu-miR-200a	miRNA	X-rays	radiation-induced oral mucositis (RIOM)	tongue tissues	25 Gy X-ray irradiation treatment	upregulated	31346357
2409	Mouse	mmu-miR-200a	miRNA	di(2-ethylhexyl) phthalate (DEHP)	skeletal muscle insulin resistance	skeletal muscle cells	di(2-ethylhexyl) phthalate (DEHP) treatment	The miR-17/Keap1-Nrf2/miR-200a axis contributed to DEHP-induced insulin resistance.	32802189
2410	Mouse	mmu-miR-200a	miRNA	ethanol (EtOH)	teratogenesis	fetal brains of mice	Ethanol?treatment	downregulated	19091803
2411	Mouse	mmu-miR-200a-3	miRNA	7-chlorokynurenic acid (7-CTKA)	antidepressant	mouse	7-CTKA intraperitoneal injection	downregulated	25034119
2412	Mouse	mmu-miR-200a-3p	miRNA	TGF-¦Â	breast cancer	normal murine mammary gland epithelial (NMuMG) cells	transforming growth factor (TGF)¦Â treatment	downregulated	30285803
2413	Mouse	mmu-miR-200a-3p	miRNA	aldose reductase	diabetic nephropathy (DN)	renal mesangial cells	aldose reductase treatment	upregulated	24161443
2414	Mouse	mmu-miR-200a-3p	miRNA	high glucose (HG)	diabetic nephropathy (DN)	SV40-MES-13?cells	high glucose treatment	downregulated	31630796
2415	Mouse	mmu-miR-200a-3p	miRNA	ethyl acetate extract isolated from rhizoma dioscoreae bulbifera	hepatotoxicity	mouse liver tissues	treat with ethyl acetate extract isolated from rhizoma dioscoreae bulbifera (450 mg/kg)	dysregulated	27609015
2416	Mouse	mmu-miR-200a-3p	miRNA	carbon tetrachloride (CCl4)	liver fibrosis		carbon tetrachloride (CCl4) treatment	lncRNA Gpr137b-ps/miR-200a-3p/CXCL14 axis that modulates HSC activation and might exert an effect on the pathogenesis of liver fibrosis.	33069761
2417	Mouse	mmu-miR-200a-3p	miRNA	dioscorea bulbifera (DB)	liver damage	livers	dioscoreae bulbifera (EF) treatment	upregulated	27609015
2418	Mouse	mmu-miR-200a-3p	miRNA	"chlorpromazine, procainamide, manganese"	systemic lupus erythematosus (SLE)	mouse	"chlorpromazine, procainamide, manganese"	dysregulated	29349090
2419	Mouse	mmu-miR-200a-3p	miRNA	coix seed Oil (CSO)	triple negative breast cancer (TNBC)	mouse triple-negative breast cancer (TNBC) tissues	coix Seed Oil (CSO) treatment	upregulated	33101013
2420	Mouse	mmu-miR-200b	miRNA	nicotine	abnormal migration and proliferation	mouse primary VSMCs	nicotine treatment	upregulated	28252009
2421	Mouse	mmu-miR-200b	miRNA	amyloid-¦Â (A¦Â)	Alzheimer's disease (AD)	murine primary neurons	amyloid-¦Â (A¦Â) treatment	upregulated	29738527
2422	Mouse	mmu-miR-200b	miRNA	alcohol	brain injury and neurodegeneration	cerebral cortex	chronic alcohol administration	downregulated	30374194
2423	Mouse	mmu-miR-200b	miRNA	aspergillus fumigatus (A. fumigatus)	bronchial asthma	bronchoalveolar lavage cells	aspergillus fumigatus infection	downregulated	29778524
2424	Mouse	mmu-miR-200b	miRNA	ovalbumin (OVA)	bronchial asthma	bronchoalveolar lavage cells	ovalbumin (OVA) treatment	downregulated	29778524
2425	Mouse	mmu-miR-200b	miRNA	hypertonicity	cellular responses to osmotic stress	mouse renal medulla	hypertonicity-induced induction	upregulated	20852262
2426	Mouse	mmu-miR-200b	miRNA	high fat diet (HFD)	chondrogenesis	white adipose tissues	high fat diet (HFD) feed	downregulated	22496873
2427	Mouse	mmu-miR-200b	miRNA	bone morphogenetic protein 2 (BMP2)	chronic pancreatitis (CP)	AR42J cells	bone morphogenetic protein 2 (BMP2) treatment	upregulated	29303912
2428	Mouse	mmu-miR-200b	miRNA	cerulein	chronic pancreatitis (CP)	pancreas	cerulein treatment	downregulated	29303912
2429	Mouse	mmu-miR-200b	miRNA	TGF-¦Â1	chronic pancreatitis (CP)	AR42J cells	TGF-¦Â1 treatment	downregulated	29303912
2430	Mouse	mmu-miR-200b	miRNA	monocrotaline (MCT)	cor pulmonale	"lungs, right ventricle (RV) and left ventricle (LV) tissues"	monocrotaline (MCT) treatment	downregulated	31730233
2431	Mouse	mmu-miR-200b	miRNA	alcohol extract of coreopsis tinctoria Nutt (AC)	diabetic nephropathy (DN)	db/db (DN) mice	alcohol extract of Coreopsis tinctoria Nutt (AC) treatment	downregulated	31032350
2432	Mouse	mmu-miR-200b	miRNA	retinoic acid (RA)	cell differentiation	embryonic stem cells (mESCs)	retinoic acid (RA) treatment	downregulated	26162091
2433	Mouse	mmu-miR-200b	miRNA	shikonin	epithelial-mesenchymal transition (EMT)	mouse skin tissues	Shikonin treatment	downregulated	23861701
2434	Mouse	mmu-miR-200b	miRNA	carbon tetrachloride (CCl4)	liver fibrosis	hepatic tissues	carbon tetrachloride (CCl4) treatment	downregulated	30924172
2435	Mouse	mmu-miR-200b	miRNA	listeria	Listeria infection	murine ileum tissues	Listeria infection	downregulated	24327339
2436	Mouse	mmu-miR-200b	miRNA	dietary methyl deficiency	hepatocellular carcinoma (HCC)	the liver tissues	Dietary methyl deficiency treatment	upregulated	20436259
2437	Mouse	mmu-miR-200b	miRNA	high glucose (HG)	cell differentiation	neural stem cells (NSCs)	high glucose treatment	downregulated	23776576
2438	Mouse	mmu-miR-200b	miRNA	leptin	obesity	hypothalamus?tissues	leptin treatment	downregulated	24394757
2439	Mouse	mmu-miR-200b	miRNA	lipopolysaccharide (LPS)	lung fibrosis	lung tissues	lipopolysaccharide (LPS) treatment	downregulated	29200203
2440	Mouse	mmu-miR-200b	miRNA	X-rays	radiation-induced oral mucositis (RIOM)	tongue tissues	25 Gy X-ray irradiation treatment	upregulated	31346357
2441	Mouse	mmu-miR-200b	miRNA	carbon tetrachloride (CCl4)	multiple myeloma (MM)	liver tissue of mouse	CCl4 treatment	upregulated	21283674
2442	Mouse	mmu-miR-200b-3p	miRNA	folic acid	Alzheimer's disease (AD)	APP/PS1 mice brains and N2a cells	Folic acid deficiency treatment	downregulated	26345540
2443	Mouse	mmu-miR-200b-3p	miRNA	TGF-¦Â	breast cancer	normal murine mammary gland epithelial (NMuMG) cells	transforming growth factor (TGF)¦Â treatment	downregulated	30285803
2444	Mouse	mmu-miR-200b-3p	miRNA	high glucose (HG)	diabetic retinopathy (DR)	retinal microvascular endothelial cells (RMECs)	high glucose treatment	downregulated	31313295
2445	Mouse	mmu-miR-200b-3p	miRNA	streptozotocin injection and a high-glucose/high-fat diet	diabetic retinopathy (DR)	retinal microvascular endothelial cells (RMECs)	streptozotocin injection and a high-glucose/high-fat diet treatment	"YAP1 may exert some promotive effects on the development of DR through its regulation of the MALAT1/miR-200b-3p/VEGFA axis, highlighting that YAP1 silencing may be instrumental for the therapeutic targeting of DR"	31313295
2446	Mouse	mmu-miR-200b-3p	miRNA	schistosoma japonicum	liver fibrosis	serum exosomes	S. japonicum infection treatment	downregulated	32443549
2447	Mouse	mmu-miR-200b-3p	miRNA	schistosomiasis japonica	hepatic fibrogenesis	serum	S. japonicum infection treatment	downregulated	30482723
2448	Mouse	mmu-miR-200b-3p	miRNA	arginine vasopressin	osmoregulation	mIMCD3 cells	exposure to arginine vasopressin treatment	downregulated	24389345
2449	Mouse	mmu-miR-200b-5p	miRNA	fatty acid amide hydrolase inhibitor (FAAH-II)	colitis	colitis mouse colon tissues	FAAH-II treatment	dysregulated	27327245
2450	Mouse	mmu-miR-200b-5p	miRNA	fatty acid amide hydrolase (FAAH) blockade	experimental colitis	colon	Fatty acid amide hydrolase (FAAH) blockade treatment	upregulated	27327245
2451	Mouse	mmu-miR-200b-5p	miRNA	X rays	ionizing radiation (IR) injury	male Kunming mice blood	0.5-2 Gy total-body carbon-ion irradiation treatment	dysregulatedin blood	28632432
2452	Mouse	mmu-miR-200b-5p	miRNA	chronic unpredictable mild stress (CUMS)	major depressive disorder (MDD)	nucleus accumbens (NAc) tissues	chronic unpredictable mild stress (CUMS) induce	downregulated	30936699
2453	Mouse	mmu-miR-200c	miRNA	ischemia/reperfusion (I/R) 	acute myocardial infarction (AMI)	heart tissues	ischemia/reperfusion (I/R) treatment	upregulated	28090786
2454	Mouse	mmu-miR-200c	miRNA	amyloid-¦Â (A¦Â)	Alzheimer's disease (AD)	murine primary neurons	amyloid-¦Â (A¦Â) treatment	upregulated	29738527
2455	Mouse	mmu-miR-200c	miRNA	Glabridin (GLA)	breast cancer	MDA-MB-231 and BT-550 breast cancer cells	Glabridin (GLA) treatment	upregulation	24754877
2456	Mouse	mmu-miR-200c	miRNA	aspergillus fumigatus (A. fumigatus)	bronchial asthma	bronchoalveolar lavage cells	aspergillus fumigatus infection	downregulated	29778524
2457	Mouse	mmu-miR-200c	miRNA	ovalbumin (OVA)	bronchial asthma	bronchoalveolar lavage cells	ovalbumin (OVA) treatment	downregulated	29778524
2458	Mouse	mmu-miR-200c	miRNA	R715 (B1R antagonist)	cerebral ischemia/reperfusion (I/R) injury	miR-200c in N9 cell and N9-derived MVs	R715 (B1R antagonist) (500 ¦Ìg/kg) treatment	downregulated in microvesicles (MVs)	28398146
2459	Mouse	mmu-miR-200c	miRNA	high fat diet (HFD)	chondrogenesis	white adipose tissues	high fat diet (HFD) feed	downregulated	22496873
2460	Mouse	mmu-miR-200c	miRNA	high glucose (HG)	diabetic vasculopathy	H5V cells	high glucose stimulation	upregulated	28627674
2461	Mouse	mmu-miR-200c	miRNA	retinoic acid (RA)	cell differentiation	embryonic stem cells (mESCs)	retinoic acid (RA) treatment	downregulated	26162091
2462	Mouse	mmu-miR-200c	miRNA	shikonin	epithelial-mesenchymal transition (EMT)	mouse skin tissues	Shikonin treatment	downregulated	23861701
2463	Mouse	mmu-miR-200c	miRNA	silica particle	epithelial-mesenchymal transition (EMT)	lung tissues	silica particles treatment	miR-200c expression levels were decreased on days 14 and 28 compared with those in the saline group	30010033
2464	Mouse	mmu-miR-200c	miRNA	high fat diet (HFD)	hepatocellular carcinoma (HCC)	plasma and hepatic tissues	high fat diet (HFD) feed	downregulated	26728044
2465	Mouse	mmu-miR-200c	miRNA	listeria	Listeria infection	murine ileum tissues	Listeria infection	downregulated	24327339
2466	Mouse	mmu-miR-200c	miRNA	"3,3'-diindolylmethane (DIM)"	multiple sclerosis (MS)	activated T cells during the development of experimental autoimmune encephalomyelitis (EAE)	"3,3'-Diindolylmethane (DIM) treatment"	upregulated	24898268
2467	Mouse	mmu-miR-200c	miRNA	methionine choline-deficient diet (MCD)	nonalcoholic steatohepatitis (NASH)	liver tissues	fed a methionine and choline deficient (MCD) diet for 2 week	upregulated in liver	29093267
2468	Mouse	mmu-miR-200c	miRNA	Porphyromonas gingivalis?lipopolysaccharide (Pg-LPS)	periodontitis in obese subjects (PiOSs)	gingival; adipose tissues	Porphyromonas gingivalis?lipopolysaccharide (Pg-LPS) treatment	downregulated	33664998
2469	Mouse	mmu-miR-200c	miRNA	propofol (PPF)	propofol-induced developmental neurotoxicity	hippocampus	propofol treatment	upregulated	30242182
2470	Mouse	mmu-miR-200c	miRNA	lipopolysaccharide (LPS)	lung fibrosis	lung tissues	lipopolysaccharide (LPS) treatment	downregulated	29200203
2471	Mouse	mmu-miR-200c	miRNA	X-rays	radiation-induced oral mucositis (RIOM)	tongue tissues	25 Gy X-ray irradiation treatment	upregulated	31346357
2472	Mouse	mmu-miR-200c	miRNA	reactive oxygen species (ROS)	spinal cord injury (SCI)	BV-2 cells	ROS treatment	upregulated	26503985
2473	Mouse	mmu-miR-200c	miRNA	split radiation	thymic lymphoma (RITL)	RITL samples	split radiation treatment	downregulated	25359176
2474	Mouse	mmu-miR-200c	miRNA	wound back skin	wound healing	8-week-old and 2-year-old mice	full-thickness 3 mm wound was introduced by punch biopsy onto back skin treatment	downregulated	28607463
2475	Mouse	mmu-miR-200c	miRNA	wound back skin	wound healing	8-week-old mice aged skin	full-thickness 3 mm wound was introduced by punch biopsy onto back skin treatment	upregulated at the early phase of wound healing in aged skin	28607463
2476	Mouse	mmu-miR-200c	miRNA	resveratrol	colorectal cancer (CRC)	HCT-116 Colorectal Cancer Cells	resveratrol (RS) treatment	upregulated	27918105
2477	Mouse	mmu-miR-200c*	miRNA	neuregulin-1£¨NRG1£©	cell differentiation	murine embryonic stem cell	neuregulin-1£¨NRG1£©	upregulated	21451102
2478	Mouse	mmu-miR-200c-3p	miRNA	IL-1B	intestinal inflammation	enterocytes	IL-1B treatment	Compared with mice given vehicle; enterocytes isolated from mice given IL1B had increased expression of MIR200C-3p	32569770
2479	Mouse	mmu-miR-200c-3p	miRNA	coix seed Oil (CSO)	triple negative breast cancer (TNBC)	mouse triple-negative breast cancer (TNBC) tissues	coix Seed Oil (CSO) treatment	upregulated	33101013
2480	Mouse	mmu-miR-200c-5p	miRNA	X-rays	bystander effect	C57BL/6 mice extracellular vesicles (EVs)	otal-body irradiated with X-rays	downregulated	28396668
2481	Mouse	mmu-miR-200s	miRNA	IL-6	insulin resistance (IR)	hepatocytes of mice	IL-6 treatment	downregulated	23798681
2482	Mouse	mmu-miR-202-3p	miRNA	carbon tetrachloride (CCl4)	liver fibrosis	liver	CCl4 treatment	downregulated	27322257
2483	Mouse	mmu-miR-203	miRNA	ischemia	acute kidney injury (AKI)	renal tubules	ischemia treatment	upregulated	27959449
2484	Mouse	mmu-miR-203	miRNA	alcohol	alcoholic liver disease (ALD)	liver tissues and AML-12 cell lines	alcohol exposure	downregulated	29670525
2485	Mouse	mmu-miR-203	miRNA	xiaoxianggou	atherosclerosis (AS)	serum	xiaoxianggou treatment	"Xiaoxianggou reverses the reduced miR-203 expression and the elevated Ets-2 expression induced by AngII,"	27470353
2486	Mouse	mmu-miR-203	miRNA	pectin (fermented to butyrate in the colon) (FPA)	colon tumorigenesis	colonic stem cells	(fermented to butyrate in the colon) (FPA) treatment	upregulated	26493444
2487	Mouse	mmu-miR-203	miRNA	high glucose (HG)	diabetic nephropathy (DN)	mouse glomerular mesangial cells?M4200 cells	high glucose treatment	downregulated	30229838
2488	Mouse	mmu-miR-203	miRNA	estradiol	differentiation capacity in mouse embryoid bodies	vascular smooth muscle cells (VSMC)	estradiol treatment	upregulated	23175673
2489	Mouse	mmu-miR-203	miRNA	sodium arsenite (NaAsO2)	DNA methylation	liver tissues	sodium arsenite treatment	upregulated	32068019
2490	Mouse	mmu-miR-203	miRNA	eimeria papillata	eimeria papillata infection	mouse jejunum	Eimeria papillata infection	upregulated	21093440
2491	Mouse	mmu-miR-203	miRNA	high fat diet (HFD)	glucose homeostasis	adipose tissue	high fat diet (HFD) feed	downregulated	31327757
2492	Mouse	mmu-miR-203	miRNA	helicobacter pylori (H. pylori)	hepatic insulin resistance	primary hepatocytes	H. pylori infection	downregulated	25689935
2493	Mouse	mmu-miR-203	miRNA	bleomycin (BLM)	idiopathic pulmonary fibrosis (IPF)	lung tissues	bleomycin (BLM) treatment	circTADA2A repressed lung-fibroblasts activation via miR-526b/Cav1 and reduced lung-fibroblasts proliferation via miR-203/Cav2.	32694556
2494	Mouse	mmu-miR-203	miRNA	bacillus calmette-guerin (BCG)	inflammatory response	macrophage RAW264.7 cells	bacille calmette-guerin (BCG) treatment	upregulated	23522925
2495	Mouse	mmu-miR-203	miRNA	lipopolysaccharide (LPS)	inflammatory response	macrophage RAW264.7 cells	lipopolysaccharide (LPS) treatment	upregulated	23522925
2496	Mouse	mmu-miR-203	miRNA	recombinant Adeno-Cre viruses (AdV-Cre)	lung adenocarcinoma (LUAD)	lung	recombinant Adeno-Cre viruses (AdV-Cre) treatment	upregulated	25359683
2497	Mouse	mmu-miR-203	miRNA	astragaloside IV (AS-IV)	osteoarthritis (OA)	ATDC5 cells	astragaloside IV (AS-IV) treatment	"AS-IV significantly reduces LPS-induced viability, apoptosis and the release of TNF-¦Á, IL-6 and iNOS mainly through up-regulating miR-203."	31906765
2498	Mouse	mmu-miR-203	miRNA	lipopolysaccharide (LPS)	osteoarthritis (OA)	ATDC5 cells	lipopolysaccharide (LPS) treatment	upregulated	29432995
2499	Mouse	mmu-miR-203	miRNA	lipopolysaccharide (LPS)	osteoarthritis (OA)	ATDC5 cells	lipopolysaccharide (LPS) treatment	upregulated	30550887
2500	Mouse	mmu-miR-203	miRNA	lipopolysaccharide (LPS)	osteoarthritis (OA)	mouse chondrogenic ATDC5 cells	lipopolysaccharide (LPS) treatment	miR-203 overexpression partially abolished the chondroprotective effects of PMS2L2.	30550887
2501	Mouse	mmu-miR-203	miRNA	IL-17	psoriasis	mouse ears	IL-17 treatment	upregulated	29039484
2502	Mouse	mmu-miR-203	miRNA	butyric acid (BA)	skin cancer	mouse skin	butyric acid (BA) treatment	upregulated	24792773
2503	Mouse	mmu-miR-203	miRNA	calcium glucarate (CAG)	skin cancer	mouse skin	calcium glucarate (CAG) treatment	upregulated	24792773
2504	Mouse	mmu-miR-203	miRNA	nicotinamide	skin cancer	mouse skin	nicotinamide(NA) treatment	upregulated	24792773
2505	Mouse	mmu-miR-203-3p	miRNA	oxygen	retinopathy of prematurity (ROP)	retinas tissue	"For OIR model construction, 7-day-old mice and their nursing mothers were maintained in 75% oxygen for 5 continuous days. On postnatal day (P) 12, the pups were returned to normoxic air and kept with their mothers for another 5 days. treatment"	downregulated in the OIR samples	31452702
2506	Mouse	mmu-miR-203-3p	miRNA	alpinia oxyphylla extract (AOE)	type 2 diabetes mellitus (T2DM)	db-/db- mouse kidney	A. oxyphylla extract (AOE) treatment	downregulated	28249617
2507	Mouse	mmu-miR-203-3p	miRNA	aerobic exercise	whole-body metabolic adaptations	adipocytes	aerobic exercise training (AET) treatment	upregulated	32900951
2508	Mouse	mmu-miR-203a-3p	miRNA	oxygen	diabetic retinopathy (DR)	mouse retinal tissues	oxygen induce treatment	downregulated	31689123
2509	Mouse	mmu-miR-203a-3p	miRNA	oxygen	diabetic retinopathy (DR)	retinal tissues	oxygen treatment	MALAT1 affect angiogenesis by sponging miR-203a-3p in DR	31689123
2510	Mouse	mmu-miR-203a-3p	miRNA	carbon tetrachloride (CCl4)	epithelial-mesenchymal transition (EMT)	liver tissues	carbon tetrachloride (CCl4) treatment	miR-203a-3p was significantly downregulated in mice with liver fibrosis.	32659284
2511	Mouse	mmu-miR-203a-3p	miRNA	carnosic acid (CA)	liver fibrosis	liver tissues	carnosic acid (CA) treatment	Inhibition of p66Shc Oxidative Signaling via CA-Induced Upregulation of miR-203a-3p Alleviates Liver Fibrosis Progression.	32781430
2512	Mouse	mmu-miR-204	miRNA	lipopolysaccharide (LPS)	acute aortic dissection (AAD)	aorta	lipopolysaccharide (LPS) treatment	downregulated	32634201
2513	Mouse	mmu-miR-204	miRNA	ischemia	acute kidney injury (AKI)	renal tubules	ischemia treatment	upregulated	27959449
2514	Mouse	mmu-miR-204	miRNA	oxidized low density lipoprotein (ox-LDL)	atherosclerosis (AS)	mouse Raw264.7 cells	oxidized low-density lipoprotein (ox-LDL) treatment	MEG3 sponged miR-204 in Raw264.7 cells treated with ox-LDL. MEG3 exerted its function via the regulation of the MEG3/miR-204/CDKN2A regulatory axis in Raw264.7 cells treated with ox-LDL.	30672051
2515	Mouse	mmu-miR-204	miRNA	puerarin	autophagy	MC3T3-E1 cells	puerarin treatment	The expression level of miR-204 was decreased by puerarin	32010248
2516	Mouse	mmu-miR-204	miRNA	puerarin	cell differentiation	MC3T3-E1 cells	Puerarin treatment	downregulated	32010248
2517	Mouse	mmu-miR-204	miRNA	puerarin	cell proliferation	MC3T3-E1 cells	Puerarin treatment	downregulated	29368357
2518	Mouse	mmu-miR-204	miRNA	puerarin	cell viability	mouse MC3T3-E1 osteoblast-like cells	0.1 mg/ml puerarin for 48 h treatment	downregulated	28901520
2519	Mouse	mmu-miR-204	miRNA	estrogen (ES)	renal fibrosis	mouse uterus tissues	Estrogen treatment	mirn451 was significantly increased by estrogen administration whereas mirn181b and mirn204 expression was significantly reduced	20720260
2520	Mouse	mmu-miR-204	miRNA	¦Â-glycerophosphate (¦Â-GP)	colorectal cancer (CRC)	mouse aortic VSMCs	¦Â-glycerophosphate treatment	miR-204 was suppressed in mouse aortic VSMCs during ¦Â-glycerophosphate-induced calcification	22871591
2521	Mouse	mmu-miR-204	miRNA	doxorubicin (DOX)	doxorubicin (DOX)-induced cardiotoxicity	heart tissues	doxorubicin (DOX) treatment	downregulated	33274007
2522	Mouse	mmu-miR-204	miRNA	tunicamycin (TM)	endoplasmic reticulum stress (ERS)	mouse endothelial cells	tunicamycin (TM) treatment	upregulated	28839162
2523	Mouse	mmu-miR-204	miRNA	high fat diet (HFD)	endoplasmic reticulum stress (ERS)	C57Bl/6 mouse vascular	high fat diet (HFD) feed	upregulated	28181559
2524	Mouse	mmu-miR-204	miRNA	high glucose (HG)	obesity	3T3-L1 cells	high glucose treatment	LncRNA TUG1 could negatively regulate miR-204 to alleviate inflammation and insulin tolerance via promoting SIRT1/GLUT4/PPAR¦Ã/AKT pathway.	32888158
2525	Mouse	mmu-miR-204	miRNA	dietary methionine restriction (MR)	osteoblast differentiation and function	"male C57BL/6J mice bone marrow,plasma and liver"	fed diets containing 0.86% or 0.12% methionine for 5 weeks	"upregulated (miR-31 in plasma and liver, and miR-133a, miR-335-5p, and miR-204 in the bone marrow"	27191548
2526	Mouse	mmu-miR-204	miRNA	oxaliplatin	oxaliplatin induced-neuropathy	primary cultured dorsal root ganglia neurons	oxaliplatin treatment	upregulated	30031110
2527	Mouse	mmu-miR-204	miRNA	oxibendazole (OBZ)	prostate cancer	22Rv1 tumors in nude mice	treated with OBZ (25 mg/kg/day) treatment	upregulated	29434928
2528	Mouse	mmu-miR-204	miRNA	hypoxia	spinal cord ischemia/reperfusion injury (SCII)	neuronal cells	hypoxia treatment	upregulated	26350953
2529	Mouse	mmu-miR-204	miRNA	candida albicans (C. albicans)	systemic Candidiasis	C57BL/6 mice	candida albicans infection	downregulated	24641951
2530	Mouse	mmu-miR-204	miRNA	high fat diet (HFD)	chondrogenesis	white adipose tissues	high fat diet (HFD) feed	downregulated	22496873
2531	Mouse	mmu-miR-204-3p	miRNA	methamphetamine (METH)	drug addiction	nucleus accumbens (NAc)	methamphetamine (METH) treatment	upregulated	31153969
2532	Mouse	mmu-miR-204-3p	miRNA	high glucose (HG)	renal and podocytes injuries	MPC5 cells	high glucose treatment	downregulated	29940664
2533	Mouse	mmu-miR-204-5p	miRNA	IL-11	aplastic anemia (AA)	mouse hematopoietic stem cell (HSC)	IL-11 treatment	downregulated	29217821
2534	Mouse	mmu-miR-204-5p	miRNA	melatonin	calcific aortic valve disease (CAVD)	valvular interstitial cells	melatonin treatment	melatonin ameliorates aortic valve calcification via the regulation of CircRIC3/miR-204-5p/DPP4 signaling in hVICs	32369647
2535	Mouse	mmu-miR-204-5p	miRNA	murine cytomegalovirus (MCMV)	murine cytomegalovirus (MCMV) infection	peripheral blood monocytes	murine cytomegalovirus (MCMV) infection	downregulated	33245094
2536	Mouse	mmu-miR-204-5p	miRNA	hypoxia	myocardial ischemia/reperfusion (I/R) injury (MIRI)	primary cultured cardiomyocyte	hypoxia induce	downregulated	31644943
2537	Mouse	mmu-miR-204-5p	miRNA	hypoxia/reoxygenation (H/R)	myocardial ischemia/reperfusion (I/R) injury (MIRI)	cardiomyocytes	hypoxia/reoxygenation (H/R) treatment	"KCNQ1OT1 could promote the LGALS3 expression by binding to miR-204-5p, which led to aggravated myocardial IR injury."	31644943
2538	Mouse	mmu-miR-204-5p	miRNA	high fat diet (HFD)	obesity	fat tissues from obese mice fed long-term with a high-fat diet (HFD)	high fat diet (HFD) feed	downregulated	29775748
2539	Mouse	mmu-miR-204-5p	miRNA	morphine	painful or stressful conditions	hippocampal	Morphine treatment	downregulated	25844808
2540	Mouse	mmu-miR-204-5p	miRNA	"1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)"	parkinson's disease (PD)	serum and substantia nigra (SN)	"1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) treatment"	upregulated	31572127
2541	Mouse	mmu-miR-204c	miRNA	ischemia	acute kidney injury (AKI)	renal tubules	ischemia treatment	upregulated	27959449
2542	Mouse	mmu-miR-204e	miRNA	ischemia	acute kidney injury (AKI)	renal tubules	ischemia treatment	upregulated	27959449
2543	Mouse	mmu-miR-205	miRNA	garcinol	acute myocardial infarction (AMI)	AMI mouse blood; heart tissues	Garcinol treatment	upregulated	33809417
2544	Mouse	mmu-miR-205	miRNA	isoproterenol	acute myocardial infarction (AMI)	blood; heart tissues	isoproterenol treatment	downregulated	33809417
2545	Mouse	mmu-miR-205	miRNA	lipopolysaccharide (LPS)	acute respiratory distress syndrome (ARDS)	lung tissues	lipopolysaccharide (LPS) treatment	"SNHG5 was downregulated, while miR-205 was upregulated in the serum of ARDS patients and lung tissues of LPS-induced mice."	33170429
2546	Mouse	mmu-miR-205	miRNA	sodium arsenite (NaAsO2)	DNA methylation	liver tissues	sodium arsenite treatment	upregulated	32068019
2547	Mouse	mmu-miR-205	miRNA	shikonin	epithelial-mesenchymal transition (EMT)	mouse skin tissues	Shikonin treatment	downregulated	23861701
2548	Mouse	mmu-miR-205	miRNA	high fat diet (HFD)	erectile dysfunction (ED)	mouse	high fat diet (HFD) feed	dysregulated	25533598
2549	Mouse	mmu-miR-205	miRNA	high fat diet (HFD)	nonalcoholic fatty liver disease (NAFLD)	mouse liver tissues	high fat diet (HFD) feed	upregulated	31799678
2550	Mouse	mmu-miR-205	miRNA	oleacein (OA)	nonalcoholic fatty liver disease (NAFLD)	mouse primary hepatocytes (PH)	oleic acid (OA) treatment	upregulated	31799678
2551	Mouse	mmu-miR-205	miRNA	erlotinib	non-small cell lung cancer (NSCLC)	murine NSCLC xenograft models	erlotinib treatment	downregulated	24911146
2552	Mouse	mmu-miR-205	miRNA	gefitinib	non-small cell lung cancer (NSCLC)	murine NSCLC xenograft models	gefitinib treatment	downregulated	24911146
2553	Mouse	mmu-miR-205	miRNA	kanamycin-furosemide	ototoxic effects of kanamycin-furosemide	serum	kanamycin-furosemide treatment	upregulated	30235835
2554	Mouse	mmu-miR-205	miRNA	baicalin (BAI)	type 1 diabetes mellitus (T1DM)	TNF-¦Á-treated pancreatic ¦Â-cell line Min6	baicalin (BAI) treatment	upregulated	30058243
2555	Mouse	mmu-miR-205	miRNA	tumor necrosis factor alpha (TNF-¦Á) 	type 1 diabetes mellitus (T1DM)	pancreatic ¦Â-cell line Min6	tumor necrosis factor alpha (TNF-¦Á) treatment	downregulated	30058243
2556	Mouse	mmu-miR-205	miRNA	IL-32	vascular injury	hIL-32¦Á-Tg and ApoE /hIL-32¦Á-Tg mice	IL-32 treatment	downregulated	28740544
2557	Mouse	mmu-miR-205	miRNA	high glucose (HG)	diabetic nephropathy (DN)	The mouse mesangial SV40©\Mes13 cells	"SV40©\Mes13 cells were cultured under normal glucose condition (Con, 5.5 mM glucose), mannitol condition (MN, 5.5 mM glucose + 24.5 mM mannitol), or HG condition (30 mM glucose) for 24 hr. treatment"	"miR-205 inhibits HG©\induced proliferation, oxidative stress, ECM accumulation, and inflammation in mesangial cells via targeting HMGB1"	31087368
2558	Mouse	mmu-miR-205-3p	miRNA	oxygen glucose deprivation (OGD)	ischemic stroke (IS)	bEnd.3 cells	Oxygen-glucose deprivation (OGD) treatment	Long noncoding RNA MALAT1 regulates apoptosis in ischemic stroke by sponging miR-205-3p and modulating PTEN expression	32655805
2559	Mouse	mmu-miR-205-5p	miRNA	curcumin (Cur)	melanoma	B78H1 cells	curcumin treatment	miRNA expression signature in tumors was substantially altered by curcumin intake with mmu-miR-205-5p over 100 times higher expressed when compared to controls.	24349037
2560	Mouse	mmu-miR-205-5p	miRNA	"1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)"	parkinson's disease (PD)	brain tissues	"1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) treatment"	"The expression levels of MALAT1 and leucine-rich repeat kinase (LRRK2) were increased, and that of miR-205-5p was decreased in the midbrains of mice in which PD was induced by MPTP."	29511451
2561	Mouse	mmu-miR-205-5p	miRNA	hypoxia	pulmonary arterial hypertension (PAH)	lung tissue	hypoxia induce	downregulated	30853343
2562	Mouse	mmu-miR-205-5p	miRNA	coix seed Oil (CSO)	triple negative breast cancer (TNBC)	mouse triple-negative breast cancer (TNBC) tissues	coix Seed Oil (CSO) treatment	miR-205-5p was substantially altered in CSO treated tumor tissues.	33101013
2563	Mouse	mmu-miR-206	miRNA	lipopolysaccharide (LPS)	Alzheimer's disease (AD)	microglial BV-2 cells	lipopolysaccharide (LPS) treatment	upregulated	27277332
2564	Mouse	mmu-miR-206	miRNA	ovalbumin (OVA)	asthma	lung tissues	ovalbumin (OVA) treatment	"The expression of RMRP and CCL2 was elevated, while miR-206 was reduced in OVA-induced mice."	33511814
2565	Mouse	mmu-miR-206	miRNA	particulate matter (PM2.5)	bronchial asthma	lung tissue	PM2.5 exposure treatment	upregulated	31520993
2566	Mouse	mmu-miR-206	miRNA	Yes-associated protein (YAP)	cardiac hypertrophy	cardiomyocytes	Yes-associated protein (YAP) treatment	upregulated	26333362
2567	Mouse	mmu-miR-206	miRNA	neurotoxicant sodium valproate (VPA)	developmental toxicity	murine embryonic stem cells (mESCs)	neurotoxicant sodium valproate (VPA) treatment	upregulated	24896083
2568	Mouse	mmu-miR-206	miRNA	ethanol (EtOH)	drinking	"mouse different brain regions, including medial prefrontal cortex (mPFC) , central amygdala (CeA), and hippocampus (HPC)"	ethanol treatment	upregulated	30790666
2569	Mouse	mmu-miR-206	miRNA	forced swim stress (FSS)	drinking	"mouse different brain regions, including medial prefrontal cortex (mPFC) , central amygdala (CeA), and hippocampus (HPC)"	the mice received either a single or 5 daily 10-min FSS sessions	upregulated	30790666
2570	Mouse	mmu-miR-206	miRNA	TGF-¦Â	epithelial-mesenchymal transition (EMT)	C2C12 cells	TGF-¦Â treatment	downregulated	21324893
2571	Mouse	mmu-miR-206	miRNA	"fasting, denervation, diabetes, and cancer cachexia"	fine-tuning the atrophy program	mouse muscles	"mouse muscles under wasting conditions such as fasting, denervation, diabetes, and cancer cachexia treatment"	wasting conditions showed an induction of miRNA-206 and miRNA-21 expression	24891504
2572	Mouse	mmu-miR-206	miRNA	adriamycin (ADR)	focal segmental glomerulosclerosis (FSGS)	glomeruli	adriamycin (ADR) treatment	upregulated	27056206
2573	Mouse	mmu-miR-206	miRNA	high fat diet (HFD)	hepatosteatosis and hyperglycemia	mouse fatty livers	high fat diet (HFD) feed	downregulated	28025059
2574	Mouse	mmu-miR-206	miRNA	4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)	lung cancer	lung cancer cells	drug treatment	lung carcinogen NNK exposure changes the expression of serum miRNAs. Serum miR-206 and miR-133b could be associated with lung carcinogenesis induced by NNK	23337359
2575	Mouse	mmu-miR-206	miRNA	botulinum toxin A (BTXA)	muscle atrophy	quadriceps muscle	botulinum toxin A (BTXA) treatment	upregulated	30427927
2576	Mouse	mmu-miR-206	miRNA	heme oxygenase-1 (HMOX1)	myoblast differentiation	C2C12 cells	Heme oxygenase-1 (HMOX1) treatment	downregulated	21827279
2577	Mouse	mmu-miR-206	miRNA	sciatic nerve partial ligation	pain	mouse dorsal root ganglion (DRG)	sciatic nerve partial ligation therapy treatment	downregulated	21385380
2578	Mouse	mmu-miR-206	miRNA	"pioglitazone and L-buthionine-S,R-sulfoximine"	skeletal muscle injury	C57BL/6J mice plasma	"pioglitazone with L-buthionine-S,R-sulfoximine, to C57BL/6J mice for 2days treatment"	upregulated in plasma	28263783
2579	Mouse	mmu-miR-206	miRNA	6-bromoindirubin-3'-oxime (BIO)	skeletal muscle differentiation	C2C12 cells	6-bromoindirubin-3'-oxime (BIO) treatment	upregulated	31792344
2580	Mouse	mmu-miR-206-3p	miRNA	angiostrongylus cantonensis (A. cantonensis)	angiostrongylus cantonensis (A. cantonensis) infection	mouse	angiostrongylus cantonensis (A. cantonensis) infection	upregulated	24682888
2581	Mouse	mmu-miR-206-3p	miRNA	donepezil	Alzheimer's disease (AD)	APP/PS1 mice	donepezil treatment	downregulated in the hippocampus and cortex	28123152
2582	Mouse	mmu-miR-206-3p	miRNA	chronic unpredictable mild stress (CUMS)	major depressive disorder (MDD)	nucleus accumbens (NAc) tissues	chronic unpredictable mild stress (CUMS) induce	upregulated	30936699
2583	Mouse	mmu-miR-206-3p	miRNA	"4,4'-methylene diphenyl diisocyanate (MDI)"	occupational asthma (OA)	Female BALB/c mice blood	"4,4'-methylene diphenyl diisocyanate (MDI) exposure"	downregulated	30074411
2584	Mouse	mmu-miR-206-3p	miRNA	"4,4'-methylene diphenyl diisocyanate (MDI)"	occupational asthma (OA)	bronchoalveolar lavage cells (BALCs)	"4,4'-methylene diphenyl diisocyanate (MDI) treatment"	downregulated	31609387
2585	Mouse	mmu-miR-206-3p	miRNA	"diisocyanate, 4,4'-methylene diphenyl diisocyanate (MDI)"	occupational asthma (OA)	Female BALB/c mice blood	Female BALB/c mice were exposed to one of three exposure regimens: dermal exposure to 1% MDI in acetone; nose-only exposure to 4580?¡À?1497?¦Ìg/m3 MDI-aerosol for 60?minutes; or MDI dermal exposure/sensitization followed by MDI-aerosol inhalation challenge.	downregulated	30074411
2586	Mouse	mmu-miR-206a-3p	miRNA	streptozocin (STZ)	diabetic retinopathy (DR)	retina and serum of diabetic mice	streptozotocin treatment	upregulated	30883703
2587	Mouse	mmu-miR-208	miRNA	IL-10	cardiac fibrosis	mouse bone marrow fibroblast progenitor cells (BM-FPCs)	IL10 treatment	downregulated	28667100
2588	Mouse	mmu-miR-208	miRNA	streptozocin (STZ)	diabetes mellitus (DM)	hearts of diabetic mice	streptozotocin (STZ) treatment	upregulated	21584493
2589	Mouse	mmu-miR-208	miRNA	bone morphogenetic protein 2 (BMP2)	impaired osteogenic differentiation	MC3T3-E1 cells; Primary murine osteoblast cells	bone morphogenetic protein 2 (BMP2) treatment	downregulated	20576608
2590	Mouse	mmu-miR-208	miRNA	cardiac ischemia reperfusion (CIR)	ischemia/reperfusion (I/R) injury	mouse	cardiac ischemia reperfusion (CIR) treatment	downregulated	29442001
2591	Mouse	mmu-miR-208a	miRNA	doxorubicin (DOX)	cardiomyocyte apoptosis	cardiomyocyte	doxorubicin treatment	upregulated	26137188
2592	Mouse	mmu-miR-208a	miRNA	streptozocin (STZ)	diabetes mellitus (DM)	CD1 mice of both genders	streptozocin (STZ) treatment	upregulated	24685144
2593	Mouse	mmu-miR-208a	miRNA	high glucose (HG)	diabetes-induced cardiac remodelling	HL-1 cardiomyocytes	high-glucose (HG) treatment	upregulated	30696455
2594	Mouse	mmu-miR-208a	miRNA	synthetic Sulfonyl-Hydrazone-1	iPSC-derived cardiac differentiation	Murine fibroblast-derived iPSCs	Synthetic Sulfonyl-Hydrazone-1 treatment	"small chemical compounds, such as SHZ, can constitute a novel and clinically feasible strategy to improve iPSC-derived cardiac differentiation"	21445862
2595	Mouse	mmu-miR-208a	miRNA	isoproterenol	isoproterenol-induced cardiac injury	heart tissues	ISO treatment	upregulated	24713317
2596	Mouse	mmu-miR-208a	miRNA	prolonged aerobic exercise	muscle hypertrophy	plasma	"impact of extended-duration, submaximal aerobic exercise treatment"	upregulated	24436293
2597	Mouse	mmu-miR-208a	miRNA	ischemia/reperfusion (I/R) 	myocardial ischaemic injury	mouse plasma;Bone marrow-derived macrophage (BMDM);Rat neonatal CMs	ischemia/reperfusion (I/R) treatment	differently regulated	28768728
2598	Mouse	mmu-miR-208a	miRNA	angiotensin II (Ang II)	weight gain	HL-1 cells	angiotensin II (Ang II) treatment	upregulated	26381051
2599	Mouse	mmu-miR-208b-3p	miRNA	luteolin	myocardial ischemia/reperfusion (I/R) injury (MIRI)	H9c2 cells	Luteolin (LUT) treatment	downregulated	26658785
2600	Mouse	mmu-miR-20a	miRNA	H2O2	Alzheimer's disease (AD)	Primary hippocampal neuron cells	H2O2 treatment	upregulated	24423585
2601	Mouse	mmu-miR-20a	miRNA	H2O2	Alzheimer's disease (AD)	senescence accelerated mouse prone 8 (SAMP8) and prone 10 (SAMP10)	"different concentrations (0, 100, 200, 400 and 800 ¦ÌM) of H2O2 treatment"	upregulated	24423585
2602	Mouse	mmu-miR-20a	miRNA	notoginsenoside R1 (NGR1)	atherosclerosis (AS)	serum;aorta	notoginsenoside R1 (NGR4) treatment	upregulated	24933211
2603	Mouse	mmu-miR-20a	miRNA	Shexiang Tongxin dropping pill (STDP)	atherosclerosis (AS)	serial transverse aortic sections	Shexiang Tongxin dropping pill (STDP) treatment	upregulated	25449459
2604	Mouse	mmu-miR-20a	miRNA	Shexiang Tongxin dropping pill (STDP)	atherosclerosis (AS)	(ApoE(-/-)) mice aortic	STDP (30 mg/kg/day) on atherosclerotic lesions treatment	upregulated	25449459
2605	Mouse	mmu-miR-20a	miRNA	hyperoxia	bronchopulmonary dysplasia (BPD)	lung tissues	hyperoxia treatment	downregulated	33143661
2606	Mouse	mmu-miR-20a	miRNA	streptozocin (STZ)	diabetes mellitus (DM)	hearts of diabetic mice	streptozotocin (STZ) treatment	downregulated	21584493
2607	Mouse	mmu-miR-20a	miRNA	high glucose (HG)	diabetic retinopathy (DR)	Mouse-derived retinal microvascular endothelial cells (RMECs)	high glucose (HG) treatment	miR-20a was significantly downregulated in HG-treated RMECs.	32776826
2608	Mouse	mmu-miR-20a	miRNA	mangiferin	endoplasmic reticulum stress (ERS)	primary mouse hepatocytes	mangiferin treatment	downregulated	32413114
2609	Mouse	mmu-miR-20a	miRNA	high fat diet (HFD)	hepatocellular carcinoma (HCC)	plasma and hepatic tissues	high fat diet (HFD) feed	downregulated	26728044
2610	Mouse	mmu-miR-20a	miRNA	progesterone (P4)	infertility	uterine horn of 6-week-old female mice (C57BL/6)	progesterone treatment	dysregulated	30603515
2611	Mouse	mmu-miR-20a	miRNA	fluid shear stress (FSS)	osteoblastic differentiation	MC3T3-E1 cells	fluid shear stress (FSS)treatment	downregulated	23595392
2612	Mouse	mmu-miR-20a	miRNA	hypoxia	osteoclast differentiation	RAW264.7 cells	"hypoxia caused induction of autophagy and osteoclast differentiation markers in . In addition, was significantly repressed treatment"	downregulated	25485521
2613	Mouse	mmu-miR-20a	miRNA	bleomycin and silica	lung fibrosis	fibroblasts	bleomycin and silica treatment	"qPCR revealed a significant increase of miR-19a, 19b, and 20a-expression in activated fibroblasts in the early phase of bleomycin and silica models."	29923329
2614	Mouse	mmu-miR-20a	miRNA	hypoxia	pulmonary hypertension (PH)	right ventricular and pulmonary arterial vascular	Hypoxia treatment	upregulated	22450430
2615	Mouse	mmu-miR-20a	miRNA	monocrotaline (MCT)	pulmonary hypertension (PH)	lung tissues	monocrotaline (MCT) treatment	upregulated	26980205
2616	Mouse	mmu-miR-20a	miRNA	cecal ligation and puncture (CLP)	sepsis	whole blood	cecal ligation and puncture (CLP) treatment	upregulated	24205035
2617	Mouse	mmu-miR-20a	miRNA	genistein	spermatogenesis	ICR mice testis	"different doses of GEN (0, 0.5, 5, 50 and 250 mg/kg/day) for 35 days"	upregulated	28938591
2618	Mouse	mmu-miR-20a*	miRNA	plasmodium chabaudi malaria	peak parasitemia	liver of mice	Plasmodium chabaudi malaria infection treatment	downregulated	21085987
2619	Mouse	mmu-miR-20a-3p	miRNA	streptozocin (STZ)	diabetic retinopathy (DR)	retina and serum of diabetic mice	streptozotocin treatment	downregulated	30883703
2620	Mouse	mmu-miR-20a-5p	miRNA	streptozocin (STZ)	diabetic retinopathy (DR)	retina and serum of diabetic mice	streptozotocin treatment	downregulated	30883703
2621	Mouse	mmu-miR-20a-5p	miRNA	high glucose (HG)	hepatic glycogen synthesis	NCTC1469 cells and Hep1-6 cells	high glucose treatment	downregulated	27019188
2622	Mouse	mmu-miR-20a-5p	miRNA	licochalcone A (LA)	lung cancer	MLE-12 cells	Licochalcone A (lico A) treatment	downregulated	32505917
2623	Mouse	mmu-miR-20a-5p	miRNA	neurotoxicant cuprizone (CPZ)	myelin abnormalities	myelin	Neurotoxicant cuprizone (CPZ) treatment	miR-155-5p and miR-20a-5p upregulations enhanced NgR induction through Smad 2 and Smad 4 suppression in demyelination.	31963761
2624	Mouse	mmu-miR-20a-5p	miRNA	free fatty acids (FFA)	nonalcoholic fatty liver disease (NAFLD)	primary mouse hepatocytes	free fatty acid (FFA) treatment	downregulated	33344451
2625	Mouse	mmu-miR-20a-5p	miRNA	IL-1¦Â	osteoarthritis (OA)	murine induced pluripotent stem cell (miPSC)	IL-1¦Â treatment	"RNA-seq results show that miR-20a-5p increase from 4 to 24 hours, but slightly decrease from 24 to 72 hours in IL-1¦Âstimulated pellets."	32767602
2626	Mouse	mmu-miR-20a-5p	miRNA	tumor necrosis factor alpha (TNF-¦Á) 	osteoarthritis (OA)	murine induced pluripotent stem cell (miPSC)	tumor necrosis factor alpha (TNF-¦Á) treatment	"RNA-seq results show that miR-20a-5p increase from 4 to 24 hours, but slightly decrease from 24 to 72 hours in TNF-¦Á stimulated pellets"	32767602
2627	Mouse	mmu-miR-20a-5p	miRNA	radiation	radiation-induced injury	blood	radiation treatment	downregulated	29799276
2628	Mouse	mmu-miR-20b	miRNA	staphylococcal enterotoxin B (SEB)	acute inflammatory lung injury	lung	staphylococcal enterotoxin B treatment	upregulated	25564423
2629	Mouse	mmu-miR-20b	miRNA	high glucose (HG)	diabetic nephropathy (DN)	immortalized mouse podocytes	HG	upregulated	28849008
2630	Mouse	mmu-miR-20b	miRNA	streptozocin (STZ)	diabetic retinopathy (DR)	retina and serum of diabetic mice	streptozotocin treatment	downregulated	30883703
2631	Mouse	mmu-miR-20b	miRNA	IL-1¦Â	osteoarthritis (OA)	chondrocytes	IL-1¦Â treatment	downregulated	32315726
2632	Mouse	mmu-miR-20b	miRNA	monocrotaline (MCT)	pulmonary hypertension (PH)	lung tissues	monocrotaline (MCT) treatment	upregulated	26980205
2633	Mouse	mmu-miR-20b	miRNA	cecal ligation and puncture (CLP)	sepsis	whole blood	cecal ligation and puncture (CLP) treatment	upregulated	24205035
2634	Mouse	mmu-miR-20b	miRNA	coxsackievirus B3 (CVB3)	viral myocarditis (VM)	mouse mouse heart tissues	infect with CVB3	upregulated	28247213
2635	Mouse	mmu-miR-20b2	miRNA	tuberculosis (MTB)	inflammation	mouse lung	infect with TB treatment	downregulated in lung	28606793
2636	Mouse	mmu-miR-20b-5p	miRNA	H2O2	hepatic ischemia/reperfusion injury (HIRI)	Primary mouse hepatocytes culture	H2O2 treatment	?HOTAIR regulates autophagy via the miR-20b-5p/ATG7 axis in hepatic I/R injury	30367982
2637	Mouse	mmu-miR-20b-5p	miRNA	ischemia/reperfusion (I/R) 	myocardial ischemia/reperfusion (I/R) injury (MIRI)	mouse cardiomyocytes	ischemia/reperfusion (I/R) treatment	The expression of circHIPK3 was upregulated during myocardial I/R injury and hypoxia/reoxygenation (H/R) injury of cardiomyocytes.	33824287
2638	Mouse	mmu-miR-20b-5p	miRNA	radiation	radiation-induced injury	blood	radiation treatment	downregulated	29799276
2639	Mouse	mmu-miR-20b-5p	miRNA	mycobacterium tuberculosis (Mtb)	tuberculosis (TB)	RAW 264.7 macrophages	Mycobacterium tuberculosis (Mtb) infection	downregulated	30378171
2640	Mouse	mmu-miR-20b-5p	miRNA	mycobacterium tuberculosis (Mtb)	tuberculosis (TB)	RAW 264.7 macrophages	Mycobacterium tuberculosis (Mtb) infection	downregulated	30378171
2641	Mouse	mmu-miR-21	miRNA	TGF-¦Â	pancreatic cancer (PC)	mouse primary fibroblasts	TGF¦Â treatment	upregulated	23469132
2642	Mouse	mmu-miR-21	miRNA	hypoxia	Alzheimer's disease (AD)	exosomes derived from mesenchymal stromal cells (MSCs)	hypoxia induce	upregulated	28970251
2643	Mouse	mmu-miR-21	miRNA	red mud	biological effects of red mud	"CBA/Ca mice liver, spleen, lung, kidney and lymph nodes"	"1, 3, 6 and 24 h after a single intraperitoneal injection of red mud treatment"	"upregulated , but the level and the peak of the alteration differed according to examined tissue"	24425836
2644	Mouse	mmu-miR-21	miRNA	Tungsten carbide-cobalt (WC-Co) nanoparticle composites	bipolar disorder type I (BD-I)	JB6 P+ cells	Tungsten carbide-cobalt (WC-Co) nanoparticle composites? treatment	WC-Co nanoparticles induce miR-21 generation	23758151
2645	Mouse	mmu-miR-21	miRNA	high tidal volume ventilation (HVTV)	lung injury	lung tissues	high tidal volume ventilation (HVTV) treatment	upregulated	22659882
2646	Mouse	mmu-miR-21	miRNA	talcum powder	atrial fibrillation (AF)	heart	talcum powder treatment	upregulated	27406600
2647	Mouse	mmu-miR-21	miRNA	oxygen glucose deprivation (OGD)	acute cerebral infarction	mouse N2A neuroblastoma cells (N2A)	oxygen-and-glucose-deprivation (OGD) treatment	upregulated	24841240
2648	Mouse	mmu-miR-21	miRNA	ischemia/reperfusion (I/R) 	acute kidney injury (AKI)	C57BL/6J mice	ischemia/reperfusion (I/R) treatment	upregulation in samples of kidney	26149640
2649	Mouse	mmu-miR-21	miRNA	ischemia	acute kidney injury (AKI)	renal tubules	ischemia treatment	upregulated	27959449
2650	Mouse	mmu-miR-21	miRNA	ischemia	acute kidney injury (AKI)	kidney tissues	subjected to 35 min occlusion of bilateral renal pedicles 4 days following preconditioning	upregulated	28677811
2651	Mouse	mmu-miR-21	miRNA	xenon (Xe)	acute kidney injury (AKI)	kidney	Xenon treatment	upregulated	25844699
2652	Mouse	mmu-miR-21	miRNA	lipopolysaccharide (LPS)	acute liver injury (ALI)	liver tissues	lipopolysaccharide (LPS) treatment	miR-21 exacerbate acute liver injury in sepsis mice by inhibiting PPAR¦Á expression.	33424957
2653	Mouse	mmu-miR-21	miRNA	Liang-Ge-San (LGS)	acute lung injury (ALI)	LPS-induced murine RAW264.7 cells	Liang-Ge-San (LGS) treatment	upregulated	31803051
2654	Mouse	mmu-miR-21	miRNA	lipopolysaccharide (LPS)	acute lung injury (ALI)	Murine RAW264.7 cells	lipopolysaccharide (LPS) treatment	downregulated	31803051
2655	Mouse	mmu-miR-21	miRNA	caerulein (Cae)	acute pancreatitis (AP)	pancreata	caerulein (Cae) treatment	miR-21 was significantly lower following caerulein treatment.	30537729
2656	Mouse	mmu-miR-21	miRNA	ethanol (EtOH)	alcoholic liver injury	liver	ethanol treatment	upregulated	25118289
2657	Mouse	mmu-miR-21	miRNA	flavonol icariin	apoptosis	mouse pronuclear embryos	icariin treatment	upregulated	24948525
2658	Mouse	mmu-miR-21	miRNA	mouse growth differentiation factor-9 (GDF-9) or in pig oocyte-conditioned medium (POCM)	apoptosis	mouse oocytectomized cumulus oophorus complexes (OOXs)	cultured with GDF-9 or in POCM	upregulated	28486664
2659	Mouse	mmu-miR-21	miRNA	¦Á-MEM medium	apoptosis	mouse oocytectomized cumulus oophorus complexes (OOXs)	¦Á-MEM medium treatment	downregulated	28486664
2660	Mouse	mmu-miR-21	miRNA	budesonide	asthma	OVA-challenged asthma mice lung tissues	budesonide treatment	downregulated	29854030
2661	Mouse	mmu-miR-21	miRNA	calcitriol	asthma	OVA-challenged asthma mice lung tissues	calcitrioltreatment	downregulated	29854030
2662	Mouse	mmu-miR-21	miRNA	ovalbumin (OVA)	asthma	lung tissues	ovalbumin (OVA) treatment	upregulated	29854030
2663	Mouse	mmu-miR-21	miRNA	bosentan	atherosclerosis (AS)	endothelial cell from apolipoprotein E-deficient (ApoE-/-) mouse model of atherosclerosis	bosentan treatment	upregulated	31886257
2664	Mouse	mmu-miR-21	miRNA	cigarette smoke (CS)	atherosclerosis (AS)	aortic tissues of ApoE KO mice	cigarette smoke (CS) exposure	upregulated	29642385
2665	Mouse	mmu-miR-21	miRNA	lipopolysaccharide (LPS)	atherosclerosis (AS)	RAW 264.7;macrophage-like cell line	lipopolysaccharide (LPS) treatment	upregulated	24502419
2666	Mouse	mmu-miR-21	miRNA	notoginsenoside R1 (NGR1)	atherosclerosis (AS)	serum;aorta	notoginsenoside R1 (NGR1) treatment	downregulated	24933211
2667	Mouse	mmu-miR-21	miRNA	high glucose (HG)	autophagy	murine podocytes cell (MPC) lines	high glucose	upregulated	26567247
2668	Mouse	mmu-miR-21	miRNA	deoxycholic acid (DCA)	bile acid-associated liver pathologies	primary rat hepatocytes	deoxycholic acid (DCA) treatment	downregulated	26621219
2669	Mouse	mmu-miR-21	miRNA	bile acids	bile-containing gastroesophageal reflux	murine hypopharyngeal mucosa (HM)	bile acids treatment	upregulated	29529473
2670	Mouse	mmu-miR-21	miRNA	saline	bile-containing gastroesophageal reflux	murine hypopharyngeal mucosa (HM)	saline treatment	upregulated	29529473
2671	Mouse	mmu-miR-21	miRNA	fludioxonil andfenhexamid	breast cancer	MCF-7;T47D; MDA-MB-231 human breast cancer cells	Fludioxonil and Fenhexamid treatment	downregulated	23052036
2672	Mouse	mmu-miR-21	miRNA	xanthomicrol	breast cancer	4T1 cells	xanthomicrol treatment	downregulated	33217075
2673	Mouse	mmu-miR-21	miRNA	doxorubicin (DOX)	cardiac cytotoxicity	heart tissue and H9C2 cells	doxorubicin (DOX) treatment	upregulated	26132560
2674	Mouse	mmu-miR-21	miRNA	angiotensin II (Ang II)	cardiac fibroblast migration	primary mouse cardiac fibroblasts (CFs)	angiotensin II (Ang II) treatment	upregulated	24447911
2675	Mouse	mmu-miR-21	miRNA	IL-10	cardiac fibrosis	mouse bone marrow fibroblast progenitor cells (BM-FPCs)	IL10 treatment	downregulated	28667100
2676	Mouse	mmu-miR-21	miRNA	streptozocin (STZ)	cardiac fibrosis	myocardium of T1DM mice	streptozotocin treatment	upregulated	31680453
2677	Mouse	mmu-miR-21	miRNA	doxorubicin (DOX)	cardiotoxicity	BALB/c mice injected C-26 tumor cells	doxorubicin treatment	upregulated	28560697
2678	Mouse	mmu-miR-21	miRNA	collagen IV and vascular endothelial growth factor (VEGF)	cardiovascular regeneration	induced pluripotent stem cells (iPSC)	collagen IV and VEGF treatment	upregulated	24356956
2679	Mouse	mmu-miR-21	miRNA	IL-6	cell apoptosis in early mouse embryo development	mouse blastocyst stage embryos cells	interleukin-6 (IL-6) treatment	"the induction of the Stat3 anti-apoptotic pathway by IL-6 is linked to miRNA-21 expression, which possibly results in the regulation of cell apoptosis in early mouse embryo development"	19437447
2680	Mouse	mmu-miR-21	miRNA	substance P (SP)	cell proliferation	Colonic epithelial exosomes were isolated from mice	substance P (SP) treatment	upregulated	31545921
2681	Mouse	mmu-miR-21	miRNA	hypoxia	cerebral ischemic stroke (CIS)	C57BL/6 J mice	MCAO treatment	downregulated	29238035
2682	Mouse	mmu-miR-21	miRNA	estradiol-17¦Â (E2)	cervical cancer (CC)	Osteosarcoma Saos2 cell line	estradiol-17¦Â (E2) treatment	downregulated	27278606
2683	Mouse	mmu-miR-21	miRNA	bile duct ligation (BDL)	cholestasis	wild-type (WT) mice	bile duct ligation (BDL)treatment	upregulated BDL wild-type (WT) mice	29229992
2684	Mouse	mmu-miR-21	miRNA	hyperoxia	chronic lung disease (CLD)	Lung and serum samples	Hyperoxic exposure	upregulated	32191117
2685	Mouse	mmu-miR-21	miRNA	cigarette smoke (CS)	chronic obstructive pulmonary disease (COPD)	lung tissues	cigarette smoke (CS) treatment	miR-21 was upregulated relative to the control in CS-exposed lungs.	30555555
2686	Mouse	mmu-miR-21	miRNA	cerulein	chronic pancreatitis (CP)	pancreas	cerulein treatment	upregulated	29303912
2687	Mouse	mmu-miR-21	miRNA	genistein	chronic vascular inflammation	aortae of LPS-treated mice	genistein (GEN) treatment	downregulated	33495831
2688	Mouse	mmu-miR-21	miRNA	lipopolysaccharide (LPS)	chronic vascular inflammation	aortae of LPS-treated mice	lipopolysaccharide (LPS) treatment	upregulated	33495831
2689	Mouse	mmu-miR-21	miRNA	trinitrobenzene sulfonic acid (TNBS)	colitis	colon tissues	trinitrobenzene sulfonic acid (TNBS) treatment	upregulated	29788092
2690	Mouse	mmu-miR-21	miRNA	ionizing radiation (IR)	colorectal cancer (CRC)	mouse hippocampal cells;brain tissues	ionizing radiation treatment	upregulated	21986536
2691	Mouse	mmu-miR-21	miRNA	IL-10	colonic inflammation	colonic intraepithelial lymphocytes	IL-10 treatment	downregulated	22043014
2692	Mouse	mmu-miR-21	miRNA	NaOH	corneal alkali burn	Corneal neovascularization	applying a paper disc (2.0-mm diameter) soaked with 2 ¦Ìl of 0.5 M NaOH in the right eye	upregulated	28052006
2693	Mouse	mmu-miR-21	miRNA	coxsackievirus B3 (CVB3)	coxsackievirus B3 (CVB3) infection disease	male A/J mice	intraperitoneally inoculation with 5¡Á103 plaque-forming unit (pfu) of CVB3 treatment	upregulated	24722419
2694	Mouse	mmu-miR-21	miRNA	hypoxia	Dendritic cell (DC) maturation	mouse bone marrow-derived DCs (BMDCs)	hypoxia induce	upregulated	30840288
2695	Mouse	mmu-miR-21	miRNA	IL-1¦Â and TNF-¦Á	diabetes mellitus (DM)	MIN6 cells	IL-1¦Â and TNF-¦Á treatment	upregulated	20086228
2696	Mouse	mmu-miR-21	miRNA	streptozocin (STZ)	diabetes mellitus (DM)	hearts of diabetic mice	streptozotocin (STZ) treatment	upregulated	21584493
2697	Mouse	mmu-miR-21	miRNA	TGF-¦Â	diabetic glomerulopathy	murine podocytes	TGF-¦Â treatment	upregulated	25145934
2698	Mouse	mmu-miR-21	miRNA	losartan	diabetic nephropathy (DN)	kidney tissues	losartan treatment	downregulated	27770539
2699	Mouse	mmu-miR-21	miRNA	streptozocin (STZ)	diabetic nephropathy (DN)	renal tissues	streptozotocin (STZ) treatment	upregulated	31655195
2700	Mouse	mmu-miR-21	miRNA	TGF-¦Â1	diabetic foot ulcer (DFU)	NIH-3T3 cells that are subjected to high glucose environment	TGF¦Â1 treatment	upregulated	25130469
2701	Mouse	mmu-miR-21	miRNA	lipopolysaccharide (LPS)	diabetic wound impairment	RAW264.7 cells	lipopolysaccharide (LPS) treatment	MiR-21 was highly induced in M1 macrophages.	32397166
2702	Mouse	mmu-miR-21	miRNA	delayed ischemic preconditioning	differentiation and contractile phenotype of smooth muscle cells (SMCs)	mouse kidney	Delayed ischemic preconditioning treatment	upregulated	22785173
2703	Mouse	mmu-miR-21	miRNA	TGF-¦Â	DNA damage	tubular epithelial cells	TGF-¦Â treatment	downregulated	23207693
2704	Mouse	mmu-miR-21	miRNA	synthetic preimplantation factor (sPIF)	duchenne muscular dystrophy (DMD)	myoblast	Synthetic preimplantation factor (sPIF) treatment	downregulated	30692507
2705	Mouse	mmu-miR-21	miRNA	high-fat/high-cholesterol diet or a high-protein diet	dyslipidemia	DO mice	a high-fat/high-cholesterol diet or a high-protein diet for 18 wk	dysregulated	28916633
2706	Mouse	mmu-miR-21	miRNA	eimeria papillata	eimeria papillata infection	mouse jejunum	Eimeria papillata infection	upregulated	21093440
2707	Mouse	mmu-miR-21	miRNA	¦Ã-rays	epithelial-mesenchymal transition (EMT)	lung tissue	irradiation with a single dose (20 Gy) of 60Co ¦Ã-rays.	upregulated	31160967
2708	Mouse	mmu-miR-21	miRNA	IL-10	epithelial-mesenchymal transition (EMT)	colonic intraepithelial lymphocytes	IL-10 treatment	upregulated	22043014
2709	Mouse	mmu-miR-21	miRNA	retinoid binding protein peptide 161-180	experimental autoimmune uveoretinitis (EAU)	ocular tissues	retinoid binding protein peptide 161-180 treatment	upregulated	20881307
2710	Mouse	mmu-miR-21	miRNA	ginsenoside Rg3	gastric precancerous lesions (GPLs)	stomach samples	Ginsenoside Rg3 (Rg3) treatment	Rg3 Ameliorates Gastric Precancerous Lesions in Atp4a -/- Mice via Inhibition of Glycolysis through PI3K/AKT/miRNA-21 Pathway	32076440
2711	Mouse	mmu-miR-21	miRNA	high fat diet (HFD)	glioblastoma multiforme (GBM)	white adipose tissues	high fat diet (HFD) feed	upregulated	21381024
2712	Mouse	mmu-miR-21	miRNA	astragaloside IV (AS-IV)	glomerular diseases	mesangial cell (MC); primary mouse podocytes; serum; kidney tissues	astragaloside IV (AS-IV) treatment	AS-IV decreased miR-21 levels.	30122901
2713	Mouse	mmu-miR-21	miRNA	sophocarpine (SC)	head and neck squamous cell carcinoma (HNSCC)	nude mouse injected with UM-SCC-22B cells	"100 mm3, SC (5 mg/kg) was intravenously injection treatment"	downregulated	28571917
2714	Mouse	mmu-miR-21	miRNA	X-rays	hematopoietic toxicity following irradiation	"spleen, thymus, bone marrow, small intestine, liver, lung, brain tissues"	Mice were subjected to total body irradiation (TBI) at a dose of 6.5 Gy using a Pantak H-320 (320kV) Precision X-Ray	"miR-21 expression was increased in radiosensitive tissues, but not in radioinsensitive tissues following TBI in wild-type mice, suggesting it may have a critical function in the normal tissue response to irradiation."	31039423
2715	Mouse	mmu-miR-21	miRNA	arsenite	liver fibrosis	primary hepatocytes ; L-02 cells	arsenic (As) exposure	The levels of miR-21 and HIF-1¦Á were also enhanced in primary hepatocytes and L-02 cells exposed to arsenite.	33310519
2716	Mouse	mmu-miR-21	miRNA	corilagin	liver fibrosis	liver tissue	cordycepin treatment	downregulated	26946098
2717	Mouse	mmu-miR-21	miRNA	bromodichloromethane (BDCM)	hepatic fibrogenesis	high-fat (60% kcal) diet-fed chronic mouse	BDCM 2.0 mmol/kg treatment	upregulated	25501551
2718	Mouse	mmu-miR-21	miRNA	leptin	hepatic fibrogenesis	liver tissues	leptin treatment	upregulated	25501551
2719	Mouse	mmu-miR-21	miRNA	betulinic acid (BA)	hepatocellular carcinoma (HCC)	HCC cells	betulinic acid (BA) treatment	upregulated	26222667
2720	Mouse	mmu-miR-21	miRNA	dehydroepiandrosterone (DHEA)	hepatocellular carcinoma (HCC)	mouse mouse liver	DHEA treatment	upregulated	24845419
2721	Mouse	mmu-miR-21	miRNA	high inorganic phosphate (Pi)	hyperphosphatemia	Mouse myocardial endothelial cells (MEC)	high Pi treatment	High Pi induced MEC apoptosis and upregulated microRNA-21 expression.	30257106
2722	Mouse	mmu-miR-21	miRNA	angiotensin II (Ang II)	hypertension	ACE2 knockout mouse kidney	angiotensin II (Ang II) treatment	upregulated in the mouse kidney	28808068
2723	Mouse	mmu-miR-21	miRNA	angiotensin II (Ang II)	hypertensive heart disease (HHD)	heart sissues	angiotensin II (Ang II) treatment	MiR-21 expression levels were significantly upregulated in the mice hearts after angiotensin II (Ang II) infusion.	32040481
2724	Mouse	mmu-miR-21	miRNA	rapamycin	hypoxia/reoxygenation (H/R) injury	islet	rapamycin treatment	upregulated	27683229
2725	Mouse	mmu-miR-21	miRNA	bleomycin (BLM)	idiopathic pulmonary fibrosis (IPF)	myofibroblasts	bleomycin (BLM) treatment	upregulated	20643828
2726	Mouse	mmu-miR-21	miRNA	granulocyte-macrophage colony stimulating factor (GM-CSF) and IL-6	immune response	bone marrow cells	GM-CSF£¬ IL-6 treatment	upregulated	24391219
2727	Mouse	mmu-miR-21	miRNA	TGF-¦Â	immune response	bone marrow cells and spleen MDSC	TGF-¦Â treatment	upregulated	24391219
2728	Mouse	mmu-miR-21	miRNA	progesterone (P4)	infertility	uterine horn of 6-week-old female mice (C57BL/6)	progesterone treatment	dysregulated	30603515
2729	Mouse	mmu-miR-21	miRNA	lipopolysaccharide (LPS)	inflammation	postefferocytotic peripheral blood monocyte-derived macrophages	lipopolysaccharide (LPS) treatment	upregulated	24391209
2730	Mouse	mmu-miR-21	miRNA	pentraxin 3 (PTX3)	inflammation	wild-type brown adipocytes	pentraxin 3 (PTX3) treatment	"PTX3 plays an anti-inflammatory role, in part through regulating miR-21 expression and secretion"	31898407
2731	Mouse	mmu-miR-21	miRNA	sodium sulfide (Na2S)	ischemic injury	mouse heart	Na2S treatment	upregulated	24825878
2732	Mouse	mmu-miR-21	miRNA	intense light	ischemic preconditioning (IPC)	mouse cardiac tissues	expose mice to intense light	upregulated in cardiac tissue	28448534
2733	Mouse	mmu-miR-21	miRNA	rapamycin	islets hypoxia/reoxygenation (H/R) injury	male C57BL/6 islets with hypoxia/reoxygenation (H/R) injury	rapamycin treatment	upregulated	27683229
2734	Mouse	mmu-miR-21	miRNA	rosiglitazone	kidney fibrosis	obesity mouse kidney	rosiglitazone treatment	downregulated	28588299
2735	Mouse	mmu-miR-21	miRNA	deoxycorticosterone acetate (DOCA)	kidney damage	hypertensive mice kidneys and urine	injection of Deoxycorticosterone acetate (Doca)	upregulated in the kidneys and urine	29255279
2736	Mouse	mmu-miR-21	miRNA	hypoxia	kidney ischemia injury	mouse renal tubular epithelial cells (RTECs)	hypoxia treatment	upregulated	31632533
2737	Mouse	mmu-miR-21	miRNA	chlorogenic acid (CGA)	liver fibrosis	schistosome-infected mice hepatic tissue	Chlorogenic acid (CGA) treatment	downregulated in hepatic tissue	27872076
2738	Mouse	mmu-miR-21	miRNA	tamoxifen (TAM)	liver regeneration	liver tissues	tamoxifen-induced Dicer1 deletion treatment	upregulated	31306658
2739	Mouse	mmu-miR-21	miRNA	nitric oxide synthase (NOS2)	lung cancer	lung tissues	nitric oxide synthase (NOS2) treatment	downregulated	22618808
2740	Mouse	mmu-miR-21	miRNA	nickel nanoparticles (nano-Ni)	lung fibrosis	lung tissues	nickel nanoparticles (Nano-Ni) treatment	Nano-Ni resulted in upregulation of miR-21.	32924694
2741	Mouse	mmu-miR-21	miRNA	inositol hexaphosphate (IP6)	lung tumorigenesis	F1 mice lung tumor	"Balb/c mice were exposed to the N-ethyl-N-nitrosourea (ENU) intraperitoneally on the 17th day of gestation. After weaning, half of the litters were fed with oral 2% IP6."	downregulated	30806292
2742	Mouse	mmu-miR-21	miRNA	N-ethyl-N-nitrosourea (ENU)	lung tumorigenesis	F1 mice lung tumor	Balb/c mice were exposed to the N-ethyl-N-nitrosourea (ENU) intraperitoneally on the 17th day of gestation.	upregulated	30806292
2743	Mouse	mmu-miR-21	miRNA	rapamycin	lymphangioleiomyomatosis (LAM)	mouse embryonic fibroblasts	medicine treatment	MicroRNA-21 is induced by rapamycin in a model of tuberous sclerosis (TSC) and lymphangioleiomyomatosis (LAM)The regulation of miR-21 by Rapamycin is cell type independent	23555865
2744	Mouse	mmu-miR-21	miRNA	binase	lymphosarcoma	RLS40 cells	binase treatment	downregulated	33147876
2745	Mouse	mmu-miR-21	miRNA	high glucose (HG)	macrophage apoptosis	Raw 264.7 macrophages	high glucose treatment	"miR-21 is sensitive to high-concentration glucose treatment in macrophages, and appears to have a protective effect in macrophage apoptosis induced by high concentrations of glucose via PDCD4."	25738901
2746	Mouse	mmu-miR-21	miRNA	interval exercise training with tamoxifen	breast cancer	Mouse mammary adenocarcinoma cell line (MC4-L2)	interval exercise training with tamoxifen treatment	downregulated	26300395
2747	Mouse	mmu-miR-21	miRNA	curcumin analog EF24	melanoma	B16 murine melanoma cells	EF24? treatment	downregulated	23940701
2748	Mouse	mmu-miR-21	miRNA	high intensity focused ultrasound (HIFU)	melanoma	melanoma cell	High intensity focused ultrasound (HIFU) treatment	downregulated	27391071
2749	Mouse	mmu-miR-21	miRNA	ischemia	myocardial apoptosis	myocardial of mice	Ischemic postconditioning (IPost)	upregulated	24098402
2750	Mouse	mmu-miR-21	miRNA	hypoxia	myocardial infarction (MI)	mouse infarcted zone	left anterior descending coronary artery was permanently ligated	upregulated in the infarcted zone	28817807
2751	Mouse	mmu-miR-21	miRNA	ischemia	myocardial ischaemic injury	mouse cardiomyocytes	ischemic pre-conditioning (IPC) treatment	"IPC-induced miRNAs trigger cardioprotection similar to the delayed phase of IPC, possibly through upregulating eNOS, HSP70, and the HSP70 transcription factor HSF-1."	19213952
2752	Mouse	mmu-miR-21	miRNA	cyclosporine A (CsA)	nephrotoxicity	mouse kidney	cyclosporine A treatment	upregulated	28414804
2753	Mouse	mmu-miR-21	miRNA	high fat diet (HFD)	nonalcoholic fatty liver disease (NAFLD)	renal tissues	high fat diet (HFD) feed	upregulated	29660503
2754	Mouse	mmu-miR-21	miRNA	high fructose	nonalcoholic fatty liver disease (NAFLD)	plasma	High fructose feed	upregulated	31030166
2755	Mouse	mmu-miR-21	miRNA	lycopene	nonalcoholic fatty liver disease (NAFLD)	mice liver tissue	Lycopene treatment	downregulated	22968990
2756	Mouse	mmu-miR-21	miRNA	microcystin (MC)	nonalcoholic fatty liver disease (NAFLD)	high-fat (60% KCal) supplemented methionine-choline-deficient (MCD-HFD) diet-induced NAFLD mice liver tissue	microcystin (MC) treatment	upregulated	31393787
2757	Mouse	mmu-miR-21	miRNA	microcystin-leucine arginine (MC-LR)	nonalcoholic fatty liver disease (NAFLD)	mouse kidney tissues and CRL-1927 cells	Microcystin-LR (MC) treatment	upregulated	31706246
2758	Mouse	mmu-miR-21	miRNA	ochratoxin A (OTA)	ochratoxin A (OTA) toxicity	Primary proximal tubular epithelial cell	ochratoxin A treatment	upregulated	28710020
2759	Mouse	mmu-miR-21	miRNA	astragaloside IV (AS-IV)	optic nerve injury	RGC-5 cells	astragaloside (AS-IV) treatment	The expression of miR-21 was significantly upregulated in OGD and AST-treated RGC-5 cells.	30551437
2760	Mouse	mmu-miR-21	miRNA	fluid shear stress (FSS)	osteoblastic differentiation	MC3T3-E1 cells	fluid shear stress (FSS)treatment	downregulated	23595392
2761	Mouse	mmu-miR-21	miRNA	tumor necrosis factor alpha (TNF-¦Á) 	osteoclast differentiation	RAW264.7 cells	tumor necrosis factor alpha (TNF-¦Á) treatment	upregulated	23078176
2762	Mouse	mmu-miR-21	miRNA	estrogen (ES)	osteoclastic apoptosis	Primary mouse bone marrow-derived monocyte£»macrophage precursors (BMMs)	Estrogen treatment	downregulated	23238785
2763	Mouse	mmu-miR-21	miRNA	anthracycline glycoside aloin	osteoclastogenesis	Raw264.7 cells	anthracycline glycoside aloin treatment	downregulated	30116953
2764	Mouse	mmu-miR-21	miRNA	particle	osteolysis	osteoclast	particle treatment	upregulated	22508494
2765	Mouse	mmu-miR-21	miRNA	aloin	osteopenic disorders	RAW 264.7 cells	aloin treatment	Aloin caused a dose-dependent decrease in the expression of all forms of miR-21.	30116953
2766	Mouse	mmu-miR-21	miRNA	1-methyl-4-phenylpyridinium (MPP+)	parkinson's disease (PD)	MES23.5 cells	1-methyl-4-phenylpyridinium (MPP+) treatment	upregulated	31555359
2767	Mouse	mmu-miR-21	miRNA	porphyromonas endodontalis lipopolysaccharide ( P. endodontalis LPS)	periodontitis	RAW264.7 and bone marrow derived macrophages (BMDM)	Porphyromonas gingivalis (P. gingivalis) lipopolysaccharide (LPS) treatment	upregulated	29884447
2768	Mouse	mmu-miR-21	miRNA	lipopolysaccharide (LPS)	peritoneal fibrosis	peritoneal mesothelial cells	lipopolysaccharide (LPS) treatment	upregulated	29207016
2769	Mouse	mmu-miR-21	miRNA	ZCL-082	premature ovarian failure (POF)	female germline stem cell (FGSC)	ZCL-082 treatment	upregulated	31319247
2770	Mouse	mmu-miR-21	miRNA	globular adiponectin	programmed cell death	RAW 264.7 macrophages	Globular adiponectin treatment	upregulated	23597671
2771	Mouse	mmu-miR-21	miRNA	astragalus saponin IV	cell proliferation	bone marrow mesenchymal cells(BMSCs)	astragalus saponin IV(AS- IV) treatment	upregulated	32381364
2772	Mouse	mmu-miR-21	miRNA	curcumin analog EF24	prostate cancer	DU145 human prostate cancer cells	EF24? treatment	downregulated	23940701
2773	Mouse	mmu-miR-21	miRNA	castration	prostate cancer	CWR22 human prostate cancer xenograft mouse	castration treatment	downregulated	25216674
2774	Mouse	mmu-miR-21	miRNA	pseudomonas aeruginosa (PA)	pseudomonas aeruginosa lung infection	sorted lung macrophages	RP73 clinical strain of P. aeruginosa infection treatment	downregulated	28422188
2775	Mouse	mmu-miR-21	miRNA	resolvin D1 (RvD1)	pseudomonas aeruginosa lung infection	sorted lung macrophages from RP73 clinical strain of P. aeruginosa infected mouse	resolvin (Rv) D1 treatment	upregulated	28422188
2776	Mouse	mmu-miR-21	miRNA	hypoxia	pulmonary vascular remodeling	lung tissues	chronic hypoxia treatment	upregulated	22227207
2777	Mouse	mmu-miR-21	miRNA	total-body irradiation (TBI)	radiation nephropathy	mouse urinary	a single LD50 of total-body irradiation (TBI) or clinically relevant fractionated doses (2 Gy twice daily for 3 days) treatment	upregulated in mouse urinary	28977780
2778	Mouse	mmu-miR-21	miRNA	radiation	radiation-induced fibrosis (RIF)	"CH3 mice muscle, skin, and subcutaneous tissue"	the right hind legs of 9-week old CH3 mice by a single-fraction dose of irradiation to 35 Gy treatment	dysregulated	24986745
2779	Mouse	mmu-miR-21	miRNA	¦Ã-rays	radiation-induced pulmonary fibrosis (RIPF)	lung tissue	irradiation with a single dose (20 Gy) of 60Co ¦Ã-rays.	upregulated	31160967
2780	Mouse	mmu-miR-21	miRNA	CoCl2	renal ischemia/reperfusion (I/R) injury	renal I/R in mice	CoCl2 was pretreated intraperitoneally 24 hours before renal I/R in mice	upregulated	28737660
2781	Mouse	mmu-miR-21	miRNA	hypoxia/reoxygenation (H/R)	renal ischemia/reperfusion (I/R) injury	bone marrow-derived dendritic cells (BMDCs)	hypoxia/reoxygenation (H/R) treatment	"Treatment with hypoxia/reoxygenation (H/R) suppressed miR-21 expression in bone marrow-derived dendritic cells (BMDCs),"	32667078
2782	Mouse	mmu-miR-21	miRNA	total flavonoids (TFs)	renal tubulointerstitial fibrosis (TIF)	mouse tubular epithelial cells (mTECs)	total flavonoids (TFs) treatment	TFs reduced miR-21 expression in a time- and dose-dependent manner in mTECs.	30212825
2783	Mouse	mmu-miR-21	miRNA	Salmonella Typhimurium	salmonella typhimurium infection	Murine macrophages(murine RAW 264.7 cells)	Salmonella Typhimurium infection treatment	upregulated	21468030
2784	Mouse	mmu-miR-21	miRNA	praziquantel (PZQ)	schistosomiasis	M1-type macrophages	Praziquantel (PZQ) treatment	PZQ inhibited NLRP3 inflammasome in M1 macrophages and reduced the expression of miR-21	32118052
2785	Mouse	mmu-miR-21	miRNA	cecal ligation and puncture (CLP)	sepsis	late sepsis	cecal ligation and puncture (CLP) treatment	upregulated	24980967
2786	Mouse	mmu-miR-21	miRNA	IL-1¦Â	sepsis	macrophages	IL-1¦Â treatment	Exosomal miR-21 secreted by IL-1¦Â-primed-mesenchymal stem cells induces macrophage M2 polarization and ameliorates sepsis.	33115604
2787	Mouse	mmu-miR-21	miRNA	lipopolysaccharide (LPS)	septic shock	bone marrow derived macrophages (BMDMs)	lipopolysaccharide (LPS) treatment	"miR-21 deficiency inhibited the ASC pyroptosome, which restrained caspase-1 activation and GSDMD cleavage, thereby preventing LPS-induced pyroptosis and septic shock."	31189875
2788	Mouse	mmu-miR-21	miRNA	"chlamydia, haemophilus influenzae, influenza, and respiratory syncytial virus"	steroid-insensitive allergic airway disease (SSIAAD)	BALB/c mice lung	infect with virus respiratory tract infections and ovalbumin	upregulated in the lung	27448447
2789	Mouse	mmu-miR-21	miRNA	nuclear factor kappa-B (NF-¦ÊB) inhibitor Bay11-708211	supraesophageal bile reflux	hypopharyngeal mucosa	NF-¦ÊB inhibitor (BAY 11-7082) treatment	"Pre- but not post-application of NF-¦ÊB inhibitor, significantly blocks overexpression of Il6 and prostaglandin H synthases 2 (Ptgs2), and reverses miR-21, miR-155, miR-99a phenotypes."	32934775
2790	Mouse	mmu-miR-21	miRNA	angiotensin II (Ang II)	thoracic aortic aneurysm and dissection (TAAD)	Smad3 (mothers against decapentaplegic homolog 3) heterozygous (S3+/-) mice	angiotensin II (Ang II) treatment	upregulated	29519942
2791	Mouse	mmu-miR-21	miRNA	radiation	thymic lymphoma (RITL)	thymic lymphoma tissue samples	radiation treatment	upregulated	21494432
2792	Mouse	mmu-miR-21	miRNA	controlled cortical impact (CCI)	traumatic brain injury (TBI)	adult (5-6 months) and aged (22-24 months) C57/BL6 mice	controlled cortical impact (CCI)	upregulated	25277076
2793	Mouse	mmu-miR-21	miRNA	controlled cortical impact (CCI)	traumatic brain injury (TBI)	mouse hippocampus	controlled cortical impact (CCI)	upregulated	28804446
2794	Mouse	mmu-miR-21	miRNA	bone morphogenetic proteins (BMPs)	trichofolliculoma-like hair follicle-derived tumours	Primary mouse epidermal keratinocytes (PMEKs)	bone morphogenetic proteins (BMPs) treatment	downregulated	21984808
2795	Mouse	mmu-miR-21	miRNA	streptozocin (STZ)	type 1 diabetes mellitus (T1DM)	NOD mice islets beta cell	streptozocin (STZ) treatment	upregulated in islets beta cell	28280903
2796	Mouse	mmu-miR-21	miRNA	high fat diet (HFD)	type 2 diabetes mellitus (T2DM)	mouse	high fat diet (HFD) feed	downregulated	28627440
2797	Mouse	mmu-miR-21	miRNA	"2,4,6-trinitrobenzene sulfonic acid (TNBS)"	ulcerative colitis (UC)	colon tissues	"2,4,6-trinitrobenzene sulfonic acid (TNBS)/ethanol treatment"	upregulated	31378906
2798	Mouse	mmu-miR-21	miRNA	azacitidine (AZA)	ulcerative colitis (UC)	"2,4,6-trinitrobenzene sulfonic acid (TNBS)/ethanol-induced ulcerative colitis (UC) mice colon tissues"	azacitidine (AZA) treatment	downregulated	31378906
2799	Mouse	mmu-miR-21	miRNA	cinnamaldehyde (CA)	ulcerative colitis (UC)	RAW264.7 cells	Cinnamaldehyde (CA) treatment	downregulated	30530166
2800	Mouse	mmu-miR-21	miRNA	cinnamaldehyde (CA)	ulcerative colitis (UC)	colon tissues	Cinnamaldehyde (CA) treatment	downregulated	30530166
2801	Mouse	mmu-miR-21	miRNA	dextran sodium sulfate (DSS)	ulcerative colitis (UC)	DSS-induced mice colon tissues	Dextran sodium sulfate (DSS) treatment	upregulated	30530166
2802	Mouse	mmu-miR-21	miRNA	mesalazine (MSLZ)	ulcerative colitis (UC)	"2,4,6-trinitrobenzene sulfonic acid (TNBS)/ethanol-induced ulcerative colitis (UC) mice colon tissues"	mesalazine (MSLZ) treatment	downregulated	31378906
2803	Mouse	mmu-miR-21	miRNA	centrin gene deleted Leishmania donovani parasites (LdCen?/?)	visceral leishmaniasis	murine DC cells	LdCen-/- parasites infection	LdCen-/- infection suppresses the expression of microRNA-21 (miR-21) in human macrophages compared to LdWT infection.	31608064
2804	Mouse	mmu-miR-21	miRNA	hypoxia	wound healing	Corneal epithelial cells	hypoxia induce	upregulated	31529118
2805	Mouse	mmu-miR-21	miRNA	TGF-¦Â1	wound healing	Corneal epithelial cells	TGF-¦Â1?treatment treatment	upregulated	31529118
2806	Mouse	mmu-miR-21	miRNA	xenon (Xe)	xenon-conferred	renal?of mice	xenon treatment	Xenon preconditioning significantly increased the expression of miR-21 in the mouse kidney	23681145
2807	Mouse	mmu-miR-21	miRNA	live L. acidophilus	¦Â-lactoglobulin (¦Â-Lg) allergy	murine splenocytes	live L. acidophilus treatment	downregulated	30156972
2808	Mouse	mmu-miR-21	miRNA	"fasting, denervation, diabetes, and cancer cachexia"	fine-tuning the atrophy program	mouse muscles	"mouse muscles under wasting conditions such as fasting, denervation, diabetes, and cancer cachexia treatment"	wasting conditions showed an induction of miRNA-206 and miRNA-21 expression	24891504
2809	Mouse	mmu-miR-21	miRNA	high fat diet (HFD)	prenatal inflammation	ovarian tissue	high fat diet (HFD) feed	"Obese mouse ovaries had decreased Irs1, Foxo3a, Cyp2e1, MiR-103, and MiR-21"	23954404
2810	Mouse	mmu-miR-21?	miRNA	high glucose (HG)	diabetic nephropathy (DN)	mouse podocytes	high glucose (HG) treatment	miR-21 expression was upregulated in HG-treated podocytes.	30212710
2811	Mouse	mmu-miR-21*	miRNA	cortical impact	traumatic brain injury (TBI)	cortex	cortical impact	upregulated	26426744
2812	Mouse	mmu-miR-210	miRNA	hypoxia	acute ischemic stroke (AIS)	brain tissues	middle cerebral artery occlusion (MCAO) treatment	upregulated in the brain	29111308
2813	Mouse	mmu-miR-210	miRNA	hypoxia	acute peripheral ischemia	skeletal muscle of mice	hypoxia treatment	upregulated	23931770
2814	Mouse	mmu-miR-210	miRNA	"toluene 2,4-diisocyanate (TDI)"	allergic disease	draining lymph node (dLN) and Treg subsets	Toluene diisocyanate (TDI) treatment	upregulated	28035981
2815	Mouse	mmu-miR-210	miRNA	hypoxia	apoptosis	mouse GC-2spd (GC-2) cells	hypoxia induce	upregulated	30431115
2816	Mouse	mmu-miR-210	miRNA	hypoxia	apoptosis	A mouse neuroblastoma neuro-2a cell	hypoxia treatment	upregulated	23108914
2817	Mouse	mmu-miR-210	miRNA	high fat diet (HFD)	atherosclerosis (AS)	purified CD31+ endothelial cells from mouse aorta	high fat diet (HFD) feed	upregulated in purified CD31+ endothelial cells from mouse aorta	28536634
2818	Mouse	mmu-miR-210	miRNA	diethylnitrosamine (DEN)	chronic cholestasis and cholangiocarcinoma	liver tissues	diethylnitrosamine (DEN) treatment	upregulated	21440549
2819	Mouse	mmu-miR-210	miRNA	bupivacaine	dorsal root ganglion	neurons	bupivacaine treatment	downregulated	26708520
2820	Mouse	mmu-miR-210	miRNA	hypoxia	hepatic ischemia/reperfusion injury (HIRI)	primary mouse hepatocytes	hypoxia treatment	downregulated	32155285
2821	Mouse	mmu-miR-210	miRNA	hypoxia	hypoxia-induced injury	mouse GC-2spd (GC-2) cells	hypoxia induce	upregulated	30431115
2822	Mouse	mmu-miR-210	miRNA	epigallocatechin-3-gallate (EGCG)	lung cancer	lung cancer cells	Green tea polyphenol EGCG treatment	upregulated	21965273
2823	Mouse	mmu-miR-210	miRNA	hypoxia	myocardial infarction (MI)	mouse bone marrow-derived MSCs exosomes	cultured under hypoxia for 24 h	upregulated in exosomes from hypoxia-treated MSCs	29141446
2824	Mouse	mmu-miR-210	miRNA	cardiac shock wave therapy (SWT)	myocardial ischemia/reperfusion (I/R) injury (MIRI)	murine adult cardiomyocyte cell line HL-1	Cardiac shock wave therapy (SWT) treatment	upregulated	31974607
2825	Mouse	mmu-miR-210	miRNA	hypoxia	myocardial ischemia/reperfusion (I/R) injury (MIRI)	murine adult cardiomyocyte cell line HL-1	hypoxia induce	upregulated	31974607
2826	Mouse	mmu-miR-210	miRNA	hypoxia	myocardial repair	mesenchymal stem cells (MSCs)	hypoxia treatment	upregulated	29141446
2827	Mouse	mmu-miR-210	miRNA	curcumin (Cur)	nasopharyngeal carcinoma (NPC)	mice	injected into the tumour centre at a concentration of 150 mg/kg treatment	dysregulated	24896104
2828	Mouse	mmu-miR-210	miRNA	hypoxic/ischemic	neonatal hypoxic-ischemic brain damage	mouse pups tissues	hypoxic-ischemic (HI) treatment	"HI insult significantly upregulated miR-210, downregulated TET2 protein abundance, and increased NF-¦ÊB subunit p65 acetylation level and its DNA binding capacity to the interleukin 1 beta (IL-1¦Â) promoter in the brain of mouse pups."	33402183
2829	Mouse	mmu-miR-210	miRNA	bupivacaine	neurotoxicity	dorsal root ganglia	bupivacaine treatment	downregulated	26708520
2830	Mouse	mmu-miR-210	miRNA	erythropoietin (EPO)	erythroid maturation	mouse fetal liver cells	erythropoietin treatment	upregulated	18492109
2831	Mouse	mmu-miR-210	miRNA	tumor necrosis factor alpha (TNF-¦Á) 	osteoclast differentiation	RAW264.7 cells	tumor necrosis factor alpha (TNF-¦Á) treatment	upregulated	23078176
2832	Mouse	mmu-miR-210	miRNA	lipopolysaccharide (LPS)	production of proinflammatory cytokines	murine macrophages	lipopolysaccharide (LPS) treatment	upregulated	22575656
2833	Mouse	mmu-miR-210	miRNA	IL-23	psoriasis	skin lesions	IL-23 treatment	upregulated	29757188
2834	Mouse	mmu-miR-210	miRNA	imiquimod (IMQ)	psoriasis	skin lesions	imiquimod treatment	upregulated	29757188
2835	Mouse	mmu-miR-210	miRNA	high glucose (HG)	type 2 diabetes mellitus (T2DM)	exosome of RAW 264.7 cells	high glucose (HG) treatment	miR-210 was highly expressed in exosomes derived from high glucose-induced macrophage RAW264.7 cells.	32258168
2836	Mouse	mmu-miR-210-3p	miRNA	"paraquat (PQ) and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)"	dopaminergic (DA) neuron differentiation	neuro-2a cells	"paraquat (PQ) and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) treatment"	dysregulated	29250806
2837	Mouse	mmu-miR-210-3p	miRNA	"1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)"	neurodegenerative diseases	N2a cells	"1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) treatment"	downregulated	29250806
2838	Mouse	mmu-miR-210-3p	miRNA	"1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)"	neurodegenerative diseases	N2a cells	"1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) treatment"	downregulated	29250806
2839	Mouse	mmu-miR-210-3p	miRNA	paraquat (PQ)	neurodegenerative diseases	N2a cells	paraquat (PQ) treatment	downregulated	29250806
2840	Mouse	mmu-miR-210-3p	miRNA	high fat diet (HFD)	obesity	liver tissues	high fat diet (HFD) feed	upregulated	32593682
2841	Mouse	mmu-miR-210-5p	miRNA	manganese (Mn)	parkinson's disease (PD)	MN9D dopaminergic cell exosomes	Mn exposure (300¦ÌM MnCl2) for 24h	upregulated in exosomes	28450057
2842	Mouse	mmu-miR-211	miRNA	arsenite	atherosclerosis (AS)	liver	arsenic (As) exposure	downregulated	22719926
2843	Mouse	mmu-miR-211	miRNA	hypoxia	hypoxic/ischemic injury	Neuro2A cells	hypoxia treatment	miR-211 was upregulated in OGD-induced ischemic injury of Neuro2A cells.	30563429
2844	Mouse	mmu-miR-211	miRNA	cecal ligation and puncture (CLP)	sepsis	Monocytes were isolated from the spleens	cecal ligation and puncture induce	downregulated	31656541
2845	Mouse	mmu-miR-211	miRNA	lipopolysaccharide (LPS)	sepsis	RAW264.7 cells	lipopolysaccharide (LPS) treatment	upregulated of NEAT1 level and downregulated of miR-495-3p/miR-211 level could aggravate inflammation in LPS-treated RAW264.7 cells.	31812793
2846	Mouse	mmu-miR-211	miRNA	candida albicans (C. albicans)	systemic Candidiasis	C57BL/6 mice	candida albicans infection	downregulated	24641951
2847	Mouse	mmu-miR-211-5p	miRNA	atractylon (Atr)	asthma	asthma mouse lung tissues; TGF-¦Â1-treated TC-1 cells	atractylon (Atr)?treatment	Atr treatment suppressed OVA-induced circRNA-0000981 and TGFBR2 expression but promoted miR-211-5p expression.	33855682
2848	Mouse	mmu-miR-211-5p	miRNA	ovalbumin (OVA)	asthma	lung tissues	ovalbumin (OVA) treatment	downregulated	33855682
2849	Mouse	mmu-miR-211-5p	miRNA	TGF-¦Â1	asthma	TC-1 cells	TGF-¦Â1 treatment	downregulated	33855682
2850	Mouse	mmu-miR-211-5p	miRNA	dioscorea bulbifera (DB)	liver damage	livers	dioscoreae bulbifera (EF) treatment	downregulated	27609015
2851	Mouse	mmu-miR-211-5p	miRNA	alpinetin (ALP)	oral squamous cell carcinoma (OSCC)	OSCC tumor tissues	alpinetin (ALP) treatment	miR-211-5p expression was significantly increased under ALP treatment in com- parison with control mice.	31403340
2852	Mouse	mmu-miR-211-5p	miRNA	insulin-transferrin-selenite (ITS)	osteoarthritis (OA)	ATDC5 cells	insulin-transferrin-selenite (ITS) treatment	upregulated	31396630
2853	Mouse	mmu-miR-212	miRNA	high fat diet (HFD)	atherosclerosis (AS)	atherosclerotic lesions and macrophages from apoE-/- mice	high fat diet (HFD) feed	downregulated	29174964
2854	Mouse	mmu-miR-212	miRNA	high fat diet (HFD)	atherosclerosis (AS)	apoE mice macrophages	high fat diet (HFD) feed	downregulated	29174964
2855	Mouse	mmu-miR-212	miRNA	hypoxia	blood-brain barrier (BBB) dysfunction	mouse brain microvascular endothelial cells (BMEC)	hypoxia induce	upregulated	30617994
2856	Mouse	mmu-miR-212	miRNA	adenine	chronic kidney disease (CKD)	kidney tissues	adenine treatment	upregulated	32526762
2857	Mouse	mmu-miR-212	miRNA	gallic acid (GA)	experimental autoimmune encephalomyelitis (EAE)	"The CD4+CD62L+ T cells were isolated from the spleen and cultured under Th17-polarizing conditions, and peritoneal macrophages were stimulated with LPS"	?gallic acid (GA)?treatment treatment	upregulated	31026283
2858	Mouse	mmu-miR-212	miRNA	lipopolysaccharide (LPS)	inflammation	RAW 264.7 cells	lipopolysaccharide (LPS) treatment	dysregulated	24792623
2859	Mouse	mmu-miR-212	miRNA	alcohol	leaky gut	intestinal	alcohol exposure	overexpression	26207424
2860	Mouse	mmu-miR-212	miRNA	methamphetamine (METH)	methamphetamine (METH) addiction	precursors	methamphetamine (METH) treatment	downregulated	29516602
2861	Mouse	mmu-miR-212	miRNA	glucose deprivation (GD)	neurodegeneration (ND)	cortical neuronal cultures from mouse brains at embryonic day 15.5	glucose deprivation treatment	downregulated	28855274
2862	Mouse	mmu-miR-212	miRNA	fatty acid	nonalcoholic fatty liver disease (NAFLD)	HepG2 cells	fatty acid treatment	upregulated	26648452
2863	Mouse	mmu-miR-212	miRNA	high fat diet (HFD)	nonalcoholic fatty liver disease (NAFLD)	mouse	high fat diet (HFD) feed	upregulated	26648452
2864	Mouse	mmu-miR-212	miRNA	long-chain fatty acid	nonalcoholic fatty liver disease (NAFLD)	HepG2 cells	long-chain fatty acid treatment	upregulated	26648452
2865	Mouse	mmu-miR-212	miRNA	running	nonalcoholic fatty liver disease (NAFLD)	HF mouse liver	HF mouse treatment	downregulated in liver	26648452
2866	Mouse	mmu-miR-212	miRNA	glutamate	pain	primary neurons in the spinal cord of mouse embryos	100 ¦Ìmol/L glutamate	upregulated	28244951
2867	Mouse	mmu-miR-212-3p	miRNA	quercetin	chronic inflammatory diseases	LPS-treated murine bone marrow¨Cderived DCs (BMDCs)	quercetin treatment	upregulated	31338984
2868	Mouse	mmu-miR-212-3p	miRNA	carbon tetrachloride (CCl4)	liver fibrosis	liver	CCl4 treatment	downregulated	27322257
2869	Mouse	mmu-miR-212-3p	miRNA	angiostrongylus cantonensis (A. cantonensis)	inflammation	male Balb/c mice	angiostrongylus cantonensis (A. cantonensis) infection	upregulated	24142285
2870	Mouse	mmu-miR-212-3p	miRNA	carbon tetrachloride (CCl4)	liver fibrosis	liver tissues	carbon tetrachloride (CCl4) treatment	upregulated	29557526
2871	Mouse	mmu-miR-212-3p	miRNA	hepatitis B virus (HBV)	liver damage	RAW264.7 cells	HBeAg treatment	miR-212-3p expression was significantly elevated in HBeAg-treated macrophages.	32767729
2872	Mouse	mmu-miR-212-3p	miRNA	lipopolysaccharide (LPS)	sepsis	RAW264.7 cells	lipopolysaccharide (LPS) treatment	upregulated	27940320
2873	Mouse	mmu-miR-212-5p	miRNA	immunoglobulin E (IgE)	asthma-induced hypotension	primary arterial smooth muscle cell (ASMC) of WT or Fc¦ÅR1-/- mice	IgE treatment	upregulated	28988887
2874	Mouse	mmu-miR-212-5p	miRNA	lipopolysaccharide (LPS)	inflammation	RAW264.7 cells	lipopolysaccharide (LPS) treatment	downregulated	32955644
2875	Mouse	mmu-miR-212-5p	miRNA	"1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)"	parkinson's disease (PD)	hippocampus	"1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) treatment"	downregulated	30364275
2876	Mouse	mmu-miR-212-5p	miRNA	angiotensin II (Ang II)	cell proliferation	cardiac fibroblasts (CFs)	angiotensin II (Ang II) treatment	downregulated	32268073
2877	Mouse	mmu-miR-212-5p	miRNA	TGF-¦Â1	cell proliferation	cardiac fibroblasts (CFs)	TGF-¦Â1 ttreatment treatment	downregulated	32268073
2878	Mouse	mmu-miR-2137	miRNA	H1N1 influenza virus	endometriosis and endometrial carcinoma	mouse lung?tissues	H1N1 influenza virus infection	upregulated	24066118
2879	Mouse	mmu-miR-2137	miRNA	cortical impact	traumatic brain injury (TBI)	cortex	cortical impact	upregulated	26426744
2880	Mouse	mmu-miR-21-3p	miRNA	caerulein and aurolithocholic acid 3-sulfate (TLC-S)	acute pancreatitis (AP)	mouse pancreatic acinar cells	caerulein and TLC-S treatment	upregulated	27686613
2881	Mouse	mmu-mir-21-3p	miRNA	second-hand smoke (SHS)	asthma	lung	second-hand smoke (SHS) treatment	upregulated	26859758
2882	Mouse	mmu-miR-21-3p	miRNA	nicotine	atherosclerosis (AS)	Raw264.7 cells	nicotine treatment	upregulated	31660076
2883	Mouse	mmu-miR-21-3p	miRNA	oxygen-glucose deprivation and reoxygenation (OGD/R)	blood-brain barrier (BBB) dysfunction	bEnd.3 cells	oxygen-glucose deprivation and reoxygenation (OGD/R) treatment	upregulated	29695199
2884	Mouse	mmu-miR-21-3p	miRNA	angiotensin II (Ang II)	cardiac hypertrophy	mouse	angiotensin II (Ang II) treatment	downregulated	25504627
2885	Mouse	mmu-miR-21-3p	miRNA	angiotensin II (Ang II)	cardiac hypertrophy	cardiomyocyte	angiotensin II (Ang II) treatment	downregulated	24743145
2886	Mouse	mmu-miR-21-3p	miRNA	lipopolysaccharide (LPS)	inflammation	RAW 264.7 cells	lipopolysaccharide (LPS) treatment	dysregulated	24792623
2887	Mouse	mmu-miR-21-3p	miRNA	particulate matter (PM2.5)	PM2.5 exposure	mosue bronchoalveolar lavage fluid (BALF)	"were subjected to intratracheal instillation of 2.5, 10, or 20mg/kg PM2.5 treatment"	upregulated in bronchoalveolar lavage fluid (BALF)	29107863
2888	Mouse	mmu-miR-21-3p	miRNA	particulate matter (PM2.5)	pulmonary toxicological	lung tissues	particulate matter (PM2.5) exposure treatment	upregulated	29107863
2889	Mouse	mmu-miR-21-3p	miRNA	oxygen glucose deprivation (OGD)	traumatic brain injury (TBI)	bEnd.3 cells	oxygen-glucose deprivation (OGD) treatment	miR-21-3p level in bEnd.3 cells with OGD treatment was increased after injury.	29695199
2890	Mouse	mmu-miR-21-3p	miRNA	wire-induced injury to carotid arteries	vessel stenosis	apolipoprotein E knockout (Apoe ) mice	injury to carotid arteries of treatment	upregulated	27622243
2891	Mouse	mmu-miR-214	miRNA	D-galactosamine (D-GalN) and TNF-¦Á	acute liver failure (ALF)	BNLCL2 cells	D-galactosamine (D-GalN) andTnF-¦Á treatment	miR214 was downregulated in D-GalN/LPS-stimulated mice and D-GalN/TNF-¦Á-stimulated BNLCL2 cells.	32377732
2892	Mouse	mmu-miR-214	miRNA	D-galactosamine/lipopolysaccharide (D-GalN/LPS)	acute liver failure (ALF)	liver tissues	D-galactosamine (D-GalN) and lipopolysaccharide (LPS) treatment	miR214 was downregulated in D-GalN/LPS-stimulated mice and D-GalN/TNF-¦Á-stimulated BNLCL2 cells.	32377732
2893	Mouse	mmu-miR-214	miRNA	angiotensin II (Ang II)	cardiac hypertrophy	cardiomyocytes	angiotensin II (Ang II) treatment	downregulated	29499950
2894	Mouse	mmu-miR-214	miRNA	angiotensin II (Ang II)	cardiac hypertrophy	neonatal mouse cardiomyocytes (NMCMs)	angiotensin II (Ang II) treatment	MicroRNA-214 contributes to Ang II-induced cardiac hypertrophy by targeting SIRT3 to provoke mitochondrial malfunction	33247214
2895	Mouse	mmu-miR-214	miRNA	ginkgolide B (GB)	cisplatin (DDP)-induced nephrotoxicity	cisplatin-treated HEI-OC1 auditory cells	cisplatin-treated HEI-OC1 auditory cells treatment	upregulation	26768586
2896	Mouse	mmu-miR-214	miRNA	high glucose (HG) and lipopolysaccharide (LPS)	diabetes-associated periodontitis	MC3T3-E1 cells	high glucose and lipopolysaccharide (LPS) co-stimulated	upregulated	31090954
2897	Mouse	mmu-miR-214	miRNA	high glucose (HG)	diabetic nephropathy (DN)	mouse proximal tubular epithelial cells MCT	high glucose (HG) treatment	upregulated	31240704
2898	Mouse	mmu-miR-214	miRNA	indoxyl sulfate (IS)	endothelial cell injury	mouse aortic endothelial cells (MAECs)	indoxyl sulfate (IS) treatment	"Following IS treatment, miR-214 was significantly downregulated in MAECs in line with enhanced cell apoptosis."	31820187
2899	Mouse	mmu-miR-214	miRNA	ethanol (EtOH)	fibrosis	primary mouse HSC	ethanol treatment	downregulated	24122827
2900	Mouse	mmu-miR-214	miRNA	H2O2	fragility fracture	MC3T3-E1 cells	treat with 400 ¦ÌM H2O2	downregulated	291645892
2901	Mouse	mmu-miR-214	miRNA	high fat diet (HFD)	hepatic insulin resistance	mouse liver tissues	high fat diet (HFD) feed	downregulated	30431065
2902	Mouse	mmu-miR-214	miRNA	palmitate	hepatic insulin resistance	mouse primary hepatocytes	palmitate treatment	downregulated	30431065
2903	Mouse	mmu-miR-214	miRNA	hypoxia	hepatic ischemia/reperfusion injury (HIRI)	mouse hepatocyte AML12	hypoxia induce	downregulated	30560327
2904	Mouse	mmu-miR-214	miRNA	hypoxia	hepatic ischemia/reperfusion injury (HIRI)	mouse hepatocyte AML12	hypoxia induce	downregulated	30560327
2905	Mouse	mmu-miR-214	miRNA	norcantharidin (NCTD)	hepatocellular carcinoma (HCC)	liver tissues	intraperitoneal injection of different concentration of NCTD treatment	upregulated	24719559
2906	Mouse	mmu-miR-214	miRNA	bleomycin (BLM)	idiopathic pulmonary fibrosis (IPF)	mouse lungs; primary lung fibroblasts	bleomycin (BLM) treatment	FENDRR reduced pulmonary fibrosis by inhibiting fibroblast activation by reducing iron concentration and acting as a competing endogenous RNA of the profibrotic microRNA-214.	31697569
2907	Mouse	mmu-miR-214	miRNA	high fat diet (HFD)	liver fibrosis	liver tissues	high fat diet (HFD) feed	upregulated	29915227
2908	Mouse	mmu-miR-214	miRNA	sildenafil	metabolic and functional derangements in the heart	heart sissues	sildenafil treatment	Co-ingestion with sildenafil blunted the alcohol-induced increase in miR-214	32535704
2909	Mouse	mmu-miR-214	miRNA	methylglyoxal (MGO)	MGO-induced endothelial insulin-resistance	mouse aortic endothelial cells (MAECs)	methylglyoxal (MGO) treatment	downregulated	29425121
2910	Mouse	mmu-miR-214	miRNA	exercise (Ex)	osteoporosis	tibia tissues and primary osteoblasts	mice were run on treadmill at moderate-intensity for five weeks or Flexcell-5000C? Tension System	downregulated	31639865
2911	Mouse	mmu-miR-214	miRNA	"1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)"	parkinson's disease (PD)	midbrain	"1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) treatment"	downregulated	26349993
2912	Mouse	mmu-miR-214	miRNA	angiotensin II (Ang II)	pathological perivascular fibrosis in hypertension	perivascular tissue	angiotensin II (Ang II) treatment	miR-214 is increased in the vasculature in Ang II-induced hypertension.	32065054
2913	Mouse	mmu-miR-214	miRNA	oxygen-glucose deprivation and reoxygenation (OGD/R)	testicular ischemia-reperfusion injury (IRI)	GC-1 cells	oxygen-glucose deprivation and reoxygenation (OGD/R) treatment	downregulated	29870987
2914	Mouse	mmu-miR-214	miRNA	dextran sodium sulfate (DSS)	ulcerative colitis (UC)	colon tissues	dextran sodiumsulfate (DSS) treatment	upregulated	31382166
2915	Mouse	mmu-miR-214	miRNA	limonin	ulcerative colitis (UC)	Ulcerative colitis (UC) mice colon tissues	limonin treatment	downregulated	31382166
2916	Mouse	mmu-miR-214	miRNA	sulfasalazine	ulcerative colitis (UC)	Ulcerative colitis (UC) mice colon tissues	sulfasalazine (SASP) treatment	downregulated	31382166
2917	Mouse	mmu-miR-214	miRNA	mechanical ventilation (MV)	ventilator-induced lung injury (VILI)	lung tissues; macrophages; fibroblasts; epithelial cells; endothelial cells	mechanical ventilation (MV) treatment	"The expression of miR-214 was increased in lung tissues and macrophages, fibroblasts, epithelial cells, and endothelial cells isolated from lung tissues in VILI mice."	33389067
2918	Mouse	mmu-miR-214-3p	miRNA	high fat diet (HFD) and sodium taurocholic	acute pancreatitis (AP)	kidney tissues	high-fat diet and sodium taurocholic injection	MiR-214-3p exacerbates kidney damages and inflammation induced by hyperlipidemic pancreatitis complicated with acute renal injury.	31790686
2919	Mouse	mmu-miR-214-3p	miRNA	streptozocin (STZ)	brain injury in diabetes mellitus (DM)	brain tissues	streptozocin (STZ) treatment	MicroRNA-214-3p (miR-214-3p) was decreased in DM mice.	32910484
2920	Mouse	mmu-miR-214-3p	miRNA	angiotensin II (Ang II)	cardiac fibrosis	myofibroblasts	angiotensin II (Ang II) treatment	downregulated	27823969
2921	Mouse	mmu-miR-214-3p	miRNA	TGF-¦Â1	cardiac fibrosis	primary cultured myofibroblasts	TGF-¦Â1 treatment	downregulated	31434695
2922	Mouse	mmu-miR-214-3p	miRNA	angiotensin II (Ang II)	cardiac hypertrophy	hypertrophic myocardium	angiotensin II (Ang II) treatment	upregulated	27796324
2923	Mouse	mmu-miR-214-3p	miRNA	high glucose (HG)	diabetic cardiomyopathy (DCM)	cardiac tissues	high glucose (HG) treatment	miR-214-3p was decreased in the HG-treated cardiac fibroblasts.	30250027
2924	Mouse	mmu-miR-214-3p	miRNA	chronic social defeat stress (CSDS)	major depressive disorder (MDD)	medial prefrontal cortex (mPFC) tissues	chronic social defeat stress (CSDS) induce	upregulated	29522177
2925	Mouse	mmu-miR-214-3p	miRNA	luteolin exerts	obesity-associated comorbidities	mesenteric vessels	luteolin exerts treatment	"In HFD mice, luteolin counteracted significantly the decreased expression of miR-214-3p."	30319424
2926	Mouse	mmu-miR-214-3p	miRNA	bis-enoxacin	osteoclastogenesis	4T1 murine breast cancer cells	bis-enoxacin treatment	upregulated	30385810
2927	Mouse	mmu-miR-214-3p	miRNA	enoxacin	osteoclastogenesis	4T1 murine breast cancer cells	Enoxacin treatment	upregulated	30385810
2928	Mouse	mmu-miR-214-3p	miRNA	high glucose (HG)	osteogenesis	bone marrow mesenchymal stem cells (BMSCs)	high glucose (HG) treatment	upregulated	31728209
2929	Mouse	mmu-miR-214-3p	miRNA	"1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)"	parkinson's disease (PD)	midbrain tissues	"1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) treatment"	downregulated	33071725
2930	Mouse	mmu-miR-214-3p	miRNA	1-methyl-4-phenylpyridinium (MPP+)	parkinson's disease (PD)	Primary Neuron	1-methyl-4-phenylpyridinium (MPP+) treatment	downregulated	33071725
2931	Mouse	mmu-miR-214-5p	miRNA	pressure overload	heart failure (HF)	heart sissues	pressure overload treatment	upregulated	33224746
2932	Mouse	mmu-miR-214-5p	miRNA	lipopolysaccharide (LPS)	inflammation	BV2 microglia	lipopolysaccharide (LPS) treatment	downregulated	30584538
2933	Mouse	mmu-miR-215	miRNA	TGF-¦Â1	diabetic nephropathy (DN)	mouse mesangial cell (MMC)	TGF-¦Â1 treatment	upregulated	23554908
2934	Mouse	mmu-miR-215	miRNA	sodium arsenite (NaAsO2)	DNA methylation	liver tissues	sodium arsenite treatment	upregulated	32068019
2935	Mouse	mmu-miR-215	miRNA	hypoxia	ischemic stroke (IS)	brain tissses	middle cerebral artery occlusion (MCAO) treatment	downregulated	29080697
2936	Mouse	mmu-mir-215-5p	miRNA	recombinant-specific gram-negative pathogen Escherichia coli (Xen14) and gram-positive pathogen Staphylococcus aureus (Xen29)	bacterial infection	blood	recombinant-specific gram-negative pathogen Escherichia coli (Xen14) and gram-positive pathogen Staphylococcus aureus (Xen29) treatment	upregulated	25563241
2937	Mouse	mmu-miR-215-5p	miRNA	doxorubicin (DOX)	doxorubicin (DOX)-induced cardiotoxicity	Plasma	doxorubicin (DOX) treatment	downregulated	30627229
2938	Mouse	mmu-miR-21-5p	miRNA	lipopolysaccharide (LPS)	acute respiratory distress syndrome (ARDS)	serum	lipopolysaccharide (LPS) treatment	upregulated	32934950
2939	Mouse	mmu-miR-21-5p	miRNA	tacrolimus (FK506)	chronic allograft dysfunction	renal proximal tubular epithelial cells (RPTECs)	tacrolimus treatment	upregulated	29362864
2940	Mouse	mmu-miR-21-5p	miRNA	ethanol (EtOH)	ethanol-induced neuroinflammation and brain damage	plasma exosomes	ethanol treatment	downregulated	32937997
2941	Mouse	mmu-miR-21-5p	miRNA	ethanol (EtOH)	ethanol-induced neuroinflammation and brain damage	brain cortices	ethanol treatment	upregulated	32937997
2942	Mouse	mmu-miR-21-5p	miRNA	lipopolysaccharide (LPS)	inflammation	RAW 264.7 cells	lipopolysaccharide (LPS) treatment	upregulated	32153563
2943	Mouse	mmu-miR-21-5p	miRNA	gastrodin and rhynchophylline	ischemia/reperfusion (I/R) injury	hypoxia-induced mouse brain tissues and BV2 cells	combination of gastrodin and rhynchophylline treatment	upregulated	31610203
2944	Mouse	mmu-miR-21-5p	miRNA	hypoxia	ischemia/reperfusion (I/R) injury	mouse brain tissues and BV2 cells	Middle cerebral artery occlusion (MCAO) mice and oxygen glucose deprivation (OGD)-treated BV2 cells were used as in vivo and in vitro models of ischaemia	downregulated	31610203
2945	Mouse	mmu-miR-21-5p	miRNA	hypoxia	lung ischemia/reperfusion (I/R) injury	mesenchymal stromal cell-secreted exosomes (MSC-Exo)	hypoxia induce	upregulated	30682335
2946	Mouse	mmu-miR-21-5p	miRNA	lipopolysaccharide (LPS)	neuroinflammation	BV2 cells	lipopolysaccharide (LPS) treatment	upregulated	31707083
2947	Mouse	mmu-miR-21-5p	miRNA	icariin (ICA)	osteogenesis	MC3T3-E1 cells	icariin treatment	upregulated	29500883
2948	Mouse	mmu-miR-21-5p	miRNA	titanium (Ti)	osteogenesis	MC3T3-E1 cells	titanium (Ti) particle treatment	downregulated	29500883
2949	Mouse	mmu-miR-21-5p	miRNA	particulate matter (PM2.5)	PM2.5 exposure	mosue bronchoalveolar lavage fluid (BALF)	"were subjected to intratracheal instillation of 2.5, 10, or 20mg/kg PM2.5 treatment"	upregulated in bronchoalveolar lavage fluid (BALF)	29107863
2950	Mouse	mmu-miR-21-5p	miRNA	particulate matter (PM2.5)	pulmonary toxicological	lung tissues	particulate matter (PM2.5) exposure treatment	upregulated	29107863
2951	Mouse	mmu-miR-21-5p	miRNA	lipopolysaccharide (LPS)	spinal cord injury (SCI)	BV2 cells	lipopolysaccharide (LPS) treatment	upregulated	32572900
2952	Mouse	mmu-miR-21-5p	miRNA	TGF-¦Â1	spinal cord injury (SCI)	Primary mouse spinal fibroblasts	transforming growth factor (TGF)-¦Â1 treatment	upregulated	29483836
2953	Mouse	mmu-miR-21-5p	miRNA	"IL-1¦Â, IFN-¦Ã and TNF-¦Á"	type 1 diabetes mellitus (T1DM)	MIN6 cells	"a mixture containing 10 ng/mL each of IL-1¦Â, IFN-¦Ã, and TNF-¦Á for 24 h"	upregulated	29445851
2954	Mouse	mmu-miR-216	miRNA	cerulean	acute pancreatitis (AP)	mouse serum and pancreatic tissues	cerulean treatment	"upregulation of miR-216a and miR-216b in the serum, downregulated of miR-216a in pancreatic tissues"	28183420
2955	Mouse	mmu-miR-216	miRNA	amyloid-¦Â (A¦Â) 1-40	age-related macular degeneration (AMD)	C57BL/6 mice eye tissues	amyloid-¦Â (A¦Â) 1-40 treatment	upregulated	28324113
2956	Mouse	mmu-miR-216a	miRNA	lipopolysaccharide (LPS)	acute lung injury (ALI)	mouse lung tissues	lipopolysaccharide (LPS) treatment	downregulated	31784954
2957	Mouse	mmu-miR-216a	miRNA	cerulean	acute pancreatitis (AP)	serum	cerulean treatment	upregulated	28183420
2958	Mouse	mmu-miR-216a	miRNA	cerulean	acute pancreatitis (AP)	pancreatic	cerulean treatment	downregulated	28183420
2959	Mouse	mmu-miR-216a	miRNA	TGF-¦Â	cardiac fibrosis	Adult mouse cardiac fibroblasts	TGF-¦Â treatment	upregulated	31059054
2960	Mouse	mmu-miR-216a	miRNA	TGF-¦Â	diabetic nephropathy (DN)	glomerular mesangial cells	TGF-¦Â treatment	upregulated	19543271
2961	Mouse	mmu-miR-216a	miRNA	TGF-¦Â	vascular smooth muscle cell calcification	kidney cells	TGF-¦Â treatment	upregulated	20713358
2962	Mouse	mmu-miR-216b	miRNA	cerulean	acute pancreatitis (AP)	serum	cerulean treatment	upregulated	28183420
2963	Mouse	mmu-miR-216b	miRNA	glyoxylate	kidney tubular cell injury	renal tubular epithelial cell	glyoxylate treatment	downregulated	31735555
2964	Mouse	mmu-miR-216b	miRNA	glyoxylate	kidney tubular cell injury	oxidative stress	glyoxylate treatment	downregulated	31735555
2965	Mouse	mmu-miR-217	miRNA	silk ascending aorta proximal	cardiac hypertrophy	C57BL/6J mice cardiomyocytes	silk suture was tightened around the ascending aorta proximal to the brachiocephalic trunk treatment	downregulated in cardiomyocytes	27893464
2966	Mouse	mmu-miR-217	miRNA	fatty acid amide hydrolase inhibitor (FAAH-II)	colitis	colitis mouse colon tissues	FAAH-II treatment	dysregulated	27327245
2967	Mouse	mmu-miR-217	miRNA	streptozocin (STZ)	diabetes mellitus (DM)	skin	streptozotocin (STZ) treatment	"GAS5 was significantly downregulated whereas miR-217 was obviously upregulated in diabetic skin, HG-induced lymphatic endothelial cells (LECs) and diabetic mouse model."	33865922
2968	Mouse	mmu-miR-217	miRNA	high glucose (HG)	diabetic nephropathy (DN)	mouse podocytes	feed with HG	upregulated	28017719
2969	Mouse	mmu-miR-217	miRNA	TGF-¦Â	diabetic nephropathy (DN)	glomerular mesangial cells	TGF-¦Â treatment	upregulated	19543271
2970	Mouse	mmu-miR-217	miRNA	sodium arsenite (NaAsO2)	DNA methylation	liver tissues	sodium arsenite treatment	downregulated	32068019
2971	Mouse	mmu-miR-217	miRNA	ethanol (EtOH)	genotoxic damage? cancer	The mouse AML-12 hepatocyte cell line and mice liver tisssue	ethanol treatment	"In AML-12 hepatocytes and in mouse livers, chronic ethanol exposure drastically and specifically induced miR-217 levels and caused excess fat accumulation"	22308024
2972	Mouse	mmu-miR-217	miRNA	ethanol (EtOH)	steatotic hepatocytes	Kupffer cells	ethanol treatment	upregulated	25797648
2973	Mouse	mmu-miR-217	miRNA	coxsackievirus B3 (CVB3)	viral myocarditis (VM)	peripheral blood and myocardial tissues of viral myocarditis mice and in CVB3-infected cardiomyocytes	Coxsackievirus B3 (CVB3) infection	upregulated	31894309
2974	Mouse	mmu-miR-217	miRNA	coxsackievirus B3 (CVB3)	viral myocarditis (VM)	peripheral blood; myocardial tissues; cardiomyocytes.	Coxsackievirus B3 (CVB3) infection	upregulated	31894309
2975	Mouse	mmu-miR-217-5p	miRNA	high fat diet (HFD)	atherosclerosis (AS)	atherosclerotic endothelial cells from apolipo protein E knockout ApoE(-/-) mice	high fat diet (HFD) feed	downregulated	31744714
2976	Mouse	mmu-miR-218	miRNA	lipopolysaccharide (LPS)	acute lung injury (ALI)	MH-S cells; RAW264.7 cells	lipopolysaccharide (LPS) treatment	MicroRNA-218 was significantly downregulated in cells treated with LPS.	30556885
2977	Mouse	mmu-miR-218	miRNA	transglutaminase 2 (TG2)	allergic inflammation	B16F1 mouse melanoma cells	TGaseII treatment	downregulated	25202021
2978	Mouse	mmu-miR-218	miRNA	intermittent hypoxia (IH)	apoptosis	normal mice aortic endothelial cells	under IH condition	upregulated	29262646
2979	Mouse	mmu-miR-218	miRNA	high glucose (HG)	diabetic nephropathy (DN)	murine podocyte	high glucose (HG) treatment	downregulated	31549412
2980	Mouse	mmu-miR-218	miRNA	high glucose (HG)	diabetic nephropathy (DN)	mouse podocytes	high glucose treatment	downregulated	31549412
2981	Mouse	mmu-miR-218	miRNA	streptozocin (STZ)	diabetic nephropathy (DN)	kidney tissues	streptozotocin (STZ) treatment	downregulated	31549412
2982	Mouse	mmu-miR-218	miRNA	lopinavir/ritonavir (LPV/RTV)	lipogenesis	3T3-L1 cells	lopinavir/ritonavir (LPV/RTV) treatment	upregulated	31133852
2983	Mouse	mmu-miR-218	miRNA	amphetamine regimen	mesocortical dopamine development in adolescence	male mice dopamine neurons	amphetamine regimen treatment	upregulated	31192517
2984	Mouse	mmu-miR-218	miRNA	isoproterenol	cardiac fibrosis	heart tissues	isoproterenol (ISO) treatment	downregulated	27174579
2985	Mouse	mmu-miR-218	miRNA	methionine choline-deficient diet (MCD)	nonalcoholic steatohepatitis (NASH)	liver tissues	methionine-choline-deficient (MCD) diet feed	downregulated	31850710
2986	Mouse	mmu-miR-218	miRNA	chronic intermittent hypoxia (CIH)	obstructive sleep apnoea-hypopnoea syndrome (OSAHS)	mouse aortic endothelial cells (MAECs)	chronic intermittent hypoxia (CIH) treatment	upregulated	29108914
2987	Mouse	mmu-miR-218	miRNA	oxygen	oxygen-induced retinopathy (OIR)	retinal tissues	Oxygen treatment	downregulated	27824019
2988	Mouse	mmu-miR-218	miRNA	RANKL (receptor activator of nuclear factor ¦ÊB ligand)	postmenopausal osteoporosis (PMOP)	osteoclastogenesis of RAW264.7 cells	50ng/mL RANKL treatment	downregulated	29271983
2989	Mouse	mmu-miR-218	miRNA	oxygen	retinal neovascularization (RNV)	retinal tissues	oxygen treatment	downregulated	26935869
2990	Mouse	mmu-miR-218	miRNA	laparotomy and exposure of the junc_x0002_tion between the large and small intestines	sepsis	mouse large and small intestines	laparotomy and exposure of the junc_x0002_tion between the large and small intestines treatment	downregulated	25043848
2991	Mouse	mmu-miR-218	miRNA	Src tyrosine kinase (Src)	tumorigenesis	The nontransformed and v-Src-transformed mouse embryonic Cx43Ko brain cells	Src tyrosine kinase (Src) treatment	downregulated	19767772
2992	Mouse	mmu-miR-218	miRNA	glucose	type 2 diabetes mellitus (T2DM)	isolated mouse islets	exposed to high levels of glucose within 1 h treatment	downregulated	25489007
2993	Mouse	mmu-miR-218-1-3p	miRNA	gentamicin	acute kidney injury (AKI)	urine	gentamicin treatment	upregulated	27074385
2994	Mouse	mmu-miR-218-2*	miRNA	clozapine (CLZ)	psychotic disorders	mouse brain	clozapine treatment	upregulated	23318695
2995	Mouse	mmu-miR-218-2*	miRNA	olanzapine (OLP)	psychotic disorders	brain tissues	clozapine treatment	upregulated	23318695
2996	Mouse	mmu-miR-218-5p	miRNA	honokiol	sepsis-induced acute kidney injury	renal tissues of sepsis-induced acute kidney injury (AKI) rats	honokiol treatment	downregulated	30833971
2997	Mouse	mmu-miR-218-5p	miRNA	ovalbumin (OVA)	asthma	Lung tissues	ovalbumin (OVA) treatment	downregulated	31520422
2998	Mouse	mmu-miR-218a-5p	miRNA	"4,4'-methylenedianiline (MDA)"	cholestasis	plasma	"4,4'-Methylenedianiline (MDA) treatment"	upregulated	30125006
2999	Mouse	mmu-miR-218a-5p	miRNA	¦Á-naphthylisothiocyanate (ANIT)	cholestasis	plasma	¦Á-naphthylisothiocyanate (ANIT) treatment	upregulated	30125006
3000	Mouse	mmu-miR-219	miRNA	arsenite	arsenic-induced neurotoxicity	hippocampus	arsenic (As) exposure	subchronic arsenic exposure induced impairment of learning and memory and significantly upregulated miRNA-219 (miR-219) expression in the mouse hippocampus.	29478199
3001	Mouse	mmu-miR-219	miRNA	complete freund's adjuvant (CFA)	chronic inflammatory pain	spinal neurons	complete Freund's adjuvant (CFA) treatment	downregulated	25031391
3002	Mouse	mmu-miR-219	miRNA	kainic acid (KA)	epilepsy	Hippocampal neurons	kainic acid (KA) treatment	downregulated	25394384
3003	Mouse	mmu-miR-219	miRNA	kainic acid (KA)	epilepsy	Hippocampal neurons	KA treatment	downregulated	25394384
3004	Mouse	mmu-miR-219	miRNA	carbon tetrachloride (CCl4)	liver fibrosis	liver tissues	CCl4 treatment	downregulated	30592264
3005	Mouse	mmu-miR-219-5p	miRNA	resolvin D1 (RvD1)	extracellular matrix synthesis	macrophages	resolvin D1 (RvD1) treatment	upregulated	24249635
3006	Mouse	mmu-miR-219-5p	miRNA	resolvin D1 (RvD1)	insulin resistance and nonalcoholic steatohepatitis (NASH)	obese mice with NASH	resolvin D1 (RvD1) treatment	upregulated	24249635
3007	Mouse	mmu-miR-219-5p	miRNA	morphine	macrophage apoptosis	RAW264.7 cells	morphine treatment	downregulated	27253431
3008	Mouse	mmu-miR-219-5p	miRNA	microwave	microwave-induced adverse health outcomes 	mouse hippocampus	7 days after 30 mW/cm microwave exposure treatment	downregulated	24748327
3009	Mouse	mmu-miR-219a-2	miRNA	hypoxia/reoxygenation (H/R)	myocardial ischemia/reperfusion (I/R) injury (MIRI)	HL-1 cells	hypoxia/reoxygenation (H/R) treatment	downregulated	32682013
3010	Mouse	mmu-miR-219a-5p	miRNA	ethanol (EtOH)	chronic alcoholic liver disease (ALD)	AML-12 cells	Ethanol exposure	downregulated	31428222
3011	Mouse	mmu-miR-219a-5p	miRNA	protocatechuic acid (PCA)	chronic alcoholic liver disease (ALD)	AML-12 cells	Protocatechuic acid (PCA) treatment	upregulated	31428222
3012	Mouse	mmu-miR-219a-5p	miRNA	anandamide and norgestimate	depression	chronic mild stress (CMS) model of depression mouse	anandamide and norgestimate treatment	downregulated	28716528
3013	Mouse	mmu-miR-219a-5p	miRNA	H2O2	hepatic ischemia/reperfusion injury (HIRI)	AML-12 and NCTC1469 cells	H2O2 treatment	downregulated	30796685
3014	Mouse	mmu-miR-219b-5p	miRNA	chronic unpredictable mild stress (CUMS)	major depressive disorder (MDD)	nucleus accumbens (NAc) tissues	chronic unpredictable mild stress (CUMS) induce	upregulated	30936699
3015	Mouse	mmu-miR-21a	miRNA	Shexiang Tongxin dropping pill (STDP)	atherosclerosis (AS)	serial transverse aortic sections	Shexiang Tongxin dropping pill (STDP) treatment	downregulated	25449459
3016	Mouse	mmu-miR-21a	miRNA	Shexiang Tongxin dropping pill (STDP)	atherosclerosis (AS)	(ApoE(-/-)) mice aortic	STDP (30 mg/kg/day) on atherosclerotic lesions treatment	downregulated	25449459
3017	Mouse	mmu-miR-21a	miRNA	helicobacter pylori (H. pylori)	gastric MALT lymphoma (GML)	GML-developing d3Tx mice stomachs	infect with H. pylori	upregulated	28560185
3018	Mouse	mmu-miR-21a-3p	miRNA	lipopolysaccharide (LPS)	acute kidney injury (AKI)	kidney tissues	lipopolysaccharide (LPS) treatment	upregulated	32727087
3019	Mouse	mmu-miR-21a-3p	miRNA	lipopolysaccharide (LPS)	acute respiratory distress syndrome (ARDS)	Mouse primary pulmonary Telocytes (TCs)	lipopolysaccharide (LPS) treatment	upregulated	31878977
3020	Mouse	mmu-miR-21a-3p	miRNA	fructus meliae toosendan (FMT)	liver damage	eft lateral liver lobe	Fructus Meliae Toosendan (FMT) treatment	upregulated	26539117
3021	Mouse	mmu-miR-21a-5p	miRNA	lipopolysaccharide (LPS)	acute kidney injury (AKI)	kidney tissues	lipopolysaccharide (LPS) treatment	miR-21a-5p was upregulated at 24h and 48h.	32727087
3022	Mouse	mmu-miR-21a-5p	miRNA	brucella abortus	brucellosis	"bone marrow-derived macrophages, spleens"	brucella abortus infection	downregulated	29942317
3023	Mouse	mmu-miR-21a-5p	miRNA	kidney transplantation	chronic renal allograft dysfunction (CAD)	mouse kidney tissues	allogenic kidney transplantation treatment	upregulated in the mouse kidney	28396121
3024	Mouse	mmu-miR-21a-5p	miRNA	echinococcus multilocularis metacestodes	echinococcus multilocularis infection	RAW 264.7 cells	E. multilocularis metacestodes treatment	upregulated	30322806
3025	Mouse	mmu-miR-21a-5p	miRNA	¦¤9-tetrahydrocannabinol (THC) and Cannabidiol (CBD)	experimental autoimmune encephalomyelitis (EAE)	murine brain-derived CD4+ T cells	¦¤9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) combination treatment	downregulated	31497013
3026	Mouse	mmu-miR-21a-5p	miRNA	E. multilocularis metacestodes	infection and immunity of E. multilocularis	RAW264¡¤7 macrophage cells	E. multilocularis metacestodes for 6 and 12 h treatment	"upregulated (mmu-miR-378d,mmu-miR-155-5p, mmu-miR-146a-5p, mmu-miR-21a-5p , mmu-miR-125a-5p) and downregulated(mmu-miR-1981-5p , mmu-miR-let-7c-1-3p)"	28942753
3027	Mouse	mmu-miR-21a-5p	miRNA	chronic unpredictable mild stress (CUMS)	major depressive disorder (MDD)	nucleus accumbens (NAc) tissues	chronic unpredictable mild stress (CUMS) induce	upregulated	30936699
3028	Mouse	mmu-miR-21a-5p	miRNA	high fat diet (HFD)	obesity	liver tissues	high fat diet (HFD) feed	upregulated	32593682
3029	Mouse	mmu-miR-21a-5p	miRNA	polymethylmethacrylate (PMMA)	particle-induced osteolysis (PIO)	primary bone marrow-derived macrophages (BMMs)	polymethylmethacrylate (PMMA) treatment	miR-21a-5p expression was promoted in PMMA-induced cells	29252185
3030	Mouse	mmu-miR-21a-5p	miRNA	alpinia oxyphylla extract (AOE)	type 2 diabetes mellitus (T2DM)	db-/db- mouse kidney	A. oxyphylla extract (AOE) treatment	downregulated	28249617
3031	Mouse	mmu-miR-21b-3p	miRNA	oxygen-glucose deprivation and reoxygenation (OGD/R)	cerebral ischemia/reperfusion (I/R) injury	NS2OY cells	oxygen-glucose deprivation and reoxygenation (OGD/R) treatment	downregulated	31217870
3032	Mouse	mmu-miR-22	miRNA	simvastatin	atherosclerosis (AS)	RAW264.7 macrophages	simvastatin treatment	miR-22 was found to be one of the most significantly upregulated miRNAs in LPS-stimulated RAW2647 macrophages after treatment with simvastatin	31949780
3033	Mouse	mmu-miR-22	miRNA	lipopolysaccharide (LPS)	Dendritic cell (DC) maturation	?Mouse Monocyte	lipopolysaccharide (LPS) treatment	upregulated	24198819
3034	Mouse	mmu-miR-22	miRNA	ultraviolet (UV) irradiation	bacterial pneumonia	Mouse embryonic fibroblast cells	UV radiation treatment	?UV radiation induces a significant increase of miR-22 expression	22166214
3035	Mouse	mmu-miR-22	miRNA	Rhesus Rotavirus (RRV)	biliary atresia (BA)	mouse	infect with Rhesus Rotavirus (RRV) treatment	upregulated	24569080
3036	Mouse	mmu-miR-22	miRNA	angiotensin II (Ang II)	cardiac hypertrophy	neonatal mouse cardiac myocytes	angiotensin II (Ang II) treatment	The expression of lnc-FTX was associated with reduced hypertrophy of neonatal mouse cardiac myocytes and regulated the PTEN/PI3K/Akt signaling pathway by sponging miRNA-22	31840653
3037	Mouse	mmu-miR-22	miRNA	isoproterenol	cardiac hypertrophy	heart tissues	prolongation of isoproterenol intervention treatment	downregulated	24504502
3038	Mouse	mmu-miR-22	miRNA	doxorubicin (DOX)	cardiotoxicity	heart tissues	"Mice were exposed to reduplicative injections of Dox (i.p., 4?mg/kg) weekly for consecutive 4 weeks to generate Dox-induced cardiotoxicity."	upregulated	31677784
3039	Mouse	mmu-miR-22	miRNA	high glucose (HG)	diabetic cardiomyopathy (DCM)	mouse cardiomyocytes	high glucose (HG) treatment	MALAT1-mediated recruitment of the histone methyltransferase EZH2 to the microRNA-22 promoter leads to cardiomyocyte apoptosis in diabetic cardiomyopathy.	33097254
3040	Mouse	mmu-miR-22	miRNA	phosphodiesterase 5 (PDE5) inhibitor	diabetic nephropathy (DN)	diabetic kidney injury mouse	PDE5is treatment	downregulated	28294194
3041	Mouse	mmu-miR-22	miRNA	tongxinluo (TXL)	diabetic nephropathy (DN)	C57BL/6J mice	TXL treatment	downregulated	24370588
3042	Mouse	mmu-miR-22	miRNA	doxorubicin (DOX)	doxorubicin (DOX)-induced cardiotoxicity	heart tissues	doxorubicin (Dox) treatment	MicroRNA-22 inhibition prevents doxorubicin-induced cardiotoxicity via upregulating SIRT1.	31677784
3043	Mouse	mmu-miR-22	miRNA	puerarin	facilitates t-tubule development	murine embryonic stem cell-derived cardiomyocytes	puerarin treatment	downregulated	25059232
3044	Mouse	mmu-miR-22	miRNA	bleomycin (BLM)	idiopathic pulmonary fibrosis (IPF)	sera	bleomycin (BLM) treatment	Exosomal miR-22 modulates fibroblast-to-myofibroblast differentiation.	31776321
3045	Mouse	mmu-miR-22	miRNA	"3,3'-diindolylmethane (DIM)"	multiple sclerosis (MS)	activated T cells during the development of experimental autoimmune encephalomyelitis (EAE)	"3,3'-Diindolylmethane (DIM) treatment"	upregulated	24898268
3046	Mouse	mmu-miR-22	miRNA	high fat diet (HFD)	nonalcoholic fatty liver disease (NAFLD)	liver tissues	high fat diet (HFD) feed	upregulated	33159388
3047	Mouse	mmu-miR-22	miRNA	streptozocin (STZ)	nonalcoholic steatohepatitis-hepatocellular carcinoma (NASH-HCC)	high fat dietmouse liver	STZ treatment	upregulated in liver	28345673
3048	Mouse	mmu-miR-22	miRNA	aerobic training	obesity	exosomes of serum	aerobic training	downregulated	32744099
3049	Mouse	mmu-miR-22	miRNA	high fat diet (HFD)	obesity	mouse brown adipose tissue (BAT)	high fat diet (HFD) feed	"Here, we show that miR-22 expression is induced during white, beige, and brown adipocyte differentiation in vitro."	33549579
3050	Mouse	mmu-miR-22	miRNA	dexamethasone (DEX)	osteoporosis	murine osteoblastic MC3T3-E1 cells	dexamethasone (DEX) treatment	The results demonstrated that miR-22 expression was upregulated in DEX-treated osteoblastic cells compared with the control group.	33732309
3051	Mouse	mmu-miR-22	miRNA	¦Â-elemene	oxygen-induced retinopathy (OIR)	Retinas tissues	¦Â-elemene treatment	upregulated	30664207
3052	Mouse	mmu-miR-22	miRNA	testosterone	prostate cancer	female mouse liver	Testosterone treatment	"upregulation of the 6 miRNAs miR-22, miR-690, miR-122, let-7A, miR-30D and let-7D"	20600201
3053	Mouse	mmu-miR-22	miRNA	haloperidol	psychotic disorders	mouse brain	clozapine treatment	upregulated	23318695
3054	Mouse	mmu-miR-22	miRNA	olanzapine (OLP)	psychotic disorders	brain tissues	clozapine treatment	upregulated	23318695
3055	Mouse	mmu-miR-22	miRNA	bleomycin (BLM)	lung fibrosis	human lung fibroblasts	bleomycin (BLM) treatment	upregulated	31776321
3056	Mouse	mmu-miR-22	miRNA	TGF-¦Â1	skeletal muscle myogenesis	mouse myoblast cell (C2C12 myoblast cell line)	transforming growth factor beta 1 (TGF-¦Â1) treatment	downregulated	29588073
3057	Mouse	mmu-miR-220b	miRNA	streptozocin (STZ)	diabetes mellitus (DM)	hearts of diabetic mice	streptozotocin (STZ) treatment	downregulated	21584493
3058	Mouse	mmu-miR-221	miRNA	red mud	biological effects of red mud	"CBA/Ca mice liver, spleen, lung, kidney and lymph nodes"	"1, 3, 6 and 24 h after a single intraperitoneal injection of red mud treatment"	"upregulated , but the level and the peak of the alteration differed according to examined tissue"	24425836
3059	Mouse	mmu-miR-221	miRNA	hydrochloric acid	acute lung injury (ALI)	C57BL/6 mice microvesicle (MV)release from lung epithelium	"hydrochloric acid (0.1 N, pH 1.5) was intratracheally instilled into the mouse lung"	upregulated in microvesicle (MV)release from lung epithelium	28674181
3060	Mouse	mmu-miR-221	miRNA	lipopolysaccharide (LPS)	asthma	P815 mast cells	lipopolysaccharide (LPS) treatment	upregulated	26901347
3061	Mouse	mmu-miR-221	miRNA	ovalbumin (OVA)	asthma	mouse lung tissue cells	OVA treatment	miRNA-221 blockade resulted in a reduction of airway inflammation in the OV A-induced murine asthma model	22572970
3062	Mouse	mmu-miR-221	miRNA	ovalbumin (OVA)	asthma	lung tissues	ovalbumin (OVA) treatment	upregulated	32714925
3063	Mouse	mmu-miR-221	miRNA	lipopolysaccharide (LPS)	bacterial pneumonia	RAW 264.7 derived extracellular vesicles (EVs)	lipopolysaccharide (LPS) treatment	upregulated	28274991
3064	Mouse	mmu-miR-221	miRNA	bile acids	bronchial epithelial inflammation in asthma	EAC cells	bile acids treatment	upregulated	23933602
3065	Mouse	mmu-miR-221	miRNA	angiotensin II (Ang II)	cardiac electrical remodeling	heart tissues	angiotensin II (Ang II) treatment	upregulated	31312877
3066	Mouse	mmu-miR-221	miRNA	angiotensin II (Ang II)	cardiac hypertrophy	heart sissues	angiotensin II (Ang II) treatment	upregulated	31312877
3067	Mouse	mmu-miR-221	miRNA	adenine	chronic kidney disease (CKD)	kidney tissues	adenine treatment	upregulated	32526762
3068	Mouse	mmu-miR-221	miRNA	streptozocin (STZ)	diabetes mellitus (DM)	hearts of diabetic mice	streptozotocin (STZ) treatment	upregulated	21584493
3069	Mouse	mmu-miR-221	miRNA	streptozocin (STZ)	diabetes mellitus (DM)	hippocampal neuron	streptozotocin induce treatment	"miR-221 was highly expressed in the diabetic mice miR-221 could bind with both lincRNA p21 and FOS miR-221 silencing in the diabetes mice reduced the cell apoptosis rate, and the expression of Bax and cleaved Caspase-3, whereas increase the Bcl-2 expression"	31081202
3070	Mouse	mmu-miR-221	miRNA	hypoxia	hypoxia-induced injury	mouse hippocampal HT22 cells	hypoxia treatment	downregulated	31512791
3071	Mouse	mmu-miR-221	miRNA	magnesium (Mg2+ )	hypoxia-induced injury	hypoxia-induced mouse hippocampal HT22 cells	Magnesium (Mg2+ ) treatment	upregulated	31512791
3072	Mouse	mmu-miR-221	miRNA	extracts from wild bitter gourd fruit (WBGE)	inflammation	TNF-¦Á-mouse lung tissues	extracts from wild bitter gourd fruit (WBGE) treatment	upregulated	29655703
3073	Mouse	mmu-miR-221	miRNA	tumor necrosis factor alpha (TNF-¦Á) 	inflammation	lung tissues	tumor necrosis factor alpha (TNF-¦Á) treatment	downregulated	29655703
3074	Mouse	mmu-miR-221	miRNA	TGF-¦Â1	inflammation	intestinal Th17 cells	TGF-¦Â1 treatment	Expression of miR-221 and miR-222 was induced by proinflammatory cytokines and repressed by the cytokine TGF-¦Â	33657395
3075	Mouse	mmu-miR-221	miRNA	vesicular stomatitis virus (VSV)	innate immune response	peritoneal macrophages	vesicular stomatitis virus (VSV) infection treatment	upregulated	30089112
3076	Mouse	mmu-miR-221	miRNA	high fat diet (HFD)	insulin resistance (IR)	C57BL/6 male mice liver and muscle	high fat diet (HFD) feed	upregulated	24130336
3077	Mouse	mmu-miR-221	miRNA	dietary methyl deficiency	hepatocellular carcinoma (HCC)	the liver tissues	Dietary methyl deficiency treatment	upregulated	20436259
3078	Mouse	mmu-miR-221	miRNA	nerve growth factor (NGF)	neuronal differentiation	rat pheochromocytoma PC12 cells	nerve growth factor (NGF) regulated	miR-221 was drastically upregulated	22465943
3079	Mouse	mmu-miR-221	miRNA	carbon tetrachloride (CCl4)	nonalcoholic steatohepatitis (NASH)	liver tissues	carbon tetrachloride (CCl4) treatment	Liver miR-221 was significantly increased in both fibrosis models compared to control mice.	30528086
3080	Mouse	mmu-miR-221	miRNA	choline deficient diet (MCDD)	nonalcoholic steatohepatitis (NASH)	liver tissues	choline deficient diet (MCDD) treatment	Liver miR-221 was significantly increased in both fibrosis models compared to control mice.	30528086
3081	Mouse	mmu-miR-221	miRNA	high fat diet (HFD)	obesity	obese adipose tissue	high fat diet (HFD) feed	upregulated	29236311
3082	Mouse	mmu-miR-221/222	miRNA	1-methyl-4-phenylpyridinium (MPP+)	parkinson's disease (PD)	MN9D dopaminergic neurons	N-methyl-4-phenylpyridinium (MPP +) treatment	downregulated	31499060
3083	Mouse	mmu-miR-221-3p	miRNA	lipopolysaccharide (LPS)	acute lung injury (ALI)	lung tissues	lipopolysaccharide (LPS) treatment	upregulated	31208297
3084	Mouse	mmu-miR-221-3p	miRNA	lipopolysaccharide (LPS)	acute respiratory distress syndrome (ARDS)	RAW 264.7 macrophages	lipopolysaccharide (LPS) treatment	LncRNA TUG1 reverses LPS-induced cell apoptosis and inflammation of macrophage via targeting MiR-221-3p/SPRED2 axis	32841583
3085	Mouse	mmu-miR-221-3p	miRNA	oxidized low density lipoprotein (ox-LDL)	atherosclerosis (AS)	RAW 264.7 cells	oxidized low-density lipoprotein (ox-LDL) treatment	ox-LDL treatment remarkably suppressed the expression of miR-221-3p in a concentration-dependent and time-dependent manner.	30362166
3086	Mouse	mmu-miR-221-3p	miRNA	"carbon-tetrachloride- and 3,5-di-diethoxycarbonyl-1,4-dihydrocollidine"	liver fibrosis	mouse hepatocytes	"carbon-tetrachloride- and 3,5-di-diethoxycarbonyl-1,4-dihydrocollidine induce"	upregulated	30582979
3087	Mouse	mmu-miR-221-3p	miRNA	oxidized low density lipoprotein (ox-LDL)	oxidative stress	The RAW264.7 cell line	oxidized low-density lipoprotein (ox-LDL) treatment	downregulated	30362166
3088	Mouse	mmu-miR-221-5p	miRNA	3¦Â-hydroxycholest-5-en-7-one	anti-inflammatory responses	RAW 264.7 cells	3¦Â-hydroxycholest-5-en-7-one treatment	upregulated	32771556
3089	Mouse	mmu-miR-222	miRNA	staphylococcal enterotoxin B (SEB)	acute inflammatory lung injury	lung	staphylococcal enterotoxin B treatment	upregulated	25564423
3090	Mouse	mmu-miR-222	miRNA	staphylococcal enterotoxin B (SEB)	acute lung injury (ALI)	lung-infiltrating mononuclear cells	staphylococcal enterotoxin B (SEB) treatment	upregulated	26818958
3091	Mouse	mmu-miR-222	miRNA	staphylococcal enterotoxin B (SEB)	acute lung injury (ALI)	lung infiltrating mononuclear cells	staphylococcal Enterotoxin B (SEB) treatment	MiR-222 was upregulated in SEB-induced inflammatory ALI.	32457280
3092	Mouse	mmu-miR-222	miRNA	arsenite	atherosclerosis (AS)	liver	arsenic (As) exposure	downregulated	22719926
3093	Mouse	mmu-miR-222	miRNA	lipopolysaccharide (LPS)	bacterial pneumonia	RAW 264.7 derived extracellular vesicles (EVs)	lipopolysaccharide (LPS) treatment	upregulated	28274991
3094	Mouse	mmu-miR-222	miRNA	celecoxib	breast cancer	ovariectomized athymic mice transplanted MCF-7 cells	celecoxib treatment	upregulated	24923427
3095	Mouse	mmu-miR-222	miRNA	bile acids	bronchial epithelial inflammation in asthma	EAC cells	bile acids treatment	upregulated	23933602
3096	Mouse	mmu-miR-222	miRNA	angiotensin II (Ang II)	cardiac electrical remodeling	heart tissues	angiotensin II (Ang II) treatment	upregulated	31312877
3097	Mouse	mmu-miR-222	miRNA	angiotensin II (Ang II)	cardiac hypertrophy	heart sissues	angiotensin II (Ang II) treatment	upregulated	31312877
3098	Mouse	mmu-miR-222	miRNA	high glucose (HG)	cardiac remodeling	mouse heart endothelial cells	high glucose (HG) treatment	downregulated	32396525
3099	Mouse	mmu-miR-222	miRNA	streptozocin (STZ)	cardiac remodeling	heart sissues	streptozocin (STZ) treatment	downregulated	32396525
3100	Mouse	mmu-miR-222	miRNA	streptozocin (STZ)	diabetes mellitus (DM)	heart tissues	streptozotocin (STZ) treatment	downregulated	31389030
3101	Mouse	mmu-miR-222	miRNA	gastrin	gastric cancer (GC)	AGSGR cells	Gastrin treatment	upregulated	27323780
3102	Mouse	mmu-miR-222	miRNA	¦Ã-rays	gastrointestinal acute radiation syndrome	Macrophages (M?) with the M2b phenotype (Pheno2b-M?)	7-10 Gy of gamma rays treatment	upregulated	29743312
3103	Mouse	mmu-miR-222	miRNA	estradiol-17¦Â (E2)	gestational diabetes mellitus (GDM)	3T3-L1 adipocytes	estradiol-17¦Â (E2) treatment	upregulated	24601884
3104	Mouse	mmu-miR-222	miRNA	streptozocin (STZ)	gestational diabetes mellitus (GDM)	placenta tissues	streptozocin treatment	MiR-222 was increased while CXCR4 was decreased in GDM patients and mice	33278386
3105	Mouse	mmu-miR-222	miRNA	exercise (Ex)	heart capacity	heart	Exercise treatment	upregulated	25863248
3106	Mouse	mmu-miR-222	miRNA	fructus meliae toosendan (FMT)	herb-induced liver injury (HILI)	serum exosome	Fructus Meliae Toosendan (FMT) treatment	downregulated	31855734
3107	Mouse	mmu-miR-222	miRNA	fructus meliae toosendan (FMT)	herb-induced liver injury (HILI)	mouse serum exosomes	Fructus Meliae Toosendan (FMT) treatment	downregulated	31855734
3108	Mouse	mmu-miR-222	miRNA	extracts from wild bitter gourd fruit (WBGE)	inflammation	TNF-¦Á-mouse lung tissues	extracts from wild bitter gourd fruit (WBGE) treatment	upregulated	29655703
3109	Mouse	mmu-miR-222	miRNA	lipopolysaccharide (LPS)	inflammation	RAW 264.7 cells	lipopolysaccharide (LPS) treatment	dysregulated	24792623
3110	Mouse	mmu-miR-222	miRNA	tumor necrosis factor alpha (TNF-¦Á) 	inflammation	lung tissues	tumor necrosis factor alpha (TNF-¦Á) treatment	downregulated	29655703
3111	Mouse	mmu-miR-222	miRNA	TGF-¦Â1	inflammation	intestinal Th17 cells	TGF-¦Â1 treatment	Expression of miR-221 and miR-222 was induced by proinflammatory cytokines and repressed by the cytokine TGF-¦Â	33657395
3112	Mouse	mmu-miR-222	miRNA	panax notoginseng saponins (PNS)	lung cancer	Lewis lung carcinoma (LLC) cell line	Panax notoginseng saponins (PNS) treatment	downregulated	27566197
3113	Mouse	mmu-miR-222	miRNA	"arsenic (As), cadmium (Cd), and lead (Pb) (As-Cd-Pb)"	metal-induced carcinogenesis	Balb/c 3T3 cell	As-Cd-Pb exposure	upregulated	31769258
3114	Mouse	mmu-miR-222	miRNA	genistein	muscle health	C2C12 myoblasts	genistein treatment	The expression of miR-222 was decreased by genistein.	32361609
3115	Mouse	mmu-miR-222	miRNA	genistein	myoblast differentiation	C2C12 cells	Genistein treatment	Genistein treatment also downregulated the expression of miR-222.	29171786
3116	Mouse	mmu-miR-222	miRNA	tumor necrosis factor alpha (TNF-¦Á) 	neonatal necrotizing enterocolitis (NEC)	M1 macrophages	tumor necrosis factor alpha (TNF-¦Á) treatment	We found that TNF-¦Á upregulated the expression of miRNA-222 and inhibited the expression of c-kit	33564933
3117	Mouse	mmu-miR-222	miRNA	carbon tetrachloride (CCl4)	nonalcoholic steatohepatitis (NASH)	liver tissues	carbon tetrachloride (CCl4) treatment	Liver miR-222 was significantly increased in both fibrosis models compared to control mice.	30528086
3118	Mouse	mmu-miR-222	miRNA	choline deficient diet (MCDD)	nonalcoholic steatohepatitis (NASH)	liver tissues	choline deficient diet (MCDD) treatment	Liver miR-222 was significantly increased in both fibrosis models compared to control mice.	30528086
3119	Mouse	mmu-miR-222	miRNA	high fat diet (HFD)	obesity	white adipose tissue	high fat diet (HFD) feed	upregulated	22496873
3120	Mouse	mmu-miR-222	miRNA	genistein	obesity and diabetes	mouse adipose tissues	genistein treatment	Genistein can inhibit obesity and downregulate the expression of miR-222 in mouse adipose tissue and 3T3-L1 cells.	32129363
3121	Mouse	mmu-miR-222	miRNA	genistein	obesity and diabetes	T3-L1 preadipocytes	genistein treatment	downregulated	32129363
3122	Mouse	mmu-miR-222	miRNA	wire-induced injury to carotid arteries	vessel stenosis	apolipoprotein E knockout (Apoe ) mice	injury to carotid arteries of treatment	upregulated	27622243
3123	Mouse	mmu-miR-222	miRNA	coxsackievirus B3 (CVB3)	viral myocarditis (VM)	mouse cardiomyocytes	Coxsachievirus B3 infection	upregulated	30669342
3124	Mouse	mmu-miR-222-3p	miRNA	bone marrow transplantation (BMT)	diabetes mellitus (DM)	mice with insulin-deficient diabetes	bone marrow transplantation (BMT) treatment	upregulated	27974246
3125	Mouse	mmu-miR-222-3p	miRNA	high fat diet (HFD)	insulin resistance (IR)	obese mice soleus muscle tissues	high fat diet (HFD) feed	upregulated	31770568
3126	Mouse	mmu-miR-222-3p	miRNA	pioglitazone	insulin resistance (IR)	obese mice soleus muscle tissues	pioglitazone (PGZ) treatment	downregulated	31770568
3127	Mouse	mmu-miR-222-3p	miRNA	hypoxia	cardiomyocytes injury	HL-1 Cells	hypoxia exposure	miR-222-3p could resume the functions of GAS5 in cell viabilities and apoptosis through protein regulation in PI3K and AKT signaling pathways.	32240616
3128	Mouse	mmu-miR-222-5p	miRNA	lipopolysaccharide (LPS)	inflammation	RAW264.7 cells	lipopolysaccharide (LPS) treatment	downregulated	32955644
3129	Mouse	mmu-miR-222-5p	miRNA	high fat diet (HFD)	obesity	liver tissues	high fat diet (HFD) feed	upregulated	32593682
3130	Mouse	mmu-miR-223	miRNA	hypoxia and load	pulmonary hypertension (PH)	murine lung;right ventricle	hypoxia and load treatment	downregulated	27013635
3131	Mouse	mmu-miR-223	miRNA	concanamycin A (Con A)	acute liver failure (ALF)	mouse	Con A treatment	dysregulated	25562161
3132	Mouse	mmu-miR-223	miRNA	Klebsiella pneumoniae	acute lung injury (ALI)	Bronchoalveolar lavage fluid (BALF) microvesicles (MVs)	Klebsiella pneumoniae infection	upregulated	31331947
3133	Mouse	mmu-miR-223	miRNA	lipopolysaccharide (LPS)	acute lung injury (ALI)	lung tissues	lipopolysaccharide (LPS) treatment	downregulated	30747229
3134	Mouse	mmu-miR-223	miRNA	lipopolysaccharide (LPS)	acute lung injury (ALI)	Bronchoalveolar lavage fluid (BALF) microvesicles (MVs)	lipopolysaccharide (LPS) treatment	upregulated	31331947
3135	Mouse	mmu-miR-223	miRNA	differentiation medium (DM)	adipogenesis	3T3-L1 cells	"3T3-L1 cells were incubated in differentiation medium (DM) supplemented with 10% FBS, 0.5 mM 3-isobutyl-1-methylxanthine, 250 nM dexamethasone, and 160 nM insulin."	downregulated	31828146
3136	Mouse	mmu-miR-223	miRNA	amyloid-¦Â (A¦Â) 1-40	age-related macular degeneration (AMD)	C57BL/6 mice eye tissues	amyloid-¦Â (A¦Â) 1-40 treatment	upregulated	28324113
3137	Mouse	mmu-miR-223	miRNA	ethanol (EtOH)	alcoholic liver disease (ALD)	mouse both serum and neutrophils	chronic-plus-binge ethanol feeding	upregulated in both serum and neutrophils	27679493
3138	Mouse	mmu-miR-223	miRNA	vesicular stomatitis virus (VSV)	antiviral immune response	murine macrophages	vesicular stomatitis virus (VSV) treatment	upregulated	27226534
3139	Mouse	mmu-miR-223	miRNA	high fat diet (HFD)	atherosclerosis (AS)	endothelium	high fat diet (HFD) feed	miR-223 was remarkably upregulated in the melatonin-treated HFD group.	29024030
3140	Mouse	mmu-miR-223	miRNA	lipopolysaccharide (LPS)	atherosclerosis (AS)	RAW 264.7 cells	lipopolysaccharide (LPS) treatment	downregulated	26492242
3141	Mouse	mmu-miR-223	miRNA	tumor necrosis factor alpha (TNF-¦Á) 	atherosclerosis (AS)	male C57BL/6J mice	tumor necrosis factor alpha (TNF-¦Á) treatment	downregulated	25463083
3142	Mouse	mmu-miR-223	miRNA	sevelamer	chronic kidney disease (CKD)	CKD mice	sevelamer treatment	upregulation	24140891
3143	Mouse	mmu-miR-223	miRNA	dextran sodium sulfate (DSS)	colitis	colon tissues	dextran sodium sulfate (DSS) treatment	upregulated	29867475
3144	Mouse	mmu-miR-223	miRNA	dextran sodium sulfate (DSS)	colitis	C57BL/6J mice colonic tissue	dextran-sulfate-sodium (DSS) treatment	upregulated	28752563
3145	Mouse	mmu-miR-223	miRNA	Lactobacillus fermentum (L. fermentum)	colitis	C57BL/7J mice colonic tissues	infect with L. fermentum	downregulated	28752563
3146	Mouse	mmu-miR-223	miRNA	probiotic Escherichia coli Nissle 1917 (EcN)	colitis	dextran sodium sulfate (DSS)-induced colitis mouse colon tissues	probiotic Escherichia coli Nissle 1917 (EcN) treatment	downregulated	29867475
3147	Mouse	mmu-miR-223	miRNA	IL-10	colonic inflammation	colonic intraepithelial lymphocytes	IL-10 treatment	downregulated	22043014
3148	Mouse	mmu-miR-223	miRNA	azoxymethane (AOM) and dextran sulfate sodium (DSS)	colorectal cancer (CRC)	mouse colon tissues	azoxymethane (AOM) and dextran sulfate sodium (DSS) treatment	upregulated	24464560
3149	Mouse	mmu-miR-223	miRNA	high glucose (HG)	diabetes mellitus (DM)	murine Min6 ¦Â-cells	high glucose (HG) treatment	upregulated	31118273
3150	Mouse	mmu-miR-223	miRNA	tumor necrosis factor alpha (TNF-¦Á) 	diabetes mellitus (DM)	murine Min6 ¦Â-cells	tumor necrosis factor alpha (TNF-¦Á) treatment	upregulated	31118273
3151	Mouse	mmu-miR-223	miRNA	H1N1 influenza virus	endometriosis and endometrial carcinoma	mouse lung?tissues	H1N1 influenza virus infection	upregulated	24066118
3152	Mouse	mmu-miR-223	miRNA	IL-10	epithelial-mesenchymal transition (EMT)	colonic intraepithelial lymphocytes	IL-10 treatment	upregulated	22043014
3153	Mouse	mmu-miR-223	miRNA	lipopolysaccharide (LPS)	inflammation	ATDC5 cells	lipopolysaccharide (LPS) treatment	downregulated	30791741
3154	Mouse	mmu-miR-223	miRNA	tripterine	inflammation	LPS-treated ATDC5 cells	Tripterine treatment	upregulated	30791741
3155	Mouse	mmu-miR-223	miRNA	dextran sodium sulfate (DSS)	inflammatory bowel disease (IBD)	terminal ileum; colon	dextran sodium sulfate (DSS) treatment	miR-223 expression in the terminal ileum and colon was increased in the DSS group.	33332758
3156	Mouse	mmu-miR-223	miRNA	dextran sodium sulfate (DSS)	inflammatory bowel disease (IBD)	colon tissues	dextran sulfate sodium (DSS) treatment	upregulated	30236870
3157	Mouse	mmu-miR-223	miRNA	dextran sodium sulfate (DSS)	inflammatory bowel disease (IBD)	terminal ileum and colon	dextran sodium sulfate (DSS) treatment	miR-223 expression in the terminal ileum and colon was increased in the DSS group compared with the WT group.	33332758
3158	Mouse	mmu-miR-223	miRNA	histone deacetylase inhibitor trichostatin A (TSA)	inflammatory diseases	TLR-triggered RAW264.7 cells	increased expression obviously in	upregulated	28881218
3159	Mouse	mmu-miR-223	miRNA	schistosoma japonicum	japonicum infection	serum	japonicum infection	upregulated	24330517
3160	Mouse	mmu-miR-223	miRNA	acetaminophen (APAP)	acetaminophen (APAP)-induced liver injury (AILI)	mouse neutrophils	acetaminophen (APAP) treatment	upregulated in neutrophils	28295449
3161	Mouse	mmu-miR-223	miRNA	dexamethasone (DEX)	macrophage inflammatory response	Mouse bone marrow-derived macrophages (BMDMs)	dexamethasone (DEX) treatment	upregulated	31262200
3162	Mouse	mmu-miR-223	miRNA	IFN-¦Ã	macrophage inflammatory response	Mouse bone marrow-derived macrophages (BMDMs)	IFN-¦Ã treatment	downregulated	31262200
3163	Mouse	mmu-miR-223	miRNA	IL-10	macrophage inflammatory response	Mouse bone marrow-derived macrophages (BMDMs)	IL-10 treatment	upregulated	31262200
3164	Mouse	mmu-miR-223	miRNA	IL-4	macrophage inflammatory response	Mouse bone marrow-derived macrophages (BMDMs)	IL-4 treatment	upregulated	31262200
3165	Mouse	mmu-miR-223	miRNA	lipopolysaccharide (LPS)	macrophage inflammatory response	Mouse bone marrow-derived macrophages (BMDMs)	lipopolysaccharide (LPS) treatment	downregulated	31262200
3166	Mouse	mmu-miR-223	miRNA	rosiglitazone	macrophage inflammatory response	Mouse bone marrow-derived macrophages (BMDMs)	rosiglitazone treatment	upregulated	31262200
3167	Mouse	mmu-miR-223	miRNA	H2O2	myocardial infarction (MI)	Primarily cultured cardiomyocytes	H2O2 treatment	upregulated	30280799
3168	Mouse	mmu-miR-223	miRNA	ovalbumin (OVA)	neutrophilic asthma	lung tissues	OVA/CFA treatment	The expression of miR-223 was upregulated in lung tissues of experimental mice model.	32423405
3169	Mouse	mmu-miR-223	miRNA	high fat diet (HFD)	nonalcoholic steatohepatitis (NASH)	hepatocytes in HFD-fed mice	high fat diet (HFD) feed	upregulated	30964207
3170	Mouse	mmu-miR-223	miRNA	clozapine (CLZ)	psychotic disorders	mouse brain	clozapine treatment	upregulated	23318695
3171	Mouse	mmu-miR-223	miRNA	olanzapine (OLP)	psychotic disorders	brain tissues	clozapine treatment	upregulated	23318695
3172	Mouse	mmu-miR-223	miRNA	photo-oxidative damage (PD)	retinal degenerative diseases	retina	photo-oxidative damage (PD) treatment	"During photo-oxidative damage (PD) in wild-type (WT) mice, miR-223 in the retina is significantly upregulated between 3 and 7 days, peaking at 5 days (P < 005), compared to dim-reared control levels"	32671067
3173	Mouse	mmu-miR-223	miRNA	leptin	age-associated loss of muscle mass	skeletal muscle	?leptin treatment	?leptin treatment increased the expression of miR-31 and miR-223	20800581
3174	Mouse	mmu-miR-223	miRNA	cecal ligation and puncture (CLP)	sepsis	mouse kidney homogenate	cecal ligation and puncture (CLP) treatment	upregulated in kidney homogenate	28515178
3175	Mouse	mmu-miR-223	miRNA	controlled cortical impact (CCI)	traumatic brain injury (TBI)	mouse hippocampus	controlled cortical impact (CCI)	upregulated	28804446
3176	Mouse	mmu-miR-223	miRNA	coxsackievirus B3 (CVB3)	viral myocarditis (VM)	heart tissues and heart-infiltrating macrophages	Coxsackievirus B3 (CVB3) infection	downregulated	29524390
3177	Mouse	mmu-miR-223	miRNA	coxsackievirus B3 (CVB3)	viral myocarditis (VM)	macrophages	coxsackievirus B3 (CVB3) treatment	"downregulated of MEG3 leads to the inhibition of inflammation and induces M2 macrophage polarization via miR-223/TRAF6/NF-¦ÊB axis, thus alleviating VMC."	33047847
3178	Mouse	mmu-miR-223*-5p	miRNA	ecal ligation and puncture (CLP)	severe septic	mouse	ligation and puncture treatment	downregulated	24486439
3179	Mouse	mmu-miR-223-3p	miRNA	angiostrongylus cantonensis (A. cantonensis)	angiostrongylus cantonensis (A. cantonensis) infection	mouse	angiostrongylus cantonensis (A. cantonensis) infection	upregulated	24682888
3180	Mouse	mmu-miR-223-3p	miRNA	"fatty acid esters of 3-chloro-1, 2-propanediol (3-MCPD)"	acute kidney injury (AKI)	kidney tissues	"Fatty acid esters of 3-chloro-1, 2-propanediol (3-MCPD) treatment"	upregulated	29860048
3181	Mouse	mmu-miR-223-3p	miRNA	lipopolysaccharide (LPS)	acute kidney injury (AKI)	kidney tissues	lipopolysaccharide (LPS) treatment	miR-223-3p was upregulated at 1.5h and 24h.	32727087
3182	Mouse	mmu-miR-223-3p	miRNA	ovalbumin (OVA)	asthma	bone marrow-derived DCs (BMDCs)	ovalbumin (OVA) treatment	OVA treatment significantly downregulated miR-223-3p in BMDCs.	32656268
3183	Mouse	mmu-miR-223-3p	miRNA	¦Á-myosin H-chain peptide	autoimmune myocarditis	serum	¦Á-myosin H-chain peptide treatment	miR-223-3p expression was significantly lower in EAM mice than that in normal mice	31743855
3184	Mouse	mmu-miR-223-3p	miRNA	azoxymethane (AOM) and dextran sulfate sodium (DSS)	colitis-associated colon cancer (CAC)	colon tissues	azoxymethane (AOM) and dextran sulfate sodium (DSS) treatment	upregulated	31275360
3185	Mouse	mmu-miR-223-3p	miRNA	pedunculoside	colitis-associated colon cancer (CAC)	CAC mice colon tissues	pedunculoside treatment	downregulated	31275360
3186	Mouse	mmu-miR-223-3p	miRNA	reconstituted high-density lipoproteins (rHDL)	diabetes-impaired angiogenesis	diabetic mice HDL fraction	reconstituted high-density lipoproteins (rHDL) treatment	upregulated	30206364
3187	Mouse	mmu-miR-223-3p	miRNA	reconstituted high-density lipoproteins (rHDL)	diabetes-impaired angiogenesis	diabetic mice plasma	reconstituted high-density lipoproteins (rHDL) treatment	downregulated	30206364
3188	Mouse	mmu-miR-223-3p	miRNA	dexamethasone (DEX)	endometrial receptivity	endometrium tissues	dexamethasone (DEX) treatment	upregulated	30993706
3189	Mouse	mmu-miR-223-3p	miRNA	¦Á-myosin H-chain peptide	experimental autoimmune myocarditis (EAM)	EAM mice serum	¦Á-myosin H-chain peptide treatment	downregulated	31743855
3190	Mouse	mmu-miR-223-3p	miRNA	monosodium urate (MSU)	gouty inflammation	mice air pouch synovium	monosodium urate treatment	downregulated	33650318
3191	Mouse	mmu-miR-223-3p	miRNA	dexamethasone (DEX)	innate immune response	immature DCs (iDCs)	dexamethasone (DEX) treatment	upregulated	30174602
3192	Mouse	mmu-miR-223-3p	miRNA	low chromium (Cr)	insulin resistance (IR)	liver	fed a control or LC diet for 13 weeks	dysregulatedin liver	29286159
3193	Mouse	mmu-miR-223-3p	miRNA	candida albicans (C. albicans)	kaposi's sarcoma (KS)	serum	candida albicans infection	upregulated	31396494
3194	Mouse	mmu-miR-223-3p	miRNA	high fat diet (HFD)	obesity	liver tissues	high fat diet (HFD) feed	upregulated	32593682
3195	Mouse	mmu-miR-223-3p	miRNA	bilateral surgical destabilization of the medial meniscus (DMM)	osteoarthritis (OA)	male C57BL6 mice	bilateral surgical destabilization of the medial meniscus (DMM) treatment	dysregulated	29255152
3196	Mouse	mmu-miR-223-3p	miRNA	IL-1¦Â	osteoarthritis (OA)	Murine primary chondrocytes were isolated from postnatal mice	IL-1¦Â treatment	downregulated	30847744
3197	Mouse	mmu-miR-223-3p	miRNA	Sinomenine (SIN)	osteoarthritis (OA)	IL-1¦Â-treated murine primary chondrocytes were isolated from postnatal mice	Sinomenine (SIN) treatment	upregulated	30847744
3198	Mouse	mmu-miR-223-3p	miRNA	rotenone (ROT)	parkinson's disease (PD)	brain tissues	rotenone treatment	downregulated	32470877
3199	Mouse	mmu-miR-223-3p	miRNA	chlamydia muridarum variants (C. muridarum Var001 [CmVar001] and CmVar004)	plvic inflammatory disease	mouse	two Chlamydia muridarum variants (C. muridarum Var001 [CmVar001] and CmVar004) infection	were upregulated during CmVar004 infection compared to CmVar001 infection	24961692
3200	Mouse	mmu-miR-223-3p	miRNA	?-glucan	rheumatoid arthritis (RA)	SKG mice plasma	injection of ?-glucan treatment	upregulated in plasma	28056105
3201	Mouse	mmu-miR-223-3p	miRNA	ecal ligation and puncture (CLP)	severe septic	mouse	ligation and puncture treatment	downregulated	24486439
3202	Mouse	mmu-miR-223-3p	miRNA	H2O2	spinal cord injury (SCI)	primary spinal neurons culture	H2O2 treatment	downregulated	30821011
3203	Mouse	mmu-miR-223-3p	miRNA	necrostatin-1 (Nec-1)	spinal cord injury (SCI)	H2O2 treated primary spinal neurons	Necrostatin-1 (Nec-1) treatment	upregulated	30821011
3204	Mouse	mmu-miR-223-3p	miRNA	PP242	uterine receptivity	epithelial endometrium	PP242 treatment	upregulated	30968418
3205	Mouse	mmu-miR-223-5p	miRNA	IL-4	spinal cord injury (SCI)	Microglia were first isolated from neonate rats	interleukin-4 (IL-4) treatment	downregulated	31799641
3206	Mouse	mmu-miR-223-5p	miRNA	lipopolysaccharide (LPS)	spinal cord injury (SCI)	Microglia were first isolated from neonate rats	lipopolysaccharide (LPS) treatment	upregulated	31799641
3207	Mouse	mmu-miR-22-3p	miRNA	light	age-related macular degeneration (AMD)	retinal tissues	"high©\intensity (5,000 lux) blue©\light with the wavelength ranging from 460 to 490 nm exposure"	downregulated	30927257
3208	Mouse	mmu-miR-22-3p	miRNA	angiotensin II (Ang II)	cardiac fibrosis	Cardiac fibroblasts (CFs)	angiotensin II (Ang II) treatment	downregulated	32329883
3209	Mouse	mmu-miR-22-3p	miRNA	nine hepatotoxic non-genotoxins (NGTXs)	genotoxicity	liver tissues	nine hepatotoxic non-genotoxins (NGTXs) treatment	downregulated	29777724
3210	Mouse	mmu-miR-22-3p	miRNA	nine hepatotoxic non-genotoxins (NGTXs)	genotoxicity	plasma	nine hepatotoxic non-genotoxins (NGTXs) treatment	upregulated	29777724
3211	Mouse	mmu-miR-22-3p	miRNA	monosodium urate (MSU)	gouty inflammation	mice air pouch synovium	monosodium urate treatment	downregulated	33650318
3212	Mouse	mmu-miR-22-3p	miRNA	calcitonin gene-related peptide (CGRP)	osteogenesis	MC3T3 cells	calcitonin gene-related peptide (CGRP) treatment	"The expression of mm9_circ_009056 was upregulated in the CGRP-induced cells, whereas miR-22-3p was obviously decreased."	29709471
3213	Mouse	mmu-miR-224	miRNA	angiotensin II (Ang II)	cardiac fibrosis	rat cardiac fibroblasts	angiotensin II (Ang II) treatment	upregulated	24649028
3214	Mouse	mmu-miR-224	miRNA	lipopolysaccharide (LPS)	inner ear inflammatory	scala tympani	LPS was injected directly into treatment	upregulated	24470395
3215	Mouse	mmu-miR-224	miRNA	ischemic brain extract (IBE)	ischemic injury	Neuro-2a mouse neuronal cells	IBE treatment	upregulated	24999036
3216	Mouse	mmu-miR-224	miRNA	TGF-¦Â1	ovulation and subsequent embryo development	mouse mural GCs and cumulus-oocyte complexes (COCs)	"by TGF-¦Â1 , which was partially mediated by treatment"	downregulated	24145127
3217	Mouse	mmu-miR-224	miRNA	Src tyrosine kinase (Src)	tumorigenesis	The nontransformed and v-Src-transformed mouse embryonic Cx43Ko brain cells	Src tyrosine kinase (Src) treatment	downregulated	19767772
3218	Mouse	mmu-mir-224-2	miRNA	bone morphogenetic protein 4 (BMP4)	apoptosis	mouse embryonic stem cells (ESCs)	bone morphogenetic protein 4 (BMP4) treatment	upregulated	25476774
3219	Mouse	mmu-miR-224-3p	miRNA	oxygen glucose deprivation (OGD)	cerebral ischemia/reperfusion (I/R) injury	N2a cells	Oxygen glucose deprivation treatment	downregulated	31134677
3220	Mouse	mmu-miR-224-5p	miRNA	pyrrolidinedithiocarbamic acid (PDTC)	adipocyte apoptosis	3T3-L1 adipocytes	"pyrrolidinedithiocarbamic acid (PDTC, 60??M) treatment"	downregulated	28488777
3221	Mouse	mmu-miR-224-5p	miRNA	tumor necrosis factor alpha (TNF-¦Á) 	adipocyte apoptosis	3T3-L1 adipocytes	tumor necrosis factor alpha (TNF-¦Á) treatment	miRNA-224-5p (miR-224) was upregulated by TNF¦Á exposure	28488777
3222	Mouse	mmu-miR-224-5p	miRNA	pyrrolidinedithiocarbamic acid (PDTC)	apoptosis	3T3-L1 adipocytes	"Pyrrolidinedithiocarbamic acid (PDTC, 60 ?M) treatment"	downregulated	28488777
3223	Mouse	mmu-miR-224-5p	miRNA	tumor necrosis factor alpha (TNF-¦Á) 	apoptosis	3T3-L1 adipocytes	TNF¦Á (20 ng/mL) treatment	upregulated	28488777
3224	Mouse	mmu-mir-227a	miRNA	bone morphogenetic protein 4 (BMP4)	apoptosis	mouse embryonic stem cells (ESCs)	bone morphogenetic protein 4 (BMP4) treatment	upregulated	25476774
3225	Mouse	mmu-miR-23	miRNA	laser	angiogenesis	endothelial cells and highly vascularized tissues	laser treatment	upregulated	21536891
3226	Mouse	mmu-miR-23	miRNA	streptozocin (STZ)	congenital heart disease (CHD)	C57BL/6 mice blood	injection of streptozotocin before mating treatment	dysregulated	27998767
3227	Mouse	mmu-miR-23	miRNA	pioglitazone	macrophage polarization	bone marrow-derived macrophages (BMDM)	pioglitazone (PGZ) treatment	upregulated	31091119
3228	Mouse	mmu-mir-23a	miRNA	bone morphogenetic protein 4 (BMP4)	apoptosis	mouse embryonic stem cells (ESCs)	bone morphogenetic protein 4 (BMP4) treatment	upregulated	25476774
3229	Mouse	mmu-miR-23a	miRNA	conjugated linoleic acid (CLA)	apoptosis	3T3-L1 adipocytes	Conjugated linoleic acids (CLAs) treatment	downregulated	27898407
3230	Mouse	mmu-miR-23a	miRNA	angiotensin II (Ang II)	macrophage polarization	RAW264.7 macrophages	angiotensin II (Ang II) treatment	NRON promotes M2 macrophage polarization and alleviates atrial fibrosis through suppressing exosomal miR-23a derived from atrial myocytes.	33246743
3231	Mouse	mmu-miR-23a	miRNA	lipopolysaccharide (LPS)	autophagy	RAW 264.7 cells	lipopolysaccharide (LPS) treatment	downregulated	29845275
3232	Mouse	mmu-miR-23a	miRNA	isoproterenol hydrochloride	cardiac hypertrophy	left ventricular specimens	isoproterenol hydrochloride treatment	upregulated	32023551
3233	Mouse	mmu-miR-23a	miRNA	resistance exercise training	chronic kidney disease (CKD)	CKD mice	muscle overload treatment	upregulated	28400445
3234	Mouse	mmu-miR-23a	miRNA	myostatin	cell differentiation	C2C12 cells	1 ¦Ìg of recombinant myostatin	dysregulated	28691106
3235	Mouse	mmu-miR-23a	miRNA	kainic acid (KA)	epilepsy	hippocampus	kainic acid (KA) treatment	upregulated	31336125
3236	Mouse	mmu-miR-23a	miRNA	pilocarpine	epilepsy	hippocampal tissues	pilocarpine treatment	upregulated	31114485
3237	Mouse	mmu-miR-23a	miRNA	berberine (BBR)	inflammation	LPS-treated RAW 264.7 macrophages	berberine (BBR) treatment	upregulated	30240693
3238	Mouse	mmu-miR-23a	miRNA	endothelin-1 (ET-1)	inflammation	herat of mice	endothelin-1 treatment	upregulated	22084234
3239	Mouse	mmu-miR-23a	miRNA	NQDI1 (apoptosis signal-regulating kinase 1 (ASK1) inhibitor)	inflammation	LPS-treated RAW 264.7 macrophages	NQDI1 treatment	upregulated	30240693
3240	Mouse	mmu-miR-23a	miRNA	phenylephrine (PE)	inflammation	herat of mice	phenylephrine treatment	upregulated	22084234
3241	Mouse	mmu-miR-23a	miRNA	TNF-¦Á and lipopolysaccharide (LPS)	inflammation	RAW 264.7 macrophages	TNF-¦Á and lipopolysaccharide (LPS) treatment	downregulated	30240693
3242	Mouse	mmu-miR-23a	miRNA	chlorogenic acid (CGA)	intestinal diseases	intestinal epithelial cells	chlorogenic acid (CGA) treatment	CGA promotes autophagy and inhibits ST infection through the GAS5/miR-23a/PTEN axis and the p38 MAPK pathway.	33240872
3243	Mouse	mmu-miR-23a	miRNA	"TCDD (2,3,7,8-tetrachlorodibenzo-p-dioxin)"	kaposi's sarcoma (KS)	fetal thymocytes of mice	"TCDD (2,3,7,8-tetrachlorodibenzo-p-dioxin) treatment"	downregulated	23024791
3244	Mouse	mmu-miR-23a	miRNA	delphinidin	muscle atrophy	dexamethasone-treated C2C12 cells	delphinidin treatment	upregulated	28000445
3245	Mouse	mmu-miR-23a	miRNA	berberine coated mannosylated liposomes (ML-BBR)	osteoclastogenesis	RANKL-stimulated bone marrow-derived monocytes/macrophages (BMMs)	berberine coated mannosylated liposomes (ML-BBR) treatment	upregulated	31261037
3246	Mouse	mmu-miR-23a	miRNA	receptor activator of nuclear factor-¦ÊB ligand (RANKL)	osteoclastogenesis	bone marrow-derived monocytes/macrophages (BMMs)	RANKL treatment	downregulated	31261037
3247	Mouse	mmu-miR-23a	miRNA	bupivacaine	painful diabetic neuropathy (PDN)	mouse microglia	bupivacaine treatment	Low concentration of Bupivacaine inhibited inflammation and promoted miR-23a expression in mice with painful diabetic neuropathy and in microglia induced by HIGH GLUCOSE.	33144067
3248	Mouse	mmu-miR-23a	miRNA	notoginsenoside R1 (NGR1)	preosteoblast differentiation	MC3T3-E1 cells	Notoginsenoside R1 (NGR1) treatment	upregulated	30831034
3249	Mouse	mmu-miR-23a	miRNA	bovine type II collagen	rheumatoid arthritis (RA)	fibroblast-like synoviocytes (FLSs)	bovine type II collagen induction	PBMC-derived exos contributes to RA development with the involvement of the miR-23a/MDM2/SIRT6 axis.	33042992
3250	Mouse	mmu-miR-23a	miRNA	lipopolysaccharide (LPS)	rheumatoid arthritis (RA)	fibroblast-like synoviocytes (FLSs)	Lipopolysaccharide (LPS) treatment	LncRNA NEAT1 shuttled by PBMC-derived exos promoted FLS proliferation and inflammation through regulating the MDM2/SIRT6 axis.	33042992
3251	Mouse	mmu-miR-23a	miRNA	controlled cortical impact (CCI)	traumatic brain injury (TBI)	mouse brain	controlled cortical impact (CCI)	downregulated	25057207
3252	Mouse	mmu-miR-23a	miRNA	etoposide (VP-16)	traumatic brain injury (TBI)	mouse primary cortical neurons	etoposide treatment	downregulated	31818176
3253	Mouse	mmu-miR-23a	miRNA	hypoxia	tubulointerstitial inflammation	mouse tubular epithelial cells	hypoxia induce	upregulated	30551896
3254	Mouse	mmu-miR-23a	miRNA	hypoxia	tubulointerstitial inflammation	mouse tubular epithelial cells (mTECs)	hypoxia treatment	upregulated	30551896
3255	Mouse	mmu-miR-23a-3p	miRNA	Japanese encephalitis virus (JEV)	Japanese encephalitis virus (JEV) infection	brain tissues; BV2 cells	Japanese encephalitis virus (JEV) infection	downregulated	32552669
3256	Mouse	mmu-miR-23a-3p	miRNA	hypoxia	oxidative stress	C57/BL6 mice	transient middle cerebral artery occlusion (MCAO) for 1h treatment	upregulated	25280466
3257	Mouse	mmu-miR-23a-3p	miRNA	dexamethasone (DEX)	stress response	mouse C2C12 myotubes	dexamethasone (DEX) treatment	downregulated	31138100
3258	Mouse	mmu-miR-23a-5p	miRNA	high NaCl	hypertonic stress	mouse inner medullary collecting duct cells (mIMCD3)	high NaCl treatment	The downregulated of miR-23a-5p facilitates cellular adaptation to hypertonic stress in mammalian renal cells through modulating HSPA1B.	33206547
3259	Mouse	mmu-miR-23a-5p	miRNA	prostaglandin E2 (PGE2)	liver fibrosis	TGF-¦Â1-treated primary hepatic stellate cells (HSCs)	PGE2 treatment	downregulated	29109031
3260	Mouse	mmu-miR-23a-5p	miRNA	TGF-¦Â1	liver fibrosis	primary hepatic stellate cells (HSCs)	TGF-¦Â1 treatment	upregulated	29109031
3261	Mouse	mmu-miR-23a-5p	miRNA	mycobacterium tuberculosis (Mtb)	tuberculosis (TB)	murine RAW264.7 cells	Mycobacterium tuberculosis (M.tb) infection	upregulated	28327409
3262	Mouse	mmu-miR-23a-5p	miRNA	ganoderma lucidum extract (GLE)	hepatocellular carcinoma (HCC)	Hepa 1-6 cells	Ganoderma lucidum extract (GLE) treatment	upregulated	32106374
3263	Mouse	mmu-miR-23b	miRNA	streptozocin (STZ)	diabetic nephropathy (DN)	C57BL/6J mice kindey	streptozocin (STZ) treatment	downregulated in peripheral blood	26839366
3264	Mouse	mmu-miR-23b	miRNA	angiotensin II (Ang II)	abdominal aortic aneurysm (AAA)	mouse aortic vascular smooth muscle cell (VSMC); ApoE-/-?mouse aortas	angiotensin II (Ang II) treatment	The expression of miR-23b was significantly reduced in the aorta during the early onset of AAA in angiotensin II-treated ApoE-/-?mice and in human AAA samples.	33737086
3265	Mouse	mmu-miR-23b	miRNA	lipopolysaccharide (LPS)	acute aortic dissection (AAD)	aorta	lipopolysaccharide (LPS) treatment	downregulated	32634201
3266	Mouse	mmu-miR-23b	miRNA	lipopolysaccharide (LPS)	acute lung injury (ALI)	murine alveolar macrophage cell line MH-S	lipopolysaccharide (LPS) treatment	LPS treatment inhibited miR-23b expression	33415668
3267	Mouse	mmu-miR-23b	miRNA	alcohol	alcoholic liver fibrosis (ALF)	mouse primary hepatic stellate cells	alcohol treatment	upregulated	29935035
3268	Mouse	mmu-miR-23b	miRNA	TGF-¦Â1	asthma	mouse airway smooth muscle cells (ASMCs)	TGF-¦Â1 treatment	upregulated	28062322
3269	Mouse	mmu-miR-23b	miRNA	high glucose (HG)	diabetic nephropathy (DN)	kidney tissues of db/db mice	high glucose (HG) treatment	downregulated	26646104
3270	Mouse	mmu-miR-23b	miRNA	myostatin	cell differentiation	C2C12 cells	1 ¦Ìg of recombinant myostatin	dysregulated	28691106
3271	Mouse	mmu-miR-23b	miRNA	TGF-¦Â	epithelial-mesenchymal transition (EMT)	MS-1 mouse pancreatic microvascular endothelial cells	TGF-¦Â treatment	upregulated	28338957
3272	Mouse	mmu-miR-23b	miRNA	hemin	neuroinflammation	BV2 cells	hemin treatment	downregulated	31536904
3273	Mouse	mmu-miR-23b	miRNA	bone morphogenetic protein 9 (BMP9)	ossification	C2C12 myoblasts	bone morphogenetic protein 9 (BMP9) treatment	downregulated	26820568
3274	Mouse	mmu-miR-23b	miRNA	lipopolysaccharide (LPS)	osteoarthritis (OA)	ATDC5 cells	lipopolysaccharide (LPS) treatment	MiR-23b was downregulated after LPS treatment.	29922435
3275	Mouse	mmu-miR-23b	miRNA	IL-17	osteoclastogenesis	mouse primary kidney cells	IL-17 treatment	downregulated	22660635
3276	Mouse	mmu-miR-23b	miRNA	lipopolysaccharide (LPS)	osteogenesis	preosteoblast MC3T3-E1 cells	lipopolysaccharide (LPS) treatment	downregulated	26961602
3277	Mouse	mmu-miR-23b	miRNA	soluble egg antigen (SEA)of Schistosoma japonicum	schistosomiasis	mouse hepatocytes (AML12)	SEA treatment	downregulated	29469324
3278	Mouse	mmu-miR-23b	miRNA	H2O2	spinal cord injury (SCI)	BV2 cells	H2O2 treatment	Treatment of BV-2 cells with H2O2 decreased the levels of miR-23b.	31949662
3279	Mouse	mmu-miR-23b	miRNA	retinoic acid (RA)	rhinovirus 1B (RV1B) infection	L929cells	Retinoic acid treatment	downregulated	21642441
3280	Mouse	mmu-miR-23b	miRNA	ovalbumin (OVA)	tolerogenic properties of dendritic cells	Bone marrow-derived dendritic cells (BMDCs)	ovalbumin (OVA) treatment	upregulated	22229716
3281	Mouse	mmu-miR-23b-3p	miRNA	high fat diet (HFD)	insulin resistance (IR)	soleus muscle tissues	high fat diet (HFD) feed	upregulated	31770568
3282	Mouse	mmu-miR-23b-3p	miRNA	pioglitazone	insulin resistance (IR)	soleus muscle tissues	pioglitazone (PGZ) treatment	downregulated	31770568
3283	Mouse	mmu-miR-23b-3p	miRNA	androgen	muscle atrophy	skeletal muscles	androgen treatment	downregulated	31958315
3284	Mouse	mmu-miR-23b-3p	miRNA	paraquat (PQ)	paraquat (PQ)-induced acute lung injury and pulmonary fibrosis	MLE-12 cells	paraquat (PQ) treatment	downregulated	32741895
3285	Mouse	mmu-miR-23b-3p	miRNA	dexamethasone (DEX)	stress response	mouse C2C12 myotubes	dexamethasone (DEX) treatment	downregulated	31138100
3286	Mouse	mmu-miR-23b-5p	miRNA	hypoxia	cardiac hypertrophy	heart tissues	thoracic aortic constriction (TAC) induce	upregulated	31103821
3287	Mouse	mmu-miR-23b-5p	miRNA	Jiang Tang Xiao Ke Granule	diabetes mellitus (DM)	liver tissues	Jiang Tang Xiao Ke treatment	downregulated	32210802
3288	Mouse	mmu-miR-23b-5p	miRNA	cold	obesity	brown adipose tissue (BAT)	cold treatment	downregulated	33015181
3289	Mouse	mmu-miR-24	miRNA	heat stress	ischemia/reperfusion (I/R) injury	the hearts and livers tissue cells	heat-shock (HS)	"Mice subjected to cytoprotective heat-shock (HS) showed a significant increase of miRNA-1, miRNA-21 and miRNA-24 in the heart."	19041309
3290	Mouse	mmu-miR-24	miRNA	lipopolysaccharide (LPS)	acute aortic dissection (AAD)	aorta	lipopolysaccharide (LPS) treatment	downregulated	32634201
3291	Mouse	mmu-miR-24	miRNA	oxygen glucose deprivation (OGD)	acute cerebral infarction	mouse N2A neuroblastoma cells (N2A)	oxygen-and-glucose-deprivation (OGD) treatment	upregulated	24841240
3292	Mouse	mmu-miR-24	miRNA	ischemia/reperfusion (I/R) 	acute kidney injury (AKI)	mouse kidney tissues	ischemia/reperfusion (I/R) treatment	upregulated	24854275
3293	Mouse	mmu-miR-24	miRNA	D-galactosamine/lipopolysaccharide (D-GalN/LPS)	acute liver failure (ALF)	mouse	intraperitoneal injection of D-galactosamine/lipopolysaccharide (D-GalN/LPS)	downregulated	29218090
3294	Mouse	mmu-miR-24	miRNA	alcohol	alcoholic liver fibrosis (ALF)	mouse primary hepatic stellate cells	alcohol treatment	upregulated	29935035
3295	Mouse	mmu-miR-24	miRNA	TGF-¦Â	cardiac fibrosis	cardiac fibroblasts (CFs)	TGF-¦Â treatment	upregulated	22260784
3296	Mouse	mmu-miR-24	miRNA	cholesterol	cholesterol-induced inhibition of insulin secretion	MIN6 cells	cholesterol treatment	upregulated	31173188
3297	Mouse	mmu-miR-24	miRNA	brucella.suis	chronic brucella infection	murine bone marrow derived macro- phages (BMDM)	brucella infection	Brucella infection upregulates miR-24.	33108406
3298	Mouse	mmu-miR-24	miRNA	streptozocin (STZ)	diabetes mellitus (DM)	hearts of diabetic mice	streptozotocin (STZ) treatment	upregulated	21584493
3299	Mouse	mmu-miR-24	miRNA	hyperglycemia	diabetes mellitus (DM)	plasma	hyperglycemia treatment	downregulated	25814526
3300	Mouse	mmu-miR-24	miRNA	high glucose (HG)	diabetic nephropathy (DN)	Mouse podocytes (MPC5)	high glucose treatment	downregulated	30095204
3301	Mouse	mmu-miR-24	miRNA	high-fat/high-cholesterol diet or a high-protein diet	dyslipidemia	DO mice	a high-fat/high-cholesterol diet or a high-protein diet for 18 wk	dysregulated	28916633
3302	Mouse	mmu-miR-24	miRNA	lipopolysaccharide (LPS)	inflammation	RAW 264.7 cells	lipopolysaccharide (LPS) treatment	dysregulated	24792623
3303	Mouse	mmu-miR-24	miRNA	ischemia	myocardial ischaemic injury	mouse cardiomyocytes	ischemic pre-conditioning (IPC) treatment	"IPC-induced miRNAs trigger cardioprotection similar to the delayed phase of IPC, possibly through upregulating eNOS, HSP70, and the HSP70 transcription factor HSF-1."	19213952
3304	Mouse	mmu-miR-24	miRNA	high fat diet (HFD)	nonalcoholic fatty liver disease (NAFLD)	liver	high fat diet (HFD) feed	microRNA-24 is significantly upregulated in the livers	24677249
3305	Mouse	mmu-miR-24	miRNA	high fat diet (HFD)	obesity	liver tissues	high fat diet (HFD) feed	upregulated	29787826
3306	Mouse	mmu-miR-24	miRNA	acetylcholine (ACh)	peripheral nerve injury (PNI)	hematopoietic stem cells (HSCs)	acetylcholine (ACh) treatment	"The therapeutic agents can thus be targeted to the enzyme protein, its encoding mRNA transcripts, or the regulator microRNA-132, opening new venues for therapeutic interference with multiple nervous and immune system diseases"	22448158
3307	Mouse	mmu-miR-24	miRNA	Staphylococcus aureus	staphylococcus aureus infection	mouse macrophage cell lines	infect with S. aureus treatment	downregulated	28303416
3308	Mouse	mmu-miR-24-1	miRNA	TGF-¦Â	epithelial-mesenchymal transition (EMT)	MS-1 mouse pancreatic microvascular endothelial cells	TGF-¦Â treatment	upregulated	28338957
3309	Mouse	mmu-miR-24-1-5p	miRNA	black raspberry (BRB) anthocyanins	colorectal cancer (CRC)	colon tissue of azoxymethane/dextran sulphate sodium-induced mice	black raspberry anthocyanins feed	upregulated	30375302
3310	Mouse	mmu-miR-24-2*	miRNA	H2O2	chronic inflammatory airway diseases	RAW 264.7 cells	H2O2 treatment	downregulated	21350856
3311	Mouse	mmu-miR-24-2-5p	miRNA	manganese (Mn)	parkinson's disease (PD)	MN9D dopaminergic cell exosomes	Mn exposure (300¦ÌM MnCl2) for 24h	upregulated in exosomes	28450057
3312	Mouse	mmu-miR-24-3p	miRNA	leishmania major (MRHO/IR/75/ER)	cutaneous Leishmaniasis (CL)	RAW264.7 cells	leishmania major (MRHO/IR/75/ER) treatment	miR-24-3p was upregulated in L. major infectioned macrophages.	33082797
3313	Mouse	mmu-miR-24-3p	miRNA	high glucose (HG)	diabetic nephropathy (DN)	Mouse mesangial cells (MCs)	high glucose treatment	downregulated	31680239
3314	Mouse	mmu-miR-24-3p	miRNA	streptozocin (STZ)	diabetic nephropathy (DN)	kidney tissues	streptozotocin treatment	downregulated	31680239
3315	Mouse	mmu-miR-24-3p	miRNA	hypoxia	ischemia/reperfusion (I/R) injury	mouse primary cardiomyocytes	hypoxia induce	downregulated	30622671
3316	Mouse	mmu-miR-24-3p	miRNA	hypoxia	ischemia/reperfusion (I/R) injury	liver tissues	"mice were ischemic for 1 h, and followed by reperfusion for 3, 6, 9, 12 h as needed."	downregulated	31735332
3317	Mouse	mmu-miR-24-3p	miRNA	Japanese encephalitis virus (JEV)	Japanese encephalitis virus (JEV) infection	brain tissues; BV2 cells	Japanese encephalitis virus (JEV) infection	downregulated	32552669
3318	Mouse	mmu-miR-25	miRNA	amyloid-¦Â (A¦Â) 1-42	Alzheimer's disease (AD)	hippocampal tissues and cells	amyloid ¦Â (A¦Â) peptide fragment 1 to 42 (A¦Â1-42) treatment	upregulated	31144355
3319	Mouse	mmu-miR-25	miRNA	corticosterone	apoptosis	Primary mouse vascular smooth muscle cells (VSMCs)	corticosterone (CORT) treatment	downregulated	30992737
3320	Mouse	mmu-miR-25	miRNA	high glucose (HG)	diabetic nephropathy (DN)	mouse glomerular mesangial cells (MMCs)	high glucose (HG) treatment	upregulated	27941951
3321	Mouse	mmu-miR-25	miRNA	TGF-¦Â	diabetic nephropathy (DN)	mouse glomerular mesangial cells (MMCs)	TGF-¦Â treatment	upregulated	27941951
3322	Mouse	mmu-miR-25	miRNA	alcohol	fetal alcohol spectrum disorders (FASD)	brain tissues	alcohol exposure	downregulated	23580197
3323	Mouse	mmu-miR-25	miRNA	hypoxia	heart failure (HF)	heart tissues	transverse aortic constriction (TAC) surgery	upregulated	30771307
3324	Mouse	mmu-miR-25	miRNA	oxygen glucose deprivation (OGD)	oxidative stress	mouse retinal pigment epithelium (RPE)	oxygen-and-glucose-deprivation (OGD) treatment	upregulated	29210651
3325	Mouse	mmu-miR-25	miRNA	lipopolysaccharide (LPS)	sepsis and septic shock	blood cells	LPS treatment	upregulated	23395002
3326	Mouse	mmu-miR-25	miRNA	ginkgolide A (GA)	sepsis-induced renal injury	kidney tissues	Ginkgolide A (GA) treatment	The sepsis-induced decrease of miR-25 was enhanced by GA treatment.	33677255
3327	Mouse	mmu-miR-25	miRNA	lipopolysaccharide (LPS)	sepsis-induced renal injury	kidney tissues	lipopolysaccharide (LPS) treatment	The sepsis-induced decrease of miR-25 was enhanced by GA treatment.	33677255
3328	Mouse	mmu-miR-25	miRNA	laminectomy at the Th9 spinal vertebra	spinal cord injury (SCI)	spinal cords	laminectomy at the Th9 spinal vertebra	downregulated in injured spinal cords	28605990
3329	Mouse	mmu-miR-25-3p	miRNA	oxidized low density lipoprotein (ox-LDL)	atherosclerosis (AS)	Primarily isolated coronary vascular endothelial cell (CVEC)	oxidized low-density lipoprotein (ox-LDL) treatment	downregulated	31632389
3330	Mouse	mmu-miR-25-3p	miRNA	thrombin	atherosclerosis (AS)	peripheral blood platelet exosomes (PLT-Exo)	thrombin treatment	upregulated	31632389
3331	Mouse	mmu-miR-25-3p	miRNA	oxygen glucose deprivation (OGD)	myocardial infarction (MI)	primary cardiomyocytes	oxygen glucose deprivation (OGD) treatment	downregulated	32371945
3332	Mouse	mmu-miR-25-5p	miRNA	lipopolysaccharide (LPS)	autophagy	RAW 264.7 cells	lipopolysaccharide (LPS) treatment	downregulated	29845275
3333	Mouse	mmu-miR-25-6p	miRNA	curcumin (Cur)	nasopharyngeal carcinoma (NPC)	mice	injected into the tumour centre at a concentration of 150 mg/kg treatment	dysregulated	24896104
3334	Mouse	mmu-miR-26	miRNA	"hexahydro-1,3,5-trinitro-1,3,5-triazine (RDX)"	tumorigenesis	brain and liver tissue cells	"hexahydro-1,3,5-trinitro-1,3,5-triazine (RDX) treatment"	downregulated	19270793
3335	Mouse	mmu-miR-26	miRNA	bushen yijing decoction (BSYJ)	systemic sclerosis (SSc)	skin tissues	Bushen Yijing decoction (BSYJ)? treatment	BSYJ-containing rat serum suppressed miR-26a expression	33843426
3336	Mouse	mmu-miR-26a	miRNA	oxytocin (OT)	"1-methyl-4-phenyl-1, 2, 3, 6- tetrahydropyridine (MPTP)-induced neurotoxicity"	brain tissues	Oxytocin (OXT) treatment	The loss of miR-26a in MPTP mice 568 was fully restored by OXT	32083584
3337	Mouse	mmu-miR-26a	miRNA	cisplatin (DDP)	acute kidney injury (AKI)	kidney tissues	cisplatin treatment	downregulated	31887787
3338	Mouse	mmu-miR-26a	miRNA	H2O2	acute myocardial infarction (AMI)	Neonatal mice cardiomyocytes (NMCMs)	hydrogen peroxid (H2O2) treatment	"forced expression of 2810403D21Rik/Mirf downregulated Mir26a to inhibit autophagy. In contrast, loss of 2810403D21Rik/Mirf resulted in upregulation of Mir26a to promote autophagy and alleviate cardiac injury, which in turn improved cardiac function in MI mice."	31512556
3339	Mouse	mmu-miR-26a	miRNA	H2O2	acute myocardial infarction (AMI)	primary neonatal mice ventricular cardiomyocytes	H2O2 treatment	MIRF contributed to cardiomyocyte apoptosis through modulating Bak1 by regulation of miR-26a.	32464547
3340	Mouse	mmu-miR-26a	miRNA	high fat diet (HFD)	acute myocardial infarction (AMI)	liver tissue	high fat diet (HFD) feed	downregulated	19835573
3341	Mouse	mmu-miR-26a	miRNA	estrogen (ES)	antibody-mediated systemic autoimmunity	B cells	estrogen treatment	downregulated	32265934
3342	Mouse	mmu-miR-26a	miRNA	histone deacetylase inhibitors (HDIs) short-chain fatty acid (SCFA) butyrate	antibody-mediated systemic autoimmunity	B cells	SCFA HDI butyrate treatment	upregulated	32265934
3343	Mouse	mmu-miR-26a	miRNA	borneol	asthma	CD4+ T cells isolated from the spleen of OVA-induced asthma mice	borneol treatment	Borneol inhibited CD4 + T cells infiltration in vivo and proliferation in vitro by downregulating miR-26a and miR-142-3p.	33272847
3344	Mouse	mmu-miR-26a	miRNA	borneol	asthma	CD4 + T cells	borneol treatment	Borneol inhibited CD4 + T cells infiltration in vivo and proliferation in vitro by downregulating miR-26a and miR-142-3p.	33272847
3345	Mouse	mmu-miR-26a	miRNA	ovalbumin (OVA)	asthma	lung tissues	OVA (ovalbumin) treatment	upregulated	31298396
3346	Mouse	mmu-miR-26a	miRNA	high fat diet (HFD)	atherosclerosis (AS)	aortic intima	high fat diet (HFD) feed	downregulated	25801675
3347	Mouse	mmu-miR-26a	miRNA	notoginsenoside R1 (NGR1)	atherosclerosis (AS)	serum;aorta	notoginsenoside R1 (NGR2) treatment	downregulated	24933211
3348	Mouse	mmu-miR-26a	miRNA	bleomycin (BLM)	idiopathic pulmonary fibrosis (IPF)	C57BL/6 mice lung	bleomycin (BLM) treatment	downregulated	24594795
3349	Mouse	mmu-miR-26a	miRNA	TGF-¦Â1	idiopathic pulmonary fibrosis (IPF)	lung tissues; pulmonary fibroblasts	TGF-¦Â1 treatment	downregulated	29952219
3350	Mouse	mmu-miR-26a	miRNA	puromycin	autoimmune glomerulonephritis	mouse podocytes	puromycin treatment	downregulated	25329154
3351	Mouse	mmu-miR-26a	miRNA	bleomycin (BLM)	lung injury	lung tissues	bleomycin (BLM) treatment	Lung miR-26a was significantly decreased 7 days after bleomycin injury.	30024304
3352	Mouse	mmu-miR-26a	miRNA	ginsenoside Rg3	male hypogonadism	MLTC-1 cells	Ginsenoside Rg3 treatment	downregulated	31296984
3353	Mouse	mmu-miR-26a	miRNA	triptolide (TPL)	male hypogonadism	MLTC-1 cells	triptolide (TPL) treatment	upregulated	31296984
3354	Mouse	mmu-miR-26a	miRNA	RANKL (receptor activator of nuclear factor ¦ÊB ligand)	cell differentiation	Murine osteoclasts	RANKL ischemia-reperfusion (I/R) treatment	upregulated	25518928
3355	Mouse	mmu-miR-26a	miRNA	bupivacaine	nerve injury	mouse dorsal root ganglia (DRG) neurons	bupivacaine treatment	downregulated	25808510
3356	Mouse	mmu-miR-26a	miRNA	A23187	nonalcoholic fatty liver disease (NAFLD)	Murine primary hepatocytes (MPHs)	A23187 treatment	upregulated	32567701
3357	Mouse	mmu-miR-26a	miRNA	high fat diet (HFD)	nonalcoholic fatty liver disease (NAFLD)	liver tissues	high fat diet (HFD) treatment	upregulated	32567701
3358	Mouse	mmu-miR-26a	miRNA	high fat diet (HFD)	nonalcoholic fatty liver disease (NAFLD)	liver tissues	high fat diet (HFD) feed	"Combining miRNA dot blot array and quantitative PCR, we find that miR-26a is specifically induced by ER stress in liver cells."	32567701
3359	Mouse	mmu-miR-26a	miRNA	oleic acid (OA)	nonalcoholic fatty liver disease (NAFLD)	Murine primary hepatocytes (MPHs)	oleate acid (OA) treatment	upregulated	32567701
3360	Mouse	mmu-miR-26a	miRNA	palmitic acid (PA)	nonalcoholic fatty liver disease (NAFLD)	Murine primary hepatocytes (MPHs)	palmitate acid (PA) treatment	upregulated	32567701
3361	Mouse	mmu-miR-26a	miRNA	thapsigargin (Tg)	nonalcoholic fatty liver disease (NAFLD)	Murine primary hepatocytes (MPHs)	thapsigargin (Tg) treatment	upregulated	32567701
3362	Mouse	mmu-miR-26a	miRNA	tunicamycin (TM)	nonalcoholic fatty liver disease (NAFLD)	Murine primary hepatocytes (MPHs)	tunicamycin (Tu) treatment	upregulated	32567701
3363	Mouse	mmu-miR-26a	miRNA	streptozocin (STZ)	nonalcoholic steatohepatitis-hepatocellular carcinoma (NASH-HCC)	high fat dietmouse liver	STZ treatment	upregulated in liver	28345673
3364	Mouse	mmu-miR-26a	miRNA	high fat diet (HFD)	obesity	adipose tissue	high fat diet (HFD) feed	downregulated	31488578
3365	Mouse	mmu-miR-26a	miRNA	polyinosinic-polycytidilic acid (Poly(I:C))	orchitis	testicular cells	poly I:C treatment	downregulated	31195953
3366	Mouse	mmu-miR-26a	miRNA	metformin (Met)	pancreatic cancer (PC)	human pancreatic cancer cells	metformin treatment	upregulated	22245693
3367	Mouse	mmu-miR-26a	miRNA	"1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)"	parkinson's disease (PD)	substantia nigra	"1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) treatment"	downregulated	30718039
3368	Mouse	mmu-miR-26a	miRNA	Vaccination during Crisis of Plasmodium chabaudi Blood-Stage Malaria	plasmodium chabaudi infection	Balb/c Mice liver	infect with Vaccination treatment	downregulated in the Liver	28123381
3369	Mouse	mmu-miR-26a	miRNA	cecal ligation and puncture (CLP)	sepsis	whole blood	cecal ligation and puncture (CLP) treatment	upregulated	24205035
3370	Mouse	mmu-miR-26a	miRNA	high fat diet (HFD)	type 2 diabetes mellitus (T2DM)	mouse serum and islets	high fat diet (HFD) feed	downregulated in the serum and islets	29191656
3371	Mouse	mmu-miR-26a	miRNA	high fat diet (HFD)	type 2 diabetes mellitus (T2DM)	serum and islets	high fat diet (HFD) feed	downregulated	29191656
3372	Mouse	mmu-miR-26a	miRNA	whole grain highland barley (WGH)	type 2 diabetes mellitus (T2DM)	liver tissues	whole grain highland barley (WGH) treatment	upregulated	33104141
3373	Mouse	mmu-miR-26a-1	miRNA	streptozocin (STZ)	nonalcoholic steatohepatitis-hepatocellular carcinoma (NASH-HCC)	high fat dietmouse liver	STZ treatment	upregulated in liver	28345673
3374	Mouse	mmu-miR-26a-5p	miRNA	histone deacetylase inhibitor (HDACi)	B cell differentiation	B cells of C57BL/6J	"stimulated with LPS and IL-4 and treated with HDI (VPA, 500 ?M) or nil for 60 h"	upregulated	28994753
3375	Mouse	mmu-miR-26a-5p	miRNA	high glucose (HG)	diabetic nephropathy (DN)	MP5 cells	high glucose (HG) treatment	downregulated	32580945
3376	Mouse	mmu-miR-26a-5p	miRNA	oxygen-glucose deprivation and reoxygenation (OGD/R)	ischemic stroke (IS)	neuro-2A (N2a) neuroblastoma cells	oxygen-glucose deprivation and reoxygenation (OGD/R) treatment	downregulated	30703362
3377	Mouse	mmu-miR-26a-5p	miRNA	hypoxia/reoxygenation (H/R)	myocardial ischemia/reperfusion (I/R) injury (MIRI)	primary cardiomyocytes	hypoxia/reoxygenation (H/R) treatment	downregulated	31994603
3378	Mouse	mmu-miR-26b	miRNA	isoproterenol	cardiac fibrosis	cardiac tissues; cardiac fibroblasts (CFs)	isoprenaline (ISO) tteatment	downregulated	33209126
3379	Mouse	mmu-miR-26b	miRNA	angiotensin II (Ang II)	cardiac hypertrophy	neonatal mouse ventricular cardiomyocytes	angiotensin II (Ang II) treatment	downregulated	31966813
3380	Mouse	mmu-miR-26b	miRNA	pectin (fermented to butyrate in the colon) (FPA)	colon tumorigenesis	colonic stem cells	(fermented to butyrate in the colon) (FPA) treatment	upregulated	26493444
3381	Mouse	mmu-miR-26b	miRNA	azoxymethane (AOM)	colorectal cancer (CRC)	plasma and colon tissues	azoxymethane (AOM) treatment	downregulated	30311185
3382	Mouse	mmu-miR-26b	miRNA	lactobacillus acidophilus and bifidobacterium bifidum probiotics	colorectal cancer (CRC)	plasma and colon tissues from azoxymethane (AOM)-treated mice	Lactobacillus acidophilus and Bifidobacterium bifidum probiotics treatment	upregulated	30311185
3383	Mouse	mmu-miR-26b	miRNA	oxygen-glucose deprivation and reoxygenation (OGD/R)	ischemic stroke (IS)	brain microvascular endothelial cell (BMEC) of C57BL/6J mice	oxygen-glucose deprivation and reoxygenation (OGD/R) treatment	downregulated	28433650
3384	Mouse	mmu-miR-26b	miRNA	arsenite	liver fibrosis	mouse liver tissues	arsenite exposure	microRNA-26b is the target regulatory point of MALAT1	31513886
3385	Mouse	mmu-miR-26b	miRNA	hypoxia	pulmonary hypertension (PH)	mouse PASMCs	hypoxia treatment	downregulated	28816418
3386	Mouse	mmu-miR-26b	miRNA	cecal ligation and puncture (CLP)	sepsis	whole blood	cecal ligation and puncture (CLP) treatment	upregulated	24205035
3387	Mouse	mmu-miR-26b-3p	miRNA	bone morphogenetic protein 2 (BMP2)	cell differentiation	MC3T3-E1 cells	bone morphogenetic protein 2 (BMP2) treatment	downregulated	29981839
3388	Mouse	mmu-miR-26b-3p	miRNA	bone morphogenetic protein 2 (BMP2)	cell differentiation	MC3T3-E1 cells	bone morphogenetic protein 2 (BMP2) treatment	downregulated	29981839
3389	Mouse	mmu-miR-26b-3p	miRNA	oxygen glucose deprivation (OGD)	myocardial infarction (MI)	primary cardiomyocytes	oxygen glucose deprivation (OGD) treatment	downregulated	32371945
3390	Mouse	mmu-miR-26b-5p	miRNA	angiotensin II (Ang II)	cardiac hypertrophy	neonatal mouse ventricular cardiomyocytes (NMVCs)	angiotensin II (Ang II) treatment	miR-26b-5p was markedly decreased in NMVCs with overexpression of circRNA_000203.	31397837
3391	Mouse	mmu-miR-26b-5p	miRNA	oxygen-glucose deprivation and reoxygenation (OGD/R)	cerebral ischemia/reperfusion (I/R) injury	Mouse N2a neuroblastoma cells	oxygen-glucose deprivation and reoxygenation (OGD/R) treatment	downregulated	31751592
3392	Mouse	mmu-miR-26b-5p	miRNA	perfluorooctanoic acid	hepatotoxicity	liver tissues	Perfluorooctanoic acid (PFOA) exposure treatment	upregulated	24459700
3393	Mouse	mmu-miR-26b-5p	miRNA	oxygen-glucose deprivation and reoxygenation (OGD/R)	intestinal hypoxia/reoxygenation injury	intestinal mucosa	oxygen-glucose deprivation and reoxygenation (OGD/R) treatment	We found that the expression of miR-26b-5p in intestinal mucosa was markedly decreased during I/R injury	33839982
3394	Mouse	mmu-miR-26b-5p	miRNA	methionine-choline-deficient and high-fat diet (MCDHF)	liver fibrosis	PDGFR-¦Â+ cells in the mouse fibrotic liver	methionine-choline-deficient and high-fat (MCDHF) diet treatment	downregulated	30901579
3395	Mouse	mmu-miR-26b-5p	miRNA	hypoxia	phenotypic switching of VSMCs	mouse vascular smooth muscle cells(mVSMCs)	hypoxia treatment	downregulated	28487943
3396	Mouse	mmu-miR-27	miRNA	flavonoid derivative (Fla-CN)	adipogenesis	3T3-L1 cells	Fla-CN treatment	upregulated	28088385
3397	Mouse	mmu-miR-27	miRNA	persimmon tannin	adipogenesis	3T3-L1 preadipocytes	persimmon tannin treatment	upregulated	25510894
3398	Mouse	mmu-miR-27	miRNA	tumor necrosis factor alpha (TNF-¦Á) 	adipogenesis	mouse embryonic fibroblast-derived 3T3-L1 preadipocytes	tumor necrosis factor alpha (TNF-¦Á) treatment	upregulated	24903074
3399	Mouse	mmu-miR-27	miRNA	laser	angiogenesis	endothelial cells and highly vascularized tissues	laser treatment	upregulated	21536891
3400	Mouse	mmu-miR-27	miRNA	high fat diet (HFD)	atherosclerosis (AS)	ApoE-/- mice serum	high fat diet (HFD) feed	downregulated	30041636
3401	Mouse	mmu-miR-27	miRNA	xanthomicrol	breast cancer	4T1 cells	xanthomicrol treatment	downregulated	33217075
3402	Mouse	mmu-miR-27	miRNA	IL-1¦Â and IFN-¦Ã	cytomegalovirus infection	NIH-3T3;SVEC4-10;C127;TCMK-1 cells;Bone marrow-derived macrophages	cytomegalovirus infection	downregulated	20047990
3403	Mouse	mmu-miR-27	miRNA	granulocyte colony-stimulating factor (CSF3)	cell differentiation	32D.cl3 cell	granulocyte colony-stimulating factor (CSF3) treatment	upregulated	19298589
3404	Mouse	mmu-miR-27	miRNA	cold	metabolic disease	mouse BAT and subcutaneous white adipose tissue (SAT)	cold exposure treatment	downregulated	24238035
3405	Mouse	mmu-miR-27	miRNA	extra-virgin olive oil rich in phenols (H-EVOO)	neuronal function	cortex	H-EVOO treatment	upregulated	26695409
3406	Mouse	mmu-miR-27	miRNA	flavonoid derivative (Fla-CN)	obesity	liver and adipose	Fla-CN treatment	upregulated	26598088
3407	Mouse	mmu-miR-27-3p	miRNA	cigarette smoke (CS)	chronic obstructive pulmonary disease (COPD)	alveolar macrophages (AMs) and the lung tissues	cigarette smoke (CS) exposure	upregulated	29572385
3408	Mouse	mmu-miR-27-3p	miRNA	lipopolysaccharide (LPS)	chronic obstructive pulmonary disease (COPD)	alveolar macrophages (AMs) and the lung tissues	lipopolysaccharide (LPS) treatment	upregulated	29572385
3409	Mouse	mmu-miR-27-3p	miRNA	andrographolide	osteoarthritis (OA)	primary chondrocytes	andrographolide (And) treatment	"miR-27-3p was significant decrease in the mice with OA, but And treatment reversed OA-induced the downregulated of miR-27-3p."	32196852
3410	Mouse	mmu-miR-27a	miRNA	red mud	biological effects of red mud	"CBA/Ca mice liver, spleen, lung, kidney and lymph nodes"	"1, 3, 6 and 24 h after a single intraperitoneal injection of red mud treatment"	"upregulated , but the level and the peak of the alteration differed according to examined tissue"	24425836
3411	Mouse	mmu-miR-27a	miRNA	lipopolysaccharide (LPS)	acute aortic dissection (AAD)	aorta	lipopolysaccharide (LPS) treatment	downregulated	32634201
3412	Mouse	mmu-miR-27a	miRNA	lipopolysaccharide (LPS)	acute lung injury (ALI)	lung tissues	lipopolysaccharide (LPS) treatment	downregulated	30231673
3413	Mouse	mmu-miR-27a	miRNA	lipopolysaccharide (LPS)	acute lung injury (ALI)	mouse lung tissues	lipopolysaccharide (LPS) treatment	downregulated	31173183
3414	Mouse	mmu-miR-27a	miRNA	lipopolysaccharide (LPS)	acute lung injury (ALI)	lung tissues; bronchoalveolar lavage fluid (BALF); splenocytes	lipopolysaccharide (LPS) treatment	downregulated	31938423
3415	Mouse	mmu-miR-27a	miRNA	sevoflurane (SEV)	acute lung injury (ALI)	LPS-induced mice lung tissues	sevoflurane treatment	upregulated	31173183
3416	Mouse	mmu-miR-27a	miRNA	CoCl2	adipogenesis	murine preadipocyte 3T3-L1 cells	CoCl2 treatment	upregulated	27939617
3417	Mouse	mmu-miR-27a	miRNA	oxidized low density lipoprotein (ox-LDL)	atherosclerosis (AS)	RAW264.7 macrophage	oxidized low-density lipoprotein (ox-LDL) treatment	downregulated	31518965
3418	Mouse	mmu-miR-27a	miRNA	angiotensin II (Ang II)	cardiovascular disease (CVD)	Primary vascular smooth muscle cells (VSMCs)	angiotensin II (Ang II) treatment	upregulated	30654940
3419	Mouse	mmu-miR-27a	miRNA	leucine	cell proliferation	The mouse myoblast cell line C2C12 (CRL-1772)	Leucine treatment	upregulated	23880856
3420	Mouse	mmu-miR-27a	miRNA	resistance exercise training	chronic kidney disease (CKD)	CKD mice	muscle overload treatment	upregulated	28400445
3421	Mouse	mmu-miR-27a	miRNA	curcumin and 3 acetyl-11-keto-¦Â-boswellic acid (AKBA)	colorectal cancer (CRC)	colorectal cancer cells	curcumin and 3 acetyl-11-keto-¦Â-boswellic acid (AKBA) treatment	downregulated	25712055
3422	Mouse	mmu-miR-27a	miRNA	chronic social defeat stress (CSDS)	depression	serum or hippocampus	chronic social defeat stress (CSDS) induce	downregulated	33402173
3423	Mouse	mmu-miR-27a	miRNA	isoliquiritin	depression	hippocampus of LPS-treated mice	isoliquiritin treatment	upregulated	33402173
3424	Mouse	mmu-miR-27a	miRNA	isoliquiritin	depression	hippocampus of chronic social defeat stress (CSDS)-induced mice	isoliquiritin treatment	upregulated	33402173
3425	Mouse	mmu-miR-27a	miRNA	lipopolysaccharide (LPS)	depression	serum or hippocampus	lipopolysaccharide (LPS) treatment	downregulated	33402173
3426	Mouse	mmu-miR-27a	miRNA	high glucose (HG)	diabetic embryopathy	C17.2 mouse neural stem cells	high glucose diet	upregulated	29100869
3427	Mouse	mmu-miR-27a	miRNA	high glucose (HG)	diabetic nephropathy (DN)	murine podocyte cell line	high glucose(30?mM)	upregulated	28277542
3428	Mouse	mmu-miR-27a	miRNA	high-fat/high-cholesterol diet or a high-protein diet	dyslipidemia	DO mice	a high-fat/high-cholesterol diet or a high-protein diet for 18 wk	dysregulated	28916633
3429	Mouse	mmu-miR-27a	miRNA	lithocholic acid (LCA)	glutathione synthesis and antioxidant capacity	Huh-7 cells	lithocholic acid (LCA) treatment	upregulated	25226451
3430	Mouse	mmu-miR-27a	miRNA	hypoxia	hepatic ischemia/reperfusion injury (HIRI)	AML12 cells	hypoxia induce	upregulated	31485635
3431	Mouse	mmu-miR-27a	miRNA	high fat diet (HFD)	hepatocellular carcinoma (HCC)	plasma and hepatic tissues	high fat diet (HFD) feed	upregulated	26728044
3432	Mouse	mmu-miR-27a	miRNA	cerasus humilis polyphenol (CHP)	HFD-induced obesity	retroperitoneal white adipocytes	cerasus humilis polyphenol (CHP) treatment	CHP significantly inhibited the expression of miR-27a/b in mice retroperitoneal white adipocytes.	32227855
3433	Mouse	mmu-miR-27a	miRNA	lipopolysaccharide (LPS)	inflammation	BMDMs	lipopolysaccharide (LPS) treatment	downregulated	24835395
3434	Mouse	mmu-miR-27a	miRNA	high fat diet (HFD)	obesity	male C57BL/6 J mice serum	high fat diet (HFD) feed	upregulated	28365247
3435	Mouse	mmu-miR-27a	miRNA	mycobacterium avium subspecies paratuberculosis (MAP)	innate immune response	"RAW264.7 and bone marrow-derived macrophage in vitro, intestine and spleen tissues in vivo"	Mycobacterium avium subspecies paratuberculosis (MAP) infection	downregulated	29375563
3436	Mouse	mmu-miR-27a	miRNA	Pam3Cys-Ser-(Lys)4 [PAM toll-like receptor (TLR)1/2 agonist]	innate immune response	RAW264.7 and bone marrow-derived macrophage	Pam3Cys-Ser-(Lys)4 [PAM toll-like receptor (TLR)1/2 agonist] treatment	downregulated	29375563
3437	Mouse	mmu-miR-27a	miRNA	high fat diet (HFD)	insulin resistance (IR)	"pancreas, liver, and white adipose tissue"	high fat diet (HFD) feed	upregulated	31562809
3438	Mouse	mmu-miR-27a	miRNA	tumor necrosis factor alpha (TNF-¦Á) 	insulin resistance (IR)	3T3-L1 cells	tumor necrosis factor alpha (TNF-¦Á) treatment	upregulated	31562809
3439	Mouse	mmu-miR-27a	miRNA	high fructose	lipid metabolism	hepatic tissues	High fructose feed	upregulated	31030166
3440	Mouse	mmu-miR-27a	miRNA	lipopolysaccharide (LPS)	liver damage	liver tissues	lipopolysaccharide (LPS) treatment	"miR-27a was approximately 5-fold downregulated in LPS group, compared with the sham group."	29156532
3441	Mouse	mmu-miR-27a	miRNA	lipopolysaccharide (LPS) and paclitaxel	liver damage	liver tissues	lipopolysaccharide (LPS) and paclitaxel treatment	"when paclitaxel was applied to septic mice (paclitaxel + LPS group), an approximately 4-fold increase of miR-27a was observed when compared with LPS group."	29156532
3442	Mouse	mmu-miR-27a	miRNA	high fat diet (HFD)	nonalcoholic fatty liver disease (NAFLD)	liver tissues	high fat diet (HFD) feed	upregulated	31889412
3443	Mouse	mmu-miR-27a	miRNA	high fat diet (HFD)	nonalcoholic fatty liver disease (NAFLD)	liver tissues	high fat diet (HFD) feed	upregulated	31889412
3444	Mouse	mmu-miR-27a	miRNA	berberine (BBR)	obesity	3T3-L1 cells	berberine (BBR) treatment	upregulated	27484069
3445	Mouse	mmu-miR-27a	miRNA	high fat diet (HFD)	obesity	"serum, skeletal muscle"	high fat diet (HFD) feed	upregulated	29721071
3446	Mouse	mmu-miR-27a	miRNA	palmitate	obesity	3T3-L1 adipocytes	palmitate treatment	upregulated	29721071
3447	Mouse	mmu-miR-27a	miRNA	persimmon tannin	obesity	3T3-L1 preadipocytes	Persimmon tannin treatment	upregulated	25510894
3448	Mouse	mmu-miR-27a	miRNA	Satb2	osteoblast differentiation and bone formation	bone marrow stromal cells (BMSCs)	Satb2 treatment	downregulated	27142530
3449	Mouse	mmu-miR-27a	miRNA	¦Â-elemene	oxygen-induced retinopathy (OIR)	Retinas tissues	¦Â-elemene treatment	upregulated	30664207
3450	Mouse	mmu-miR-27a	miRNA	Vaccination during Crisis of Plasmodium chabaudi Blood-Stage Malaria	plasmodium chabaudi infection	Balb/c Mice liver	infect with Vaccination treatment	downregulated in the Liver	28123381
3451	Mouse	mmu-miR-27a	miRNA	hypoxia	pulmonary hypertension (PH)	mouse lung tissues	hypoxia treatment	downregulated	24244514
3452	Mouse	mmu-miR-27a	miRNA	Fc	sepsis	LPS induced sepsis mice model	Fc treatment	downregulated	26171875
3453	Mouse	mmu-miR-27a	miRNA	laparotomy and exposure of the junc_x0002_tion between the large and small intestines	sepsis	mouse large and small intestines	laparotomy and exposure of the junc_x0002_tion between the large and small intestines treatment	upregulated	25043848
3454	Mouse	mmu-miR-27a	miRNA	lipopolysaccharide (LPS)	sepsis	liver tissues	lipopolysaccharide (LPS) treatment	downregulated	29156532
3455	Mouse	mmu-miR-27a	miRNA	paclitaxel (PTX)	sepsis	mouse liver tissues	paclitaxel treatment	upregulated	29156532
3456	Mouse	mmu-miR-27a	miRNA	controlled cortical impact (CCI)	traumatic brain injury (TBI)	mouse brain	controlled cortical impact (CCI)	downregulated	25057207
3457	Mouse	mmu-miR-27a	miRNA	high glucose (HG)	type 1 diabetic embryopathy	C17.2 neural stem cells	High-glucose treatment	upregulated	29100869
3458	Mouse	mmu-miR-27a	miRNA	streptozocin (STZ)	type 1 diabetic embryopathy	embryos on embryonic day 8.5 from diabetic dams	streptozotocin (STZ) treatment	upregulated	29100869
3459	Mouse	mmu-miR-27a*	miRNA	H2O2	chronic inflammatory airway diseases	RAW 264.7 cells	H2O2 treatment	downregulated	21350856
3460	Mouse	mmu-miR-27a*	miRNA	lipopolysaccharide (LPS)	macrophage inflammatory response	RAW264.7 macrophage cells	lipopolysaccharide (LPS) treatment	downregulated	22415194
3461	Mouse	mmu-miR-27a-3p	miRNA	oxygen-glucose deprivation and reoxygenation (OGD/R)	cerebral infarction (CI)	HT22 cells	oxygen-glucose deprivation and reoxygenation (OGD/R) treatment	"Circ_HECTD1 and FSTL1 were highly expressed, and miR-27a-3p was decreased in OGD/R-treated HT22 cells"	33843447
3462	Mouse	mmu-miR-27a-3p	miRNA	high glucose (HG)	diabetic nephropathy (DN)	podocytes	high glucose (HG) treatment	4930556M19Rik overexpression slowed HG-induced podocyte injury by downregulating miR-27a-3p and upregulating TIMP3.	32896839
3463	Mouse	mmu-miR-27a-3p	miRNA	oxygen-glucose deprivation and reoxygenation (OGD/R)	ischemic stroke (IS)	HT22 cells	oxygen-glucose deprivation and reoxygenation (OGD/R) treatment	MiR-27a-3p was downregulated in OGD/R-treated HT22 cells	33875617
3464	Mouse	mmu-miR-27a-3p	miRNA	Japanese encephalitis virus (JEV)	Japanese encephalitis virus (JEV) infection	brain tissues; BV2 cells	Japanese encephalitis virus (JEV) infection	downregulated	32552669
3465	Mouse	mmu-miR-27a-3p	miRNA	leptin	liver fibrosis	primary cultured hepatic stellate cell (HSC)	leptin treatment	upregulated	29548749
3466	Mouse	mmu-miR-27a-3p	miRNA	sevoflurane (SEV)	neurotoxicity	neonatal mice	sevoflurane treatment	upregulated	28881034
3467	Mouse	mmu-miR-27a-3p	miRNA	brown rice	obesity	serum; white adipose tissue (WAT); lleum	brown rice treatment	downregulated	32975270
3468	Mouse	mmu-miR-27a-3p	miRNA	brown rice	obesity	liver tissues	brown rice treatment	upregulated	32975270
3469	Mouse	mmu-miR-27a-3p	miRNA	high fat diet (HFD)	obesity	liver tissues	high fat diet (HFD) feed	upregulated	32593682
3470	Mouse	mmu-miR-27a-3p	miRNA	whole grain diets	obesity	serum; white adipose tissue (WAT); lleum	whole grain diets treatment	downregulated	32975270
3471	Mouse	mmu-miR-27a-3p	miRNA	whole grain diets	obesity	liver tissues	whole grain diets treatment	upregulated	32975270
3472	Mouse	mmu-miR-27a-3p	miRNA	melatonin	protecting neural stem cells (NSCs) from reactive oxygen species (ROS)	neural stem cells	Melatonin treatment	melatonin appeared to protect NSCs from H2O2-induced ROS by modification of the MEG3/miRNA-27a-3p/MAP2K4 axis.	32599124
3473	Mouse	mmu-miR-27a-3p	miRNA	H2O2	spinal cord injury (SCI)	C8-D1A and C8-B4 cells	hydrogen peroxide (H2O2) treatment	downregulated	30229811
3474	Mouse	mmu-miR-27a-5p	miRNA	streptozocin (STZ)	diabetic retinopathy (DR)	retina and serum of diabetic mice	streptozotocin treatment	upregulated	30883703
3475	Mouse	mmu-miR-27a-5p	miRNA	lipopolysaccharide (LPS)	inflammation	RAW 264.7 cells	lipopolysaccharide (LPS) treatment	dysregulated	24792623
3476	Mouse	mmu-miR-27b	miRNA	lipopolysaccharide (LPS)	acute lung injury (ALI)	bronchoalveolar lavage fluid (BALF)	lipopolysaccharides (LPS) treatment	upregulated	30584668
3477	Mouse	mmu-miR-27b	miRNA	CoCl2	adipogenesis	murine preadipocyte 3T3-L1 cells	CoCl2 treatment	upregulated	27939617
3478	Mouse	mmu-miR-27b	miRNA	alcohol	alcoholic liver fibrosis (ALF)	mouse primary hepatic stellate cells	alcohol treatment	upregulated	29935035
3479	Mouse	mmu-miR-27b	miRNA	oxidized low density lipoprotein (ox-LDL)	atherosclerosis (AS)	RAW264.7 macrophage	oxidized low-density lipoprotein (ox-LDL) treatment	downregulated	31518965
3480	Mouse	mmu-miR-27b	miRNA	palmitic acid (PA)	atrial arrhythmia	atrial cardiomyocytes	palmitic acid (PA) treatment	upregulated	26654778
3481	Mouse	mmu-miR-27b	miRNA	angiotensin II (Ang II)	atrial fibrosis	left atrium	angiotensin II (Ang II) treatment	The expression of miR-27b was significantly reduced after angiotensin II (AngII) infusion.	29671258
3482	Mouse	mmu-miR-27b	miRNA	angiotensin II (Ang II)	cardiac hypertrophy	primary neonatal mouse cardiomyocytes (NMCMs)	angiotensin II (Ang II) treatment	MiR-27b was downregulated in cardiomyocyte was subjected to AngII treatment.	32439330
3483	Mouse	mmu-miR-27b	miRNA	interleukin-1 receptor antagonist protein (IRAP)	cartilage impact injury	porcine knee joint	Interleukin-1 Receptor Antagonist Protein (IRAP) treatment	upregulated	26521750
3484	Mouse	mmu-miR-27b	miRNA	dexamethasone (DEX)	central fat accumulation	primary SVF cells derived from mouse SAT and VAT	dexamethasone (DEX) treatment	upregulated	25187367
3485	Mouse	mmu-miR-27b	miRNA	IFN-¦Ã	chronic inflammatory diseases	liver epithelial cells	IFN-¦Ãtreatment	downregulated	26631623
3486	Mouse	mmu-miR-27b	miRNA	cerulein	chronic pancreatitis (CP)	pancreas	cerulein treatment	downregulated	29303912
3487	Mouse	mmu-miR-27b	miRNA	streptozocin (STZ)	critical limb ischemia (CLI) in diabetes mellitus	ischemic hindlimbs	streptozotocin (STZ) treatment	downregulated	30972183
3488	Mouse	mmu-miR-27b	miRNA	nitric oxide (NO)	duchenne muscular dystrophy (DMD)	FAP cells	nitric oxide (NO) treatment	upregulated	24170326
3489	Mouse	mmu-miR-27b	miRNA	TGF-¦Â	epithelial-mesenchymal transition (EMT)	MS-1 mouse pancreatic microvascular endothelial cells	TGF-¦Â treatment	upregulated	28338957
3490	Mouse	mmu-miR-27b	miRNA	complement C3a	focal segmental glomerulosclerosis (FSGS)	tubular cells	C3a treatment	downregulated	30679767
3491	Mouse	mmu-miR-27b	miRNA	lithocholic acid (LCA)	glutathione synthesis and antioxidant capacity	Huh-7 cells	lithocholic acid (LCA) treatment	upregulated	25226451
3492	Mouse	mmu-miR-27b	miRNA	cerasus humilis polyphenol (CHP)	HFD-induced obesity	retroperitoneal white adipocytes	cerasus humilis polyphenol (CHP) treatment	CHP significantly inhibited the expression of miR-27a/b in mice retroperitoneal white adipocytes.	32227855
3493	Mouse	mmu-miR-27b	miRNA	mycobacterium tuberculosis (Mtb)	innate immune response	murine BMDMs and macrophage-like RAW264.7 cells	Mycobacterium tuberculosis infection	upregulated	29661829
3494	Mouse	mmu-miR-27b	miRNA	high fat diet (HFD)	insulin resistance (IR)	Epididymal white adipose tissue (eWAT)	high fat diet (HFD) feed	upregulated	29455245
3495	Mouse	mmu-miR-27b	miRNA	insulin	insulin resistance (IR)	The mouse 3T3-L1 preadipocyte cell line	insulin treatment	upregulated	29455245
3496	Mouse	mmu-miR-27b	miRNA	ischemic brain extract (IBE)	ischemic injury	Neuro-2a mouse neuronal cells	IBE treatment	downregulated	24999036
3497	Mouse	mmu-miR-27b	miRNA	ionizing radiation (IR)	leukemia	C57BL/6 mouse thymus tissue	IR treatment	downregulated	24974217
3498	Mouse	mmu-miR-27b	miRNA	berberine (BBR)	obesity	3T3-L1 cells	berberine (BBR) treatment	upregulated	27484069
3499	Mouse	mmu-miR-27b	miRNA	persimmon tannin	obesity	3T3-L1 preadipocytes	Persimmon tannin treatment	upregulated	25510894
3500	Mouse	mmu-miR-27b	miRNA	puromycin aminonucleoside (PAN)	podocyte protection	non-human primates (NHPs)	puromycin aminonucleoside (PAN) treatment	"In NHP primary podocyte culture, significant downregulated of miR-27b was observed during treatment of puromycin aminonucleoside (PAN), a classic nephrotoxin"	30429458
3501	Mouse	mmu-miR-27b	miRNA	ginsenoside Rb1	adipogenesis	3T3-L1 cells	Ginsenoside-Rb1? treatment	downregulated	22893262
3502	Mouse	mmu-miR-27b	miRNA	soluble egg antigen (SEA)of Schistosoma japonicum	schistosomiasis	mouse hepatocytes (AML12)	SEA treatment	downregulated	29469324
3503	Mouse	mmu-miR-27b	miRNA	methylglyoxal (MGO)	type 2 diabetes mellitus (T2DM)	mouse bone marrow progenitor cell (BMPCs )	24 h of exposure to methylglyoxal (MGO) or oxidized low-density lipoprotein	downregulated	28698281
3504	Mouse	mmu-miR-27b	miRNA	oxidized low density lipoprotein (ox-LDL)	type 2 diabetes mellitus (T2DM)	mouse bone marrow progenitor cell (BMPCs )	oxidized low-density lipoprotein (ox-LDL) treatment	downregulated	28698281
3505	Mouse	mmu-miR-27b	miRNA	lipopolysaccharide (LPS)	acute lung injury (ALI)	lung tissues	lipopolysaccharide (LPS) treatment	upregulated	30584668
3506	Mouse	mmu-miR-27b	miRNA	cryptosporidium parvum	cryptosporidium parvum infection	biliary epithelial cells	cryptosporidium parvum? infection	upregulated	22615562
3507	Mouse	mmu-miR-27b*	miRNA	H2O2	chronic inflammatory airway diseases	RAW 264.7 cells	H2O2 treatment	downregulated	21350856
3508	Mouse	mmu-miR-27b-3p	miRNA	reconstituted high-density lipoproteins (rHDL)	diabetes-impaired angiogenesis	diabetic mice HDL fraction	reconstituted high-density lipoproteins (rHDL) treatment	upregulated	30206364
3509	Mouse	mmu-miR-27b-3p	miRNA	reconstituted high-density lipoproteins (rHDL)	diabetes-impaired angiogenesis	diabetic mice plasma	reconstituted high-density lipoproteins (rHDL) treatment	downregulated	30206364
3510	Mouse	mmu-miR-27b-3p	miRNA	high glucose (HG)	diabetic nephropathy (DN)	mice mesangial cells	high glucose (HG) treatment	downregulated	30549040
3511	Mouse	mmu-miR-27b-3p	miRNA	high glucose (HG)	diabetic nephropathy (DN)	mice mesangial cells	high glucose (HG) treatment	miR-27b-3p was decreased in high-glucose-induced mice mesangial cells.	30549040
3512	Mouse	mmu-miR-27b-3p	miRNA	streptozocin (STZ)	diabetic retinopathy (DR)	retina and serum of diabetic mice	streptozotocin treatment	upregulated	30883703
3513	Mouse	mmu-miR-27b-3p	miRNA	Rg3-enhanced red ginseng extract (Rg3E)	endometriosis	endometriosis mose endometriotic tissue	8 weeks of Rg3E treatment	downregulated in endometriotic tissue	29247225
3514	Mouse	mmu-miR-27b-3p	miRNA	high glucose (HG)	epithelial-mesenchymal transition (EMT)	mice mesangial cells	high glucose (HG) treatment	downregulated	30549040
3515	Mouse	mmu-miR-27b-3p	miRNA	high glucose (HG)	fibrosis	mice mesangial cells	high glucose (HG) treatment	downregulated	30549040
3516	Mouse	mmu-miR-27b-3p	miRNA	leptin	liver fibrosis	primary cultured hepatic stellate cell (HSC)	leptin treatment	upregulated	29548749
3517	Mouse	mmu-miR-27b-3p	miRNA	"15-deoxy-¦¤12, 14-prostaglandin J2 (15d-PGJ2)"	liver damage	bone marrow (BM)-derived macrophage (BMM) of liver injury mouse	"15-deoxy-¦¤12, 14-prostaglandin J2 (15d-PGJ2) treatment"	upregulated	28748390
3518	Mouse	mmu-miR-27b-3p	miRNA	retinoic acid (RA)	myogenic hypoplasia	C2C12 cells	retinoic acid (RA) treatment	upregulated	27889377
3519	Mouse	mmu-miR-27b-3p	miRNA	retinoic acid (RA)	myogenic hypoplasia	C2C12 cells	retinoic acid (RA) treatment	upregulated	27889377
3520	Mouse	mmu-miR-27b-3p	miRNA	high fat diet (HFD)	obesity	mice epididymal white adipose tissue (eWAT)	high fat diet (HFD) feed	upregulated	30778336
3521	Mouse	mmu-miR-27b-5p	miRNA	¦¤9-tetrahydrocannabinol (THC) and Cannabidiol (CBD)	experimental autoimmune encephalomyelitis (EAE)	murine brain-derived CD4+ T cells	¦¤9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) combination treatment	downregulated	31497013
3522	Mouse	mmu-miR-28	miRNA	H2O2	cardiovascular disease (CVD)	cardiomyocytes	H2O2 treatment	upregulated	26364613
3523	Mouse	mmu-miR-281	miRNA	platelet derived growth factor-BB (PDGF-BB)	pulmonary arterial hypertension (PAH)	pulmonary artery smooth muscle cells (PASMCs)	platelet-derived growth factor (PDGF)-BB treatment	downregulated	29514810
3524	Mouse	mmu-miR-28-5p	miRNA	perfluorooctanoic acid	hepatotoxicity	liver tissues	Perfluorooctanoic acid (PFOA) exposure treatment	upregulated	24459700
3525	Mouse	mmu-miR-28-5p	miRNA	dexamethasone (DEX)	stress response	mouse C2C12 myotubes	dexamethasone (DEX) treatment	downregulated	31138100
3526	Mouse	mmu-miR-2861	miRNA	Silica nanoparticles (SiNPs)	apoptosis	Primary mouse spermatocyte cells (GC-2spd)	SiNPs treatment	"SiNPs could cause apoptosis of spermatocyte cells by inhibiting the expression of miRNA-2861, thereby resulting in the upregulation of mRNA expression of fas/fasl/ripk1 and activating the death receptor pathway of spermatocyte cells"	31071558
3527	Mouse	mmu-miR-28a-5p	miRNA	prostaglandin E2 (PGE2)	liver fibrosis	TGF-¦Â1-treated primary hepatic stellate cells (HSCs)	PGE2 treatment	downregulated	29109031
3528	Mouse	mmu-miR-28a-5p	miRNA	TGF-¦Â1	liver fibrosis	primary hepatic stellate cells (HSCs)	TGF-¦Â1 treatment	upregulated	29109031
3529	Mouse	mmu-miR-29	miRNA	bleomycin (BLM)	apoptosis	lung tissues	bleomycin (BLM) treatment	miR-29 was a downstream target gene of Smad3 and negatively regulated by TGF-¦Â/Smad signaling in fibrosis	22395530
3530	Mouse	mmu-miR-29	miRNA	2-acetyl-5-tetrahydroxybutyl imidazole (THI)	breast cancer	C2C12 cells	2-acetyl-5-tetrahydroxybutyl imidazole (THI) treatment	upregulated	24077965
3531	Mouse	mmu-miR-29	miRNA	lipopolysaccharide (LPS)	breast cancer	lung tissues	lipopolysaccharide (LPS) treatment	micro-RNA-29 decreased	22718803
3532	Mouse	mmu-miR-29	miRNA	sphingosine-1-phosphate (S1P)	breast cancer	C2C12 cells	sphingosine-1-phosphate (S1P) treatment	upregulated	24077965
3533	Mouse	mmu-miR-29	miRNA	xanthomicrol	breast cancer	4T1 cells	xanthomicrol treatment	upregulated	33217075
3534	Mouse	mmu-miR-29	miRNA	fundus photocoagulation with a krypton red laser	choroidal neovascularization (CNV)	C57BL/6 mice	fundus photocoagulation with a krypton red laser treatment	downregulated	24886609
3535	Mouse	mmu-miR-29	miRNA	dipeptidyl peptidase-4 (DPP-4)	diabetes mellitus (DM)	Streptozotocin-induced diabetic CD-1 mice	DPP-4 treatment	downregulated	24574044
3536	Mouse	mmu-miR-29	miRNA	IL-6	diabetic cardiomyopathy (DCM)	heart tissues	IL-6 treatment	downregulated	26972749
3537	Mouse	mmu-miR-29	miRNA	streptozocin (STZ)	diabetic retinopathy (DR)	Mouse retinal tissues	"Mice in the normal group were raised with normal diet each day, and those in the model group were fed with high-fat diet for 4 weeks. Then, mice in the normal group were intraperitoneally injected with normal saline and those in the model group were injected with 100 mg/kg STZ (streptozocin), for 4 consecutive weeks. treatment"	downregulated	31114980
3538	Mouse	mmu-miR-29	miRNA	2-acetyl-5-tetrahydroxybutyl imidazole (THI)	duchenne muscular dystrophy (DMD)	mdx mice	2-acetyl-5-tetrahydroxybutyl imidazole (THI) treatment	downregulated	24077965
3539	Mouse	mmu-miR-29	miRNA	high fat diet (HFD)	inflammatory response	skeletal muscle of mice	high fat diet (HFD) feed	"miR-375, miR-29, miR-320, miR-103/107 and miR-126, play a crucial role in the regulation of glucose and lipid metabolism through the control of pancreatic islet cell function"	22395471
3540	Mouse	mmu-miR-29	miRNA	baicalin (BAI)	keloids	NIH-3T3 cells	baicalin (BAI) treatment	upregulated	31081145
3541	Mouse	mmu-miR-29	miRNA	estradiol	liver fibrosis	mice liver cells	estradiol treatment	estrogen can inhibit CCl4-induced hepatic injury through the induction of hepatic miR-29.	22393047
3542	Mouse	mmu-miR-29	miRNA	carbon tetrachloride (CCl4)	liver inflammation and fibrogenesis	macrophages	carbon tetrachloride (CCl4) treatment	Both HuR and miR-29s regulate expression of CB1 involved in infiltration of bone marrow monocyte/macrophage in chronic liver injury	31495934
3543	Mouse	mmu-miR-29	miRNA	cyclosporine A (CsA)	nephrotoxicity	mouse kidney	cyclosporine A treatment	upregulated	28414804
3544	Mouse	mmu-miR-29	miRNA	angiotensin II (Ang II)	osteogenesis	heart tissues	angiotensin II (Ang II) treatment	Smad7 plays a protective role in AngII-mediated cardiac remodeling via mechanisms involving the Sp1-TGF-¦Â/Smad3-NF.¦ÊB-miR-29 regulatory network	23894614
3545	Mouse	mmu-miR-29	miRNA	16¦Á-hydroxyestrone (16¦ÁOHE)	pulmonary arterial hypertension (PAH)	lung tissues	16¦Á-hydroxyestrone (16¦ÁOHE) treatment	upregulated	26487756
3546	Mouse	mmu-miR-29	miRNA	ionizing radiation (IR)	pulmonary arterial hypertension (PAH)	fibroblasts	ionizing radiation treatment	miR-29 family members were downregulated in irradiated mouse fibroblasts.	29230533
3547	Mouse	mmu-miR-29	miRNA	synthetic RNA duplexes	lung fibrosis	adult male C56Bl6 mice lung	intravenous injection treatment	upregulated	25239947
3548	Mouse	mmu-miR-29	miRNA	ionizing radiation (IR)	radiation-induced fibrosis (RIF)	mouse fibroblasts	ionizing radiation treatment	downregulated	29230533
3549	Mouse	mmu-miR-29	miRNA	high fat diet (HFD)	type 2 diabetes mellitus (T2DM)	female C57BL/6J mice	high fat diet (HFD) feed	upregulated	24722248
3550	Mouse	mmu-miR-29	miRNA	TGF-¦Â	epithelial-mesenchymal transition (EMT)	C2C12 cells	TGF-¦Â treatment	downregulated	21324893
3551	Mouse	mmu-miR-290	miRNA	folate	cervical cancer (CC)	mouse embryonic stem cells (mESCs	folate deficiency induced	downregulated	22828209
3552	Mouse	mmu-miR-290-5p	miRNA	dextran sodium sulfate (DSS)	crohn disease (CD)	mouse peripheral blood CD4+ T cells	dextran sodium salt (DSS) treatment	downregulated	24356810
3553	Mouse	mmu-miR-290-5p	miRNA	propofol (PPF)	sepsis-induced renal injury	kidney tissues	Propofol treatment	Propofol increased miR-290-5p expression and decreased CCL-2 and inflammatory cytokines levels in the kidney for septic mice	30328934
3554	Mouse	mmu-miR-290b-5p	miRNA	embryo	embryo implantation	mouse uterine	embryo implantation	downregulated	29096585
3555	Mouse	mmu-miR-291	miRNA	"1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)"	neurodegenerative diseases	neuronal cells	"1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) treatment"	downregulated	31658060
3556	Mouse	mmu-miR-2911	miRNA	honeysuckle (HS)	influenza A virus (IAV) infection	mouse mouse peripheral blood and lung	drinking or gavage feeding of HS treatment	upregulated	25287280
3557	Mouse	mmu-miR-291a	miRNA	sodium arsenite (NaAsO2)	arsenic inhibited cellular differentiation	pluripotent P19 mouse embryonal carcinoma cells	sodium arsenite treatment	upregulated	29121352
3558	Mouse	mmu-miR-291a-3p	miRNA	Jiang Tang Xiao Ke Granule	diabetes mellitus (DM)	KKAy diabetic mice	Jiang Tang Xiao Ke Granule treatment	dysregulated	29163176
3559	Mouse	mmu-miR-291b	miRNA	hyaluronic acid 35 (HA35)	alcoholic liver disease (ALD)	C57BL6/J mice pretreate with ethanol Kupffer cells	15?mg/kg HA35 in sterile saline during the last three days of feeding	downregulated	29142263
3560	Mouse	mmu-miR-291b-3p	miRNA	metformin (Met)	fatty liver disease	liver tissues	metformin treatment	downregulated	27013659
3561	Mouse	mmu-miR-291b-3p	miRNA	high fat diet (HFD)	hyperglycemia and insulin resistance	C57BL/6 J mouse liver	high fat diet (HFD) feed	upregulated in liver	28054586
3562	Mouse	mmu-miR-291b-3p	miRNA	H2O2	oxdative stress	EOMA mouse endothelial cells	H2O2 treatment	upregulated	30106126
3563	Mouse	mmu-miR-291b-5p	miRNA	polyphenols	cell function	mice liver cells	Polyphenols treatment	downregulated	22253797
3564	Mouse	mmu-miR-292	miRNA	peritoneal dialysis fluid (PDF)	peritoneal fibrosis	peritoneal tissues	peritoneal dialysis fluid (PDF) treatment	upregulated	25827714
3565	Mouse	mmu-miR-292-3p	miRNA	engrafting E6.5 embryos (wildtype or Gtl2((-/+)))	teratomas	mice	engrafting E6.5 embryos (wildtype or Gtl2((-/+))) treatment	downregulated	25355544
3566	Mouse	mmu-miR-293	miRNA	engrafting E6.5 embryos (wildtype or Gtl2((-/+)))	teratomas	mice	engrafting E6.5 embryos (wildtype or Gtl2((-/+))) treatment	downregulated	25355544
3567	Mouse	mmu-miR-294	miRNA	recombinant Adeno-Cre viruses (AdV-Cre)	lung adenocarcinoma (LUAD)	lung	recombinant Adeno-Cre viruses (AdV-Cre) treatment	upregulated	25359683
3568	Mouse	mmu-miR-294-3p	miRNA	leishmania	leishmaniasis	Bone marrowderived macrophages (BMDMs)	Leishmania infection	upregulated	30949455
3569	Mouse	mmu-miR-295	miRNA	engrafting E6.5 embryos (wildtype or Gtl2((-/+)))	teratomas	mice	engrafting E6.5 embryos (wildtype or Gtl2((-/+))) treatment	downregulated	25355544
3570	Mouse	mmu-miR-295*	miRNA	recombinant Adeno-Cre viruses (AdV-Cre)	lung adenocarcinoma (LUAD)	lung	recombinant Adeno-Cre viruses (AdV-Cre) treatment	upregulated	25359683
3571	Mouse	mmu-miR-295-5p	miRNA	dendrobine	liver damage	liver tissues	dendrobine treatment	Dendrobine downregulated the levels of mmu-miR-295-5p	32633153
3572	Mouse	mmu-miR-296	miRNA	H2O2	Alzheimer's disease (AD)	Primary hippocampal neuron cells	H2O2 treatment	upregulated	24423585
3573	Mouse	mmu-miR-296	miRNA	H2O2	Alzheimer's disease (AD)	senescence accelerated mouse prone 8 (SAMP8) and prone 10 (SAMP10)	"different concentrations (0, 100, 200, 400 and 800 ¦ÌM) of H2O2 treatment"	upregulated	24423585
3574	Mouse	mmu-miR-296	miRNA	peritoneal dialysis fluid (PDF)	peritoneal fibrosis	peritoneal tissues	peritoneal dialysis fluid (PDF) treatment	upregulated	25827714
3575	Mouse	mmu-miR-296	miRNA	ethanol (EtOH)	teratogenesis	fetal brains of mice	Ethanol?treatment	downregulated	19091803
3576	Mouse	mmu-miR-296-3p	miRNA	neuregulin-1£¨NRG1£©	cell differentiation	murine embryonic stem cell	neuregulin-1£¨NRG1£©	upregulated	21451102
3577	Mouse	mmu-miR-296-3p	miRNA	destabilization of medial meniscus (DMM)	osteoarthritis (OA)	artilage tissues	destabilization of medial meniscus (DMM) treatment	CircCDH13 contributes to OA pathogenesis by functioning as a sponge of miR-296-3p and regulating the miR-296-3p-PTEN pathway.	33037617
3578	Mouse	mmu-miR-296-5p	miRNA	polyphenols	cell function	mice liver cells	Polyphenols treatment	downregulated	22253797
3579	Mouse	mmu-miR-296-5p	miRNA	barium chloride	muscle injury	C2C12 cells	barium chloride treatment	upregulated	32954829
3580	Mouse	mmu-miR-297	miRNA	lipopolysaccharide (LPS)	acute lung injury (ALI)	serum	lipopolysaccharide (LPS) treatment	downregulated	31945608
3581	Mouse	mmu-miR-297	miRNA	Aluminum oxide nanoparticles (Al2O3 NPs)	pulmonary inflammation	bronchoalveolar lavage fluid (BALF)	aluminum oxide nanoparticles (Al2O3 NPs) treatment	upregulated	31918133
3582	Mouse	mmu-miR-297a	miRNA	hypoxia/reoxygenation (H/R)	myocardial injury	HL-1 cells	hypoxia/reoxygenation (H/R) treatment	1700020I14Rik/miR-297a/CGRP axis suppressed myocardial cell apoptosis in myocardial I/R injury.	32298875
3583	Mouse	mmu-miR-297b-5p	miRNA	palmitic acid (PA)	impaired insulin secretion	¦Â-TC-6 cells	palmitic acid treatment	downregulated	32302972
3584	Mouse	mmu-miR-297b-5p	miRNA	stearic acid	impaired insulin secretion	¦Â-TC-6 cells	stearic acid treatment	downregulated	32302972
3585	Mouse	mmu-miR-297b-5p	miRNA	stearic acid	type 2 diabetes mellitus (T2DM)	¦Â-TC6 cells; mouse islets	stearic acid (C18:0) treatment	miR-297b-5p expression was significantly lower in ¦Â-TC6 cells and mouse islets in stearic acid than in control group	31961705
3586	Mouse	mmu-miR-298	miRNA	hypoxia	ischemic stroke (IS)	N2a cells	hypoxia induce	downregulated	30021197
3587	Mouse	mmu-mir-298-5p	miRNA	second-hand smoke (SHS)	asthma	lung	second-hand smoke (SHS) treatment	upregulated	26859758
3588	Mouse	mmu-miR-298-5p	miRNA	chlamydia muridarum variants (C. muridarum Var001 [CmVar001] and CmVar004)	plvic inflammatory disease	mouse	two Chlamydia muridarum variants (C. muridarum Var001 [CmVar001] and CmVar004) infection	were upregulated during CmVar004 infection compared to CmVar001 infection	24961692
3589	Mouse	mmu-miR-299-5p	miRNA	starvation	Alzheimer's disease (AD)	Hippocampal	starvation treatment	downregulated	27080144
3590	Mouse	mmu-miR-299a-3p	miRNA	chlamydia muridarum variants (C. muridarum Var001 [CmVar001] and CmVar004)	plvic inflammatory disease	mouse	two Chlamydia muridarum variants (C. muridarum Var001 [CmVar001] and CmVar004) infection	were upregulated during CmVar004 infection compared to CmVar001 infection	24961692
3591	Mouse	mmu-miR-29a	miRNA	lipopolysaccharide (LPS)	sepsis	myocardial tissue and heart infiltrating macrophages	lipopolysaccharide (LPS) treatment	downregulated	33840587
3592	Mouse	mmu-miR-29a	miRNA	"7,12-dimethylbenz(¦Á)anthracene (DMBA)"	"7,12-dimethylbenz(¦Á)anthracene (DMBA) toxicity"	liver tissues	"7,12-dimethylbenz(¦Á)anthracene (DMBA) treatment"	miR-29a was upregulated in the liver tissues of female mice.	32871758
3593	Mouse	mmu-miR-29a	miRNA	"7,12-dimethylbenz(¦Á)anthracene (DMBA)"	"7,12-dimethylbenz(¦Á)anthracene (DMBA) toxicity"	spleen tissues	"7,12-dimethylbenz(¦Á)anthracene (DMBA) treatment"	miR-29a was downregulated in the spleen tissues of male mice.	32871758
3594	Mouse	mmu-miR-29a	miRNA	folate	apoptosis	mouse embryonic stem cells (mESCs)	folate deficiency induced	upregulated	22828209
3595	Mouse	mmu-miR-29a	miRNA	cholesterol	atherosclerosis (AS)	"apoE-/- mice serum, endothelial, macrophages"	cholesterol feed	downregulated	29074464
3596	Mouse	mmu-miR-29a	miRNA	IFN-¦Á	autocrine and paracrine modulation	thymic epithelial cell	IFN-¦Á treatment	The thymic epithelial microRNA network elevates the threshold for infection-associated thymic involution via miR-29a mediated suppression of the IFN-¦Á receptor	22179202
3597	Mouse	mmu-miR-29a	miRNA	hyperoxia	bronchopulmonary dysplasia (BPD)	lung tissues of neonatal mice with hyperoxia-induced BPD and mouse alveolar epithelial cells (MLE-12)	hyperoxia induce	upregulated	31892308
3598	Mouse	mmu-miR-29a	miRNA	curcumin (Cur)	cell proliferation	TGF¦Â1-induced NIH-3T3 cells	curcumin (CUR) treatment	upregulated	31710976
3599	Mouse	mmu-miR-29a	miRNA	TGF-¦Â1	cell proliferation	NIH-3T3 cells	Transforming growth factor-¦Â (TGF¦Â1) treatment	downregulated	31710976
3600	Mouse	mmu-miR-29a	miRNA	hyperglycemia	diabetes mellitus (DM)	streptozotocin-induced diabetic mice	hyperglycemia treatment	downregulated	24578127
3601	Mouse	mmu-miR-29a	miRNA	insulin	diabetes mellitus (DM)	mouse cardiomyocyte HL-1 cells	insulin treatment	downregulated	25062042
3602	Mouse	mmu-miR-29a	miRNA	rapamycin	diabetes mellitus (DM)	mouse cardiomyocyte HL-1 cells	rapamycin (Rap) treatment	upregulated	25062042
3603	Mouse	mmu-miR-29a	miRNA	streptozocin (STZ)	diabetes mellitus (DM)	hearts of diabetic mice	streptozotocin (STZ) treatment	downregulated	21584493
3604	Mouse	mmu-miR-29a	miRNA	notoginsenoside R1 (NGR1)	diabetes mellitus (DM)	TNF-¦Á-treated Min6 cells	Notoginsenoside R1 (NGR1) treatment	upregulated	31184222
3605	Mouse	mmu-miR-29a	miRNA	notoginsenoside R1 (NGR1)	diabetes mellitus (DM)	TNF-¦Á-treated rat primary islets ¦Â cells	Notoginsenoside R1 (NGR1) treatment	upregulated	31184222
3606	Mouse	mmu-miR-29a	miRNA	tumor necrosis factor alpha (TNF-¦Á) 	diabetes mellitus (DM)	Min6 cells	tumor necrosis factor alpha (TNF-¦Á) treatment	downregulated	31184222
3607	Mouse	mmu-miR-29a	miRNA	tumor necrosis factor alpha (TNF-¦Á) 	diabetes mellitus (DM)	rat primary islets ¦Â cells	tumor necrosis factor alpha (TNF-¦Á) treatment	downregulated	31184222
3608	Mouse	mmu-miR-29a	miRNA	streptozocin (STZ)	diabetic glomerulopathy	glomeruli tissues	streptozotocin (STZ) treatment	downregulated	30642005
3609	Mouse	mmu-miR-29a	miRNA	streptozocin (STZ)	diabetic nephropathy (DN)	kidney tissues	streptozotocin treatment	Knockdown of LncRNA-H19 Ameliorates Kidney Fibrosis in Diabetic Mice by Suppressing miR-29a-Mediated EndMT	33324218
3610	Mouse	mmu-miR-29a	miRNA	streptozocin (STZ)	diabetic retinopathy (DR)	retina	streptozocin (STZ) treatment	downregulated	32182570
3611	Mouse	mmu-miR-29a	miRNA	"2,4,6-trinitrobenzene sulfonic acid (TNBS)"	diarrhea-predominant irritable bowel syndrome (IBS-D)	Intestinal mucosa	"2,4,6-trinitrobenzene sulfonic acid (TNBS)/ethanol treatment"	Inhibition of miRNA-29a regulates intestinal barrier function in diarrhea-predominant irritable bowel syndrome by upregulating ZO-1 and CLDN1	33093893
3612	Mouse	mmu-miR-29a	miRNA	polychlorinated biphenyls (PCBs)	cell differentiation	P19 mouse embryonal carcinoma cells	polychlorinated biphenyls (PCBs) treatment	upregulated	23443104
3613	Mouse	mmu-miR-29a	miRNA	high glucose (HG)	high glucose (HG)-induced apoptosis	mouse podocytes	high glucose (HG) treatment	The expression of miR-29a was significantly decreased in the HG-treated podocytes.	30575934
3614	Mouse	mmu-miR-29a	miRNA	lipopolysaccharide (LPS)	inflammation	RAW264.7 cells	lipopolysaccharide (LPS) treatment	upregulated	28811129
3615	Mouse	mmu-miR-29a	miRNA	glucocorticoid (GC)	inflammatory diseases	Murine osteoblast	glucocorticoid treatment	upregulated	24096265
3616	Mouse	mmu-miR-29a	miRNA	saturated fatty acids (SFA) palmitate (PA)	insulin resistance (IR)	L6 GLUT4myc	saturated fatty acids (SFA) palmitate (PA) treatment	upregulated	24844433
3617	Mouse	mmu-miR-29a	miRNA	palmitic acid (PA)	insulin resistance (IR)	C2C12 myotubes	palmitic acid (PA) treatment	PA treatment increased the expression of miR-29a in a time-and dose-dependent manner	29693165
3618	Mouse	mmu-miR-29a	miRNA	water avoidance stress (WAS)	irritable bowel syndrome (IBS)	mouse intestinal tissues	water avoidance stress (WAS) induce treatment	upregulated	30827505
3619	Mouse	mmu-miR-29a	miRNA	"2,4,6-trinitrobenzene sulfonic acid (TNBS)"	irritable bowel syndrome with diarrhea (IBS-D)	C57BL/6 strain mouse	"2,4,6-trinitrobenzene sulfonic acid (TNBS)/ethanol treatment"	upregulated	25277410
3620	Mouse	mmu-miR-29a	miRNA	angiotensin II (Ang II)	left ventricular (LV) remodeling	heart sissues	angiotensin II (Ang II) treatment	"MicroRNA-29a attenuates angiotensin-II induced-left ventricular remodeling by inhibiting collagen, TGF-¦Â and SMAD2/3 expression"	32165882
3621	Mouse	mmu-miR-29a	miRNA	carbon tetrachloride (CCl4)	liver fibrosis	liver tissues	intraperitoneal injection of CCl4	upregulated	28768954
3622	Mouse	mmu-miR-29a	miRNA	carbon tetrachloride (CCl4)	liver fibrosis	liver tissues	CCl? treatment	downregulated	30781750
3623	Mouse	mmu-miR-29a	miRNA	high fat diet (HFD)	nonalcoholic fatty liver disease (NAFLD)	hepatic tissue	high fat diet (HFD) feed	downregulated	31652636
3624	Mouse	mmu-miR-29a	miRNA	methionine choline-deficient diet (MCD)	nonalcoholic steatohepatitis (NASH)	liver tissues	methionine-choline-deficient (MCD) diet feed	downregulated	30917489
3625	Mouse	mmu-miR-29a	miRNA	IL-2¦Â	osteoarthritis (OA)	cultured chondrocyte-like ATDC5 cells	?IL-1¦Â treatment	downregulated	30993110
3626	Mouse	mmu-miR-29a	miRNA	hypoxia	oxidative stress	Primary cultures of neonatal mouse cardiomyocytes	hypoxia induce	downregulated	31885817
3627	Mouse	mmu-miR-29a	miRNA	Vaccination during Crisis of Plasmodium chabaudi Blood-Stage Malaria	plasmodium chabaudi infection	Balb/c Mice liver	infect with Vaccination treatment	downregulated in the Liver	28123381
3628	Mouse	mmu-miR-29a	miRNA	fibroblast growth factor 2 (FGF2)	regeneration of skeletal muscle	Skeletal muscle	fibroblast growth factor-2 (FGF2) treatment	we demonstrate using microRNA (miRNA) profiling in mouse and human myoblasts that the capacity of FGF2 to stimulate myoblast proliferation is mediated by miR-29a. FGF2 induces miR-29a expression and inhibition of miR-29a using pharmacological or genetic deletion decreases myoblast proliferation.	26731484
3629	Mouse	mmu-miR-29a	miRNA	streptozocin (STZ)	renal fibrosis	glomeruli	streptozocin (STZ) treatment	downregulated	27460630
3630	Mouse	mmu-miR-29a	miRNA	retinoic acid (RA)	retinal degenerative diseases	primary retinal progenitor cells (RPCs)	retinoic acid (RA) treatment	upregulated	29670089
3631	Mouse	mmu-miR-29a	miRNA	whole grain highland barley (WGH)	type 2 diabetes mellitus (T2DM)	liver tissues	whole grain highland barley (WGH) treatment	downregulated	33104141
3632	Mouse	mmu-miR-29a	miRNA	dextran sodium sulfate (DSS)	ulcerative colitis (UC)	mouse	dextran sodium sulfate (DSS) treatment	upregulated	25674218
3633	Mouse	mmu-miR-29a	miRNA	dextran sodium sulfate (DSS)	ulcerative colitis (UC)	colon tissues	dextran sulfate sodium treatment	upregulated	29916896
3634	Mouse	mmu-miR-29a-3p	miRNA	angiotensin II (Ang II)	myocardial infarction (MI)	neonatal mouse cardiac fibroblasts (CFs)	angiotensin II (Ang II) treatment	downregulated	33235025
3635	Mouse	mmu-miR-29a-3p	miRNA	leonurine (LE)	myocardial infarction (MI)	myocardial infarction (MI) mouse heart tissues; angiotensin II (AngII)-treated neonatal mouse cardiac fibroblasts (CFs)	leonurine (LE)?treatment	upregulated	33235025
3636	Mouse	mmu-miR-29a-3p	miRNA	lipopolysaccharide (LPS)	acute respiratory distress syndrome (ARDS)	serum	lipopolysaccharide (LPS) treatment	upregulated	32934950
3637	Mouse	mmu-miR-29a-3p	miRNA	hyperoxia	bronchopulmonary dysplasia (BPD)	MLE-12 cells	hyperoxia treatment	upregulated	33194901
3638	Mouse	mmu-miR-29a-3p	miRNA	hypoxia	cell differentiation	mouse (GL261 and G422) glioma cell lines	hypoxia induce	upregulated	30536597
3639	Mouse	mmu-miR-29a-3p	miRNA	astaxanthin	colorectal cancer (CRC)	Mouse colon cancer cell CT26	astaxanthin (ATX) treatment	upregulated	31263239
3640	Mouse	mmu-miR-29a-3p	miRNA	streptozocin (STZ)	diabetic retinopathy (DR)	retinal vessels	streptozotocin (STZ) treatment	downregulated	32343678
3641	Mouse	mmu-miR-29a-3p	miRNA	fluke Fasciola gigantica (FgESPs)	F. gigantica infection	liver tissues	fluke Fasciola gigantica (FgESPs) infection	downregulated	33332355
3642	Mouse	mmu-miR-29a-3p	miRNA	microcystin (MC)	female mammals' reproductive toxicity	mouse granulosa cells (mGCs)	microcystin-LR (MC-LR) for 48 h	dysregulated	28161121
3643	Mouse	mmu-miR-29a-3p	miRNA	paraquat (PQ)	paraquat (PQ)-induced acute lung injury and pulmonary fibrosis	MLE-12 cells	paraquat (PQ) treatment	downregulated	32741895
3644	Mouse	mmu-miR-29a-c	miRNA	angiotensin II (Ang II)	cardiac fibrosis	mouse heart	angiotensin II (Ang II) treatment	downregulated	24569834
3645	Mouse	mmu-miR-29a-c	miRNA	high glucose (HG)	hepatic gluconeogenesis	primary mouse hepatocytes	diet-induced obese (DIO)	"Adenovirus-mediated overexpression of miR-29a-c in the livers of db/m, db/db, and DIO mice decreased fasting blood glucose levels and improved glucose tolerance"	23111009
3646	Mouse	mmu-miR-29b	miRNA	high fat diet (HFD)	apoptosis	apoE knock-out mice	high fat diet (HFD) feed	upregulated	25131924
3647	Mouse	mmu-miR-29b	miRNA	folate	apoptosis	mouse embryonic stem cells (mESCs)	folate deficiency induced	upregulated	22828209
3648	Mouse	mmu-miR-29b	miRNA	ovalbumin (OVA)	asthma	lung and spleen tissues	OVA treatment	downregulated	31412349
3649	Mouse	mmu-miR-29b	miRNA	high fat diet (HFD)	atherosclerosis (AS)	serum	high fat diet (HFD) feed	upregulated	29398368
3650	Mouse	mmu-miR-29b	miRNA	insulin-like growth factor binding protein-related protein 1 (IGFBPrP1)	autophagy	hepatic stellate cell (HSC)	IGFBPrP1 treatment	downregulated	31610195
3651	Mouse	mmu-miR-29b	miRNA	TGF-¦Â	bone marrow transplantation	mouse alveolar macrophage	TGF-¦Â treatment	upregulated	25361568
3652	Mouse	mmu-miR-29b	miRNA	oxygen-glucose deprivation and reoxygenation (OGD/R)	cerebral ischemia/reperfusion (I/R) injury	N2a cells	oxygen-glucose deprivation and reoxygenation (OGD/R) treatment	upregulated	30233687
3653	Mouse	mmu-miR-29b	miRNA	oxygen-glucose deprivation and reoxygenation (OGD/R)	cerebral ischemia injury (CII)	N2a cells	oxygen-glucose deprivation and reoxygenation (OGD/R) treatment	miR-29b in N2a neuroblastoma cells decreased following oxygen and glucose deprivation/reperfusion (OGD/R) treatment	29399057
3654	Mouse	mmu-miR-29b	miRNA	insulin	diabetes mellitus (DM)	mouse cardiomyocyte HL-1 cells	insulin treatment	downregulated	25062042
3655	Mouse	mmu-miR-29b	miRNA	rapamycin	diabetes mellitus (DM)	mouse cardiomyocyte HL-1 cells	rapamycin (Rap) treatment	upregulated	25062042
3656	Mouse	mmu-miR-29b	miRNA	resveratrol	diabetic retinopathy (DR)	retinal cells	resveratrol (Res) treatment	diabetes-induced downregulated expression of miR-29b and upregulated expression of SP1 could be rescued by RSV in vivo and in vitro (P < 005)	27311771
3657	Mouse	mmu-miR-29b	miRNA	streptozocin (STZ)	diabetic retinopathy (DR)	mouse retion	STZ treatment	downregulated	28246353
3658	Mouse	mmu-miR-29b	miRNA	streptozocin (STZ)	diabetic retinopathy (DR)	retinal tissues	streptozotocin (STZ) treatment	downregulated	32497630
3659	Mouse	mmu-miR-29b	miRNA	TGF-¦Â	DNA damage	tubular epithelial cells	TGF-¦Â treatment	downregulated	23207693
3660	Mouse	mmu-miR-29b	miRNA	carbon tetrachloride (CCl4)	extracellular-matrix (ECM) and fibril formation	mouse	CCl4 treatment	downregulated	24650661
3661	Mouse	mmu-miR-29b	miRNA	repeated social defeat (RSD)	gastric cancer (GC)	"male C57BL/6 (5 ¨C 6 weeks old) and CD-1 (12 months old, retired breeders) mice"	intruder attack mice treatment	significantly upregulated expression	25317829
3662	Mouse	mmu-miR-29b	miRNA	supercritical-carbon dioxide fluid of C. indicum (CISCFE)	hepatocellular carcinoma (HCC)	mouse H22	CISCFE combined with Bleomycin (BLM) treatment	upregulated	28245556
3663	Mouse	mmu-miR-29b	miRNA	scald	hypertrophic scars (HS)	mouse thermal injury tissue	scald skin treatment	downregulated in thermal injury tissue	28092445
3664	Mouse	mmu-miR-29b	miRNA	ICAT (inhibitor of ¦Â-catenin and T cell factor)	fetal mouse neurogenesis	neural stem cells (NSCs)	ICAT treatment	upregulated	25321480
3665	Mouse	mmu-miR-29b	miRNA	"2,4,6-trinitrobenzene sulfonic acid (TNBS)"	irritable bowel syndrome with diarrhea (IBS-D)	C57BL/6 strain mouse	"2,4,6-trinitrobenzene sulfonic acid (TNBS)/ethanol treatment"	upregulated	25277410
3666	Mouse	mmu-miR-29b	miRNA	oxygen glucose deprivation (OGD)	ischemic stroke (IS)	HT22 cells	oxygen-glucose deprivation (OGD) treatment	Long non-coding RNA H19 inhibition ameliorates oxygen-glucose deprivation-induced cell apoptosis and inflammatory cytokine expression by regulating the microRNA-29b/SIRT1/PGC-1¦Á axis	33313940
3667	Mouse	mmu-miR-29b	miRNA	Japanese encephalitis virus (JEV)	Japanese encephalitis virus (JEV) infection	Mouse microglia cell line (BV-2)	Japanese encephalitis virus (JEV) treatment	significant upregulated of miR-29b in JEV-infected mouse microglial cell line (BV-2) and primary microglial cells.	24236890
3668	Mouse	mmu-miR-29b	miRNA	TGF-¦Â	liver fibrosis	primary hepatic stellate cells (HSCs)	TGF-¦Â treatment	downregulated	32893175
3669	Mouse	mmu-miR-29b	miRNA	methamphetamine (METH)	methamphetamine (METH) addiction	precursors	methamphetamine (METH) treatment	downregulated	29516602
3670	Mouse	mmu-miR-29b	miRNA	Japanese encephalitis virus (JEV)	microglial activation	mouse microglial cell line (BV-2)	JEV infected treatment	upregulated	24236890
3671	Mouse	mmu-miR-29b	miRNA	urethane	mouse lung tumors	lung tissues	urethane treatment	downregulated	24361357
3672	Mouse	mmu-miR-29b	miRNA	angiotensin II (Ang II)	muscle atrophy	C2C12 cells	angiotensin II (Ang II) treatment	miR-29b is elevated in AngII-induced muscle atrophy.	33614226
3673	Mouse	mmu-miR-29b	miRNA	high fat diet (HFD)	myocardial dysfunction	heart tissues	high fat diet (HFD) feed	miRNA-29b was reduced in the heart of HF diet-fed mice.	30362585
3674	Mouse	mmu-miR-29b	miRNA	berberine (BBR)	myocardial infarction (MI)	MI C57BL6 mice	berberine (BBR) treatment	upregulated	28722488
3675	Mouse	mmu-miR-29b	miRNA	oxygen-glucose deprivation and reoxygenation (OGD/R)	neuroblastoma (NB)	N2a neuroblastoma cells	oxygen-glucose deprivation and reoxygenation (OGD/R) treatment	downregulated	29399057
3676	Mouse	mmu-miR-29b	miRNA	high fat diet (HFD)	obesity	mouse heart tissues	high fat diet (HFD) feed	downregulated	30362585
3677	Mouse	mmu-miR-29b	miRNA	tumor necrosis factor alpha (TNF-¦Á) 	osteoclast differentiation	RAW264.7 cells	tumor necrosis factor alpha (TNF-¦Á) treatment	upregulated	23078176
3678	Mouse	mmu-miR-29b	miRNA	lipopolysaccharide (LPS)	osteoclastogenesis	mouse tibiae and cultured osteoclasts (OCs)	lipopolysaccharide (LPS) treatment	upregulated	31093317
3679	Mouse	mmu-miR-29b	miRNA	PD fluid (PDF)	peritoneal fibrosis	mosue renal tissue	PDF day 14 treatment	downregulated	25046436
3680	Mouse	mmu-miR-29b	miRNA	platelet derived growth factor-BB (PDGF-BB)	proliferative vascular diseases	primary vascular smooth muscle cells (VSMCs) of aorta in mice	platelet-derived growth factor-BB (PDGF-BB) treatment	upregulated	30231015
3681	Mouse	mmu-miR-29b	miRNA	hypoxia	pulmonary arterial hypertension (PAH)	pulmonary artery tissues	hypoxia induce	downregulated	29662889
3682	Mouse	mmu-miR-29b	miRNA	astilbin	lung fibrosis	lung tissues	astilbin induce	"miR©\29b©\2©\5p increased under astilbin treatment compared with BLM treatment, Its expression was inversely correlated with circRNAs©\949 and 662."	31448882
3683	Mouse	mmu-miR-29b	miRNA	angiotensin II (Ang II)	renal inflammation and fibrosis	kidney of mice	angiotensin II (Ang II) treatment	downregulated	23301086
3684	Mouse	mmu-miR-29b	miRNA	di-n-butyl phthalate (DBP)	reproductive toxicity	"The mouse spermatogenesis pathway cell lines, GC-1 spg (catalog number: CRL-2053) and GC-2 spd (catalog number: CRL-2196)"	Di-n-butyl phthalate (DBP) treatment	upregulated	30952838
3685	Mouse	mmu-miR-29b	miRNA	supernatants from silica-treated macrophages	silicosis	NIH-3T3 and MRC-5	supernatants from silica-treated macrophages treatment	downregulated	30090550
3686	Mouse	mmu-miR-29b	miRNA	silica	silicosis	lung tissue	silica treatment	downregulated	30529807
3687	Mouse	mmu-miR-29b	miRNA	brucea javanica oil (BJO)	temporal lobe epilepsy (TLE)	HT22 cells	brucea javanica oil (BJO) treatment	BJO and BE-BJO significantly induced H22 cell apoptosis by upregulating the miRNA-29b gene level.	33341052
3688	Mouse	mmu-miR-29b*	miRNA	H2O2	chronic inflammatory airway diseases	RAW 264.7 cells	H2O2 treatment	downregulated	21350856
3689	Mouse	mmu-miR-29b-1*	miRNA	H1N1 influenza virus	endometriosis and endometrial carcinoma	mouse lung?tissues	H1N1 influenza virus infection	upregulated	24066118
3690	Mouse	mmu-miR-29b-1-5p	miRNA	H2O2	cardiovascular disease (CVD)	cardiomyocytes	hydrogen peroxide (H2O2 ) treatment	The expression of miR-29b-1-5p was upregulated in I/R injured hearts and in hydrogen peroxide treated cardiomyocytes.	29117536
3691	Mouse	mmu-miR-29b-1-5p	miRNA	methimazole (MTZ)	liver damage	liver tissues	methimazole (MTZ) treatment	upregulated	27421576
3692	Mouse	mmu-miR-29b-3	miRNA	cigarette smoke (CS)	renal fibrosis	5/6th partial nephrectomy (PNx) surgery	5/6th partial nephrectomy (PNx) surgery treatment	downregulated in renal and cardiac	27789733
3693	Mouse	mmu-miR-29b-3p	miRNA	"1,2-dichloroethane (1,2-DCE)"	brain edema	brain parenchyma and around the vessels of the cerebral cortex	"1,2-dichloroethane (1,2-DCE) treatment"	upregulated	31734271
3694	Mouse	mmu-miR-29b-3p	miRNA	"1,2-dichloroethane (1,2-DCE)"	brain edema	brain cortex	"1,2-dichloroethane (1,2-DCE) treatment"	upregulated	31734271
3695	Mouse	mmu-miR-29b-3p	miRNA	angiotensin II (Ang II)	cardiac fibrosis	cardiac fibroblasts (CFs)	angiotensin II (Ang II) treatment	"?miR-29b-3p-induced inhibition of CFs proliferation and migration and alters the expression levels of miR-29b-3p targeting genes (a-SMA, COL1A1, COL3A1) in vitro."	30967276
3696	Mouse	mmu-miR-29b-3p	miRNA	angiotensin II (Ang II)	cardiac fibrosis	myocardium of Ang-II-infused migration inhibitory factor (MIF)-KO mice	angiotensin II (Ang II) treatment	downregulated	31175931
3697	Mouse	mmu-miR-29b-3p	miRNA	angiotensin II (Ang II)	cardiac fibrosis	mouse cardiac fibroblasts (CFs) with MIF overexpression or by treatment with MIF protein	angiotensin II (Ang II) treatment	upregulated	31175931
3698	Mouse	mmu-miR-29b-3p	miRNA	microcystin (MC)	female mammals' reproductive toxicity	mouse granulosa cells (mGCs)	microcystin-LR (MC-LR) for 48 h	dysregulated	28161121
3699	Mouse	mmu-miR-29b-3p	miRNA	luteinising hormone (LH)	functions of Leydig cells	mouse TM3 Leydig cells	luteinising hormone (LH) treatment	upregulated	28762514
3700	Mouse	mmu-miR-29b-3p	miRNA	schistosoma japonicum	liver fibrosis	liver tissues	Schistosoma japonicum infection treatment	downregulated	29091295
3701	Mouse	mmu-miR-29b-3p	miRNA	IL-1¦Â	osteoarthritis (OA)	ATDC5 cells	IL-1¦Â treatment	OIP5-AS1 was downregulated while miR-29b-3p was upregulated in OA models.	32037864
3702	Mouse	mmu-miR-29b-3p	miRNA	cigarette smoke extract (CSE)	smoke-induced lung injury (SILI)	lung tissues	cigarette smoke extract (CSE) treatment	upregulated	33523607
3703	Mouse	mmu-miR-29b-3p	miRNA	Rb3	smoke-induced lung injury (SILI)	lung tissues	Rb3 treatment	downregulated	33523607
3704	Mouse	mmu-miR-29b-3p	miRNA	luteinising hormone (LH)	steroidogenesis	mouse TM3 Leydig cells	luteinising hormone(LH) treatment	dysregulated	28762514
3705	Mouse	mmu-miR-29b-3p	miRNA	dextran sodium sulfate (DSS)	ulcerative colitis (UC)	colon	dextran sodium sulfate (DSS) exposure	TUG1 inhibits IEC apoptosis and UC progression by regulating the balance of HuR and miR-29b-3p.	33047284
3706	Mouse	mmu-miR-29b-3p	miRNA	dextran sodium sulfate (DSS)	ulcerative colitis (UC)	colon tissues	dextran sodium sulfate (DSS) treatment	upregulated	33047284
3707	Mouse	mmu-miR-29b-3p	miRNA	tumor necrosis factor alpha (TNF-¦Á) 	ulcerative colitis (UC)	YAMC cells	tumor necrosis factor alpha (TNF-¦Á) treatment	TUG1 inhibits IEC apoptosis and UC progression by regulating the balance of HuR and miR-29b-3p	33047284
3708	Mouse	mmu-miR-29b-3p	miRNA	tumor necrosis factor alpha (TNF-¦Á) 	ulcerative colitis (UC)	murine colonic epithelial YAMC cells	tumor necrosis factor alpha (TNF-¦Á) treatment	upregulated	33047284
3709	Mouse	mmu-miR-29c	miRNA	lipopolysaccharide (LPS)	cardiac fibrosis	C57/Bl6 mice heart	LPS (10 mg/kg)were injected intraperitoneally once a week for 1-4 weeks treatment	downregulated	25233448
3710	Mouse	mmu-miR-29c	miRNA	panax notoginseng saponins (PNS)	cardiovascular disease (CVD)	hearts	Panax notoginseng saponins (PNS) treatment	upregulated	28017695
3711	Mouse	mmu-miR-29c	miRNA	insulin	diabetes mellitus (DM)	mouse cardiomyocyte HL-1 cells	insulin treatment	downregulated	25062042
3712	Mouse	mmu-miR-29c	miRNA	rapamycin	diabetes mellitus (DM)	mouse cardiomyocyte HL-1 cells	rapamycin (Rap) treatment	upregulated	25062042
3713	Mouse	mmu-miR-29c	miRNA	hypoxia inducible factor (HIF)-1	heart failure (HF)	heart tissues	hypoxia-inducible factor (HIF)-1 induce	upregulated	30575439
3714	Mouse	mmu-miR-29c	miRNA	influenza A virus (IAV)	immune response	lung tissues	influenza A virus infection	downregulated	30513647
3715	Mouse	mmu-miR-29c	miRNA	exenatide (EXA)	insulin sensitivity	pancreas	exenatide treatment	"The levels of miRNA-15a, 29c, 124a, and 375 in the pancreas were significantly increased in HFD control mice.These effects were reversed by treatment with exenatide."	26314504
3716	Mouse	mmu-miR-29c	miRNA	exenatide (EXA)	insulin sensitivity	liver	exenatide treatment	"the levels of miRNA-29c, 124a, and 146a in the liver were significantly increased. These effects were reversed by treatment with exenatide."	26314504
3717	Mouse	mmu-miR-29c	miRNA	exenatide (EXA)	insulin sensitivity	muscle	exenatide treatment	"The levels of miRNA-15a, 29c, 124a, and 146a in the muscle were significantly increased. These effects were reversed by treatment with exenatide."	26314504
3718	Mouse	mmu-miR-29c	miRNA	exenatide (EXA)	insulin sensitivity	serum	exenatide treatment	"the levels of miRNA-15a, 29c, 124a, and 375 in the serum were significantly decreased. These effects were reversed by treatment with exenatide."	26314504
3719	Mouse	mmu-miR-29c	miRNA	high fat diet (HFD)	insulin sensitivity	pancreas	high fat diet (HFD) feed	upregulated	26314504
3720	Mouse	mmu-miR-29c	miRNA	high fat diet (HFD)	insulin sensitivity	muscle	high fat diet (HFD) feed	upregulated	26314504
3721	Mouse	mmu-miR-29c	miRNA	high fat diet (HFD)	insulin sensitivity	serum	high fat diet (HFD) feed	downregulated	26314504
3722	Mouse	mmu-miR-29c	miRNA	high fat diet (HFD)	insulin sensitivity	liver	high fat diet (HFD) feed	upregulated	26314504
3723	Mouse	mmu-miR-29c	miRNA	panax notoginseng saponins (PNS)	myocardial injury	myocardial injury C57BL/6J mice	panax notoginseng saponins (PNS) treatment	upregulated	28017695
3724	Mouse	mmu-miR-29c	miRNA	isoproterenol	myocardial injury	heart tissues	isoproterenol (ISO) treatment	downregulated	28017695
3725	Mouse	mmu-miR-29c	miRNA	"1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)"	parkinson's disease (PD)	substantia nigra pars compacta (SNpc)	"1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) treatment"	downregulated	31732967
3726	Mouse	mmu-miR-29c	miRNA	"1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)"	parkinson's disease (PD)	substantia nigra pars compacta (SNpc)	"1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) treatment"	miR-29c was down-expressed but SP1 was high-expressed in substantia nigra pars compacta (SNpc) of MPTP-induced PD mice.	31732967
3727	Mouse	mmu-miR-29c	miRNA	lipopolysaccharide (LPS)	parkinson's disease (PD)	BV-2 cells	lipopolysaccharide (LPS) treatment	miR-29c was downregulated in LPS-induced BV-2 cells.	32160394
3728	Mouse	mmu-miR-29c	miRNA	silica	silicosis	lung tissues	silica treatment	downregulated	29216763
3729	Mouse	mmu-miR-29c	miRNA	oxygen-glucose deprivation and reoxygenation (OGD/R)	stroke	HT22 cells	oxygen-glucose deprivation and reoxygenation (OGD/R) treatment	downregulated	31698040
3730	Mouse	mmu-miR-29c	miRNA	ethanol (EtOH)	teratogenesis	fetal brains of mice	Ethanol?treatment	downregulated	19091803
3731	Mouse	mmu-miR-29c*	miRNA	isoproterenol	cardiac fibrosis	heart tissues	isoproterenol (ISO) treatment	downregulated	27174579
3732	Mouse	mmu-miR-29c-3p	miRNA	ozone (O3)	asthma	CD4+ T cells and ASMCs	ozone treatment	lncRNA PVT1-miR-15a-5p/miR-29c-3p-PI3K-Akt-mTOR axis was implicated in ozone-induced asthma development by promoting ASMC proliferation and Th1/Th2 imbalance	33223504
3733	Mouse	mmu-miR-29c-3p	miRNA	angiotensin II (Ang II)	cardiac fibrosis	myocardium of Ang-II-infused migration inhibitory factor (MIF)-KO mice	angiotensin II (Ang II) treatment	downregulated	31175931
3734	Mouse	mmu-miR-29c-3p	miRNA	angiotensin II (Ang II)	cardiac fibrosis	mouse cardiac fibroblasts (CFs) with MIF overexpression or by treatment with MIF protein	angiotensin II (Ang II) treatment	upregulated	31175931
3735	Mouse	mmu-miR-29c-3p	miRNA	high glucose (HG)	diabetic nephropathy (DN)	Mouse primary kidney GEC (C57-6014G) and mouse glomerular mesangial cells (GMC) (SV40 MES 13) and derived exosomes	high glucose (HG) treatment	upregulated	31497190
3736	Mouse	mmu-miR-29c-3p	miRNA	high glucose (HG)	dysfunction of endothelial progenitor cells (EPCs)	EPCs	high glucose (HG) treatment	TUG1 restores high glucose-treated EPC function by regulating miR-29c-3p/PDGF-BB/Wnt signaling.	33059750
3737	Mouse	mmu-miR-29c-3p	miRNA	microcystin (MC)	female mammals' reproductive toxicity	mouse granulosa cells (mGCs)	microcystin-LR (MC-LR) for 48 h	dysregulated	28161121
3738	Mouse	mmu-miR-29c-3p	miRNA	carbon tetrachloride (CCl4)	hepatotoxicity	blood	carbon tetrachloride (CCl4) treatment	upregulated	32528856
3739	Mouse	mmu-miR-29c-3p	miRNA	licochalcone A (LA)	lung cancer	MLE-12 cells	Licochalcone A (lico A) treatment	downregulated	32505917
3740	Mouse	mmu-miR-29c-3p	miRNA	alpinia oxyphylla extract (AOE)	type 2 diabetes mellitus (T2DM)	db-/db- mouse kidney	A. oxyphylla extract (AOE) treatment	downregulated	28249617
3741	Mouse	mmu-miR-30	miRNA	TGF-¦Â	renal fibrosis	podocytes in normal mice	TGF-¦Â treatment	downregulated	24086574
3742	Mouse	mmu-miR-30	miRNA	high fat diet (HFD)	atherosclerosis (AS)	endothelial cell	high fat diet (HFD) feed	upregulated	26488467
3743	Mouse	mmu-miR-30	miRNA	melatonin	breast cancer	mouse breast cancer cell lines 4T1 and MA-891	Melatonin treatment	upregulated	31955008
3744	Mouse	mmu-miR-30	miRNA	melatonin	breast cancer	?4T1 cells; 891 cells	Melatonin treatment	Melatonin regulated breast cancer progression by the lnc010561/miR-30/FKBP3 axis.	31955008
3745	Mouse	mmu-miR-30	miRNA	streptozocin (STZ)	congenital heart disease (CHD)	C57BL/6 mice blood	injection of streptozotocin before mating treatment	dysregulated	27998767
3746	Mouse	mmu-miR-30	miRNA	chronic social defeat stress (CSDS)	depression	neurogenic dentate gyrus (DG) region	chronic social defeat stress (CSDS) induce	downregulated	31440139
3747	Mouse	mmu-miR-30	miRNA	TGF-¦Â1	epithelial-mesenchymal transition (EMT)	hepatocyte	TGF-¦Â1 treatment	downregulated	22227196
3748	Mouse	mmu-miR-30	miRNA	carbon tetrachloride (CCl4)	liver fibrosis	hepatic stellate cells (HSCs)	CCl4 treatment	downregulated	25912033
3749	Mouse	mmu-miR-30	miRNA	carbon tetrachloride (CCl4)	liver fibrosis	liver tissues	carbon tetrachloride (CCl4) treatment	downregulated in	28592847
3750	Mouse	mmu-miR-30	miRNA	TGF-¦Â	liver fibrosis	liver	TGF-¦Â treatment	downregulated	26120970
3751	Mouse	mmu-miR-30	miRNA	cyclosporine A (CsA)	nephrotoxicity	mouse kidney	cyclosporine A treatment	upregulated	28414804
3752	Mouse	mmu-miR-30	miRNA	extra-virgin olive oil rich in phenols (H-EVOO)	neuronal function	cortex	H-EVOO treatment	upregulated	26695409
3753	Mouse	mmu-miR-30	miRNA	angiotensin II (Ang II)	podocyte injury	mouse podocytes	angiotensin II (Ang II) treatment	downregulated in the podocytes	28540409
3754	Mouse	mmu-miR-30	miRNA	lipopolysaccharide (LPS)	podocytopathy	podocytes	lipopolysaccharide (LPS) treatment	downregulated	31127093
3755	Mouse	mmu-miR-300	miRNA	lipopolysaccharide (LPS)	inflammation	mouse blood	lipopolysaccharide (LPS) treatment	upregulated in the blood samples	29441890
3756	Mouse	mmu-miR-300	miRNA	dopamine	neurodegeneration (ND)	N2a cells	dopamine treatment	downregulated	30738894
3757	Mouse	mmu-miR-300	miRNA	metformin (Met)	nonalcoholic steatohepatitis (NASH)	liver tissues	metformin treatment	upregulated	25672270
3758	Mouse	mmu-miR-301a	miRNA	notoginsenoside R1 (NGR1)	ankylosing spondylitis (AS)	ATDC5 cells	Notoginsenoside R1 (NG-R1) treatment	Notoginsenoside R1 suppresses miR-301a via NF-¦ÊB pathway in lipopolysaccharide-treated ATDC5 cells.	31837326
3759	Mouse	mmu-miR-301a	miRNA	lipopolysaccharide (LPS)	inflammation	ATDC5 cells	lipopolysaccharide (LPS) treatment	upregulated	31837326
3760	Mouse	mmu-miR-301a	miRNA	notoginsenoside R1 (NGR1)	inflammation	LPS-treated ATDC5 cells	Notoginsenoside R1 (NG-R1) treatment	downregulated	31837326
3761	Mouse	mmu-miR-301a	miRNA	tumor necrosis factor alpha (TNF-¦Á) 	inflammatory bowel disease (IBD)	CD4+ T cells	tumor necrosis factor alpha (TNF-¦Á) treatment	upregulated	26338824
3762	Mouse	mmu-miR-301a	miRNA	Japanese encephalitis virus (JEV)	Japanese encephalitis virus (JEV) infection	mouse hippocampal neuronal cell line HT22	JEV (strain GP78) infection	upregulated	28196914
3763	Mouse	mmu-miR-301a	miRNA	lipopolysaccharide (LPS)	osteoarthritis (OA)	murine chondrogenic ATDC5 cells	lipopolysaccharide (LPS) treatment	upregulated	31966769
3764	Mouse	mmu-miR-301a	miRNA	anandamide (AEA)	pro-inflammatory activity	mouse	anandamide treatment	AEA differentil regulate the expression of miRNA	24699635
3765	Mouse	mmu-miR-301a	miRNA	TGF-¦Â	lung fibrosis	mouse embryonic fibroblasts (MEFs)	TGF-¦Â treatment	upregulated	32585629
3766	Mouse	mmu-miR-301a	miRNA	Japanese encephalitis virus (JEV)	viral-induced neuroinflammation	BV2 cells and primary microglial cells were isolated from postnatal day 0 (P0) to P2 BALB/c mouse pups	Japanese encephalitis virus (JEV) infection	upregulated	31527198
3767	Mouse	mmu-miR-301a-3p	miRNA	electroacupuncture (EA)	electroacupuncture (EA)	CD4 T cells	electroacupuncture (EA) treatment	upregulated	32026263
3768	Mouse	mmu-miR-301a-3p	miRNA	high glucose (HG)	glomerulonephritis	Mice MPC5 podocytes	high glucose (HG) treatment	downregulated	29434693
3769	Mouse	mmu-miR-301a-3p	miRNA	brucella.suis	innate immune response	RAW264.7 cells	brucella.suis infection	upregulated	29387067
3770	Mouse	mmu-miR-301b-3p	miRNA	doxorubicin (DOX)	doxorubicin (DOX)-induced cardiotoxicity	plasma	doxorubicin (DOX) treatment	upregulated	30453253
3771	Mouse	mmu-miR-301b-3p	miRNA	6-hydroxydopamine (6-OHDA)	parkinson's disease (PD)	dopaminergic neuron	6-hydroxydopamine (6-OHDA) treatment	LncRNA H19 diminishes dopaminergic neuron loss by mediating microRNA-301b-3p in Parkinson's disease via the HPRT1-mediated Wnt/¦Â-catenin signaling pathway.	32434961
3772	Mouse	mmu-miR-302	miRNA	Streptococcus pneumoniae (Sp)	bacterial pneumonia	alveolar epithelial cells (AEC)	Streptococcus pneumoniae (Sp) infection treatment	upregulated	30971494
3773	Mouse	mmu-miR-302	miRNA	alpinetin (ALP)	colitis	CD4+ T cells and colons of dextran sulfate sodium (DSS)-induced colitis mice	alpinetin (ALP) treatment	upregulated	30166541
3774	Mouse	mmu-miR-302a	miRNA	folate	cervical cancer (CC)	mouse embryonic stem cells (mESCs	folate deficiency induced	downregulated	22828209
3775	Mouse	mmu-miR-302a	miRNA	folate	apoptosis	mouse embryonic stem cells	folate treatment	MicroRNA-302a is involved in folate deficiency-induced apoptosis through the AKT-FOXO1-BIM pathway in mouse embryonic stem cells	33372619
3776	Mouse	mmu-miR-302a	miRNA	engrafting E6.5 embryos (wildtype or Gtl2((-/+)))	teratomas	mice	engrafting E6.5 embryos (wildtype or Gtl2((-/+))) treatment	downregulated	25355544
3777	Mouse	mmu-miR-302a-3p	miRNA	high glucagon	diabetes mellitus (DM)	primary hepatocytes	high glucagon treatment	Hmigh glucagon treatment could time-dependently decrease the mRNA expression of miR-302a-3p.	30260029
3778	Mouse	mmu-miR-302a-3p	miRNA	high glucagon	hepatic gluconeogenesis	mouse primary hepatocytes	high glucagon treatment	"MEG3 served as a competing endogenous RNA (ceRNA) to upregulate CRTC2 by targeting miR-302a-3p in primary hepatocytes, thereby increasing PGC-1¦Á-PEPCK/G6Pc."	30260029
3779	Mouse	mmu-miR-302a-3p	miRNA	oxygen-glucose deprivation and reoxygenation (OGD/R)	ischemic stroke (IS)	HT22 cells	oxygen-glucose deprivation and reoxygenation (OGD/R) treatment	"The SNHG15 and STAT1/NF-¦ÊB pathways were both distinctly upregulated, while miR-302a-3p was notably downregulated in the ischemia cortex"	33779086
3780	Mouse	mmu-miR-302a-3p	miRNA	dioscorea bulbifera (DB)	liver damage	livers	dioscoreae bulbifera (EF) treatment	downregulated	27609015
3781	Mouse	mmu-miR-302a-3p	miRNA	hypoxia/reoxygenation (H/R)	myocardial ischemia/reperfusion (I/R) injury (MIRI)	mouse cardiomyocytes	hypoxia/reoxygenation (H/R) treatment	MiR-302a-3p expression was significantly upregulated in mice subjected to MIRI and in H/R-treated mouse cardiomyocytes.	32866521
3782	Mouse	mmu-miR-302b	miRNA	monosodium urate (MSU)	gouty arthritis	mouse air membranes	monosodium urate (MSU) crystal treatment	upregulated	29482609
3783	Mouse	mmu-miR-302b	miRNA	pseudomonas aeruginosa (PA)	respiratory bacterial infection	alveolar macrophages (AMs) were obtained from bronchoalveolar lavage (BAL) of C57BL/6 mice	Gram-negative bacterium Pseudomonas aeruginosa infection treatment	upregulated	24717937
3784	Mouse	mmu-miR-302b-5p	miRNA	"1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)"	parkinson's disease (PD)	brain tissues	"1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) treatment"	miR-302b-5p expression was remarkably decreased after the treatment of MPTP in comparison with Normal tissues.	32474958
3785	Mouse	mmu-miR-302c	miRNA	carbon tetrachloride (CCl4)	liver fibrosis	hepatic stellate cells (HSCs)	carbon tetrachloride (CCl4) treatment	Induction of E6AP by microRNA-302c dysregulation inhibits TGF-¦Â-dependent fibrogenesis in hepatic stellate cells.	33037648
3786	Mouse	mmu-miR-302c	miRNA	engrafting E6.5 embryos (wildtype or Gtl2((-/+)))	teratomas	mice	engrafting E6.5 embryos (wildtype or Gtl2((-/+))) treatment	downregulated	25355544
3787	Mouse	mmu-miR-302d-3p	miRNA	leishmania	leishmaniasis	Bone marrowderived macrophages (BMDMs)	Leishmania infection	upregulated	30949455
3788	Mouse	mmu-miR-302e	miRNA	lipopolysaccharide (LPS)	infantile pneumonia (IP)	Lung tissue from 1 week old C57BL/6 mice	lipopolysaccharides (LPS) treatment	downregulated	31115487
3789	Mouse	mmu-miR-3061-3p	miRNA	propofol (PPF)	propofol-induced developmental neurotoxicity	hippocampus	propofol treatment	downregulated	30242182
3790	Mouse	mmu-miR-3068	miRNA	walnut	colorectal cancer (CRC)	colorectal tumor tissue	walnut-containing diet treatment	downregulated	25882694
3791	Mouse	mmu-miR-3070-2-3p	miRNA	high fat diet (HFD)	compensatory hyperplasia of islets	hepatocellular extracellular vesicles (EVs)	?high-fat diet (HFD) feed treatment	downregulated	31284955
3792	Mouse	mmu-miR-3075-5p	miRNA	vorinostat (SAHA)	atherosclerosis (AS)	aortic tissues	vorinostat treatment	downregulated	30284929
3793	Mouse	mmu-miR-3077	miRNA	177lu-octreotate	neuroendocrine tumors	Female BALB/c nude mice	"inject 1.3, 3.6, 14, 45, or 140 MBq 177Lu-octreotate treatment"	"miR-194, miR-107, miR-3090, and miR-3077 were commonly regulated"	25386939
3794	Mouse	mmu-miR-3082-5p	miRNA	"2, 3, 7, 8-tetrachlorodibenzo-p-dioxin (TCDD)"	bordetella pertussis infection	Pertussis Toxin (PTX) treated mice CD4+ T cells	"2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) treatment"	upregulated	31681214
3795	Mouse	mmu-miR-3082-5p	miRNA	enterovirus 71 (EV71)	enterovirus 71 (EV71) infection	mouse	infect with EV71	downregulated	28469998
3796	Mouse	mmu-miR-3090	miRNA	177lu-octreotate	neuroendocrine tumors	Female BALB/c nude mice	"inject 1.3, 3.6, 14, 45, or 140 MBq 177Lu-octreotate treatment"	"miR-194, miR-107, miR-3090, and miR-3077 were commonly regulated"	25386939
3797	Mouse	mmu-miR-3090-5p	miRNA	poly(ethylenimine) (PEI)	cell death	MEF cells	poly(ethylenimine) (PEI) treatment	upregulated	26158199
3798	Mouse	mmu-miR-30a	miRNA	coxsackievirus B3 (CVB3)	acute viral myocarditis (VM)	mouse heart tissues	Coxsackievirus B3 (CVB3) infection	upregulated	30915768
3799	Mouse	mmu-miR-30a	miRNA	alcohol	alcoholic hepatitis (AH)	sera	alcohol exposure	upregulated	26264599
3800	Mouse	mmu-miR-30a	miRNA	ovalbumin (OVA)	asthma	lung tissues	ovalbumin (OVA) treatment	downregulated	31748850
3801	Mouse	mmu-miR-30a	miRNA	diethylstilbestrol (DES)	diethylstilbestrol (DES) triggers thymic atrophy	mouse thymocytes	Diethylstilbestrol (DES) treatment	downregulated	30153466
3802	Mouse	mmu-miR-30a	miRNA	hypoxia	ischemic brain injury	Neuronal Cells	middle cerebral artery occlusion (MCAO) treatment	downregulated	28854438
3803	Mouse	mmu-miR-30a	miRNA	hypoxia	ischemic stroke (IS)	brain tissues	6 h middle cerebral artery occlusion without reperfusion treatment	upregulation in the brain of mice	24771295
3804	Mouse	mmu-miR-30a	miRNA	hypoxia	ischemic stroke (IS)	brain and N2A cells	peri-infarct region of mice with 1 h MCAO/24 h reperfusion and in N2A cells after 1 h OGD/6-48 h reoxygenation treatment	significantly downregulated	24771295
3805	Mouse	mmu-miR-30a	miRNA	angiotensin-(1-7)	mitochondrial fission	HG-induced podocytes	angiotensin-(1-7) treatment	upregulated	27789249
3806	Mouse	mmu-miR-30a	miRNA	oxygen glucose deprivation (OGD)	neural ischemic injury	cortical neurons	oxygen-glucose deprivation (OGD) treatment	downregulated	26301516
3807	Mouse	mmu-miR-30a	miRNA	RANKL (receptor activator of nuclear factor ¦ÊB ligand)	osteoclastogenesis	mouse bone marrow-derived monocytes (BMMs)	30 ng/ml M-CSF and 100 ng/ml RANKL for 4 days treatment	downregulated	29312525
3808	Mouse	mmu-miR-30a	miRNA	Vaccination during Crisis of Plasmodium chabaudi Blood-Stage Malaria	plasmodium chabaudi infection	Balb/c Mice liver	infect with Vaccination treatment	downregulated in the Liver	28123381
3809	Mouse	mmu-miR-30a	miRNA	radiation	radiation-induced fibrosis (RIF)	"CH3 mice muscle, skin, and subcutaneous tissue"	the right hind legs of 9-week old CH3 mice by a single-fraction dose of irradiation to 35 Gy treatment	dysregulated	24986745
3810	Mouse	mmu-miR-30a	miRNA	ischemia	renal fibrosis	Renal tissues	the left ureter was ligated at the lower pole level of kidney for 7 days	downregulated	28285987
3811	Mouse	mmu-miR-30a*	miRNA	high fat diet (HFD)	chondrogenesis	white adipose tissues	high fat diet (HFD) feed	downregulated	22496873
3812	Mouse	mmu-miR-30a-3p	miRNA	deoxycorticosterone acetate-salt hypertension	hypertensive nephropathy (HN)	kidney tissues	deoxycorticosterone acetate-salt hypertension treatment	downregulated	31782248
3813	Mouse	mmu-miR-30a-3p	miRNA	ethanol (EtOH)	teratogenesis	fetal brains of mice	Ethanol?treatment	upregulated	19091803
3814	Mouse	mmu-miR-30a-5p	miRNA	alcohol	alcohol toxicity	male C57BL/6J mice	mimics binge alcohol drinking in humans treatment	upregulated	25330738
3815	Mouse	mmu-miR-30a-5p	miRNA	pentachlorophenol (PCP)	developmental toxicity	pregnancy ICR mice placental chorionic villi	Pentachlorophenol (PCP) exposure treatment	downregulated	30597782
3816	Mouse	mmu-miR-30a-5p	miRNA	pilocarpine	epilepsy	male NMRI mice	inject intraperitoneally with pilocarpine treatment	downregulated	25078263
3817	Mouse	mmu-miR-30a-5p	miRNA	alcohol	excessive alcohol intake	medial PFC (mPFC)	alcohol exposure	upregulated	25330738
3818	Mouse	mmu-miR-30a-5p	miRNA	high fat diet (HFD)	obesity	adipose tissue macrophages (ATMs)	high fat diet (HFD) feed	downregulated	29899524
3819	Mouse	mmu-miR-30a-5p	miRNA	Co-Cr-Mo metal particles (CoPs)	particle-induced osteolysis (PIO)	MC3T3-E1 cells	Co-Cr-Mo metal particles (CoPs) treatment	"CoPs could up-regulate TSIX level, down-regulate miR-30a-5p expression."	29260905
3820	Mouse	mmu-miR-30a-5p	miRNA	Co-Cr-Mo metal particles (CoPs)	particle-induced osteolysis (PIO)	MC3T3-E1 cells	Co-Cr-Mo metal particles (CoPs) treatment	downregulated	29260905
3821	Mouse	mmu-miR-30a-5p	miRNA	pentachlorophenol (PCP)	pentachlorophenol (PCP) developmental toxicity	pregnancy ICR mice placenta	Pentachlorophenol (PCP) treatment	downregulated	30597782
3822	Mouse	mmu-miR-30a-5p	miRNA	coxsackievirus B3 (CVB3)	viral myocarditis (VM)	heart tissues	coxsackievirus B3 (CVB3) treatment	miR-30a-5p was found to be highly expressed in VMC mice.	33416455
3823	Mouse	mmu-miR-30b	miRNA	alcohol	alcoholic hepatitis (AH)	sera	alcohol exposure	upregulated	26264599
3824	Mouse	mmu-miR-30b	miRNA	metformin (Met)	anti-cancer therapy	mice with 4-months-exposure of smoke	oral metformin was used at a dose of 800 mg/kg diet treatment	upregulated	24683044
3825	Mouse	mmu-miR-30b	miRNA	fish oil	brown adipose tissue thermogenesis	brown adipocytes	fish oil treatment	upregulated	27489163
3826	Mouse	mmu-miR-30b	miRNA	TGF-¦Â1	chondrocyte differentiation	mouse embryo-derived stem cells C3H10T1/2	TGF-¦Â3 treatment	downregulated	29285169
3827	Mouse	mmu-miR-30b	miRNA	mechanical unloading	disuse osteoporosis (DOP)	MC3T3-E1 cells	Mechanical unloading treatment	upregulated	31757419
3828	Mouse	mmu-miR-30b	miRNA	high glucose (HG)	neural tube defects (NTDs)	neural stem cells (NSCs) isolated from the forebrain of diabetic pregnancy embryos	exposed to low or high glucose or hypoxia	upregulated	28798665
3829	Mouse	mmu-miR-30b	miRNA	hypoxia	neural tube defects (NTDs)	neural stem cells (NSCs) isolated from the forebrain of diabetic pregnancy embryos	exposed to low or high glucose or hypoxia	upregulated	28798665
3830	Mouse	mmu-miR-30b	miRNA	low glucose (LG)	neural tube defects (NTDs)	neural stem cells (NSCs) isolated from the forebrain of diabetic pregnancy embryos	exposed to low or high glucose or hypoxia	upregulated	28798665
3831	Mouse	mmu-miR-30b	miRNA	chronic intermittent hypoxia (CIH)	obstructive sleep apnoea-hypopnoea syndrome (OSAHS)	mouse aortic endothelial cells (MAECs)	chronic intermittent hypoxia (CIH) treatment	upregulated	29108914
3832	Mouse	mmu-miR-30b	miRNA	tumor necrosis factor alpha (TNF-¦Á) 	osteoarthritis (OA)	ADTC5 cells	tumor necrosis factor alpha (TNF-¦Á) treatment	upregulated	27941314
3833	Mouse	mmu-miR-30b	miRNA	IL-1¦Â	¦Â-cell dysfunction	MIN6 cells	IL-1¦Â treatment	upregulated	26367486
3834	Mouse	mmu-miR-30b-3p	miRNA	angiotensin II (Ang II)	cardiac hypertrophy	HL-1 cells	angiotensin II (Ang II) treatment	downregulated	33130312
3835	Mouse	mmu-miR-30b-3p	miRNA	angiotensin II (Ang II)	cardiac hypertrophy	The cardiomyocyte-like HL-1 cell lines	angiotensin II (Ang II) treatment	downregulated	33130312
3836	Mouse	mmu-miR-30b-5p	miRNA	lipopolysaccharide (LPS)	acute lung injury (ALI)	"lung tissue, serum, and bronchoalveolar lavage fluid of mice"	lipopolysaccharide (LPS) treatment	downregulated	30600796
3837	Mouse	mmu-miR-30b-5p	miRNA	angiotensin II (Ang II)	cardiac fibrosis	Cardiac fibroblasts (CFs)	angiotensin II (Ang II) treatment	downregulated	32329883
3838	Mouse	mmu-miR-30b-5p	miRNA	high glucose (HG)	diabetic nephropathy (DN)	renal tissues	high glucose (HG) treatment	"In high glucose induced HK-2 cells, expression levels of miR-30b-5p and E-cadherin were decreased, while SNAI1, a-SMA and Vimentin were increased."	33383483
3839	Mouse	mmu-miR-30c	miRNA	adherent-invasive escherichia coli (AIEC)	crohn disease (CD)	mouse enterocytes	adherent invasive escherichia coli (AIEC) treatment	upregulated	24148619
3840	Mouse	mmu-miR-30c	miRNA	mechanical unloading	disuse osteoporosis (DOP)	MC3T3-E1 cells	Mechanical unloading treatment	upregulated	31757419
3841	Mouse	mmu-miR-30c-1*	miRNA	polyphenols	cell function	mice liver cells	Polyphenols treatment	downregulated	22253797
3842	Mouse	mmu-miR-30c-1*	miRNA	isoproterenol	cardiac fibrosis	heart tissues	isoproterenol (ISO) treatment	downregulated	27174579
3843	Mouse	mmu-miR-30c-1-3p	miRNA	benzo(a)pyrene (BaP)	lung fibrosis	lung tissues	benzo(a)pyrene (BaP) exposure	downregulated	30543962
3844	Mouse	mmu-miR-30c-1-3p	miRNA	benzo(a)pyrene (BaP)	lung fibrosis	lung tissues	benzo(a)pyrene (BaP) exposure	downregulated	30543962
3845	Mouse	mmu-miR-30c-1-3p	miRNA	sulfur dioxide (SO2)	lung fibrosis	lung tissues	SO2 treatment	downregulated	30543962
3846	Mouse	mmu-miR-30c-1-3p	miRNA	sulfur dioxide (SO2)	lung fibrosis	lung tissues	sulfur dioxide (SO2)?exposure treatment	downregulated	30543962
3847	Mouse	mmu-miR-30c-2-3p	miRNA	tanshinone IIA (Tan IIA)	atherosclerosis (AS)	RAW 264.7 cells	Tanshinone IIA (Tan) treatment	upregulated	32337768
3848	Mouse	mmu-miR-30c-5p	miRNA	cocaine	cocaine abuse-related cardiovascular disease	aortic smooth muscle cells	Cocaine treatment	upregulated	29483230
3849	Mouse	mmu-miR-30c-5p	miRNA	cryptococcosis	cryptococcal meningitis	BV2 cells	cryptococcosis infection	downregulated	31958475
3850	Mouse	mmu-miR-30c-5p	miRNA	high fat diet (HFD)	obesity	adipose tissue macrophages (ATMs)	high fat diet (HFD) feed	downregulated	29899524
3851	Mouse	mmu-miR-30d	miRNA	mechanical unloading	disuse osteoporosis (DOP)	MC3T3-E1 cells	Mechanical unloading treatment	upregulated	31757419
3852	Mouse	mmu-miR-30d	miRNA	lipopolysaccharide (LPS)	epithelial-mesenchymal transition (EMT)	hippocampus	lipopolysaccharide (LPS) treatment	LPS administration in mice significantly decreased miR-30d expression in the hippocampus.	29260931
3853	Mouse	mmu-miR-30D	miRNA	testosterone	prostate cancer	female mouse liver	Testosterone treatment	"upregulation of the 6 miRNAs miR-22, miR-690, miR-122, let-7A, miR-30D and let-7D"	20600201
3854	Mouse	mmu-miR-30d	miRNA	streptozocin (STZ)	type 2 diabetes mellitus (T2DM)	islet ¦Â-cell	streptozotocin (STZ) treatment	downregulated	29663360
3855	Mouse	mmu-miR-30d-5p	miRNA	oxygen-glucose deprivation and reoxygenation (OGD/R)	cerebral ischemia/reperfusion (I/R) injury	Mouse N2a cells	oxygen-glucose deprivation and reoxygenation (OGD/R) treatment	downregulated	33833132
3856	Mouse	mmu-miR-30d-5p	miRNA	FTY720-mitoxy	parkinson's disease (PD)	dopaminergic MN16D cells	FTY720-Mitoxy treatment	upregulated	30359694
3857	Mouse	mmu-miR-30d-5p	miRNA	FTY720-Mitoxy	parkinson's disease (PD)	MN9D cells	FTY720-Mitoxy treatment	upregulated	30359694
3858	Mouse	mmu-miR-30e	miRNA	lipopolysaccharide (LPS)	acute aortic dissection (AAD)	aorta	lipopolysaccharide (LPS) treatment	downregulated	32634201
3859	Mouse	mmu-miR-30e	miRNA	mechanical unloading	disuse osteoporosis (DOP)	MC3T3-E1 cells	Mechanical unloading treatment	upregulated	31757419
3860	Mouse	mmu-miR-30e	miRNA	TGF-¦Â1	kidney fibrosis	tubular epithelial cell	TGF-¦Â1 treatment	downregulated	23515048
3861	Mouse	mmu-miR-30e	miRNA	"1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)"	parkinson's disease (PD)	mouse substantia nigra pars compacta (SNpc)	"1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) treatment"	downregulated in substantia nigra pars compacta (SNpc)	29274035
3862	Mouse	mmu-miR-30e	miRNA	"1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)"	parkinson's disease (PD)	substantia nigra pars compacta (SNpc)	"1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) treatment"	downregulated	29274035
3863	Mouse	mmu-miR-30e	miRNA	microwave	microwave-induced adverse health outcomes 	mouse hippocampus	7 days after 30 mW/cm microwave exposure treatment	downregulated	24748327
3864	Mouse	mmu-miR-30e	miRNA	aldosterone	podocyte apoptosis and mitochondrial dysfunction	mouse proximal tubule cells (MPC5)	aldosterone treatment	downregulated	27974319
3865	Mouse	mmu-miR-30e	miRNA	anandamide (AEA)	pro-inflammatory activity	mouse	anandamide treatment	AEA differentil regulate the expression of miRNA	24699635
3866	Mouse	mmu-miR-30e	miRNA	melatonin	radiation-induced injury	15 Gy irradiation exposured RAW 264.7 cells	Melatonin treatment	upregulated	30755784
3867	Mouse	mmu-miR-30e	miRNA	¦Ã-rays	radiation-induced injury	RAW 264.7 cells	15 Gy irradiation exposure treatment	downregulated	30755784
3868	Mouse	mmu-miR-30e*	miRNA	isoproterenol	cardiac fibrosis	heart tissues	isoproterenol (ISO) treatment	downregulated	27174579
3869	Mouse	mmu-miR-30e*	miRNA	high fat diet (HFD)	chondrogenesis	white adipose tissues	high fat diet (HFD) feed	downregulated	22496873
3870	Mouse	mmu-miR-30e-5p	miRNA	particulate matter (PM2.5)	chronic obstructive pulmonary disease (COPD)	lung tissues; blood; RAW264.7 cells	Fine particulate matter (PM2.5) treatment	downregulated	32707273
3871	Mouse	mmu-miR-30e-5p	miRNA	"CB1 antagonist, AM251"	diet-induced obesity (DIO)	F4/80+ cells from stromal vascular fractions (SVF) of epididymal fat	"CB1 antagonist, AM251 treatment"	upregulated	31134094
3872	Mouse	mmu-miR-30e-5p	miRNA	deflazacort	inflammation	RAW 264.7 cells	deflazacort treatment	downregulated	32153563
3873	Mouse	mmu-miR-30e-5p	miRNA	lipopolysaccharide (LPS)	inflammation	RAW 264.7 cells	lipopolysaccharide (LPS) treatment	upregulated	32153563
3874	Mouse	mmu-miR-30e-5p	miRNA	prednisolone	inflammation	RAW 264.7 cells	lipopolysaccharide (LPS) treatment	downregulated	32153563
3875	Mouse	mmu-miR-30e-5p	miRNA	leishmania	leishmaniasis	Bone marrowderived macrophages (BMDMs)	Leishmania infection	upregulated	30949455
3876	Mouse	mmu-miR-30e-5p	miRNA	high fat diet (HFD)	obesity	adipose tissue macrophages (ATMs)	high fat diet (HFD) feed	downregulated	29899524
3877	Mouse	mmu-miR-30e-5p	miRNA	ethanol (EtOH)	teratogenesis	fetal brains of mice	Ethanol?treatment	downregulated	19091803
3878	Mouse	mmu-miR-31	miRNA	staphylococcal enterotoxin B (SEB)	acute inflammatory lung injury	lung	staphylococcal enterotoxin B treatment	upregulated	25564423
3879	Mouse	mmu-miR-31	miRNA	ovalbumin (OVA)	allergic rhinitis (AR)	nasal mucosa	ovalbumin (OVA) treatment	The expression levels of miR-31 were significantly decreased in the nasal mucosa of the AR group compared with those in the control group.	33179116
3880	Mouse	mmu-miR-31	miRNA	ovalbumin (OVA)	asthma	lung tissues	OVA (ovalbumin) treatment	upregulated	31298396
3881	Mouse	mmu-miR-31	miRNA	cerulein	chronic pancreatitis (CP)	pancreas	cerulein treatment	upregulated	29303912
3882	Mouse	mmu-miR-31	miRNA	"2,4,6-trinitrobenzene sulfonic acid (TNBS)"	colitis	CD4+ T cells	"2,4,6-Trinitrobenzenesulfonic acid solution (TNBS) treatment"	upregulated	31730734
3883	Mouse	mmu-miR-31	miRNA	resveratrol	colitis	CD4+ T cells	resveratrol (RS) treatment	downregulated	31730734
3884	Mouse	mmu-miR-31	miRNA	resveratrol	colitis	mesenteric lymph node (MLN)	resveratrol (RS) treatment	Resveratrol Downregulates miR-31 to Promote T Regulatory Cells during Prevention of TNBS-Induced Colitis	31730734
3885	Mouse	mmu-miR-31	miRNA	IL-10	colonic inflammation	colonic intraepithelial lymphocytes	IL-10 treatment	downregulated	22043014
3886	Mouse	mmu-miR-31	miRNA	IL-10	epithelial-mesenchymal transition (EMT)	colonic intraepithelial lymphocytes	IL-10 treatment	upregulated	22043014
3887	Mouse	mmu-miR-31	miRNA	high fat diet (HFD)	hepatocellular carcinoma (HCC)	plasma and hepatic tissues	high fat diet (HFD) feed	upregulated	26728044
3888	Mouse	mmu-miR-31	miRNA	angiotensin II (Ang II)	hypertension	"the aorta, splenic CD4+ T cells, and kidney leukocytes"	angiotensin II (Ang II) treatment	upregulated	30929511
3889	Mouse	mmu-miR-31	miRNA	oxygen glucose deprivation (OGD)	ischemic stroke (IS)	mouse brain and astrocytes	"C57BL/6J mice were used to establish the middle cerebral artery occlusion (MCAO) model. Following the establishment of an oxygen-glucose deprivation (OGD) model, the astrocytes were cocultured with neuronal OGD.? treatment"	downregulated	31517390
3890	Mouse	mmu-miR-31	miRNA	"TCDD (2,3,7,8-tetrachlorodibenzo-p-dioxin)"	kaposi's sarcoma (KS)	fetal thymocytes of mice	"TCDD (2,3,7,8-tetrachlorodibenzo-p-dioxin) treatment"	downregulated	23024791
3891	Mouse	mmu-miR-31	miRNA	"indole-3-carbinol (I3C) and 3,3'-diindolylmethane (DIM)"	liver damage	SEB into D-galactosamine-sensitized female C57BL/6 mice	"indole-3-carbinol (I3C) and 3,3'-diindolylmethane (DIM) treatment"	downregulated	25706292
3892	Mouse	mmu-miR-31	miRNA	binase	lymphosarcoma	RLS40 cells	binase treatment	downregulated	33147876
3893	Mouse	mmu-miR-31	miRNA	stretch	myoblast proliferation	C2C12 myoblasts	stretch treatment	downregulated	27840929
3894	Mouse	mmu-miR-31	miRNA	dietary methionine restriction (MR)	osteoblast differentiation and function	"male C57BL/6J mice bone marrow,plasma and liver"	fed diets containing 0.86% or 0.12% methionine for 5 weeks	"upregulated (miR-31 in plasma and liver, and miR-133a, miR-335-5p, and miR-204 in the bone marrow"	27191548
3895	Mouse	mmu-miR-31	miRNA	nuclear factor kappa-B (NF-¦ÊB)	psoriatic	keratinocytes	NF-¦ÊB treatment	upregulated	26138368
3896	Mouse	mmu-miR-31	miRNA	clozapine (CLZ)	psychotic disorders	mouse brain	clozapine treatment	upregulated	23318695
3897	Mouse	mmu-miR-31	miRNA	leptin	age-associated loss of muscle mass	skeletal muscle	?leptin treatment	?leptin treatment increased the expression of miR-31 and miR-223	20800581
3898	Mouse	mmu-miR-31	miRNA	"2,4,6-trinitrobenzene sulfonic acid (TNBS)"	ulcerative colitis (UC)	colon tissues	"2,4,6-trinitrobenzene sulfonic acid (TNBS)/ethanol treatment"	upregulated	31378906
3899	Mouse	mmu-miR-31	miRNA	azacitidine (AZA)	ulcerative colitis (UC)	"2,4,6-trinitrobenzene sulfonic acid (TNBS)/ethanol-induced ulcerative colitis (UC) mice colon tissues"	azacitidine (AZA) treatment	downregulated	31378906
3900	Mouse	mmu-miR-31	miRNA	mesalazine (MSLZ)	ulcerative colitis (UC)	"2,4,6-trinitrobenzene sulfonic acid (TNBS)/ethanol-induced ulcerative colitis (UC) mice colon tissues"	mesalazine (MSLZ) treatment	downregulated	31378906
3901	Mouse	mmu-miR-3100-5p	miRNA	propofol (PPF)	propofol-induced developmental neurotoxicity	hippocampus	propofol treatment	upregulated	30242182
3902	Mouse	mmu-miR-3102-3p	miRNA	Japanese encephalitis virus (JEV)	Japanese encephalitis virus (JEV) infection	brain tissues; BV2 cells	Japanese encephalitis virus (JEV) infection	upregulated	32552669
3903	Mouse	mmu-miR-3102-3p	miRNA	ganoderma lucidum extract (GLE)	hepatocellular carcinoma (HCC)	Hepa 1-6 cells	Ganoderma lucidum extract (GLE) treatment	upregulated	32106374
3904	Mouse	mmu-miR-3104-5p	miRNA	dioscorea bulbifera (DB)	liver damage	livers	dioscoreae bulbifera (EF) treatment	upregulated	27609015
3905	Mouse	mmu-miR-3107*	miRNA	isoproterenol	cardiac fibrosis	heart tissues	isoproterenol (ISO) treatment	downregulated	27174579
3906	Mouse	mmu-miR-3113	miRNA	azoxymethane (AOM)	colorectal cancer (CRC)	mouse colon tissues	azoxymethane (AOM) treatment	upregulated in colon samples	29066742
3907	Mouse	mmu-miR-31-3p	miRNA	dextran sodium sulfate (DSS)	colitis	male C57BL/6J mice colon	DSS treatment	upregulated	29253460
3908	Mouse	mmu-miR-31-3p	miRNA	trinitrobenzene sulfonic acid (TNBS)	colitis	male C57BL/6J mice colon	TNBS treatment	upregulated	29253460
3909	Mouse	mmu-miR-31-5p	miRNA	astaxanthin	neuroinflammation	Lipopolysaccharide (LPS)-treated BV2 cells	astaxanthin (ATX) treatment	downregulated	33359248
3910	Mouse	mmu-miR-31-5p	miRNA	azoxymethane (AOM) and dextran sulfate sodium (DSS)	colitis-associated colon cancer (CAC)	colon tissue	azoxymethane (AOM) and dextran sulfate sodium (DSS) treatment	upregulated	31100679
3911	Mouse	mmu-miR-31-5p	miRNA	azoxymethane (AOM) and dextran sulfate sodium (DSS)	colitis-associated colon cancer (CAC)	colon tissues	azoxymethane (AOM) and dextran sulfate sodium (DSS) treatment	upregulated	31275360
3912	Mouse	mmu-miR-31-5p	miRNA	pedunculoside	colitis-associated colon cancer (CAC)	CAC mice colon tissues	pedunculoside treatment	downregulated	31275360
3913	Mouse	mmu-miR-31-5p	miRNA	water extract of I. rotunda (WIR)	colitis-associated colon cancer (CAC)	CAC mice colon tissue	water extract of I. rotunda (WIR) treatment	downregulated	31100679
3914	Mouse	mmu-miR-31-5p	miRNA	solar particle event (SPE)	colorectal cancer (CRC)	plasma of a colorectal cancer susceptible mouse	solar particle event (SPE) treatment	downregulated	26432591
3915	Mouse	mmu-miR-31-5p	miRNA	¦¤9-tetrahydrocannabinol (THC) and Cannabidiol (CBD)	experimental autoimmune encephalomyelitis (EAE)	murine brain-derived CD4+ T cells	¦¤9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) combination treatment	downregulated	31497013
3916	Mouse	mmu-miR-31-5p	miRNA	chronic unpredictable mild stress (CUMS)	major depressive disorder (MDD)	nucleus accumbens (NAc) tissues	chronic unpredictable mild stress (CUMS) induce	upregulated	30936699
3917	Mouse	mmu-miR-31-5p	miRNA	barium chloride	muscle injury	C2C12 cells	barium chloride treatment	upregulated	32954829
3918	Mouse	mmu-miR-31-5p	miRNA	retinoic acid (RA)	cell proliferation	embryonic tongue and C2C12 myoblasts	retinoid acid treatment	upregulated	28526071
3919	Mouse	mmu-miR-31-5p	miRNA	imiquimod (IMQ)	psoriasis	skin tissues	imiquimod (IMQ) treatment	upregulated	31278779
3920	Mouse	mmu-miR-31-5p	miRNA	lipopolysaccharide (LPS)	sepsis	RAW264.7 cells	lipopolysaccharide (LPS) treatment	"NEAT1 and POU domain class 2 transcription factor 1 (POU2F1) were highly expressed in LPS-induced septic RAW264.7 cells, opposite to miR-31-5p expression."	33710444
3921	Mouse	mmu-miR-31-5p	miRNA	L©\arginine	severe acute pancreatitis (SAP)	pancreatic tissues	L-arginine treatment	downregulated	33122522
3922	Mouse	mmu-miR-3162-3p	miRNA	ovalbumin (OVA)	asthma	lung tissues	ovalbumin treatment	upregulated	32610326
3923	Mouse	mmu-miR-3185	miRNA	mechanical asphyxia	asphyxial death	heart tissues	mechanical asphyxia treatment	miR-3185 was upregulated in cardiac tissues among cases of mechanical asphyxia.	32320934
3924	Mouse	mmu-miR-32	miRNA	high glucose (HG)	liver fibrosis	AML12 cells	high glucose (HG) treatment	upregulated	30816482
3925	Mouse	mmu-miR-32	miRNA	high glucose (HG)	mesenchymal stem cells (MSCs) dysfunction	mice bone marrow-derived mesenchymal stem cells	high glucose treatment	downregulated	23524257
3926	Mouse	mmu-miR-32	miRNA	microwave	microwave-induced adverse health outcomes 	mouse hippocampus	7 days after 30 mW/cm microwave exposure treatment	downregulated	24748327
3927	Mouse	mmu-miR-320	miRNA	"anti-benzo[a]pyrene-trans-7,8-diol-9,10-epoxide (anti-BPDE)"	bronchial epithelial cell cancer	16HBE-T cells	"anti-benzo[a]pyrene-trans-7,8-diol-9,10-epoxide (anti-BPDE) treatment"	upregulated	19462682
3928	Mouse	mmu-miR-320	miRNA	palmitic acid (PA)	inflammation	mature 3T3-L1 adipocytes	palmitic acid (PA) treatment	upregulated	31634961
3929	Mouse	mmu-miR-320	miRNA	high fat diet (HFD)	inflammatory response	skeletal muscle of mice	high fat diet (HFD) feed	"miR-375, miR-29, miR-320, miR-103/107 and miR-126, play a crucial role in the regulation of glucose and lipid metabolism through the control of pancreatic islet cell function"	22395471
3930	Mouse	mmu-miR-320	miRNA	metformin (Met)	insulin resistance (IR)	3T3L1 cells	Metformin treatment	IR adipocytes downregulated miR-320 in response to Metformin graded concentrations.	32367399
3931	Mouse	mmu-miR-320	miRNA	prion	neurodegeneration (ND)	the brains tissues	prion infection treatment	upregulated	18987751
3932	Mouse	mmu-miR-320	miRNA	pregnant mare serum gonadotropin	reproduction and some steroid-related disorders	mouse ovarian granulosa cells	pregnant mare serum gonadotropin treatment	suppression of miR-320 expression in a time-dependent manner	24828505
3933	Mouse	mmu-miR-3202	miRNA	high glucose (HG)	apoptosis	endothelial cell line H5V	high-glucose	upregulated	28228635
3934	Mouse	mmu-miR-320-3p	miRNA	Jiang Tang Xiao Ke Granule	diabetes mellitus (DM)	KKAy diabetic mice	Jiang Tang Xiao Ke Granule treatment	dysregulated	29163176
3935	Mouse	mmu-miR-320-3p	miRNA	high glucose (HG)	diabetic cardiomyopathy (DCM)	newborn mouse cardiomyocyte (NMC)	high glucose (HG) treatment	Gas5/miR-320-3p/Tcf3 pathway was found to modulate the apoptosis of NMC.	32003049
3936	Mouse	mmu-miR-320-3p	miRNA	glyphosate	neurodevelopmental disorder	prefrontal cortex of mouse offspring	glyphosate	dysregulated	29467848
3937	Mouse	mmu-miR-320-3p	miRNA	busulphan	sertoli cells-only syndrome (SCOS)	murine testis	busulphan treatment	upregulated	30237478
3938	Mouse	mmu-miR-320-3p	miRNA	carbon tetrachloride (CCl4)	steatosis	plasma	carbon tetrachloride (CCl4) treatment	upregulated	30125006
3939	Mouse	mmu-miR-320-3p	miRNA	dexamethasone (DEX)	steatosis	plasma	dexamethasone (DEX) treatment	upregulated	30125006
3940	Mouse	mmu-miR-320a	miRNA	hypoxia	diabetic retinopathy (DR)	Mu?ller cells	hypoxia treatment	miR-320a was reduced by hypoixa treatment.	32830348
3941	Mouse	mmu-miR-320a	miRNA	IL-33	inflammatory bowel disease (IBD)	intestinal epithelial cell (IEC) isolated from IL-33-treated dextran sodium sulfate (DSS) colitic mice	IL-33 treatment	upregulated	30224451
3942	Mouse	mmu-miR-320c	miRNA	streptozocin (STZ)	type 1 diabetes mellitus (T1DM)	serum	streptozocin (STZ) treatment	Secretions of miR-320c was significantly increased in streptozotocin-treated mice	29370422
3943	Mouse	mmu-miR-322	miRNA	hypoxia	hypoxia-induced cardiac dysfunctions	cardiomyocytes	hypoxia treatment	upregulated	27398164
3944	Mouse	mmu-miR-322	miRNA	lipopolysaccharide (LPS)	inflammation	RAW264.7 cells	lipopolysaccharide (LPS) treatment	downregulated	27986864
3945	Mouse	mmu-miR-322	miRNA	dexamethasone (DEX)	muscle atrophy	Murine C2C12 myoblast cells	dexamethasone (DEX) treatment	upregulated	23716137
3946	Mouse	mmu-miR-322	miRNA	plasmodium	plasmodium infection	exosomes derived from the plasma	infect with Plasmodium treatment	upregulated	28650446
3947	Mouse	mmu-miR-322	miRNA	glucose	type 2 diabetes mellitus (T2DM)	isolated mouse islets	exposed to high levels of glucose within 1 h treatment	downregulated	25489007
3948	Mouse	mmu-miR-322/424	miRNA	carbon tetrachloride (CCl4)	liver fibrosis	mouse liver tissue	CCl4 treatment	"miR-322/424 level in liver cirrhosis patients, mouse liver fibrosis induced by CCl4?and BDL, and rat liver fibrosis induced by CCl4?and dimethylnitrosamine was increased."	33333053
3949	Mouse	mmu-miR-322-3p	miRNA	liraglutide	type 2 diabetes mellitus (T2DM)	whole bone marrow exosomes	liraglutide 0.2 mg/kg for 2 months	dysregulated	29133778
3950	Mouse	mmu-miR-322-5p	miRNA	angiotensin II (Ang II)	cardiac hypertrophy	primary cardiomyocytes (PCM)	angiotensin II (Ang II) treatment	downregulated	32436661
3951	Mouse	mmu-miR-322-5p	miRNA	glyphosate	neurodevelopmental disorder	prefrontal cortex of mouse offspring	glyphosate	dysregulated	29467848
3952	Mouse	mmu-miR-322-5p	miRNA	high fat diet (HFD)	obesity	liver tissues	high fat diet (HFD) feed	upregulated	32593682
3953	Mouse	mmu-miR-324-3p	miRNA	¦Â-glycerophosphate (¦Â-GP) and pyruvic acid	coronary artery calcification (CAC)	mouse smooth muscle cell line (MOVAS-1)	¦Â-glycerophosphate (¦Â-GP) and pyruvic acid treatment	upregulated	31733402
3954	Mouse	mmu-miR-324-3p	miRNA	¦Â-glycerophosphate (¦Â-GP) and pyruvic acid	coronary artery calcification (CAC)	exosomes from mouse vascular smooth muscle cells line MOVAS-1	"To induce calcification, the MOVAS-1 cells were maintained in normal cell culture medium supplied with 10 mM ¦Â-glycerophosphate (¦Â-GP) (Sigma, UK) and 10 nM pyruvic acid for 21 d successively, and the culture medium was renewed every 3 d."	upregulated	31733402
3955	Mouse	mmu-miR-324-3p	miRNA	prednisolone	duchenne muscular dystrophy (DMD)	diaphragm muscle	prednisolone treatment	downregulated	29883261
3956	Mouse	mmu-miR-324-3p	miRNA	vamorolone	duchenne muscular dystrophy (DMD)	diaphragm muscle	vamorolone treatment	downregulated	29883261
3957	Mouse	mmu-miR-324-3p	miRNA	urocortin 1 (Ucn-1)	myocardial ischemia/reperfusion (I/R) injury (MIRI)	I/R mosue	administration of Ucn-1 at the beginning of reperfusion treatment	upregulated	28827743
3958	Mouse	mmu-miR-324-5p	miRNA	high glucose (HG)	diabetic nephropathy (DN)	Mouse podocytes (MPC5)	high glucose treatment	upregulated	30095204
3959	Mouse	mmu-miR-324-5p	miRNA	polychlorinated biphenyls (PCBs)	cell differentiation	P19 mouse embryonal carcinoma cells	polychlorinated biphenyls (PCBs) treatment	downregulated	23443104
3960	Mouse	mmu-miR-325	miRNA	anoxia/reoxygenation (A/R)	heart failure (HF)	cardiomyocytes were isolated from 1-2 days old mice	anoxia(5% CO2 and 95% N2 )and subjected to reoxygenation (95% O2 and 5% CO2) treatment	upregulated	24531537
3961	Mouse	mmu-miR-325	miRNA	ischemia/reperfusion (I/R) 	heart failure (HF)	heart tissues	ischemia/reperfusion (I/R) treatment	upregulated	24531537
3962	Mouse	mmu-miR-325-3p	miRNA	IL-1¦Â	cementum regeneration	"The cementoblast cell line, named OCCM©\30"	interleukin 1¦Â (IL1¦Â) treatment	upregulated	31680324
3963	Mouse	mmu-miR-325-3p	miRNA	hypoxia	myocardial infarction (MI)	primary cultured cardiomyocytes	hypoxia induce	downregulated	31248365
3964	Mouse	mmu-miR-325-3p	miRNA	chlamydia muridarum variants (C. muridarum Var001 [CmVar001] and CmVar004)	plvic inflammatory disease	mouse	two Chlamydia muridarum variants (C. muridarum Var001 [CmVar001] and CmVar004) infection	were upregulated during CmVar004 infection compared to CmVar001 infection	24961692
3965	Mouse	mmu-miR-325-3p	miRNA	lipopolysaccharide (LPS)	spinal cord injury (SCI)	primary microglia/BV2 cells	lipopolysaccharide (LPS) treatment	downregulated	30911940
3966	Mouse	mmu-miR-325-3p	miRNA	lipopolysaccharide (LPS)	spinal cord injury (SCI)	BV2 cells	lipopolysaccharides (LPS) treatment	LncRNA H19 Regulates Lipopolysaccharide (LPS)-Induced Apoptosis and Inflammation of BV2 Microglia Cells Through Targeting miR-325-3p/NEUROD4 Axis.	33205379
3967	Mouse	mmu-miR-325-3p	miRNA	mycobacterium tuberculosis (Mtb)	tuberculosis (TB)	RAW 264.7 cells	M. tuberculosis infection	microRNA-325-3p (miR-325-3p) is upregulated after M. tuberculosis infection.	32487755
3968	Mouse	mmu-miR-325-5p	miRNA	manganese (Mn)	parkinson's disease (PD)	MN9D dopaminergic cell exosomes	Mn exposure (300¦ÌM MnCl2) for 24h	upregulated in exosomes	28450057
3969	Mouse	mmu-miR-32-5p	miRNA	lipopolysaccharide (LPS)	depression	hippocampus and prefrontal cortex	lipopolysaccharide (LPS) treatment	upregulated	31698013
3970	Mouse	mmu-miR-32-5p	miRNA	doxorubicin (DOX)	doxorubicin (DOX)-induced cardiotoxicity	plasma	doxorubicin (DOX) treatment	upregulated	30453253
3971	Mouse	mmu-miR-32-5p	miRNA	perfluorooctanoic acid	hepatotoxicity	liver tissues	Perfluorooctanoic acid (PFOA) exposure treatment	upregulated	24459700
3972	Mouse	mmu-miR-326	miRNA	lipopolysaccharide (LPS)	acute lung injury (ALI)	lung tissues	lipopolysaccharide (LPS) treatment	upregulated	29727715
3973	Mouse	mmu-miR-326	miRNA	0.05% NaI	autoimmune thyroiditis (AIT)	thyroid tissues	0.05% NaI treatment	upregulated	29181619
3974	Mouse	mmu-miR-326	miRNA	NaI	autoimmune thyroiditis (AIT)	spleen tissues	0.05% NaI treatment	upregulated	29181619
3975	Mouse	mmu-miR-326	miRNA	lipopolysaccharide (LPS)	autophagy	RAW 264.7 cells	lipopolysaccharide (LPS) treatment	downregulated	29845275
3976	Mouse	mmu-miR-326	miRNA	IL-10	epithelial-mesenchymal transition (EMT)	colonic intraepithelial lymphocytes	IL-10 treatment	upregulated	22043014
3977	Mouse	mmu-miR-326	miRNA	carbon tetrachloride (CCl4)	liver fibrosis	liver tissues	CCl4 treatment	downregulated	31692098
3978	Mouse	mmu-miR-326	miRNA	natalizumab	multiple sclerosis (MS)	MS mouse CD4(+) T cells	natalizumab treatment	downregulated	25642434
3979	Mouse	mmu-miR-326	miRNA	"1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)"	parkinson's disease (PD)	Parkinson's disease (PD)	"1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) treatment"	downregulated	31135066
3980	Mouse	mmu-miR-326	miRNA	"1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)"	parkinson's disease (PD)	Parkinson's disease (PD)	"1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) treatment"	downregulated	31270675
3981	Mouse	mmu-miR-326	miRNA	natalizumab	relapsing-remitting multiple sclerosis (RRMS)	splenocytes	natalizumab treatment	downregulated	25642434
3982	Mouse	mmu-miR-326	miRNA	lipopolysaccharide (LPS)	sepsis-induced acute lung injury	murine lungs; RAW264.7	lipopolysaccharide (LPS) treatment	miR-326 was downregulated in murine lungs and macrophages upon lipopolysaccharide (LPS) stimulation.	32530324
3983	Mouse	mmu-miR-326	miRNA	silicon dioxide (SiO2)	silicosis	HBE and A549 cells	silicon dioxide (SiO2) treatment	"miR-326 is downregulated in the fibrotic lung tissues of silica-treated mice, while increased expression of miR-326 attenuates silica-induced pulmonary fibrosis in vivo"	31642316
3984	Mouse	mmu-miR-326-3p	miRNA	Japanese encephalitis virus (JEV)	Japanese encephalitis virus (JEV) infection	brain tissues; BV2 cells	Japanese encephalitis virus (JEV) infection	downregulated	32552669
3985	Mouse	mmu-miR-326-3p	miRNA	cadmium (Cd)	toxic effects of cadmium	rat kidneys; NRK-52E	cadmium (Cd) treatment	upregulated	31626960
3986	Mouse	mmu-miR-326-5p	miRNA	"15-deoxy-¦¤12, 14-prostaglandin J2 (15d-PGJ2)"	liver damage	bone marrow (BM)-derived macrophage (BMM) of liver injury mouse	"15-deoxy-¦¤12, 14-prostaglandin J2 (15d-PGJ2) treatment"	upregulated	28748390
3987	Mouse	mmu-miR-327	miRNA	low chromium (Cr)	insulin resistance (IR)	liver	fed a control or LC diet for 13 weeks	dysregulatedin liver	29286159
3988	Mouse	mmu-miR-328	miRNA	isoproterenol	cardiac hypertrophy	heart tissues	ISO treatment	upregulated	24631114
3989	Mouse	mmu-miR-328	miRNA	prion	neurodegeneration (ND)	the brains tissues	prion infection treatment	upregulated	18987751
3990	Mouse	mmu-miR-328-3p	miRNA	dietary methionine restriction (MR)	diet-induced obesity (DIO)	high-fat-diet-induced obesity (DIO) mouse liver tissues	dietary methionine restriction (MR) treatment	upregulated	30512228
3991	Mouse	mmu-miR-328-3p	miRNA	high fat diet (HFD)	diet-induced obesity (DIO)	liver tissues	high fat diet (HFD) feed	downregulated	30512228
3992	Mouse	mmu-miR-328-3p	miRNA	hypoxia	hypoxic pulmonary hypertension (HPH)	pulmonary artery smooth muscle cells (PASMCs)	hypoxia induce	"Lower expression of miR-328-3p were observed in iPAH-PASMCs and relevant HPH models. Upregulation of lncRNA-MEG3 sequesters cytoplasmic miR-328-3p, eventually leading to expression of IGF1R, revealing a regulatory mechanism by lncRNAs in hypoxia-induced PASMC proliferation."	31477557
3993	Mouse	mmu-miR-328-3p	miRNA	licochalcone A (LA)	lung cancer	MLE-12 cells	Licochalcone A (lico A) treatment	upregulated	32505917
3994	Mouse	mmu-miR-328-3p	miRNA	murine cytomegalovirus (MCMV)	murine cytomegalovirus (MCMV) infection	cardiac tissue	murine cytomegalovirus (MCMV) infection	downregulated	33245094
3995	Mouse	mmu-miR-329	miRNA	D-galactosamine/lipopolysaccharide (D-GalN/LPS)	acute liver injury (ALI)	liver tissues	D-GalN/LPS treatment	downregulated	31061003
3996	Mouse	mmu-miR-329	miRNA	H2O2	Alzheimer's disease (AD)	Primary hippocampal neuron cells	H2O2 treatment	upregulated	24423585
3997	Mouse	mmu-miR-329	miRNA	H2O2	Alzheimer's disease (AD)	senescence accelerated mouse prone 8 (SAMP8) and prone 10 (SAMP10)	"different concentrations (0, 100, 200, 400 and 800 ¦ÌM) of H2O2 treatment"	upregulated	24423585
3998	Mouse	mmu-miR-329	miRNA	clozapine (CLZ)	psychotic disorders	mouse brain	clozapine treatment	upregulated	23318695
3999	Mouse	mmu-miR-329-3p	miRNA	microcystin-leucine arginine (MC-LR)	male infertility	GT1-7 cells	Microcystin-leucine arginine (MC-LR) treatment	downregulated	30064084
4000	Mouse	mmu-miR-33	miRNA	lipopolysaccharide (LPS)	acute lung injury (ALI)	Pulmonary microvascular endothelial cells (PMVECs)	lipopolysaccharide (LPS) treatment	downregulated	30761836
4001	Mouse	mmu-miR-33	miRNA	farnesoid X receptor (FXR)	cholesterol homeostasis	hepatic	farnesoid X receptor (FXR) treatment	upregulated	25593129
4002	Mouse	mmu-miR-33	miRNA	averrhoa carambola free phenolic extract (ACF)	hepatic steatosis	leptin receptor-deficient (db/db) mice	averrhoa carambola free phenolic extract (ACF) treatment	downregulated	29090700
4003	Mouse	mmu-miR-33	miRNA	lychee pulp phenolics (LPPs)	hypolipidemic mechanism	high-fat diet (HFD) mouse hepatocytes	lychee pulp phenolics (LPPs) treatment	downregulated in mouse hepatocytes	28121324
4004	Mouse	mmu-miR-33	miRNA	glucagon-like peptide-1 (GLP-1)	lipotoxic oxidative stress	FFA-treated INS-1 cells	GLP-1	downregulated	27956176
4005	Mouse	mmu-miR-33	miRNA	lonicera caerulea berry polyphenols (LCBP)	macrophage foam cell formation	ox-LDL-treated RAW264.7	Lonicera caerulea berry polyphenols (LCBP) treatment	downregulated	31146527
4006	Mouse	mmu-miR-33	miRNA	oxidized low density lipoprotein (ox-LDL)	macrophage foam cell formation	RAW264.7	oxidized low-density lipoprotein (ox-LDL) treatment	upregulated	31146527
4007	Mouse	mmu-miR-33	miRNA	high glucose (HG) and cholesterol-lowering drugs atorvastatin and pitavastatin	metabolic syndrome	Murine macrophage cell line RAW264.7	high glucose and cholesterol-lowering drugs atorvastatin and pitavastatin treatment	upregulated	27139226
4008	Mouse	mmu-miR-33	miRNA	aerobic exercise	nonalcoholic fatty liver disease (NAFLD)	non-alcoholic fatty liver disease (NAFLD) mouse liver tissues	aerobic exercise training (AET) treatment	upregulated	28163011
4009	Mouse	mmu-miR-33	miRNA	high fat diet (HFD)	nonalcoholic fatty liver disease (NAFLD)	mouse liver tissues	high fat diet (HFD) feed	downregulated	28163011
4010	Mouse	mmu-miR-33	miRNA	high fat diet (HFD)	obesity	mouse	high fat diet (HFD) feed	downregulated	28163011
4011	Mouse	mmu-miR-33	miRNA	training	obesity	obesity mouse liver	continuous endurance training treatment	upregulated	28163011
4012	Mouse	mmu-miR-33	miRNA	fructo-oligosaccharides (FOS)	tubulointerstitial fibrosis (TIF)	liver tissue of mice	?fructo-oligosaccharides (FOS)treatment treatment	upregulated	23203768
4013	Mouse	mmu-miR-330	miRNA	"7,12-dimethylbenz(¦Á)anthracene (DMBA)"	"7,12-dimethylbenz(¦Á)anthracene (DMBA) toxicity"	liver tissues	"7,12-dimethylbenz(¦Á)anthracene (DMBA) treatment"	miR-330 was upregulated in the liver tissues of male mice.	32871758
4014	Mouse	mmu-miR-330	miRNA	"7,12-dimethylbenz(¦Á)anthracene (DMBA)"	"7,12-dimethylbenz(¦Á)anthracene (DMBA) toxicity"	kidneny tissues	"7,12-dimethylbenz(¦Á)anthracene (DMBA) treatment"	miR-330 was upregulated in the kidney tissues of female mice.	32871758
4015	Mouse	mmu-miR-330	miRNA	"7,12-dimethylbenz(¦Á)anthracene (DMBA)"	"7,12-dimethylbenz(¦Á)anthracene (DMBA) toxicity"	kidneny tissues	"7,12-dimethylbenz(¦Á)anthracene (DMBA) treatment"	miR-330 was downregulated in the kidney tissues of male mice.	32871758
4016	Mouse	mmu-miR-330	miRNA	lipopolysaccharide (LPS)	parkinson's disease (PD)	primary microglial cells	lipopolysaccharide (LPS) treatment	The expression of microRNA-330 increased in the first 4 days and reached a plateau subsequently after LPS treatment	33325083
4017	Mouse	mmu-miR-330-3p	miRNA	phenylephrine (PE)	cardiac hypertrophy	cardiomyocytes	phenylephrine (PE) treatment	downregulated	30297107
4018	Mouse	mmu-miR-330-3p	miRNA	hypoxia	hepatic ischemia/reperfusion injury (HIRI)	AML12 cells	hypoxia treatment	downregulated	30269356
4019	Mouse	mmu-miR-330-3p	miRNA	mineral oil	hepatic ischemia/reperfusion injury (HIRI)	AML12 cells	mineral oil treatment	downregulated	30269356
4020	Mouse	mmu-miR-330-5p	miRNA	lipopolysaccharide (LPS)	pulmonary vascular endothelial cell (PVEC) injury	human pulmonary microvascular endothelial cells (HPMECs)	lipopolysaccharide (LPS) treatment	"PRNCR1 and TLR4 levels were significantly upregulated in LPS-treated PVEC, both in vivo and in vitro, while miR-330-5p were downregulated. Inhibiting PRNCR1 or overexpressing miR-330-5p markedly attenuated LPS-induced PVEC injury."	33049095
4021	Mouse	mmu-miR-330-5p	miRNA	lipopolysaccharide (LPS)	sepsis-induced myocardial injury	HL-1 cells	lipopolysaccharide (LPS) treatment	LncRNA MIAT Promotes Inflammation and Oxidative Stress in Sepsis-Induced Cardiac Injury by Targeting miR-330-5p/TRAF6/NF-¦ÊB Axis	32556678
4022	Mouse	mmu-miR-330-5p	miRNA	high fat diet (HFD)	type 2 diabetes mellitus (T2DM)	isolated adipose tissue macrophages	high fat diet (HFD) feed	upregulated	29433065
4023	Mouse	mmu-miR-331	miRNA	stretch	myoblast proliferation	C2C12 myoblasts	stretch treatment	downregulated	27840929
4024	Mouse	mmu-miR-331-3p	miRNA	pilocarpine	epilepsy	male NMRI mice	inject intraperitoneally with pilocarpine treatment	downregulated	25078263
4025	Mouse	mmu-miR-331-3p	miRNA	hemin	intracerebral haemorrhage (ICH)	BV2 cells	hemin treatment	downregulated	32596340
4026	Mouse	mmu-miR-331-5p	miRNA	gastrodin and rhynchophylline	ischemia/reperfusion (I/R) injury	hypoxia-induced mouse brain tissues and BV2 cells	combination of gastrodin and rhynchophylline treatment	upregulated	31610203
4027	Mouse	mmu-miR-331-5p	miRNA	oxygen glucose deprivation (OGD)	ischemia/reperfusion (I/R) injury	mouse brain tissues and BV2 cells	Middle cerebral artery occlusion (MCAO) mice and oxygen glucose deprivation (OGD)-treated BV2 cells were used as in vivo and in vitro models of ischaemia treatment	downregulated	31610203
4028	Mouse	mmu-miR-33-3p	miRNA	X-rays	bystander effect	C57BL/6 mice extracellular vesicles (EVs)	otal-body irradiated with X-rays	downregulated	28396668
4029	Mouse	mmu-miR-335	miRNA	C-phycocyanin (CPC)	Alzheimer's disease (AD)	hippocampal tissues	C-phycocyanin (CPC) treatment	downregulated	33312721
4030	Mouse	mmu-miR-335	miRNA	green tea (GT)	obesity	adipose tissues	green tea (GT) treatment	GT reverses HFD-induced upregulated of miR-155 and -335 in epididymal adipose tissues.	29734116
4031	Mouse	mmu-miR-335	miRNA	traditional Chinese medicine Changqin NO. 1	traumatic brain injury (TBI)	brain tissues and primary neurons	traditional Chinese medicine Changqin NO. 1 treatment	Changqin NO 1 promoted neuroprotective effects by inhibiting neuronal apoptosis via the GAS5/miR-335/Rasa1 axis in TBI	30653462
4032	Mouse	mmu-miR-335-3p	miRNA	high fat diet (HFD)	hepatic insulin resistance	mouse liver tissues	high fat diet (HFD) feed	upregulated	30820263
4033	Mouse	mmu-miR-335-3p	miRNA	chronic unpredictable mild stress (CUMS)	major depressive disorder (MDD)	nucleus accumbens (NAc) tissues	chronic unpredictable mild stress (CUMS) induce	downregulated	30936699
4034	Mouse	mmu-miR-335-5p	miRNA	high glucose (HG)	diabetic osteoporosis	MC3T3-E1 osteoblast cell line	high glucose treatment	downregulated	26986081
4035	Mouse	mmu-miR-335-5p	miRNA	streptozocin (STZ)	gestational diabetes mellitus (GDM)	pancreatic islet ¦Â-cells	streptozotocin (STZ) treatment	upregulated	30341900
4036	Mouse	mmu-miR-335-5p	miRNA	spatial learning	impairment in long-term memory	CD1 male mice	spatial learning with morris water maze treatment	downregulated in hippocampal	28039088
4037	Mouse	mmu-miR-335-5p	miRNA	dietary methionine restriction (MR)	osteoblast differentiation and function	"male C57BL/6J mice bone marrow,plasma and liver"	fed diets containing 0.86% or 0.12% methionine for 5 weeks	"upregulated (miR-31 in plasma and liver, and miR-133a, miR-335-5p, and miR-204 in the bone marrow"	27191548
4038	Mouse	mmu-miR-335-5p	miRNA	tumor necrosis factor alpha (TNF-¦Á) 	osteogenesis	MC3T3-E1 cells; primary calvarial osteoblasts	tumor necrosis factor alpha (TNF-¦Á) treatment	downregulated	32468044
4039	Mouse	mmu-miR-335-5p	miRNA	¦Â-elemene	oxygen-induced retinopathy (OIR)	Retinas tissues	¦Â-elemene treatment	upregulated	30664207
4040	Mouse	mmu-miR-33-5p	miRNA	bupivacaine	apoptosis	dorsal root ganglion (DRG) cells	bupivacaine treatment	upregulated	30617464
4041	Mouse	mmu-miR-337-3p	miRNA	prion	neurodegeneration (ND)	the brains tissues	prion infection treatment	downregulated	18987751
4042	Mouse	mmu-miR-337-3p	miRNA	ganoderma lucidum extract (GLE)	hepatocellular carcinoma (HCC)	Hepa 1-6 cells	Ganoderma lucidum extract (GLE) treatment	upregulated	32106374
4043	Mouse	mmu-miR-337-5p	miRNA	clozapine (CLZ)	psychotic disorders	mouse brain	clozapine treatment	upregulated	23318695
4044	Mouse	mmu-miR-338	miRNA	anoxia/reoxygenation (A/R)	autophagy	cardiomyocytes	anoxia/reoxygenation (A/R) treatment	miR-338 was significantly downregulated in cardiomyocytes in response to A/R.	29247537
4045	Mouse	mmu-miR-338	miRNA	oxygen glucose deprivation (OGD)	brain vascular dysfunction	brain microvascular endothelial cell (BMEC)	oxygen-glucose deprivation (OGD) treatment	SNHG1 and miR-338 were upregulated in OGD induced BMEC.	30414401
4046	Mouse	mmu-miR-338	miRNA	bisphenol A (BPA)	glucose homeostasis	mice (4 wk old)	bisphenol A (BPA) treatment	downregulated	28774890
4047	Mouse	mmu-miR-338	miRNA	bisphenol A (BPA)	glucose homeostasis	mice (4 wk old)	bisphenol A (BPA) treatment	long-term BPA exposure upregulated miR-338	28774890
4048	Mouse	mmu-miR-338	miRNA	hypoxia	ischemic stroke (IS)	Mice primary brain microvascular endothelial cells (BMEC)	oxygen/glucose-deprived (OGD)?treatment	upregulated	30414401
4049	Mouse	mmu-miR-338	miRNA	microwave	microwave-induced adverse health outcomes 	mouse hippocampus	7 days after 30 mW/cm microwave exposure treatment	downregulated	24748327
4050	Mouse	mmu-miR-338-3p	miRNA	N-acetyl-p-aminophenol (APAP)	acute liver injury (ALI)	liver tissues	N-acetyl-p-aminophenol (APAP) treatment	The results revealed that miR-338-3p was significantly upregulated following the intraperitoneal administration of APAP.	32331846
4051	Mouse	mmu-miR-338-3p	miRNA	paeonol (PAE)	atherosclerosis (AS)	vascular endothelial cells (VECs)	Paeonol treatment	Paeonol regulated VEC development via downregulating miR-338-3p expression	32770325
4052	Mouse	mmu-miR-338-3p	miRNA	tumor necrosis factor alpha (TNF-¦Á) 	gluconeogenesis	the livers of mice and in mouse HEPA1-6 hepatocytes	tumor necrosis factor alpha (TNF-¦Á) treatment	downregulated	30132533
4053	Mouse	mmu-miR-338-3p	miRNA	perfluoroalkyl chemicals (PFASs)	hepatotoxicity	male BALB/c mice liver	PFASs treatment	downregulated	25181679
4054	Mouse	mmu-miR-338-3p	miRNA	N-acetyl-p-aminophenol (APAP)	liver damage	liver tissues	N-acetyl-p-aminophenol (APAP) treatment	upregulated	32331846
4055	Mouse	mmu-miR-338-3p	miRNA	chronic unpredictable mild stress (CUMS)	major depressive disorder (MDD)	nucleus accumbens (NAc) tissues	chronic unpredictable mild stress (CUMS) induce	upregulated	30936699
4056	Mouse	mmu-miR-338-3p	miRNA	prion	neurodegeneration (ND)	the brains tissues	prion infection treatment	downregulated	18987751
4057	Mouse	mmu-miR-338-3p	miRNA	dexamethasone (DEX)	osteoclast differentiation	osteoclast	dexamethasone (DEX) treatment	downregulated	27706599
4058	Mouse	mmu-miR-338-3p	miRNA	macrophage colony-stimulating factor (M-CSF) and receptor activator of NF-¦ÊB ligand (RANKL)	osteoclastogenesis	murine RAW264.7 cells	macrophage colony-stimulating factor (M-CSF) and receptor activator of NF-¦ÊB ligand (RANKL) treatment	upregulated	30716449
4059	Mouse	mmu-miR-338-3p	miRNA	bilateral surgical destabilization of the medial meniscus (DMM)	osteoporosis	BALB/c mice bone marrow cell	ovariectomized (OVX) treatment	upregulated	24648262
4060	Mouse	mmu-miR-338-3p	miRNA	bleomycin (BLM)	lung fibrosis	fibroblast	bleomycin (BLM) treatment	downregulated	30796204
4061	Mouse	mmu-miR-338-3p	miRNA	high fat diet (HFD)	type 2 diabetes mellitus (T2DM)	C57BL/6J mice livers	high fat diet (HFD) feed	downregulated	28467989
4062	Mouse	mmu-miR-339	miRNA	calorie restriction (CR)	hepatic steatosis	high-fat (HF) diet-induced obesity prone (OP) mice thyroid and liver tissues	calorie restriction (CR) treatment	upregulated	31863770
4063	Mouse	mmu-miR-339	miRNA	exercise (Ex)	hepatic steatosis	high-fat (HF) diet-induced obesity prone (OP) mice thyroid and liver tissues	exercise (Ex) treatment	upregulated	31863770
4064	Mouse	mmu-miR-339	miRNA	high fat diet (HFD)	hepatic steatosis	mice thyroid and liver tissues	high fat diet (HFD) feed	downregulated	31863770
4065	Mouse	mmu-miR-339	miRNA	low fat diet (LFD)	hepatic steatosis	high-fat (HF) diet-induced obesity prone (OP) mice thyroid and liver tissues	low-fat diet (LF) treatment	upregulated	31863770
4066	Mouse	mmu-miR-339	miRNA	quercetin	hepatic steatosis	high-fat (HF) diet-induced obesity prone (OP) mice thyroid and liver tissues	quercetin (Que) treatment	upregulated	31863770
4067	Mouse	mmu-miR-339	miRNA	low fat diet (LFD)	obesity	thyroid	low fat diet (LFD) treatment	downregulated	31863770
4068	Mouse	mmu-miR-339	miRNA	low fat diet (LFD)	obesity	thyroid	low fat diet (LFD) treatment	upregulated	31863770
4069	Mouse	mmu-miR-339	miRNA	quercetin	obesity	thyroid	quercetin (QUE) treatment	upregulated	31863770
4070	Mouse	mmu-miR-339	miRNA	ethanol (EtOH)	teratogenesis	fetal brains of mice	Ethanol?treatment	downregulated	19091803
4071	Mouse	mmu-miR-339-3p	miRNA	inorganic nitrite	acute myocardial infarction (AMI)	heart tissues	single-dose of nitrite	downregulated	28090786
4072	Mouse	mmu-miR-339-3p	miRNA	ischemia/reperfusion (I/R) 	acute myocardial infarction (AMI)	heart tissues	ischemia/reperfusion (I/R) treatment	upregulated	28090786
4073	Mouse	mmu-miR-339-3p	miRNA	morphine and fentanyl	¦Ì-Opioid receptor (MOR) biosynthesis	hippocampal?tissues	morphine and fentanyl treatment	upregulated	23085997
4074	Mouse	mmu-miR-339-5p	miRNA	folic acid	Alzheimer's disease (AD)	APP/PS1 mice brains and N2a cells	Folic acid deficiency treatment	downregulated	26345540
4075	Mouse	mmu-miR-339-5p	miRNA	alcohol	brain-inflammation	mouse brain tissue and isolated microglial cells	alcohol exposure	upregulated	25172655
4076	Mouse	mmu-miR-339-5p	miRNA	oxygen glucose deprivation (OGD)	hypoxic/ischemic brain damage (HIBD)	primary mouse hippocampal neurons cells	Oxygen-glucose deprivation (OGD) treatment	lncRNA NEAT1 upregulated HOXA1 to alleviate HIBD in mice by binding to miR-339-5p	32163893
4077	Mouse	mmu-miR-339-5p	miRNA	olanzapine (OLP)	psychotic disorders	brain tissues	clozapine treatment	upregulated	23318695
4078	Mouse	mmu-miR-339-5p	miRNA	lipopolysaccharide (LPS)	sepsis	RAW264.7 cells	lipopolysaccharide (LPS) treatment	downregulated	31852965
4079	Mouse	mmu-miR-339-5p	miRNA	paeonol (PAE)	sepsis	LPS-treated RAW264.7 cells	paeonol treatment	upregulated	31852965
4080	Mouse	mmu-miR-33a	miRNA	high fructose	adipogenesis	white adipose tissue	High fructose feed	downregulated	31030166
4081	Mouse	mmu-miR-33a	miRNA	lipopolysaccharide (LPS)	autophagy	RAW 264.7 cells	lipopolysaccharide (LPS) treatment	downregulated	29845275
4082	Mouse	mmu-miR-33a	miRNA	urolithin A (UA)	endothelial dysfunction	RAW264.7 cells	Urolithin A (UA) treatment	Urolithin A attenuated ox-LDL-induced cholesterol accumulation in macrophages partly through regulating miR-33a and ERK/AMPK/SREBP1 signaling pathways	32236173
4083	Mouse	mmu-miR-33a	miRNA	high fat diet (HFD)	fatty liver disease	liver tissues	high fat diet (HFD) feed	Treatment with HFD significantly increased the expression of miR-33a in liver tissues.	30324697
4084	Mouse	mmu-miR-33a	miRNA	palmitic acid (PA)	fatty liver disease	mouse primary hepatocytes	palmitic acid (PA) treatment	Treatment with palmitic acid (PA) increased the expression of miR-33a in hepatocytes	30324697
4085	Mouse	mmu-miR-33a	miRNA	IL-6	gallbladder cancer (GBC)	gastric cancer SGC-7902 cells	IL-6 treatment	downregulated	27769047
4086	Mouse	mmu-miR-33a	miRNA	TGF-¦Â1	liver fibrosis	hepatic stellate cells (HSC) from C57BL/6 mice	TGF-¦Â1 treatment	upregulated	25155445
4087	Mouse	mmu-miR-33a-5p	miRNA	tumor necrosis factor alpha (TNF-¦Á) 	osteogenesis	mBMSCs	tumor necrosis factor alpha (TNF-¦Á) treatment	upregulated	26785690
4088	Mouse	mmu-miR-34	miRNA	xanthomicrol	breast cancer	4T1 cells	xanthomicrol treatment	upregulated	33217075
4089	Mouse	mmu-miR-34	miRNA	cyclophosphamide	embryonic maldevelopment	the fore- and hindlimbs of mice	cyclophosphamide treatment	upregulated	20170545
4090	Mouse	mmu-miR-34	miRNA	adenoviral and lentiviral	lung cancer	KrasG12D/?;Trp53 lung epithelial cell lines	adenoviral and lentiviral treatment	In vivo treatment with miR-34a prevented tumor formation and progression in KrasLSL-G12D/?;Trp53LSL-R172H/?mice.	22964582
4091	Mouse	mmu-miR-34	miRNA	extra-virgin olive oil rich in phenols (H-EVOO)	neuronal function	cortex	H-EVOO treatment	upregulated	26695409
4092	Mouse	mmu-miR-340	miRNA	repeated social defeat (RSD)	gastric cancer (GC)	"male C57BL/6 (5 ¨C 6 weeks old) and CD-1 (12 months old, retired breeders) mice"	intruder attack mice treatment	significantly upregulated expression	25317829
4093	Mouse	mmu-miR-340	miRNA	hypoxia/reoxygenation (H/R)	myocardial ischemia/reperfusion (I/R) injury (MIRI)	cardiomyocytes	hypoxia/reoxygenation (H/R) treatment	downregulated	33164260
4094	Mouse	mmu-miR-340	miRNA	dexmedetomidine (DEX)	neuroinflammation	BV2 cells	dexamethasone (DEX) treatment	upregulated	31631971
4095	Mouse	mmu-miR-340	miRNA	particulate matter (PM2.5)	PM2.5 exposure	mosue bronchoalveolar lavage fluid (BALF)	"were subjected to intratracheal instillation of 2.5, 10, or 20mg/kg PM2.5 treatment"	upregulated in bronchoalveolar lavage fluid (BALF)	29107863
4096	Mouse	mmu-miR-340	miRNA	particulate matter (PM2.5)	pulmonary toxicological	lung tissues	particulate matter (PM2.5) exposure treatment	upregulated	29107863
4097	Mouse	mmu-miR-340-5p	miRNA	high fat diet (HFD)	hepatocellular carcinoma (HCC)	plasma and hepatic tissues	high fat diet (HFD) feed	downregulated	26728044
4098	Mouse	mmu-miR-340-5p	miRNA	lipopolysaccharide (LPS)	intracerebral haemorrhage (ICH)	BV-2 cells	lipopolysaccharide (LPS) treatment	downregulated	33176298
4099	Mouse	mmu-mir-341-3p	miRNA	second-hand smoke (SHS)	asthma	lung	second-hand smoke (SHS) treatment	upregulated	26859758
4100	Mouse	mmu-miR-342	miRNA	low-protein diet (LP0.5)	glucose homeostasis	¦Â cells	low-protein diet (LP0.5)	downregulated	25180600
4101	Mouse	mmu-miR-342	miRNA	tumor necrosis factor alpha (TNF-¦Á) 	microglial neuroinflammation	Murine N9 microglia cells	tumor necrosis factor alpha (TNF-¦Á) treatment	TNF-¦Á stimulation induced the upregulation of miR-342	32488063
4102	Mouse	mmu-miR-342-3p	miRNA	hyperoxia	bronchopulmonary dysplasia (BPD)	lung tissues	hyperoxia treatment	downregulated	27484068
4103	Mouse	mmu-miR-342-3p	miRNA	high glucose (HG)	diabetic nephropathy (DN)	mouse renal mesangial cells (MCs)	high-glucose treatment	downregulated	31746345
4104	Mouse	mmu-miR-342-3p	miRNA	azilsartan medoxomil (AZL-M)	heart failure (HF)	plasma	azilsartan medoxomil (AZL-M) treatment	"MiR-146a, miR-149, miR-150, and miR-342-3p were reproducibly reduced in the plasma of CSQ-tg mice."	27321284
4105	Mouse	mmu-miR-342-3p	miRNA	azilsartan medoxomil (AZL-M)	heart failure (HF)	calsequestrin (CSQ)-tg mouse	azilsartan medoxomil (AZL-M) treatment	upregulated	27321284
4106	Mouse	mmu-miR-342-3p	miRNA	carbon tetrachloride (CCl4)	liver fibrosis	liver	CCl4 treatment	upregulated	27322257
4107	Mouse	mmu-miR-342-3p	miRNA	X rays	ionizing radiation (IR) injury	male Kunming mice blood	0.5-2 Gy total-body carbon-ion irradiation treatment	dysregulatedin blood	28632432
4108	Mouse	mmu-miR-342-3p	miRNA	prion	neurodegeneration (ND)	the brains tissues	prion infection treatment	upregulated	18987751
4109	Mouse	mmu-miR-342-3p	miRNA	metformin (Met)	nonalcoholic steatohepatitis (NASH)	liver tissues	metformin treatment	upregulated	25672270
4110	Mouse	mmu-miR-342-5p	miRNA	hyperoxia	bronchopulmonary dysplasia (BPD)	primary type II alveolar epithelial cell (T2AEC); MLE12 cells and neonatal mouse lungs	hyperoxia induce	"Hyperoxia decreased miR-342-5p levels in primary T2AECs, MLE12 cells and neonatal mouse lungs."	33434946
4111	Mouse	mmu-miR-342-5p	miRNA	osteogenic differentiation medium	cell differentiation	MC3T3-E1 cells	"n osteogenic differentiation media that consisted of ¦Á-MEM, 10% FBS, 10 mM ¦Â-glycerophosphate, 50 ¦Ìg/mL ascorbic acid treatment"	downregulated	31398664
4112	Mouse	mmu-miR-342-5p	miRNA	clozapine (CLZ)	psychotic disorders	mouse brain	clozapine treatment	upregulated	23318695
4113	Mouse	mmu-miR-343	miRNA	dioscorea bulbifera (DB)	liver damage	livers	dioscoreae bulbifera (EF) treatment	upregulated	27609015
4114	Mouse	mmu-miR-344	miRNA	propofol (PPF)	propofol-induced developmental neurotoxicity	hippocampus	propofol treatment	downregulated	30242182
4115	Mouse	mmu-miR-344f-3p	miRNA	propofol (PPF)	propofol-induced developmental neurotoxicity	hippocampus	propofol treatment	downregulated	30242182
4116	Mouse	mmu-miR-344g-5p	miRNA	delvestidine (DLTD)	bone marrow-derived dendritic cells (BMDCs) maturity	bone marrow-derived dendritic cells (BMDCs)	Delvestidine (DLTD) treatment	upregulated	32871480
4117	Mouse	mmu-miR-345-5p	miRNA	lipopolysaccharide (LPS)	resistant depression (TRD)	BV2 cells	lipopolysaccharide (LPS) treatment	upregulated	32730696
4118	Mouse	mmu-miR-34-5p	miRNA	¦¤9-tetrahydrocannabinol (THC)	acute respiratory distress syndrome (ARDS)	lung-infiltrated mononuclear cells (MNCs)	¦¤9Tetrahydrocannabinol (THC) treatment	downregulated	32612530
4119	Mouse	mmu-miR-346	miRNA	house dust mite (HDM)	asthma	C57BL/6J mice airway-secreted EVs (AEVs) were isolated from bronchoalveolar lavage fluid (BALF)	HDM treatment	dysregulated in airway-secreted EVs (AEVs) were isolated from bronchoalveolar lavage fluid (BALF)	28859242
4120	Mouse	mmu-miR-346	miRNA	cigarette smoke (CS)	rheumatoid arthritis (RA)	Th17 cells	cigarette smoke (CS) exposure	CS markedly increased the expression of miR-346 in the Th17 cells from the lymph nodes of AIA mice.	33443169
4121	Mouse	mmu-miR-346	miRNA	cigarette smoke extract (CSE)	rheumatoid arthritis (RA)	Th17 cells	cigarette smoke extract (CSE) treatment	upregulated	33443169
4122	Mouse	mmu-miR-346	miRNA	lipopolysaccharide (LPS)	sepsis	mouse macrophage cell line RAW264.7	lipopolysaccharide (LPS) treatment	"MALAT1 inhibited RAW264.7?cell proliferation, while miR-346 promoted its proliferation."	31494280
4123	Mouse	mmu-miR-346-3p	miRNA	poly(ethylenimine) (PEI)	cell death	MEF cells	poly(ethylenimine) (PEI) treatment	upregulated	26158199
4124	Mouse	mmu-miR-3472	miRNA	cyclophosphamide (CP)	chronic ovarian dysfunction	ovarian tissues	cyclophosphamide (CP) treatment	"CP treatment decreased the expression of miR-365-1-5p and miR-574-5p and increased that of miR-3472 and miR-667-3p, whereas SM administration restored the expression levels of these microRNAs to those in the Con mice."	33318603
4125	Mouse	mmu-miR-3472	miRNA	samul-tang (SM)	chronic ovarian dysfunction	ovarian tissues	samul-tang (SM) treatment	"CP treatment decreased the expression of miR-365-1-5p and miR-574-5p and increased that of miR-3472 and miR-667-3p, whereas SM administration restored the expression levels of these microRNAs to those in the Con mice"	33318603
4126	Mouse	mmu-miR-3473a	miRNA	enterovirus 71 (EV71)	enterovirus 71 (EV71) infection	mouse	infect with EV71	downregulated	28469998
4127	Mouse	mmu-miR-3473b	miRNA	bilateral surgical destabilization of the medial meniscus (DMM)	osteoarthritis (OA)	male C57BL6 mice	bilateral surgical destabilization of the medial meniscus (DMM) treatment	dysregulated	29255152
4128	Mouse	mmu-miR-3473b	miRNA	hypoxia	stroke	primary cultured mouse neurons	oxygen-glucose deprivation (OGD) treatment	upregulated	29317607
4129	Mouse	mmu-miR-3473b	miRNA	lipopolysaccharide (LPS)	stroke	BV2 microglial cells	lipopolysaccharide (LPS) treatment	upregulated	29317607
4130	Mouse	mmu-miR-3473g	miRNA	microcystin-leucine arginine (MC-LR)	effects of microcystin-leucine arginine (MC-LR) on fertility	mouse granulosa	microcystin-leucine arginine (MC-LR) treatment	MC-LR inhibited miR-3473g expression of mouse granulosa cells both in vitro and in vivo.	31710595
4131	Mouse	mmu-miR-3474	miRNA	high glucose (HG)	diabetic nephropathy (DN)	mouse podocytes	high glucose (HG) treatment	downregulated	33224036
4132	Mouse	mmu-miR-34a	miRNA	staphylococcal enterotoxin B (SEB)	acute inflammatory lung injury	lung	staphylococcal enterotoxin B treatment	upregulated	25564423
4133	Mouse	mmu-miR-34a	miRNA	cisplatin (DDP)	acute kidney injury (AKI)	kidney	cisplatin treatment	upregulated	24759152
4134	Mouse	mmu-miR-34a	miRNA	hyperoxia	acute lung injury (ALI)	"whole lungs, isolated endothelial cells (ECs) from lungs"	hyperoxia induce	upregulated	30512967
4135	Mouse	mmu-miR-34a	miRNA	lipopolysaccharide (LPS)	acute lung injury (ALI)	lungs tissues;endothelial cells (ECs)	lipopolysaccharide (LPS) treatment	upregulated	30512967
4136	Mouse	mmu-miR-34a	miRNA	lipopolysaccharide (LPS)	acute lung injury (ALI)	mouse alveolar type II epithelial (AT-II) cells	lipopolysaccharide (LPS) treatment	upregulated	28321785
4137	Mouse	mmu-miR-34a	miRNA	lipopolysaccharide (LPS)	acute respiratory distress syndrome (ARDS)	lung macrophages	lipopolysaccharides (LPS) treatment	upregulated	32825525
4138	Mouse	mmu-miR-34a	miRNA	¦Â-cypermethrin (¦Â-CYP)	adipogenesis	3T3-L1 cells	¦Â-cypermethrin (¦Â-CYP) treatment	downregulated	32637997
4139	Mouse	mmu-miR-34a	miRNA	alcohol	alcoholic liver disease (ALD)	mouse	chronic alcohol administration	upregulated	29128099
4140	Mouse	mmu-miR-34a	miRNA	resveratrol	allergic asthma (AA)	pulmonary inflammatory cells	resveratrol (RSV) treatment	Resveratrol attenuates allergic asthma by downregulating miR-34a that induces increased expression of FOXP3.	30619345
4141	Mouse	mmu-miR-34a	miRNA	tiaoxin recipe	Alzheimer's disease (AD)	cortex and hippocampus of APPswe/PS1¦¤E9 (APP/PS1) double transgenic mice	Tiaoxin Recipe treatment	downregulated	31548147
4142	Mouse	mmu-miR-34a	miRNA	aluminum (Al)	Alzheimer's disease (AD)	murine microglial cell line	aluminum treatment	downregulated	23778113
4143	Mouse	mmu-miR-34a	miRNA	amyloid-¦Â (A¦Â) 1-42	Alzheimer's disease (AD)	cortical neurons	amyloid ¦Â1-42?(A¦Â) treatment	downregulated	26459758
4144	Mouse	mmu-miR-34a	miRNA	ketamine	apoptosis	one-month old C57/BL6 mice hippocampal	"received daily intraperitoneal injection of anesthesia (ketamine, 50 mg/kg) for 7 days treatment"	upregulated	25400756
4145	Mouse	mmu-miR-34a	miRNA	palmitate	apoptosis	Min6 pancreatic ¦Â -cell	palmitate treatment	upregulated	24829923
4146	Mouse	mmu-miR-34a	miRNA	folate	apoptosis	mouse embryonic stem cells (mESCs)	folate deficiency induced	upregulated	22828209
4147	Mouse	mmu-miR-34a	miRNA	kanamycin	apoptosis	inner ear tissues	kanamycin treatment	strong upregulated of miR-34a and miR-34c	21067520
4148	Mouse	mmu-miR-34a	miRNA	high fat diet (HFD)	atherosclerosis (AS)	aortic arch	high fat diet (HFD) feed	upregulated	29704100
4149	Mouse	mmu-miR-34a	miRNA	lipopolysaccharide (LPS)	Dendritic cell (DC) maturation	?Mouse Monocyte	lipopolysaccharide (LPS) treatment	upregulated	24198819
4150	Mouse	mmu-miR-34a	miRNA	melatonin	Benzo(a)pyrene (BaP)-induced hepatotoxicity	liver tissues	melatonin treatment	Exposure of mice to 20 mg/kg of melatonin resulted in a significant decrease in hepatic miR-34a expression (1.2-fold) compared with the BaP treated mice.	32247962
4151	Mouse	mmu-miR-34a	miRNA	tumor necrosis factor alpha (TNF-¦Á) 	bone regeneration	bone marrow mesenchymal stromal cells (BMSCs)	tumor necrosis factor alpha (TNF-¦Á) treatment	downregulated	31308031
4152	Mouse	mmu-miR-34a	miRNA	D-galactose (D-Gal)	brain aging	brain tissues	D-Galactose treatment	upregulated	31420820
4153	Mouse	mmu-miR-34a	miRNA	urolithin A (UA)	brain aging	D-gal-induced brain aging mice brain tissues	?urolithin A treatment	downregulated	31420820
4154	Mouse	mmu-miR-34a	miRNA	hyperoxia	bronchopulmonary dysplasia (BPD)	platelet-derived growth factor receptor (PDGFR)¦Á-expressing myofibroblasts	hyperoxia induce	upregulated	30770339
4155	Mouse	mmu-miR-34a	miRNA	myostatin	browning of white adipocytes	C2C12 myoblasts	myostatin treatment	upregulated	27297797
4156	Mouse	mmu-miR-34a	miRNA	N-ethyl-N-nitrosourea (ENU)	tumorigenesis	spleen tissues	N-ethyl-N-nitrosourea (ENU) treatment	upregulated	22297810
4157	Mouse	mmu-miR-34a	miRNA	TGF-¦Â1	cardiac fibrosis	cardiac fibroblasts	TGF-¦Â1 treatment	upregulated	25322725
4158	Mouse	mmu-miR-34a	miRNA	phenylephrine (PE)	cardiac hypertrophy	cardiomyocytes; cardiac fibroblasts	phenylephrine (PE) treatment	LncRNA TUG1 alleviates cardiac hypertrophy by targeting miR©\34a/DKK1/Wnt©\¦Â©\catenin signalling	32057178
4159	Mouse	mmu-miR-34a	miRNA	programmed death-1 (PD-1) inhibitor	cardiac injury	HL-1 cells	programmed death-1 (PD-1) inhibitor treatment	upregulated	32709878
4160	Mouse	mmu-miR-34a	miRNA	aldosterone	cardiovascular disease (CVD)	primary mouse cardiomyocytes or mouse heart tissues	aldosterone treatment	TRIF/miR-34a mediates aldosterone-induced cardiac inflammation and remodeling	32776109
4161	Mouse	mmu-miR-34a	miRNA	quercetin	apoptosis	HepG2 and Huh7 cells	quercetin treatment	upregulated	25896587
4162	Mouse	mmu-miR-34a	miRNA	diethylnitrosamine (DEN)	chronic cholestasis and cholangiocarcinoma	liver tissues	diethylnitrosamine (DEN) treatment	downregulated	21440549
4163	Mouse	mmu-miR-34a	miRNA	trichostatin A (TSA)	chronic obstructive pulmonary disease (COPD)	lung tissue of rats	trichostatin A (TSA) treatment	upregulated	21224215
4164	Mouse	mmu-miR-34a	miRNA	curcumin and 3 acetyl-11-keto-¦Â-boswellic acid (AKBA)	colorectal cancer (CRC)	colorectal cancer cells	curcumin and 3 acetyl-11-keto-¦Â-boswellic acid (AKBA) treatment	upregulated	25712055
4165	Mouse	mmu-miR-34a	miRNA	chronic stress	depression	ouse raphe nuclei	chronic stress exposure	upregulated	31482401
4166	Mouse	mmu-miR-34a	miRNA	chronic stress	depression	raphe nuclei	chronic stress exposure	"microRNA-34a, under chronic stress, is significantly upregulated in the mouse raphe nuclei."	31482401
4167	Mouse	mmu-miR-34a	miRNA	IL-1¦Â and TNF-¦Á	diabetes mellitus (DM)	MIN6 cells	IL-1¦Â and TNF-¦Á treatment	upregulated	20086228
4168	Mouse	mmu-miR-34a	miRNA	streptozocin (STZ)	diabetes-induced testicular apoptotic cell death (TACD)	testes	streptozotocin (STZ) treatment	upregulated	30030567
4169	Mouse	mmu-miR-34a	miRNA	high glucose (HG)	diabetic cardiomyopathy (DCM)	H9c2 cells	high glucose (HG) treatment	miR-34a was upregulated in HG-stimulated H9c2.	30216438
4170	Mouse	mmu-miR-34a	miRNA	high glucose (HG)	diabetic cardiomyopathy (DCM)	cardiomyocytes	high glucose treatment	upregulated	32212062
4171	Mouse	mmu-miR-34a	miRNA	high glucose (HG)	diabetic cardiomyopathy (DCM)	primary mouse cardiac fibroblasts (CFs)	high glucose (HG) treatment	The HG stimulation of CFs for 48?h significantly downregulated the expression level of miR-34a.	33289184
4172	Mouse	mmu-miR-34a	miRNA	high glucose (HG)	diabetic cardiomyopathy (DCM)	cardiac tissues	high glucose (HG) treatment	"The HG stimulation of CFs for 48 h significantly downregulated the expression level of miR-34a and was associated with increased Type I collagen expression, cell viability, and migration and decreased apoptosis."	33289184
4173	Mouse	mmu-miR-34a	miRNA	streptozocin (STZ)	diabetic cardiomyopathy (DCM)	mouse heart tissues	streptozotocin (STZ) treatment	HOTAIR protected against DCM via activation of the SIRT1 expression by sponging miR-34a	30216438
4174	Mouse	mmu-miR-34a	miRNA	high glucose (HG)	diabetes-associated endothelial dysfunction	primary cultured endothelial cells (ECs)	high glucose (HG) treatment	upregulated	30793480
4175	Mouse	mmu-miR-34a	miRNA	pifithrin-¦Á (PFT-¦Á)	diabetes-associated endothelial dysfunction	high glucose (HG)-treated primary cultured endothelial cells (ECs)	pifithrin-¦Á (PFT-¦Á) treatment	downregulated	30793480
4176	Mouse	mmu-miR-34a	miRNA	hyperoside	diabetic nephropathy (DN)	SV40-MES13 cells	hyperoside treatment	Hyperoside inhibits the proliferation of SV40-MES13 cells through the suppression of the ERK/CREB/miRNA-34a signaling pathway.	32774360
4177	Mouse	mmu-miR-34a	miRNA	streptozocin (STZ)	diabetic nephropathy (DN)	serum	streptozotocin (STZ) treatment	"The expression of acetylated p53 and miR-34a was upregulated, SIRT1was downregulated in glomeruli from patients with DN and STZ induced diabetic mice, as well as in human podocytes treated with advanced glycation end (AGE)"	33932899
4178	Mouse	mmu-miR-34a	miRNA	high glucose (HG)	diabetic vasculopathy	"MMECs, mouse micro vascular endothelial cells originated from mouse pancreas"	high glucose (HG) treatment	upregulated	26582729
4179	Mouse	mmu-miR-34a	miRNA	¦Ã-rays	DNA damage	Hematopoietic stem cells (HSCs)	Mice were exposed to various doses of total bodyirradiation (TBI) in a [60Co]¦Ã-irradiator	downregulated	30922079
4180	Mouse	mmu-miR-34a	miRNA	sodium arsenite (NaAsO2)	DNA methylation	liver tissues	sodium arsenite treatment	upregulated	32068019
4181	Mouse	mmu-miR-34a	miRNA	doxorubicin (DOX)	doxorubicin (DOX)-induced cardiotoxicity	male B6C3F1 mice	were injected intravenously with 3mg/kg doxorubicin treatment	upregulated	25448438
4182	Mouse	mmu-miR-34a	miRNA	kainic acid (KA)	epilepsy	mouse intraamygdala	intraamygdala microinjection of kainic acid	upregulated	22436728
4183	Mouse	mmu-miR-34a	miRNA	"dibenz[a,h]anthracene"	glucose homeostasis	liver tissue of mice	"dibenz[a,h]anthracene treatment"	upregulated	23793610
4184	Mouse	mmu-miR-34a	miRNA	ischemia	hepatic ischemia/reperfusion injury (HIRI)	HL7702 cells	hepatic ischemia-reperfusion (HIR)	downregulated	28708282
4185	Mouse	mmu-miR-34a	miRNA	averrhoa carambola free phenolic extract (ACF)	hepatic steatosis	leptin receptor-deficient (db/db) mice	averrhoa carambola free phenolic extract (ACF) treatment	downregulated	29090700
4186	Mouse	mmu-miR-34a	miRNA	high fat diet (HFD)	hepatic steatosis	hepatic	high fat diet (HFD) feed	upregulated	26608583
4187	Mouse	mmu-miR-34a	miRNA	perfluoroalkyl chemicals (PFASs)	hepatotoxicity	male BALB/c mice liver	PFASs treatment	upregulated	25181679
4188	Mouse	mmu-miR-34a	miRNA	perfluorooctanoic acid	hepatotoxicity	mouse liver tissues	Perfluorooctanoic acid (PFOA) exposure treatment	upregulated	30342367
4189	Mouse	mmu-miR-34a	miRNA	high methionine diet	hyperhomocysteinemia (HHcy)	ApoE mice	feed with high methionine diet	downregulated	28485501
4190	Mouse	mmu-miR-34a	miRNA	hyperoxia	hyperoxia-induced acute lung injury (HALI)	neonatal mice lungs	exposed to hyperoxia	upregulated	29079808
4191	Mouse	mmu-miR-34a	miRNA	administering adenine and allantoxanic acid potassium salt	hyperuricemia	renal tissues	administering adenine and allantoxanic acid potassium salt treatment	upregulated	25535087
4192	Mouse	mmu-miR-34a	miRNA	Xie-Zhuo-Chu-Bi-Fang (XZCBF)	hyperuricemia	mouse	XZCBF for 15 days treatment	upregulated	25535087
4193	Mouse	mmu-miR-34a	miRNA	"bleomycin, cigarette smoke, silica, or sepsis"	idiopathic pulmonary fibrosis (IPF)	mouse lung tissues	caveolin-2 scaffolding domain peptide (CSP) treatment	upregulated	28273432
4194	Mouse	mmu-miR-34a	miRNA	caveolin-1 scaffolding domain peptide (CSP)	idiopathic pulmonary fibrosis (IPF)	mouse lung tissues	caveolin-1 scaffolding domain peptide (CSP) treatment	downregulated	28273432
4195	Mouse	mmu-miR-34a	miRNA	complete freund's adjuvant (CFA)	inflammation	spinal cord	complete Freund's adjuvant (CFA) treatment	upregulated	31296380
4196	Mouse	mmu-miR-34a	miRNA	flaxseed (FS)	inflammation	mouse exposed to X-ray	fed 10% FS or a 0% FS isocaloric control diet treatment	dysregulated	24755684
4197	Mouse	mmu-miR-34a	miRNA	lipopolysaccharide (LPS)	inflammation	J774A.1 (mouse macrophage cell line)	lipopolysaccharide (LPS) treatment	downregulated	29773953
4198	Mouse	mmu-miR-34a	miRNA	lipopolysaccharide (LPS)	inflammatory response	Murine macrophage cell line RAW264.7	lipopolysaccharide (LPS) treatment	downregulated	22483937
4199	Mouse	mmu-miR-34a	miRNA	cannabinoids	innate immune response	LPS-treated BV-2 microglial cells	cannabinoids treatment	upregulated	30742662
4200	Mouse	mmu-miR-34a	miRNA	carbon monoxide (CO)	ischemia/reperfusion (I/R) injury	hepatocytes	carbon monoxide (CO) treatment	downregulated	25916635
4201	Mouse	mmu-miR-34a	miRNA	tubulointerstitial spaces	kidney fibrosis	microvesicles isolated from obstructed kidney	tubulointerstitial spaces treatment	upregulated	25107369
4202	Mouse	mmu-miR-34a	miRNA	ionizing radiation (IR)	leukemia	mouse thymus and spleen tissue cells	irradiated	upregulated	18823940
4203	Mouse	mmu-miR-34a	miRNA	low frequency magnetic fields (LF-MF)	Lewis lung cancer	lung cancer cells	"exposed to a LF-MF (0.4T, 7.5 Hz) for 35 days"	upregulated	28389657
4204	Mouse	mmu-miR-34a	miRNA	resistin	lipid metabolism	male C57BL/6 mice liver	resistin treatment	upregulated in the liver	29197627
4205	Mouse	mmu-miR-34a	miRNA	dietary methyl deficiency	hepatocellular carcinoma (HCC)	the liver tissues	Dietary methyl deficiency treatment	upregulated	20436259
4206	Mouse	mmu-miR-34a	miRNA	bleomycin (BLM)	lung fibrosis	RLE/Abca3 cells	bleomycin (BLM) treatment	upregulated	28408209
4207	Mouse	mmu-miR-34a	miRNA	methotrexate (MTX)	lung fibrosis	RLE/Abca3 cells	methotrexate (MTX) treatment	upregulated	28408209
4208	Mouse	mmu-miR-34a	miRNA	TGF-¦Â1	lung fibrosis	RLE/Abca3 cells	TGF-¦Â1 treatment	upregulated	28408209
4209	Mouse	mmu-miR-34a	miRNA	crocin	myocardial ischemia/reperfusion (I/R) injury (MIRI)	I/R-induced primary cardiomyocytes	crocin treatment	downregulated	29424794
4210	Mouse	mmu-miR-34a	miRNA	ischemia/reperfusion (I/R) 	myocardial ischaemic injury	mouse plasma;Bone marrow-derived macrophage (BMDM);Rat neonatal CMs	ischemia/reperfusion (I/R) treatment	differently regulated	28768728
4211	Mouse	mmu-miR-34a	miRNA	cadmium (Cd)	nephrotoxicity	mouse kidney	cadmium (Cd) treatment	"Furthermore, Cd-caused detrimental changes through inducing inflammation and apoptosis via the miR-34a/Sirt1/p53 axis."	33823310
4212	Mouse	mmu-miR-34a	miRNA	human immunodeficiency virus (HIV)-1 Tat	neuroinflammation	mouse microglia	Human immunodeficiency virus (HIV)-1 Tat treatment	upregulated	30872089
4213	Mouse	mmu-miR-34a	miRNA	berberine (BBR)	nonalcoholic fatty liver disease (NAFLD)	mouse liver	berberine (BBR) treatment	BBR's beneficial effects are linked with the downregulated of microRNA34a and long noncoding RNA H19	33494295
4214	Mouse	mmu-miR-34a	miRNA	"berberis aristata, elaeis guineensis?and?coffea canephora"	nonalcoholic fatty liver disease (NAFLD)	mouse liver tissues	"Berberis Aristata, Elaeis Guineensis?and?Coffea Canephora treatment"	both these miRNAs had similar levels to SD-mice in HFD+E-mice	33924725
4215	Mouse	mmu-miR-34a	miRNA	green tea (GT)	nonalcoholic fatty liver disease (NAFLD)	liver tissues from Male C57Bl/6 mice were fed with a high-fat diet for 4 weeks	green tea (GT) treatment	downregulated	31885789
4216	Mouse	mmu-miR-34a	miRNA	high fat diet (HFD)	nonalcoholic fatty liver disease (NAFLD)	hepatocytes	high fat diet (HFD) feed	upregulated	26330104
4217	Mouse	mmu-miR-34a	miRNA	high fat diet (HFD)	nonalcoholic fatty liver disease (NAFLD)	liver tissues	high fat diet (HFD) feed	upregulated	31885789
4218	Mouse	mmu-miR-34a	miRNA	high fat diet (HFD)	nonalcoholic fatty liver disease (NAFLD)	mouse liver tissues	high fat diet (HFD) feed	both these miRNAs had similar levels to SD-mice in HFD+E-mice	33924725
4219	Mouse	mmu-miR-34a	miRNA	palmitate	nonalcoholic fatty liver disease (NAFLD)	cholangiocytes of C57BL/6J mice	PA treatment	upregulated	28250026
4220	Mouse	mmu-miR-34a	miRNA	palmitic acid (PA)	nonalcoholic fatty liver disease (NAFLD)	C2C12 muscle cells	palmitic acid (PA) treatment	upregulated	31139863
4221	Mouse	mmu-miR-34a	miRNA	metformin (Met)	nonalcoholic steatohepatitis (NASH)	liver tissues	metformin treatment	upregulated	25672270
4222	Mouse	mmu-miR-34a	miRNA	cisplatin (DDP)	ochratoxin A (OTA) nephrotoxicity	HEI-OC1 auditory cells	cisplatin treatment	upregulated	24922076
4223	Mouse	mmu-miR-34a	miRNA	ochratoxin A (OTA)	ochratoxin A (OTA) toxicity	Primary proximal tubular epithelial cell	ochratoxin A treatment	upregulated	28710020
4224	Mouse	mmu-miR-34a	miRNA	fluid shear stress (FSS)	osteoblastic differentiation	MC3T3-E1 cells	fluid shear stress (FSS)treatment	downregulated	23595392
4225	Mouse	mmu-miR-34a	miRNA	tert-butyl hydroperoxide (TBHP)	oxidative stress	adult male mice strain Balb/c	TBHP treatment	differently regulated	25141839
4226	Mouse	mmu-miR-34a	miRNA	perfluorooctanoic acid	perfluorooctanoic acid (PFOA)-induced liver toxicity	mouse liver tissues	Perfluorooctanoic acid (PFOA) exposure treatment	upregulated	30342367
4227	Mouse	mmu-miR-34a	miRNA	apigenin	peritoneal fibrosis	mouse mesothelial peritoneal cells (MMCs)	apigenin treatment	"Apigenin treatment induced a significant decrease in miR34a expression levels in HG-treated MMCs. Moreover, both apigenin treatment and miR34a depletion."	30474876
4228	Mouse	mmu-miR-34a	miRNA	radiation	radiation-induced fibrosis (RIF)	"CH3 mice muscle, skin, and subcutaneous tissue"	the right hind legs of 9-week old CH3 mice by a single-fraction dose of irradiation to 35 Gy treatment	dysregulated	24986745
4229	Mouse	mmu-miR-34a	miRNA	lipopolysaccharide (LPS)	regeneration of the intestinal epithelia	intestinal tissues	lipopolysaccharide (LPS) treatment	downregulated	29621481
4230	Mouse	mmu-miR-34a	miRNA	SDF-1¦Á analog CTCE-0214 (CTCE)	sepsis	mouse with polymicrobial sepsis	EPC therapy treatment	upregulated in endothelial progenitor cells (EPCs)	24707934
4231	Mouse	mmu-miR-34a	miRNA	streptozocin (STZ)	smooth muscle cell differentiation	mouse liver	streptozotocin (STZ) treatment	Upregulation of miR-34a and downregulated of miR-122 was found in livers of STZ-induced diabetic mice	19372595
4232	Mouse	mmu-miR-34a	miRNA	lipopolysaccharide (LPS)	spinal cord injury (SCI)	BV-2 cells	lipopolysaccharide (LPS) treatment	downregulated	32096191
4233	Mouse	mmu-miR-34a	miRNA	"5-Aza-2'-deoxycytidine (5-Aza-dC, decitabine)"	teratogenesis	mouse and rat limb buds	"5-Aza-2'-deoxycytidine (5-Aza-dC, decitabine) treatment"	miR-34 family members are the most upregulated miRNAs	24623309
4234	Mouse	mmu-miR-34a	miRNA	dasatinib and quercetin	uterine fibrosis	uterine	dasatinib plus quercetin treatment	D+Q treatment decreased miR-34a.	31955151
4235	Mouse	mmu-miR-34a	miRNA	H2O2	cardiomyocyte apoptosis	bone marrow-derived mononuclear cells (BMCs)	H(2)O(2) treatment	upregulated	22403243
4236	Mouse	mmu-miR-34a	miRNA	insulin-like growth factor 1 (IGF-1)	leukemia	bone marrow-derived mononuclear cells (BMCs)	?IGF-1(insulin-like growth factors-1) treatment	downregulated	22403243
4237	Mouse	mmu-miR-34a-5p	miRNA	amyloid-¦Â (A¦Â)	Alzheimer's disease (AD)	primary mouse cortical neurons (MCN) and Neuro2a (N2a) cells	amyloid-¦Â (A¦Â) treatment	downregulated	32251872
4238	Mouse	mmu-miR-34a-5p	miRNA	7-chlorokynurenic acid (7-CTKA)	antidepressant	mouse	7-CTKA intraperitoneal injection	downregulated	25034119
4239	Mouse	mmu-miR-34a-5p	miRNA	melatonin	anti-inflammatory responses	RAW264.7 cells (a murine macrophage cell line) and mouse bone marrow-derived macrophages (BMDMs)	metformin treatment	Metformin might show anti-inflammatory effects in macrophages through the induction of Dicer and the subsequent upregulation of miR-34a-5p and miR-125b-5p.	31102492
4240	Mouse	mmu-miR-34a-5p	miRNA	doxorubicin (DOX)	cardiotoxicity	"plasma and heart, HL-1 cells"	doxorubicin (DOX) treatment	upregulated	30453253
4241	Mouse	mmu-miR-34a-5p	miRNA	total abdominal irradiation (TAI)	cognitive deficits	mouse small intestine tissues and peripheral blood (PD)	TAI treatment	upregulated in small intestine tissues and peripheral blood (PD)	28668331
4242	Mouse	mmu-miR-34a-5p	miRNA	doxorubicin (DOX)	doxorubicin (DOX)-induced cardiotoxicity	plasma	doxorubicin (DOX) treatment	upregulated	30453253
4243	Mouse	mmu-miR-34a-5p	miRNA	doxorubicin (DOX)	doxorubicin (DOX)-induced cardiotoxicity	Plasma	doxorubicin (DOX) treatment	upregulated	30627229
4244	Mouse	mmu-miR-34a-5p	miRNA	carbon tetrachloride (CCl4)	liver fibrosis	liver	CCl4 treatment	upregulated	27322257
4245	Mouse	mmu-miR-34a-5p	miRNA	high fat diet (HFD)	hepatic insulin resistance	mouse liver tissues	high fat diet (HFD) feed	upregulated	30820263
4246	Mouse	mmu-miR-34a-5p	miRNA	dexamethasone (DEX)	innate immune response	immature DCs (iDCs)	dexamethasone (DEX) treatment	downregulated	30174602
4247	Mouse	mmu-miR-34a-5p	miRNA	X-rays	intestinal damage	small intestine	X-ray exposure	upregulated	32323814
4248	Mouse	mmu-miR-34a-5p	miRNA	ischemia/reperfusion (I/R) 	intestinal hypoxia/reoxygenation injury	C57BL/6 mice were induced	ischemia/reperfusion (I/R) treatment	upregulation	26935288
4249	Mouse	mmu-miR-34a-5p	miRNA	stearic acid	lipotoxicity	INS-1 cells	stearic-acid treatment	upregulated	26969487
4250	Mouse	mmu-miR-34a-5p	miRNA	carbon tetrachloride (CCl4)	liver fibrosis	liver tissues	carbon tetrachloride (CCl4) treatment	downregulated	29957876
4251	Mouse	mmu-miR-34a-5p	miRNA	dioscorea bulbifera (DB)	liver damage	livers	dioscoreae bulbifera (EF) treatment	upregulated	27609015
4252	Mouse	mmu-miR-34a-5p	miRNA	"2,2',4,4'-tetrabromodiphenyl ether (BDE47)"	mitophagy	mouse livers	"2,2',4,4'-Tetrabromodiphenyl ether (BDE-47) treatment"	upregulated	31838391
4253	Mouse	mmu-miR-34a-5p	miRNA	"2,2',4,4'-tetrabromodiphenyl ether (BDE47)"	mitophagy	Hepa1-6 cells	"2,2',4,4'-Tetrabromodiphenyl ether (BDE-47) treatment"	upregulated	31838391
4254	Mouse	mmu-miR-34a-5p	miRNA	hypoxia	myocardial infarction (MI)	HL-1 cells	hypoxia induce	upregulated	30312158
4255	Mouse	mmu-miR-34a-5p	miRNA	high fat diet (HFD)	nonalcoholic fatty liver disease (NAFLD)	mouse liver tissue	high fat diet (HFD) feed	upregulated	30898698
4256	Mouse	mmu-miR-34a-5p	miRNA	high fat diet (HFD)	nonalcoholic fatty liver disease (NAFLD)	liver tissues	high fat diet (HFD) feed	upregulated	31500354
4257	Mouse	mmu-miR-34a-5p	miRNA	melatonin	nonalcoholic fatty liver disease (NAFLD)	high-fat diet (HFD)-fed mice liver tissues	melatonin treatment	downregulated	31500354
4258	Mouse	mmu-miR-34a-5p	miRNA	enoxacin	obesity	white subcutaneous (9W)	enoxacin treatment	Enoxacin led to a reduction of miR-34a-5p expression.	33268375
4259	Mouse	mmu-miR-34a-5p	miRNA	metformin (Met)	type 2 diabetes mellitus (T2DM)	RAW264.7 cells	metformin (Met) treatment	Metformin might show anti-inflammatory effects in macrophages through the induction of Dicer and the subsequent upregulation of miR-34a-5p and miR-125b-5p.	31102492
4260	Mouse	mmu-miR-34b	miRNA	doxorubicin (DOX)	cardiotoxicity	HL-1 cells	Doxorubicin (DOX) treatment	upregulated	31627713
4261	Mouse	mmu-miR-34b	miRNA	si-jun-zi-tang (SJZT)	melanoma	B16 cells	Si-Jun-Zi-Tang (SJZT) treatment	"Mechanistic investigations revealed that SJZT elevated miR-34b (a tumor suppressing miRNA), and lowered c-Met (a miR-34b target gene) and ¦Â-catenin (a downstream molecule of c-Met signaling) expression levels in the B16 tumors."	32505839
4262	Mouse	mmu-miR-34b	miRNA	extremely low-frequency magnetic fields (ELF-MFs)	neurodegeneration (ND)	mouse primary cortical neurons	ELF-MFs	downregulated	29039021
4263	Mouse	mmu-miR-34b	miRNA	extremely low-frequency magnetic fields (ELF-MFs)	neurodegenerative diseases	mouse primary cortical neurons	extremely low-frequency magnetic fields (ELF-MFs) treatment	downregulated	29039021
4264	Mouse	mmu-miR-34b	miRNA	high inorganic phosphate (Pi)	vascular calcification (VC)	primary cultured mouse vascular smooth muscle cells (VSMCs) or mouse arteries derived from 5/6 nephrectomy	high inorganic phosphate (Pi) treatment	downregulated	31129659
4265	Mouse	mmu-miR-34b-3p	miRNA	high glucose (HG)	diabetic cardiomyopathy (DCM)	HL-1 cells	high glucose (HG) treatment	LncRNA GAS5 inhibits NLRP3 inflammasome activation-mediated pyroptosis in diabetic cardiomyopathy by targeting miR-34b-3p/AHR	33092444
4266	Mouse	mmu-miR-34b-3p	miRNA	doxorubicin (DOX)	doxorubicin (DOX)-induced cardiotoxicity	plasma	doxorubicin (DOX) treatment	upregulated	30453253
4267	Mouse	mmu-miR-34b-3p	miRNA	single dose irradiation	ionizing radiation (IR) injury	LLC1 cells	single dose (SD) irradiation treatment	upregulated	28599420
4268	Mouse	mmu-miR-34b-3p	miRNA	chronic unpredictable mild stress (CUMS)	major depressive disorder (MDD)	nucleus accumbens (NAc) tissues	chronic unpredictable mild stress (CUMS) induce	upregulated	30936699
4269	Mouse	mmu-miR-34b-5p	miRNA	lipopolysaccharide (LPS)	acute lung injury (ALI)	lung tissues	lipopolysaccharide (LPS) treatment	upregulated	29150939
4270	Mouse	mmu-miR-34b-5p	miRNA	lipopolysaccharide (LPS)	acute lung injury (ALI)	lung tissues; primary murine pulmonary microvascular endothelial cells (PMVECs)	lipopolysaccharide (LPS) treatment	upregulated	32087725
4271	Mouse	mmu-miR-34b-5p	miRNA	pressure overload	heart failure (HF)	heart sissues	pressure overload treatment	upregulated	33224746
4272	Mouse	mmu-miR-34b-5p	miRNA	N-ethyl-N-nitrosourea (ENU)	hepatocellular carcinoma (HCC)	liver tissues	N-ethyl-N-nitrosourea (ENU) treatment	upragulated	21029445
4273	Mouse	mmu-miR-34b-5p	miRNA	bleomycin (BLM)	lung fibrosis	lung tissues	bleomycin (BLM) treatment	upregulated	30915776
4274	Mouse	mmu-miR-34b-5p	miRNA	chronic unpredictable mild stress (CUMS)	major depressive disorder (MDD)	nucleus accumbens (NAc) tissues	chronic unpredictable mild stress (CUMS) induce	upregulated	30936699
4275	Mouse	mmu-miR-34b-5p	miRNA	glyphosate	neurodevelopmental disorder	prefrontal cortex of mouse offspring	glyphosate	dysregulated	29467848
4276	Mouse	mmu-miR-34c	miRNA	kanamycin	apoptosis	inner ear tissues	kanamycin treatment	strong upregulated of miR-34a and miR-34c	21067520
4277	Mouse	mmu-miR-34c	miRNA	doxorubicin (DOX)	cardiotoxicity	HL-1 cells	Doxorubicin (DOX) treatment	upregulated	31627713
4278	Mouse	mmu-miR-34c	miRNA	high glucose (HG)	diabetic nephropathy (DN)	podocyte	high glucose treatment	downregulated	26191142
4279	Mouse	mmu-miR-34c	miRNA	streptozocin (STZ)	diabetic peripheral neuropathy (DPN)	trigeminal ganglion (TG) tissue	streptozotocin (STZ) treatment	upregulated	30601927
4280	Mouse	mmu-miR-34c	miRNA	extremely low-frequency magnetic fields (ELF-MFs)	neurodegeneration (ND)	mouse primary cortical neurons	ELF-MFs	downregulated	29039021
4281	Mouse	mmu-miR-34c	miRNA	extremely low-frequency magnetic fields (ELF-MFs)	neurodegenerative diseases	mouse primary cortical neurons	extremely low-frequency magnetic fields (ELF-MFs) treatment	downregulated	29039021
4282	Mouse	mmu-miR-34c	miRNA	ketamine	neurotoxicity	hippocampal	Ketamine treatment	upregulated	25052764
4283	Mouse	mmu-miR-34c	miRNA	fluid shear stress (FSS)	osteoblastic differentiation	MC3T3-E1 cells	fluid shear stress (FSS)treatment	downregulated	23595392
4284	Mouse	mmu-miR-34c	miRNA	icariin (ICA)	osteoporosis	(LPS)-induced bone loss via an osteogenic	Icariine treatment	"MiRNA-34c was dramatically upregulated after LPS stimulation; however, Icariine preincubation reversed miRNA-34c level."	27492554
4285	Mouse	mmu-miR-34c-3p	miRNA	lipopolysaccharide (LPS)	acute lung injury (ALI)	mouse alveolar macrophages (MH-S) and lung tissues	lipopolysaccharide (LPS) treatment	lncRNA SNHG14 silencing alleviated inflammation in LPS-induced ALI through miR-34c-3p-mediated inhibition of WISP1.	31660971
4286	Mouse	mmu-miR-34c-3p	miRNA	doxorubicin (DOX)	doxorubicin (DOX)-induced cardiotoxicity	plasma	doxorubicin (DOX) treatment	upregulated	30453253
4287	Mouse	mmu-miR-34c-3p	miRNA	chronic unpredictable mild stress (CUMS)	major depressive disorder (MDD)	nucleus accumbens (NAc) tissues	chronic unpredictable mild stress (CUMS) induce	upregulated	30936699
4288	Mouse	mmu-miR-34c-5p	miRNA	single dose irradiation	ionizing radiation (IR) injury	LLC1 cells	single dose (SD) irradiation treatment	upregulated	28599420
4289	Mouse	mmu-miR-34c-5p	miRNA	chronic unpredictable mild stress (CUMS)	major depressive disorder (MDD)	nucleus accumbens (NAc) tissues	chronic unpredictable mild stress (CUMS) induce	upregulated	30936699
4290	Mouse	mmu-miR-34c-5p	miRNA	high fat diet (HFD)	obesity	liver tissues	high fat diet (HFD) feed	upregulated	32593682
4291	Mouse	mmu-miR-34c-5p	miRNA	aldosterone	renal fibrosis	mouse cortical collecting duct cells	aldosterone treatment (10-6 M; 3 days)	downregulated	29070573
4292	Mouse	mmu-miR-34c-5p	miRNA	aldosterone	renal fibrosis	mouse cortical collecting duct cells	aldosterone treatment (10-6 M; 3 days)	dysregulated	29070573
4293	Mouse	mmu-miR-350	miRNA	smoking	smoking-related interstitial fibrosis (SRIF)	C57 mice circulating	6 months of chronic mainstream smoking exposure treatment	downregulated	22782705
4294	Mouse	mmu-miR-351	miRNA	ischemia/reperfusion (I/R) 	acute myocardial infarction (AMI)	heart tissues	ischemia/reperfusion (I/R) treatment	upregulated	28090786
4295	Mouse	mmu-miR-351	miRNA	high glucose (HG)	diabetic nephropathy (DN)	Mouse podocytes (MPC5)	high glucose treatment	upregulated	30095204
4296	Mouse	mmu-miR-351	miRNA	streptozocin (STZ)	gestational diabetes mellitus (GDM)	liver tissues	streptozotocin (STZ) treatment	downregulated	31287224
4297	Mouse	mmu-miR-351	miRNA	Schistosoma	liver fibrosis	primary hepatic stellate cells (HSCs)	Schistosoma infection treatment	"the expr+B5808:J5808ession of host miR-351 in HSCs was markedly reduced during the early stage of Schistosoma infection However, this expression was significantly increased during the later stage of infection (after 52 d of infection)"	29255036
4298	Mouse	mmu-miR-351	miRNA	dexamethasone (DEX)	muscle atrophy	Murine C2C12 myoblast cells	dexamethasone (DEX) treatment	upregulated	23716137
4299	Mouse	mmu-miR-351	miRNA	prion	pancreatic cancer (PC)	The mouse neuroblastoma cell line N2a	prion treatment	downregulated of mmu-miR-351 and mmu-miR-542-5p	22985096
4300	Mouse	mmu-miR-351	miRNA	lipopolysaccharide (LPS)	sepsis-induced skeletal muscle wasting	long extensor muscle tissues of the toes	lipopolysaccharide (LPS) treatment	downregulated	30040486
4301	Mouse	mmu-miR-351-5p	miRNA	histone deacetylase inhibitor (HDACi)	B cell differentiation	B cells of C57BL/6J	"stimulated with LPS and IL-4 and treated with HDI (VPA, 500 ?M) or nil for 60 h"	upregulated	28994753
4302	Mouse	mmu-miR-351-5p	miRNA	brucella.suis	innate immune response	RAW264.7 cells	brucella.suis infection	upregulated	29387067
4303	Mouse	mmu-miR-351-5p	miRNA	chronic unpredictable mild stress (CUMS)	major depressive disorder (MDD)	nucleus accumbens (NAc) tissues	chronic unpredictable mild stress (CUMS) induce	downregulated	30936699
4304	Mouse	mmu-miR-361	miRNA	histone deacetylase inhibitors (HDIs) short-chain fatty acid (SCFA) butyrate	antibody-mediated systemic autoimmunity	B cells	SCFA HDI butyrate treatment	upregulated	32265934
4305	Mouse	mmu-miR-361	miRNA	arsenite	atherosclerosis (AS)	liver	arsenic (As) exposure	upregulated	22719926
4306	Mouse	mmu-miR-361-3p	miRNA	nonylphenol (NP)	male infertility	GC-1 spermatogonia cell line	high concentration of NP	downregulated	29024157
4307	Mouse	mmu-miR-361-5p	miRNA	histone deacetylase inhibitor (HDACi)	B cell differentiation	B cells of C57BL/6J	"stimulated with LPS and IL-4 and treated with HDI (VPA, 500 ?M) or nil for 60 h"	upregulated	28994753
4308	Mouse	mmu-miR-361-5p	miRNA	angiotensin II (Ang II)	cardiac hypertrophy	Cardiomyocytes isolated from newborn mouse hearts	angiotensin II (Ang II) treatment	STAT3-inducetd upregulation of lncRNA MEG3 controls cardiac hypertrophy by regulating miR-362-5p/HDAC9 axis.	30679521
4309	Mouse	mmu-miR-361-5p	miRNA	high fat diet (HFD)	nonalcoholic fatty liver disease (NAFLD)	liver tissues	high fat diet (HFD) feed	upregulated	30309516
4310	Mouse	mmu-miR-362	miRNA	ethanol (EtOH)	teratogenesis	fetal brains of mice	Ethanol?treatment	downregulated	19091803
4311	Mouse	mmu-miR-362-3p	miRNA	curcumin (Cur)	anti-inflammatory responses	BV2 cells	curcumin treatment	miR-362-3p expression was upregulated by curcumin.	32472295
4312	Mouse	mmu-miR-362-3p	miRNA	perfluoroalkyl chemicals (PFASs)	hepatotoxicity	male BALB/c mice liver	PFASs treatment	downregulated	25181679
4313	Mouse	mmu-miR-363	miRNA	"anti-benzo[a]pyrene-trans-7,8-diol-9,10-epoxide (anti-BPDE)"	bronchial epithelial cell cancer	16HBE-T cells	"anti-benzo[a]pyrene-trans-7,8-diol-9,10-epoxide (anti-BPDE) treatment"	downregulated	19462682
4314	Mouse	mmu-miR-363	miRNA	Staphylococcus aureus	inflammation	mouse mammary tissue	intramammary infection of Globally Staphylococcus aureus treatment	differently regulated	25075227
4315	Mouse	mmu-miR-363-3p	miRNA	resveratrol	hepatic insulin resistance	HepG2 cells	resveratrol (Res) treatment	RSV improves insulin resistance by upregulating miRNA mmu-miR-363-3p via the PI3K-Akt pathway	32104036
4316	Mouse	mmu-miR-365	miRNA	oxidized low density lipoprotein (ox-LDL)	atherosclerosis (AS)	mouse macrophages atherogenic Evs	oxidized low-density lipoprotein (ox-LDL) treatment	enrichment in atherogenic EVs	28882869
4317	Mouse	mmu-miR-365	miRNA	oxidized low density lipoprotein (ox-LDL)	atherosclerosis (AS)	peritoneal macrophages; Bone-marrow derived macrophages (BMDMs)	oxidized low-density lipoprotein (ox-LDL) treatment	upregulated	28882869
4318	Mouse	mmu-miR-365	miRNA	dexamethasone (DEX)	osteoporosis	MC3T3-E1 osteoblasts	dexamethasone (DEX) treatment	downregulated	28471397
4319	Mouse	mmu-miR-365	miRNA	type II collagen and freund's adjuvant	rheumatoid arthritis (RA)	synovial tissues	type II collagen and freund's adjuvant treatment	MiR-365 expression decreased in synovial tissues of RA mice	31881377
4320	Mouse	mmu-miR-365	miRNA	curcumin (Cur)	secondary osteoporosis	bone	curcumin treatment	downregulated	26884838
4321	Mouse	mmu-miR-365	miRNA	mycobacterium tuberculosis (Mtb)	tuberculosis (TB)	M(IL-4/IL-13) macrophages	Mycobacterium tuberculosis (Mtb) HN878 infection	upregulated	30941122
4322	Mouse	mmu-miR-365-1-5p	miRNA	cyclophosphamide (CP)	chronic ovarian dysfunction	ovarian tissues	cyclophosphamide (CP) treatment	"CP treatment decreased the expression of miR-365-1-5p and miR-574-5p and increased that of miR-3472 and miR-667-3p, whereas SM administration restored the expression levels of these microRNAs to those in the Con mice."	33318603
4323	Mouse	mmu-miR-365-1-5p	miRNA	samul-tang (SM)	chronic ovarian dysfunction	ovarian tissues	samul-tang (SM) treatment	"CP treatment decreased the expression of miR-365-1-5p and miR-574-5p and increased that of miR-3472 and miR-667-3p, whereas SM administration restored the expression levels of these microRNAs to those in the Con mice"	33318603
4324	Mouse	mmu-miR-3653-3p	miRNA	melatonin	osteoporosis	human bone marrow mesenchymal stem cell (hBMSC)	melatonin (MEL) treatment	Circ_0003865 expression in BMSCs was significantly decreased by MEL treatment.	33632317
4325	Mouse	mmu-miR-365-3p	miRNA	complete freund's adjuvant (CFA)	chronic inflammatory pain	spinal cord	complete Freund's adjuvant (CFA) treatment	A significant increase in miR-365-3p expression was observed from day 1 to day 7 after CFA in- jection.	31914601
4326	Mouse	mmu-miR-367	miRNA	engrafting E6.5 embryos (wildtype or Gtl2((-/+)))	teratomas	mice	engrafting E6.5 embryos (wildtype or Gtl2((-/+))) treatment	downregulated	25355544
4327	Mouse	mmu-miR-367-3p	miRNA	toosendanin (TSN)	liver damage	mouse serum	toosendanin (TSN) treatment	upregulated	30844585
4328	Mouse	mmu-miR-369-3p	miRNA	quercetin	chronic inflammatory diseases	LPS-treated murine bone marrow¨Cderived DCs (BMDCs)	quercetin treatment	upregulated	31338984
4329	Mouse	mmu-miR-369-3p	miRNA	dextran sodium sulfate (DSS)	colitis	colon tissues and isolated CD11c+ cells from colon	dextran-sulfate-sodium (DSS) treatment	downregulated	31338984
4330	Mouse	mmu-miR-369-3p	miRNA	quercetin	colitis	DSS-induced colitis mice colon tissues and isolated CD11c+ cells from colon	quercetin treatment	upregulated	31338984
4331	Mouse	mmu-miR-369-3p	miRNA	bleomycin (BLM)	idiopathic pulmonary fibrosis (IPF)	A549 cells	bleomycin (BLM) treatment	TRIM2 expression was increased and miR-369-3p expression was decreased in the lung tissues of mice with BLM-induced fibrosis and in TGF-¦Â1-stimulated A549 cells. DLEU2 directly targeted miR-369-3p.	33760118
4332	Mouse	mmu-miR-369-3p	miRNA	TGF-¦Â1	idiopathic pulmonary fibrosis (IPF)	A549 cells	TGF-¦Â1 treatment	TRIM2 expression was increased and miR-369-3p expression was decreased in the lung tissues of mice with BLM-induced fibrosis and in TGF-¦Â1-stimulated A549 cells DLEU2 directly targeted miR-369-3p	33760118
4333	Mouse	mmu-miR-3695	miRNA	luteinising hormone (LH)	functions of Leydig cells	mouse TM3 Leydig cells	luteinising hormone (LH) treatment	upregulated	28762514
4334	Mouse	mmu-miR-3695	miRNA	luteinising hormone (LH)	steroidogenesis	mouse TM3 Leydig cells	luteinising hormone(LH) treatment	dysregulated	28762514
4335	Mouse	mmu-miR-369-5p	miRNA	alcohol	fetal alcohol spectrum disorders (FASD)	brain tissues	alcohol exposure	downregulated	23580197
4336	Mouse	mmu-miR-369-5p	miRNA	N-ethyl-N-nitrosourea (ENU)	hepatocellular carcinoma (HCC)	liver tissues	N-ethyl-N-nitrosourea (ENU) treatment	downregulated	21029445
4337	Mouse	mmu-miR-370	miRNA	high glucose (HG)	diabetic nephropathy (DN)	Mouse podocytes (MPC5)	high glucose treatment	upregulated	30095204
4338	Mouse	mmu-miR-370	miRNA	ischemia	hepatic ischemia/reperfusion injury (HIRI)	male C57BL/6 mice	hepatic ischemia-reperfusion (HIR)	upregulated	24351048
4339	Mouse	mmu-miR-370	miRNA	ischemia/reperfusion (I/R) 	hepatic ischemia/reperfusion injury (HIRI)	liver tissues	ischemia/reperfusion (I/R) treatment	upregulated	28043920
4340	Mouse	mmu-miR-370	miRNA	glucagon-like peptide-1 (GLP-1)	lipotoxic oxidative stress	FFA-treated INS-1 cells	GLP-1	downregulated	27956176
4341	Mouse	mmu-miR-370	miRNA	ischemia/reperfusion (I/R) 	hepatic ischemia/reperfusion injury (HIRI)	C57BL/6 mice liver	ischemia/reperfusion (I/R) treatment	upregulated	28043920
4342	Mouse	mmu-miR-370	miRNA	hypoxia	myocardial ischemia/reperfusion (I/R) injury (MIRI)	cardiomyocytes	"The left anterior descending coronary artery was ligated with 6-0 sutures ?1.5 mm from the tip of the left auricle with a hollow plastic tube. After 30 min of ischemia, the hollow plastic tube was cut and blood flow was restored"	downregulated	30856533
4343	Mouse	mmu-miR-370	miRNA	sevoflurane (SEV)	myocardial ischemia/reperfusion (I/R) injury (MIRI)	cardiomyocytes	sevoflurane anesthetic preconditioning (SAP) treatment	upregulated	30856533
4344	Mouse	mmu-miR-370	miRNA	salidroside (SAL)	type 2 diabetes mellitus (T2DM)	liver tissue of mice	Salidroside treatment	downregulated	26948318
4345	Mouse	mmu-miR-370-3p	miRNA	fructus meliae toosendan (FMT)	liver damage	serum	Fructus Meliae Toosendan water extract (FMT) treatment	downregulated	29434260
4346	Mouse	mmu-miR-370-3p	miRNA	lipopolysaccharide (LPS)	sepsis	RAW 264.7	lipopolysaccharide (LPS) treatment	LncRNA NEAT1 promoted the inflammation and apoptosis while restrained the proliferation of LPS-stimulated RAW 264.7 cells through the miR-370-3p/TSP-1 axis.	31957847
4347	Mouse	mmu-miR-370-3p	miRNA	lipopolysaccharide (LPS)	sepsis	RAW 264.7 cells; HL-1 cells	lipopolysaccharides (LPS) treatment	downregulated	34004695
4348	Mouse	mmu-miR-371	miRNA	"5-Aza-2'-deoxycytidine (5-Aza-dC, decitabine)"	gastric cancer (GC)	balb/c nu-nu mice injected with 107 GC cells	"5-Aza-2'-deoxycytidine (5-Aza-dC, decitabine) treatment"	upregulated	25270964
4349	Mouse	mmu-miR-371-5p	miRNA	lipopolysaccharide (LPS)	autophagy	RAW 264.7 cells	lipopolysaccharide (LPS) treatment	downregulated	29845275
4350	Mouse	mmu-miR-373	miRNA	streptozocin (STZ)	diabetes mellitus (DM)	hearts of diabetic mice	streptozotocin (STZ) treatment	downregulated	21584493
4351	Mouse	mmu-miR-374	miRNA	histone deacetylase inhibitor (HDACi)	hypercalciuric diseases	mouse	HDAC inhibitors treatment	upregulated	25071082
4352	Mouse	mmu-miR-374	miRNA	hypoxia	myocardial ischemia/reperfusion (I/R) injury (MIRI)	heart tissues	The left anterior descending branch of LCA was ligated.	downregulated	30565678
4353	Mouse	mmu-miR-374	miRNA	thoracic epidural anesthesia (TEA)	myocardial ischemia/reperfusion (I/R) injury (MIRI)	myocardial I/R mice heart tissues	thoracic epidural anesthesia (TEA) treatment	upregulated	30565678
4354	Mouse	mmu-miR-374	miRNA	anandamide (AEA)	pro-inflammatory activity	mouse	anandamide treatment	AEA differentil regulate the expression of miRNA	24699635
4355	Mouse	mmu-miR-374	miRNA	propofol (PPF)	propofol-induced developmental neurotoxicity	hippocampus	propofol treatment	upregulated	30242182
4356	Mouse	mmu-miR-374*	miRNA	polyphenols	cell function	mice liver cells	Polyphenols treatment	downregulated	22253797
4357	Mouse	mmu-miR-374*	miRNA	plasmodium chabaudi malaria	peak parasitemia	liver of mice	Plasmodium chabaudi malaria infection treatment	downregulated	21085987
4358	Mouse	mmu-miR-374-5p	miRNA	"paraquat (PQ) and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)"	dopaminergic (DA) neuron differentiation	neuro-2a cells	"paraquat (PQ) and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) treatment"	dysregulated	29250806
4359	Mouse	mmu-miR-374-5p	miRNA	"1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)"	neurodegenerative diseases	N2a cells	"1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) treatment"	downregulated	29250806
4360	Mouse	mmu-miR-374-5p	miRNA	"1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)"	neurodegenerative diseases	N2a cells	"1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) treatment"	downregulated	29250806
4361	Mouse	mmu-miR-374-5p	miRNA	paraquat (PQ)	neurodegenerative diseases	N2a cells	paraquat (PQ) treatment	downregulated	29250806
4362	Mouse	mmu-miR-374a-5p	miRNA	lipopolysaccharide (LPS)	neonatal hypoxic-ischemic encephalopathy 	BV-2 cells	lipopolysaccharide (LPS) treatment	downregulated	32464126
4363	Mouse	mmu-miR-374b	miRNA	¦¤9-tetrahydrocannabinol (THC)	inflammation	total lymph node cells and CD4(+) T cells	¦¤9-Tetrahydrocannabinol (THC) treatment	downregulated	27268054
4364	Mouse	mmu-miR-374b-5p	miRNA	amyloid-¦Â (A¦Â) 25-35	Alzheimer's disease (AD)	BV2 cells	amyloid-¦Â (A¦Â) 25-35 treatment	"The expression of MAGI2-AS3 was increased, and miR-374b-5p was decreased in both SH-SY5Y and BV2 cells exposed to A¦Â25-35."	33279663
4365	Mouse	mmu-miR-374b-5p	miRNA	amyloid-¦Â (A¦Â) 25-35	Alzheimer's disease (AD)	BV2 cells	amyloid-¦Â (A¦Â) 25-35 treatment	MAGI2-AS3/miR-374b-5p axis regulates A¦Â-induced neurotoxicity in SH-SY5Y cells and neuroinflammation in BV2 cells.	33279663
4366	Mouse	mmu-miR-374c	miRNA	myelin oligodendrocyte glycoprotein	experimental autoimmune encephalomyelitis (EAE)	spleen and brain tissues	myelin oligodendrocyte glycoprotein treatment	downregulated	31756487
4367	Mouse	mmu-miR-374c	miRNA	hypoxia	hypoxic pulmonary hypertension (HPH)	pulmonary artery smooth muscle cells (PASMCs)	hypoxic treatment	mmu_circ_0000790 Is Involved in Pulmonary Vascular Remodeling in Mice with HPH via MicroRNA-374c-Mediated FOXC1.	32199127
4368	Mouse	mmu-miR-374c-5p	miRNA	palmitic acid (PA)	impaired insulin secretion	¦Â-TC-6 cells	palmitic acid treatment	upregulated	32302972
4369	Mouse	mmu-miR-374c-5p	miRNA	stearic acid	impaired insulin secretion	¦Â-TC-6 cells	stearic acid treatment	upregulated	32302972
4370	Mouse	mmu-miR-375	miRNA	streptozocin (STZ)	¦Â-cell death and diabetes	mice ?peripheral blood and mice islets	?streptozotocin (STZ) treatment	"High-dose STZ administration dramatically increased circulating miR-375 levels, prior to the onset of hyperglycemia"	23321698
4371	Mouse	mmu-miR-375	miRNA	ovalbumin (OVA)	allergic rhinitis (AR)	the epithelia of nasal mucosa of allergic rhinitis mice	ovalbumin (OVA) treatment	downregulated	29677549
4372	Mouse	mmu-miR-375	miRNA	liraglutide	apoptosis	"mouse pancreatic ¦Á-cell line, ¦Á-TC1-6, and mouse pancreatic ¦Â-cell line, ¦Â-TC-tet"	could increase the level of and cell in pancreatic ¦Á-cells	upregulated	29225111
4373	Mouse	mmu-miR-375	miRNA	high fat diet (HFD)	atherosclerosis (AS)	heart tissues of ApoE-/- mice	high fat diet (HFD) feed	upregulated	30870679
4374	Mouse	mmu-miR-375	miRNA	tanshinone IIA (Tan IIA)	atherosclerosis (AS)	heart tissues of high-fat diet (HFD) fed ApoE-/- mice	Tanshinone IIA (TNA) treatment	downregulated	30870679
4375	Mouse	mmu-miR-375	miRNA	dextran sodium sulfate (DSS)	colitis	colon tissues	dextran sodium sulfate (DSS) treatment	downregulated	29867475
4376	Mouse	mmu-miR-375	miRNA	doxycycline	colitis	colon tissues	doxycycline (DXC) treatment	upregulated	30076847
4377	Mouse	mmu-miR-375	miRNA	minocycline (MNC)	colitis	colon tissues	minocycline (MNC) treatment	upregulated	30076847
4378	Mouse	mmu-miR-375	miRNA	tetracycline (TTC)	colitis	colon tissues	tetracycline (TTC) treatment	upregulated	30076847
4379	Mouse	mmu-miR-375	miRNA	tigecycline (TGC)	colitis	colon tissues	tigecycline (TGC) treatment	upregulated	30076847
4380	Mouse	mmu-miR-375	miRNA	streptozocin (STZ)	diabetic nephropathy (DN)	proximal colon myenteric plexus	streptozotocin (STZ) treatment	upregulated	30140011
4381	Mouse	mmu-miR-375	miRNA	dextran sodium sulfate (DSS)	inflammatory bowel disease (IBD)	colon tissues	dextran sulfate sodium (DSS) treatment	downregulated	30236870
4382	Mouse	mmu-miR-375	miRNA	high fat diet (HFD)	inflammatory response	skeletal muscle of mice	high fat diet (HFD) feed	"miR-375, miR-29, miR-320, miR-103/107 and miR-126, play a crucial role in the regulation of glucose and lipid metabolism through the control of pancreatic islet cell function"	22395471
4383	Mouse	mmu-miR-375	miRNA	high fat diet (HFD)	insulin resistance (IR)	Fecal exosomes released from intestinal epithelial cells (IECs)	?high-fat diet?feed treatment	We report that HFD feeding increased the expression of AhR and inhibited the expression of miR-375 and VAMP7	33754048
4384	Mouse	mmu-miR-375	miRNA	exenatide (EXA)	insulin sensitivity	pancreas	exenatide treatment	"The levels of miRNA-15a, 29c, 124a, and 375 in the pancreas were significantly increased in HFD control mice.These effects were reversed by treatment with exenatide."	26314504
4385	Mouse	mmu-miR-375	miRNA	exenatide (EXA)	insulin sensitivity	serum	exenatide treatment	"the levels of miRNA-15a, 29c, 124a, and 375 in the serum were significantly decreased. These effects were reversed by treatment with exenatide."	26314504
4386	Mouse	mmu-miR-375	miRNA	high fat diet (HFD)	insulin sensitivity	pancreas	high fat diet (HFD) feed	upregulated	26314504
4387	Mouse	mmu-miR-375	miRNA	high fat diet (HFD)	insulin sensitivity	serum	high fat diet (HFD) feed	downregulated	26314504
4388	Mouse	mmu-miR-375	miRNA	human islet grafts of adoptive lymphocyte transfer (ALT)	islets of Langerhans	mouse circulation	ALT	upregulated	27700000
4389	Mouse	mmu-miR-375	miRNA	concanamycin A (Con A)	liver damage	primary Kupffer cells	concanavalin A (ConA) treatment	upregulated	30206980
4390	Mouse	mmu-miR-375	miRNA	concanamycin A (Con A)	liver damage	liver tissues	concanavalin A (ConA) treatment	upregulated	30206980
4391	Mouse	mmu-miR-375	miRNA	streptozocin (STZ)	loss and apoptosis of beta cell	mouse blood plasma	STZ treatment	upregulated in blood plasma	29040320
4392	Mouse	mmu-miR-375	miRNA	morphine	morphine tolerance	CD-1 mice dorsal root ganglia (DRG)	chronic morphine treatment	downregulated in mouse dorsal root ganglia (DRG)	28603428
4393	Mouse	mmu-miR-375	miRNA	hypoxia	myocardial infarction (MI)	neonatal mouse ventricular cardiomyocytes (NMCMs)	hypoxia treatment	LNC_000898 could protect the heart against MI injury by regulating miR-375/PDK1.	32398474
4394	Mouse	mmu-miR-375	miRNA	cisplatin (DDP)	nephrotoxicity	mouse kidney proximal tubular cells	cisplatin treatment	upregulated	28119452
4395	Mouse	mmu-miR-375	miRNA	high fat diet (HFD)	nonalcoholic fatty liver disease (NAFLD)	liver tissues	high fat diet (HFD) feed	upregulated	29569260
4396	Mouse	mmu-miR-375	miRNA	IL-1¦Â	osteoarthritis (OA)	primary cultured chondrocytes	IL-1¦Â treatment	upregulated	32045921
4397	Mouse	mmu-miR-375	miRNA	astaxanthin	prostate cancer	Pca mouse tumor tissues	intragastrically administered 100 mg/kg astaxanthin (HA)	upregulated	28282880
4398	Mouse	mmu-miR-375	miRNA	kainic acid (KA)	temporal lobe epilepsy (TLE)	hippocampal tissues	kainic acid (KA) treatment	UCA1 was overexpressed in mice and the overexpression of UCA1 significantly reversed the abnormal proliferation of hippocampal neurons in epilepsy mice.	33829718
4399	Mouse	mmu-miR-375	miRNA	liraglutide	type 2 diabetes mellitus (T2DM)	"mouse pancreatic ¦Á-cell line, ¦Á-TC1-6"	liraglutide treatment	upregulated	29225111
4400	Mouse	mmu-miR-375	miRNA	liraglutide	type 2 diabetes mellitus (T2DM)	"mouse pancreatic ¦Â-cell line, ¦Â-TC-tet"	liraglutide treatment	downregulated	29225111
4401	Mouse	mmu-miR-375-3p	miRNA	X-rays	bystander effect	C57BL/6 mice extracellular vesicles (EVs)	otal-body irradiated with X-rays	upregulated	28396668
4402	Mouse	mmu-miR-375-3p	miRNA	solar particle event (SPE)	colorectal cancer (CRC)	plasma of a colorectal cancer susceptible mouse	solar particle event (SPE) treatment	downregulated	26432591
4403	Mouse	mmu-miR-375-3p	miRNA	streptozocin (STZ)	islets damage	serum exosomes	streptozocin (STZ) treatment	Exosomal mmu-miR-375-3p dramatically increased in serum of STZ treated mouse prior to the disturbance of blood glucose and insulin	30552311
4404	Mouse	mmu-miR-375-3p	miRNA	X-rays	vulvovaginal candidiasis (VVC)	serum	mouse whole body exposure to 7?Gy of X-rays. treatment	upregulated	29358747
4405	Mouse	mmu-miR-376	miRNA	antioxidant of bamboo leaves (AOB)	vascular development	embryoid bodies (EBs)	antioxidant of bamboo leaves (AOB) treatment	miR-376 was markedly downregulated following AOB treatment compared with the control.	29207159
4406	Mouse	mmu-miR-376a	miRNA	metformin (Met)	nonalcoholic steatohepatitis (NASH)	liver tissues	metformin treatment	upregulated	25672270
4407	Mouse	mmu-miR-376b-3p	miRNA	dihydroartemisinin (DHA)	inflammation	Mouse aortic vascular smooth muscle cells (VSMCs)	dihydroartemisinin (DHA) treatment	DHA was observed to directly depress the HG-induced expression of miR-376b-3p.	32753318
4408	Mouse	mmu-miR-376b-3p	miRNA	Japanese encephalitis virus (JEV)	Japanese encephalitis virus (JEV) infection	BV-2 cells; mouse neuroblastoma cell line NA; mouse brain endothelial cell line bEnd.3 	Japanese encephalitis virus (JEV) infection	downregulated	32461319
4409	Mouse	mmu-miR-376b-3p	miRNA	FTY-720	parkinson's disease (PD)	dopaminergic MN9D cells	FTY720 treatment	upregulated	30359694
4410	Mouse	mmu-miR-376b-3p	miRNA	FTY720-C2	parkinson's disease (PD)	dopaminergic MN10D cells	FTY720-C2 treatment	upregulated	30359694
4411	Mouse	mmu-miR-376b-3p	miRNA	FTY720-mitoxy	parkinson's disease (PD)	dopaminergic MN11D cells	FTY720-Mitoxy treatment	upregulated	30359694
4412	Mouse	mmu-miR-376b-3p	miRNA	FTY720-C2	parkinson's disease (PD)	MN9D cells	FTY720-C2 treatment	upregulated	30359694
4413	Mouse	mmu-miR-377	miRNA	cyclosporine A (CsA)	cardiomyocyte apoptosis	cardiomyocytes	cyclosporine A treatment	the expression of microRNA (miR)-377 was regulated by CsA.	26948033
4414	Mouse	mmu-miR-377	miRNA	hypoxia	cerebral ischemia injury (CII)	mouse brain microvascular endothelial cells (BMECs)	oxygen-glucose deprivation (OGD) induce	"lncRNA NEAT1 facilitated the survival and angiogenesis of OGD-induced BMECs via targeting miR-377 and promoting the expression of VEGFA, SIRT1, and BCL-XL."	30408478
4415	Mouse	mmu-miR-377	miRNA	oxygen glucose deprivation (OGD)	cerebral ischemia injury (CII)	brain microvascular endothelial cells (BMECs)	oxygen-glucose deprivation (OGD) treatment	Upregulation of lncRNA NEAT1 and downregulated of miR-377 were also observed under OGD conditions	30408478
4416	Mouse	mmu-miR-377	miRNA	high glucose (HG)	diabetic nephropathy (DN)	mesangial cells	high glucose treatment	upregulated	18716028
4417	Mouse	mmu-miR-377	miRNA	high glucose (HG)	diabetic nephropathy (DN)	Mouse podocytes (MPC5)	high glucose treatment	upregulated	30095204
4418	Mouse	mmu-miR-377	miRNA	TGF-¦Â	diabetic nephropathy (DN)	mesangial cells	transforming growth factor-¦Â treatment	?upregulated	18716028
4419	Mouse	mmu-miR-377	miRNA	plasmodium chabaudi malaria	peak parasitemia	liver of mice	Plasmodium chabaudi malaria infection treatment	downregulated	21085987
4420	Mouse	mmu-miR-377	miRNA	IFN-¦Ã	sj?gren's syndrome (SS)	salivary gland epithelial cells (SGECs)	interferon gamma (IFN-¦Ã) treatment	downregulated	31198060
4421	Mouse	mmu-miR-377-3p	miRNA	high fat diet (HFD)	atherosclerosis (AS)	aorta tissues	high fat diet (HFD) feed	Deletion of ApoE and HFD treatment significantly downregulated miR-377-3p levels in aorta tissues.	32373927
4422	Mouse	mmu-miR-377-3p	miRNA	chronic unpredictable mild stress (CUMS)	major depressive disorder (MDD)	nucleus accumbens (NAc) tissues	chronic unpredictable mild stress (CUMS) induce	downregulated	30936699
4423	Mouse	mmu-miR-378	miRNA	coenzyme Q10 (CoQ10)	atherosclerosis (AS)	mouse J774.A1 THP-1 macrophages	CoQ10 treatment	downregulated	24675662
4424	Mouse	mmu-miR-378	miRNA	oxygen glucose deprivation (OGD)	autophagy	primary neurons; brain tissues	oxygen glucose deprivation (OGD) treatment	downregulated	32605923
4425	Mouse	mmu-miR-378	miRNA	fish oil	brown adipose tissue thermogenesis	brown adipocytes	fish oil treatment	upregulated	27489163
4426	Mouse	mmu-miR-378	miRNA	TGF-¦Â1	cardiac fibrosis	mouse cardiac fibroblasts (CFs)	TGF-¦Â1 treatment	downregulated	31220469
4427	Mouse	mmu-miR-378	miRNA	angiotensin II (Ang II)	cardiac hypertrophy	cardiate	angiotensin II (Ang II) treatment	upregulated	25104350
4428	Mouse	mmu-miR-378	miRNA	high fat diet (HFD)	chondrogenesis	white adipose tissues	high fat diet (HFD) feed	downregulated	22496873
4429	Mouse	mmu-miR-378	miRNA	astragaloside IV (AS-IV)	diabetic nephropathy (DN)	high glucose-treated the mouse podocyte clone 5 (MPC5) cells	astragaloside (AS-IV) treatment	upregulated	29792879
4430	Mouse	mmu-miR-378	miRNA	high glucose (HG)	diabetic nephropathy (DN)	The mouse podocyte clone 5 (MPC5) cells	high glucose (HG) treatment	downregulated	29792879
4431	Mouse	mmu-miR-378	miRNA	fish oil	hepatosteatosis	mice liver tissues	Fisetin treatment	downregulated	23818290
4432	Mouse	mmu-miR-378	miRNA	ischemia	intestinal ischemia/reperfusion (I/R) injury	?intestinal mucosal cell	intestinal ischemia/reperfusion (I/R)	downregulated	29022896
4433	Mouse	mmu-miR-378	miRNA	electrical stimulation (EleS)	ischemic heart disease (IHD)	cardiac stem cells (CSCs)	electrical stimulation (EleS) treatment	miR-378 as a potential Ctgf regulator in (EleS)CSCs	24067999
4434	Mouse	mmu-miR-378	miRNA	oxygen glucose deprivation (OGD)	ischemic stroke (IS)	N2A cells	oxygen-glucose deprivation (OGD) treatment	downregulated	27598143
4435	Mouse	mmu-miR-378	miRNA	listeria	Listeria infection	murine ileum tissues	Listeria infection	downregulated	24327339
4436	Mouse	mmu-miR-378	miRNA	stretch	myoblast proliferation	C2C12 myoblasts	stretch treatment	downregulated	27840929
4437	Mouse	mmu-miR-378	miRNA	high fat diet (HFD)	nonalcoholic fatty liver disease (NAFLD)	liver tissues	high fat diet (HFD) feed	miR-378 was significantly increased in fatty livers of dietary obese mice and human hepatoma HepG2 cells with accumulated lipid.	29625129
4438	Mouse	mmu-miR-378	miRNA	high fat diet (HFD)	nonalcoholic fatty liver disease (NAFLD)	mouse liver	high fat diet (HFD) feed	upregulated	30218679
4439	Mouse	mmu-miR-378	miRNA	high fat diet (HFD)	nonalcoholic fatty liver disease (NAFLD)	liver tissues	high fat diet (HFD) feed	upregulated	30281809
4440	Mouse	mmu-miR-378	miRNA	high glucose (HG)	osteogenesis	mouse osteoblastic cell line MC3T3-E1	"high glucose (15.5, 25.5 or 35.5 mM) treatment"	upregulated	25400823
4441	Mouse	mmu-miR-378	miRNA	propofol (PPF)	propofol-induced developmental neurotoxicity	hippocampus	propofol treatment	upregulated	30242182
4442	Mouse	mmu-miR-378	miRNA	olanzapine (OLP)	psychotic disorders	brain tissues	clozapine treatment	upregulated	23318695
4443	Mouse	mmu-miR-378	miRNA	mycobacterium tuberculosis (Mtb)	pulmonary tuberculosis (PTB)	lung tissues	mycobacterium tuberculosis (Mtb) treatment	downregulated	33089914
4444	Mouse	mmu-miR-378	miRNA	pSTAT3-specific inhibitor AG-490	pulmonary tuberculosis (PTB)	lung tissues	pSTAT3-specific inhibitor AG-490 treatment	upregulated	33089914
4445	Mouse	mmu-miR-378-3p	miRNA	"paraquat (PQ) and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)"	dopaminergic (DA) neuron differentiation	neuro-2a cells	"paraquat (PQ) and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) treatment"	dysregulated	29250806
4446	Mouse	mmu-miR-378-3p	miRNA	morphine	morphine tolerance	brainstem	morphine treatment	Chronic morphine treatment significantly increased the miR-378-3p level in the brainstem of the morphine tolerant mice.	31999011
4447	Mouse	mmu-miR-378-3p	miRNA	"1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)"	neurodegenerative diseases	N2a cells	"1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) treatment"	upregulated	29250806
4448	Mouse	mmu-miR-378-5p	miRNA	"1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)"	neurodegenerative diseases	N2a cells	"1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) treatment"	upregulated	29250806
4449	Mouse	mmu-miR-378a	miRNA	lipopolysaccharide (LPS)	acute aortic dissection (AAD)	aorta	lipopolysaccharide (LPS) treatment	downregulated	32634201
4450	Mouse	mmu-miR-378a	miRNA	high fat diet (HFD)	atherosclerosis (AS)	the aorta of ApoE-/- mice	high fat diet (HFD) feed	downregulated	30929259
4451	Mouse	mmu-miR-378a	miRNA	nano-titanium dioxide (nano-TiO2)	cardiovascular function	mouse heart tissues	Nano-titanium dioxide (nano-TiO2) treatment	upregulated	30704319
4452	Mouse	mmu-miR-378a-3p	miRNA	ionizing radiation (IR)	abdominal cancer	small intestines	ionizing radiation (IR) treatment	miR-378a-3p was markedly upregulated in the small intestines of mice after total abdominal irradiation.	32800335
4453	Mouse	mmu-miR-378a-3p	miRNA	high fat diet (HFD)	adipogenesis	mouse	high fat diet (HFD) feed	upregulated	25529446
4454	Mouse	mmu-miR-378a-3p	miRNA	high fat diet (HFD)	adipogenesis and obesity	adipose	high fat diet (HFD) feed	upregulated	25529446
4455	Mouse	mmu-miR-378a-3p	miRNA	Jiang Tang Xiao Ke Granule	diabetes mellitus (DM)	KKAy diabetic mice	Jiang Tang Xiao Ke Granule treatment	dysregulated	29163176
4456	Mouse	mmu-miR-378a-3p	miRNA	carbon tetrachloride (CCl4)	hepatic fibrogenesis	hepatic stellate cells (HSCs)	CCl4 treatment	downregulated	27001906
4457	Mouse	mmu-miR-378a-3p	miRNA	carbon tetrachloride (CCl4)	liver fibrosis	liver	CCl4 treatment	downregulated	27322257
4458	Mouse	mmu-miR-378a-3p	miRNA	high fat diet (HFD)	hyperlipidemia	fatty livers	high fat diet (HFD) feed	Activation of microRNA-378a-3p biogenesis promotes hepatic secretion of VLDL and hyperlipidemia by modulating ApoB100-Sortilin1 axis	32226531
4459	Mouse	mmu-miR-378a-3p	miRNA	carbon tetrachloride (CCl4)	liver fibrosis	primary hepatic stellate cell (HSC)	CCl4 treatment	downregulated	31272073
4460	Mouse	mmu-miR-378a-5p	miRNA	tanshinone IIA (Tan IIA)	atherosclerosis (AS)	RAW 264.7 cells	Tanshinone IIA (Tan) treatment	upregulated	32337768
4461	Mouse	mmu-miR-378b	miRNA	luteinising hormone (LH)	functions of Leydig cells	mouse TM3 Leydig cells	luteinising hormone (LH) treatment	upregulated	28762514
4462	Mouse	mmu-miR-378b	miRNA	carbon tetrachloride (CCl4)	hepatic fibrogenesis	hepatic stellate cells (HSCs)	CCl4 treatment	downregulated	27001906
4463	Mouse	mmu-miR-378b	miRNA	carbon tetrachloride (CCl4)	liver fibrosis	liver	CCl4 treatment	downregulated	27322257
4464	Mouse	mmu-miR-378b	miRNA	luteinising hormone (LH)	steroidogenesis	mouse TM3 Leydig cells	luteinising hormone(LH) treatment	dysregulated	28762514
4465	Mouse	mmu-miR-378c	miRNA	tanshinone IIA (Tan IIA)	atherosclerosis (AS)	RAW 264.7 cells	Tanshinone IIA (Tan) treatment	upregulated	32337768
4466	Mouse	mmu-miR-378d	miRNA	echinococcus multilocularis metacestodes	echinococcus multilocularis infection	RAW 264.7 cells	E. multilocularis metacestodes treatment	upregulated	30322806
4467	Mouse	mmu-miR-378d	miRNA	carbon tetrachloride (CCl4)	hepatic fibrogenesis	hepatic stellate cells (HSCs)	CCl4 treatment	downregulated	27001906
4468	Mouse	mmu-miR-378d	miRNA	carbon tetrachloride (CCl4)	liver fibrosis	liver	CCl4 treatment	downregulated	27322257
4469	Mouse	mmu-miR-378d	miRNA	E. multilocularis metacestodes	infection and immunity of E. multilocularis	RAW264¡¤7 macrophage cells	E. multilocularis metacestodes for 6 and 12 h treatment	"upregulated (mmu-miR-378d,mmu-miR-155-5p, mmu-miR-146a-5p, mmu-miR-21a-5p , mmu-miR-125a-5p) and downregulated(mmu-miR-1981-5p , mmu-miR-let-7c-1-3p)"	28942753
4470	Mouse	mmu-miR-378d	miRNA	chronic unpredictable mild stress (CUMS)	major depressive disorder (MDD)	nucleus accumbens (NAc) tissues	chronic unpredictable mild stress (CUMS) induce	upregulated	30936699
4471	Mouse	mmu-miR-378d	miRNA	alpinia oxyphylla extract (AOE)	type 2 diabetes mellitus (T2DM)	db-/db- mouse kidney	A. oxyphylla extract (AOE) treatment	upregulated	28249617
4472	Mouse	mmu-miR-379	miRNA	dexamethasone (DEX)	duchenne muscular dystrophy (DMD)	muscle	dexamethasone (DEX) treatment	dexamethasone resulted in reduced muscle expression of miR-379.	32499563
4473	Mouse	mmu-miR-379	miRNA	cigarette smoke (CS)	ovarian toxicity	ovarian tissues	cigarette smoke (CS) treatment	downregulated	29377183
4474	Mouse	mmu-miR-379-5p	miRNA	arsenite	arsenite-induced liver damage	liver tissue	arsenite exposure	downregulated	30643918
4475	Mouse	mmu-miR-379-5p	miRNA	high glucose (HG)	diabetic nephropathy (DN)	mouse mesangial cells (MMCs)	high glucose (HG) treatment	downregulated	31485601
4476	Mouse	mmu-miR-380-3p	miRNA	cigarette smoke (CS)	chronic obstructive pulmonary disease (COPD)	lung tissue and alveolar macrophages	cigarette smoke (CS) exposure	upregulated	31819170
4477	Mouse	mmu-miR-380-3p	miRNA	paraquat (PQ)	paraquat (PQ)-induced toxicity	mouse neuroblastoma (N2a) cells or tert-Butylhydroquinone (TBHQ)-treated N2a cells	paraquat (PQ) exposure	downregulated	31368498
4478	Mouse	mmu-miR-380-3p	miRNA	tert-butyl hydroperoxide (TBHP)	paraquat (PQ)-induced toxicity	mouse neuroblastoma (N2a) cells	tert-Butylhydroquinone (TBHQ) treatment	upregulated	31368498
4479	Mouse	mmu-miR-381	miRNA	dexmedetomidine (DEX)	acute lung injury (ALI)	LPS-induced acute lung injury mouse lung tissues	dexmedetomidine (Dex) treatment	upregulated	30102002
4480	Mouse	mmu-miR-381	miRNA	lipopolysaccharide (LPS)	acute lung injury (ALI)	lung tissues	lipopolysaccharide (LPS) treatment	downregulated	30102002
4481	Mouse	mmu-miR-381	miRNA	H2O2	myocardial infarction (MI)	Primary cultured cardiomyocyte	H2O2 treatment	upregulated	30105734
4482	Mouse	mmu-miR-381	miRNA	hypoxia	myocardial infarction (MI)	Primary cultured cardiomyocyte	hypoxia induce	upregulated	30105734
4483	Mouse	mmu-miR-381-3p	miRNA	"2, 3, 7, 8-tetrachlorodibenzo-p-dioxin (TCDD)"	cleft palate (CP)	E13.5 and E14.5 fetal palates	"On embryonic day 10.5 (E10.5), the pregnant mice in TCDD group were orally administrated with TCDD at dosage of 28 ¦Ìg/kg, while the pregnant mice in control group received equivalent corn oil. The pregnant mice in each group were sacrificed on E13.5 and E14.5, fetal palates were collected for analysis."	downregulated	31512462
4484	Mouse	mmu-miR-381-3p	miRNA	streptozocin (STZ)	diabetic retinopathy (DR)	retina and serum of diabetic mice	streptozotocin treatment	upregulated	30883703
4485	Mouse	mmu-miR-381-3p	miRNA	"4,4'-methylene diphenyl diisocyanate (MDI)"	occupational asthma (OA)	Female BALB/c mice blood	"4,4'-methylene diphenyl diisocyanate (MDI) exposure"	downregulated	30074411
4486	Mouse	mmu-miR-381-3p	miRNA	"4,4'-methylene diphenyl diisocyanate (MDI)"	occupational asthma (OA)	bronchoalveolar lavage cells (BALCs)	"4,4'-methylene diphenyl diisocyanate (MDI) treatment"	downregulated	31609387
4487	Mouse	mmu-miR-381-3p	miRNA	"diisocyanate, 4,4'-methylene diphenyl diisocyanate (MDI)"	occupational asthma (OA)	Female BALB/c mice blood	Female BALB/c mice were exposed to one of three exposure regimens: dermal exposure to 1% MDI in acetone; nose-only exposure to 4580?¡À?1497?¦Ìg/m3 MDI-aerosol for 60?minutes; or MDI dermal exposure/sensitization followed by MDI-aerosol inhalation challenge.	downregulated	30074411
4488	Mouse	mmu-miR-382	miRNA	streptozocin (STZ)	diabetic nephropathy (DN)	renal tissues	streptozotocin (STZ) treatment	upregulated	29701296
4489	Mouse	mmu-miR-382	miRNA	¦Â-lapachone (BLC)	obesity	white adipose	¦Â-lapachone (BLC) treatment	downregulated	27246910
4490	Mouse	mmu-miR-382	miRNA	ochratoxin A (OTA)	ochratoxin A (OTA) toxicity	Primary proximal tubular epithelial cell	ochratoxin A treatment	upregulated	28710020
4491	Mouse	mmu-miR-382-3p	miRNA	exercise (Ex)	insulin resistance (IR)	serum from IR mouse	swimming	upregulated	31479923
4492	Mouse	mmu-miR-382-5p	miRNA	anandamide and norgestimate	depression	chronic mild stress (CMS) model of depression mouse	anandamide and norgestimate treatment	upregulated	28716528
4493	Mouse	mmu-miR-383	miRNA	calorie restriction (CR)	hepatic steatosis	high-fat (HF) diet-induced obesity prone (OP) mice thyroid and liver tissues	calorie restriction (CR) treatment	upregulated	31863770
4494	Mouse	mmu-miR-383	miRNA	exercise (Ex)	hepatic steatosis	high-fat (HF) diet-induced obesity prone (OP) mice thyroid and liver tissues	exercise (Ex) treatment	upregulated	31863770
4495	Mouse	mmu-miR-383	miRNA	high fat diet (HFD)	hepatic steatosis	mice thyroid and liver tissues	high fat diet (HFD) feed	downregulated	31863770
4496	Mouse	mmu-miR-383	miRNA	low fat diet (LFD)	hepatic steatosis	high-fat (HF) diet-induced obesity prone (OP) mice thyroid and liver tissues	low-fat diet (LF) treatment	upregulated	31863770
4497	Mouse	mmu-miR-383	miRNA	quercetin	hepatic steatosis	high-fat (HF) diet-induced obesity prone (OP) mice thyroid and liver tissues	quercetin (Que) treatment	upregulated	31863770
4498	Mouse	mmu-miR-383	miRNA	high glucose (HG)	high-fat induced diabetes	Islet beta-cell	high glucose (HG) treatment	miR-383 ameliorates high glucose-induced ¦Â-cells apoptosis and hyperglycemia in high-fat induced diabetic mice.	33058915
4499	Mouse	mmu-miR-383	miRNA	lipopolysaccharide (LPS)	inflammation	RAW264.7 cells	lipopolysaccharide (LPS) treatment	upregulated	26639663
4500	Mouse	mmu-miR-383	miRNA	methyltransferase G9a	liver mature	liver tissues from liver-specific knockout (Liv-KO) of G9a mice	liver-specific knockout (Liv-KO) of G9a	upregulated	29912608
4501	Mouse	mmu-miR-383	miRNA	low fat diet (LFD)	obesity	thyroid	low fat diet (LFD) treatment	downregulated	31863770
4502	Mouse	mmu-miR-383	miRNA	low fat diet (LFD)	obesity	thyroid	low fat diet (LFD) treatment	upregulated	31863770
4503	Mouse	mmu-miR-383	miRNA	quercetin	obesity	thyroid	quercetin (QUE) treatment	upregulated	31863770
4504	Mouse	mmu-miR-383-5p	miRNA	delvestidine (DLTD)	bone marrow-derived dendritic cells (BMDCs) maturity	bone marrow-derived dendritic cells (BMDCs)	Delvestidine (DLTD) treatment	upregulated	32871480
4505	Mouse	mmu-miR-383-5p	miRNA	resveratrol	diabetic nephropathy (DN)	db/db mice podocyte	resveratrol (RS) treatment	downregulated	28374806
4506	Mouse	mmu-miR-384	miRNA	ovalbumin (OVA)	asthma	mouse purified airway smooth muscle cells	OVA treatment	downregulated	28978085
4507	Mouse	mmu-miR-384	miRNA	hypoxia	ischemic brain injury	HT22 cells and hippocampal tissues	hypoxia induce	upregulated	31165722
4508	Mouse	mmu-miR-384-3p	miRNA	streptozocin (STZ)	diabetic retinopathy (DR)	retinal tissues	streptozotocin (STZ) treatment	downregulated	30191948
4509	Mouse	mmu-miR-384-3p	miRNA	propofol (PPF)	propofol-induced developmental neurotoxicity	hippocampus	propofol treatment	upregulated	30242182
4510	Mouse	mmu-miR-384-5p	miRNA	high fat diet (HFD)	atherosclerosis (AS)	macrophages	high fat diet (HFD) feed	upregulated	27158352
4511	Mouse	mmu-miR-384-5p	miRNA	angiotensin II (Ang II)	cardiac hypertrophy	primary cardiomyocytes (PCM)	angiotensin II (Ang II) treatment	downregulated	32436661
4512	Mouse	mmu-miR-384-5p	miRNA	streptozocin (STZ)	diabetic encephalopathy	Inflammatory macrophages were isolated from the brain of the mice	streptozotocin (STZ) treatment	downregulated	29511445
4513	Mouse	mmu-miR-392	miRNA	mycobacterium tuberculosis (Mtb)	pulmonary tuberculosis (PTB)	lung tissues	mycobacterium tuberculosis (Mtb) treatment	downregulated	33089914
4514	Mouse	mmu-miR-392	miRNA	pSTAT3-specific inhibitor AG-490	pulmonary tuberculosis (PTB)	lung tissues	pSTAT3-specific inhibitor AG-490 treatment	upregulated	33089914
4515	Mouse	mmu-miR-3963	miRNA	bilateral surgical destabilization of the medial meniscus (DMM)	osteoarthritis (OA)	male C57BL6 mice	bilateral surgical destabilization of the medial meniscus (DMM) treatment	dysregulated	29255152
4516	Mouse	mmu-miR-3p	miRNA	ultraviolet (UV) irradiation	skin inflammation	epidermis	UV exposure treatment	upregulated	27250636
4517	Mouse	mmu-miR-409-3p	miRNA	chronic social instability stress	embryonic development	sperm	chronic social instability stress treatment	"we found that exposure of male mice to chronic social instability stress, which leads to elevated anxiety in their female offspring across at least three generations through the paternal lineage, elevates sperm miR-409-3p levels not only in exposed males, but also in sperm of their F1 and F2 male offspring."	32333826
4518	Mouse	mmu-miR-409-3p	miRNA	IL-17	experimental autoimmune encephalomyelitis (EAE)	astrocytes from EAE mice	interleukin-17 (IL-17) treatment	upregulated	30294880
4519	Mouse	mmu-miR-409-3p	miRNA	nine hepatotoxic non-genotoxins (NGTXs)	genotoxicity	liver tissues	nine hepatotoxic non-genotoxins (NGTXs) treatment	downregulated	29777724
4520	Mouse	mmu-miR-409-3p	miRNA	nine hepatotoxic non-genotoxins (NGTXs)	genotoxicity	plasma	nine hepatotoxic non-genotoxins (NGTXs) treatment	upregulated	29777724
4521	Mouse	mmu-miR-409-3p	miRNA	choline- and folate-deficient (CFD) diet	liver damage	plasma	choline- and folate-deficient (CFD) diet treatment	upregulated	26878785
4522	Mouse	mmu-miR-409-3p	miRNA	IL-17	multiple sclerosis (MS)	Primary mouse astrocytes	interleukin-17 (IL-17) treatment	upregulated	30294880
4523	Mouse	mmu-miR-409-3p	miRNA	choline- and folate-deficient (CFD) diet	nonalcoholic fatty liver disease (NAFLD)	plasma	choline- and folate-deficient (CFD) treatment	upregulated	26878785
4524	Mouse	mmu-miR-409-5p	miRNA	amyloid-¦Â (A¦Â) 1-42	Alzheimer's disease (AD)	mice cortexes	amyloid ¦Â1-42?(A¦Â) treatment	downregulated	31849582
4525	Mouse	mmu-miR-409-5p	miRNA	high glucose (HG)	diabetic retinopathy (DR)	retinal microvascular endothelial cells (RMECs)	high glucose (HG) treatment	upregulated	32292119
4526	Mouse	mmu-miR-409-5p	miRNA	high glucose (HG)	diabetic retinopathy (DR)	retinal tissues	high glucose (HG) treatment	upregulated	32292119
4527	Mouse	mmu-miR-410	miRNA	hesperetin	acute lung injury (ALI)	lung tissues	Hesperetin (Hesp) treatment	MicroRNA-410 (miR-410) levels were significantly lower in the lung tissues of ALI mice and were reversed after Hesp treatment.	32762101
4528	Mouse	mmu-miR-410	miRNA	Tangeretin	gastric cancer (GC)	gastric cancer cells	Tangeretin treatment	upregulated	25998143
4529	Mouse	mmu-miR-410	miRNA	choline- and folate-deficient (CFD) diet	liver damage	plasma	choline- and folate-deficient (CFD) diet treatment	upregulated	26878785
4530	Mouse	mmu-miR-410	miRNA	choline- and folate-deficient (CFD) diet	nonalcoholic fatty liver disease (NAFLD)	plasma	choline- and folate-deficient (CFD) treatment	upregulated	26878785
4531	Mouse	mmu-miR-410	miRNA	olanzapine (OLP)	psychotic disorders	brain tissues	clozapine treatment	upregulated	23318695
4532	Mouse	mmu-miR-410	miRNA	hypoxia	pulmonary arterial hypertension (PAH)	lung tissues	hypoxia induce	downregulated	31289307
4533	Mouse	mmu-miR-410-3p	miRNA	lipopolysaccharide (LPS)	osteoarthritis (OA)	chondrocytes	lipopolysaccharide (LPS) treatment	downregulated	32709223
4534	Mouse	mmu-miR-410-3p	miRNA	lipopolysaccharide (LPS)	sepsis-induced myocardial injury	cardiomyocytes	lipopolysaccharide (LPS) treatment	"miR-410-3p was downregulated, while TLR2 was upregulated in LPS-induced mice and cardiomyocytes."	33230433
4535	Mouse	mmu-miR-411-5p	miRNA	Ultra-high molecular weight polyethylene (UHMWPE)	particle-induced osteolysis (PIO)	mesenchymal stem cells (MSCs)	Ultra-high molecular weight polyethylene (UHMWPE) treatment	The expression of miR-411-5p was decreased in osteolysis mice and UHMWPE-induced mMSCs	32061766
4536	Mouse	mmu-miR-412-5p	miRNA	oxygen	retinopathy of prematurity (ROP)	retinas tissue	"For OIR model construction, 7-day-old mice and their nursing mothers were maintained in 75% oxygen for 5 continuous days. On postnatal day (P) 12, the pups were returned to normoxic air and kept with their mothers for another 5 days. treatment"	downregulated in the OIR samples	31452702
4537	Mouse	mmu-miR-421	miRNA	hyperoxia	bronchopulmonary dysplasia (BPD)	lung tissues	hyperoxia induce	upregulated	31144392
4538	Mouse	mmu-miR-421	miRNA	¦¤9-tetrahydrocannabinol (THC)	inflammation	total lymph node cells and CD4(+) T cells	¦¤9-Tetrahydrocannabinol (THC) treatment	downregulated	27268054
4539	Mouse	mmu-miR-421	miRNA	cortisone	rheumatoid arthritis (RA)	synovial tissues	cortisone treatment	downregulated	31646548
4540	Mouse	mmu-miR-422a	miRNA	oxygen-glucose deprivation and reoxygenation (OGD/R)	neuron apoptosis	primary murine neurons	oxygen-glucose deprivation and reoxygenation (OGD/R) treatment	upregulated	32999283
4541	Mouse	mmu-miR-423-5p	miRNA	high glucose (HG)	diabetic nephropathy (DN)	immortalized mouse podocyte cell line (MPC5)	high glucose (HG) treatment	downregulated	30245133
4542	Mouse	mmu-miR-423?5p	miRNA	carbon tetrachloride (CCl4)	hepatotoxicity	blood	carbon tetrachloride (CCl4) treatment	upregulated	32528856
4543	Mouse	mmu-miR-423?5p	miRNA	lipopolysaccharide (LPS)	inflammation	RAW 264.7 cells	lipopolysaccharide (LPS) treatment	upregulated	32153563
4544	Mouse	mmu-miR-424	miRNA	lipopolysaccharide (LPS)	acute lung injury (ALI)	Mouse pulmonary microvascular endothelial cells (MPVECs)	lipopolysaccharide (LPS) treatment	downregulated	32818819
4545	Mouse	mmu-miR-424	miRNA	lipopolysaccharide (LPS)	acute lung injury (ALI)	lung tissues	lipopolysaccharide (LPS) treatment	THRIL accelerates sepsis-induced lung injury by sponging miR-424 and further restoring ROCK2.	32818819
4546	Mouse	mmu-miR-424	miRNA	tanshinone IIA (Tan IIA)	fracture healing	mouse pre-osteoblast MC3T3-E1 cells	Tanshinone IIA (Tan IIA) treatment	downregulated	31306638
4547	Mouse	mmu-miR-424	miRNA	hypoxia	ischemia/reperfusion (I/R) injury	Proximal kidney tubular cells	hypoxia induce	upregulated	31105811
4548	Mouse	mmu-miR-424	miRNA	ischemia/reperfusion (I/R) 	transient cerebral ischemia	peri-infarct cortex	ischemia/reperfusion (I/R) treatment	MiR-424 levels in the peri-infarct cortex increased at 1 and 4 hours then decreased 24 hours after reperfusion	25523055
4549	Mouse	mmu-miR-424	miRNA	transient cerebral ischemia	transient cerebral ischemia/reperfusion injury	C57/BL6 mice the peri infarct cortex	middle cerebral artery occlusion for 1 hour followed by reperfusion (ischemia/reperfusion) treatment	upregulated at 1 and 4 hours then downregulated 24 hours after reperfusion	25523055
4550	Mouse	mmu-miR-424-5p	miRNA	saturated fatty acids (SFA) palmitate (PA)	obesity-induced hepatic insulin resistance	liver tissues	saturated fatty acids (SFA) palmitate (PA) treatment	miR-424-5p was upregulated in both PA-treated HFD-fed mice	30033101
4551	Mouse	mmu-miR-425	miRNA	doxorubicin (DOX)	doxorubicin (DOX)-induced cardiotoxicity	heart sissues	doxorubicin (DOX) treatment	DOX resulted in a remarkable decrease of miR-425 in heart tissues.	32092815
4552	Mouse	mmu-miR-425	miRNA	"1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)"	parkinson's disease (PD)	substantia nigra tissue	"1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) treatment"	downregulated	31383850
4553	Mouse	mmu-miR-425-3p	miRNA	coxsackievirus B3 (CVB3)	viral myocarditis (VM)	myocardial tissues	Coxsackievirus B3 (CVB3) infection	miR-425-3p was lowly expressed in myocardial tissues of mice with viral myocarditis.	33332750
4554	Mouse	mmu-miR-425-5p	miRNA	oxygen glucose deprivation (OGD)	ischemic stroke (IS)	mouse brain microvascular endothelial cell (BMEC)	oxygen-glucose deprivation (OGD) treatment	upregulated	33491845
4555	Mouse	mmu-miR-425-5p	miRNA	lipopolysaccharide (LPS)	sepsis	liver tissues	lipopolysaccharide (LPS) treatment	downregulated	32002587
4556	Mouse	mmu-miR-4262	miRNA	angiotensin-converting enzyme 2 (ACE2)	acute lung injury (ALI)	lung	angiotensin converting enzyme 2 (ACE2) treatment	ACE2 appeared to significantly suppress the upregulation of miR-4262 in mouse lung after ALI	26356266
4557	Mouse	mmu-miR-429	miRNA	lipopolysaccharide (LPS)	acute lung injury (ALI)	MLE-12 cells; lung tissues	lipopolysaccharide (LPS) treatment	miR-429 was increased in lung tissues from LPS-induced ALI mice and LPS-treated MLE-12 cells.	31837322
4558	Mouse	mmu-miR-429	miRNA	lipopolysaccharide (LPS)	acute lung injury (ALI)	murine alveolar epithelial cell line MLE-12	lipopolysaccharide (LPS) treatment	GAS5 suppresses inflammatory responses and apoptosis of alveolar epithelial cell MLE-12 by targeting miR-429/DUSP1 axis.	31837322
4559	Mouse	mmu-miR-429	miRNA	amyloid-¦Â (A¦Â) 25-35	Alzheimer's disease (AD)	primary mouse cortical neurons	amyloid-¦Â (A¦Â) 25-35 treatment	upregulated	30264333
4560	Mouse	mmu-miR-429	miRNA	oxygen-glucose deprivation and reoxygenation (OGD/R)	cerebral ischemia/reperfusion (I/R) injury	Mouse brain microvascular endothelial cells (BMECs)	oxygen-glucose deprivation and reoxygenation (OGD/R) treatment	downregulated	32404105
4561	Mouse	mmu-miR-429	miRNA	dextran sodium sulfate (DSS)	colitis	colons	dextran sulphate sodium [DSS] treatment	downregulated	26818658
4562	Mouse	mmu-miR-429	miRNA	dextran sodium sulfate (DSS)	colitis	colon tissues	dextran sulfate sodium (DSS) treatment	downregulated	30334065
4563	Mouse	mmu-miR-429	miRNA	hypoxia	hypoxic/ischemic brain damage (HIBD)	mouse primary hippocampal neurons	hypoxia induce	downregulated	31185248
4564	Mouse	mmu-miR-429	miRNA	lipopolysaccharide (LPS)	microglial neuroinflammation	BV-2 microglia	lipopolysaccharide (LPS) treatment	upregulated	31896511
4565	Mouse	mmu-miR-429	miRNA	anoxia/reoxygenation (A/R)	myocardial infarction (MI)	primary cultured cardiomyocytes	anoxia/reoxygenation (AR) treatment	downregulated	31494170
4566	Mouse	mmu-miR-429	miRNA	leptin	obesity	hypothalamus?tissues	leptin treatment	downregulated	24394757
4567	Mouse	mmu-miR-429	miRNA	CoCl2	osteoblastic differentiation	MC3T3-E1 cells	CoCl2 treatment	upregulated	27576955
4568	Mouse	mmu-miR-429	miRNA	lipopolysaccharide (LPS)	traumatic brain injury (TBI)	BV-2 cells	lipopolysaccharide (LPS) treatment	LPS and TBI significantly induce the up-expression of miR-429.	31896511
4569	Mouse	mmu-miR-429	miRNA	insulin-like growth factor 1 (IGF-1)	unilateral ureteral obstruction (UUO)	mouse renal epithelial cells	insulin-like growth factor-1 (IGF-1) treatment	downregulated	27301852
4570	Mouse	mmu-miR-429-3p	miRNA	TGF-¦Â	breast cancer	normal murine mammary gland epithelial (NMuMG) cells	transforming growth factor (TGF)¦Â treatment	downregulated	30285803
4571	Mouse	mmu-miR-429-3p	miRNA	dioscorea bulbifera (DB)	liver damage	livers	dioscoreae bulbifera (EF) treatment	upregulated	27609015
4572	Mouse	mmu-miR-429-3p	miRNA	coix seed Oil (CSO)	triple negative breast cancer (TNBC)	mouse triple-negative breast cancer (TNBC) tissues	coix Seed Oil (CSO) treatment	upregulated	33101013
4573	Mouse	mmu-miR-431-5p	miRNA	doxorubicin (DOX)	doxorubicin (DOX)-induced cardiotoxicity	plasma	doxorubicin (DOX) treatment	downregulated	30453253
4574	Mouse	mmu-miR-431-5p	miRNA	angiotensin II (Ang II)	hypertension	mesenteric arteries	angiotensin II (Ang II) treatment	upregulated	30929512
4575	Mouse	mmu-miR-432	miRNA	propofol (PPF)	propofol-induced developmental neurotoxicity	hippocampus	propofol treatment	downregulated	30242182
4576	Mouse	mmu-miR-432-5p	miRNA	angiotensin II (Ang II)	cardiac hypertrophy	cardiomyocyte	angiotensin II (Ang II) treatment	downregulated	29966657
4577	Mouse	mmu-miR-433	miRNA	inorganic nitrite	acute myocardial infarction (AMI)	heart tissues	single-dose of nitrite	downregulated	28090786
4578	Mouse	mmu-miR-433	miRNA	ischemia/reperfusion (I/R) 	acute myocardial infarction (AMI)	heart tissues	ischemia/reperfusion (I/R) treatment	upregulated	28090786
4579	Mouse	mmu-miR-433	miRNA	amyloid-¦Â (A¦Â) 1-40	age-related macular degeneration (AMD)	C57BL/6 mice eye tissues	amyloid-¦Â (A¦Â) 1-40 treatment	downregulated	28324113
4580	Mouse	mmu-miR-433	miRNA	amyloid-¦Â (A¦Â)	Alzheimer's disease (AD)	SH-SY5Y cells; SK-N-SH cells	amyloid-¦Â (A¦Â) treatment	downregulated	32871216
4581	Mouse	mmu-miR-433	miRNA	TGF-¦Â	cardiac fibrosis	primary adult cardiac fibroblasts	TGF-¦Â treatment	"Inhibition of miR-433 attenuated cardiac fibroblast proliferation and myofibroblast differentiation in murine post-MI models and in fibroblasts induced by TGF-¦Â and AngII stimulation In contrast, upregulation of miR-433 promoted cardiac fibrotic response CircNFIB acts as a competing endogenous RNA for miR-433"	31316543
4582	Mouse	mmu-miR-433	miRNA	high glucose (HG)	diabetes mellitus (DM)	Min-6 pancreatic ¦Â cells	high-glucose medium	downregulated	28713945
4583	Mouse	mmu-miR-433	miRNA	"5-Aza-2'-deoxycytidine (5-Aza-dC, decitabine)"	gastric cancer (GC)	balb/c nu-nu mice injected with 107 GC cells	"5-Aza-2'-deoxycytidine (5-Aza-dC, decitabine) treatment"	upregulated	25270964
4584	Mouse	mmu-miR-433-3p	miRNA	ginkgo biloba extract (GBE)	hepatocellular carcinoma (HCC)	non-tumor (ENT) liver	ginkgo biloba extract (GBE) treatment	upregulated	32306082
4585	Mouse	mmu-mir-434-3p	miRNA	recombinant-specific gram-negative pathogen Escherichia coli (Xen14) and gram-positive pathogen Staphylococcus aureus (Xen29)	bacterial infection	blood	recombinant-specific gram-negative pathogen Escherichia coli (Xen14) and gram-positive pathogen Staphylococcus aureus (Xen29) treatment	upregulated	25563241
4586	Mouse	mmu-miR-434-3p	miRNA	long-term bed rest	disuse muscle atrophy	mouse both serum and muscle	long-term bed rest	downregulated	28329037
4587	Mouse	mmu-miR-434-3p	miRNA	pilocarpine	epilepsy	blood and brain	pilocarpine treatment	upregulated	32590288
4588	Mouse	mmu-miR-434-3p	miRNA	Ultra-high molecular weight polyethylene (UHMWPE)	particle-induced osteolysis (PIO)	mesenchymal stem cells (MSCs)	Ultra-high molecular weight polyethylene (UHMWPE) treatment	The expression of miR-434-3p was decreased in osteolysis mice and UHMWPE-induced mMSCs	32061766
4589	Mouse	mmu-miR-434-5p	miRNA	olanzapine (OLP)	psychotic disorders	brain tissues	clozapine treatment	upregulated	23318695
4590	Mouse	mmu-miR-448	miRNA	ischemia/reperfusion (I/R) 	acute ischemic and hemorrhagic stroke	mouse circulation	ischemia/reperfusion (I/R) treatment	upregulated	28193834
4591	Mouse	mmu-miR-448	miRNA	high fat diet (HFD)	atherosclerosis (AS)	aortic smooth muscle cell (ASMCs)	high fat diet (HFD) feed	miR-448 was highly expressed in aortic smooth muscle of AS model mice.	32848826
4592	Mouse	mmu-miR-448	miRNA	lipopolysaccharide (LPS)	endometriosis	uterine tissue	lipopolysaccharides (LPS) treatment	downregulated	31674024
4593	Mouse	mmu-miR-448	miRNA	bleomycin (BLM)	idiopathic pulmonary fibrosis (IPF)	lung tissues	bleomycin (BLM) treatment	downregulated	31506947
4594	Mouse	mmu-miR-448	miRNA	high fat diet (HFD)	type 2 diabetes mellitus (T2DM)	T2D mice-derived macrophages	high fat diet (HFD) feed	downregulated	30536833
4595	Mouse	mmu-miR-448	miRNA	streptozocin (STZ)	type 2 diabetes mellitus (T2DM)	T2D mice-derived macrophages	streptozotocin (STZ) treatment	downregulated	30536833
4596	Mouse	mmu-miR-448	miRNA	streptozocin (STZ)	type 2 diabetes mellitus (T2DM)	T2D mice-derived macrophages	Type 2 diabetes models in C57BL/6J mice were generated by a combination administration of streptozotocin (STZ) and a high-fat diet (HFD) treatment	downregulated	30536833
4597	Mouse	mmu-miR-448-5p	miRNA	ovalbumin (OVA)	asthma	lung tissues	ovalbumin solution treatment	downregulated	30362537
4598	Mouse	mmu-miR-448-5p	miRNA	morphine	painful or stressful conditions	hippocampal	Morphine treatment	downregulated	25844808
4599	Mouse	mmu-miR-449	miRNA	cyclopamine	regulating the activity of Shh signaling	embryonic lung cultures	cyclopamine treatment	dysregulated	24617895
4600	Mouse	mmu-miR-449a	miRNA	histone deacetylase (HDAC)	diabetes mellitus (DM)	C2C12 cells	histone deacetylase (HDAC) treatment	upregulated	27184529
4601	Mouse	mmu-miR-449a	miRNA	bone morphogenetic protein 9 (BMP9)	osteogenesis	The conditionally immortalized mouse multipotent adipose-derived cells iMADs	bone morphogenetic protein 9 (BMP9) treatment	downregulated	31825894
4602	Mouse	mmu-miR-449a	miRNA	silica	silicosis	lung	silica treatment	downregulated	27351886
4603	Mouse	mmu-miR-449a-5p	miRNA	methimazole (MTZ)	liver damage	liver tissues	methimazole (MTZ) treatment	upregulated	27421576
4604	Mouse	mmu-miR-449b	miRNA	bone morphogenetic protein 9 (BMP9)	osteogenesis	The conditionally immortalized mouse multipotent adipose-derived cells iMADs	bone morphogenetic protein 9 (BMP9) treatment	downregulated	31825894
4605	Mouse	mmu-miR-450b-3p	miRNA	manganese (Mn)	parkinson's disease (PD)	MN9D dopaminergic cell exosomes	Mn exposure (300¦ÌM MnCl2) for 24h	upregulated in exosomes	28450057
4606	Mouse	mmu-miR-450b-3p	miRNA	Silica nanoparticles (SiNPs)	reproductive toxicity	testis; GC-2spd cells	Silica nanoparticles (SiNPs) treatment	"The results showed that SiNPs induced the apoptosis of spermatogenic cells, decreased the quantity and quality of the sperm, reduced the expressions of miR-450 b-3p"	33652185
4607	Mouse	mmu-miR-450b-5p	miRNA	bleomycin (BLM)	idiopathic pulmonary fibrosis (IPF)	lung fibroblasts	bleomycin (BLM) treatment	downregulated	32848140
4608	Mouse	mmu-miR-450b-5p	miRNA	plasmodium chabaudi malaria	peak parasitemia	liver of mice	Plasmodium chabaudi malaria infection treatment	downregulated	21085987
4609	Mouse	mmu-miR-451	miRNA	aspergillus fumigatus (A. fumigatus)	asthma	lung tissues	Aspergillus fumigatus (DRA) treatment	downregulated	32159972
4610	Mouse	mmu-miR-451	miRNA	hyperoxia	bronchopulmonary dysplasia (BPD)	mouse lung endothelial cells (MLECs); lung tissues	hyperoxia treatment	Increased expression of miR-451 was noted in MLECs exposed to hyperoxia and in lungs of BPD mice.	32321512
4611	Mouse	mmu-miR-451	miRNA	genistein	cardiac hypertrophy	isoproterenol-treated mice heart tissues	genistein treatment	upregulated	30798118
4612	Mouse	mmu-miR-451	miRNA	isoproterenol	cardiac hypertrophy	heart tissues	isoprenaline (ISO) tteatment	downregulated	30798118
4613	Mouse	mmu-miR-451	miRNA	doxorubicin (DOX)	cardiotoxicity	heart tissues and cardiomyocytes	doxorubicin treatment	upregulated	31355248
4614	Mouse	mmu-miR-451	miRNA	complete freund's adjuvant (CFA)	chronic inflammatory pain	spinal dorsal horn and spinal microglia	complete Freund's adjuvant (CFA) treatment	downregulated	30069596
4615	Mouse	mmu-miR-451	miRNA	estrogen (ES)	renal fibrosis	mouse uterus tissues	Estrogen treatment	mirn451 was significantly increased by estrogen administration whereas mirn181b and mirn204 expression was significantly reduced	20720260
4616	Mouse	mmu-miR-451	miRNA	streptozocin (STZ)	diabetic cardiomyopathy (DCM)	heart tissues	streptozotocin (STZ) treatment	upregulated	30872181
4617	Mouse	mmu-miR-451	miRNA	kainic acid (KA)	epilepsy	hippocampus	kainic acid (KA) treatment	upregulated	31870266
4618	Mouse	mmu-miR-451	miRNA	lipopolysaccharide (LPS)	bacterial infection	"the whole blood, serum and white blood cells (WBCs) of C57BL/6 and Tlr2-/- mice"	lipopolysaccharide (LPS) treatment	upregulated	23286671
4619	Mouse	mmu-miR-451	miRNA	high glucose (HG)	inflammation	glomerular mesangial cells (SV40-MES-13)	high glucose (HG) treatment	upregulated	31652441
4620	Mouse	mmu-miR-451	miRNA	high fat diet (HFD)	nonalcoholic fatty liver disease (NAFLD)	liver	high fat diet (HFD) feed	downregulated	25957914
4621	Mouse	mmu-miR-451	miRNA	high fat diet (HFD)	nonalcoholic fatty liver disease (NAFLD)	liver tissues	high fat diet (HFD) feed	downregulated	31396337
4622	Mouse	mmu-miR-451	miRNA	swimming	nonalcoholic fatty liver disease (NAFLD)	high fat diet (HFD)-fed mice liver tissues	swim training induce treatment	upregulated	31396337
4623	Mouse	mmu-miR-451	miRNA	lipopolysaccharide (LPS)	nonalcoholic steatohepatitis (NASH)	NCTC1469 cells and Raw264.7 cells	LPS (Lipopolysaccharide) treatment	downregulated	31816816
4624	Mouse	mmu-miR-451	miRNA	genistein	obesity and diabetes	mouse adipose tissues	genistein treatment	upregulated	32129363
4625	Mouse	mmu-miR-451	miRNA	monocrotaline (MCT)	pulmonary hypertension (PH)	plasma	monocrotaline (MCT) treatment	downregulated	29795360
4626	Mouse	mmu-miR-451	miRNA	cecal ligation and puncture (CLP)	sepsis	whole blood	cecal ligation and puncture (CLP) treatment	upregulated	24205035
4627	Mouse	mmu-miR-451	miRNA	cortical impact	traumatic brain injury (TBI)	cortex	cortical impact	upregulated	26426744
4628	Mouse	mmu-miR-451	miRNA	high fat diet (HFD)	type 2 diabetes mellitus (T2DM)	type 2 DM mouse hearts	high fat diet (HFD) feed	upregulated	25362209
4629	Mouse	mmu-miR-451	miRNA	whole grain highland barley (WGH)	type 2 diabetes mellitus (T2DM)	liver tissues	whole grain highland barley (WGH) treatment	upregulated	33104141
4630	Mouse	mmu-miR-451a	miRNA	lipopolysaccharide (LPS)	acute kidney injury (AKI)	kidney tissues	lipopolysaccharide (LPS) treatment	miR-451a was upregulated at 24h.	32727087
4631	Mouse	mmu-miR-451a	miRNA	3¦Â-hydroxycholest-5-en-7-one	anti-inflammatory responses	RAW 264.7 cells	3¦Â-hydroxycholest-5-en-7-one treatment	upregulated	32771556
4632	Mouse	mmu-miR-451a	miRNA	ovalbumin (OVA)	asthma	airway epithelium	ovalbumin (OVA) treatment	downregulated	32234673
4633	Mouse	mmu-miR-451a	miRNA	doxorubicin (DOX)	cardiotoxicity	"plasma and heart, HL-1 cells"	doxorubicin (DOX) treatment	downregulated	30453253
4634	Mouse	mmu-miR-451a	miRNA	quercetin	chronic inflammatory diseases	LPS-treated murine bone marrow¨Cderived DCs (BMDCs)	quercetin treatment	upregulated	31338984
4635	Mouse	mmu-miR-451a	miRNA	doxorubicin (DOX)	doxorubicin (DOX)-induced cardiotoxicity	plasma	doxorubicin (DOX) treatment	downregulated	30453253
4636	Mouse	mmu-miR-451a	miRNA	electroacupuncture (EA)	electroacupuncture (EA)	CD4 T cells	electroacupuncture (EA) treatment	upregulated	32026263
4637	Mouse	mmu-miR-451a	miRNA	"1,2-Dichloroethane (1,2-DCE)"	glucose homeostasis	NIH Swiss mice	"1,2-dichloroethane (1,2-DCE) treatment"	upregulated in the livers	28960355
4638	Mouse	mmu-miR-451a	miRNA	"1,2-dichloroethane (1,2-DCE)"	glycerol gluconeogenesis	liver tissues	"1,2-dichloroethane (1,2-DCE) treatment"	"miR-451a was significantly upregulated in the liver tissue of mice exposed to 700 mg m -3 1,2-DCE."	28960355
4639	Mouse	mmu-miR-451a	miRNA	lipopolysaccharide (LPS)	inflammation	RAW264.7 cells	lipopolysaccharide (LPS) treatment	upregulated	26639663
4640	Mouse	mmu-miR-451a	miRNA	free fatty acids (FFA)	nonalcoholic fatty liver disease (NAFLD)	AML12 cells	"free fatty acids (FFAs; oleate/palmitate, 2:1 ratio) treatment"	downregulated	29604329
4641	Mouse	mmu-miR-451a	miRNA	high fat diet (HFD)	nonalcoholic fatty liver disease (NAFLD)	liver tissues	high fat diet (HFD) feed	downregulated	29604329
4642	Mouse	mmu-miR-451a	miRNA	parathyroid hormone (PTH)	osteoblastic differentiation	mice calvarial osteoblasts (MCOs)	parathyroid hormone (PTH) treatment	PTH promotes glucose dependent miR-451a expression which stimulates osteoblast differentiation	30218791
4643	Mouse	mmu-miR-452	miRNA	hypoxia	sleep apnea syndrome (SAS)	mouse 3T3-L1 cells	hypoxia treatment	downregulated	31013606
4644	Mouse	mmu-miR-454	miRNA	lipopolysaccharide (LPS)	acute lung injury (ALI)	lung tissues	lipopolysaccharide (LPS) treatment	upregulated	26741509
4645	Mouse	mmu-miR-455	miRNA	candida albicans (C. albicans)	Alzheimer's disease (AD)	mouse macrophages	candida albicans infection	upregulated	21060679
4646	Mouse	mmu-miR-455	miRNA	oral gavage	anti-inflammatory responses	dextran sodium sulfate (DSS)-induced colitis-associated tumorigenesis Apc(Min/+) mouse	via oral gavage for 5 weeks treatment	upregulated	24817032
4647	Mouse	mmu-miR-455	miRNA	angiotensin II (Ang II)	cardiac fibrosis	cardiomyocytes of C57BL/6 mice	angiotensin II (Ang II) treatment	downregulated	28753062
4648	Mouse	mmu-miR-455	miRNA	norcantharidin (NCTD)	hepatocellular carcinoma (HCC)	liver tissues	intraperitoneal injection of different concentration of NCTD treatment	upregulated	24719559
4649	Mouse	mmu-miR-455-3p	miRNA	bleomycin (BLM)	idiopathic pulmonary fibrosis (IPF)	pulmonary fbrotic tissues	bleomycin (BLM) treatment	upregulated	33549106
4650	Mouse	mmu-miR-455-3p	miRNA	TGF-¦Â1	idiopathic pulmonary fibrosis (IPF)	Primary mouse lung fbroblasts	TGF-¦Â1 treatment	downregulated	33549106
4651	Mouse	mmu-miR-455-3p	miRNA	amyloid-¦Â (A¦Â) 1-42	Alzheimer's disease (AD)	mouse neuroblastoma cells	amyloid ¦Â1-42?(A¦Â) treatment	upregulated	28934394
4652	Mouse	mmu-miR-455-3p	miRNA	high glucose (HG)	diabetic nephropathy (DN)	SV40-MES13 cells	high-glucose (HG) treatment	downregulated	31934070
4653	Mouse	mmu-miR-455-3p	miRNA	prednisolone	duchenne muscular dystrophy (DMD)	diaphragm muscle	prednisolone treatment	downregulated	29883261
4654	Mouse	mmu-miR-455-3p	miRNA	vamorolone	duchenne muscular dystrophy (DMD)	diaphragm muscle	vamorolone treatment	downregulated	29883261
4655	Mouse	mmu-miR-455-3p	miRNA	oxygen glucose deprivation (OGD)	ischemic stroke (IS)	mouse neuronal cells	oxygen-glucose deprivation (OGD) treatment	downregulated	33738662
4656	Mouse	mmu-miR-455-3p	miRNA	bile duct ligation (BDL)	liver fibrosis	liver tissues	bile duct ligation (BDL) treatment	downregulated	31150929
4657	Mouse	mmu-miR-455-3p	miRNA	carbon tetrachloride (CCl4)	liver fibrosis	liver tissues	carbon tetrachloride (CCl4) treatment	downregulated	31150929
4658	Mouse	mmu-miR-455-3p	miRNA	high fat diet (HFD)	liver fibrosis	liver tissues	high fat diet (HFD) feed	downregulated	31150929
4659	Mouse	mmu-miR-455-3p	miRNA	ferric ammonium citrate (FAC)	osteoporosis	osteoblast cell lines MC3T3-E1	ferric ammonium citrate (FAC) treatment	downregulated	29042277
4660	Mouse	mmu-miR-455-3p	miRNA	ferric ammonium citrate (FAC)	oxidative stress	osteoblast cell lines MC3T3-E1	FAC	downregulated	29042277
4661	Mouse	mmu-miR-455-3p	miRNA	morphine	painful or stressful conditions	hippocampal	Morphine treatment	downregulated	25844808
4662	Mouse	mmu-miR-455-3p	miRNA	cinnamic acid (CNA)	traumatic brain injury (TBI)	dendritic spines from TBI mice	cinnamic acid (CNA) treatment	upregulated	31473194
4663	Mouse	mmu-miR-455-5p	miRNA	prednisolone	duchenne muscular dystrophy (DMD)	diaphragm muscle	prednisolone treatment	downregulated	29883261
4664	Mouse	mmu-miR-455-5p	miRNA	vamorolone	duchenne muscular dystrophy (DMD)	diaphragm muscle	vamorolone treatment	downregulated	29883261
4665	Mouse	mmu-miR-455-5p	miRNA	cold	obesity	brown adipose tissue (BAT)	cold treatment	downregulated	33015181
4666	Mouse	mmu-miR-463-3p	miRNA	hypoxia	tibial nerve regeneration	primary tibial nerve cells	oxygen-glucose deprivation treatment	upregulated	31468997
4667	Mouse	mmu-miR-464	miRNA	plasmodium chabaudi malaria	peak parasitemia	liver of mice	Plasmodium chabaudi malaria infection treatment	downregulated	21085987
4668	Mouse	mmu-miR-465b-5p	miRNA	all-trans retinoic acid (ATRA)	cleft palate (CP)	palate	all-trans retinoic acid (ATRA) treatment	?NONMMUT004850.2/NONMMUT024276.2-miR-741-3p/miR-465b-5p-Prkar1¦Á?could potentially serve as an important regulatory mechanism of palatal fusion in the development of the cleft palate.	32042778
4669	Mouse	mmu-miR-465b-5p	miRNA	neuregulin-1£¨NRG1£©	cell differentiation	murine embryonic stem cell	neuregulin-1£¨NRG1£©	downregulated	21451102
4670	Mouse	mmu-miR-465d	miRNA	plasmodium chabaudi malaria	peak parasitemia	liver of mice	Plasmodium chabaudi malaria infection treatment	downregulated	21085987
4671	Mouse	mmu-miR-466	miRNA	lipopolysaccharide (LPS)	acute respiratory distress syndrome (ARDS)	bronchoalveolar lavage fluid (BALF)	lipopolysaccharide (LPS) treatment	upregulated	31221118
4672	Mouse	mmu-miR-466	miRNA	cannabinoid receptor 1 (CB1) antagonists SR141716A	diet-induced obesity (DIO)	mouse adipose tissue macrophage (ATM)	SR141716A treatment	downregulated	30910812
4673	Mouse	mmu-miR-466a-3p	miRNA	ovalbumin (OVA)	allergic rhinitis (AR)	nasal mucosa tissues	ovalbumin (OVA) treatment	downregulated	31081939
4674	Mouse	mmu-miR-466a-3p	miRNA	high glucose (HG)	cell differentiation	neural stem cells (NSCs)	high glucose treatment	downregulated	23776576
4675	Mouse	mmu-miR-466a-3p	miRNA	arginine vasopressin	osmoregulation	mIMCD3 cells	exposure to arginine vasopressin treatment	downregulated	24389345
4676	Mouse	mmu-miR-466b-3p	miRNA	arginine vasopressin	osmoregulation	mIMCD3 cells	exposure to arginine vasopressin treatment	downregulated	24389345
4677	Mouse	mmu-miR-466c-3p	miRNA	dexamethasone (DEX)	muscle atrophy	Murine C2C12 myoblast cells	dexamethasone (DEX) treatment	downregulated	23716137
4678	Mouse	mmu-miR-466c-3p	miRNA	arginine vasopressin	osmoregulation	mIMCD3 cells	exposure to arginine vasopressin treatment	downregulated	24389345
4679	Mouse	mmu-miR-466d-3p	miRNA	Japanese encephalitis virus (JEV)	Japanese encephalitis virus (JEV) infection	BV-2 cells; mouse neuroblastoma cell line NA; mouse brain endothelial cell line bEnd.3 	Japanese encephalitis virus (JEV) infection	downregulated	32461319
4680	Mouse	mmu-miR-466d-3p	miRNA	high glucose (HG)	cell differentiation	neural stem cells (NSCs)	high glucose treatment	downregulated	23776576
4681	Mouse	mmu-miR-466d-3p	miRNA	plasmodium chabaudi malaria	peak parasitemia	liver of mice	Plasmodium chabaudi malaria infection treatment	downregulated	21085987
4682	Mouse	mmu-miR-466d-5p	miRNA	Japanese encephalitis virus (JEV)	Japanese encephalitis virus (JEV) infection	BV-2 cells; mouse neuroblastoma cell line NA; mouse brain endothelial cell line bEnd.3 	Japanese encephalitis virus (JEV) infection	downregulated	32461319
4683	Mouse	mmu-miR-466d-6p	miRNA	Japanese encephalitis virus (JEV)	Japanese encephalitis virus (JEV) infection	BV-2 cells; mouse neuroblastoma cell line NA; mouse brain endothelial cell line bEnd.3 	Japanese encephalitis virus (JEV) infection	downregulated	32461319
4684	Mouse	mmu-miR-466e	miRNA	high fat diet (HFD)	chronic oxidative stress	mouse exposed to X-rays	high fat diet (HFD) feed	upregulated	25171162
4685	Mouse	mmu-miR-466e-3p	miRNA	arginine vasopressin	osmoregulation	mIMCD3 cells	exposure to arginine vasopressin treatment	downregulated	24389345
4686	Mouse	mmu-miR-466f	miRNA	dexamethasone (DEX)	muscle atrophy	Murine C2C12 myoblast cells	dexamethasone (DEX) treatment	upregulated	23716137
4687	Mouse	mmu-miR-466f-3p	miRNA	low chromium (Cr)	insulin resistance (IR)	liver	fed a control or LC diet for 13 weeks	dysregulatedin liver	29286159
4688	Mouse	mmu-miR-466h-5p	miRNA	H1N1 influenza virus	endometriosis and endometrial carcinoma	mouse lung?tissues	H1N1 influenza virus infection	upregulated	24066118
4689	Mouse	mmu-miR-466i-5p	miRNA	carbon tetrachloride (CCl4)	liver fibrosis	liver	CCl4 treatment	upregulated	27322257
4690	Mouse	mmu-miR-466j	miRNA	dexamethasone (DEX)	muscle atrophy	Murine C2C12 myoblast cells	dexamethasone (DEX) treatment	upregulated	23716137
4691	Mouse	mmu-miR-466m-3p	miRNA	lipopolysaccharide (LPS)	acute lung injury (ALI)	MLE-12 cells	lipopolysaccharide (LPS) treatment	Hsp4 alleviates lipopolysaccharide-induced apoptosis of lung epithelial cells via miRNA-466m-3p/DNAjb6 axis.	32976821
4692	Mouse	mmu-miR-466p-3p	miRNA	arginine vasopressin	osmoregulation	mIMCD3 cells	exposure to arginine vasopressin treatment	downregulated	24389345
4693	Mouse	mmu-miR-467a	miRNA	arsenite	atherosclerosis (AS)	liver	arsenic (As) exposure	upregulated	22719926
4694	Mouse	mmu-miR-467a	miRNA	radiation	radiocarcinogenesis	mouse thymic lymphoma tissues	radiation treatment	upregulated	25552935
4695	Mouse	mmu-miR-467a*	miRNA	dexamethasone (DEX)	muscle atrophy	Murine C2C12 myoblast cells	dexamethasone (DEX) treatment	downregulated	23716137
4696	Mouse	mmu-miR-467a-3p	miRNA	Japanese encephalitis virus (JEV)	Japanese encephalitis virus (JEV) infection	BV-2 cells; mouse neuroblastoma cell line NA; mouse brain endothelial cell line bEnd.3 	Japanese encephalitis virus (JEV) infection	downregulated	32461319
4697	Mouse	mmu-miR-467a-3p	miRNA	ganoderma lucidum extract (GLE)	hepatocellular carcinoma (HCC)	Hepa 1-6 cells	Ganoderma lucidum extract (GLE) treatment	upregulated	32106374
4698	Mouse	mmu-miR-467a-5p	miRNA	Japanese encephalitis virus (JEV)	Japanese encephalitis virus (JEV) infection	BV-2 cells; mouse neuroblastoma cell line NA; mouse brain endothelial cell line bEnd.3 	Japanese encephalitis virus (JEV) infection	downregulated	32461319
4699	Mouse	mmu-miR-467b	miRNA	high fat diet (HFD)	nonalcoholic fatty liver disease (NAFLD)	mice liver cells	high fat diet (HFD) feed	downregulated	21986524
4700	Mouse	mmu-miR-467b*	miRNA	polyphenols	cell function	mice liver cells	Polyphenols treatment	downregulated	22253797
4701	Mouse	mmu-miR-467c	miRNA	walnut	colorectal cancer (CRC)	colorectal tumor tissue	walnut-containing diet treatment	downregulated	25882694
4702	Mouse	mmu-miR-468-3p	miRNA	enterovirus 71 (EV71)	enterovirus 71 (EV71) infection	mouse	infect with EV71	downregulated	28469998
4703	Mouse	mmu-miR-471-3p	miRNA	advanced glycation end product (AGE)	diabetic cardiomyopathy (DCM)	RAW264.7 cells	advanced glycation end products (AGEs) treatment	"Meanwhile, miR-471-3p was significantly upregulated in RAW264.7 cells induced by AGEs and inhibition of miR-471-3p could reduce the inflammatory polarization of macrophages."	33417962
4704	Mouse	mmu-miR-483	miRNA	ischemia	acute kidney injury (AKI)	renal tubules	ischemia treatment	upregulated	27959449
4705	Mouse	mmu-miR-483	miRNA	recombinant Adeno-Cre viruses (AdV-Cre)	lung adenocarcinoma (LUAD)	lung	recombinant Adeno-Cre viruses (AdV-Cre) treatment	downregulated	25359683
4706	Mouse	mmu-miR-483*	miRNA	high fat diet (HFD)	acute myocardial infarction (AMI)	liver tissue	high fat diet (HFD) feed	downregulated	19835573
4707	Mouse	mmu-miR-483-3p	miRNA	black raspberry (BRB) anthocyanins	colorectal cancer (CRC)	colon tissues	black raspberry (BRB) anthocyanins treatment	downregulated	31763724
4708	Mouse	mmu-miR-483-3p	miRNA	black raspberry (BRB) anthocyanins	colorectal cancer (CRC)	azoxymethane (AOM)/dextran sulphate sodium (DSS)-induced CRC mouse	black raspberry (BRB) anthocyanins treatment	downregulated	31763724
4709	Mouse	mmu-miR-483-3p	miRNA	streptozocin (STZ)	diabetic cardiomyopathy (DCM)	cardiomyocyte	streptozotocin treatment	upregulated	27346130
4710	Mouse	mmu-miR-483-5p	miRNA	grape seed procyanidin B2 (GSP)	adipogenesis	3T3-L1 preadipocyte cell line	3T3-L1 preadipocyte cell line treatment	downregulated	28011376
4711	Mouse	mmu-miR-483-5p	miRNA	grape seed procyanidin B2 (GSP)	adipogenesis	3T3-L1 cells	GSP (dissolved in deionized water) (10¨C200 ug/ml)	downregulated	28011376
4712	Mouse	mmu-miR-483-5p	miRNA	rapamycin complex 1 (mTORC1)	osteoarthritis (OA)	Col2a1TSC1KO mice chondrocytes	rapamycin complex 1 (mTORC1) deficiency treatment	upregulated	30145794
4713	Mouse	mmu-miR-484	miRNA	ischemia/reperfusion (I/R) 	acute myocardial infarction (AMI)	heart tissues	ischemia/reperfusion (I/R) treatment	upregulated	28090786
4714	Mouse	mmu-miR-484	miRNA	high fat diet (HFD)	hepatocellular carcinoma (HCC)	plasma and hepatic tissues	high fat diet (HFD) feed	upregulated	26728044
4715	Mouse	mmu-miR-484	miRNA	extra-virgin olive oil rich in phenols (H-EVOO)	neuronal function	cortex	H-EVOO treatment	upregulated	26695409
4716	Mouse	mmu-miR-485	miRNA	ovalbumin (OVA)	asthma	lung tissues	ovalbumin (OVA) treatment	downregulated	30463065
4717	Mouse	mmu-miR-485	miRNA	oxygen glucose deprivation (OGD)	brain ischemia-reperfusion (I/R) injury	N2a cells	oxygen and glucose deprivation (OGD) treatment	downregulated	32860611
4718	Mouse	mmu-miR-485-3p	miRNA	amyloid-¦Â (A¦Â)	Alzheimer's disease (AD)	BV2 cells	amyloid-¦Â (A¦Â) treatment	upregulated	33220166
4719	Mouse	mmu-miR-485-3p	miRNA	amyloid-¦Â (A¦Â) 1-42	Alzheimer's disease (AD)	BV2 cells	amyloid ¦Â1-42?(A¦Â) treatment	upregulated	33220166
4720	Mouse	mmu-miR-486	miRNA	low frequency magnetic fields (LF-MF)	cell proliferation and migration	"293T cells and Lung cancer cell lines (A549, LLC)"	LF-MFs treatment	upregulated	28924214
4721	Mouse	mmu-miR-486	miRNA	radiation	thymic lymphoma (RITL)	mouse lymphoma cells line (EL4)	radiation treatment	"Based on this network, we identified a critical miRNA, miR-486, which was the most downregulated in the radiation-induced carcinogenesis"	33692937
4722	Mouse	mmu-miR-486-5p	miRNA	lipopolysaccharide (LPS)	acute lung injury (ALI)	lung tissues	lipopolysaccharides (LPS) treatment	upregulated	31940107
4723	Mouse	mmu-miR-486-5p	miRNA	(-)-epigallocatechin gallate (EGCG)	aging	C2C12 cells	(-)-Epigallocatechin gallate (EGCG) treatment	EGCG stimulated AKT phosphorylation and inhibited FoxO1a-mediated MuRF1 and Atrogin-1 transcription via up-regulating the expression of miR-486 in skeletal muscle of 40-wk-old SAMP8 mice as well as late passage C2C12 cells.	32710883
4724	Mouse	mmu-miR-486-5p	miRNA	lipopolysaccharide (LPS)	osteoarthritis (OA)	ATDC5 cells	lipopolysaccharide (LPS) treatment	miR-486-5p was significantly upregulated in LPS-induced ATDC5 cells.	32705174
4725	Mouse	mmu-miR-486a-3p	miRNA	sublytic complement C5b-9 (sC5b-9)	renal inflammatory diseases	MPC5 cells	sublytic complement C5b-9 (sC5b-9) treatment	downregulated	33296289
4726	Mouse	mmu-miR-486a-5p	miRNA	chronic unpredictable mild stress (CUMS)	major depressive disorder (MDD)	nucleus accumbens (NAc) tissues	chronic unpredictable mild stress (CUMS) induce	downregulated	30936699
4727	Mouse	mmu-miR-486a-5p	miRNA	high fat diet (HFD)	obesity	liver tissues	high fat diet (HFD) feed	upregulated	32593682
4728	Mouse	mmu-miR-486b-3p	miRNA	lipopolysaccharide (LPS)	acute lung injury (ALI)	RAW264.7 cells	lipopolysaccharide (LPS) treatment	miR-476 486b-3p levels decreased with exposure to LPS.	32421439
4729	Mouse	mmu-miR-487b	miRNA	lipopolysaccharide (LPS)	macrophage homeostasis	mouse bone marrow-derived macrophages (BMDMs)	lipopolysaccharide (LPS) treatment	downregulated	26936882
4730	Mouse	mmu-miR-487b	miRNA	astaxanthin	prostate cancer	Pca mouse tumor tissues	intragastrically administered 100 mg/kg astaxanthin (HA)	upregulated	28282880
4731	Mouse	mmu-miR-488	miRNA	peritoneal dialysis fluid (PDF)	peritoneal fibrosis	peritoneal tissues	peritoneal dialysis fluid (PDF) treatment	upregulated	25827714
4732	Mouse	mmu-miR-488-3p	miRNA	hypoxia	acute myocardial infarction (AMI)	primary cardiomyocytes;MCM cells	hypoxia induce	miRNA-488-3p expression decreased in hypoxia-preconditioning primary cardiomyocytes or MCM cells in a time-dependent manner.	31210328
4733	Mouse	mmu-miR-488-3p	miRNA	hypoxia	acute myocardial infarction (AMI)	mouse heart tissues	ligation of the anterior descending coronary artery (LAD) treatment	downregulated	31210328
4734	Mouse	mmu-miR-489	miRNA	isoproterenol	cardiac fibrosis	heart tissue and cardiac fibroblasts (CFs)	isoprenaline (ISO) tteatment	downregulated	32104288
4735	Mouse	mmu-miR-489	miRNA	silica	lung fibrosis	lung	silica treatment	downregulated	27506999
4736	Mouse	mmu-miR-489	miRNA	silica	lung fibrosis	C57BL/6 male mice lung tissues	silica treatment	upregulated in lung tissues	28780788
4737	Mouse	mmu-miR-490-3p	miRNA	pilocarpine	epilepsy	hippocampal tissues	pilocarpine treatment	"Psmd11 was upregulated by Peg13 at a miR-490-3p dependent way, thus inactivating the Wnt/¦Â-catenin pathway and alleviating epilepsy course in mice"	33437373
4738	Mouse	mmu-miR-490-3p	miRNA	N-methyl-N-nitrosourea (MNU)	gastric cancer (GC)	gastric cancer cells	N-methyl-N-nitrosourea (MNU) treatment	downregulated	25503559
4739	Mouse	mmu-miR-490-3p	miRNA	silica	silicosis	lung tissues	silica treatment	MiR-490-3p was significantly downregulated in silica-induced fibrotic mouse lung tissues and TGF-¦Â1 treated fibroblasts	33482250
4740	Mouse	mmu-miR-490-3p	miRNA	H2O2	spinal cord injury (SCI)	C8-D1A cells; C8-B4 cells	H2O2 treatment	downregulated	30575927
4741	Mouse	mmu-miR-491	miRNA	tumour-derived TGF-¦Â	anti-cancer therapy	mouse CD8+T cells	tumor necrosis factor alpha (TNF-¦Á) treatment	upregulation	27484289
4742	Mouse	mmu-miR-491	miRNA	arsenic trioxide (ATO)	hepatocellular carcinoma (HCC)	mice xenograft models	arsenic trioxide (As2O3) treatment	upregulated	25304214
4743	Mouse	mmu-miR-491	miRNA	anandamide (AEA)	pro-inflammatory activity	mouse	anandamide treatment	AEA differentil regulate the expression of miRNA	24699635
4744	Mouse	mmu-miR-491-5p	miRNA	anti-fas receptor antibodies	acute liver injury (ALI)	Hep G2 cells	anti-fas receptor antibodies	upregulated	20015148
4745	Mouse	mmu-miR-491-5p	miRNA	cold	obesity	brown adipose tissue (BAT)	cold treatment	downregulated	33015181
4746	Mouse	mmu-miR-493-5p	miRNA	"anti-benzo[a]pyrene-trans-7,8-diol-9,10-epoxide (anti-BPDE)"	bronchial epithelial cell cancer	16HBE-T cells	"anti-benzo[a]pyrene-trans-7,8-diol-9,10-epoxide (anti-BPDE) treatment"	downregulated	19462682
4747	Mouse	mmu-miR-494	miRNA	tumor necrosis factor alpha (TNF-¦Á) 	inflammation	mouse C2C12 myotubes	tumor necrosis factor alpha (TNF-¦Á) treatment	upregulated	24349514
4748	Mouse	mmu-miR-494	miRNA	staphylococcal enterotoxin B (SEB)	acute lung injury (ALI)	lung-infiltrating mononuclear cells	staphylococcal enterotoxin B (SEB) treatment	upregulated	26818958
4749	Mouse	mmu-miR-494	miRNA	high fat diet (HFD)	acute myocardial infarction (AMI)	liver tissue	high fat diet (HFD) feed	downregulated	19835573
4750	Mouse	mmu-miR-494	miRNA	tumor necrosis factor alpha (TNF-¦Á) 	apoptosis	vascular smooth muscle cells (VSMCs)	tumor necrosis factor alpha (TNF-¦Á) treatment	downregulated	30942414
4751	Mouse	mmu-miR-494	miRNA	"N1-[(4-methoxy)methyl]-4-methyl-1,2-Benzenediamine (FC-99)"	arthritis	Murine monocyte/macrophage cell line RAW264.7	"N1-[(4-methoxy)methyl]-4-methyl-1,2-Benzenediamine (FC-99) treatment"	upregulated	31881378
4752	Mouse	mmu-miR-494	miRNA	"anti-benzo[a]pyrene-trans-7,8-diol-9,10-epoxide (anti-BPDE)"	bronchial epithelial cell cancer	16HBE-T cells	"anti-benzo[a]pyrene-trans-7,8-diol-9,10-epoxide (anti-BPDE) treatment"	upregulated	19462682
4753	Mouse	mmu-miR-494	miRNA	silica nanoparticles (SiNPs) mycin	cell toxicity	mouse spermatocyte cells (GC-2spd cells)	SiNPs treatment	"inhibitor of miRNA-494 could attenuate the expression levels of AMPK, TSC, LC3¢ò and alleviate the decreased of AKT, mTOR, p-mTOR induced by SiNPs"	31541822
4754	Mouse	mmu-miR-494	miRNA	azoxymethane (AOM)	colorectal cancer (CRC)	mouse colon tissues	azoxymethane (AOM) treatment	upregulated in colon samples	29066742
4755	Mouse	mmu-miR-494	miRNA	oxygen glucose deprivation (OGD)	ischemic stroke (IS)	Primary cultured cortical neuronal	OGD treatment	miR-494 levels were reduced in neurons but increased in the medium after OGD	31510852
4756	Mouse	mmu-miR-494	miRNA	cyclosporine A (CsA)	nephrotoxicity	tubular epithelial cell	cyclosporine A treatment	upregulated	25854542
4757	Mouse	mmu-miR-494	miRNA	"FC-99 (N1-[(4-methoxy)methyl]-4-methyl-1,2-Benzenediamine)"	rheumatoid arthritis (RA)	macrophages	"FC-99 (N1-[(4-methoxy)methyl]-4-methyl-1,2-Benzenediamine) treatment"	FC-99 relieved macrophages inflammation via the miR-494/TN-C/NF-¦ÊB pathway	31881378
4758	Mouse	mmu-miR-494-3p	miRNA	rice bran phenolic extract (RBPE)	alcoholic liver disease (ALD)	liver tissues	rice bran phenolic extract (RBPE) treatment	Rice Bran Phenolic Extract Confers Protective Effects against Alcoholic Liver Disease in Mice by Alleviating Mitochondrial Dysfunction via the PGC-1¦Á-TFAM Pathway Mediated by microRNA-494-3p	33094608
4759	Mouse	mmu-miR-494-3p	miRNA	poly(ethylenimine) (PEI)	cell death	MEF cells	poly(ethylenimine) (PEI) treatment	upregulated	26158199
4760	Mouse	mmu-miR-494-3p	miRNA	compression force (CF)	cell proliferation	"MC3T3-E1, a pre-osteoblastic cell line"	Compressive force treatment	upregulated	25795570
4761	Mouse	mmu-miR-494-3p	miRNA	lipopolysaccharide (LPS)	inflammation	RAW264.7 macrophages	lipopolysaccharide?(LPS) treatment	upregulated	30942409
4762	Mouse	mmu-miR-494-3p	miRNA	lipopolysaccharide (LPS)	inflammation	RAW264.7 cells	lipopolysaccharides (LPS) treatment	downregulated	31002148
4763	Mouse	mmu-miR-494-3p	miRNA	high fat diet (HFD)	obesity	mice heart tissues	high fat diet (HFD) feed	downregulated	30629164
4764	Mouse	mmu-miR-495	miRNA	ovalbumin (OVA)	allergic rhinitis (AR)	CD4+ Th2 cells	ovalbumin induction	downregulated	32242002
4765	Mouse	mmu-miR-495	miRNA	alcohol	fetal alcohol spectrum disorders (FASD)	brain tissues	alcohol exposure	downregulated	23580197
4766	Mouse	mmu-miR-495	miRNA	dextran sodium sulfate (DSS)	inflammatory bowel disease (IBD)	colitis tissues	dextran sulfate sodium (DSS) treatment	miR-495 was lowly expressed in the DSS-induced colitis tissues.	31251902
4767	Mouse	mmu-miR-495	miRNA	choline- and folate-deficient (CFD) diet	liver damage	plasma	choline- and folate-deficient (CFD) diet treatment	upregulated	26878785
4768	Mouse	mmu-miR-495	miRNA	choline- and folate-deficient (CFD) diet	nonalcoholic fatty liver disease (NAFLD)	plasma	choline- and folate-deficient (CFD) treatment	upregulated	26878785
4769	Mouse	mmu-miR-495	miRNA	H2O2	spinal cord injury (SCI)	mouse SCNs	H2O2 treatment	"Interestingly, the expression of miR-495 was markedly suppressed when SCNs were exposed to H2O2."	33850858
4770	Mouse	mmu-miR-495	miRNA	high fat diet (HFD)	type 2 diabetes mellitus (T2DM)	mouse peritoneal macrophages	high fat diet (HFD) feed	upregulated	31709454
4771	Mouse	mmu-miR-495-3p	miRNA	ischemia/reperfusion (I/R) 	intestinal hypoxia/reoxygenation injury	C57BL/6 mice were induced	ischemia/reperfusion (I/R) treatment	upregulation	26935288
4772	Mouse	mmu-miR-495-3p	miRNA	lipopolysaccharide (LPS)	sepsis	RAW264.7 cells	lipopolysaccharide (LPS) treatment	downregulated	31812793
4773	Mouse	mmu-miR-495-3p	miRNA	lipopolysaccharide (LPS)	sepsis	RAW264.7 cells	lipopolysaccharide (LPS) treatment	upregulated of NEAT1 level and downregulated of miR-495-3p/miR-211 level could aggravate inflammation in LPS-treated RAW264.7 cells.	31812793
4774	Mouse	mmu-miR-496	miRNA	ethanol (EtOH)	teratogenesis	fetal brains of mice	Ethanol?treatment	downregulated	19091803
4775	Mouse	mmu-miR-497	miRNA	arsenite	atherosclerosis (AS)	liver	arsenic (As) exposure	downregulated	22719926
4776	Mouse	mmu-miR-497	miRNA	melatonin	chronic liver disease	C57BL/6 wild type (WT) mice pretreat with alcohol	melatonin (10 mg/kg body weight) supplemented by daily oral gavage at 09:00 hr during the last 2 weeks	upregulated	28095641
4777	Mouse	mmu-miR-497	miRNA	streptozocin (STZ)	diabetic foot ulcer (DFU)	wound lesion of diabetic mice	streptozotocin treatment	downregulated	31707336
4778	Mouse	mmu-miR-497	miRNA	streptozocin (STZ)	diabetic retinopathy (DR)	skin tissues	streptozotocin treatment	downregulated	31707336
4779	Mouse	mmu-miR-497	miRNA	prednisolone	duchenne muscular dystrophy (DMD)	diaphragm muscle	prednisolone treatment	downregulated	29883261
4780	Mouse	mmu-miR-497	miRNA	vamorolone	duchenne muscular dystrophy (DMD)	diaphragm muscle	vamorolone treatment	downregulated	29883261
4781	Mouse	mmu-miR-497	miRNA	IL-17	encephalomyelitis (EAE)	astrocytes in EAE mice	IL-17 treatment	downregulated	28458392
4782	Mouse	mmu-miR-497	miRNA	"5-Aza-2'-deoxycytidine (5-Aza-dC, decitabine)"	muscle cell proliferation and differentiation	mouse skeletal myoblast C2C12 cells	"5-Aza-2'-deoxycytidine (5-Aza-dC, decitabine) treatment"	upregulated	28255268
4783	Mouse	mmu-miR-497	miRNA	plasmodium	plasmodium infection	exosomes derived from the plasma	infect with Plasmodium treatment	upregulated	28650446
4784	Mouse	mmu-miR-497a-5p	miRNA	lipopolysaccharide (LPS)	acute lung injury (ALI)	lung tissues	lipopolysaccharide (LPS) treatment	downregulated	31148190
4785	Mouse	mmu-miR-497a-5p	miRNA	alloxan	diabetic retinopathy (DR)	renal tissues	alloxan treatment	downregulated	29312507
4786	Mouse	mmu-miR-497a-5p	miRNA	metformin (Met)	diabetic retinopathy (DR)	renal tissues	metformin treatment	upregulated	29312507
4787	Mouse	mmu-miR-498	miRNA	"anti-benzo[a]pyrene-trans-7,8-diol-9,10-epoxide (anti-BPDE)"	bronchial epithelial cell cancer	16HBE-T cells	"anti-benzo[a]pyrene-trans-7,8-diol-9,10-epoxide (anti-BPDE) treatment"	upregulated	19462682
4788	Mouse	mmu-miR-498	miRNA	"1,25-dihydroxyvitamin D 3 (calcitriol) analogue EB1089"	estrogen-sensitive tumors	mouse	"1,25-dihydroxyvitamin D 3 (calcitriol) analogue EB1089 treatment"	upregulated	25252917
4789	Mouse	mmu-miR-499	miRNA	influenza virus	H9N2 influenza virus infection	Dendritic cells (DCs)	H9N2 avian influenza virus (H9N2 AIV) treatment	upregulated	27285980
4790	Mouse	mmu-miR-499	miRNA	puromycin aminonucleoside (PAN)	minimal change disease (MCD)	kidney tissues	puromycin aminonucleoside (PAN) treatment	PAN exposure reduced miR-499 expression in the kidneys of mice	29448244
4791	Mouse	mmu-miR-499	miRNA	conjugated linoleic acid (cLA) and nitrite	myocardial infarction (MI)	myocardial infarction	conjugated linoleic acid (cLA) and nitrite treatment	upregulated	24363996
4792	Mouse	mmu-miR-499	miRNA	insulin	obesity	mouse skeletal muscle satellite cells (SMSCs)	insulin treatment	downregulated	30097922
4793	Mouse	mmu-miR-499-3p	miRNA	streptozocin (STZ)	diabetes mellitus (DM)	hearts of diabetic mice	streptozotocin (STZ) treatment	upregulated	21584493
4794	Mouse	mmu-miR-499-5p	miRNA	lipopolysaccharide (LPS)	acute lung injury (ALI)	lung tissues	lipopolysaccharide (LPS) treatment	miR-499-5p was upregulated in LPS-treated lung tissues.	33307898
4795	Mouse	mmu-miR-499-5p	miRNA	high glucose (HG)	cardiac hypertrophy	HL-1 cells	high glucose (HG) treatment	downregulated	32269707
4796	Mouse	mmu-miR-499-5p	miRNA	doxorubicin (DOX)	doxorubicin (DOX)-induced cardiotoxicity	plasma	doxorubicin (DOX) treatment	upregulated	30453253
4797	Mouse	mmu-miR-499¨C5p	miRNA	prolonged aerobic exercise	muscle hypertrophy	plasma	"impact of extended-duration, submaximal aerobic exercise treatment"	upregulated	24436293
4798	Mouse	mmu-miR-499a-5p	miRNA	doxorubicin (DOX)	doxorubicin (DOX)-induced cardiotoxicity	Plasma	doxorubicin (DOX) treatment	downregulated	30627229
4799	Mouse	mmu-miR-499a-5p	miRNA	IL-3¦Â	intervertebral disc degeneration (IDD)	nucleus pulposus (NP) cell	?IL-1¦Â treatment	"XIST expression was upregulated in the NP tissues of patients with IDD, and IL-1¦Â treatment resulted in a degradation of NPCs"	33722663
4800	Mouse	mmu-miR-500	miRNA	stretch	myoblast proliferation	C2C12 myoblasts	stretch treatment	downregulated	27840929
4801	Mouse	mmu-miR-501	miRNA	cardiotoxin (CTX)	skeletal muscle regeneration	myogenic progenitor cells (MPs) and non-myogenic fibroblast-adipocyte progenitors (FAPs)	cardiotoxin (CTX) treatment	"In the mdx mouse model, which models a pathological disease state, not only was miR-501 induced in regenerating skeletal muscle, but also its serum levels were increased, which correlated with the disease state of the animals."	27707793
4802	Mouse	mmu-miR-501-5p	miRNA	second-hand smoke (SHS)	asthma	lung	second-hand smoke (SHS) treatment	upregulated	26859758
4803	Mouse	mmu-miR-503	miRNA	oxidized low density lipoprotein (ox-LDL)	atherosclerosis (AS)	mouse macrophages atherogenic Evs	oxidized low-density lipoprotein (ox-LDL) treatment	enrichment in atherogenic EVs	28882869
4804	Mouse	mmu-miR-503	miRNA	oxidized low density lipoprotein (ox-LDL)	atherosclerosis (AS)	peritoneal macrophages; Bone-marrow derived macrophages (BMDMs)	oxidized low-density lipoprotein (ox-LDL) treatment	upregulated	28882869
4805	Mouse	mmu-miR-503	miRNA	photobiomodulation therapy (PBMT)	cell proliferation	mouse pre-osteoblast cell line MC3T3-E1	"Photobiomodulation therapy (PBMT) (The PBMT parameters were as follows: 808 nm continuous wavelength, 0.401 W output power, 0.042 W/cm2 power density, 9.6 cm2 spot size, 36 J energy, 3.75 J/cm2 energy density, 90 s irradiation for three times per 12 h, 14.5 cm distance of the laser source and the angle of divergence of the laser beam was 7¡ã) treatment"	downregulated	30218348
4806	Mouse	mmu-miR-503	miRNA	photobiomodulation therapy (PBMT)	cell proliferation	mouse pre-osteoblast cell line MC3T3-E1	"The PBMT parameters were as follows: 808 nm continuous wavelength, 0.401 W output power, 0.042 W/cm2 power density, 9.6 cm2 spot size, 36 J energy, 3.75 J/cm2 energy density, 90 s irradiation for three times per 12 h, 14.5 cm distance of the laser source and the angle of divergence of the laser beam was 7¡ã. treatment"	downregulated	30218348
4807	Mouse	mmu-miR-503	miRNA	losartan	diabetic nephropathy (DN)	kidney tissues	losartan treatment	downregulated	27770539
4808	Mouse	mmu-miR-503	miRNA	hypoxia	ischemic injury	mouse bone marrow derived endothelial progenitor cells (EPCs)	hypoxia induce	downregulated	29800588
4809	Mouse	mmu-miR-503	miRNA	dexamethasone (DEX)	muscle atrophy	Murine C2C12 myoblast cells	dexamethasone (DEX) treatment	upregulated	23716137
4810	Mouse	mmu-miR-503	miRNA	oleanolic acid (OLA)	osteoclastogenesis	RANKL-induced RAW264.7 cells	oleanolic acid (OLA) treatment	upregulated	31176167
4811	Mouse	mmu-miR-503	miRNA	receptor activator of nuclear factor-¦ÊB ligand (RANKL)	osteoclastogenesis	RAW264.7 cells	RANKL treatment	downregulated	31176167
4812	Mouse	mmu-miR-503	miRNA	silica	lung fibrosis	mouse lung tissues	silica treatment	downregulated in	28900284
4813	Mouse	mmu-miR-503*	miRNA	dexamethasone (DEX)	muscle atrophy	Murine C2C12 myoblast cells	dexamethasone (DEX) treatment	upregulated	23716137
4814	Mouse	mmu-miR-503-5p	miRNA	"paraquat (PQ) and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)"	dopaminergic (DA) neuron differentiation	neuro-2a cells	"paraquat (PQ) and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) treatment"	dysregulated	29250806
4815	Mouse	mmu-miR-503-5p	miRNA	lipopolysaccharide (LPS)	inflammation	RAW264.7 cells	lipopolysaccharide (LPS) treatment	downregulated	32955644
4816	Mouse	mmu-miR-503-5p	miRNA	"1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)"	neurodegenerative diseases	N2a cells	"1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) treatment"	downregulated	29250806
4817	Mouse	mmu-miR-503-5p	miRNA	"1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)"	neurodegenerative diseases	N2a cells	"1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) treatment"	downregulated	29250806
4818	Mouse	mmu-miR-503-5p	miRNA	paraquat (PQ)	neurodegenerative diseases	N2a cells	paraquat (PQ) treatment	downregulated	29250806
4819	Mouse	mmu-miR-504-3p	miRNA	high fat diet (HFD)	compensatory hyperplasia of islets	hepatocellular extracellular vesicles (EVs)	?high-fat diet (HFD) feed treatment	downregulated	31284955
4820	Mouse	mmu-miR-505-5p	miRNA	streptozocin (STZ)	diabetic pregnancy	female mice hyperglycemic ED9.5 embryos	streptozotocin treatment	dysregulatedin hyperglycemic ED95 embryos	27908722
4821	Mouse	mmu-miR-505-5p	miRNA	manganese (Mn)	parkinson's disease (PD)	MN9D dopaminergic cell exosomes	Mn exposure (300¦ÌM MnCl2) for 24h	upregulated in exosomes	28450057
4822	Mouse	mmu-miR-506	miRNA	lipopolysaccharide (LPS)	lung fibrosis	lung tissues	lipopolysaccharide (LPS) treatment	downregulated	31214773
4823	Mouse	mmu-miR-5097	miRNA	stretch	myoblast proliferation	C2C12 myoblasts	stretch treatment	downregulated	27840929
4824	Mouse	mmu-miR-5107-5p	miRNA	enterovirus 71 (EV71)	enterovirus 71 (EV71) infection	mouse	infect with EV71	downregulated	28469998
4825	Mouse	mmu-miR-5107-5p	miRNA	oxygen	retinopathy of prematurity (ROP)	C57BL/6 neonatal mice retinal tissue	7-day-old mice were maintained in 75% oxygen conditions for 5 days treatment	dysregulatedin retinal tissue	27922698
4826	Mouse	mmu-miR-511	miRNA	¦Ã-rays	leukemia	the whole blood cells of mice	Gy ¦Ã-rays treatment	miRNA signatures induced by ionising radiation in mouse blood are radiation type- and radiation dose-specific	21271940
4827	Mouse	mmu-miR-5112	miRNA	hypoxia	ischemic injury	bone marrow mesenchymal stem cells (BM-MSCs)	hypoxia treatment	upregulated	30613290
4828	Mouse	mmu-miR-5112	miRNA	chronic sleep fragmentation (SF)	obstructive sleep apnea (OSA)	C57/B6 mice	chronic sleep treatment	"upregulation(mmu-miR-5128,mmu-miR-6366), downregulated(mmu-miR-5112) in plasma-derived exosomes"	27419627
4829	Mouse	mmu-miR-511-3p	miRNA	angiostrongylus cantonensis (A. cantonensis)	angiostrongylus cantonensis (A. cantonensis) infection	mouse	angiostrongylus cantonensis (A. cantonensis) infection	upregulated	24682888
4830	Mouse	mmu-mir-511-3p	miRNA	second-hand smoke (SHS)	asthma	lung	second-hand smoke (SHS) treatment	upregulated	26859758
4831	Mouse	mmu-miR-511-3p	miRNA	delvestidine (DLTD)	bone marrow-derived dendritic cells (BMDCs) maturity	bone marrow-derived dendritic cells (BMDCs)	Delvestidine (DLTD) treatment	upregulated	32871480
4832	Mouse	mmu-miR-5115	miRNA	ischemia	acute kidney injury (AKI)	renal tubules	ischemia treatment	upregulated	27959449
4833	Mouse	mmu-miR-511-5p	miRNA	angiostrongylus cantonensis (A. cantonensis)	angiostrongylus cantonensis (A. cantonensis) infection	mouse	angiostrongylus cantonensis (A. cantonensis) infection	upregulated	24682888
4834	Mouse	mmu-miR-5119	miRNA	carbon tetrachloride (CCl4)	liver fibrosis	liver	CCl4 treatment	upregulated	27322257
4835	Mouse	mmu-miR-5128	miRNA	chronic sleep fragmentation (SF)	obstructive sleep apnea (OSA)	C57/B6 mice	chronic sleep treatment	"upregulation(mmu-miR-5128,mmu-miR-6366), downregulated(mmu-miR-5112) in plasma-derived exosomes"	27419627
4836	Mouse	mmu-miR-5128	miRNA	oxygen	retinopathy of prematurity (ROP)	retinas tissue	"For OIR model construction, 7-day-old mice and their nursing mothers were maintained in 75% oxygen for 5 continuous days. On postnatal day (P) 12, the pups were returned to normoxic air and kept with their mothers for another 5 days. treatment"	downregulated in the OIR samples	31452702
4837	Mouse	mmu-miR-5129-5p	miRNA	dioscorea bulbifera (DB)	liver damage	livers	dioscoreae bulbifera (EF) treatment	downregulated	27609015
4838	Mouse	mmu-miR-5130	miRNA	dioscorea bulbifera (DB)	liver damage	livers	dioscoreae bulbifera (EF) treatment	downregulated	27609015
4839	Mouse	mmu-miR-51302	miRNA	ethyl acetate extract isolated from rhizoma dioscoreae bulbifera	hepatotoxicity	mouse liver tissues	treat with ethyl acetate extract isolated from rhizoma dioscoreae bulbifera (450 mg/kg)	dysregulated	27609015
4840	Mouse	mmu-miR-5132-5p	miRNA	ethyl acetate extract isolated from rhizoma dioscoreae bulbifera	hepatotoxicity	mouse liver tissues	treat with ethyl acetate extract isolated from rhizoma dioscoreae bulbifera (450 mg/kg)	dysregulated	27609015
4841	Mouse	mmu-miR-5132-5p	miRNA	dioscorea bulbifera (DB)	liver damage	livers	dioscoreae bulbifera (EF) treatment	downregulated	27609015
4842	Mouse	mmu-miR-515-5p	miRNA	cigarette smoke (CS)	epithelial-mesenchymal transition (EMT)	lung tissues	Cigarette smoke (CS) exposure	downregulated	32768781
4843	Mouse	mmu-miR-515-5p	miRNA	H2O2	ischemia/reperfusion (I/R) injury	Primary cardiomyocytes	H2O2 treatment	LINC00511 accelerates the proliferation of cardiomyocytes after I/R by targeting miRNA-515-5p.	32141575
4844	Mouse	mmu-miR-520h	miRNA	high glucose (HG)	diabetic nephropathy (DN)	SV40-MES-13?cells	high glucose (HG) treatment	downregulated	31630796
4845	Mouse	mmu-miR-525-5p	miRNA	angiotensin II (Ang II)	cardiac hypertrophy	Cardiomyocytes were isolated from the neonatal mouse	angiotensin II (Ang II) treatment	SP1-induced upregulation of lncRNA SYNE1-AS1 promoted CH via miR-525-5p/SP1 axis.	30652310
4846	Mouse	mmu-miR-526b	miRNA	bleomycin (BLM)	idiopathic pulmonary fibrosis (IPF)	lung tissues	bleomycin (BLM) treatment	circTADA2A repressed lung-fibroblasts activation via miR-526b/Cav1 and reduced lung-fibroblasts proliferation via miR-203/Cav2.	32694556
4847	Mouse	mmu-miR-526b-3p	miRNA	doxorubicin (DOX)	doxorubicin (DOX)-induced cardiotoxicity	heart sissues	doxorubicin (DOX) treatment	Cardiac miR-526b-3p presented the most significant elevation responding to DOX treatment in mice.	31958751
4848	Mouse	mmu-miR-532	miRNA	high glucose (HG)	diabetic foot ulcer (DFU)	AC-16 cells	high glucose (HG) treatment	High glucose significantly upregulated miR-532 expression in the cardiomyocytes after 48 h.	32418060
4849	Mouse	mmu-miR-532-3p	miRNA	chronic unpredictable mild stress (CUMS)	major depressive disorder (MDD)	nucleus accumbens (NAc) tissues	chronic unpredictable mild stress (CUMS) induce	downregulated	30936699
4850	Mouse	mmu-miR-532-5p	miRNA	adiponectin	frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS)	?adipose tissue (AT)	adiponectin (ApN) treatment	downregulated	23015294
4851	Mouse	mmu-miR-532-5p	miRNA	schistosoma japonicum	liver fibrosis	serum exosomes	S. japonicum infection treatment	"miR-532-5p was decresed on 4 and 6 weeks after S japonicum infection, while increased on 9 weeks"	32443549
4852	Mouse	mmu-miR-532-5p	miRNA	oxygen glucose deprivation (OGD)	ischemic stroke (IS)	N2a cells	oxygen-glucose deprivation (OGD) treatment	miR-532-5p level was decreased and the PTEN level was increased in OGD-treated N2a cells in vitro.	32086725
4853	Mouse	mmu-miR-532-5p	miRNA	lipopolysaccharide (LPS)	macrophage inflammatory response	RAW264.7 macrophage cells	lipopolysaccharide (LPS) treatment	downregulated	22415194
4854	Mouse	mmu-miR-532-5p	miRNA	chronic unpredictable mild stress (CUMS)	major depressive disorder (MDD)	hippocampus	chronic unpredictable mild stress (CUMS) treatment	MiR-532-5p was significantly reduced in the hippocampus of mice treated with CUMS.	33209030
4855	Mouse	mmu-miR-532-5p	miRNA	lipopolysaccharide (LPS)	major depressive disorder (MDD)	BV2 cells	lipopolysaccharide (LPS) treatment	downregulated	33209030
4856	Mouse	mmu-miR-532-5p	miRNA	high fat diet (HFD)	obesity	liver tissues	high fat diet (HFD) feed	upregulated	32593682
4857	Mouse	mmu-miR-539-5p	miRNA	lipopolysaccharide (LPS)	sepsis-induced acute lung injury	primary murine pulmonary microvascular endothelial cells (MPVECs)	lipopolysaccharide (LPS) treatment	downregulated	31825519
4858	Mouse	mmu-miR-540	miRNA	augmenter of liver regeneration (ALR)	hepatic steatosis	mouse liver tissues and primary hepatocytes	augmenter of liver regeneration (ALR) treatment	upregulated	30540918
4859	Mouse	mmu-miR-540	miRNA	augmenter of liver regeneration (ALR)	steatosis	hepatocytes	augmenter of liver regeneration (ALR) deficiency	upregulated	30540918
4860	Mouse	mmu-miR-540-3p	miRNA	Japanese encephalitis virus (JEV)	Japanese encephalitis virus (JEV) infection	BV-2 cells; mouse neuroblastoma cell line NA; mouse brain endothelial cell line bEnd.3 	Japanese encephalitis virus (JEV) infection	downregulated	32461319
4861	Mouse	mmu-miR-541	miRNA	angiotensin II (Ang II)	cardiac hypertrophy	mouse cardio myocytes	angiotensin II (Ang II) treatment	downregulated	24722296
4862	Mouse	mmu-miR-541	miRNA	microcystin-leucine arginine (MC-LR)	decline in sperm quality and damage to testicular structure	Mouse GC-1 cells	Microcystin-leucine arginine (MC-LR)? treatment	upregulated	27608041
4863	Mouse	mmu-miR-541	miRNA	cortical impact	traumatic brain injury (TBI)	cortex	cortical impact	downregulated	26426744
4864	Mouse	mmu-mir-541-5p	miRNA	second-hand smoke (SHS)	asthma	lung	second-hand smoke (SHS) treatment	upregulated	26859758
4865	Mouse	mmu-miR-542-3p	miRNA	carbon tetrachloride (CCl4)	liver fibrosis	liver tissues	carbon tetrachloride (CCl4) treatment	upregulated	30368874
4866	Mouse	mmu-miR-542-5p	miRNA	pristimerin	glioblastoma multiforme (GBM)	mouse GL261 glioma cells	Pristimerin treatment	downregulated	31015365
4867	Mouse	mmu-miR-542-5p	miRNA	oleic acid (OA)	hyperglycemia and hyperlipoidemia	hepatocytes; AML-12 cells	oleate treatment	downregulated	32882762
4868	Mouse	mmu-miR-542-5p	miRNA	silica suspension	lung fibrosis	lung tissues	silica suspension treatment	downregulated	30467286
4869	Mouse	mmu-miR-542-5p	miRNA	TGF-¦Â1	lung fibrosis	mouse fibroblast (NIH-3T3)	transforming growth factor ¦Â1 (TGF-¦Â1) treatment	downregulated	30467286
4870	Mouse	mmu-miR-542-5p	miRNA	L©\arginine	severe acute pancreatitis (SAP)	lung tissues	"the SAP group (WT mice were intraperitoneally injected with 8% L©\arginine (4 mg/g) once per hour, twice in total, with the time of the second L©\arginine injection defined as day 0, and the mice were killed in a humane manner at day 3)"	downregulated	30216510
4871	Mouse	mmu-miR-542-5p	miRNA	prion	pancreatic cancer (PC)	N2a cells	prion treatment	downregulated of mmu-miR-351 and mmu-miR-542-5p	22985096
4872	Mouse	mmu-miR-543	miRNA	coxsackievirus B3 (CVB3)	viral myocarditis (VM)	peripheral blood and myocardial tissues of viral myocarditis mice and in CVB3-infected cardiomyocytes	Coxsackievirus B3 (CVB3) infection	upregulated	31894309
4873	Mouse	mmu-miR-543	miRNA	coxsackievirus B3 (CVB3)	viral myocarditis (VM)	peripheral blood; myocardial tissues; cardiomyocytes.	Coxsackievirus B3 (CVB3) infection	upregulated	31894309
4874	Mouse	mmu-miR-543-3p	miRNA	nine hepatotoxic non-genotoxins (NGTXs)	genotoxicity	liver tissues	nine hepatotoxic non-genotoxins (NGTXs) treatment	downregulated	29777724
4875	Mouse	mmu-miR-543-3p	miRNA	nine hepatotoxic non-genotoxins (NGTXs)	genotoxicity	plasma	nine hepatotoxic non-genotoxins (NGTXs) treatment	upregulated	29777724
4876	Mouse	mmu-miR-543-3p	miRNA	"2, 3, 7, 8-tetrachlorodibenzo-p-dioxin (TCDD)"	inflammation	myeloid-derived suppressor cells (MDSCs)	"2, 3, 7, 8-tetrachlorodibenzo-p-dioxin (TCDD) treatment"	downregulated	31492743
4877	Mouse	mmu-miR-544	miRNA	clozapine (CLZ)	psychotic disorders	mouse brain	clozapine treatment	upregulated	23318695
4878	Mouse	mmu-miR-5622-3p	miRNA	high fat diet (HFD)	compensatory hyperplasia of islets	hepatocellular extracellular vesicles (EVs)	?high-fat diet (HFD) feed treatment	downregulated	31284955
4879	Mouse	mmu-miR-5709-5p	miRNA	dioscorea bulbifera (DB)	liver damage	livers	dioscoreae bulbifera (EF) treatment	downregulated	27609015
4880	Mouse	mmu-miR-574-3p	miRNA	house dust mite (HDM)	asthma	C57BL/6J mice airway-secreted EVs (AEVs) were isolated from bronchoalveolar lavage fluid (BALF)	HDM treatment	dysregulated in airway-secreted EVs (AEVs) were isolated from bronchoalveolar lavage fluid (BALF)	28859242
4881	Mouse	mmu-miR-574-3p	miRNA	high fat diet (HFD)	hepatocellular carcinoma (HCC)	plasma and hepatic tissues	high fat diet (HFD) feed	upregulated	26728044
4882	Mouse	mmu-miR-574-3p	miRNA	curcumin (Cur)	nasopharyngeal carcinoma (NPC)	mice	injected into the tumour centre at a concentration of 150 mg/kg treatment	dysregulated	24896104
4883	Mouse	mmu-miR-574-3p	miRNA	morphine	painful or stressful conditions	hippocampal	Morphine treatment	downregulated	25844808
4884	Mouse	mmu-miR-574-5p	miRNA	lipopolysaccharide (LPS)	acute respiratory distress syndrome (ARDS)	lung tissues	lipopolysaccharide (LPS) treatment	"In ARDS models, microRNA-574-5p (miR-574-5p) expression could be induced by the TLR4/NF-¦ÊB pathway upon LPS stimulation."	33202146
4885	Mouse	mmu-miR-574-5p	miRNA	house dust mite (HDM)	asthma	C57BL/6J mice airway-secreted EVs (AEVs) were isolated from bronchoalveolar lavage fluid (BALF)	HDM treatment	dysregulated in airway-secreted EVs (AEVs) were isolated from bronchoalveolar lavage fluid (BALF)	28859242
4886	Mouse	mmu-miR-574-5p	miRNA	cyclophosphamide (CP)	chronic ovarian dysfunction	ovarian tissues	cyclophosphamide (CP) treatment	"CP treatment decreased the expression of miR-365-1-5p and miR-574-5p and increased that of miR-3472 and miR-667-3p, whereas SM administration restored the expression levels of these microRNAs to those in the Con mice."	33318603
4887	Mouse	mmu-miR-574-5p	miRNA	samul-tang (SM)	chronic ovarian dysfunction	ovarian tissues	samul-tang (SM) treatment	"CP treatment decreased the expression of miR-365-1-5p and miR-574-5p and increased that of miR-3472 and miR-667-3p, whereas SM administration restored the expression levels of these microRNAs to those in the Con mice"	33318603
4888	Mouse	mmu-miR-574-5p	miRNA	carbon tetrachloride (CCl4)	liver fibrosis	liver	CCl4 treatment	upregulated	27322257
4889	Mouse	mmu-miR-574-5p	miRNA	X rays	ionizing radiation (IR) injury	male Kunming mice blood	0.5-2 Gy total-body carbon-ion irradiation treatment	dysregulatedin blood	28632432
4890	Mouse	mmu-miR-574-5p	miRNA	Japanese encephalitis virus (JEV)	Japanese encephalitis virus (JEV) infection	BV-2 cells; mouse neuroblastoma cell line NA; mouse brain endothelial cell line bEnd.3 	Japanese encephalitis virus (JEV) infection	downregulated	32461319
4891	Mouse	mmu-miR-574-5p	miRNA	chronic unpredictable mild stress (CUMS)	major depressive disorder (MDD)	nucleus accumbens (NAc) tissues	chronic unpredictable mild stress (CUMS) induce	downregulated	30936699
4892	Mouse	mmu-miR-574-5p	miRNA	particulate matter (PM2.5)	neuroinflammation	C57BL/6 mice	received oropharyngeal aspiration ofPM2.5 treatment	downregulated	28851397
4893	Mouse	mmu-miR-575	miRNA	l-lysine	hemin-insulted mouse cortical neurons	cortical neurons	l-lysine treatment	miR-575 expression was increased in L-lysine treated group.	31987833
4894	Mouse	mmu-miR-577	miRNA	hypoxia	myocardial infarction (MI)	myocardial tissues; primary cardiomyocytes;MCM cells	hypoxia induce	downregulated	31773708
4895	Mouse	mmu-miR-582-5p	miRNA	hypoxia	cerebral ischemic stroke (CIS)	N2A cells	oxygen-glucose deprivation/reoxygenation (OGD/R) induce	downregulated	30327244
4896	Mouse	mmu-miR-582-5p	miRNA	hypoxia	cerebral ischemic stroke (CIS)	N2A cells	oxygen-glucose deprivation/reoxygenation (OGD/R) treatment	downregulated	30327244
4897	Mouse	mmu-miR-582-5p	miRNA	chronic unpredictable mild stress (CUMS)	depression	NAc tissue	chronic unpredictable mild stress (CUMS) treatment	upregulated	31430030
4898	Mouse	mmu-miR-582-5p	miRNA	electroacupuncture (EA)	electroacupuncture (EA)	CD4 T cells	electroacupuncture (EA) treatment	upregulated	32026263
4899	Mouse	mmu-miR-584	miRNA	lipopolysaccharide (LPS)	autophagy	RAW 264.7 cells	lipopolysaccharide (LPS) treatment	downregulated	29845275
4900	Mouse	mmu-miR-590	miRNA	high fat diet (HFD)	atherosclerosis (AS)	ApoE-/- mice aorta tissues	high fat diet (HFD) feed	downregulated	30799593
4901	Mouse	mmu-miR-590	miRNA	zingerone	cell differentiation	mouse mesenchymal stem cells (mMSCs)	Zingerone treatment	upregulated	31091349
4902	Mouse	mmu-miR-590-3p	miRNA	lipopolysaccharide (LPS)	acute kidney injury (AKI)	Mouse podocytes (MPC5) and kidney tissues	lipopolysaccharide (LPS) treatment	downregulated	30392071
4903	Mouse	mmu-miR-590-3p	miRNA	YKL-40	rheumatoid arthritis (RA)	mouse osteoblastic cell line MC3T3-E1	stimulated with YKL-40 for 24 h treatment	downregulated	28448439
4904	Mouse	mmu-miR-590-5p	miRNA	"2,4,6-trinitrobenzene sulfonic acid (TNBS)"	colitis	colon tissues	"2,4,6-trinitrobenzene sulfonic acid (TNBS)/ethanol treatment"	downregulated	29912317
4905	Mouse	mmu-miR-590-5p	miRNA	high glucose (HG)	diabetic osteoporosis	MC3T3-E1 cell	high glucose (HG) treatment	downregulated	30803283
4906	Mouse	mmu-miR-590-5p	miRNA	lipopolysaccharide (LPS)	intracerebral haemorrhage (ICH)	Primary microglia cells	lipopolysaccharide (LPS) treatment	downregulated	30190124
4907	Mouse	mmu-miR-592	miRNA	arsenite	atherosclerosis (AS)	liver	arsenic (As) exposure	downregulated	22719926
4908	Mouse	mmu-miR-592-5p	miRNA	quercetin	chronic inflammatory diseases	LPS-treated murine bone marrow¨Cderived DCs (BMDCs)	quercetin treatment	upregulated	31338984
4909	Mouse	mmu-miR-592-5p	miRNA	high fat diet (HFD)	hepatic insulin resistance	mouse liver tissues	high fat diet (HFD) feed	downregulated	30820263
4910	Mouse	mmu-miR-592-5p	miRNA	hypoxia	hypoxic/ischemic brain damage (HIBD)	hippocampal neuronal in a neonatal mouse	hypoxia induce	downregulated	29402808
4911	Mouse	mmu-miR-596	miRNA	lipopolysaccharide (LPS)	autophagy	RAW 264.7 cells	lipopolysaccharide (LPS) treatment	downregulated	29845275
4912	Mouse	mmu-miR-602	miRNA	lipopolysaccharide (LPS)	autophagy	RAW 264.7 cells	lipopolysaccharide (LPS) treatment	downregulated	29845275
4913	Mouse	mmu-miR-6089	miRNA	bovine type II collagen	rheumatoid arthritis (RA)	synovial macrophages	bovine type II collagen induction	circRNA_09505 can function as a miR-6089 sponge and regulate inflammation via miR-6089/AKT1/NF-¦ÊB axis in collagen-induced arthritis (CIA) mice mice.	33028811
4914	Mouse	mmu-miR-615-3p	miRNA	hypoxia	cell proliferation	brain tissue of micce	hypoxia treatment	downregulated	22171942
4915	Mouse	mmu-miR-615-5p	miRNA	adriamycin (ADR)	focal segmental glomerulosclerosis (FSGS)	kidney tissues	adriamycin (ADR) treatment	downregulated	32800553
4916	Mouse	mmu-miR-615-5p	miRNA	recombinant Adeno-Cre viruses (AdV-Cre)	lung adenocarcinoma (LUAD)	lung	recombinant Adeno-Cre viruses (AdV-Cre) treatment	downregulated	25359683
4917	Mouse	mmu-miR-618	miRNA	RANKL (receptor activator of nuclear factor ¦ÊB ligand)	postmenopausal osteoporosis (PMOP)	osteoclastogenesis of RAW264.7 cells	50ng/mL RANKL treatment	downregulated	29271983
4918	Mouse	mmu-miR-630	miRNA	bone morphogenetic protein 4 (BMP4) and TGF-¦Â2	heterotopic ossification (HO)	BALB/c-nu mice	bone morphogenetic protein 4 (BMP4) and TGF-¦Â2 treatment	downregulated	26940839
4919	Mouse	mmu-miR-6366	miRNA	chronic sleep fragmentation (SF)	obstructive sleep apnea (OSA)	C57/B6 mice	chronic sleep treatment	"upregulation(mmu-miR-5128,mmu-miR-6366), downregulated(mmu-miR-5112) in plasma-derived exosomes"	27419627
4920	Mouse	mmu-miR-640	miRNA	sevoflurane (SEV)	sevoflurane-induced abnormal cognition	primary hippocampal neurons	sevoflurane treatment	Overexpression of lncRNA Gm43050 alleviates apoptosis and inflammation response induced by sevoflurane treatment by regulating miR-640/ZFP91	32913509
4921	Mouse	mmu-miR-650	miRNA	dextran sodium sulfate (DSS)	ulcerative colitis (UC)	colon tissues	dextran sulfate sodium (DSS) treatment	upregulated	31399193
4922	Mouse	mmu-miR-6516-3p	miRNA	manganese (Mn)	parkinson's disease (PD)	MN9D dopaminergic cell exosomes	Mn exposure (300¦ÌM MnCl2) for 24h	upregulated in exosomes	28450057
4923	Mouse	mmu-miR-652	miRNA	prednisolone	duchenne muscular dystrophy (DMD)	diaphragm muscle	prednisolone treatment	downregulated	29883261
4924	Mouse	mmu-miR-652	miRNA	vamorolone	duchenne muscular dystrophy (DMD)	diaphragm muscle	vamorolone treatment	downregulated	29883261
4925	Mouse	mmu-miR-652	miRNA	carbon tetrachloride (CCl4)	liver fibrosis	liver tissues	intraperitoneal injection of CCl4	upregulated	28768954
4926	Mouse	mmu-miR-652-3p	miRNA	oxygen glucose deprivation (OGD)	cerebral ischemia/reperfusion (I/R) injury	N2a cells	oxygen glucose deprivation (OGD) treatment	upregulation of lncRNA HCP5 may exacerbate cerebral ischemic reperfusion injury by sponging miR-652-3p	32657103
4927	Mouse	mmu-miR-652-5p	miRNA	dioscorea bulbifera (DB)	liver damage	livers	dioscoreae bulbifera (EF) treatment	downregulated	27609015
4928	Mouse	mmu-miR-653-5p	miRNA	IL-1¦Â	chondrocyte apoptosis	ATDC5	IL-1¦Â treatment	upregulated	32517436
4929	Mouse	mmu-miR-6538	miRNA	high glucose (HG)	diabetic nephropathy (DN)	mouse podocytes	high glucose (HG) treatment	downregulated	33224036
4930	Mouse	mmu-miR-654-5p	miRNA	Tripterysium Glycosides Tablets (TGT)	rheumatoid arthritis (RA)	peripheral blood	Tripterysium Glycosides Tablets (TGT) treatment	upregulated	33135351
4931	Mouse	mmu-miR-660-3p	miRNA	carbon tetrachloride (CCl4)	liver fibrosis	liver tissues	carbon tetrachloride (CCl4) treatment	It showed that the expression levels of hsa-miR- 660-3p significantly increased over time upon CCl4 injection.	32584784
4932	Mouse	mmu-miR-665	miRNA	phenylephrine (PE)	heart failure (HF)	cultured cardiomyocytes	phenylephrine (PE) treatment	upregulated	31664601
4933	Mouse	mmu-miR-665	miRNA	dextran sodium sulfate (DSS)	inflammatory bowel disease (IBD)	C57BL/6 mice colonic mucosal tissues	dextran sodium sulfate (DSS) treatment	upregulated in colonic mucosal tissues	28333149
4934	Mouse	mmu-miR-665	miRNA	propofol (PPF)	propofol-induced developmental neurotoxicity	hippocampus	propofol treatment	downregulated	30242182
4935	Mouse	mmu-miR-665-3p	miRNA	Sheng-ji Hua-yu (SJHY) formula	diabetic foot ulcer (DFU)	skin tissues	Sheng-ji Hua-yu (SJHY) treatment	upregulated	33271241
4936	Mouse	mmu-miR-665-3p	miRNA	Sheng-ji Hua-yu (SJHY) formula	diabetic foot ulcer (DFU)	ulceration surface	sheng-ji Hua-yu (SJHY) formula treatment	"RNA-seq identified 11 DE circRNAs and 476 DE mRNAs between SJHY formula-treated and diabetic mice, including 4 upregulated and 7 downregulated circRNAs, 311 upregulated and 165 downregulated mRNAs CircRNA-Krt13/miR-665-3p/Itga3 and circRNA-Krt14/miR-706/Mylk4 pathways were built, which may contribute to the healing of SJHY formula-treated diabetic wounds"	33271241
4937	Mouse	mmu-miR-665-3p	miRNA	oxygen glucose deprivation (OGD)	ischemic stroke (IS)	BV2 cells	oxygen-glucose deprivation (OGD) treatment	downregulated	32512270
4938	Mouse	mmu-miR-667-3p	miRNA	cyclophosphamide (CP)	chronic ovarian dysfunction	ovarian tissues	cyclophosphamide (CP) treatment	"CP treatment decreased the expression of miR-365-1-5p and miR-574-5p and increased that of miR-3472 and miR-667-3p, whereas SM administration restored the expression levels of these microRNAs to those in the Con mice."	33318603
4939	Mouse	mmu-miR-667-3p	miRNA	samul-tang (SM)	chronic ovarian dysfunction	ovarian tissues	samul-tang (SM) treatment	"CP treatment decreased the expression of miR-365-1-5p and miR-574-5p and increased that of miR-3472 and miR-667-3p, whereas SM administration restored the expression levels of these microRNAs to those in the Con mice"	33318603
4940	Mouse	mmu-miR-668	miRNA	lipopolysaccharide (LPS)	bacterial infection	"the whole blood, serum and white blood cells (WBCs) of C57BL/6 and Tlr2-/- mice"	lipopolysaccharide (LPS) treatment	upregulated	23286671
4941	Mouse	mmu-miR-668	miRNA	smoking	smoking-related interstitial fibrosis (SRIF)	peripheral blood of mice	smoking treatment	upregulated	22782705
4942	Mouse	mmu-miR-668	miRNA	smoking	smoking-related interstitial fibrosis (SRIF)	C57 mice circulating	6 months of chronic mainstream smoking exposure treatment	upregulated	22782705
4943	Mouse	mmu-miR-669a-5p	miRNA	propofol (PPF)	propofol-induced developmental neurotoxicity	hippocampus	propofol treatment	downregulated	30242182
4944	Mouse	mmu-miR-669b-5p	miRNA	D-mannose	adipogenesis	adipose tissue-derived stem cells (ADSCs)	D-Mannose treatment	miR669b-5p expression level was significantly upregulated in the D-mannose group.	33376493
4945	Mouse	mmu-miR-669b-5p	miRNA	manganese (Mn)	parkinson's disease (PD)	MN9D dopaminergic cell exosomes	Mn exposure (300¦ÌM MnCl2) for 24h	upregulated in exosomes	28450057
4946	Mouse	mmu-miR-669c-3p	miRNA	oxygen-glucose deprivation and reoxygenation (OGD/R)	ischemic stroke (IS)	primary microglial cultures	oxygen-glucose deprivation and reoxygenation (OGD/R) treatment	MiR-669c-3p expression is increased in primary cortical neurons exposed to excitotoxic injury.	32560730
4947	Mouse	mmu-miR-669n	miRNA	enterovirus 71 (EV71)	enterovirus 71 (EV71) infection	mouse	infect with EV71	downregulated	28469998
4948	Mouse	mmu-miR-669n	miRNA	chloroquine	macrophage activation	LPS-treated RAW264.7 cells	Chloroquine (CQ) treatment	downregulated	26807181
4949	Mouse	mmu-miR-669n	miRNA	¦Â-elemene	oxygen-induced retinopathy (OIR)	Retinas tissues	¦Â-elemene treatment	upregulated	30664207
4950	Mouse	mmu-miR-669o-5p	miRNA	X-rays	bystander effect	C57BL/6 mice extracellular vesicles (EVs)	otal-body irradiated with X-rays	downregulated	28396668
4951	Mouse	mmu-miR-670	miRNA	oxygen-glucose deprivation and reoxygenation (OGD/R)	cerebral ischemia/reperfusion (I/R) injury	Mouse N2a cells	oxygen-glucose deprivation and reoxygenation (OGD/R) treatment	"Our results showed that after ischemia/reperfusion injury, miR-670 expression was obviously increased"	33269746
4952	Mouse	mmu-miR-671	miRNA	lead (Pb)	lead (Pb) toxicity	mouse neuroblastoma N2a cells	PbAc treatment	downregulated	27604105
4953	Mouse	mmu-miR-671-5p	miRNA	chronic unpredictable mild stress (CUMS)	major depressive disorder (MDD)	nucleus accumbens (NAc) tissues	chronic unpredictable mild stress (CUMS) induce	downregulated	30936699
4954	Mouse	mmu-miR-674	miRNA	influenza virus	H9N2 influenza virus infection	Dendritic cells (DCs)	H9N2 avian influenza virus (H9N2 AIV) treatment	upregulated	27285980
4955	Mouse	mmu-miR-674-5p	miRNA	Japanese encephalitis virus (JEV)	Japanese encephalitis virus (JEV) infection	BV-2 cells; mouse neuroblastoma cell line NA; mouse brain endothelial cell line bEnd.3 	Japanese encephalitis virus (JEV) infection	downregulated	32461319
4956	Mouse	mmu-miR-675	miRNA	TGF-¦Â1	cardiac fibrosis	Cardiac fibroblasts (CFs)	transforming growth factor beta 1 (TGF¦Â1) treatment	downregulated	30953355
4957	Mouse	mmu-miR-675	miRNA	synthetic preimplantation factor (sPIF)	duchenne muscular dystrophy (DMD)	myoblast	Synthetic preimplantation factor (sPIF) treatment	upregulated	30692507
4958	Mouse	mmu-mir-676-3p	miRNA	recombinant-specific gram-negative pathogen Escherichia coli (Xen14) and gram-positive pathogen Staphylococcus aureus (Xen29)	bacterial infection	blood	recombinant-specific gram-negative pathogen Escherichia coli (Xen14) and gram-positive pathogen Staphylococcus aureus (Xen29) treatment	upregulated	25563241
4959	Mouse	mmu-miR-677	miRNA	plasmodium chabaudi malaria	peak parasitemia	liver of mice	Plasmodium chabaudi malaria infection treatment	downregulated	21085987
4960	Mouse	mmu-miR-677-5p	miRNA	TGF-¦Â1	ischemia-reperfusion (IR)-induced late fibrosis of kidney	kidney tissues	TGF-¦Â1 treatment	LncRNA (Gm12840) could act as a sponge for miR-677-5p to mediate fibroblast activation induced by TGF-¦Â1 via the WISP1/PKB (Akt) signaling pathway	33351669
4961	Mouse	mmu-miR-679	miRNA	arsenite	atherosclerosis (AS)	liver	arsenic (As) exposure	downregulated	22719926
4962	Mouse	mmu-miR-682	miRNA	ischemia	intestinal ischemia/reperfusion (I/R) injury	intestinal epithelial cells	intestinal I/R injury	upregulation	27124584
4963	Mouse	mmu-miR-682	miRNA	dioscorea bulbifera (DB)	liver damage	livers	dioscoreae bulbifera (EF) treatment	upregulated	27609015
4964	Mouse	mmu-miR-687	miRNA	lipopolysaccharide (LPS)	acute kidney injury (AKI)	renal tubular epithelial (PTEC) cells	lipopolysaccharide (LPS) treatment	upregulated	32655407
4965	Mouse	mmu-miR-690	miRNA	angiotensin II (Ang II)	obesity	3T3-L1 cells	angiotensin II (Ang II) treatment	upregulated	32466437
4966	Mouse	mmu-miR-690	miRNA	testosterone	prostate cancer	female mouse liver	Testosterone treatment	"upregulation of the 6 miRNAs miR-22, miR-690, miR-122, let-7A, miR-30D and let-7D"	20600201
4967	Mouse	mmu-miR-690	miRNA	clozapine (CLZ)	psychotic disorders	mouse brain	clozapine treatment	upregulated	23318695
4968	Mouse	mmu-miR-690	miRNA	¦¤9-tetrahydrocannabinol (THC)	¦¤9-tetrahydrocannabinol toxicity	CD11b£«Gr-1£«MDSCs	¦¤9-Tetrahydrocannabinol (THC) treatment	upregulated	24202177
4969	Mouse	mmu-miR-6906-5p	miRNA	indole-3-carbinol (I3C)	colitis	Mesenteric lymph nodes	Indole-3-carbinol (I3C) treatment	downregulated	32921956
4970	Mouse	mmu-miR-691	miRNA	cigarette smoke (CS)	ovarian toxicity	ovarian tissues	cigarette smoke (CS) treatment	upregulated	29377183
4971	Mouse	mmu-miR-691	miRNA	particulate matter (PM2.5)	PM2.5 exposure	mosue bronchoalveolar lavage fluid (BALF)	"were subjected to intratracheal instillation of 2.5, 10, or 20mg/kg PM2.5 treatment"	upregulated in bronchoalveolar lavage fluid (BALF)	29107863
4972	Mouse	mmu-miR-691	miRNA	particulate matter (PM2.5)	pulmonary toxicological	lung tissues	particulate matter (PM2.5) exposure treatment	upregulated	29107863
4973	Mouse	mmu-miR-691	miRNA	dextran sodium sulfate (DSS)	ulcerative colitis (UC)	colonic tissues	dextran sulfate sodium (DSS) treatment	upregulated	32779953
4974	Mouse	mmu-miR-6914-5p	miRNA	mesalamine	inflammatory bowel disease (IBD)	DSS-induced IBD mouse colon tissues	"Mesalazine (5-aminosalicylic acid, 5-ASA) treatment"	"The network analysis of circRNA-miRNA-mRNAs identified an important pathway, i.e., chr10:115386962-115390436+/mmu-miR-6914-5p/Atg7, which is related to autophagy."	33819198
4975	Mouse	mmu-miR-692	miRNA	dioscorea bulbifera (DB)	liver damage	livers	dioscoreae bulbifera (EF) treatment	upregulated	27609015
4976	Mouse	mmu-miR-6931	miRNA	dicalcium silicate microparticle (C2S)	bone and dental tissue regenerative applications	mesenchymal stem cells (MSCs)	dicalcium silicate microparticle (C2S) treatment	downregulated	32463418
4977	Mouse	mmu-miR-693-3p	miRNA	propofol (PPF)	propofol-induced developmental neurotoxicity	hippocampus	propofol treatment	downregulated	30242182
4978	Mouse	mmu-miR-694	miRNA	plasmodium chabaudi malaria	peak parasitemia	liver of mice	Plasmodium chabaudi malaria infection treatment	downregulated	21085987
4979	Mouse	mmu-miR-696	miRNA	resistin	ectopic deposition of lipids	C2C12 cells	resistin treatment	upregulated	25962325
4980	Mouse	mmu-miR-696	miRNA	AICAR	metabolic syndrome	C2C12 cells	AMP-activated protein kinase (AMPK) activator AICAR treatment	upregulated	33812060
4981	Mouse	mmu-miR-696	miRNA	high fat diet (HFD)	metabolic syndrome	Tibialis anterior (TA) and extensor digitorum longus (EDL) muscles	high fat diet (HFD) feed	we found that miR-696 was highly expressed in the skeletal muscle of STZ-induced diabetic mice and chronic high-fat-fed mice.	33812060
4982	Mouse	mmu-miR-696	miRNA	palmitic acid (PA)	metabolic syndrome	C2C12 muscle cells	palmitic acid (PA) treatment	upregulated	33812060
4983	Mouse	mmu-miR-696	miRNA	streptozocin (STZ)	metabolic syndrome	Tibialis anterior (TA) muscle	streptozotocin (STZ) treatment	miR-696 was highly expressed in the skeletal muscle of STZ-induced diabetic mice and chronic high-fat-fed mice.	33812060
4984	Mouse	mmu-miR-698	miRNA	D-galactosamine/lipopolysaccharide (D-GalN/LPS)	acute liver injury (ALI)	liver tissues	D-GalN/LPS treatment	downregulated	31061003
4985	Mouse	mmu-miR-7	miRNA	high fat diet (HFD)	Alzheimer's disease (AD)	brain tissues	high fat diet (HFD) feed	upregulated	31501273
4986	Mouse	mmu-miR-7	miRNA	insulin	Alzheimer's disease (AD)	N2a cells	insulin treatment	upregulated	31501273
4987	Mouse	mmu-miR-7	miRNA	oxygen glucose deprivation (OGD)	brain ischemic injury	astrocytes	oxygen-glucose deprivation (OGD) treatment	downregulated	26961366
4988	Mouse	mmu-miR-7	miRNA	lipopolysaccharide (LPS)	brain tissue inflammation (BTI)	brain tissues	lipopolysaccharide (LPS) treatment	upregulated	31959187
4989	Mouse	mmu-miR-7	miRNA	lipopolysaccharide (LPS)	cerebral hemorrhage	BV2 microglia	lipopolysaccharides (LPS) treatment	downregulated	30229834
4990	Mouse	mmu-miR-7	miRNA	bleomycin (BLM)	idiopathic pulmonary fibrosis (IPF)	lung lobes	bleomycin (BLM) treatment	downregulated	31786325
4991	Mouse	mmu-miR-7	miRNA	trinitrobenzene sulfonic acid (TNBS)	inflammatory bowel disease (IBD)	intestinal tissues	TNBS treatment	upregulated	31494796
4992	Mouse	mmu-miR-7	miRNA	ionizing radiation (IR)	leukemia	mouse thymus and spleen tissue cells	irradiated	downregulated	18823940
4993	Mouse	mmu-miR-7	miRNA	focal brain irradiation	radiation induced bystander effect (RIBE)	mouse	"10 Gy or sham irradiation of mice brains, lung tissues"	upregulated	29104495
4994	Mouse	mmu-miR-7	miRNA	silica	silicosis	lung tissues	silica treatment	miR-7 is downregulated in lung tissues during silica-induced pulmonary fibrosis	30202956
4995	Mouse	mmu-miR-700	miRNA	streptozocin (STZ)	diabetes mellitus (DM)	hearts of diabetic mice	streptozotocin (STZ) treatment	upregulated	21584493
4996	Mouse	mmu-miR-700	miRNA	smoking	smoking-related interstitial fibrosis (SRIF)	peripheral blood of mice	smoking treatment	upregulated	22782705
4997	Mouse	mmu-miR-700	miRNA	smoking	smoking-related interstitial fibrosis (SRIF)	C57 mice circulating	6 months of chronic mainstream smoking exposure treatment	upregulated	22782705
4998	Mouse	mmu-miR-7025	miRNA	hypoxia	ischemic injury	bone marrow mesenchymal stem cells (BM-MSCs)	hypoxia treatment	upregulated	30613290
4999	Mouse	mmu-miR-702-5p	miRNA	house dust mite (HDM)	asthma	C57BL/6J mice airway-secreted EVs (AEVs) were isolated from bronchoalveolar lavage fluid (BALF)	HDM treatment	dysregulated in airway-secreted EVs (AEVs) were isolated from bronchoalveolar lavage fluid (BALF)	28859242
5000	Mouse	mmu-miR-7045	miRNA	hypoxia	ischemic injury	bone marrow mesenchymal stem cells (BM-MSCs)	hypoxia treatment	upregulated	30613290
5001	Mouse	mmu-miR-705	miRNA	alcohol	alcoholic liver disease (ALD)	mouse liver cells	Lieber-DeCarli alcohol treatment	upragulated	19572984
5002	Mouse	mmu-miR-705	miRNA	methionine choline-deficient diet (MCD)	alcoholic liver disease (ALD)	liver tissues	methionine-choline-deficient (MCD) diets treatment	upragulated	19572984
5003	Mouse	mmu-miR-705	miRNA	streptozocin (STZ)	diabetes mellitus (DM)	hearts of diabetic mice	streptozotocin (STZ) treatment	upregulated	21584493
5004	Mouse	mmu-miR-705	miRNA	metformin (Met)	nonalcoholic steatohepatitis (NASH)	liver tissues	metformin treatment	downregulated	25672270
5005	Mouse	mmu-miR-706	miRNA	laboratory-attenuated vesicular stomatitis virus	apoptosis	The baby hamster kidney (BHK-21) cell lin	laboratory-attenuated vesicular stomatitis virus treatment	upregulated	20625776
5006	Mouse	mmu-miR-706	miRNA	Sheng-ji Hua-yu (SJHY) formula	diabetic foot ulcer (DFU)	skin tissues	Sheng-ji Hua-yu (SJHY) treatment	upregulated	33271241
5007	Mouse	mmu-miR-706	miRNA	Sheng-ji Hua-yu (SJHY) formula	diabetic foot ulcer (DFU)	ulceration surface	sheng-ji Hua-yu (SJHY) formula treatment	"RNA-seq identified 11 DE circRNAs and 476 DE mRNAs between SJHY formula-treated and diabetic mice, including 4 upregulated and 7 downregulated circRNAs, 311 upregulated and 165 downregulated mRNAs CircRNA-Krt13/miR-665-3p/Itga3 and circRNA-Krt14/miR-706/Mylk4 pathways were built, which may contribute to the healing of SJHY formula-treated diabetic wounds"	33271241
5008	Mouse	mmu-miR-706	miRNA	low glucose (LG)	endoplasmic reticulum stress (ERS)	NIH3T3 cells	low glucose media treatment	upregulated	31863666
5009	Mouse	mmu-miR-706	miRNA	thapsigargin (Tg)	endoplasmic reticulum stress (ERS)	NIH3T3 cells	thapsigargin (Tg) treatment	upregulated	31863666
5010	Mouse	mmu-miR-706	miRNA	thapsigargin (Tg)	endoplasmic reticulum stress (ERS)	AML12 mouse hepatic cells	thapsigargin (Tg) treatment	upregulated	31863666
5011	Mouse	mmu-miR-706	miRNA	tunicamycin (TM)	endoplasmic reticulum stress (ERS)	NIH3T3 cells	tunicamycin (TM) treatment	upregulated	31863666
5012	Mouse	mmu-miR-706	miRNA	H2O2	hepatic fibrogenesis	liver fibrogenic cells	oxidative stress	downregulated	27876854
5013	Mouse	mmu-miR-706-5p	miRNA	¦¤9-tetrahydrocannabinol (THC) and Cannabidiol (CBD)	experimental autoimmune encephalomyelitis (EAE)	murine brain-derived CD4+ T cells	¦¤9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) combination treatment	upregulated	31497013
5014	Mouse	mmu-miR-708	miRNA	dexamethasone (DEX)	muscle atrophy	Murine C2C12 myoblast cells	dexamethasone (DEX) treatment	downregulated	23716137
5015	Mouse	mmu-miR-708	miRNA	dexamethasone (DEX)	ovarian cancer (OC)	C57BL/6-derived ovarian cancer ID-8 cells	dexamethasone (DEX) treatment	upregulated	28591224
5016	Mouse	mmu-miR-708	miRNA	low glucose (LG)	¦Â-cell apoptosis	mouse pancreatic islets	low glucose concentrations	upregulated	28970284
5017	Mouse	mmu-miR-708-3p	miRNA	lipopolysaccharide (LPS)	inflammation	RAW264.7 cells	lipopolysaccharide (LPS) treatment	downregulated	32955644
5018	Mouse	mmu-miR-708-5p	miRNA	lipopolysaccharide (LPS)	inflammation	RAW264.7 cells	lipopolysaccharide (LPS) treatment	downregulated	32955644
5019	Mouse	mmu-miR-709	miRNA	cisplatin (DDP)	acute kidney injury (AKI)	mouse proximal tubular cells (PTCs)	cisplatin treatment	upregulated	29042455
5020	Mouse	mmu-miR-709	miRNA	aldosterone	argonaute protein induct kidney	murine inner medullary collecting duct (mIMCD-3) cell line	aldosterone treatment	downregulated	24632479
5021	Mouse	mmu-miR-709	miRNA	sodium arsenite (NaAsO2)	arsenic inhibited cellular differentiation	pluripotent P19 mouse embryonal carcinoma cells	sodium arsenite treatment	upregulated	29121352
5022	Mouse	mmu-miR-709	miRNA	enterovirus 71 (EV71)	enterovirus 71 (EV71) infection	mouse	infect with EV71	downregulated	28469998
5023	Mouse	mmu-miR-709	miRNA	high fat diet (HFD)	high fat diet?influence	liver tissue	high fat diet (HFD) feed	upregulated	19835573
5024	Mouse	mmu-miR-709	miRNA	lipopolysaccharide (LPS)	inflammation	RAW264.7 cells	lipopolysaccharide (LPS) treatment	upregulated	27232654
5025	Mouse	mmu-miR-709	miRNA	cisplatin (DDP)	mitochondrial dysfunction	proximal tubular cells (PTCs)	cisplatin (DPP) treatment	upregulated	29042455
5026	Mouse	mmu-miR-711	miRNA	hypoxia	ischemic injury	bone marrow mesenchymal stem cells (BM-MSCs)	hypoxia treatment	upregulated	30613290
5027	Mouse	mmu-miR-711	miRNA	ionizing radiation (IR)	ionizing radiation (IR) injury	hippocampus; neurons	ionizing radiation (IR) treatment	"miR-711 was upregulated in the cortex at all time points and in the hippocampus and isolated neurons at 6 h, 24 h and 7 d after IR exposure."	32718090
5028	Mouse	mmu-miR-7116	miRNA	¦¤9-tetrahydrocannabinol (THC) and Cannabidiol (CBD)	experimental autoimmune encephalomyelitis (EAE)	murine brain-derived CD4+ T cells	¦¤9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) combination treatment	upregulated	31497013
5029	Mouse	mmu-miR-7116-5p	miRNA	"1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)"	parkinson's disease (PD)	brain tissues	"1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) treatment"	downregulated	28543680
5030	Mouse	mmu-miR-712	miRNA	TGF-¦Â1	chronic inflammatory diseases	RAW 264.7 mouse macrophages	LPS and IFN-¦Ã treatment	downregulated	27992764
5031	Mouse	mmu-miR-712	miRNA	IFN-¦Ã and lipopolysaccharide (LPS)	insulin sensitivity	RAW 264.7	LPS? treatment	downregulated	27992764
5032	Mouse	mmu-miR-712	miRNA	propofol (PPF)	propofol-induced developmental neurotoxicity	hippocampus	propofol treatment	downregulated	30242182
5033	Mouse	mmu-miR-712-5p	miRNA	tanshinone IIA (Tan IIA)	inflammation	Mouse aortic vascular smooth muscle cell (VSMC)	Tanshinone ¢òA (Tan ¢òA) treatment	Tan IIA inhibits VSMC inflammation via suppressing miR-712-5p upregulation by TNF-¦Á	32387370
5034	Mouse	mmu-miR-7-1-3p	miRNA	lipopolysaccharide (LPS)	autophagy	RAW 264.7 cells	lipopolysaccharide (LPS) treatment	downregulated	29845275
5035	Mouse	mmu-miR-714	miRNA	clamping the renal pedicle	bilateral renal ischemia	C57Bl/6 mice plasma and kidneys	clamping the renal pedicle treatment	upregulated	24695114
5036	Mouse	mmu-miR-717	miRNA	hypertonicity	cellular responses to osmotic stress	mouse renal medulla	hypertonicity-induced induction	upregulated	20852262
5037	Mouse	mmu-miR-718	miRNA	lipopolysaccharide (LPS)	inflammation	mouse spleens	lipopolysaccharide (LPS) treatment	upregulated	28209713
5038	Mouse	mmu-miR-718	miRNA	dioscorea bulbifera (DB)	liver damage	livers	dioscoreae bulbifera (EF) treatment	downregulated	27609015
5039	Mouse	mmu-miR-718	miRNA	chronic intermittent hypoxia (CIH)	obstructive sleep apnoea-hypopnoea syndrome (OSAHS)	mouse aortic endothelial cells (MAECs)	chronic intermittent hypoxia (CIH) treatment	downregulated	29108914
5040	Mouse	mmu-miR-719	miRNA	arsenite	atherosclerosis (AS)	liver	arsenic (As) exposure	downregulated	22719926
5041	Mouse	mmu-miR-720	miRNA	D-galactosamine/lipopolysaccharide (D-GalN/LPS)	acute liver injury (ALI)	liver tissues	D-GalN/LPS treatment	downregulated	31061003
5042	Mouse	mmu-miR-720	miRNA	high fat diet (HFD)	erectile dysfunction (ED)	mouse	high fat diet (HFD) feed	dysregulated	25533598
5043	Mouse	mmu-miR-720	miRNA	high fat diet (HFD)	hepatocellular carcinoma (HCC)	plasma and hepatic tissues	high fat diet (HFD) feed	downregulated	26728044
5044	Mouse	mmu-miR-721	miRNA	enterovirus 71 (EV71)	enterovirus 71 (EV71) infection	mouse	infect with EV71	downregulated	28469998
5045	Mouse	mmu-miR-7218-5p	miRNA	high fat diet (HFD)	compensatory hyperplasia of islets	hepatocellular extracellular vesicles (EVs)	?high-fat diet (HFD) feed treatment	downregulated	31284955
5046	Mouse	mmu-miR-7219-5p	miRNA	high fat diet (HFD)	compensatory hyperplasia of islets	hepatocellular extracellular vesicles (EVs)	?high-fat diet (HFD) feed treatment	downregulated	31284955
5047	Mouse	mmu-miR-7224-3p	miRNA	high glucose (HG)	diabetic nephropathy (DN)	mouse podocytes	high glucose (HG) treatment	downregulated	33224036
5048	Mouse	mmu-miR-7239-5p	miRNA	dextran sodium sulfate (DSS)	ulcerative colitis (UC)	colonic tissues	dextran sulfate sodium (DSS) treatment	upregulated	32779953
5049	Mouse	mmu-miR-7240-5p	miRNA	subchronic deoxynivalenol (DON)	liver damage	liver tissues; Hepa 1-6 cells	subchronic deoxynivalenol (DON) exposure treatment	downregulated	32439590
5050	Mouse	mmu-miR-741-3p	miRNA	all-trans retinoic acid (ATRA)	cleft palate (CP)	palate	all-trans retinoic acid (ATRA) treatment	?NONMMUT004850.2/NONMMUT024276.2-miR-741-3p/miR-465b-5p-Prkar1¦Á?could potentially serve as an important regulatory mechanism of palatal fusion in the development of the cleft palate.	32042778
5051	Mouse	mmu-miR-741-3p	miRNA	pressure overload	heart failure (HF)	heart sissues	pressure overload treatment	downregulated	33224746
5052	Mouse	mmu-miR-741-3p	miRNA	radiation	radiation-induced brain injury (RBI)	hippocampus	radiation treatment	"microRNA sequencing was used to discover differential miRNAs in the hippocampus of RBI-modeled mice, which suggested that miR-741-3p was most significantly upregulated"	33544844
5053	Mouse	mmu-miR-744	miRNA	alcohol	alcoholic hepatitis (AH)	sera	alcohol exposure	upregulated	26264599
5054	Mouse	mmu-miR-744	miRNA	carbon tetrachloride (CCl4)	liver cirrhosis	sera and livers	CCl4 treatment	downregulated	31643031
5055	Mouse	mmu-miR-744-3p	miRNA	X-rays	bystander effect	C57BL/6 mice extracellular vesicles (EVs)	otal-body irradiated with X-rays	downregulated	28396668
5056	Mouse	mmu-miR-7-5p	miRNA	hyperoxia	experimental retinopathy	C57BL/6J mice endothelial cells	"exposed to hyperoxia (75% oxygen) in an incubation chamber (Stuart Scientific, Redhill, UK) with their nursing mothers for 5 days and then returned to ambient air"	upregulated	28353063
5057	Mouse	mmu-miR-7-5p	miRNA	diosbuibin B (DB)	gastric cancer (GC)	"human gastric cancer cell lines (MGC803, BGC-823 and SGC7901)"	Diosbulbin-B (DB)?treatment	knock-down of CircRNA CDR1as specifically promoted the cytotoxic effects of low-dose DB on GC cells instead of hepatocytes by regulating miR-7-5p/REG¦Ã axis.	31542615
5058	Mouse	mmu-miR-761	miRNA	hypoxia/reoxygenation (H/R)	acute myocardial infarction (AMI)	HL-1 Cells	hypoxia/reoxygenation (H/R) treatment	ZFAS1 was upregulated and miR-761 was downregulated in the serum of patients with AMI and H/R-induced HL-1 cells.	32833901
5059	Mouse	mmu-miR-761	miRNA	angiotensin II (Ang II)	atherosclerosis and restenosis	SMCs	angiotensin II (Ang II) treatment	downregulated	26444612
5060	Mouse	mmu-miR-762	miRNA	lipopolysaccharide (LPS)	acute kidney injury (AKI)	kidney tissues	lipopolysaccharide (LPS) treatment	miR-762 was upregulated at 6h.	32727087
5061	Mouse	mmu-miR-762	miRNA	house dust mite (HDM)	asthma	C57BL/6J mice airway-secreted EVs (AEVs) were isolated from bronchoalveolar lavage fluid (BALF)	HDM treatment	dysregulated in airway-secreted EVs (AEVs) were isolated from bronchoalveolar lavage fluid (BALF)	28859242
5062	Mouse	mmu-miR-762	miRNA	thyroxine T4	cardiac hypertrophy	heart tissues	thyroxine T4 treatment	downregulated	31522342
5063	Mouse	mmu-miR-762	miRNA	cannabinoid receptor 1 (CB1) antagonists SR141716A	diet-induced obesity (DIO)	mouse adipose tissue macrophage (ATM)	SR141716A treatment	downregulated	30910812
5064	Mouse	mmu-miR-762	miRNA	polychlorinated biphenyls (PCBs)	cell differentiation	P19 mouse embryonal carcinoma cells	polychlorinated biphenyls (PCBs) treatment	downregulated	23443104
5065	Mouse	mmu-miR-762	miRNA	anoxia/reoxygenation (A/R)	myocardial infarction (MI)	Neonatal mouse cardiomyocytes	anoxia/reoxygenation (A/R) treatment	miR-762 predominantly translocated in the mitochondria and was significantly upregulated upon anoxia/reoxygenation (A/R) treatment.	31235686
5066	Mouse	mmu-miR-764-3p	miRNA	TGF-¦Â1	treat steroid-related diseases	ovarian granulosa cells	TGF-¦Â1 treatment	upregulated	26676955
5067	Mouse	mmu-miR-765	miRNA	oxygen-glucose deprivation and reoxygenation (OGD/R)	cerebral ischemia/reperfusion (I/R) injury	N2a cells	oxygen-glucose deprivation and reoxygenation (OGD/R) treatment	downregulated	33068927
5068	Mouse	mmu-miR-7654-3p	miRNA	high fat diet (HFD)	compensatory hyperplasia of islets	hepatocellular extracellular vesicles (EVs)	?high-fat diet (HFD) feed treatment	downregulated	31284955
5069	Mouse	mmu-miR-766-3p	miRNA	oxygen-glucose deprivation and reoxygenation (OGD/R)	cerebral ischemia/reperfusion (I/R) injury	N2a cells	oxygen-glucose deprivation and reoxygenation (OGD/R) treatment	Gm11974/miR-766-3p/NR3C2 axis plays important role in cerebral I/R injury	31556305
5070	Mouse	mmu-miR-7670-3p	miRNA	oxygen glucose deprivation (OGD)	ischemic stroke (IS)	primary astrocytes	oxygen glucose deprivation (OGD) treatment	circSHOC2 in IPAS-EXOs suppressed neuronal apoptosis and ameliorated neuronal damage by regulating autophagy and acting on the miR-7670-3p/SIRT1 axis	33230464
5071	Mouse	mmu-miR-770-5p	miRNA	high glucose (HG)	diabetic nephropathy (DN)	mouse podocytes	In vitro podocyte model of DN was conducted by treatment conditionally immortalized mouse podocytes with HG (30 mM D-glucose).	upregulated	30779094
5072	Mouse	mmu-miR-770-5p	miRNA	high glucose (HG)	diabetic nephropathy (DN)	mouse podocytes	high glucose (HG) treatment	MiR-770-5p was upregulated and TIMP3 was downregulated in DN kidney tissues and HG-stimulated podocytes.	32309847
5073	Mouse	mmu-miR-770-5p	miRNA	streptozocin (STZ)	diabetic pregnancy	female mice hyperglycemic ED9.5 embryos	streptozotocin treatment	dysregulatedin hyperglycemic ED95 embryos	27908722
5074	Mouse	mmu-miR-770-5p	miRNA	H2O2	ischemia/reperfusion (I/R) injury	cardiomyocytes	H2O2 treatment	NHG16 accelerates the proliferative ability of cardiomyocytes following IRI by negatively regulating miRNA-770-5p.	32855691
5075	Mouse	mmu-miR-784	miRNA	indole-3-carbinol (I3C)	colitis	Mesenteric lymph nodes	Indole-3-carbinol (I3C) treatment	downregulated	32921956
5076	Mouse	mmu-miR-7a	miRNA	sevoflurane (SEV)	effects of sevoflurane during early development	mouse embryonic stem cells	Sevoflurane treatment	upregulated	27535693
5077	Mouse	mmu-miR-7a	miRNA	H1N1 influenza virus	endometriosis and endometrial carcinoma	mouse lung?tissues	H1N1 influenza virus infection	upregulated	24066118
5078	Mouse	mmu-miR-7a	miRNA	murine cytomegalovirus (MCMV)	murine cytomegalovirus (MCMV) infection	NIH 3T3 cells;TCMK-1 cells	Murine cytomegalovirus treatment	downregulated	22442111
5079	Mouse	mmu-miR-7a	miRNA	dexamethasone (DEX)	muscle atrophy	Murine C2C12 myoblast cells	dexamethasone (DEX) treatment	downregulated	23716137
5080	Mouse	mmu-miR-7a	miRNA	curcumin (Cur)	myocardial infarction (MI)	cardiac myocytes	curcumin treatment	upregulated	27261602
5081	Mouse	mmu-miR-7a	miRNA	hypoxia	myocardial infarction (MI)	cardiomyocytes	hypoxia treatment	upregulated	26998750
5082	Mouse	mmu-miR-7a-1	miRNA	"3,5-diethoxycarbonyl-1,4-dihydrocollidine (DDC)"	sclerosing cholangitis	ngn-3-heterozygous (+/-) mice	were subjected to DDC feeding (a model of sclerosing cholangitis) treatment	upregulated	24925797
5083	Mouse	mmu-miR-7a-2	miRNA	"3,5-diethoxycarbonyl-1,4-dihydrocollidine (DDC)"	sclerosing cholangitis	ngn-3-heterozygous (+/-) mice	were subjected to DDC feeding (a model of sclerosing cholangitis) treatment	upregulated	24925797
5084	Mouse	mmu-miR-7a-2-3p	miRNA	chronic unpredictable mild stress (CUMS)	major depressive disorder (MDD)	nucleus accumbens (NAc) tissues	chronic unpredictable mild stress (CUMS) induce	downregulated	30936699
5085	Mouse	mmu-miR-7a-5p	miRNA	lipopolysaccharide (LPS)	acute respiratory distress syndrome (ARDS)	serum	lipopolysaccharide (LPS) treatment	upregulated	32934950
5086	Mouse	mmu-miR-7a-5p	miRNA	lipopolysaccharide (LPS)	cardiomyocytes injury	Mouse cardiomyocytes MCM cells	lipopolysaccharide (LPS) treatment	The expression of miR-7a-5p was significantly reduced in myocardial cells in the LPS group.	33029099
5087	Mouse	mmu-miR-7a-5p	miRNA	butyrate	diabetic nephropathy (DN)	SV40-MES-13 cells	butyrate treatment	"miR-7a-5p was significantly decreased in the HG-induced SV40-MES-13 cells, while giving butyrate reversed this change."	32539181
5088	Mouse	mmu-miR-7a-5p	miRNA	lipopolysaccharide (LPS)	inflammation	RAW264.7 cells	lipopolysaccharide (LPS) treatment	downregulated	32955644
5089	Mouse	mmu-miR-7a-5p	miRNA	FTY720-C2	parkinson's disease (PD)	dopaminergic MN14D cells	FTY720-C2 treatment	upregulated	30359694
5090	Mouse	mmu-miR-7a-5p	miRNA	FTY720-C2	parkinson's disease (PD)	MN9D cells	FTY720-C2 treatment	upregulated	30359694
5091	Mouse	mmu-miR-7a-5p	miRNA	lipopolysaccharide + ATP	traumatic brain injury (TBI)	microglia	lipopolysaccharide + ATP treatment	downregulated	33189612
5092	Mouse	mmu-miR-7a-5p	miRNA	alpinia oxyphylla extract (AOE)	type 2 diabetes mellitus (T2DM)	db-/db- mouse kidney	A. oxyphylla extract (AOE) treatment	downregulated	28249617
5093	Mouse	mmu-miR-7b	miRNA	lipopolysaccharide (LPS)	acute respiratory distress syndrome (ARDS)	serum	lipopolysaccharide (LPS) treatment	upregulated	32934950
5094	Mouse	mmu-miR-7b	miRNA	angiotensin II (Ang II)	chronic heart failure (CHF)	NG108 cells	angiotensin II (Ang II) treatment	upregulated	26699387
5095	Mouse	mmu-miR-7b	miRNA	sevoflurane (SEV)	effects of sevoflurane during early development	mouse embryonic stem cells	Sevoflurane treatment	upregulated	27535693
5096	Mouse	mmu-miR-7b	miRNA	curcumin (Cur)	myocardial infarction (MI)	cardiac myocytes	curcumin treatment	upregulated	27261602
5097	Mouse	mmu-miR-7b	miRNA	macrophage colony-stimulating factor (M-CSF) and receptor activator of NF-¦ÊB ligand (RANKL)	osteoclast-related bone disorders	RAW264.7 cells	macrophage colony-stimulating factor (M-CSF) and receptor activator of NF-¦ÊB ligand (RANKL) treatment	downregulated	25123438
5098	Mouse	mmu-miR-7b-5p	miRNA	lipopolysaccharide (LPS)	inflammation	RAW264.7 cells	lipopolysaccharide (LPS) treatment	upregulated	32955644
5099	Mouse	mmu-miR-7c	miRNA	coronary artery ligation	myocardial ischaemic injury	heart	subjected to coronary artery ligation	downregulated	26655604
5100	Mouse	mmu-miR-7c-5p	miRNA	learning	persistent memory	C57BL/6J mouse hippocampal	Object-location memory task	upregulated	28927503
5101	Mouse	mmu-miR-7g	miRNA	coronary artery ligation	myocardial ischaemic injury	heart	subjected to coronary artery ligation	downregulated	26655604
5102	Mouse	mmu-miR-802	miRNA	lipopolysaccharide (LPS)	acute respiratory distress syndrome (ARDS)	lung tissues and RAW264.7 cells	lipopolysaccharide (LPS) treatment	downregulated	31696241
5103	Mouse	mmu-miR-802	miRNA	high fat diet (HFD)	insulin resistance (IR)	mice liver tissues	high fat diet (HFD) treatment	upregulated	23389544
5104	Mouse	mmu-miR-802	miRNA	high fat diet (HFD)	insulin resistance (IR)	liver tissues	high fat diet (HFD) feed	upregulated	31173239
5105	Mouse	mmu-miR-802	miRNA	particulate matter (PM2.5)	malignant pulmonary disorders	serum	PM2.5 treatment	downregulated	27144337
5106	Mouse	mmu-miR-802	miRNA	high fat diet (HFD)	obesity	renal tissues	high fat diet (HFD) feed	upregulated	30729676
5107	Mouse	mmu-miR-802	miRNA	obeticholic acid	obesity	mouse liver tissue	obeticholic acid treatment	"In obese mice, activation of FXR by obeticholic acid treatment reduced miR-802 levels and improved insulin resistance and hepatosteatosis"	33328206
5108	Mouse	mmu-miR-802	miRNA	obeticholic acid	obesity-related diseases	liver tissues	obeticholic acid treatment	Activation of FXR by obeticholic acid treatment reduced miR-802 levels.	33328206
5109	Mouse	mmu-miR-82-5p	miRNA	fatty acid amide hydrolase inhibitor (FAAH-II)	colitis	colitis mouse colon tissues	FAAH-II treatment	dysregulated	27327245
5110	Mouse	mmu-miR-872	miRNA	dexamethasone (DEX)	muscle atrophy	Murine C2C12 myoblast cells	dexamethasone (DEX) treatment	upregulated	23716137
5111	Mouse	mmu-miR-872	miRNA	cigarette smoke (CS)	ovarian toxicity	ovarian tissues	cigarette smoke (CS) treatment	upregulated	29377183
5112	Mouse	mmu-miR-873	miRNA	high glucose (HG)	diabetic nephropathy (DN)	Mouse podocytes (MPC5)	high glucose treatment	upregulated	30095204
5113	Mouse	mmu-miR-873	miRNA	IL-17	multiple sclerosis (MS)	mouse primary astrocytes	stimulat IL-17 treatment	upregulated	25183005
5114	Mouse	mmu-miR-873-5p	miRNA	colistin	colistin-induced kidney injury	Mouse renal tubular epithelial cells (mRTECs)	colistin treatment	downregulated	31156435
5115	Mouse	mmu-miR-873-5p	miRNA	medium deficient in methionine and choline (MDMC)	nonalcoholic fatty liver disease (NAFLD)	Mouse primary hepatocytes	medium deficient in methionine and choline (MDMC) treatment	upregulated	31668391
5116	Mouse	mmu-miR-873-5p	miRNA	oleic acid (OA)	nonalcoholic fatty liver disease (NAFLD)	Mouse primary hepatocytes	oleic acid (OA) treatment	upregulated	31668391
5117	Mouse	mmu-miR-873a-5p	miRNA	morphine	morphine tolerance	spinal cord	?morphine?treatment treatment	upregulated	31024249
5118	Mouse	mmu-miR-874	miRNA	high glucose (HG)	diabetic nephropathy (DN)	mouse podocyte	high glucose treatment	downregulated	30171701
5119	Mouse	mmu-miR-874	miRNA	ischemia	intestinal ischemic injury	C57BL/6 mice	abdomen was opened and the superior mesenteric artery (SMA) treatment	upregulated	24462679
5120	Mouse	mmu-miR-874	miRNA	lipopolysaccharide (LPS)	sepsis	mice cardiomyocytes UL-1 cells	lipopolysaccharide (LPS) treatment	upregulated	30021355
5121	Mouse	mmu-miR-874-3p	miRNA	ischemia/reperfusion (I/R) 	acute kidney injury (AKI)	kidney tissues	ischemia/reperfusion (I/R) treatment	dysregulated	29245971
5122	Mouse	mmu-miR-874-3p	miRNA	doxorubicin (DOX)	doxorubicin (DOX)-induced renal podocyte injury	mouse primary podocytes; kidney tissues	doxorubicin (DOX) treatment	upregulated	32908641
5123	Mouse	mmu-miR-874-3p	miRNA	lipopolysaccharide (LPS)	major depressive disorder (MDD)	prefrontal cortex (PFC)	lipopolysaccharide (LPS) treatment	LPS upregulated miR-874-3p concomitantly with increase in IDO1 expression in the prefrontal cortex (PFC).	33095942
5124	Mouse	mmu-miR-874-3p	miRNA	testosterone	polycystic ovarian syndrome (PCOS)	granulosa cell (GC)	?testosterone treatment	"Compared with vehicle-treated GCs, miR-874-3p expression levels were significantly increased in testosterone-treated GCs"	33732332
5125	Mouse	mmu-miR-875-5p	miRNA	carbon tetrachloride (CCl4)	liver fibrosis	Mouse liver tissues and primary hepatic stellate cells (HSCs)	carbon tetrachloride (CCl4) treatment	downregulated	31617598
5126	Mouse	mmu-miR-875-5p	miRNA	icariin (ICA)	liver fibrosis	primary hepatic stellate cells (HSCs)	icariin treatment	upregulated	31617598
5127	Mouse	mmu-miR-875-5p	miRNA	icariin (ICA)	liver fibrosis	mouse primary hepatic stellate cells (HSCs)	Icariin treatment	Icariin induced miR-875-5p upregulation.	31617598
5128	Mouse	mmu-miR-876	miRNA	high fat diet (HFD)	atherosclerosis (AS)	apoE (-/-) mice endothelial cells	high fat diet (HFD) feed	upregulated	28723693
5129	Mouse	mmu-miR-877*	miRNA	clamping the renal pedicle	bilateral renal ischemia	C57Bl/6 mice plasma and kidneys	clamping the renal pedicle treatment	upregulated	24695114
5130	Mouse	mmu-miR-877-3p	miRNA	H2O2	myocardial ischemia/reperfusion (I/R) injury (MIRI)	cardiomyocytes	H2O2 treatment	upregulated	31284127
5131	Mouse	mmu-miR-877-5p	miRNA	Trovafloxacin	liver damage	liver	Trovafloxacin treatment	upregulated	27713024
5132	Mouse	mmu-miR-877-5p	miRNA	IL-1¦Â	osteoarthritis (OA)	primary mouse chondrocytes	IL-1¦Â treatment	miR-877-5p expression levels significantly declined in IL- 1¦Â-stimulated chondrocytes in a concentration-dependent manner.	32584470
5133	Mouse	mmu-miR-879-5p	miRNA	chronic unpredictable mild stress (CUMS)	depression	NAc tissue	chronic unpredictable mild stress (CUMS) treatment	upregulated	31430030
5134	Mouse	mmu-miR-882	miRNA	melatonin	osteoporosis	Raw264.7 cells	Melatonin treatment	Melatonin downregulates miR-882 expression in RANKL-induced Raw264.7 cells.	33416111
5135	Mouse	mmu-miR-882	miRNA	propofol (PPF)	propofol-induced developmental neurotoxicity	hippocampus	propofol treatment	upregulated	30242182
5136	Mouse	mmu-miR-9	miRNA	baicalin (BAI)	aberrant scar	NIH-3T3 cells	baicalin (BAI) treatment	upregulated	31362535
5137	Mouse	mmu-miR-9	miRNA	differentiation medium (DM)	adipogenesis	3T3-L1 cells	"3T3-L1 cells were incubated in differentiation medium (DM) supplemented with 10% FBS, 0.5 mM 3-isobutyl-1-methylxanthine, 250 nM dexamethasone, and 160 nM insulin."	upregulated	31759991
5138	Mouse	mmu-miR-9	miRNA	epigallocatechin-3-gallate (EGCG)	Alzheimer's disease (AD)	AD mouse serum	EGCG treatment groups (2 mg/kg/day)	upregulated	28731435
5139	Mouse	mmu-miR-9	miRNA	osthole	Alzheimer's disease (AD)	NSCs isolated from the SVZ region of newborn (0¨C2 days) C57BL/6 mice	osthole treatment	upregulated	28659755
5140	Mouse	mmu-miR-9	miRNA	arsenite	arsenic induted deficits in differentiation	prenatal C57BL/6 mouse brain	arsenic (As) exposure	downregulated	27751817
5141	Mouse	mmu-miR-9	miRNA	sodium arsenite (NaAsO2)	arsenic inhibited cellular differentiation	pluripotent P19 mouse embryonal carcinoma cells	sodium arsenite treatment	downregulated	29121352
5142	Mouse	mmu-miR-9	miRNA	IFN-¦Ã and lipopolysaccharide (LPS)	asthma	lung tissues	"IFN-¦Ã,LPS treatment"	upregulated	25772595
5143	Mouse	mmu-miR-9	miRNA	isoflurane	central nervous system of the developing fetus	mouse embryonic stem cell (mES cell)	isoflurane treatment	upregulated	25892252
5144	Mouse	mmu-miR-9	miRNA	oxygen-glucose deprivation and reoxygenation (OGD/R)	cerebral ischemia/reperfusion (I/R) injury	mouse primary cortical neurons	oxygen-glucose deprivation and reoxygenation (OGD/R) treatment	downregulated	31837324
5145	Mouse	mmu-miR-9	miRNA	oxygen-glucose deprivation and reoxygenation (OGD/R)	cerebral ischemia/reperfusion (I/R) injury	primary cortical neurons	oxygen-glucose deprivation and reoxygenation (OGD/R) treatment	downregulated	31837324
5146	Mouse	mmu-miR-9	miRNA	"5-Aza-2'-deoxycytidine (5-Aza-dC, decitabine)"	gastric cancer (GC)	balb/c nu-nu mice injected with 107 GC cells	"5-Aza-2'-deoxycytidine (5-Aza-dC, decitabine) treatment"	upregulated	25270964
5147	Mouse	mmu-miR-9	miRNA	histone deacetylase inhibitor (HDACi)	hypercalciuric diseases	mouse	HDAC inhibitors treatment	upregulated	25071082
5148	Mouse	mmu-miR-9	miRNA	bleomycin (BLM)	idiopathic pulmonary fibrosis (IPF)	lung tissues	bleomycin (BLM) treatment	upregulated	30144053
5149	Mouse	mmu-miR-9	miRNA	lipopolysaccharide (LPS)	inflammation	Raw264.7 cells	lipopolysaccharide (LPS) treatment	upregulated	30552873
5150	Mouse	mmu-miR-9	miRNA	lipopolysaccharide (LPS)	inflammation	macrophages	lipopolysaccharide (LPS) treatment	upregulated	30552873
5151	Mouse	mmu-miR-9	miRNA	lipopolysaccharide (LPS)	inflammation	Kupffer cells or RAW 264.7 macrophages	lipopolysaccharide (LPS) treatment	upregulated	31099043
5152	Mouse	mmu-miR-9	miRNA	aluminum-sulfate	inflammatory neurodegeneration	C57BL/6J mice blood	serum exposure to a standard mouse diet that included aluminum-sulfate	upregulated	29354323
5153	Mouse	mmu-miR-9	miRNA	CCL2	macrophage polarization	CC chemokine 2(CCL2) pre-treated mouse bone marrow-derived macrophages (BMDMs)	CCL2 treatment	upregulated	28242024
5154	Mouse	mmu-miR-9	miRNA	chronic unpredictable stress (CUMS) and lipopolysaccharide (LPS)	major depressive disorder (MDD)	plasma; hippocampus	chronic unpredictable stress (CUS) and lipopolysaccharide (LPS) treatment	upregulated	30413800
5155	Mouse	mmu-miR-9	miRNA	retinoic acid (RA)	cell differentiation	Neuro-2A cells	retinoic acid? treatment	upregulated	31823894
5156	Mouse	mmu-miR-9	miRNA	green tea polyphenols (GTP)	osteoarthritis (OA)	LPS treated ATDC5 cells	green tea polyphenols (GTP) treatment	upregulated	31102286
5157	Mouse	mmu-miR-9	miRNA	lipopolysaccharide (LPS)	osteoarthritis (OA)	ATDC5 cells	lipopolysaccharide (LPS) treatment	upregulated	31102286
5158	Mouse	mmu-miR-9	miRNA	resveratrol	osteoarthritis (OA)	mouse chondrocytes	resveratrol (Res) treatment	The relative expression level of miR-9 significantly increased following treatment with Res in a dose-dependent manner	32104302
5159	Mouse	mmu-miR-9	miRNA	microwave	microwave-induced adverse health outcomes 	mouse hippocampus	7 days after 30 mW/cm microwave exposure treatment	downregulated	24748327
5160	Mouse	mmu-miR-9	miRNA	bone morphogenetic protein 2 (BMP2)	repair of spinal cord injury	pre-osteoblast cell line MC3T3-E1	bone morphogenetic protein 2 (BMP2) treatment	downregulated	26359086
5161	Mouse	mmu-miR-9	miRNA	lipopolysaccharide (LPS)	sepsis	RAW264.7 cells	lipopolysaccharide (LPS) treatment	upregulated	31174089
5162	Mouse	mmu-miR-9	miRNA	ethanol (EtOH)	teratogenesis	fetal brains of mice	Ethanol?treatment	upregulated	19091803
5163	Mouse	mmu-miR-9	miRNA	zika virus (ZIKV)	Zika virus (ZIKV) infection	embryonic mouse cortex	Zika virus (ZIKV) infection treatment	upregulated	30264295
5164	Mouse	mmu-miR-9	miRNA	live L. acidophilus	¦Â-lactoglobulin (¦Â-Lg) allergy	murine splenocytes	live L. acidophilus treatment	downregulated	30156972
5165	Mouse	mmu-miR-9*	miRNA	arsenite	arsenic induted deficits in differentiation	prenatal C57BL/6 mouse brain	arsenic (As) exposure	downregulated	27751817
5166	Mouse	mmu-miR-90-3p	miRNA	N-ethyl-N-nitrosourea (ENU)	hepatocellular carcinoma (HCC)	liver tissues	N-ethyl-N-nitrosourea (ENU) treatment	upragulated	21029445
5167	Mouse	mmu-miR-9-1	miRNA	"7,12-dimethylbenz(¦Á)anthracene (DMBA)"	"7,12-dimethylbenz(¦Á)anthracene (DMBA) toxicity"	liver tissues	"7,12-dimethylbenz(¦Á)anthracene (DMBA) treatment"	miR-9-1 was downregulated in the liver tissues od female mice.	32871758
5168	Mouse	mmu-miR-9-1	miRNA	"7,12-dimethylbenz(¦Á)anthracene (DMBA)"	"7,12-dimethylbenz(¦Á)anthracene (DMBA) toxicity"	liver tissues	"7,12-dimethylbenz(¦Á)anthracene (DMBA) treatment"	miR-9-1 was downregulated in the liver tissues of male mice.	32871758
5169	Mouse	mmu-miR-9-1	miRNA	"7,12-dimethylbenz(¦Á)anthracene (DMBA)"	"7,12-dimethylbenz(¦Á)anthracene (DMBA) toxicity"	kidneny tissues	"7,12-dimethylbenz(¦Á)anthracene (DMBA) treatment"	miR-9-1 was upregulated in the kidney tissues od female mice.	32871758
5170	Mouse	mmu-miR-9-1	miRNA	"7,12-dimethylbenz(¦Á)anthracene (DMBA)"	"7,12-dimethylbenz(¦Á)anthracene (DMBA) toxicity"	kidneny tissues	"7,12-dimethylbenz(¦Á)anthracene (DMBA) treatment"	miR-9-1 wasdownregulated in the kidney tissues of male mice.	32871758
5171	Mouse	mmu-miR-9-1	miRNA	VitB12	methylmalonic acidemia (MMA)	newborn BalB/C mice	VitB12 treatment	downregulated	24390963
5172	Mouse	mmu-miR-92	miRNA	hyperoxia	bronchopulmonary dysplasia (BPD)	lung tissues	hyperoxia treatment	downregulated	33143661
5173	Mouse	mmu-miR-92	miRNA	contextual fear conditioning	contextual fear conditioning	mouse hippocampus	training mice in contextual fear conditioning treatment	upregulated	24990518
5174	Mouse	mmu-miR-92	miRNA	ischemia/reperfusion (I/R) 	head and neck squamous cell carcinoma (HNSCC)	heart tissues	ischemia/reperfusion (I/R) treatment	the miR-17-92 cluster may protect the heart by diminishing the apoptosis and alleviating ischemia/reperfusion injury	23639284
5175	Mouse	mmu-miR-92	miRNA	¦¤9-tetrahydrocannabinol (THC)	inflammation	total lymph node cells and CD4(+) T cells	¦¤9-Tetrahydrocannabinol (THC) treatment	downregulated	27268054
5176	Mouse	mmu-miR-92	miRNA	imiquimod (IMQ)	psoriasis-like dermatitis	the mouse skin tissues	IMQ treatment	dysregulated	27579777
5177	Mouse	mmu-miR-92a	miRNA	lipopolysaccharide (LPS)	acute lung injury (ALI)	lung tissues; splenocytes; bronchoalveolar lavage fluid (BALF)	lipopolysaccharide (LPS) treatment	miR-92a was markedly upregulated in the lung tissues of ALI mice.	30138892
5178	Mouse	mmu-miR-92a	miRNA	sodium arsenite (NaAsO2)	arsenic inhibited cellular differentiation	pluripotent P19 mouse embryonal carcinoma cells	sodium arsenite treatment	upregulated	29121352
5179	Mouse	mmu-miR-92a	miRNA	high methionine diet	atherosclerosis (AS)	aorta	high-methionine diet treatment	downregulated	33045026
5180	Mouse	mmu-miR-92a	miRNA	ML-7 (an inhibitor of myosin light chain kinase)	atherosclerosis (AS)	atherosclerosis mice aortic vessels	ML-7 (an inhibitor of myosin light chain kinase) treatment	downregulated	30907506
5181	Mouse	mmu-miR-92a	miRNA	berberine (BBR)	beige adipogenesis	Mouse 3T3-L1 pre-adipocytes	berberine (BBR) treatment	downregulated	31234575
5182	Mouse	mmu-miR-92a	miRNA	high glucose (HG)	diabetes mellitus (DM)	Min-6 mouse pancreatic b cells	high glucose (HG) treatment	The expression of miRNA-92a was significantly increased.	29660330
5183	Mouse	mmu-miR-92a	miRNA	astragalus polysaccharide (APS)	inflammation	LPS-treated ATDC5 cells	astragalus polysaccharide (APS) treatment	downregulated	31302422
5184	Mouse	mmu-miR-92a	miRNA	lipopolysaccharide (LPS)	inflammation	ATDC5 cells	lipopolysaccharide (LPS) treatment	upregulated	31302422
5185	Mouse	mmu-miR-92a	miRNA	vesicular stomatitis virus (VSV)	innate immune response	mice peritoneal macrophages	vesicular stomatitis virus (VSV) infection	upregulated	30160073
5186	Mouse	mmu-miR-92a	miRNA	hypoxia	ischemic injury	bone marrow mesenchymal stem cells (BM-MSCs)	hypoxia treatment	upregulated	30613290
5187	Mouse	mmu-miR-92a	miRNA	hypoxia	myogenic-lineage differentiation	?hypoxia-primed embryoid bodies (Hyp-EBs)	hypoxia treatment	hypoxic priming enhances EB commitment to the myogenic lineage through miR-92a/Sp1/MyoD regulatory axis.	31606324
5188	Mouse	mmu-miR-92a	miRNA	hypoxia	myogenic-lineage differentiation	embryoid bodies	hypoxia induce	downregulated	31606324
5189	Mouse	mmu-miR-92a	miRNA	ethanol (EtOH)	oxidative stress	MH-S cells	ethanol treatment	downregulated	33278514
5190	Mouse	mmu-miR-92a-2-5p	miRNA	schistosoma japonicum	liver fibrosis	mouse liver tissues	Schistosoma japonicum infection treatment	downregulated	30708193
5191	Mouse	mmu-miR-92a-3p	miRNA	hypoxia	cell differentiation	mouse (GL261 and G422) glioma cell lines	hypoxia induce	upregulated	30536597
5192	Mouse	mmu-miR-92a-3p	miRNA	reconstituted high-density lipoproteins (rHDL)	diabetes-impaired angiogenesis	diabetic mice HDL fraction	reconstituted high-density lipoproteins (rHDL) treatment	upregulated	30206364
5193	Mouse	mmu-miR-92a-3p	miRNA	reconstituted high-density lipoproteins (rHDL)	diabetes-impaired angiogenesis	diabetic mice plasma	reconstituted high-density lipoproteins (rHDL) treatment	downregulated	30206364
5194	Mouse	mmu-miR-92a-3p	miRNA	schistosoma japonicum	liver fibrosis	serum exosomes	S. japonicum infection treatment	miR-92a-3p was decresed on 6 weeks after S japonicum infection	32443549
5195	Mouse	mmu-miR-92b	miRNA	histone deacetylase inhibitors (HDIs) short-chain fatty acid (SCFA) butyrate	antibody-mediated systemic autoimmunity	B cells	SCFA HDI butyrate treatment	upregulated	32265934
5196	Mouse	mmu-miR-92b	miRNA	smoking	smoking-related interstitial fibrosis (SRIF)	peripheral blood of mice	smoking treatment	upregulated	22782705
5197	Mouse	mmu-miR-92b	miRNA	smoking	smoking-related interstitial fibrosis (SRIF)	C57 mice circulating	6 months of chronic mainstream smoking exposure treatment	upregulated	22782705
5198	Mouse	mmu-miR-92b-3p	miRNA	angiotensin II (Ang II)	cardiac hypertrophy	mouse	angiotensin II (Ang II) treatment	upregulated	29190899
5199	Mouse	mmu-miR-92b-3p	miRNA	angiotensin II (Ang II)	cardiac hypertrophy	Neonatal mouse ventricular cells (NMVCs)	angiotensin II (Ang II) treatment	upregulated	31283925
5200	Mouse	mmu-miR-92b-3p	miRNA	advanced glycation end product (AGE)	diabetic nephropathy (DN)	kidney tissues	advanced glycation end products (AGEs) treatment	MiR-92b-3p is Induced by Advanced Glycation End Products and Involved in the Pathogenesis of Diabetic Nephropathy.	32215042
5201	Mouse	mmu-miR-92b-3p	miRNA	carbon tetrachloride (CCl4)	liver fibrosis	hepatic stellate cells (HSCs)	carbon tetrachloride (CCl4) treatment	"For instance, the expression of circPSD3, a circRNA derived from the Pleckstrin and Sec7 domain-containing 3 (PSD3) gene, was considerably downregulated in primary hepatic stellate cells (HSCs) and liver tissues of mice with CCl4-induced HF compared to those in the vehicle group."	33614234
5202	Mouse	mmu-miR-92b-3p	miRNA	dipogenic differentiation mixture (MDI)	liver fibrosis	LX-2 cells	dipogenic differentiation mixture (MDI) treatment	"We found that miR-92b-3p was highly expressed both in fibrotic liver tissues from patients and model mice and in activated LX-2 cells stimulated with TGF-¦Â1. However, the expression of miR-92b-3p was downregulated in inactivated LX-2 cells treated with adipogenic differentiation mixture (MDI)."	33618248
5203	Mouse	mmu-miR-92b-3p	miRNA	TGF-¦Â1	liver fibrosis	LX-2 cells	TGF-¦Â1 treatment	"We found that miR-92b-3p was highly expressed both in fibrotic liver tissues from patients and model mice and in activated LX-2 cells stimulated with TGF-¦Â1 However, the expression of miR-92b-3p was downregulated in inactivated LX-2 cells treated with adipogenic differentiation mixture (MDI)"	33618248
5204	Mouse	mmu-miR-93	miRNA	red mud	biological effects of red mud	"CBA/Ca mice liver, spleen, lung, kidney and lymph nodes"	"1, 3, 6 and 24 h after a single intraperitoneal injection of red mud treatment"	"upregulated , but the level and the peak of the alteration differed according to examined tissue"	24425836
5205	Mouse	mmu-miR-93	miRNA	lipopolysaccharide (LPS)	acute lung injury (ALI)	lung tissues; bronchoalveolar lavage fluid (BALF)	lipopolysaccharide (LPS) treatment	downregulated	32468034
5206	Mouse	mmu-miR-93	miRNA	high fat diet (HFD)	brown adipocyte differentiation	brown adipose tissues	high fat diet (HFD) feed	upregulated	23954633
5207	Mouse	mmu-miR-93	miRNA	isoprenaline	cardiac hypertrophy	primary cardiomyocytes	isoprenaline (ISO) tteatment	CHRF expression was upregulated and miR-93 expression was downregulated in mice and cellular models of cardiac hypertrophy.	29747050
5208	Mouse	mmu-miR-93	miRNA	cigarette smoke (CS)	emphysema	lung tissues	Cigarette smoke (CS) exposure	upregulated	33660100
5209	Mouse	mmu-miR-93	miRNA	high fat diet (HFD)	hepatocellular carcinoma (HCC)	plasma and hepatic tissues	high fat diet (HFD) feed	downregulated	26728044
5210	Mouse	mmu-miR-93	miRNA	influenza A virus (IAV)	influenza A virus (IAV) infection	MLE- 12 cells	influenza A virus (IAV) infection	influenza A virus (IAV) infection significantly inhibited miR-93 expression in alveolar epithelial type II cells through RIG-I/JNK pathway.	32652502
5211	Mouse	mmu-miR-93	miRNA	"3,3'-diindolylmethane (DIM)"	multiple sclerosis (MS)	activated T cells during the development of experimental autoimmune encephalomyelitis (EAE)	"3,3'-Diindolylmethane (DIM) treatment"	upregulated	24898268
5212	Mouse	mmu-miR-93	miRNA	lipopolysaccharide (LPS)	osteoarthritis (OA)	primary chondrocytes	lipopolysaccharide (LPS) treatment	downregulated	30569118
5213	Mouse	mmu-miR-93	miRNA	lipopolysaccharide (LPS)	osteoarthritis (OA)	primary chondrocytes	lipopolysaccharide (LPS) treatment	miR-93 levels wsa downregulated in a dose-dependent manner by lipopolysaccharide (LPS) treatment.	30569118
5214	Mouse	mmu-miR-93	miRNA	¦Â-elemene	oxygen-induced retinopathy (OIR)	Retinas tissues	¦Â-elemene treatment	upregulated	30664207
5215	Mouse	mmu-miR-93	miRNA	lipopolysaccharide (LPS)	parkinson's disease (PD)	BV2 cells	lipopolysaccharide (LPS) treatment	?It was found that the expression of miR-93 was downregulated in LPS-exposed BV2 cells.	33900518
5216	Mouse	mmu-miR-93	miRNA	curcumin (Cur)	peripheral arterial disease (PAD)	muscle tissues	curcumin treatment	upregulated	30651865
5217	Mouse	mmu-miR-93	miRNA	curcumin (Cur)	peripheral arterial disease (PAD)	ischemic muscle tissues	curcumin treatment	upregulated	30651865
5218	Mouse	mmu-miR-9-3	miRNA	"7,12-dimethylbenz(¦Á)anthracene (DMBA)"	"7,12-dimethylbenz(¦Á)anthracene (DMBA) toxicity"	liver tissues	"7,12-dimethylbenz(¦Á)anthracene (DMBA) treatment"	miR-9-3 was upregulated in the liver tissues of female mice.	32871758
5219	Mouse	mmu-miR-9-3	miRNA	"7,12-dimethylbenz(¦Á)anthracene (DMBA)"	"7,12-dimethylbenz(¦Á)anthracene (DMBA) toxicity"	liver tissues	"7,12-dimethylbenz(¦Á)anthracene (DMBA) treatment"	miR-9-3 was downregulated in the liver tissues of male mice.	32871758
5220	Mouse	mmu-miR-9-3	miRNA	"7,12-dimethylbenz(¦Á)anthracene (DMBA)"	"7,12-dimethylbenz(¦Á)anthracene (DMBA) toxicity"	spleen tissues	"7,12-dimethylbenz(¦Á)anthracene (DMBA) treatment"	miR-9-3 was upregulated in the spleen tissues of female mice.	32871758
5221	Mouse	mmu-miR-9-3	miRNA	"7,12-dimethylbenz(¦Á)anthracene (DMBA)"	"7,12-dimethylbenz(¦Á)anthracene (DMBA) toxicity"	kidneny tissues	"7,12-dimethylbenz(¦Á)anthracene (DMBA) treatment"	miR-9-3 was upregulated in the lkidney tissues of female mice.	32871758
5222	Mouse	mmu-miR-93-5p	miRNA	high glucose (HG)	diabetic nephropathy (DN)	Mouse primary kidney GEC (C57-6014G) and mouse glomerular mesangial cells (GMC) (SV40 MES 13)-derived exosomes	high glucose (HG) treatment	upregulated	31497190
5223	Mouse	mmu-miR-93-5p	miRNA	streptozocin (STZ)	diabetic nephropathy (DN)	mouse renal tissues	streptozotocin (STZ) treatment	silenced XIST inducing miR-93-5p-dependent CDKN1A inhibition was beneficial for preventing renal interstitial fibrosis in DN	31545928
5224	Mouse	mmu-miR-93-5p	miRNA	doxorubicin (DOX)	doxorubicin (DOX)-induced cardiotoxicity	plasma	doxorubicin (DOX) treatment	downregulated	30453253
5225	Mouse	mmu-miR-93-5p	miRNA	ultraviolet (UV) irradiation	skin damage	primary murine skin fibroblasts	UVB treatment	he Meg3 functioned as a competing endogenous RNA (ceRNA) that acted as a sponge for miR-93-5p and thereby modulated the expression of Epiregulin (Ereg)	31761787
5226	Mouse	mmu-miR-9-3p	miRNA	dexamethasone (DEX)	innate immune response	immature DCs (iDCs)	dexamethasone (DEX) treatment	downregulated	30174602
5227	Mouse	mmu-miR-9-3p	miRNA	IL-10	innate immune response	immature DCs (iDCs)	IL-10 treatment	downregulated	30174602
5228	Mouse	mmu-miR-9-3p	miRNA	X rays	ionizing radiation (IR) injury	male Kunming mice blood	0.5-2 Gy total-body carbon-ion irradiation treatment	dysregulatedin blood	28632432
5229	Mouse	mmu-miR-9-3p	miRNA	bone morphogenetic proteins (BMPs)	osteogenesis	pluripotent stem (iPS) cells	bone morphogenetic proteins (BMPs) treatment	downregulated	22937097
5230	Mouse	mmu-miR-9-3p	miRNA	learning	persistent memory	C57BL/6J mouse hippocampal	Object-location memory task	upregulated	28927503
5231	Mouse	mmu-miR-943-3p	miRNA	ovalbumin (OVA)	allergic asthma (AA)	lung tissues	ovalbumin (OVA) induce	upregulated	31101982
5232	Mouse	mmu-miR-9-5p	miRNA	amyloid-¦Â (A¦Â) 25-35	Alzheimer's disease (AD)	HT22 cells	amyloid-¦Â (A¦Â) 25-35 treatment	MiR-9-5p was downregulated in A¦Â25-35-induced HT22 cells.	32713252
5233	Mouse	mmu-miR-9-5p	miRNA	oxygen glucose deprivation (OGD)	angiogenesis	Brain microvascular endothelial cells (BMECs)	an oxygen glucose deprivation (OGD) treatment	miRNA-9-5p was significantly increased in the traumatic foci after TBI	32502567
5234	Mouse	mmu-miR-9-5p	miRNA	anandamide and norgestimate	depression	chronic mild stress (CMS) model of depression mouse	anandamide and norgestimate treatment	upregulated	28716528
5235	Mouse	mmu-miR-9-5p	miRNA	dexamethasone (DEX)	innate immune response	immature DCs (iDCs)	dexamethasone (DEX) treatment	downregulated	30174602
5236	Mouse	mmu-miR-9-5p	miRNA	IL-10	innate immune response	immature DCs (iDCs)	IL-10 treatment	downregulated	30174602
5237	Mouse	mmu-miR-9-5p	miRNA	IL-1¦Â	osteoarthritis (OA)	"CHON-001, ATDC5 cells"	IL-1¦Â treatment	"MEG3 expression in chondrocytes was downregulated by the stimulation of IL-1¦Â, and MEG3 negatively regulated miR-9-5p expression but positively regulated KLF4 expression."	33776787
5238	Mouse	mmu-miR-9-5p	miRNA	FTY720-C2	parkinson's disease (PD)	dopaminergic MN15D cells	FTY720-C2 treatment	upregulated	30359694
5239	Mouse	mmu-miR-9-5p	miRNA	FTY720-C2	parkinson's disease (PD)	MN9D cells	FTY720-C2 treatment	upregulated	30359694
5240	Mouse	mmu-miR-96	miRNA	emulsion (proteoglycan)	ankylosing spondylitis (AS)	cartilage tissues	emulsion (proteoglycan) treatment	upregulated	31111563
5241	Mouse	mmu-miR-96	miRNA	angiotensin II (Ang II)	atrial fibrosis	atrial tissues	angiotensin II (Ang II) treatment	upregulated	32034721
5242	Mouse	mmu-miR-96	miRNA	alcohol	brain injury and neurodegeneration	cerebral cortex	chronic alcohol administration	downregulated	30374194
5243	Mouse	mmu-miR-96	miRNA	resveratrol	colorectal cancer (CRC)	mouse colorectal carcinoma (CRC) tissues	resveratrol (RS) treatment	upregulated	25280562
5244	Mouse	mmu-miR-96	miRNA	microcystin-leucine arginine (MC-LR)	cytotoxicity	GC-1 cells	Microcystin (MC)-LR treatment	miR-96 was downregulated most dramatically	24803159
5245	Mouse	mmu-miR-96	miRNA	grape seed proanthocyandin extract (GSPE)	dyslipidemia	high-fat diet (HFD)-fed mice liver tissues	grape seed proanthocyanidins extracts (GSPE) treatment	downregulated	30848548
5246	Mouse	mmu-miR-96	miRNA	high fat diet (HFD)	dyslipidemia	liver tissues	high fat diet (HFD) feed	upregulated	30848548
5247	Mouse	mmu-miR-96	miRNA	TGF-¦Â1	liver fibrosis	hepaticstellatecells(HSCs)	TGF-¦Â1 treatment	Exogenous expression of TGF-¦Â1 in mouse primary HSCs significantly increased expression of miR-96 in a concentration- and time-dependent manner	30406154
5248	Mouse	mmu-miR-96	miRNA	lipopolysaccharide (LPS)	inflammation	BV2 cells	lipopolysaccharide (LPS) treatment	downregulated	31150368
5249	Mouse	mmu-miR-96	miRNA	triptolide (TPL)	inflammation	LPS-treated BV2 cells	triptolide treatment	upregulated	31150368
5250	Mouse	mmu-miR-96	miRNA	lipopolysaccharide (LPS)	innate immune response	RAW264.7 cells	lipopolysaccharide (LPS) treatment	upregulated	30625496
5251	Mouse	mmu-miR-96	miRNA	pseudomonas aeruginosa (PA)	innate immune response	RAW264.7 cells	Pseudomonas aeruginosa (PA) infection treatment	upregulated	30625496
5252	Mouse	mmu-miR-96	miRNA	narrow band noise	noise-induced deafness	outer hair cells	2-4 kHz narrow band noise at 100 dB SPL 6h per day for 3 consecutive days treatment	downregulated	25026825
5253	Mouse	mmu-miR-96	miRNA	perfluorooctanoic acid	perfluorooctanoic acid toxicity	mouse liver tissues	Perfluorooctanoic acid (PFOA) exposure treatment	upregulated	25092180
5254	Mouse	mmu-miR-96	miRNA	schistosoma	schistosomiasis hepatic fibrosis	hepaticstellatecells(HSCs)	Schistosoma infection treatment	"Schistosoma induces the expression of transforming growth factor ¦Â1 (TGF-¦Â1), which in turn upregulates the expression of miR-96 through SMAD2/3-DROSHA-mediated post-transcriptional regulation"	30406154
5255	Mouse	mmu-miR-96	miRNA	high fat diet (HFD)	type 2 diabetes mellitus (T2DM)	pancreatic ¦Â cells	high fat diet (HFD) feed	upregulated	31506178
5256	Mouse	mmu-miR-96	miRNA	high glucose (HG)	type 2 diabetes mellitus (T2DM)	MIN6 cells	high glucose treatment	upregulated	31506178
5257	Mouse	mmu-miR-96	miRNA	tumor necrosis factor alpha (TNF-¦Á) 	type 2 diabetes mellitus (T2DM)	MIN6 cells	tumor necrosis factor alpha (TNF-¦Á) treatment	upregulated	31506178
5258	Mouse	mmu-miR-96-5p	miRNA	lipopolysaccharide (LPS)	inflammation	RAW264.7 cells	lipopolysaccharide (LPS) treatment	downregulated	32955644
5259	Mouse	mmu-miR-96-5p	miRNA	FTY720-mitoxy	multiple system atrophy (MSA)	brain tissues	FTY720-Mitoxy treatment	downregulated	31751571
5260	Mouse	mmu-miR-96-5p	miRNA	palmitic acid (PA)	myogenesis and muscle homeostasis	C2C12 cells	Long-chain SFA palmitic acid (PA) treatment	upregulated	33322515
5261	Mouse	mmu-miR-96-5p	miRNA	lipopolysaccharide (LPS)	neonatal sepsis (NS)	RAW264.7 cells	lipopolysaccharide (LPS) treatment	The expression of miR-96-5p was decreased in LPS-induced inflammatory responses.	32618342
5262	Mouse	mmu-miR-96-5p	miRNA	high fat diet (HFD) and streptozotocin (STZ)	renal fibrosis	kidney tissues	high fat diet (HFD) and streptozotocin (STZ) treatment	miR-96-5p was downregulated in the renal tissues of DM mice.	31810140
5263	Mouse	mmu-miR-96-5p	miRNA	cyclophosphamide (CP)	systemic lupus erythematosus (SLE)	C3.MRL-Faslpr/J mice	C3.MRL-Faslpr/J mice treatment	downregulated	27924862
5264	Mouse	mmu-miR-98	miRNA	ischemia	acute myocardial infarction (AMI)	neonatal rat ventricular myocytes (NRVCs)	LAD artery	downregulated	28784995
5265	Mouse	mmu-miR-98	miRNA	ischemia/reperfusion (I/R) 	acute myocardial infarction (AMI)	heart tissues	ischemia/reperfusion (I/R) treatment	upregulated	28090786
5266	Mouse	mmu-miR-98	miRNA	scopolamine	Alzheimer's disease (AD)	brain tissues and hippocampal neurons	scopolamine treatment	downregulated	30365070
5267	Mouse	mmu-miR-98	miRNA	scopolamine	Alzheimer's disease (AD)	brain tissues and hippocampal neurons	scopolamine treatment	downregulated	30365070
5268	Mouse	mmu-miR-98	miRNA	nicotine	asthma	lung fibroblast (LF)	nicotine treatment	downregulated	33082140
5269	Mouse	mmu-miR-98	miRNA	rosiglitazone	asthma	lung fibroblast (LF)	rosiglitazone treatment	upregulated	33082140
5270	Mouse	mmu-miR-98	miRNA	lipopolysaccharide (LPS)	hepatocellular carcinoma (HCC)	RAW 264.7 cell line	LPS treatment	miR-98 expression in macrophages significantly decreased following LPS stimulation	21609717
5271	Mouse	mmu-miR-98	miRNA	cardiac ¦Á-myosin heavy chain peptides (MyHC-¦Á)	myocarditis	BALB/c mice B cells isolated from the mouse hearts	MyHC-¦Á treatment	upregulated in B cells isolated from the mouse hearts	27913008
5272	Mouse	mmu-miR-98	miRNA	IL-1¦Â	osteoarthritis (OA)	C57BL/6 mice OA chondrocytes	IL-1¦Â treatment	upregulated	28765925
5273	Mouse	mmu-miR-98	miRNA	plasmodium chabaudi malaria	peak parasitemia	liver of mice	Plasmodium chabaudi malaria infection treatment	downregulated	21085987
5274	Mouse	mmu-miR-98	miRNA	propofol (PPF)	propofol-induced developmental neurotoxicity	hippocampus	propofol treatment	downregulated	30242182
5275	Mouse	mmu-miR-98	miRNA	vitamin D	prostate cancer	LNCaP cells	vitamin D treatment	"the finding that growth inhibitive miR-98 is induced by 1,25-VD provides a potential therapeutic target for prostate cancer and a potential biomarker for 1,25-VD anti-tumor action"	23188821
5276	Mouse	mmu-miR-98	miRNA	sevoflurane (SEV)	cognitive impairment	adult mice	1 or 2 minimal alveolar concentrations sevoflurane for 4 or 8 h treatment	upregulated	28260068
5277	Mouse	mmu-miR-98	miRNA	hypoxia	pulmonary hypertension (PH)	lung tissues	hypoxia treatment	downregulated	26098770
5278	Mouse	mmu-miR-98-5p	miRNA	3¦Â-hydroxycholest-5-en-7-one	anti-inflammatory responses	RAW 264.7 cells	3¦Â-hydroxycholest-5-en-7-one treatment	downregulated	32771556
5279	Mouse	mmu-miR-98-5p	miRNA	oxygen-glucose deprivation and reoxygenation (OGD/R)	cerebral ischemia/reperfusion (I/R) injury	HT22 cells	oxygen-glucose deprivation and reoxygenation (OGD/R) treatment	miR-98-5p expression is decreased in response to OGD/R treatment in neurons	30449595
5280	Mouse	mmu-miR-98-5p	miRNA	dextran sodium sulfate (DSS)	inflammatory bowel disease (IBD)	colonic tissues	dextran sulphate sodium (DSS) treatment	miR-98-5p expression in the colonic tissues of mice was upregulated.	32242402
5281	Mouse	mmu-miR-98-5p	miRNA	estradiol-17¦Â (E2)	systemic lupus erythematosus (SLE)	murine B cells	estradiol-17¦Â (E2) treatment	downegulated	25912736
5282	Mouse	mmu-miR-99	miRNA	streptozocin (STZ)	congenital heart disease (CHD)	C57BL/6 mice blood	injection of streptozotocin before mating treatment	dysregulated	27998767
5283	Mouse	mmu-miR-99a	miRNA	angiotensin II (Ang II)	allergic airway inflammation	murine bone marrow-derived macrophages (BMDMs)	angiotensin II (Ang II) treatment	downregulated	32458348
5284	Mouse	mmu-miR-99a	miRNA	TGF-¦Â	hepatic genotoxicity	normal murine mammary gland cells	TGF-¦Â treatment	mir-99a and mir-99b may function as modulators within a complex network of factors regulating TGF-¦Â induced breast epithelial to mesenchymal transition	22299047
5285	Mouse	mmu-miR-99a	miRNA	rapamycin	HIV-associated nephropathy(HIVAN)	mice renal tissues	Rapamycin treatment	downregulated	23611955
5286	Mouse	mmu-miR-99a	miRNA	nuclear factor kappa-B (NF-¦ÊB) inhibitor Bay11-708211	supraesophageal bile reflux	hypopharyngeal mucosa	NF-¦ÊB inhibitor (BAY 11-7082) treatment	"Pre- but not post-application of NF-¦ÊB inhibitor, significantly blocks overexpression of Il6 and prostaglandin H synthases 2 (Ptgs2), and reverses miR-21, miR-155, miR-99a phenotypes."	32934775
5287	Mouse	mmu-miR-99a-5p	miRNA	high fat diet (HFD)	atherosclerosis (AS)	Apolipoprotein E knockout mice heart tissues	high fat diet (HFD) feed	downregulated	31325426
5288	Mouse	mmu-miR-99b	miRNA	lipopolysaccharide (LPS)	acute lung injury (ALI)	lung tissues	lipopolysaccharide (LPS) treatment	upregulated	32360624
5289	Mouse	mmu-miR-99b	miRNA	high fat diet (HFD)	hepatocellular carcinoma (HCC)	plasma and hepatic tissues	high fat diet (HFD) feed	upregulated	26728044
5290	Mouse	mmu-miR-99b	miRNA	mycobacterium tuberculosis (Mtb)	immune responses	dendritic cells (DCs) and macrophages	Mycobacterium tuberculosis infection	upregulated	23233675
5291	Mouse	mmu-miR-99b	miRNA	streptozocin (STZ)	nonalcoholic steatohepatitis-hepatocellular carcinoma (NASH-HCC)	high fat dietmouse liver	STZ treatment	upregulated in liver	28345673
5292	Mouse	mmu-miR-99b	miRNA	lipopolysaccharide (LPS)	sepsis	RAW264.7 cells	lipopolysaccharide (LPS) treatment	upregulated	27538453
5293	Mouse	mmu-miR-99b	miRNA	TGF-¦Â	hepatic genotoxicity	normal murine mammary gland cells	TGF-¦Â treatment	mir-99a and mir-99b may function as modulators within a complex network of factors regulating TGF-¦Â induced breast epithelial to mesenchymal transition	22299047
5294	Mouse	mmu-miR-99b-3p	miRNA	angiotensin II (Ang II)	cardiac fibrosis	heart tissue	angiotensin II (Ang II) treatment	We showed that Ang II infusion induced cardiac disfunction and fibrosis accompanied by markedly increased expression level of miR-99b-3p in heart tissues.	32814818
5295	Mouse	mmu-miR-99b-3p	miRNA	angiotensin II (Ang II)	cardiac fibrosis	heart sissues	angiotensin II (Ang II) treatment	upregulated	32814818
5296	Mouse	mmu-miR-99b-5p	miRNA	amyloid-¦Â (A¦Â)	Alzheimer's disease (AD)	Cortexes of the brains	amyloid-¦Â (A¦Â) treatment	downregulated	26635599
5297	Mouse	mmu-miR-9a-5p	miRNA	lipopolysaccharide (LPS)	acute respiratory distress syndrome (ARDS)	serum	lipopolysaccharide (LPS) treatment	upregulated	32934950
5298	Mouse	mmu-miR-9a-5p	miRNA	static water pressure	liver fibrosis	hepatic stellate cells (HSCs)	static water pressure treatment	upregulated	26379395
5299	Mouse	mmu-miR-9a-5p	miRNA	liraglutide	type 2 diabetes mellitus (T2DM)	whole bone marrow exosomes	liraglutide 0.2 mg/kg for 2 months	dysregulated	29133778
5300	Mouse	mmu-miR-BART13	miRNA	epstein-barr virus (EBV)	nasopharyngeal carcinoma (NPC)	Mutu I and Mutu III cell lines	infection with EBV treatment	upregulated	25213622
5301	Mouse	mmu-miR-BART3	miRNA	epstein-barr virus (EBV)	nasopharyngeal carcinoma (NPC)	Mutu I and Mutu III cell lines	infection with EBV treatment	upregulated	25213622
5302	Mouse	mmu-miR-BART7	miRNA	epstein-barr virus (EBV)	nasopharyngeal carcinoma (NPC)	Mutu I and Mutu III cell lines	infection with EBV treatment	upregulated	25213622
5303	Mouse	mmu-miR-PC-5P-12969	miRNA	oxygen-glucose deprivation and reoxygenation (OGD/R)	ischemic stroke (IS)	mouse primary hippocampal neuronal cells (HT22)	oxygen-glucose deprivation and reoxygenation (OGD/R) treatment	upregulated	30953313
